{"Peptide_Sequence": "AA", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "51.4 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "3", " Ligand_ID": "AA_minimized.pdb_3", " Smiles": "C[C@H](N)C(=O)N[C@@H](C)C(O)=O", " MW": "160.17", " logP": "-3.25", " logD": "-3.86", " logSw": "1.41", " tPSA": "96.87", " RotatableB": "3", " RigidB": "3", " Flexibility": "0.5", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "11", " CarbonAtoms": "6", " HeteroAtoms": "5", " ratio_H_by_C": "0.83", " Lipinski_Violation": "0", " Solubility_mg_per_l": "657655.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 160.171", "link_html_complex": "/ACE_complex_html/ACE_AA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AA.png", "phi_psi": "/peptide_da/AA.pdb", "link_html_peptide": "/Peptide_html/AA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AA.pdb", "link_png_peptide": "/Peptide_pics/AA.png"}
{"Peptide_Sequence": "AAATP", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": "100 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "2", " Ligand_ID": "AAATP_minimized.pdb_2", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "429.47", " logP": "-6.01", " logD": "-7.22", " logSw": "1.88", " tPSA": "195.61", " RotatableB": "9", " RigidB": "14", " Flexibility": "0.39", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2807768.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.468", "link_html_complex": "/ACE_complex_html/ACE_AAATP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AAATP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AAATP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AAATP.png", "phi_psi": "/peptide_da/AAATP.pdb", "link_html_peptide": "/Peptide_html/AAATP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AAATP.pdb", "link_png_peptide": "/Peptide_pics/AAATP.png"}
{"Peptide_Sequence": "AAATPL", " Origin": "Dry-cured ham", " Peptide_Preparation": "Artifically synthesized", " Isolation_Method": "solid phase extraction", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Escudero, E., Mora, L., & Toldr\u00e1, F. (2014). Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chemistry, 161, 305\u2013311. doi:10.1016/j.foodchem.2014.03.117", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1", " Ligand_ID": "AAATPL_minimized.pdb_1", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O", " MW": "542.63", " logP": "-4.77", " logD": "-6.51", " logSw": "0.66", " tPSA": "224.71", " RotatableB": "13", " RigidB": "16", " Flexibility": "0.45", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1048630.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 542.626", "link_html_complex": "/ACE_complex_html/ACE_AAATPL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AAATPL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AAATPL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AAATPL.png", "phi_psi": "/peptide_da/AAATPL.pdb", "link_html_peptide": "/Peptide_html/AAATPL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AAATPL.pdb", "link_png_peptide": "/Peptide_pics/AAATPL.png"}
{"Peptide_Sequence": "AAP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "30 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "5", " Ligand_ID": "AAP_minimized.pdb_5", " Smiles": "C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "257.29", " logP": "-4.22", " logD": "-5.17", " logSw": "1.49", " tPSA": "117.18", " RotatableB": "4", " RigidB": "10", " Flexibility": "0.29", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1138668.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 257.286", "link_html_complex": "/ACE_complex_html/ACE_AAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AAP.png", "phi_psi": "/peptide_da/AAP.pdb", "link_html_peptide": "/Peptide_html/AAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AAP.pdb", "link_png_peptide": "/Peptide_pics/AAP.png"}
{"Peptide_Sequence": "AAPLAP", " Origin": "Dry-cured ham", " Peptide_Preparation": "Artifically synthesized", " Isolation_Method": "solid phase extraction", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "14.38 \u03bcM", " Reference": "Escudero, E., Mora, L., & Toldr\u00e1, F. (2014). Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chemistry, 161, 305\u2013311. doi:10.1016/j.foodchem.2014.03.117", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "4", " Ligand_ID": "AAPLAP_minimized.pdb_4", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "538.64", " logP": "-4.02", " logD": "-5.62", " logSw": "0.08", " tPSA": "195.69", " RotatableB": "11", " RigidB": "21", " Flexibility": "0.34", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "582944.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 538.637", "link_html_complex": "/ACE_complex_html/ACE_AAPLAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AAPLAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AAPLAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AAPLAP.png", "phi_psi": "/peptide_da/AAPLAP.pdb", "link_html_peptide": "/Peptide_html/AAPLAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AAPLAP.pdb", "link_png_peptide": "/Peptide_pics/AAPLAP.png"}
{"Peptide_Sequence": "ACHP", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "360.7 \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "6", " Ligand_ID": "ACHP_minimized.pdb_6", " Smiles": "C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "426.49", " logP": "-4.37", " logD": "-6.17", " logSw": "0.8", " tPSA": "213.76", " RotatableB": "9", " RigidB": "17", " Flexibility": "0.35", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "17", " HeteroAtoms": "12", " ratio_H_by_C": "0.71", " Lipinski_Violation": "2", " Solubility_mg_per_l": "944991.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 426.49", "link_html_complex": "/ACE_complex_html/ACE_ACHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ACHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ACHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ACHP.png", "phi_psi": "/peptide_da/ACHP.pdb", "link_html_peptide": "/Peptide_html/ACHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ACHP.pdb", "link_png_peptide": "/Peptide_pics/ACHP.png"}
{"Peptide_Sequence": "ADHP", " Origin": "synthetic", " Peptide_Preparation": "simulated gastrointestinal digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">500 \u03bcg/mL", " Reference": "Miguel, M., et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin.\" Journal of Agricultural and Food Chemistry 54.3 (2006): 726-731.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "8", " Ligand_ID": "ADHP_minimized.pdb_8", " Smiles": "C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "438.44", " logP": "-5.17", " logD": "-9.48", " logSw": "1.29", " tPSA": "215.09", " RotatableB": "10", " RigidB": "18", " Flexibility": "0.36", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "31", " CarbonAtoms": "18", " HeteroAtoms": "13", " ratio_H_by_C": "0.72", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1598949.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 438.435", "link_html_complex": "/ACE_complex_html/ACE_ADHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ADHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ADHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ADHP.png", "phi_psi": "/peptide_da/ADHP.pdb", "link_html_peptide": "/Peptide_html/ADHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ADHP.pdb", "link_png_peptide": "/Peptide_pics/ADHP.png"}
{"Peptide_Sequence": "ADHPF", " Origin": "synthetic", " Peptide_Preparation": "simulated gastrointestinal digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Miguel, M., et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin.\" Journal of Agricultural and Food Chemistry 54.3 (2006): 726-731.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "7", " Ligand_ID": "ADHPF_minimized.pdb_7", " Smiles": "C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "585.61", " logP": "-3.22", " logD": "-8.34", " logSw": "-0.62", " tPSA": "244.19", " RotatableB": "14", " RigidB": "26", " Flexibility": "0.35", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "313802.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 585.609", "link_html_complex": "/ACE_complex_html/ACE_ADHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ADHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ADHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ADHPF.png", "phi_psi": "/peptide_da/ADHPF.pdb", "link_html_peptide": "/Peptide_html/ADHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ADHPF.pdb", "link_png_peptide": "/Peptide_pics/ADHPF.png"}
{"Peptide_Sequence": "ADW", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "9", " Ligand_ID": "ADW_minimized.pdb_9", " Smiles": "C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "390.39", " logP": "-3.33", " logD": "-6.9", " logSw": "0.3", " tPSA": "181.89", " RotatableB": "9", " RigidB": "16", " Flexibility": "0.36", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "526065.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.39", "link_html_complex": "/ACE_complex_html/ACE_ADW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ADW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ADW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ADW.png", "phi_psi": "/peptide_da/ADW.pdb", "link_html_peptide": "/Peptide_html/ADW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ADW.pdb", "link_png_peptide": "/Peptide_pics/ADW.png"}
{"Peptide_Sequence": "AEFGS", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "10", " Ligand_ID": "AEFGS_minimized.pdb_10", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "509.51", " logP": "-4.84", " logD": "-9.9", " logSw": "0.97", " tPSA": "244.53", " RotatableB": "15", " RigidB": "16", " Flexibility": "0.48", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "36", " CarbonAtoms": "22", " HeteroAtoms": "14", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1349406.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.51", "link_html_complex": "/ACE_complex_html/ACE_AEFGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AEFGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AEFGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AEFGS.png", "phi_psi": "/peptide_da/AEFGS.pdb", "link_html_peptide": "/Peptide_html/AEFGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AEFGS.pdb", "link_png_peptide": "/Peptide_pics/AEFGS.png"}
{"Peptide_Sequence": "AEL", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "57.1  \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "11", " Ligand_ID": "AEL_minimized.pdb_11", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N)C(O)=O", " MW": "331.36", " logP": "-3.86", " logD": "-7.43", " logSw": "1.2", " tPSA": "166.1", " RotatableB": "10", " RigidB": "6", " Flexibility": "0.63", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1097245.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 331.365", "link_html_complex": "/ACE_complex_html/ACE_AEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AEL.png", "phi_psi": "/peptide_da/AEL.pdb", "link_html_peptide": "/Peptide_html/AEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AEL.pdb", "link_png_peptide": "/Peptide_pics/AEL.png"}
{"Peptide_Sequence": "AF", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "15.2 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "17", " Ligand_ID": "AF_minimized.pdb_17", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "236.27", " logP": "-2.47", " logD": "-2.2", " logSw": "0.45", " tPSA": "96.87", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "12", " HeteroAtoms": "5", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "369319.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 236.267", "link_html_complex": "/ACE_complex_html/ACE_AF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AF.png", "phi_psi": "/peptide_da/AF.pdb", "link_html_peptide": "/Peptide_html/AF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AF.pdb", "link_png_peptide": "/Peptide_pics/AF.png"}
{"Peptide_Sequence": "AFDAVGVK", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "12", " Ligand_ID": "AFDAVGVK_minimized.pdb_12", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "805.92", " logP": "-6.44", " logD": "-8.35", " logSw": "0.83", " tPSA": "339.24", " RotatableB": "25", " RigidB": "22", " Flexibility": "0.53", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1852357.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 805.918", "link_html_complex": "/ACE_complex_html/ACE_AFDAVGVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFDAVGVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFDAVGVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFDAVGVK.png", "phi_psi": "/peptide_da/AFDAVGVK.pdb", "link_html_peptide": "/Peptide_html/AFDAVGVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFDAVGVK.pdb", "link_png_peptide": "/Peptide_pics/AFDAVGVK.png"}
{"Peptide_Sequence": "AFKAWAVAR", " Origin": "Human Serum Albumin(HSA)", " Peptide_Preparation": "Tryptic hydrolysis of HSA followed by Reversed phase Gradient HPLC", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung method described by Maruyama et. al.", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.7 \u03bcM", " Reference": "Wanasundara, P. K. J. P. D., Ross, A. R. S., Amarowicz, R., Ambrose, S. J., Pegg, R. B., & Shand, P. J. (2002). Peptides with Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity from Defibrinated, Hydrolyzed Bovine Plasma. Journal of Agricultural and Food Chemistry, 50(24), 6981\u20136988. doi:10.1021/jf025592e", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "13", " Ligand_ID": "AFKAWAVAR_minimized.pdb_13", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1019.2", " logP": "-2.75", " logD": "-7.83", " logSw": "-2.46", " tPSA": "407.64", " RotatableB": "31", " RigidB": "34", " Flexibility": "0.48", " HBD": "18", " HBA": "24", " HBD_HBA": "42", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "73", " CarbonAtoms": "49", " HeteroAtoms": "24", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "87420.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1019.2", "link_html_complex": "/ACE_complex_html/ACE_AFKAWAVAR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFKAWAVAR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFKAWAVAR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFKAWAVAR.png", "phi_psi": "/peptide_da/AFKAWAVAR.pdb", "link_html_peptide": "/Peptide_html/AFKAWAVAR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFKAWAVAR.pdb", "link_png_peptide": "/Peptide_pics/AFKAWAVAR.png"}
{"Peptide_Sequence": "AFKDEDTEEVPFR", " Origin": "Ostrich egg whites", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "Chromatographic separation", " ACE_inhibition_assay": " Asoodeh et al. (2012)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "80.2 \u03bcM", " Reference": "Tanzadehpanah, Hamid, et al. \"Identification of a novel angiotensin-I converting enzyme inhibitory peptide from ostrich egg white and studying its interactions with the enzyme.\" Innovative food science & emerging technologies 18 (2013): 212-219.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1582.67", "link_html_complex": "/ACE_complex_html/ACE_AFKDEDTEEVPFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFKDEDTEEVPFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFKDEDTEEVPFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFKDEDTEEVPFR.png", "phi_psi": "/peptide_da/AFKDEDTEEVPFR.pdb", "link_html_peptide": "/Peptide_html/AFKDEDTEEVPFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFKDEDTEEVPFR.pdb", "link_png_peptide": "/Peptide_pics/AFKDEDTEEVPFR.png"}
{"Peptide_Sequence": "AFL", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "63.8 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "16", " Ligand_ID": "AFL_minimized.pdb_16", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(O)=O", " MW": "349.42", " logP": "-1.72", " logD": "-2.5", " logSw": "-0.41", " tPSA": "125.97", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "18", " HeteroAtoms": "7", " ratio_H_by_C": "0.39", " Lipinski_Violation": "0", " Solubility_mg_per_l": "230919.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 349.425", "link_html_complex": "/ACE_complex_html/ACE_AFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFL.png", "phi_psi": "/peptide_da/AFL.pdb", "link_html_peptide": "/Peptide_html/AFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFL.pdb", "link_png_peptide": "/Peptide_pics/AFL.png"}
{"Peptide_Sequence": "AFLL", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "15", " Ligand_ID": "AFLL_minimized.pdb_15", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(O)=O", " MW": "462.58", " logP": "-1", " logD": "-2.05", " logSw": "-1.28", " tPSA": "155.07", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "24", " HeteroAtoms": "9", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "128288.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 462.582", "link_html_complex": "/ACE_complex_html/ACE_AFLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFLL.png", "phi_psi": "/peptide_da/AFLL.pdb", "link_html_peptide": "/Peptide_html/AFLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFLL.pdb", "link_png_peptide": "/Peptide_pics/AFLL.png"}
{"Peptide_Sequence": "AFP", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "610 \u03bcM", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "19", " Ligand_ID": "AFP_minimized.pdb_19", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "333.38", " logP": "-1.48", " logD": "-3.51", " logSw": "-0.67", " tPSA": "117.18", " RotatableB": "6", " RigidB": "16", " Flexibility": "0.27", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "170077.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.382", "link_html_complex": "/ACE_complex_html/ACE_AFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFP.png", "phi_psi": "/peptide_da/AFP.pdb", "link_html_peptide": "/Peptide_html/AFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFP.pdb", "link_png_peptide": "/Peptide_pics/AFP.png"}
{"Peptide_Sequence": "AFPGS", " Origin": "Plant and milk derived ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.7\u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "18", " Ligand_ID": "AFPGS_minimized.pdb_18", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "477.51", " logP": "-3.92", " logD": "-6.64", " logSw": "0.33", " tPSA": "195.61", " RotatableB": "11", " RigidB": "20", " Flexibility": "0.35", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "662030.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 477.511", "link_html_complex": "/ACE_complex_html/ACE_AFPGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFPGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFPGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFPGS.png", "phi_psi": "/peptide_da/AFPGS.pdb", "link_html_peptide": "/Peptide_html/AFPGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFPGS.pdb", "link_png_peptide": "/Peptide_pics/AFPGS.png"}
{"Peptide_Sequence": "AFPRS", " Origin": "Plant derived ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "20", " Ligand_ID": "AFPRS_minimized.pdb_20", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O", " MW": "576.65", " logP": "-3.99", " logD": "-8.31", " logSw": "0.1", " tPSA": "259.25", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "637090.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 576.645", "link_html_complex": "/ACE_complex_html/ACE_AFPRS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFPRS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFPRS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFPRS.png", "phi_psi": "/peptide_da/AFPRS.pdb", "link_html_peptide": "/Peptide_html/AFPRS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFPRS.pdb", "link_png_peptide": "/Peptide_pics/AFPRS.png"}
{"Peptide_Sequence": "AFVGYVLP", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "18.02 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "21", " Ligand_ID": "AFVGYVLP_minimized.pdb_21", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "865.03", " logP": "1.2", " logD": "-2.73", " logSw": "-4.58", " tPSA": "282.91", " RotatableB": "22", " RigidB": "32", " Flexibility": "0.41", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "62", " CarbonAtoms": "44", " HeteroAtoms": "18", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8891.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 865.027", "link_html_complex": "/ACE_complex_html/ACE_AFVGYVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AFVGYVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AFVGYVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AFVGYVLP.png", "phi_psi": "/peptide_da/AFVGYVLP.pdb", "link_html_peptide": "/Peptide_html/AFVGYVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AFVGYVLP.pdb", "link_png_peptide": "/Peptide_pics/AFVGYVLP.png"}
{"Peptide_Sequence": "AG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-5", "Serial_ID": "24", " Ligand_ID": "AG_minimized.pdb_24", " Smiles": "C[C@H](N)C(=O)NCC(O)=O", " MW": "146.14", " logP": "-3.65", " logD": "-4.43", " logSw": "1.75", " tPSA": "96.87", " RotatableB": "3", " RigidB": "3", " Flexibility": "0.5", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "10", " CarbonAtoms": "5", " HeteroAtoms": "5", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "842185.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 146.144", "link_html_complex": "/ACE_complex_html/ACE_AG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AG.png", "phi_psi": "/peptide_da/AG.pdb", "link_html_peptide": "/Peptide_html/AG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AG.pdb", "link_png_peptide": "/Peptide_pics/AG.png"}
{"Peptide_Sequence": "AGLAPY", " Origin": "egg white", " Peptide_Preparation": "heating, centrigugation", " Isolation_Method": "ion-exchange column", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Liu, JingBo, et al. \"Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates.\" Food chemistry 122.4 (2010): 1159-1163.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "22", " Ligand_ID": "AGLAPY_minimized.pdb_22", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "590.67", " logP": "-3.32", " logD": "-5.11", " logSw": "-0.54", " tPSA": "224.71", " RotatableB": "14", " RigidB": "22", " Flexibility": "0.39", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "28", " HeteroAtoms": "14", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "344417.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 590.668", "link_html_complex": "/ACE_complex_html/ACE_AGLAPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGLAPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGLAPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGLAPY.png", "phi_psi": "/peptide_da/AGLAPY.pdb", "link_html_peptide": "/Peptide_html/AGLAPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGLAPY.pdb", "link_png_peptide": "/Peptide_pics/AGLAPY.png"}
{"Peptide_Sequence": "AGLP", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "23", " Ligand_ID": "AGLP_minimized.pdb_23", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.42", " logP": "-3.56", " logD": "-5.31", " logSw": "0.72", " tPSA": "146.28", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "732977.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.417", "link_html_complex": "/ACE_complex_html/ACE_AGLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGLP.png", "phi_psi": "/peptide_da/AGLP.pdb", "link_html_peptide": "/Peptide_html/AGLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGLP.pdb", "link_png_peptide": "/Peptide_pics/AGLP.png"}
{"Peptide_Sequence": "AGP", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "560 \u03bcM", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "25", " Ligand_ID": "AGP_minimized.pdb_25", " Smiles": "C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "243.26", " logP": "-3.36", " logD": "-5.75", " logSw": "1.03", " tPSA": "117.18", " RotatableB": "4", " RigidB": "10", " Flexibility": "0.29", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "683153.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.26", "link_html_complex": "/ACE_complex_html/ACE_AGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGP.png", "phi_psi": "/peptide_da/AGP.pdb", "link_html_peptide": "/Peptide_html/AGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGP.pdb", "link_png_peptide": "/Peptide_pics/AGP.png"}
{"Peptide_Sequence": "AGPVLL", " Origin": "rice wine", " Peptide_Preparation": "", " Isolation_Method": "UF, Chromatography, SPEC, RP-HPCL, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Kang, Min Gu, et al. \"Characterization of new antihypertensive angiotensin I-converting enzyme inhibitory peptides from Korean traditional rice wine.\" Journal of microbiology and biotechnology 22.3 (2012): 339-342.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "26", " Ligand_ID": "AGPVLL_minimized.pdb_26", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)N)C(C)C)C(O)=O", " MW": "568.71", " logP": "-2.46", " logD": "-4.24", " logSw": "-0.83", " tPSA": "204.48", " RotatableB": "15", " RigidB": "16", " Flexibility": "0.48", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "248933.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 568.706", "link_html_complex": "/ACE_complex_html/ACE_AGPVLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGPVLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGPVLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGPVLL.png", "phi_psi": "/peptide_da/AGPVLL.pdb", "link_html_peptide": "/Peptide_html/AGPVLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGPVLL.pdb", "link_png_peptide": "/Peptide_pics/AGPVLL.png"}
{"Peptide_Sequence": "AGS", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "527.9 \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "27", " Ligand_ID": "AGS_minimized.pdb_27", " Smiles": "C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "233.22", " logP": "-4.96", " logD": "-7.09", " logSw": "2.23", " tPSA": "146.2", " RotatableB": "6", " RigidB": "5", " Flexibility": "0.55", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "8", " HeteroAtoms": "8", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2179421.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 233.222", "link_html_complex": "/ACE_complex_html/ACE_AGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGS.png", "phi_psi": "/peptide_da/AGS.pdb", "link_html_peptide": "/Peptide_html/AGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGS.pdb", "link_png_peptide": "/Peptide_pics/AGS.png"}
{"Peptide_Sequence": "AGSP", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "37.2  \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "28", " Ligand_ID": "AGSP_minimized.pdb_28", " Smiles": "C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "330.34", " logP": "-5.93", " logD": "-7.71", " logSw": "2.31", " tPSA": "166.51", " RotatableB": "7", " RigidB": "12", " Flexibility": "0.37", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "3327325.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.337", "link_html_complex": "/ACE_complex_html/ACE_AGSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGSP.png", "phi_psi": "/peptide_da/AGSP.pdb", "link_html_peptide": "/Peptide_html/AGSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGSP.pdb", "link_png_peptide": "/Peptide_pics/AGSP.png"}
{"Peptide_Sequence": "AGSS", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "672.1  \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "29", " Ligand_ID": "AGSS_minimized.pdb_29", " Smiles": "C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O", " MW": "320.3", " logP": "-6.26", " logD": "-9.06", " logSw": "2.71", " tPSA": "195.53", " RotatableB": "9", " RigidB": "7", " Flexibility": "0.56", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "11", " HeteroAtoms": "11", " ratio_H_by_C": "1", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4823238.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 320.299", "link_html_complex": "/ACE_complex_html/ACE_AGSS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGSS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGSS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGSS.png", "phi_psi": "/peptide_da/AGSS.pdb", "link_html_peptide": "/Peptide_html/AGSS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGSS.pdb", "link_png_peptide": "/Peptide_pics/AGSS.png"}
{"Peptide_Sequence": "AGTTCLFTPLALPYDYSH", " Origin": "egg yolk", " Peptide_Preparation": "unconventional proteinase from Asian pumpkin", " Isolation_Method": "ultrafiltration, HPLC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung with modification described by Miguel et. al. 2004", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.08 \u03bcmol/L", " Reference": "Eckert, Ewelina, et al. \"Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia).\" Journal of proteomics 110 (2014): 107-116.", " Binding_Energy_kcal_per_mol": "4.4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1970.2", "link_html_complex": "/ACE_complex_html/ACE_AGTTCLFTPLALPYDYSH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGTTCLFTPLALPYDYSH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGTTCLFTPLALPYDYSH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGTTCLFTPLALPYDYSH.png", "phi_psi": "/peptide_da/AGTTCLFTPLALPYDYSH.pdb", "link_html_peptide": "/Peptide_html/AGTTCLFTPLALPYDYSH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGTTCLFTPLALPYDYSH.pdb", "link_png_peptide": "/Peptide_pics/AGTTCLFTPLALPYDYSH.png"}
{"Peptide_Sequence": "AGW", " Origin": "milk derived ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "31", " Ligand_ID": "AGW_minimized.pdb_31", " Smiles": "C[C@H](N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "332.35", " logP": "-2.86", " logD": "-4.24", " logSw": "0.21", " tPSA": "141.76", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "410773.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 332.354", "link_html_complex": "/ACE_complex_html/ACE_AGW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AGW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AGW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AGW.png", "phi_psi": "/peptide_da/AGW.pdb", "link_html_peptide": "/Peptide_html/AGW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AGW.pdb", "link_png_peptide": "/Peptide_pics/AGW.png"}
{"Peptide_Sequence": "AH", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": "CoMFA models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "52 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "35", " Ligand_ID": "AH_minimized.pdb_35", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "226.23", " logP": "-3.57", " logD": "-4.29", " logSw": "1.21", " tPSA": "125.55", " RotatableB": "5", " RigidB": "8", " Flexibility": "0.38", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "9", " HeteroAtoms": "7", " ratio_H_by_C": "0.78", " Lipinski_Violation": "0", " Solubility_mg_per_l": "761041.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 226.232", "link_html_complex": "/ACE_complex_html/ACE_AH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AH.png", "phi_psi": "/peptide_da/AH.pdb", "link_html_peptide": "/Peptide_html/AH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AH.pdb", "link_png_peptide": "/Peptide_pics/AH.png"}
{"Peptide_Sequence": "AHEPVK", " Origin": "mushroom", " Peptide_Preparation": "centrifugation, precipitation", " Isolation_Method": "precipitation, RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "62.8 \u03bcM", " Reference": "Lau, Ching Ching, Noorlidah Abdullah, and Adawiyah Suriza Shuib. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from an edible mushroom, Pleurotus cystidiosus OK Miller identified by LC-MS/MS.\" BMC complementary and alternative medicine 13.1 (2013): 313.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "32", " Ligand_ID": "AHEPVK_minimized.pdb_32", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "679.76", " logP": "-6.26", " logD": "-9.18", " logSw": "1.17", " tPSA": "300.93", " RotatableB": "20", " RigidB": "22", " Flexibility": "0.48", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "30", " HeteroAtoms": "18", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2192636.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 679.765", "link_html_complex": "/ACE_complex_html/ACE_AHEPVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AHEPVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AHEPVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AHEPVK.png", "phi_psi": "/peptide_da/AHEPVK.pdb", "link_html_peptide": "/Peptide_html/AHEPVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AHEPVK.pdb", "link_png_peptide": "/Peptide_pics/AHEPVK.png"}
{"Peptide_Sequence": "AHHP", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "847.6 \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "33", " Ligand_ID": "AHHP_minimized.pdb_33", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "460.49", " logP": "-5.61", " logD": "-6.7", " logSw": "1.38", " tPSA": "203.64", " RotatableB": "10", " RigidB": "22", " Flexibility": "0.31", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1826677.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 460.487", "link_html_complex": "/ACE_complex_html/ACE_AHHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AHHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AHHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AHHP.png", "phi_psi": "/peptide_da/AHHP.pdb", "link_html_peptide": "/Peptide_html/AHHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AHHP.pdb", "link_png_peptide": "/Peptide_pics/AHHP.png"}
{"Peptide_Sequence": "AHLL", " Origin": "Loach", " Peptide_Preparation": "homogenization,enzymatic proteolysis", " Isolation_Method": "ultrafiltration, GFC, HPLC", " ACE_inhibition_assay": "Modified Shalaby et. al. (2004)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "33.7 \u03bcM", " Reference": "Li, Ying, et al. \"Purification of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide with an antihypertensive effect from loach (Misgurnus anguillicaudatus).\" Journal of agricultural and food chemistry 60.5 (2012): 1320-1325.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "34", " Ligand_ID": "AHLL_minimized.pdb_34", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(O)=O", " MW": "452.55", " logP": "-1.35", " logD": "-4.22", " logSw": "-0.99", " tPSA": "183.75", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "167869.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 452.548", "link_html_complex": "/ACE_complex_html/ACE_AHLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AHLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AHLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AHLL.png", "phi_psi": "/peptide_da/AHLL.pdb", "link_html_peptide": "/Peptide_html/AHLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AHLL.pdb", "link_png_peptide": "/Peptide_pics/AHLL.png"}
{"Peptide_Sequence": "AHSY", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "11.6 \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "36", " Ligand_ID": "AHSY_minimized.pdb_36", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "476.48", " logP": "-3.81", " logD": "-6.57", " logSw": "0.27", " tPSA": "224.21", " RotatableB": "12", " RigidB": "18", " Flexibility": "0.4", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "21", " HeteroAtoms": "13", " ratio_H_by_C": "0.62", " Lipinski_Violation": "2", " Solubility_mg_per_l": "622190.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 476.483", "link_html_complex": "/ACE_complex_html/ACE_AHSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AHSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AHSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AHSY.png", "phi_psi": "/peptide_da/AHSY.pdb", "link_html_peptide": "/Peptide_html/AHSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AHSY.pdb", "link_png_peptide": "/Peptide_pics/AHSY.png"}
{"Peptide_Sequence": "AI", " Origin": "Fermented soybean seasoning ", " Peptide_Preparation": "acid hydrolysis method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "colorimetric assay kit  from Fujirebio Corp. (Tokyo, Japan)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Nakahara, Takeharu, et al. \"Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances.\" Journal of agricultural and food chemistry 58.2 (2009): 821-827.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "37", " Ligand_ID": "AI_minimized.pdb_37", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(O)=O", " MW": "202.25", " logP": "-2.6", " logD": "-2.52", " logSw": "0.87", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "9", " HeteroAtoms": "5", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "484711.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 202.251", "link_html_complex": "/ACE_complex_html/ACE_AI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AI.png", "phi_psi": "/peptide_da/AI.pdb", "link_html_peptide": "/Peptide_html/AI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AI.pdb", "link_png_peptide": "/Peptide_pics/AI.png"}
{"Peptide_Sequence": "AIP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "670 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "38", " Ligand_ID": "AIP_minimized.pdb_38", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "299.37", " logP": "-2.04", " logD": "-3.8", " logSw": "-0.01", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "294947.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.366", "link_html_complex": "/ACE_complex_html/ACE_AIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AIP.png", "phi_psi": "/peptide_da/AIP.pdb", "link_html_peptide": "/Peptide_html/AIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AIP.pdb", "link_png_peptide": "/Peptide_pics/AIP.png"}
{"Peptide_Sequence": "AIPP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "900  \u03bcM", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "39", " Ligand_ID": "AIPP_minimized.pdb_39", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "396.48", " logP": "-1.83", " logD": "-4.48", " logSw": "-0.68", " tPSA": "137.49", " RotatableB": "7", " RigidB": "17", " Flexibility": "0.29", " HBD": "4", " HBA": "9", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "0", " Solubility_mg_per_l": "200205.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 396.481", "link_html_complex": "/ACE_complex_html/ACE_AIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AIPP.png", "phi_psi": "/peptide_da/AIPP.pdb", "link_html_peptide": "/Peptide_html/AIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AIPP.pdb", "link_png_peptide": "/Peptide_pics/AIPP.png"}
{"Peptide_Sequence": "AIYK", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "213 \u03bcM", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "40", " Ligand_ID": "AIYK_minimized.pdb_40", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "493.6", " logP": "-2.53", " logD": "-3.44", " logSw": "-0.38", " tPSA": "202.94", " RotatableB": "15", " RigidB": "13", " Flexibility": "0.54", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "24", " HeteroAtoms": "11", " ratio_H_by_C": "0.46", " Lipinski_Violation": "2", " Solubility_mg_per_l": "338769.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 493.596", "link_html_complex": "/ACE_complex_html/ACE_AIYK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AIYK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AIYK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AIYK.png", "phi_psi": "/peptide_da/AIYK.pdb", "link_html_peptide": "/Peptide_html/AIYK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AIYK.pdb", "link_png_peptide": "/Peptide_pics/AIYK.png"}
{"Peptide_Sequence": "AKC", " Origin": "meat-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "41", " Ligand_ID": "AKC_minimized.pdb_41", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O", " MW": "320.41", " logP": "-3.82", " logD": "-7.09", " logSw": "1.24", " tPSA": "192.41", " RotatableB": "10", " RigidB": "5", " Flexibility": "0.67", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1107282.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 320.407", "link_html_complex": "/ACE_complex_html/ACE_AKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKC.png", "phi_psi": "/peptide_da/AKC.pdb", "link_html_peptide": "/Peptide_html/AKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKC.pdb", "link_png_peptide": "/Peptide_pics/AKC.png"}
{"Peptide_Sequence": "AKDQG", " Origin": "meat-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "42", " Ligand_ID": "AKDQG_minimized.pdb_42", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "517.53", " logP": "-8.96", " logD": "-14.37", " logSw": "3.78", " tPSA": "295.03", " RotatableB": "18", " RigidB": "12", " Flexibility": "0.6", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "20", " HeteroAtoms": "16", " ratio_H_by_C": "0.8", " Lipinski_Violation": "3", " Solubility_mg_per_l": "22769267.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 517.533", "link_html_complex": "/ACE_complex_html/ACE_AKDQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKDQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKDQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKDQG.png", "phi_psi": "/peptide_da/AKDQG.pdb", "link_html_peptide": "/Peptide_html/AKDQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKDQG.pdb", "link_png_peptide": "/Peptide_pics/AKDQG.png"}
{"Peptide_Sequence": "AKF", " Origin": "hen egg white lysozyme", " Peptide_Preparation": " simulated human gastrointestinal digestion", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.5 \u03bcM", " Reference": "Rao, Shengqi, et al. \"ACE inhibitory peptides and antioxidant peptides derived from in vitro digestion hydrolysate of hen egg white lysozyme.\" Food chemistry 135.3 (2012): 1245-1252.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "43", " Ligand_ID": "AKF_minimized.pdb_43", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "364.44", " logP": "-2.02", " logD": "-5.51", " logSw": "-0.18", " tPSA": "153.61", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "303449.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 364.439", "link_html_complex": "/ACE_complex_html/ACE_AKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKF.png", "phi_psi": "/peptide_da/AKF.pdb", "link_html_peptide": "/Peptide_html/AKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKF.pdb", "link_png_peptide": "/Peptide_pics/AKF.png"}
{"Peptide_Sequence": "AKK", " Origin": "Sardine muscles", " Peptide_Preparation": "alkakine protease", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "2,4,6-trinitroben-zene sulfonate (TNBS) method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.13 \u03bcM", " Reference": "Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., & Osajima, Y. (1994). Angiotensin I-converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58(12), 2244\u20132245. doi:10.1271/bbb.58.2244 ", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "44", " Ligand_ID": "AKK_minimized.pdb_44", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "345.44", " logP": "-5.14", " logD": "-8.31", " logSw": "2.11", " tPSA": "181.25", " RotatableB": "13", " RigidB": "5", " Flexibility": "0.72", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2862064.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 345.438", "link_html_complex": "/ACE_complex_html/ACE_AKK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKK.png", "phi_psi": "/peptide_da/AKK.pdb", "link_html_peptide": "/Peptide_html/AKK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKK.pdb", "link_png_peptide": "/Peptide_pics/AKK.png"}
{"Peptide_Sequence": "AKLEK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "45", " Ligand_ID": "AKLEK_minimized.pdb_45", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "587.71", " logP": "-5.95", " logD": "-8.92", " logSw": "1.72", " tPSA": "279.58", " RotatableB": "22", " RigidB": "10", " Flexibility": "0.69", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3271273.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 587.709", "link_html_complex": "/ACE_complex_html/ACE_AKLEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKLEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKLEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKLEK.png", "phi_psi": "/peptide_da/AKLEK.pdb", "link_html_peptide": "/Peptide_html/AKLEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKLEK.pdb", "link_png_peptide": "/Peptide_pics/AKLEK.png"}
{"Peptide_Sequence": "AKP", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "47", " Ligand_ID": "AKP_minimized.pdb_47", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "314.38", " logP": "-4.46", " logD": "-6.9", " logSw": "1.55", " tPSA": "144.82", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1479182", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 314.381", "link_html_complex": "/ACE_complex_html/ACE_AKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKP.png", "phi_psi": "/peptide_da/AKP.pdb", "link_html_peptide": "/Peptide_html/AKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKP.pdb", "link_png_peptide": "/Peptide_pics/AKP.png"}
{"Peptide_Sequence": "AKPEG", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "46", " Ligand_ID": "AKPEG_minimized.pdb_46", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O", " MW": "500.55", " logP": "-8.65", " logD": "-13.66", " logSw": "3.5", " tPSA": "243.15", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "16511535.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 500.546", "link_html_complex": "/ACE_complex_html/ACE_AKPEG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKPEG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKPEG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKPEG.png", "phi_psi": "/peptide_da/AKPEG.pdb", "link_html_peptide": "/Peptide_html/AKPEG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKPEG.pdb", "link_png_peptide": "/Peptide_pics/AKPEG.png"}
{"Peptide_Sequence": "AKSCQ", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "48", " Ligand_ID": "AKSCQ_minimized.pdb_48", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "535.61", " logP": "-6.54", " logD": "-11.56", " logSw": "2.15", " tPSA": "313.93", " RotatableB": "18", " RigidB": "11", " Flexibility": "0.62", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "20", " HeteroAtoms": "16", " ratio_H_by_C": "0.8", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4586181.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 535.614", "link_html_complex": "/ACE_complex_html/ACE_AKSCQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKSCQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKSCQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKSCQ.png", "phi_psi": "/peptide_da/AKSCQ.pdb", "link_html_peptide": "/Peptide_html/AKSCQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKSCQ.pdb", "link_png_peptide": "/Peptide_pics/AKSCQ.png"}
{"Peptide_Sequence": "AKYCY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "19.95 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "49", " Ligand_ID": "AKYCY_minimized.pdb_49", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "646.75", " logP": "-1.86", " logD": "-6.63", " logSw": "-1.59", " tPSA": "291.07", " RotatableB": "18", " RigidB": "21", " Flexibility": "0.46", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "131606.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 646.754", "link_html_complex": "/ACE_complex_html/ACE_AKYCY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKYCY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKYCY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKYCY.png", "phi_psi": "/peptide_da/AKYCY.pdb", "link_html_peptide": "/Peptide_html/AKYCY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKYCY.pdb", "link_png_peptide": "/Peptide_pics/AKYCY.png"}
{"Peptide_Sequence": "AKYSY", " Origin": "Nori (Porphyya yezoensis)", " Peptide_Preparation": "Pepsin", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "1.5 \u03bcM", " Reference": "Saito, M., and H. Hagino. \"Antihypertensive effect of oligopeptides derived from nori (Porphyra yezoensis) and Ala-Lys-Tyr-Ser-Tyr in rats.\" Journal of Japanese Society of Nutrition and Food Science (Japan) (2005).", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "50", " Ligand_ID": "AKYSY_minimized.pdb_50", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "630.69", " logP": "-2.83", " logD": "-8.02", " logSw": "-0.88", " tPSA": "272.5", " RotatableB": "18", " RigidB": "21", " Flexibility": "0.46", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "261222.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 630.689", "link_html_complex": "/ACE_complex_html/ACE_AKYSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AKYSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AKYSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AKYSY.png", "phi_psi": "/peptide_da/AKYSY.pdb", "link_html_peptide": "/Peptide_html/AKYSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AKYSY.pdb", "link_png_peptide": "/Peptide_pics/AKYSY.png"}
{"Peptide_Sequence": "AL", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "55", " Ligand_ID": "AL_minimized.pdb_55", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(O)=O", " MW": "202.25", " logP": "-2.79", " logD": "-2.6", " logSw": "0.99", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "9", " HeteroAtoms": "5", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "546346.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 202.251", "link_html_complex": "/ACE_complex_html/ACE_AL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AL.png", "phi_psi": "/peptide_da/AL.pdb", "link_html_peptide": "/Peptide_html/AL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AL.pdb", "link_png_peptide": "/Peptide_pics/AL.png"}
{"Peptide_Sequence": "ALAFQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "165.96 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "51", " Ligand_ID": "ALAFQ_minimized.pdb_51", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "548.63", " logP": "-3.39", " logD": "-5.1", " logSw": "-0.11", " tPSA": "227.26", " RotatableB": "16", " RigidB": "17", " Flexibility": "0.48", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "493443.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 548.632", "link_html_complex": "/ACE_complex_html/ACE_ALAFQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALAFQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALAFQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALAFQ.png", "phi_psi": "/peptide_da/ALAFQ.pdb", "link_html_peptide": "/Peptide_html/ALAFQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALAFQ.pdb", "link_png_peptide": "/Peptide_pics/ALAFQ.png"}
{"Peptide_Sequence": "ALEP", " Origin": "Amaranthus hypochondriacus 11S globulin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6320 \u03bcM", " Reference": "Vecchi, B., and M. C. A\u00f1\u00f3n. \"ACE inhibitory tetrapeptides from Amaranthus hypochondriacus 11S globulin.\" Phytochemistry 70.7 (2009): 864-870.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "52", " Ligand_ID": "ALEP_minimized.pdb_52", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "428.48", " logP": "-4.33", " logD": "-8.49", " logSw": "0.96", " tPSA": "186.41", " RotatableB": "11", " RigidB": "13", " Flexibility": "0.46", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "19", " HeteroAtoms": "11", " ratio_H_by_C": "0.58", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1116069.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 428.48", "link_html_complex": "/ACE_complex_html/ACE_ALEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALEP.png", "phi_psi": "/peptide_da/ALEP.pdb", "link_html_peptide": "/Peptide_html/ALEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALEP.pdb", "link_png_peptide": "/Peptide_pics/ALEP.png"}
{"Peptide_Sequence": "ALKAWSVAR", " Origin": "bovine  serum  albumin ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "3 \u03bcM", " Reference": "FitzGerald, R. J., and H. Meisel. \"Lactokinins: Whey protein\u2010derived ACE inhibitory peptides.\" Food/Nahrung 43.3 (1999): 165-167.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "53", " Ligand_ID": "ALKAWSVAR_minimized.pdb_53", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1001.18", " logP": "-4.47", " logD": "-9.28", " logSw": "-1.16", " tPSA": "427.87", " RotatableB": "32", " RigidB": "28", " Flexibility": "0.53", " HBD": "19", " HBA": "25", " HBD_HBA": "44", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "71", " CarbonAtoms": "46", " HeteroAtoms": "25", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "312435.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1001.18", "link_html_complex": "/ACE_complex_html/ACE_ALKAWSVAR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALKAWSVAR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALKAWSVAR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALKAWSVAR.png", "phi_psi": "/peptide_da/ALKAWSVAR.pdb", "link_html_peptide": "/Peptide_html/ALKAWSVAR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALKAWSVAR.pdb", "link_png_peptide": "/Peptide_pics/ALKAWSVAR.png"}
{"Peptide_Sequence": "ALLVP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "4.88 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "54", " Ligand_ID": "ALLVP_minimized.pdb_54", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "511.65", " logP": "-1.79", " logD": "-3.17", " logSw": "-1.03", " tPSA": "175.38", " RotatableB": "13", " RigidB": "14", " Flexibility": "0.48", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "25", " HeteroAtoms": "11", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "183293.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 511.655", "link_html_complex": "/ACE_complex_html/ACE_ALLVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALLVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALLVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALLVP.png", "phi_psi": "/peptide_da/ALLVP.pdb", "link_html_peptide": "/Peptide_html/ALLVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALLVP.pdb", "link_png_peptide": "/Peptide_pics/ALLVP.png"}
{"Peptide_Sequence": "ALMSPH", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "56", " Ligand_ID": "ALMSPH_minimized.pdb_56", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "654.78", " logP": "-3.29", " logD": "-5.92", " logSw": "-0.68", " tPSA": "278.69", " RotatableB": "18", " RigidB": "21", " Flexibility": "0.46", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "28", " HeteroAtoms": "17", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "331859.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 654.779", "link_html_complex": "/ACE_complex_html/ACE_ALMSPH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALMSPH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALMSPH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALMSPH.png", "phi_psi": "/peptide_da/ALMSPH.pdb", "link_html_peptide": "/Peptide_html/ALMSPH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALMSPH.pdb", "link_png_peptide": "/Peptide_pics/ALMSPH.png"}
{"Peptide_Sequence": "ALNEINQFY", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "219 \u03bcM", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "57", " Ligand_ID": "ALNEINQFY_minimized.pdb_57", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1111.2", " logP": "-4.27", " logD": "-11.19", " logSw": "-1.92", " tPSA": "490.2", " RotatableB": "33", " RigidB": "36", " Flexibility": "0.48", " HBD": "19", " HBA": "28", " HBD_HBA": "47", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "79", " CarbonAtoms": "51", " HeteroAtoms": "28", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "163007.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1111.2", "link_html_complex": "/ACE_complex_html/ACE_ALNEINQFY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALNEINQFY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALNEINQFY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALNEINQFY.png", "phi_psi": "/peptide_da/ALNEINQFY.pdb", "link_html_peptide": "/Peptide_html/ALNEINQFY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALNEINQFY.pdb", "link_png_peptide": "/Peptide_pics/ALNEINQFY.png"}
{"Peptide_Sequence": "ALNEINQFYQK", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "264 \u03bcM", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "58", " Ligand_ID": "ALNEINQFYQK_minimized.pdb_58", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1367.51", " logP": "-8.46", " logD": "-12.16", " logSw": "-0.2", " tPSA": "619.13", " RotatableB": "43", " RigidB": "42", " Flexibility": "0.51", " HBD": "25", " HBA": "35", " HBD_HBA": "60", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "97", " CarbonAtoms": "62", " HeteroAtoms": "35", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1122728.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1367.51", "link_html_complex": "/ACE_complex_html/ACE_ALNEINQFYQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALNEINQFYQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALNEINQFYQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALNEINQFYQK.png", "phi_psi": "/peptide_da/ALNEINQFYQK.pdb", "link_html_peptide": "/Peptide_html/ALNEINQFYQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALNEINQFYQK.pdb", "link_png_peptide": "/Peptide_pics/ALNEINQFYQK.png"}
{"Peptide_Sequence": "ALP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "240 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "63", " Ligand_ID": "ALP_minimized.pdb_63", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "299.37", " logP": "-2.9", " logD": "-3.88", " logSw": "0.53", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "507043.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.366", "link_html_complex": "/ACE_complex_html/ACE_ALP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALP.png", "phi_psi": "/peptide_da/ALP.pdb", "link_html_peptide": "/Peptide_html/ALP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALP.pdb", "link_png_peptide": "/Peptide_pics/ALP.png"}
{"Peptide_Sequence": "ALPH", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1800 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "60", " Ligand_ID": "ALPH_minimized.pdb_60", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "436.51", " logP": "-3.88", " logD": "-4.45", " logSw": "0.5", " tPSA": "174.96", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "719198.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 436.505", "link_html_complex": "/ACE_complex_html/ACE_ALPH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPH.png", "phi_psi": "/peptide_da/ALPH.pdb", "link_html_peptide": "/Peptide_html/ALPH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPH.pdb", "link_png_peptide": "/Peptide_pics/ALPH.png"}
{"Peptide_Sequence": "ALPHA", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "59", " Ligand_ID": "ALPHA_minimized.pdb_59", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(O)=O", " MW": "507.58", " logP": "-4.13", " logD": "-5.51", " logSw": "0.36", " tPSA": "204.06", " RotatableB": "12", " RigidB": "19", " Flexibility": "0.39", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "724774.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 507.583", "link_html_complex": "/ACE_complex_html/ACE_ALPHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPHA.png", "phi_psi": "/peptide_da/ALPHA.pdb", "link_html_peptide": "/Peptide_html/ALPHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPHA.pdb", "link_png_peptide": "/Peptide_pics/ALPHA.png"}
{"Peptide_Sequence": "ALPM", " Origin": "Commercial Whey Produc", " Peptide_Preparation": "", " Isolation_Method": "gel filteration chromatography", " ACE_inhibition_assay": "Abubakar et al.,1996, 1998", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "928 \u03bcM", " Reference": "Murakami, M., et al. \"Structural analysis of a new anti-hypertensive peptide (\u03b2-lactosin B) isolated from a commercial whey product.\" Journal of dairy science 87.7 (2004): 1967-1974.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "64", " Ligand_ID": "ALPM_minimized.pdb_64", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(O)=O", " MW": "430.56", " logP": "-3", " logD": "-4.14", " logSw": "0.11", " tPSA": "171.58", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "478955.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 430.562", "link_html_complex": "/ACE_complex_html/ACE_ALPM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPM.png", "phi_psi": "/peptide_da/ALPM.pdb", "link_html_peptide": "/Peptide_html/ALPM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPM.pdb", "link_png_peptide": "/Peptide_pics/ALPM.png"}
{"Peptide_Sequence": "ALPMH", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "521 \u03bcM", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "62", " Ligand_ID": "ALPMH_minimized.pdb_62", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "567.7", " logP": "-3.49", " logD": "-4.33", " logSw": "-0.22", " tPSA": "229.36", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "456823.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 567.701", "link_html_complex": "/ACE_complex_html/ACE_ALPMH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPMH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPMH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPMH.png", "phi_psi": "/peptide_da/ALPMH.pdb", "link_html_peptide": "/Peptide_html/ALPMH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPMH.pdb", "link_png_peptide": "/Peptide_pics/ALPMH.png"}
{"Peptide_Sequence": "ALPMHIR", " Origin": "lactoglobulin", " Peptide_Preparation": "Trypsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "42.6 \u03bcM", " Reference": "Mullally MM, Meisel H, FitzGerald RJ. Identification of a novel angiotensin-I converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine _x005F_x0003_-lactoglobulin. FEBS Lett 1997;402: 99\u2013101.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "61", " Ligand_ID": "ALPMHIR_minimized.pdb_61", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "837.04", " logP": "-1.99", " logD": "-5.29", " logSw": "-2.09", " tPSA": "351.2", " RotatableB": "26", " RigidB": "24", " Flexibility": "0.52", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "58", " CarbonAtoms": "37", " HeteroAtoms": "21", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "103500.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 837.045", "link_html_complex": "/ACE_complex_html/ACE_ALPMHIR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPMHIR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPMHIR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPMHIR.png", "phi_psi": "/peptide_da/ALPMHIR.pdb", "link_html_peptide": "/Peptide_html/ALPMHIR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPMHIR.pdb", "link_png_peptide": "/Peptide_pics/ALPMHIR.png"}
{"Peptide_Sequence": "ALPP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "280 \u03bcM", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "65", " Ligand_ID": "ALPP_minimized.pdb_65", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "396.48", " logP": "-2.85", " logD": "-4.54", " logSw": "-0.04", " tPSA": "137.49", " RotatableB": "7", " RigidB": "17", " Flexibility": "0.29", " HBD": "4", " HBA": "9", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "0", " Solubility_mg_per_l": "380674.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 396.481", "link_html_complex": "/ACE_complex_html/ACE_ALPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ALPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ALPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ALPP.png", "phi_psi": "/peptide_da/ALPP.pdb", "link_html_peptide": "/Peptide_html/ALPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ALPP.pdb", "link_png_peptide": "/Peptide_pics/ALPP.png"}
{"Peptide_Sequence": "AMK", " Origin": "hen egg white lysozyme", " Peptide_Preparation": " simulated human gastrointestinal digestion", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "94.2 \u03bcM", " Reference": "Rao, Shengqi, et al. \"ACE inhibitory peptides and antioxidant peptides derived from in vitro digestion hydrolysate of hen egg white lysozyme.\" Food chemistry 135.3 (2012): 1245-1252.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "66", " Ligand_ID": "AMK_minimized.pdb_66", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "348.46", " logP": "-4.27", " logD": "-4.93", " logSw": "1.48", " tPSA": "178.91", " RotatableB": "12", " RigidB": "5", " Flexibility": "0.71", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1533282.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 348.462", "link_html_complex": "/ACE_complex_html/ACE_AMK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMK.png", "phi_psi": "/peptide_da/AMK.pdb", "link_html_peptide": "/Peptide_html/AMK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMK.pdb", "link_png_peptide": "/Peptide_pics/AMK.png"}
{"Peptide_Sequence": "AMKPW", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "580 \u03bcM", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "68", " Ligand_ID": "AMKPW_minimized.pdb_68", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "631.79", " logP": "-1.93", " logD": "-6.91", " logSw": "-1.49", " tPSA": "244.11", " RotatableB": "17", " RigidB": "24", " Flexibility": "0.41", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "141817.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 631.787", "link_html_complex": "/ACE_complex_html/ACE_AMKPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMKPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMKPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMKPW.png", "phi_psi": "/peptide_da/AMKPW.pdb", "link_html_peptide": "/Peptide_html/AMKPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMKPW.pdb", "link_png_peptide": "/Peptide_pics/AMKPW.png"}
{"Peptide_Sequence": "AMKPWIQPK", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "600 \u03bcM", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "67", " Ligand_ID": "AMKPWIQPK_minimized.pdb_67", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1098.36", " logP": "-2.37", " logD": "-8.42", " logSw": "-3.02", " tPSA": "422.45", " RotatableB": "33", " RigidB": "39", " Flexibility": "0.46", " HBD": "16", " HBA": "24", " HBD_HBA": "40", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "77", " CarbonAtoms": "52", " HeteroAtoms": "25", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "53581.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1098.36", "link_html_complex": "/ACE_complex_html/ACE_AMKPWIQPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMKPWIQPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMKPWIQPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMKPWIQPK.png", "phi_psi": "/peptide_da/AMKPWIQPK.pdb", "link_html_peptide": "/Peptide_html/AMKPWIQPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMKPWIQPK.pdb", "link_png_peptide": "/Peptide_pics/AMKPWIQPK.png"}
{"Peptide_Sequence": "AMNPP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "304.5 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "69", " Ligand_ID": "AMNPP_minimized.pdb_69", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "528.62", " logP": "-4.28", " logD": "-7.12", " logSw": "0.37", " tPSA": "234.98", " RotatableB": "12", " RigidB": "21", " Flexibility": "0.36", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "22", " HeteroAtoms": "14", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "766026.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 528.622", "link_html_complex": "/ACE_complex_html/ACE_AMNPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMNPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMNPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMNPP.png", "phi_psi": "/peptide_da/AMNPP.pdb", "link_html_peptide": "/Peptide_html/AMNPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMNPP.pdb", "link_png_peptide": "/Peptide_pics/AMNPP.png"}
{"Peptide_Sequence": "AMPKPW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "580 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "70", " Ligand_ID": "AMPKPW_minimized.pdb_70", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "728.9", " logP": "-1.54", " logD": "-7.17", " logSw": "-2.27", " tPSA": "264.42", " RotatableB": "18", " RigidB": "31", " Flexibility": "0.37", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "35", " HeteroAtoms": "16", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "75632.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 728.902", "link_html_complex": "/ACE_complex_html/ACE_AMPKPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMPKPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMPKPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMPKPW.png", "phi_psi": "/peptide_da/AMPKPW.pdb", "link_html_peptide": "/Peptide_html/AMPKPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMPKPW.pdb", "link_png_peptide": "/Peptide_pics/AMPKPW.png"}
{"Peptide_Sequence": "AMQS", " Origin": "rapeseed", " Peptide_Preparation": "proteolytic enzymes", " Isolation_Method": "octadecyl silica (ODS) column, cyanopropyl silica (CN) column, phenetyl silica and nitrophenetyl column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with modification by Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Marczak, Ewa D., et al. \"New antihypertensive peptides isolated from rapeseed.\" Peptides 24.6 (2003): 791-798.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "71", " Ligand_ID": "AMQS_minimized.pdb_71", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "435.5", " logP": "-5.33", " logD": "-7.94", " logSw": "1.74", " tPSA": "243.69", " RotatableB": "14", " RigidB": "9", " Flexibility": "0.61", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "16", " HeteroAtoms": "13", " ratio_H_by_C": "0.81", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2485704.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 435.496", "link_html_complex": "/ACE_complex_html/ACE_AMQS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMQS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMQS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMQS.png", "phi_psi": "/peptide_da/AMQS.pdb", "link_html_peptide": "/Peptide_html/AMQS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMQS.pdb", "link_png_peptide": "/Peptide_pics/AMQS.png"}
{"Peptide_Sequence": "AMY", " Origin": "wheat germ", " Peptide_Preparation": "", " Isolation_Method": "ethanol precipitation and chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "5.86 \u03bcM", " Reference": "Yang, Runqiang, et al. \"Accumulation and identification of angiotensin-converting enzyme inhibitory peptides from wheat germ.\" Journal of agricultural and food chemistry 59.8 (2011): 3598-3605.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "72", " Ligand_ID": "AMY_minimized.pdb_72", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "383.46", " logP": "-2.28", " logD": "-3.46", " logSw": "-0.21", " tPSA": "171.5", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "311411.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 383.463", "link_html_complex": "/ACE_complex_html/ACE_AMY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AMY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AMY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AMY.png", "phi_psi": "/peptide_da/AMY.pdb", "link_html_peptide": "/Peptide_html/AMY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AMY.pdb", "link_png_peptide": "/Peptide_pics/AMY.png"}
{"Peptide_Sequence": "ANPAVVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "25 \u03bcM", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "73", " Ligand_ID": "ANPAVVRP_minimized.pdb_73", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "822.95", " logP": "-4.58", " logD": "-9.93", " logSw": "-0.6", " tPSA": "360.62", " RotatableB": "22", " RigidB": "28", " Flexibility": "0.44", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "58", " CarbonAtoms": "36", " HeteroAtoms": "22", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "449437.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 822.952", "link_html_complex": "/ACE_complex_html/ACE_ANPAVVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ANPAVVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ANPAVVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ANPAVVRP.png", "phi_psi": "/peptide_da/ANPAVVRP.pdb", "link_html_peptide": "/Peptide_html/ANPAVVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ANPAVVRP.pdb", "link_png_peptide": "/Peptide_pics/ANPAVVRP.png"}
{"Peptide_Sequence": "AP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "230 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "77", " Ligand_ID": "AP_minimized.pdb_77", " Smiles": "C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "186.21", " logP": "-2.71", " logD": "-3.58", " logSw": "0.84", " tPSA": "88.08", " RotatableB": "2", " RigidB": "8", " Flexibility": "0.2", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "433405.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 186.208", "link_html_complex": "/ACE_complex_html/ACE_AP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AP.png", "phi_psi": "/peptide_da/AP.pdb", "link_html_peptide": "/Peptide_html/AP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AP.pdb", "link_png_peptide": "/Peptide_pics/AP.png"}
{"Peptide_Sequence": "APER", " Origin": " trevally proteins", " Peptide_Preparation": "Bromelain hydrolysis", " Isolation_Method": "molecular weight cut-off (MWCO) membranes, RP-HPLC", " ACE_inhibition_assay": "Nakamura et\u2009al. (1995) and Tsai, Chen, Pan, Gong, and Chung (2008) with modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "190.88 \u03bcM", " Reference": "Salampessy, Junus, et al. \"Functional and potential therapeutic ACE-inhibitory peptides derived from bromelain hydrolysis of trevally proteins.\" Journal of functional foods 14 (2015): 716-725.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "74", " Ligand_ID": "APER_minimized.pdb_74", " Smiles": "C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "471.51", " logP": "-6.22", " logD": "-9.46", " logSw": "2.08", " tPSA": "250.05", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "19", " HeteroAtoms": "14", " ratio_H_by_C": "0.74", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3771342.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 471.508", "link_html_complex": "/ACE_complex_html/ACE_APER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APER.png", "phi_psi": "/peptide_da/APER.pdb", "link_html_peptide": "/Peptide_html/APER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APER.pdb", "link_png_peptide": "/Peptide_pics/APER.png"}
{"Peptide_Sequence": "APGAGVY", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.7 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "75", " Ligand_ID": "APGAGVY_minimized.pdb_75", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "633.69", " logP": "-3.17", " logD": "-6.57", " logSw": "-0.83", " tPSA": "253.81", " RotatableB": "15", " RigidB": "24", " Flexibility": "0.38", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "275699.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 633.693", "link_html_complex": "/ACE_complex_html/ACE_APGAGVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APGAGVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APGAGVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APGAGVY.png", "phi_psi": "/peptide_da/APGAGVY.pdb", "link_html_peptide": "/Peptide_html/APGAGVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APGAGVY.pdb", "link_png_peptide": "/Peptide_pics/APGAGVY.png"}
{"Peptide_Sequence": "APGAPGPVG", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "16.2 \u03bcM", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "76", " Ligand_ID": "APGAPGPVG_minimized.pdb_76", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)NCC(O)=O", " MW": "721.8", " logP": "-4.35", " logD": "-9.02", " logSw": "-0.58", " tPSA": "274.2", " RotatableB": "15", " RigidB": "32", " Flexibility": "0.32", " HBD": "8", " HBA": "19", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "32", " HeteroAtoms": "19", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "402252.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 721.802", "link_html_complex": "/ACE_complex_html/ACE_APGAPGPVG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APGAPGPVG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APGAPGPVG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APGAPGPVG.png", "phi_psi": "/peptide_da/APGAPGPVG.pdb", "link_html_peptide": "/Peptide_html/APGAPGPVG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APGAPGPVG.pdb", "link_png_peptide": "/Peptide_pics/APGAPGPVG.png"}
{"Peptide_Sequence": "APP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "257 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "78", " Ligand_ID": "APP_minimized.pdb_78", " Smiles": "C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "283.32", " logP": "-2.66", " logD": "-4.89", " logSw": "0.28", " tPSA": "108.39", " RotatableB": "3", " RigidB": "15", " Flexibility": "0.17", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "373823.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 283.324", "link_html_complex": "/ACE_complex_html/ACE_APP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APP.png", "phi_psi": "/peptide_da/APP.pdb", "link_html_peptide": "/Peptide_html/APP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APP.pdb", "link_png_peptide": "/Peptide_pics/APP.png"}
{"Peptide_Sequence": "APSAK", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "325.7 \u03bcM", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "79", " Ligand_ID": "APSAK_minimized.pdb_79", " Smiles": "C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "472.54", " logP": "-6.42", " logD": "-7.42", " logSw": "2.13", " tPSA": "223.25", " RotatableB": "13", " RigidB": "14", " Flexibility": "0.48", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3987785.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.536", "link_html_complex": "/ACE_complex_html/ACE_APSAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APSAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APSAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APSAK.png", "phi_psi": "/peptide_da/APSAK.pdb", "link_html_peptide": "/Peptide_html/APSAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APSAK.pdb", "link_png_peptide": "/Peptide_pics/APSAK.png"}
{"Peptide_Sequence": "APVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "627 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "80", " Ligand_ID": "APVPP_minimized.pdb_80", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "479.57", " logP": "-2.14", " logD": "-5.19", " logSw": "-1", " tPSA": "157.8", " RotatableB": "7", " RigidB": "24", " Flexibility": "0.23", " HBD": "4", " HBA": "11", " HBD_HBA": "15", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "175872.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 479.57", "link_html_complex": "/ACE_complex_html/ACE_APVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_APVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_APVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_APVPP.png", "phi_psi": "/peptide_da/APVPP.pdb", "link_html_peptide": "/Peptide_html/APVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/APVPP.pdb", "link_png_peptide": "/Peptide_pics/APVPP.png"}
{"Peptide_Sequence": "AQK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1800 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-6.4", "Serial_ID": "81", " Ligand_ID": "AQK_minimized.pdb_81", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "345.39", " logP": "-6.07", " logD": "-6.74", " logSw": "2.63", " tPSA": "196.7", " RotatableB": "12", " RigidB": "7", " Flexibility": "0.63", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "4814275.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 345.395", "link_html_complex": "/ACE_complex_html/ACE_AQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AQK.png", "phi_psi": "/peptide_da/AQK.pdb", "link_html_peptide": "/Peptide_html/AQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AQK.pdb", "link_png_peptide": "/Peptide_pics/AQK.png"}
{"Peptide_Sequence": "AQL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "82", " Ligand_ID": "AQL_minimized.pdb_82", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(O)=O", " MW": "330.38", " logP": "-4.51", " logD": "-5.33", " logSw": "1.61", " tPSA": "169.06", " RotatableB": "10", " RigidB": "7", " Flexibility": "0.59", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1657701.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.38", "link_html_complex": "/ACE_complex_html/ACE_AQL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AQL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AQL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AQL.png", "phi_psi": "/peptide_da/AQL.pdb", "link_html_peptide": "/Peptide_html/AQL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AQL.pdb", "link_png_peptide": "/Peptide_pics/AQL.png"}
{"Peptide_Sequence": "AQQLAAQLPAMCR", " Origin": " wheat gluten protein", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al. (1979) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "68 \u03bcM", " Reference": "Asoodeh, Ahmad, et al. \"Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: biochemical characterization and molecular docking study.\" Journal of Cereal Science 60.1 (2014): 92-98.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "83", " Ligand_ID": "AQQLAAQLPAMCR_minimized.pdb_83", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1400.67", " logP": "-8.35", " logD": "-11.54", " logSw": "-0.36", " tPSA": "665.19", " RotatableB": "44", " RigidB": "37", " Flexibility": "0.54", " HBD": "24", " HBA": "36", " HBD_HBA": "60", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "96", " CarbonAtoms": "58", " HeteroAtoms": "38", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "977554.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1400.67", "link_html_complex": "/ACE_complex_html/ACE_AQQLAAQLPAMCR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AQQLAAQLPAMCR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AQQLAAQLPAMCR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AQQLAAQLPAMCR.png", "phi_psi": "/peptide_da/AQQLAAQLPAMCR.pdb", "link_html_peptide": "/Peptide_html/AQQLAAQLPAMCR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AQQLAAQLPAMCR.pdb", "link_png_peptide": "/Peptide_pics/AQQLAAQLPAMCR.png"}
{"Peptide_Sequence": "AQTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "76 \u03bcM", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "84", " Ligand_ID": "AQTQSLVYP_minimized.pdb_84", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1006.11", " logP": "-5.19", " logD": "-9.29", " logSw": "-0.99", " tPSA": "438.65", " RotatableB": "28", " RigidB": "32", " Flexibility": "0.47", " HBD": "17", " HBA": "26", " HBD_HBA": "43", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "71", " CarbonAtoms": "45", " HeteroAtoms": "26", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "373305.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1006.11", "link_html_complex": "/ACE_complex_html/ACE_AQTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AQTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AQTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AQTQSLVYP.png", "phi_psi": "/peptide_da/AQTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/AQTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AQTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/AQTQSLVYP.png"}
{"Peptide_Sequence": "AR", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "95.5  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "90", " Ligand_ID": "AR_minimized.pdb_90", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "245.28", " logP": "-4.07", " logD": "-5.85", " logSw": "1.73", " tPSA": "160.51", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "17", " CarbonAtoms": "9", " HeteroAtoms": "8", " ratio_H_by_C": "0.89", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1385431.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.279", "link_html_complex": "/ACE_complex_html/ACE_AR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AR.png", "phi_psi": "/peptide_da/AR.pdb", "link_html_peptide": "/Peptide_html/AR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AR.pdb", "link_png_peptide": "/Peptide_pics/AR.png"}
{"Peptide_Sequence": "ARCRG", " Origin": "meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "85", " Ligand_ID": "ARCRG_minimized.pdb_85", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O", " MW": "561.66", " logP": "-6.13", " logD": "-12.89", " logSw": "1.86", " tPSA": "350.25", " RotatableB": "20", " RigidB": "11", " Flexibility": "0.65", " HBD": "15", " HBA": "17", " HBD_HBA": "32", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "38", " CarbonAtoms": "20", " HeteroAtoms": "18", " ratio_H_by_C": "0.9", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3606561.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 561.658", "link_html_complex": "/ACE_complex_html/ACE_ARCRG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARCRG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARCRG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARCRG.png", "phi_psi": "/peptide_da/ARCRG.pdb", "link_html_peptide": "/Peptide_html/ARCRG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARCRG.pdb", "link_png_peptide": "/Peptide_pics/ARCRG.png"}
{"Peptide_Sequence": "ARF", " Origin": "plant derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "86", " Ligand_ID": "ARF_minimized.pdb_86", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "392.45", " logP": "-4.21", " logD": "-6.39", " logSw": "1.09", " tPSA": "189.61", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1169373.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.453", "link_html_complex": "/ACE_complex_html/ACE_ARF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARF.png", "phi_psi": "/peptide_da/ARF.pdb", "link_html_peptide": "/Peptide_html/ARF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARF.pdb", "link_png_peptide": "/Peptide_pics/ARF.png"}
{"Peptide_Sequence": "ARHEI", " Origin": "milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "87", " Ligand_ID": "ARHEI_minimized.pdb_87", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(O)=O", " MW": "624.69", " logP": "-4.26", " logD": "-13.06", " logSw": "0.31", " tPSA": "316.62", " RotatableB": "21", " RigidB": "16", " Flexibility": "0.57", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "26", " HeteroAtoms": "18", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "855711.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 624.69", "link_html_complex": "/ACE_complex_html/ACE_ARHEI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARHEI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARHEI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARHEI.png", "phi_psi": "/peptide_da/ARHEI.pdb", "link_html_peptide": "/Peptide_html/ARHEI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARHEI.pdb", "link_png_peptide": "/Peptide_pics/ARHEI.png"}
{"Peptide_Sequence": "ARHPH", " Origin": "probiotic yoghurt", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971) with modifications (Donkor et al., 2005)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.46 \u03bcg/ml", " Reference": "Donkor, Osaana N., et al. \"ACE-inhibitory activity of probiotic yoghurt.\" International dairy journal 17.11 (2007): 1321-1331.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "88", " Ligand_ID": "ARHPH_minimized.pdb_88", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "616.67", " logP": "-5", " logD": "-10.91", " logSw": "0.52", " tPSA": "296.38", " RotatableB": "17", " RigidB": "25", " Flexibility": "0.4", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "26", " HeteroAtoms": "18", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1037815.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 616.673", "link_html_complex": "/ACE_complex_html/ACE_ARHPH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARHPH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARHPH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARHPH.png", "phi_psi": "/peptide_da/ARHPH.pdb", "link_html_peptide": "/Peptide_html/ARHPH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARHPH.pdb", "link_png_peptide": "/Peptide_pics/ARHPH.png"}
{"Peptide_Sequence": "ARHPHP", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "89", " Ligand_ID": "ARHPHP_minimized.pdb_89", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "713.79", " logP": "-4.95", " logD": "-11.2", " logSw": "-0.03", " tPSA": "316.69", " RotatableB": "18", " RigidB": "32", " Flexibility": "0.36", " HBD": "12", " HBA": "20", " HBD_HBA": "32", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "31", " HeteroAtoms": "20", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "689585.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 713.788", "link_html_complex": "/ACE_complex_html/ACE_ARHPHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARHPHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARHPHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARHPHP.png", "phi_psi": "/peptide_da/ARHPHP.pdb", "link_html_peptide": "/Peptide_html/ARHPHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARHPHP.pdb", "link_png_peptide": "/Peptide_pics/ARHPHP.png"}
{"Peptide_Sequence": "ARPAK", " Origin": "FIBRIN(OGEN) ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Ryan et. al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "19\u03bcM", " Reference": "Saldeen, Tom, James W. Ryan, and Pierre Berryer. \"A peptide derived from fibrin (ogen) inhibits angiotensin converting enzyme and potentiates the effects of bradykinin.\" Thrombosis research 23.4 (1981): 465-470.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "91", " Ligand_ID": "ARPAK_minimized.pdb_91", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "541.64", " logP": "-6.27", " logD": "-9.68", " logSw": "1.87", " tPSA": "266.66", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3528101.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 541.644", "link_html_complex": "/ACE_complex_html/ACE_ARPAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARPAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARPAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARPAK.png", "phi_psi": "/peptide_da/ARPAK.pdb", "link_html_peptide": "/Peptide_html/ARPAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARPAK.pdb", "link_png_peptide": "/Peptide_pics/ARPAK.png"}
{"Peptide_Sequence": "ARPSR", " Origin": "plant derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "92", " Ligand_ID": "ARPSR_minimized.pdb_92", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "585.66", " logP": "-7.91", " logD": "-11.32", " logSw": "2.77", " tPSA": "322.89", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9311084.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 585.657", "link_html_complex": "/ACE_complex_html/ACE_ARPSR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARPSR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARPSR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARPSR.png", "phi_psi": "/peptide_da/ARPSR.pdb", "link_html_peptide": "/Peptide_html/ARPSR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARPSR.pdb", "link_png_peptide": "/Peptide_pics/ARPSR.png"}
{"Peptide_Sequence": "ARY", " Origin": "milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "93", " Ligand_ID": "ARY_minimized.pdb_93", " Smiles": "C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "408.45", " logP": "-4.8", " logD": "-6.7", " logSw": "1.37", " tPSA": "209.84", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1600508.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 408.452", "link_html_complex": "/ACE_complex_html/ACE_ARY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ARY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ARY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ARY.png", "phi_psi": "/peptide_da/ARY.pdb", "link_html_peptide": "/Peptide_html/ARY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ARY.pdb", "link_png_peptide": "/Peptide_pics/ARY.png"}
{"Peptide_Sequence": "ASGPINFT", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": "975 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "94", " Ligand_ID": "ASGPINFT_minimized.pdb_94", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "805.87", " logP": "-5.15", " logD": "-8.92", " logSw": "-0.18", " tPSA": "346.23", " RotatableB": "22", " RigidB": "28", " Flexibility": "0.44", " HBD": "13", " HBA": "21", " HBD_HBA": "34", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "36", " HeteroAtoms": "21", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "673414.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 805.875", "link_html_complex": "/ACE_complex_html/ACE_ASGPINFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASGPINFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASGPINFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASGPINFT.png", "phi_psi": "/peptide_da/ASGPINFT.pdb", "link_html_peptide": "/Peptide_html/ASGPINFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASGPINFT.pdb", "link_png_peptide": "/Peptide_pics/ASGPINFT.png"}
{"Peptide_Sequence": "ASL", " Origin": "silkworm pupa", " Peptide_Preparation": "gastrointestinal endopeptidases ", " Isolation_Method": "ultrafiltration, gel filtration chromatography and RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "102.15 \u03bcM", " Reference": "Wu, Qiongying, et al. \"A novel angiotensin-\u0406 converting enzyme (ACE) inhibitory peptide from gastrointestinal protease hydrolysate of silkworm pupa (Bombyx mori) protein: biochemical characterization and molecular docking study.\" Peptides 68 (2015): 17-24.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "95", " Ligand_ID": "ASL_minimized.pdb_95", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(O)=O", " MW": "289.33", " logP": "-3.67", " logD": "-5.22", " logSw": "1.21", " tPSA": "146.2", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "966640.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 289.328", "link_html_complex": "/ACE_complex_html/ACE_ASL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASL.png", "phi_psi": "/peptide_da/ASL.pdb", "link_html_peptide": "/Peptide_html/ASL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASL.pdb", "link_png_peptide": "/Peptide_pics/ASL.png"}
{"Peptide_Sequence": "ASP", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "242.3 \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "96", " Ligand_ID": "ASP_minimized.pdb_96", " Smiles": "C[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "273.29", " logP": "-5.27", " logD": "-6.24", " logSw": "2.12", " tPSA": "137.41", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "0", " Solubility_mg_per_l": "2267076.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 273.286", "link_html_complex": "/ACE_complex_html/ACE_ASP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASP.png", "phi_psi": "/peptide_da/ASP.pdb", "link_html_peptide": "/Peptide_html/ASP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASP.pdb", "link_png_peptide": "/Peptide_pics/ASP.png"}
{"Peptide_Sequence": "ASW", " Origin": "meat derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "97", " Ligand_ID": "ASW_minimized.pdb_97", " Smiles": "C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "362.38", " logP": "-3.51", " logD": "-4.73", " logSw": "0.51", " tPSA": "161.99", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "605761.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 362.38", "link_html_complex": "/ACE_complex_html/ACE_ASW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASW.png", "phi_psi": "/peptide_da/ASW.pdb", "link_html_peptide": "/Peptide_html/ASW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASW.pdb", "link_png_peptide": "/Peptide_pics/ASW.png"}
{"Peptide_Sequence": "ASYDTKF", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "920 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "99", " Ligand_ID": "ASYDTKF_minimized.pdb_99", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "830.88", " logP": "-6.75", " logD": "-11.93", " logSw": "0.83", " tPSA": "370.83", " RotatableB": "25", " RigidB": "26", " Flexibility": "0.49", " HBD": "15", " HBA": "21", " HBD_HBA": "36", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "38", " HeteroAtoms": "21", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1910154.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 830.881", "link_html_complex": "/ACE_complex_html/ACE_ASYDTKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASYDTKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASYDTKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASYDTKF.png", "phi_psi": "/peptide_da/ASYDTKF.pdb", "link_html_peptide": "/Peptide_html/ASYDTKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASYDTKF.pdb", "link_png_peptide": "/Peptide_pics/ASYDTKF.png"}
{"Peptide_Sequence": "ASYDTKFE", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">10000 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "98", " Ligand_ID": "ASYDTKFE_minimized.pdb_98", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "960", " logP": "-7.51", " logD": "-17.65", " logSw": "0.85", " tPSA": "440.06", " RotatableB": "30", " RigidB": "29", " Flexibility": "0.51", " HBD": "17", " HBA": "25", " HBD_HBA": "42", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "68", " CarbonAtoms": "43", " HeteroAtoms": "25", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2247157.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 959.995", "link_html_complex": "/ACE_complex_html/ACE_ASYDTKFE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ASYDTKFE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ASYDTKFE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ASYDTKFE.png", "phi_psi": "/peptide_da/ASYDTKFE.pdb", "link_html_peptide": "/Peptide_html/ASYDTKFE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ASYDTKFE.pdb", "link_png_peptide": "/Peptide_pics/ASYDTKFE.png"}
{"Peptide_Sequence": "ATF", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "100", " Ligand_ID": "ATF_minimized.pdb_100", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "337.37", " logP": "-3.35", " logD": "-4.41", " logSw": "0.61", " tPSA": "146.2", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "622357.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 337.371", "link_html_complex": "/ACE_complex_html/ACE_ATF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ATF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ATF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ATF.png", "phi_psi": "/peptide_da/ATF.pdb", "link_html_peptide": "/Peptide_html/ATF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ATF.pdb", "link_png_peptide": "/Peptide_pics/ATF.png"}
{"Peptide_Sequence": "AV", " Origin": " trevally proteins", " Peptide_Preparation": "Bromelain hydrolysis", " Isolation_Method": "molecular weight cut-off (MWCO) membranes, RP-HPLC", " ACE_inhibition_assay": "Nakamura et\u2009al. (1995) and Tsai, Chen, Pan, Gong, and Chung (2008) with modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "371.89", " Reference": "Salampessy, Junus, et al. \"Functional and potential therapeutic ACE-inhibitory peptides derived from bromelain hydrolysis of trevally proteins.\" Journal of functional foods 14 (2015): 716-725.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "103", " Ligand_ID": "AV_minimized.pdb_103", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(O)=O", " MW": "188.22", " logP": "-2.96", " logD": "-2.97", " logSw": "1.12", " tPSA": "96.87", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "577924.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 188.224", "link_html_complex": "/ACE_complex_html/ACE_AV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AV.png", "phi_psi": "/peptide_da/AV.pdb", "link_html_peptide": "/Peptide_html/AV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AV.pdb", "link_png_peptide": "/Peptide_pics/AV.png"}
{"Peptide_Sequence": "AVF", " Origin": "insect protein", " Peptide_Preparation": "human gastrointestinal digestion", " Isolation_Method": "SEC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "1374 \u03bcM", " Reference": "Vercruysse, Lieselot, et al. \"Ala-Val-Phe and Val-Phe: ACE inhibitory peptides derived from insect protein with antihypertensive activity in spontaneously hypertensive rats.\" Peptides 31.3 (2010): 482-488.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "101", " Ligand_ID": "AVF_minimized.pdb_101", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "335.4", " logP": "-2.35", " logD": "-2.86", " logSw": "0", " tPSA": "125.97", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "334868.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 335.398", "link_html_complex": "/ACE_complex_html/ACE_AVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVF.png", "phi_psi": "/peptide_da/AVF.pdb", "link_html_peptide": "/Peptide_html/AVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVF.pdb", "link_png_peptide": "/Peptide_pics/AVF.png"}
{"Peptide_Sequence": "AVL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.\n", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "102", " Ligand_ID": "AVL_minimized.pdb_102", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(O)=O", " MW": "301.38", " logP": "-2.81", " logD": "-3.23", " logSw": "0.59", " tPSA": "125.97", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "543543.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.382", "link_html_complex": "/ACE_complex_html/ACE_AVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVL.png", "phi_psi": "/peptide_da/AVL.pdb", "link_html_peptide": "/Peptide_html/AVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVL.pdb", "link_png_peptide": "/Peptide_pics/AVL.png"}
{"Peptide_Sequence": "AVNPIR", " Origin": " latex of Ficus carica", " Peptide_Preparation": "", " Isolation_Method": "ultrafilteration, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified  by Maruyama et. al. (1985).", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "13 \u03bcM", " Reference": "Maruyama, Susumu, Shinsuke Miyoshi, and Hideoki Tanaka. \"Angiotensin I-converting enzyme inhibitors derived from Ficus carica.\" Agricultural and biological chemistry 53.10 (1989): 2763-2767.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "104", " Ligand_ID": "AVNPIR_minimized.pdb_104", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "668.79", " logP": "-5.72", " logD": "-6.74", " logSw": "0.94", " tPSA": "311.21", " RotatableB": "20", " RigidB": "19", " Flexibility": "0.51", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1707172.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 668.785", "link_html_complex": "/ACE_complex_html/ACE_AVNPIR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVNPIR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVNPIR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVNPIR.png", "phi_psi": "/peptide_da/AVNPIR.pdb", "link_html_peptide": "/Peptide_html/AVNPIR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVNPIR.pdb", "link_png_peptide": "/Peptide_pics/AVNPIR.png"}
{"Peptide_Sequence": "AVP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "340 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "105", " Ligand_ID": "AVP_minimized.pdb_105", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "285.34", " logP": "-3.26", " logD": "-4.26", " logSw": "0.77", " tPSA": "117.18", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "619166.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_AVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVP.png", "phi_psi": "/peptide_da/AVP.pdb", "link_html_peptide": "/Peptide_html/AVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVP.pdb", "link_png_peptide": "/Peptide_pics/AVP.png"}
{"Peptide_Sequence": "AVPYP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "80 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "106", " Ligand_ID": "AVPYP_minimized.pdb_106", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "545.63", " logP": "-1.2", " logD": "-4.13", " logSw": "-1.86", " tPSA": "186.82", " RotatableB": "10", " RigidB": "25", " Flexibility": "0.29", " HBD": "6", " HBA": "12", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "27", " HeteroAtoms": "12", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "84615.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 545.628", "link_html_complex": "/ACE_complex_html/ACE_AVPYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVPYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVPYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVPYP.png", "phi_psi": "/peptide_da/AVPYP.pdb", "link_html_peptide": "/Peptide_html/AVPYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVPYP.pdb", "link_png_peptide": "/Peptide_pics/AVPYP.png"}
{"Peptide_Sequence": "AVPYPQP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "80 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "107", " Ligand_ID": "AVPYPQP_minimized.pdb_107", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "770.87", " logP": "-2.57", " logD": "-6.09", " logSw": "-1.99", " tPSA": "279.32", " RotatableB": "16", " RigidB": "36", " Flexibility": "0.31", " HBD": "9", " HBA": "18", " HBD_HBA": "27", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "37", " HeteroAtoms": "18", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "105898.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 770.872", "link_html_complex": "/ACE_complex_html/ACE_AVPYPQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVPYPQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVPYPQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVPYPQP.png", "phi_psi": "/peptide_da/AVPYPQP.pdb", "link_html_peptide": "/Peptide_html/AVPYPQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVPYPQP.pdb", "link_png_peptide": "/Peptide_pics/AVPYPQP.png"}
{"Peptide_Sequence": "AVPYPQR", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "15 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "108", " Ligand_ID": "AVPYPQR_minimized.pdb_108", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "829.94", " logP": "-3.7", " logD": "-6.7", " logSw": "-1.24", " tPSA": "351.75", " RotatableB": "22", " RigidB": "32", " Flexibility": "0.41", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "59", " CarbonAtoms": "38", " HeteroAtoms": "21", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "240106.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 829.943", "link_html_complex": "/ACE_complex_html/ACE_AVPYPQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVPYPQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVPYPQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVPYPQR.png", "phi_psi": "/peptide_da/AVPYPQR.pdb", "link_html_peptide": "/Peptide_html/AVPYPQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVPYPQR.pdb", "link_png_peptide": "/Peptide_pics/AVPYPQR.png"}
{"Peptide_Sequence": "AVV", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "66.6 \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "109", " Ligand_ID": "AVV_minimized.pdb_109", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(O)=O", " MW": "287.36", " logP": "-3.42", " logD": "-3.61", " logSw": "0.99", " tPSA": "125.97", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "777214.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.355", "link_html_complex": "/ACE_complex_html/ACE_AVV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVV.png", "phi_psi": "/peptide_da/AVV.pdb", "link_html_peptide": "/Peptide_html/AVV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVV.pdb", "link_png_peptide": "/Peptide_pics/AVV.png"}
{"Peptide_Sequence": "AVVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "74 \u03bcM", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "110", " Ligand_ID": "AVVRP_minimized.pdb_110", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "540.66", " logP": "-4.29", " logD": "-7.15", " logSw": "0.5", " tPSA": "239.02", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "891954.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 540.656", "link_html_complex": "/ACE_complex_html/ACE_AVVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AVVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AVVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AVVRP.png", "phi_psi": "/peptide_da/AVVRP.pdb", "link_html_peptide": "/Peptide_html/AVVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AVVRP.pdb", "link_png_peptide": "/Peptide_pics/AVVRP.png"}
{"Peptide_Sequence": "AW", " Origin": "lyzozyme", " Peptide_Preparation": "chymotrypsin and thermolysin", " Isolation_Method": "", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "20 \u03bcmol/L", " Reference": "D. Lunow, S. Kaiser, S. Br\u00fcckner, A. Gotsch and T. Henle,\n Eur. Food Res. Technol., 2013, 237, 27\u201337.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "111", " Ligand_ID": "AW_minimized.pdb_111", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "275.3", " logP": "-2.21", " logD": "-2.1", " logSw": "0", " tPSA": "112.66", " RotatableB": "5", " RigidB": "13", " Flexibility": "0.28", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "274045.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 275.303", "link_html_complex": "/ACE_complex_html/ACE_AW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AW.png", "phi_psi": "/peptide_da/AW.pdb", "link_html_peptide": "/Peptide_html/AW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AW.pdb", "link_png_peptide": "/Peptide_pics/AW.png"}
{"Peptide_Sequence": "AWPF", " Origin": "wine", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "18.3 \u03bcM", " Reference": "Garc\u00eda, M. C., et al. \"Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities.\" Talanta 106 (2013): 328-349.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "112", " Ligand_ID": "AWPF_minimized.pdb_112", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "519.59", " logP": "-0.49", " logD": "-2.63", " logSw": "-2.25", " tPSA": "162.07", " RotatableB": "10", " RigidB": "28", " Flexibility": "0.26", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "28", " HeteroAtoms": "10", " ratio_H_by_C": "0.36", " Lipinski_Violation": "2", " Solubility_mg_per_l": "54813.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 519.592", "link_html_complex": "/ACE_complex_html/ACE_AWPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AWPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AWPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AWPF.png", "phi_psi": "/peptide_da/AWPF.pdb", "link_html_peptide": "/Peptide_html/AWPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AWPF.pdb", "link_png_peptide": "/Peptide_pics/AWPF.png"}
{"Peptide_Sequence": "AWW", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "6.5 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "113", " Ligand_ID": "AWW_minimized.pdb_113", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "461.51", " logP": "-0.52", " logD": "-1.9", " logSw": "-2", " tPSA": "157.55", " RotatableB": "9", " RigidB": "25", " Flexibility": "0.26", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "25", " HeteroAtoms": "9", " ratio_H_by_C": "0.36", " Lipinski_Violation": "1", " Solubility_mg_per_l": "62575.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.24", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 461.513", "link_html_complex": "/ACE_complex_html/ACE_AWW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AWW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AWW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AWW.png", "phi_psi": "/peptide_da/AWW.pdb", "link_html_peptide": "/Peptide_html/AWW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AWW.pdb", "link_png_peptide": "/Peptide_pics/AWW.png"}
{"Peptide_Sequence": "AY", " Origin": "Fermented soybean seasoning ", " Peptide_Preparation": "acid hydrolysis method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "colorimetric assay kit  from Fujirebio Corp. (Tokyo, Japan)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Nakahara, Takeharu, et al. \"Antihypertensive effect of peptide-enriched soy sauce-like seasoning and identification of its angiotensin I-converting enzyme inhibitory substances.\" Journal of agricultural and food chemistry 58.2 (2009): 821-827.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "122", " Ligand_ID": "AY_minimized.pdb_122", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "252.27", " logP": "-3.48", " logD": "-2.51", " logSw": "0.99", " tPSA": "117.1", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "677388.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 252.266", "link_html_complex": "/ACE_complex_html/ACE_AY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AY.png", "phi_psi": "/peptide_da/AY.pdb", "link_html_peptide": "/Peptide_html/AY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AY.pdb", "link_png_peptide": "/Peptide_pics/AY.png"}
{"Peptide_Sequence": "AYEES", " Origin": "meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "6.5 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "114", " Ligand_ID": "AYEES_minimized.pdb_114", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "597.57", " logP": "-4.85", " logD": "-13.94", " logSw": "0.64", " tPSA": "304.89", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "42", " CarbonAtoms": "25", " HeteroAtoms": "17", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1134295.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 597.572", "link_html_complex": "/ACE_complex_html/ACE_AYEES.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYEES.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYEES.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYEES.png", "phi_psi": "/peptide_da/AYEES.pdb", "link_html_peptide": "/Peptide_html/AYEES.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYEES.pdb", "link_png_peptide": "/Peptide_pics/AYEES.png"}
{"Peptide_Sequence": "AYFTPE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "104.7 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "115", " Ligand_ID": "AYFTPE_minimized.pdb_115", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "726.77", " logP": "-2.27", " logD": "-8.46", " logSw": "-1.82", " tPSA": "285.07", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "117931.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 726.773", "link_html_complex": "/ACE_complex_html/ACE_AYFTPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYFTPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYFTPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYFTPE.png", "phi_psi": "/peptide_da/AYFTPE.pdb", "link_html_peptide": "/Peptide_html/AYFTPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYFTPE.pdb", "link_png_peptide": "/Peptide_pics/AYFTPE.png"}
{"Peptide_Sequence": "AYFYP", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-11.1", "Serial_ID": "119", " Ligand_ID": "AYFYP_minimized.pdb_119", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "659.73", " logP": "0.48", " logD": "-2.26", " logSw": "-3.46", " tPSA": "215.84", " RotatableB": "14", " RigidB": "32", " Flexibility": "0.3", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "35", " HeteroAtoms": "13", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "20768.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.34", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 659.729", "link_html_complex": "/ACE_complex_html/ACE_AYFYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYFYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYFYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYFYP.png", "phi_psi": "/peptide_da/AYFYP.pdb", "link_html_peptide": "/Peptide_html/AYFYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYFYP.pdb", "link_png_peptide": "/Peptide_pics/AYFYP.png"}
{"Peptide_Sequence": "AYFYPE", " Origin": "alpha-s1 casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "106 \u03bcM", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "118", " Ligand_ID": "AYFYPE_minimized.pdb_118", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "788.84", " logP": "-1.92", " logD": "-6.44", " logSw": "-2.39", " tPSA": "285.07", " RotatableB": "19", " RigidB": "35", " Flexibility": "0.35", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "71986.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 788.843", "link_html_complex": "/ACE_complex_html/ACE_AYFYPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYFYPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYFYPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYFYPE.png", "phi_psi": "/peptide_da/AYFYPE.pdb", "link_html_peptide": "/Peptide_html/AYFYPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYFYPE.pdb", "link_png_peptide": "/Peptide_pics/AYFYPE.png"}
{"Peptide_Sequence": "AYFYPEL", " Origin": "casein derived", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifications by Quir\u00f3s et al. (2007)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "6.5 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "117", " Ligand_ID": "AYFYPEL_minimized.pdb_117", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(O)=O", " MW": "902", " logP": "-0.86", " logD": "-5.74", " logSw": "-3.48", " tPSA": "314.17", " RotatableB": "23", " RigidB": "37", " Flexibility": "0.38", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "65", " CarbonAtoms": "46", " HeteroAtoms": "19", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "27787.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 902", "link_html_complex": "/ACE_complex_html/ACE_AYFYPEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYFYPEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYFYPEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYFYPEL.png", "phi_psi": "/peptide_da/AYFYPEL.pdb", "link_html_peptide": "/Peptide_html/AYFYPEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYFYPEL.pdb", "link_png_peptide": "/Peptide_pics/AYFYPEL.png"}
{"Peptide_Sequence": "AYFYPELF", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.5 \u03bcM", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "116", " Ligand_ID": "AYFYPELF_minimized.pdb_116", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1049.17", " logP": "0.48", " logD": "-4.54", " logSw": "-4.99", " tPSA": "343.27", " RotatableB": "27", " RigidB": "45", " Flexibility": "0.38", " HBD": "12", " HBA": "21", " HBD_HBA": "33", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "76", " CarbonAtoms": "55", " HeteroAtoms": "21", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7150.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1049.17", "link_html_complex": "/ACE_complex_html/ACE_AYFYPELF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYFYPELF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYFYPELF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYFYPELF.png", "phi_psi": "/peptide_da/AYFYPELF.pdb", "link_html_peptide": "/Peptide_html/AYFYPELF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYFYPELF.pdb", "link_png_peptide": "/Peptide_pics/AYFYPELF.png"}
{"Peptide_Sequence": "AYIASKGL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "28.8 \u03bcg/ml", " Reference": "Mimura, Tsutomu, et al. \"Angiotensin converting enzyme inhibitor.\" U.S. Patent No. 5,098,887. 24 Mar. 1992.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "120", " Ligand_ID": "AYIASKGL_minimized.pdb_120", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "821.96", " logP": "-3.79", " logD": "-8.9", " logSw": "-0.87", " tPSA": "339.57", " RotatableB": "26", " RigidB": "21", " Flexibility": "0.55", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "58", " CarbonAtoms": "38", " HeteroAtoms": "20", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "344654.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 821.96", "link_html_complex": "/ACE_complex_html/ACE_AYIASKGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYIASKGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYIASKGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYIASKGL.png", "phi_psi": "/peptide_da/AYIASKGL.pdb", "link_html_peptide": "/Peptide_html/AYIASKGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYIASKGL.pdb", "link_png_peptide": "/Peptide_pics/AYIASKGL.png"}
{"Peptide_Sequence": "AYKRQ", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "121", " Ligand_ID": "AYKRQ_minimized.pdb_121", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "664.75", " logP": "-5", " logD": "-11.74", " logSw": "0.66", " tPSA": "338.77", " RotatableB": "23", " RigidB": "18", " Flexibility": "0.56", " HBD": "16", " HBA": "18", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1285891.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 664.754", "link_html_complex": "/ACE_complex_html/ACE_AYKRQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYKRQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYKRQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYKRQ.png", "phi_psi": "/peptide_da/AYKRQ.pdb", "link_html_peptide": "/Peptide_html/AYKRQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYKRQ.pdb", "link_png_peptide": "/Peptide_pics/AYKRQ.png"}
{"Peptide_Sequence": "AYPS", " Origin": "alpha-s1 casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "123", " Ligand_ID": "AYPS_minimized.pdb_123", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O", " MW": "436.46", " logP": "-4.78", " logD": "-5.79", " logSw": "0.98", " tPSA": "186.74", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1167704.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 436.459", "link_html_complex": "/ACE_complex_html/ACE_AYPS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYPS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYPS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYPS.png", "phi_psi": "/peptide_da/AYPS.pdb", "link_html_peptide": "/Peptide_html/AYPS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYPS.pdb", "link_png_peptide": "/Peptide_pics/AYPS.png"}
{"Peptide_Sequence": "AYTQQ", " Origin": "meat-protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "124", " Ligand_ID": "AYTQQ_minimized.pdb_124", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "609.63", " logP": "-6.54", " logD": "-8.53", " logSw": "1.57", " tPSA": "310.81", " RotatableB": "17", " RigidB": "19", " Flexibility": "0.47", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2925455.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 609.629", "link_html_complex": "/ACE_complex_html/ACE_AYTQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYTQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYTQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYTQQ.png", "phi_psi": "/peptide_da/AYTQQ.pdb", "link_html_peptide": "/Peptide_html/AYTQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYTQQ.pdb", "link_png_peptide": "/Peptide_pics/AYTQQ.png"}
{"Peptide_Sequence": "AYW", " Origin": "plant derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "125", " Ligand_ID": "AYW_minimized.pdb_125", " Smiles": "C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "438.48", " logP": "-1.38", " logD": "-2.33", " logSw": "-1.29", " tPSA": "161.99", " RotatableB": "9", " RigidB": "21", " Flexibility": "0.3", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "23", " HeteroAtoms": "9", " ratio_H_by_C": "0.39", " Lipinski_Violation": "1", " Solubility_mg_per_l": "121118.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.26", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 438.476", "link_html_complex": "/ACE_complex_html/ACE_AYW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_AYW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_AYW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_AYW.png", "phi_psi": "/peptide_da/AYW.pdb", "link_html_peptide": "/Peptide_html/AYW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/AYW.pdb", "link_png_peptide": "/Peptide_pics/AYW.png"}
{"Peptide_Sequence": "CF", " Origin": "shark meat", " Peptide_Preparation": "Protease hydrolysis", " Isolation_Method": "ultrafiltration, gel chromatography, RP-HPLC", " ACE_inhibition_assay": "He et al. (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.96 \u03bcM", " Reference": "Wu, Hao, et al. \"Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate.\" Process Biochemistry 43.4 (2008): 457-461.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "127", " Ligand_ID": "CF_minimized.pdb_127", " Smiles": "N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "268.33", " logP": "-2.55", " logD": "-2.18", " logSw": "0.37", " tPSA": "135.67", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "387795.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 268.331", "link_html_complex": "/ACE_complex_html/ACE_CF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CF.png", "phi_psi": "/peptide_da/CF.pdb", "link_html_peptide": "/Peptide_html/CF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CF.pdb", "link_png_peptide": "/Peptide_pics/CF.png"}
{"Peptide_Sequence": "CFCTKPC", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.31 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "126", " Ligand_ID": "CFCTKPC_minimized.pdb_126", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(O)=O", " MW": "801.01", " logP": "-3.71", " logD": "-8.42", " logSw": "-1.06", " tPSA": "397.85", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "277724.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 801.007", "link_html_complex": "/ACE_complex_html/ACE_CFCTKPC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CFCTKPC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CFCTKPC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CFCTKPC.png", "phi_psi": "/peptide_da/CFCTKPC.pdb", "link_html_peptide": "/Peptide_html/CFCTKPC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CFCTKPC.pdb", "link_png_peptide": "/Peptide_pics/CFCTKPC.png"}
{"Peptide_Sequence": "CMENSA", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "788 \u03bcM", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "128", " Ligand_ID": "CMENSA_minimized.pdb_128", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O", " MW": "653.73", " logP": "-6.79", " logD": "-12.7", " logSw": "1.77", " tPSA": "380.82", " RotatableB": "21", " RigidB": "14", " Flexibility": "0.6", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "23", " HeteroAtoms": "20", " ratio_H_by_C": "0.87", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3840227.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 653.725", "link_html_complex": "/ACE_complex_html/ACE_CMENSA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CMENSA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CMENSA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CMENSA.png", "phi_psi": "/peptide_da/CMENSA.pdb", "link_html_peptide": "/Peptide_html/CMENSA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CMENSA.pdb", "link_png_peptide": "/Peptide_pics/CMENSA.png"}
{"Peptide_Sequence": "CRQNTLGHNTQTSIAQ", " Origin": "sea cucumber (Stichopus horrens)", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": " 0.08 mM", " Reference": "Forghani, Bita, et al. \"Purification and characterization of angiotensin converting enzyme-inhibitory peptides derived from Stichopus horrens: Stability study against the ACE and inhibition kinetics.\" Journal of functional foods 20 (2016): 276-290.", " Binding_Energy_kcal_per_mol": "-4.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1771.91", "link_html_complex": "/ACE_complex_html/ACE_CRQNTLGHNTQTSIAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CRQNTLGHNTQTSIAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CRQNTLGHNTQTSIAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CRQNTLGHNTQTSIAQ.png", "phi_psi": "/peptide_da/CRQNTLGHNTQTSIAQ.pdb", "link_html_peptide": "/Peptide_html/CRQNTLGHNTQTSIAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CRQNTLGHNTQTSIAQ.pdb", "link_png_peptide": "/Peptide_pics/CRQNTLGHNTQTSIAQ.png"}
{"Peptide_Sequence": "CVL", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.8 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "130", " Ligand_ID": "CVL_minimized.pdb_130", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(O)=O", " MW": "333.45", " logP": "-2.97", " logD": "-3.09", " logSw": "0.56", " tPSA": "164.77", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "0", " Solubility_mg_per_l": "582432.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.446", "link_html_complex": "/ACE_complex_html/ACE_CVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CVL.png", "phi_psi": "/peptide_da/CVL.pdb", "link_html_peptide": "/Peptide_html/CVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CVL.pdb", "link_png_peptide": "/Peptide_pics/CVL.png"}
{"Peptide_Sequence": "CVTPALR", " Origin": "Peanut Protein", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Wu et al. (2005)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "26.84 \u03bcg/mL", " Reference": "Liu, Li-na, Sheng-hua Zhang, and Dong-ping He. \"Detection of an angiotensin converting enzyme inhibitory peptide from peanut protein isolate and peanut polypeptides by western blot and dot blot hybridization.\" European Food Research and Technology 230.1 (2009): 89.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "131", " Ligand_ID": "CVTPALR_minimized.pdb_131", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "758.93", " logP": "-5.15", " logD": "-6.26", " logSw": "0.15", " tPSA": "356.25", " RotatableB": "22", " RigidB": "19", " Flexibility": "0.54", " HBD": "13", " HBA": "19", " HBD_HBA": "32", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "52", " CarbonAtoms": "32", " HeteroAtoms": "20", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "882753.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 758.929", "link_html_complex": "/ACE_complex_html/ACE_CVTPALR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CVTPALR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CVTPALR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CVTPALR.png", "phi_psi": "/peptide_da/CVTPALR.pdb", "link_html_peptide": "/Peptide_html/CVTPALR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CVTPALR.pdb", "link_png_peptide": "/Peptide_pics/CVTPALR.png"}
{"Peptide_Sequence": "CWLPVY", " Origin": "dried salt fish", " Peptide_Preparation": "protease digestion", " Isolation_Method": "GFC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "22.20 \u03bcM", " Reference": "Astawan, Made, et al. \"Effects of angiotensin I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats.\" Bioscience, biotechnology, and biochemistry 59.3 (1995): 425-429.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "132", " Ligand_ID": "CWLPVY_minimized.pdb_132", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "779.95", " logP": "0.85", " logD": "-1.63", " logSw": "-4.13", " tPSA": "279.3", " RotatableB": "18", " RigidB": "32", " Flexibility": "0.36", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "39", " HeteroAtoms": "16", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12594.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 779.944", "link_html_complex": "/ACE_complex_html/ACE_CWLPVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_CWLPVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_CWLPVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_CWLPVY.png", "phi_psi": "/peptide_da/CWLPVY.pdb", "link_html_peptide": "/Peptide_html/CWLPVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/CWLPVY.pdb", "link_png_peptide": "/Peptide_pics/CWLPVY.png"}
{"Peptide_Sequence": "DA", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "3800.00 \u03bcM", " Reference": "Angiotensin converting enzyme inhibitors:Evolution of a new class of antihypertensive drugs (page 19). in:   Horovitz Z. P. (Ed.)(1981), Mechanisms of action and clinical implications, Urban & Schwarzenberg.", " Binding_Energy_kcal_per_mol": "-5.7", "Serial_ID": "134", " Ligand_ID": "DA_minimized.pdb_134", " Smiles": "C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(O)=O", " MW": "204.18", " logP": "-4.12", " logD": "-7.51", " logSw": "1.82", " tPSA": "137", " RotatableB": "5", " RigidB": "4", " Flexibility": "0.56", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1259770.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 204.181", "link_html_complex": "/ACE_complex_html/ACE_DA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DA.png", "phi_psi": "/peptide_da/DA.pdb", "link_html_peptide": "/Peptide_html/DA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DA.pdb", "link_png_peptide": "/Peptide_pics/DA.png"}
{"Peptide_Sequence": "DAGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "162.3 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "133", " Ligand_ID": "DAGP_minimized.pdb_133", " Smiles": "C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "358.35", " logP": "-4.72", " logD": "-8.95", " logSw": "1.44", " tPSA": "186.41", " RotatableB": "8", " RigidB": "13", " Flexibility": "0.38", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "14", " HeteroAtoms": "11", " ratio_H_by_C": "0.79", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1512244.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.347", "link_html_complex": "/ACE_complex_html/ACE_DAGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DAGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DAGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DAGP.png", "phi_psi": "/peptide_da/DAGP.pdb", "link_html_peptide": "/Peptide_html/DAGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DAGP.pdb", "link_png_peptide": "/Peptide_pics/DAGP.png"}
{"Peptide_Sequence": "DAQSAPLRVY", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "12.2 \u03bcM", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "135", " Ligand_ID": "DAQSAPLRVY_minimized.pdb_135", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1119.23", " logP": "-5.36", " logD": "-9.63", " logSw": "-1.19", " tPSA": "508.2", " RotatableB": "34", " RigidB": "34", " Flexibility": "0.5", " HBD": "20", " HBA": "30", " HBD_HBA": "50", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "79", " CarbonAtoms": "49", " HeteroAtoms": "30", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "341620.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1119.23", "link_html_complex": "/ACE_complex_html/ACE_DAQSAPLRVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DAQSAPLRVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DAQSAPLRVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DAQSAPLRVY.png", "phi_psi": "/peptide_da/DAQSAPLRVY.pdb", "link_html_peptide": "/Peptide_html/DAQSAPLRVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DAQSAPLRVY.pdb", "link_png_peptide": "/Peptide_pics/DAQSAPLRVY.png"}
{"Peptide_Sequence": "DAYPSGAW", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "98 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "136", " Ligand_ID": "DAYPSGAW_minimized.pdb_136", " Smiles": "C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "865.89", " logP": "-4.18", " logD": "-8.97", " logSw": "-1.29", " tPSA": "359.06", " RotatableB": "21", " RigidB": "37", " Flexibility": "0.36", " HBD": "13", " HBA": "22", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "62", " CarbonAtoms": "40", " HeteroAtoms": "22", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "238992.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 865.885", "link_html_complex": "/ACE_complex_html/ACE_DAYPSGAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DAYPSGAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DAYPSGAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DAYPSGAW.png", "phi_psi": "/peptide_da/DAYPSGAW.pdb", "link_html_peptide": "/Peptide_html/DAYPSGAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DAYPSGAW.pdb", "link_png_peptide": "/Peptide_pics/DAYPSGAW.png"}
{"Peptide_Sequence": "DDTGHDFEDTGEAM", " Origin": "rotifer (Brachionus rotundiformis)", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.64 \u03bcM", " Reference": "Lee, Jung Kwon, et al. \"Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis.\" Bioresource Technology 100.21 (2009): 5255-5259.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1539.49", "link_html_complex": "/ACE_complex_html/ACE_DDTGHDFEDTGEAM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DDTGHDFEDTGEAM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DDTGHDFEDTGEAM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DDTGHDFEDTGEAM.png", "phi_psi": "/peptide_da/DDTGHDFEDTGEAM.pdb", "link_html_peptide": "/Peptide_html/DDTGHDFEDTGEAM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DDTGHDFEDTGEAM.pdb", "link_png_peptide": "/Peptide_pics/DDTGHDFEDTGEAM.png"}
{"Peptide_Sequence": "DELQDKIHPFAQTQSLVYPFPGPIPNS", " Origin": "casein", " Peptide_Preparation": "trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "4 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "86.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 3039.35", "link_html_complex": "/ACE_complex_html/ACE_DELQDKIHPFAQTQSLVYPFPGPIPNS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DELQDKIHPFAQTQSLVYPFPGPIPNS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DELQDKIHPFAQTQSLVYPFPGPIPNS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DELQDKIHPFAQTQSLVYPFPGPIPNS.png", "phi_psi": "/peptide_da/DELQDKIHPFAQTQSLVYPFPGPIPNS.pdb", "link_html_peptide": "/Peptide_html/DELQDKIHPFAQTQSLVYPFPGPIPNS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DELQDKIHPFAQTQSLVYPFPGPIPNS.pdb", "link_png_peptide": "/Peptide_pics/DELQDKIHPFAQTQSLVYPFPGPIPNS.png"}
{"Peptide_Sequence": "DF", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "360 \u03bcM", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "141", " Ligand_ID": "DF_minimized.pdb_141", " Smiles": "N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "280.28", " logP": "-3.34", " logD": "-5.81", " logSw": "0.87", " tPSA": "137", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "665759.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 280.277", "link_html_complex": "/ACE_complex_html/ACE_DF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DF.png", "phi_psi": "/peptide_da/DF.pdb", "link_html_peptide": "/Peptide_html/DF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DF.pdb", "link_png_peptide": "/Peptide_pics/DF.png"}
{"Peptide_Sequence": "DFG", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "44.7 \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "139", " Ligand_ID": "DFG_minimized.pdb_139", " Smiles": "N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O", " MW": "337.33", " logP": "-4.16", " logD": "-6.99", " logSw": "1.18", " tPSA": "166.1", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1097913.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 337.328", "link_html_complex": "/ACE_complex_html/ACE_DFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DFG.png", "phi_psi": "/peptide_da/DFG.pdb", "link_html_peptide": "/Peptide_html/DFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DFG.pdb", "link_png_peptide": "/Peptide_pics/DFG.png"}
{"Peptide_Sequence": "DFHINQ", " Origin": "beef", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Jang, Aera, et al. \"Antimicrobial and human cancer cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory peptides.\" Food Chemistry 107.1 (2008): 327-336.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "140", " Ligand_ID": "DFHINQ_minimized.pdb_140", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "772.81", " logP": "-5.14", " logD": "-9.89", " logSw": "0.05", " tPSA": "368.26", " RotatableB": "23", " RigidB": "27", " Flexibility": "0.46", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "55", " CarbonAtoms": "34", " HeteroAtoms": "21", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "809004.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 772.805", "link_html_complex": "/ACE_complex_html/ACE_DFHINQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DFHINQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DFHINQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DFHINQ.png", "phi_psi": "/peptide_da/DFHINQ.pdb", "link_html_peptide": "/Peptide_html/DFHINQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DFHINQ.pdb", "link_png_peptide": "/Peptide_pics/DFHINQ.png"}
{"Peptide_Sequence": "DFVAP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Casokinins as bioactive peptides in the primary strucure of casein. In: Food proteins, structure and functionality ed Schwenke K.D., Mothes R., VCh, Weinheim - New York - Basel - Cambridge - Tokyo, pp 67-75", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "142", " Ligand_ID": "DFVAP_minimized.pdb_142", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "547.6", " logP": "-2.02", " logD": "-6.41", " logSw": "-1.16", " tPSA": "215.51", " RotatableB": "13", " RigidB": "21", " Flexibility": "0.38", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "171160.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 547.601", "link_html_complex": "/ACE_complex_html/ACE_DFVAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DFVAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DFVAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DFVAP.png", "phi_psi": "/peptide_da/DFVAP.pdb", "link_html_peptide": "/Peptide_html/DFVAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DFVAP.pdb", "link_png_peptide": "/Peptide_pics/DFVAP.png"}
{"Peptide_Sequence": "DG", " Origin": "Soy-protein-derived", " Peptide_Preparation": " Wu (1998)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "12.3 \u03bcM", " Reference": "Wu, Jianping, and Xiaolin Ding. \"Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides.\" Food research international 35.4 (2002): 367-375.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "144", " Ligand_ID": "DG_minimized.pdb_144", " Smiles": "N[C@@H](CC(O)=O)C(=O)NCC(O)=O", " MW": "190.15", " logP": "-4.52", " logD": "-8.1", " logSw": "2.16", " tPSA": "137", " RotatableB": "5", " RigidB": "4", " Flexibility": "0.56", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "13", " CarbonAtoms": "6", " HeteroAtoms": "7", " ratio_H_by_C": "1.17", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1646619.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 190.154", "link_html_complex": "/ACE_complex_html/ACE_DG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DG.png", "phi_psi": "/peptide_da/DG.pdb", "link_html_peptide": "/Peptide_html/DG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DG.pdb", "link_png_peptide": "/Peptide_pics/DG.png"}
{"Peptide_Sequence": "DGL", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.16 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "143", " Ligand_ID": "DGL_minimized.pdb_143", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)CC(O)=O)C(O)=O", " MW": "303.31", " logP": "-3.45", " logD": "-7.36", " logSw": "1.05", " tPSA": "166.1", " RotatableB": "9", " RigidB": "6", " Flexibility": "0.6", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "864134.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.312", "link_html_complex": "/ACE_complex_html/ACE_DGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DGL.png", "phi_psi": "/peptide_da/DGL.pdb", "link_html_peptide": "/Peptide_html/DGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DGL.pdb", "link_png_peptide": "/Peptide_pics/DGL.png"}
{"Peptide_Sequence": "DGSRQPV", " Origin": "Egg whites", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) modified", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "145", " Ligand_ID": "DGSRQPV_minimized.pdb_145", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CC(O)=O)C(O)=O", " MW": "757.79", " logP": "-7.55", " logD": "-11.2", " logSw": "1.8", " tPSA": "400.67", " RotatableB": "24", " RigidB": "22", " Flexibility": "0.52", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "30", " HeteroAtoms": "23", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4594413.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 757.792", "link_html_complex": "/ACE_complex_html/ACE_DGSRQPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DGSRQPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DGSRQPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DGSRQPV.png", "phi_psi": "/peptide_da/DGSRQPV.pdb", "link_html_peptide": "/Peptide_html/DGSRQPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DGSRQPV.pdb", "link_png_peptide": "/Peptide_pics/DGSRQPV.png"}
{"Peptide_Sequence": "DGVVYY", " Origin": "tomato waste proteins", " Peptide_Preparation": "", " Isolation_Method": "GF, RP-HPLC, SEC, membrane filteration", " ACE_inhibition_assay": "Sentandreu & Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "Moayedi, Ali, et al. \"Peptidomic analysis of antioxidant and ACE-inhibitory peptides obtained from tomato waste proteins fermented using Bacillus subtilis.\" Food chemistry 250 (2018): 180-187.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "146", " Ligand_ID": "DGVVYY_minimized.pdb_146", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "714.76", " logP": "-2.33", " logD": "-5.88", " logSw": "-1.64", " tPSA": "293.86", " RotatableB": "19", " RigidB": "24", " Flexibility": "0.44", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "138486.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 714.763", "link_html_complex": "/ACE_complex_html/ACE_DGVVYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DGVVYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DGVVYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DGVVYY.png", "phi_psi": "/peptide_da/DGVVYY.pdb", "link_html_peptide": "/Peptide_html/DGVVYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DGVVYY.pdb", "link_png_peptide": "/Peptide_pics/DGVVYY.png"}
{"Peptide_Sequence": "DHPFLF", " Origin": "Egg", " Peptide_Preparation": "Alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Yu, Zhipeng, et al. \"QIGLF, a novel angiotensin I\u2010converting enzyme\u2010inhibitory peptide from egg white protein.\" Journal of the Science of Food and Agriculture 91.5 (2011): 921-926.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "147", " Ligand_ID": "DHPFLF_minimized.pdb_147", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "774.86", " logP": "-0.57", " logD": "-5.29", " logSw": "-3.08", " tPSA": "273.29", " RotatableB": "20", " RigidB": "34", " Flexibility": "0.37", " HBD": "9", " HBA": "17", " HBD_HBA": "26", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "56", " CarbonAtoms": "39", " HeteroAtoms": "17", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "35479.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 774.863", "link_html_complex": "/ACE_complex_html/ACE_DHPFLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DHPFLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DHPFLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DHPFLF.png", "phi_psi": "/peptide_da/DHPFLF.pdb", "link_html_peptide": "/Peptide_html/DHPFLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DHPFLF.pdb", "link_png_peptide": "/Peptide_pics/DHPFLF.png"}
{"Peptide_Sequence": "DIGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "194.2 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "148", " Ligand_ID": "DIGP_minimized.pdb_148", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "400.43", " logP": "-3.4", " logD": "-7.67", " logSw": "0.48", " tPSA": "186.41", " RotatableB": "10", " RigidB": "13", " Flexibility": "0.43", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "646701.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.427", "link_html_complex": "/ACE_complex_html/ACE_DIGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DIGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DIGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DIGP.png", "phi_psi": "/peptide_da/DIGP.pdb", "link_html_peptide": "/Peptide_html/DIGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DIGP.pdb", "link_png_peptide": "/Peptide_pics/DIGP.png"}
{"Peptide_Sequence": "DIGYY", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.4 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "149", " Ligand_ID": "DIGYY_minimized.pdb_149", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "629.66", " logP": "-2.32", " logD": "-5.76", " logSw": "-1.27", " tPSA": "264.76", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "177537.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 629.658", "link_html_complex": "/ACE_complex_html/ACE_DIGYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DIGYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DIGYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DIGYY.png", "phi_psi": "/peptide_da/DIGYY.pdb", "link_html_peptide": "/Peptide_html/DIGYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DIGYY.pdb", "link_png_peptide": "/Peptide_pics/DIGYY.png"}
{"Peptide_Sequence": "DILN", " Origin": "egg", " Peptide_Preparation": "synthesized", " Isolation_Method": "Chemical synthesis", " ACE_inhibition_assay": "Hernandez-Ledesma et al. (2005)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "73.4 \u03bcg", " Reference": "Pokora, M., et al. \"An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides.\" Food chemistry 151 (2014): 500-505.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "150", " Ligand_ID": "DILN_minimized.pdb_150", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "473.52", " logP": "-3.7", " logD": "-7.53", " logSw": "0.55", " tPSA": "238.29", " RotatableB": "15", " RigidB": "10", " Flexibility": "0.6", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "816778.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.52", "link_html_complex": "/ACE_complex_html/ACE_DILN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DILN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DILN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DILN.png", "phi_psi": "/peptide_da/DILN.pdb", "link_html_peptide": "/Peptide_html/DILN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DILN.pdb", "link_png_peptide": "/Peptide_pics/DILN.png"}
{"Peptide_Sequence": "DKIHP", " Origin": "Cabrales, Manchego, Roncal, Idiaz\u00e1bal, Mah\u00f3n, goat  cheese", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "113.1 \u03bcM", " Reference": "El-Salam, MH Abd, and S. El-Shibiny. \"Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products.\" Food Reviews International 29.1 (2013): 1-23.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "152", " Ligand_ID": "DKIHP_minimized.pdb_152", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "608.69", " logP": "-6.01", " logD": "-7.22", " logSw": "1.32", " tPSA": "271.83", " RotatableB": "18", " RigidB": "20", " Flexibility": "0.47", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "27", " HeteroAtoms": "16", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2273818.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 608.687", "link_html_complex": "/ACE_complex_html/ACE_DKIHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DKIHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DKIHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DKIHP.png", "phi_psi": "/peptide_da/DKIHP.pdb", "link_html_peptide": "/Peptide_html/DKIHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DKIHP.pdb", "link_png_peptide": "/Peptide_pics/DKIHP.png"}
{"Peptide_Sequence": "DKIHPF", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "151", " Ligand_ID": "DKIHPF_minimized.pdb_151", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "755.86", " logP": "-4.67", " logD": "-6.1", " logSw": "-0.21", " tPSA": "300.93", " RotatableB": "22", " RigidB": "28", " Flexibility": "0.44", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "36", " HeteroAtoms": "18", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "613723.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 755.861", "link_html_complex": "/ACE_complex_html/ACE_DKIHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DKIHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DKIHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DKIHPF.png", "phi_psi": "/peptide_da/DKIHPF.pdb", "link_html_peptide": "/Peptide_html/DKIHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DKIHPF.pdb", "link_png_peptide": "/Peptide_pics/DKIHPF.png"}
{"Peptide_Sequence": "DKIYPSFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "107 \u03bcM", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-3.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1806.06", "link_html_complex": "/ACE_complex_html/ACE_DKIYPSFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DKIYPSFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DKIYPSFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DKIYPSFQPQPLIYP.png", "phi_psi": "/peptide_da/DKIYPSFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/DKIYPSFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DKIYPSFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/DKIYPSFQPQPLIYP.png"}
{"Peptide_Sequence": "DKVGINY", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "99.9 \u03bcM", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "154", " Ligand_ID": "DKVGINY_minimized.pdb_154", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "807.89", " logP": "-6.3", " logD": "-7.87", " logSw": "0.8", " tPSA": "373.46", " RotatableB": "26", " RigidB": "22", " Flexibility": "0.54", " HBD": "15", " HBA": "21", " HBD_HBA": "36", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "36", " HeteroAtoms": "21", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1792839.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 807.891", "link_html_complex": "/ACE_complex_html/ACE_DKVGINY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DKVGINY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DKVGINY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DKVGINY.png", "phi_psi": "/peptide_da/DKVGINY.pdb", "link_html_peptide": "/Peptide_html/DKVGINY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DKVGINY.pdb", "link_png_peptide": "/Peptide_pics/DKVGINY.png"}
{"Peptide_Sequence": "DKVGINYW", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "25.4 \u03bcM", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "155", " Ligand_ID": "DKVGINYW_minimized.pdb_155", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "994.1", " logP": "-6.17", " logD": "-6.65", " logSw": "-0.22", " tPSA": "418.35", " RotatableB": "30", " RigidB": "34", " Flexibility": "0.47", " HBD": "17", " HBA": "24", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "71", " CarbonAtoms": "47", " HeteroAtoms": "24", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "800373.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 994.101", "link_html_complex": "/ACE_complex_html/ACE_DKVGINYW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DKVGINYW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DKVGINYW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DKVGINYW.png", "phi_psi": "/peptide_da/DKVGINYW.pdb", "link_html_peptide": "/Peptide_html/DKVGINYW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DKVGINYW.pdb", "link_png_peptide": "/Peptide_pics/DKVGINYW.png"}
{"Peptide_Sequence": "DL", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2000 \u03bcM", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "157", " Ligand_ID": "DL_minimized.pdb_157", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(O)=O", " MW": "246.26", " logP": "-3.66", " logD": "-6.14", " logSw": "1.4", " tPSA": "137", " RotatableB": "7", " RigidB": "4", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "999620", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 246.26", "link_html_complex": "/ACE_complex_html/ACE_DL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DL.png", "phi_psi": "/peptide_da/DL.pdb", "link_html_peptide": "/Peptide_html/DL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DL.pdb", "link_png_peptide": "/Peptide_pics/DL.png"}
{"Peptide_Sequence": "DLGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "149 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "156", " Ligand_ID": "DLGP_minimized.pdb_156", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "400.43", " logP": "-4.42", " logD": "-7.72", " logSw": "1.12", " tPSA": "186.41", " RotatableB": "10", " RigidB": "13", " Flexibility": "0.43", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1229649.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.427", "link_html_complex": "/ACE_complex_html/ACE_DLGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DLGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DLGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DLGP.png", "phi_psi": "/peptide_da/DLGP.pdb", "link_html_peptide": "/Peptide_html/DLGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DLGP.pdb", "link_png_peptide": "/Peptide_pics/DLGP.png"}
{"Peptide_Sequence": "DLP", " Origin": "Soy-protein-derived", " Peptide_Preparation": " Wu (1998)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.8 \u03bcM", " Reference": "Wu, Jianping, and Xiaolin Ding. \"Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides.\" Food research international 35.4 (2002): 367-375.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "158", " Ligand_ID": "DLP_minimized.pdb_158", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "343.38", " logP": "-3.77", " logD": "-6.5", " logSw": "0.93", " tPSA": "157.31", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "0", " Solubility_mg_per_l": "873926.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 343.375", "link_html_complex": "/ACE_complex_html/ACE_DLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DLP.png", "phi_psi": "/peptide_da/DLP.pdb", "link_html_peptide": "/Peptide_html/DLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DLP.pdb", "link_png_peptide": "/Peptide_pics/DLP.png"}
{"Peptide_Sequence": "DLQGK", " Origin": "egg white", " Peptide_Preparation": "heating, centrigugation", " Isolation_Method": "ion-exchange column", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Liu, JingBo, et al. \"Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates.\" Food chemistry 122.4 (2010): 1159-1163.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "159", " Ligand_ID": "DLQGK_minimized.pdb_159", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "559.61", " logP": "-7.64", " logD": "-8.82", " logSw": "2.82", " tPSA": "295.03", " RotatableB": "20", " RigidB": "12", " Flexibility": "0.63", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "23", " HeteroAtoms": "16", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9422391.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 559.613", "link_html_complex": "/ACE_complex_html/ACE_DLQGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DLQGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DLQGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DLQGK.png", "phi_psi": "/peptide_da/DLQGK.pdb", "link_html_peptide": "/Peptide_html/DLQGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DLQGK.pdb", "link_png_peptide": "/Peptide_pics/DLQGK.png"}
{"Peptide_Sequence": "DLTDY", " Origin": "Oyster protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Yamamoto et al. (1980) with some modificatio", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "0.143 \u03bcM", " Reference": "Shiozaki, Kazuhiro, et al. \"Identification of oyster-derived hypotensive peptide acting as angiotensin-I-converting enzyme inhibitor.\" Fisheries Science 76.5 (2010): 865-872.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "160", " Ligand_ID": "DLTDY_minimized.pdb_160", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "625.62", " logP": "-4.63", " logD": "-11.27", " logSw": "0.33", " tPSA": "304.89", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "44", " CarbonAtoms": "27", " HeteroAtoms": "17", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "872430.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 625.625", "link_html_complex": "/ACE_complex_html/ACE_DLTDY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DLTDY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DLTDY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DLTDY.png", "phi_psi": "/peptide_da/DLTDY.pdb", "link_html_peptide": "/Peptide_html/DLTDY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DLTDY.pdb", "link_png_peptide": "/Peptide_pics/DLTDY.png"}
{"Peptide_Sequence": "DM", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "600 \u03bcM", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-5.7", "Serial_ID": "162", " Ligand_ID": "DM_minimized.pdb_162", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CC(O)=O)C(O)=O", " MW": "264.3", " logP": "-4.06", " logD": "-6.83", " logSw": "1.61", " tPSA": "162.3", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "9", " HeteroAtoms": "8", " ratio_H_by_C": "0.89", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1318470.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 264.299", "link_html_complex": "/ACE_complex_html/ACE_DM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DM.png", "phi_psi": "/peptide_da/DM.pdb", "link_html_peptide": "/Peptide_html/DM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DM.pdb", "link_png_peptide": "/Peptide_pics/DM.png"}
{"Peptide_Sequence": "DMIPAQK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "45 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "161", " Ligand_ID": "DMIPAQK_minimized.pdb_161", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "801.95", " logP": "-6.8", " logD": "-8.32", " logSw": "1.19", " tPSA": "369.74", " RotatableB": "26", " RigidB": "21", " Flexibility": "0.55", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "34", " HeteroAtoms": "21", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2630558.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 801.951", "link_html_complex": "/ACE_complex_html/ACE_DMIPAQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DMIPAQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DMIPAQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DMIPAQK.png", "phi_psi": "/peptide_da/DMIPAQK.pdb", "link_html_peptide": "/Peptide_html/DMIPAQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DMIPAQK.pdb", "link_png_peptide": "/Peptide_pics/DMIPAQK.png"}
{"Peptide_Sequence": "DP", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "fermented by Lactobacillus fermentum SM 605", " Isolation_Method": "UF, GF, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.15 \u03bcM", " Reference": "Wang, Yu-Kai, et al. \"Production of novel angiotensin I-converting enzyme inhibitory peptides by fermentation of marine shrimp Acetes chinensis with Lactobacillus fermentum SM 605.\" Applied microbiology and biotechnology 79.5 (2008): 785-791.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "163", " Ligand_ID": "DP_minimized.pdb_163", " Smiles": "N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "230.22", " logP": "-3.58", " logD": "-7.22", " logSw": "1.25", " tPSA": "128.21", " RotatableB": "4", " RigidB": "9", " Flexibility": "0.31", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "16", " CarbonAtoms": "9", " HeteroAtoms": "7", " ratio_H_by_C": "0.78", " Lipinski_Violation": "0", " Solubility_mg_per_l": "805187.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 230.218", "link_html_complex": "/ACE_complex_html/ACE_DP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DP.png", "phi_psi": "/peptide_da/DP.pdb", "link_html_peptide": "/Peptide_html/DP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DP.pdb", "link_png_peptide": "/Peptide_pics/DP.png"}
{"Peptide_Sequence": "DPYKLRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "30.5 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "164", " Ligand_ID": "DPYKLRP_minimized.pdb_164", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "888.02", " logP": "-5.56", " logD": "-9.17", " logSw": "-0.16", " tPSA": "376.43", " RotatableB": "26", " RigidB": "31", " Flexibility": "0.46", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "63", " CarbonAtoms": "41", " HeteroAtoms": "22", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "755494.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 888.022", "link_html_complex": "/ACE_complex_html/ACE_DPYKLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DPYKLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DPYKLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DPYKLRP.png", "phi_psi": "/peptide_da/DPYKLRP.pdb", "link_html_peptide": "/Peptide_html/DPYKLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DPYKLRP.pdb", "link_png_peptide": "/Peptide_pics/DPYKLRP.png"}
{"Peptide_Sequence": "DTGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "<1500 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "165", " Ligand_ID": "DTGP_minimized.pdb_165", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "388.37", " logP": "-5.34", " logD": "-9.64", " logSw": "1.71", " tPSA": "206.64", " RotatableB": "9", " RigidB": "13", " Flexibility": "0.41", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "27", " CarbonAtoms": "15", " HeteroAtoms": "12", " ratio_H_by_C": "0.8", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2147916.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 388.373", "link_html_complex": "/ACE_complex_html/ACE_DTGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DTGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DTGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DTGP.png", "phi_psi": "/peptide_da/DTGP.pdb", "link_html_peptide": "/Peptide_html/DTGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DTGP.pdb", "link_png_peptide": "/Peptide_pics/DTGP.png"}
{"Peptide_Sequence": "DTW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "260 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "166", " Ligand_ID": "DTW_minimized.pdb_166", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "420.42", " logP": "-3.95", " logD": "-6.93", " logSw": "0.58", " tPSA": "202.12", " RotatableB": "10", " RigidB": "16", " Flexibility": "0.38", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "19", " HeteroAtoms": "11", " ratio_H_by_C": "0.58", " Lipinski_Violation": "2", " Solubility_mg_per_l": "749817.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.37", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 420.416", "link_html_complex": "/ACE_complex_html/ACE_DTW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DTW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DTW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DTW.png", "phi_psi": "/peptide_da/DTW.pdb", "link_html_peptide": "/Peptide_html/DTW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DTW.pdb", "link_png_peptide": "/Peptide_pics/DTW.png"}
{"Peptide_Sequence": "DVITGA", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo, in-vitro", " IC50_micromol_per_L": "900 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "167", " Ligand_ID": "DVITGA_minimized.pdb_167", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C)C(O)=O", " MW": "574.62", " logP": "-5.07", " logD": "-8.78", " logSw": "0.91", " tPSA": "273.63", " RotatableB": "17", " RigidB": "12", " Flexibility": "0.59", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1432454.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 574.624", "link_html_complex": "/ACE_complex_html/ACE_DVITGA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DVITGA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DVITGA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DVITGA.png", "phi_psi": "/peptide_da/DVITGA.pdb", "link_html_peptide": "/Peptide_html/DVITGA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DVITGA.pdb", "link_png_peptide": "/Peptide_pics/DVITGA.png"}
{"Peptide_Sequence": "DVWY", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "690 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-10.9", "Serial_ID": "168", " Ligand_ID": "DVWY_minimized.pdb_168", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "581.62", " logP": "-1.54", " logD": "-4.69", " logSw": "-1.7", " tPSA": "231.22", " RotatableB": "14", " RigidB": "24", " Flexibility": "0.37", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "106679.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.34", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 581.617", "link_html_complex": "/ACE_complex_html/ACE_DVWY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DVWY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DVWY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DVWY.png", "phi_psi": "/peptide_da/DVWY.pdb", "link_html_peptide": "/Peptide_html/DVWY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DVWY.pdb", "link_png_peptide": "/Peptide_pics/DVWY.png"}
{"Peptide_Sequence": "DW", " Origin": "hum salmon head", " Peptide_Preparation": "commercial protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "13 \u03bcM", " Reference": "OHTA, Tomoki, et al. \"Antihypertensive action of the orally administered protease hydrolysates of chum salmon head and their angiotensin I-converting enzyme inhibitory peptides.\" Food Science and Technology International, Tokyo 3.4 (1997): 339-343.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "169", " Ligand_ID": "DW_minimized.pdb_169", " Smiles": "N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "319.31", " logP": "-3.08", " logD": "-5.67", " logSw": "0.42", " tPSA": "152.79", " RotatableB": "7", " RigidB": "14", " Flexibility": "0.33", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "484119.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 319.313", "link_html_complex": "/ACE_complex_html/ACE_DW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DW.png", "phi_psi": "/peptide_da/DW.pdb", "link_html_peptide": "/Peptide_html/DW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DW.pdb", "link_png_peptide": "/Peptide_pics/DW.png"}
{"Peptide_Sequence": "DY", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "100 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "172", " Ligand_ID": "DY_minimized.pdb_172", " Smiles": "N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "296.28", " logP": "-4.35", " logD": "-6.19", " logSw": "1.41", " tPSA": "157.23", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1208192.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 296.276", "link_html_complex": "/ACE_complex_html/ACE_DY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DY.png", "phi_psi": "/peptide_da/DY.pdb", "link_html_peptide": "/Peptide_html/DY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DY.pdb", "link_png_peptide": "/Peptide_pics/DY.png"}
{"Peptide_Sequence": "DYG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2700 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "171", " Ligand_ID": "DYG_minimized.pdb_171", " Smiles": "N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O", " MW": "353.33", " logP": "-4.52", " logD": "-7.34", " logSw": "1.31", " tPSA": "186.33", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "15", " HeteroAtoms": "10", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1309573.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 353.327", "link_html_complex": "/ACE_complex_html/ACE_DYG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DYG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DYG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DYG.png", "phi_psi": "/peptide_da/DYG.pdb", "link_html_peptide": "/Peptide_html/DYG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DYG.pdb", "link_png_peptide": "/Peptide_pics/DYG.png"}
{"Peptide_Sequence": "DYGLYP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "62 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "170", " Ligand_ID": "DYGLYP_minimized.pdb_170", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "726.77", " logP": "-3.13", " logD": "-6.09", " logSw": "-1.28", " tPSA": "285.07", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "202736.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 726.773", "link_html_complex": "/ACE_complex_html/ACE_DYGLYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DYGLYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DYGLYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DYGLYP.png", "phi_psi": "/peptide_da/DYGLYP.pdb", "link_html_peptide": "/Peptide_html/DYGLYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DYGLYP.pdb", "link_png_peptide": "/Peptide_pics/DYGLYP.png"}
{"Peptide_Sequence": "DYVGN", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.72 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "173", " Ligand_ID": "DYVGN_minimized.pdb_173", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "566.56", " logP": "-5.43", " logD": "-9.05", " logSw": "1.06", " tPSA": "287.62", " RotatableB": "16", " RigidB": "18", " Flexibility": "0.47", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1642224.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 566.561", "link_html_complex": "/ACE_complex_html/ACE_DYVGN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_DYVGN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_DYVGN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_DYVGN.png", "phi_psi": "/peptide_da/DYVGN.pdb", "link_html_peptide": "/Peptide_html/DYVGN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/DYVGN.pdb", "link_png_peptide": "/Peptide_pics/DYVGN.png"}
{"Peptide_Sequence": "EA", " Origin": "meat proteins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Lafarga, Tomas, Paula O\u2019Connor, and Maria Hayes. \"Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis.\" Peptides 59 (2014): 53-62.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "174", " Ligand_ID": "EA_minimized.pdb_174", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "218.21", " logP": "-3.76", " logD": "-7.18", " logSw": "1.57", " tPSA": "137", " RotatableB": "6", " RigidB": "4", " Flexibility": "0.6", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "15", " CarbonAtoms": "8", " HeteroAtoms": "7", " ratio_H_by_C": "0.88", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1050856.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 218.207", "link_html_complex": "/ACE_complex_html/ACE_EA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EA.png", "phi_psi": "/peptide_da/EA.pdb", "link_html_peptide": "/Peptide_html/EA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EA.pdb", "link_png_peptide": "/Peptide_pics/EA.png"}
{"Peptide_Sequence": "EAP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "175", " Ligand_ID": "EAP_minimized.pdb_175", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "315.32", " logP": "-4.73", " logD": "-7.65", " logSw": "1.65", " tPSA": "157.31", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1636797.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 315.322", "link_html_complex": "/ACE_complex_html/ACE_EAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EAP.png", "phi_psi": "/peptide_da/EAP.pdb", "link_html_peptide": "/Peptide_html/EAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EAP.pdb", "link_png_peptide": "/Peptide_pics/EAP.png"}
{"Peptide_Sequence": "EAPPK", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "176", " Ligand_ID": "EAPPK_minimized.pdb_176", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "540.61", " logP": "-6.43", " logD": "-7.73", " logSw": "1.78", " tPSA": "234.36", " RotatableB": "14", " RigidB": "20", " Flexibility": "0.41", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3215753.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 540.61", "link_html_complex": "/ACE_complex_html/ACE_EAPPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EAPPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EAPPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EAPPK.png", "phi_psi": "/peptide_da/EAPPK.pdb", "link_html_peptide": "/Peptide_html/EAPPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EAPPK.pdb", "link_png_peptide": "/Peptide_pics/EAPPK.png"}
{"Peptide_Sequence": "EDENNPFYLR", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "730 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "177", " Ligand_ID": "EDENNPFYLR_minimized.pdb_177", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1296.34", " logP": "-6.58", " logD": "-17.01", " logSw": "-1.14", " tPSA": "611.32", " RotatableB": "40", " RigidB": "44", " Flexibility": "0.48", " HBD": "23", " HBA": "35", " HBD_HBA": "58", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "-2", " HeavyAtoms": "92", " CarbonAtoms": "57", " HeteroAtoms": "35", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "413250.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1296.34", "link_html_complex": "/ACE_complex_html/ACE_EDENNPFYLR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EDENNPFYLR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EDENNPFYLR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EDENNPFYLR.png", "phi_psi": "/peptide_da/EDENNPFYLR.pdb", "link_html_peptide": "/Peptide_html/EDENNPFYLR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EDENNPFYLR.pdb", "link_png_peptide": "/Peptide_pics/EDENNPFYLR.png"}
{"Peptide_Sequence": "EEAGG", " Origin": "meat-derived, fish-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "178", " Ligand_ID": "EEAGG_minimized.pdb_178", " Smiles": "C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(=O)NCC(O)=O", " MW": "461.42", " logP": "-5.84", " logD": "-13.69", " logSw": "1.97", " tPSA": "264.43", " RotatableB": "15", " RigidB": "11", " Flexibility": "0.58", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "32", " CarbonAtoms": "17", " HeteroAtoms": "15", " ratio_H_by_C": "0.88", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3303340.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 461.424", "link_html_complex": "/ACE_complex_html/ACE_EEAGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EEAGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EEAGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EEAGG.png", "phi_psi": "/peptide_da/EEAGG.pdb", "link_html_peptide": "/Peptide_html/EEAGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EEAGG.pdb", "link_png_peptide": "/Peptide_pics/EEAGG.png"}
{"Peptide_Sequence": "EEYPDL", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "179", " Ligand_ID": "EEYPDL_minimized.pdb_179", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "764.78", " logP": "-4.81", " logD": "-14.19", " logSw": "-0.14", " tPSA": "345.1", " RotatableB": "22", " RigidB": "25", " Flexibility": "0.47", " HBD": "11", " HBA": "20", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-3", " HeavyAtoms": "54", " CarbonAtoms": "34", " HeteroAtoms": "20", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "662976.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 764.777", "link_html_complex": "/ACE_complex_html/ACE_EEYPDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EEYPDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EEYPDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EEYPDL.png", "phi_psi": "/peptide_da/EEYPDL.pdb", "link_html_peptide": "/Peptide_html/EEYPDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EEYPDL.pdb", "link_png_peptide": "/Peptide_pics/EEYPDL.png"}
{"Peptide_Sequence": "EG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "10000 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.8", "Serial_ID": "181", " Ligand_ID": "EG_minimized.pdb_181", " Smiles": "N[C@@H](CCC(O)=O)C(=O)NCC(O)=O", " MW": "204.18", " logP": "-2.66", " logD": "-7.79", " logSw": "0.97", " tPSA": "137", " RotatableB": "6", " RigidB": "4", " Flexibility": "0.6", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "536402.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 204.181", "link_html_complex": "/ACE_complex_html/ACE_EG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EG.png", "phi_psi": "/peptide_da/EG.pdb", "link_html_peptide": "/Peptide_html/EG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EG.pdb", "link_png_peptide": "/Peptide_pics/EG.png"}
{"Peptide_Sequence": "EGEPR", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "728.2 \u03bcM", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "180", " Ligand_ID": "EGEPR_minimized.pdb_180", " Smiles": "N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "586.6", " logP": "-7.46", " logD": "-12.33", " logSw": "2.48", " tPSA": "319.28", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6983068.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 586.595", "link_html_complex": "/ACE_complex_html/ACE_EGEPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EGEPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EGEPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EGEPR.png", "phi_psi": "/peptide_da/EGEPR.pdb", "link_html_peptide": "/Peptide_html/EGEPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EGEPR.pdb", "link_png_peptide": "/Peptide_pics/EGEPR.png"}
{"Peptide_Sequence": "EGPKLVAS", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "17.5 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "182", " Ligand_ID": "EGPKLVAS_minimized.pdb_182", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O", " MW": "799.91", " logP": "-6.66", " logD": "-9.09", " logSw": "1.05", " tPSA": "350.68", " RotatableB": "25", " RigidB": "21", " Flexibility": "0.54", " HBD": "13", " HBA": "21", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "35", " HeteroAtoms": "21", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2277531.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 799.912", "link_html_complex": "/ACE_complex_html/ACE_EGPKLVAS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EGPKLVAS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EGPKLVAS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EGPKLVAS.png", "phi_psi": "/peptide_da/EGPKLVAS.pdb", "link_html_peptide": "/Peptide_html/EGPKLVAS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EGPKLVAS.pdb", "link_png_peptide": "/Peptide_pics/EGPKLVAS.png"}
{"Peptide_Sequence": "EIPT", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "183", " Ligand_ID": "EIPT_minimized.pdb_183", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "458.51", " logP": "-4.77", " logD": "-7.55", " logSw": "1.11", " tPSA": "206.64", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "20", " HeteroAtoms": "12", " ratio_H_by_C": "0.6", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1397354.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 458.506", "link_html_complex": "/ACE_complex_html/ACE_EIPT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EIPT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EIPT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EIPT.png", "phi_psi": "/peptide_da/EIPT.pdb", "link_html_peptide": "/Peptide_html/EIPT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EIPT.pdb", "link_png_peptide": "/Peptide_pics/EIPT.png"}
{"Peptide_Sequence": "EIVPNSAEERLH", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "184", " Ligand_ID": "EIVPNSAEERLH_minimized.pdb_184", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "1393.5", " logP": "-7.04", " logD": "-18.69", " logSw": "-1.03", " tPSA": "655.11", " RotatableB": "46", " RigidB": "39", " Flexibility": "0.54", " HBD": "24", " HBA": "39", " HBD_HBA": "63", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "-2", " HeavyAtoms": "98", " CarbonAtoms": "59", " HeteroAtoms": "39", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "498694.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1393.5", "link_html_complex": "/ACE_complex_html/ACE_EIVPNSAEERLH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EIVPNSAEERLH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EIVPNSAEERLH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EIVPNSAEERLH.png", "phi_psi": "/peptide_da/EIVPNSAEERLH.pdb", "link_html_peptide": "/Peptide_html/EIVPNSAEERLH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EIVPNSAEERLH.pdb", "link_png_peptide": "/Peptide_pics/EIVPNSAEERLH.png"}
{"Peptide_Sequence": "EK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "188", " Ligand_ID": "EK_minimized.pdb_188", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "275.3", " logP": "-6.28", " logD": "-6.63", " logSw": "3.07", " tPSA": "164.64", " RotatableB": "10", " RigidB": "4", " Flexibility": "0.71", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "5927734.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 275.302", "link_html_complex": "/ACE_complex_html/ACE_EK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EK.png", "phi_psi": "/peptide_da/EK.pdb", "link_html_peptide": "/Peptide_html/EK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EK.pdb", "link_png_peptide": "/Peptide_pics/EK.png"}
{"Peptide_Sequence": "EKDERF", " Origin": "ovine milk", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "UF, FPLC, RP-HPLC, IT-MS (CE-MS)", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "14.3 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "185", " Ligand_ID": "EKDERF_minimized.pdb_185", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "822.86", " logP": "-7.91", " logD": "-14.1", " logSw": "1.98", " tPSA": "424.94", " RotatableB": "30", " RigidB": "21", " Flexibility": "0.59", " HBD": "17", " HBA": "23", " HBD_HBA": "40", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "7", " TotalCharge": "-1", " HeavyAtoms": "58", " CarbonAtoms": "35", " HeteroAtoms": "23", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5971174.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 822.863", "link_html_complex": "/ACE_complex_html/ACE_EKDERF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EKDERF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EKDERF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EKDERF.png", "phi_psi": "/peptide_da/EKDERF.pdb", "link_html_peptide": "/Peptide_html/EKDERF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EKDERF.pdb", "link_png_peptide": "/Peptide_pics/EKDERF.png"}
{"Peptide_Sequence": "EKERERQ", " Origin": "Porcine Skeletal Muscle Troponin", " Peptide_Preparation": "Katayama et al (2003)", " Isolation_Method": "AEC, RP-HPLC, GF", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "552.5 \u03bcM", " Reference": "Katayama, Kazunori, et al. \"Porcine skeletal muscle troponin is a good source of peptides with angiotensin-I converting enzyme inhibitory activity and antihypertensive effects in spontaneously hypertensive rats.\" Journal of Agricultural and Food Chemistry 56.2 (2007): 355-360.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "186", " Ligand_ID": "EKERERQ_minimized.pdb_186", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "974.03", " logP": "-11.38", " logD": "-16.79", " logSw": "3.86", " tPSA": "560.77", " RotatableB": "39", " RigidB": "20", " Flexibility": "0.66", " HBD": "24", " HBA": "30", " HBD_HBA": "54", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "8", " TotalCharge": "0", " HeavyAtoms": "68", " CarbonAtoms": "38", " HeteroAtoms": "30", " ratio_H_by_C": "0.79", " Lipinski_Violation": "3", " Solubility_mg_per_l": "46437179.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 974.03", "link_html_complex": "/ACE_complex_html/ACE_EKERERQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EKERERQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EKERERQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EKERERQ.png", "phi_psi": "/peptide_da/EKERERQ.pdb", "link_html_peptide": "/Peptide_html/EKERERQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EKERERQ.pdb", "link_png_peptide": "/Peptide_pics/EKERERQ.png"}
{"Peptide_Sequence": "EKGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "129.9 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "187", " Ligand_ID": "EKGP_minimized.pdb_187", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "429.47", " logP": "-6.88", " logD": "-8.04", " logSw": "2.69", " tPSA": "214.05", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "6324874.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.468", "link_html_complex": "/ACE_complex_html/ACE_EKGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EKGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EKGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EKGP.png", "phi_psi": "/peptide_da/EKGP.pdb", "link_html_peptide": "/Peptide_html/EKGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EKGP.pdb", "link_png_peptide": "/Peptide_pics/EKGP.png"}
{"Peptide_Sequence": "EKSYELP", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "14.41 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "189", " Ligand_ID": "EKSYELP_minimized.pdb_189", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "864.94", " logP": "-6.25", " logD": "-11.14", " logSw": "0.48", " tPSA": "381.94", " RotatableB": "27", " RigidB": "26", " Flexibility": "0.51", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "61", " CarbonAtoms": "39", " HeteroAtoms": "22", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1398063.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 864.939", "link_html_complex": "/ACE_complex_html/ACE_EKSYELP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EKSYELP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EKSYELP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EKSYELP.png", "phi_psi": "/peptide_da/EKSYELP.pdb", "link_html_peptide": "/Peptide_html/EKSYELP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EKSYELP.pdb", "link_png_peptide": "/Peptide_pics/EKSYELP.png"}
{"Peptide_Sequence": "ELIN", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "190", " Ligand_ID": "ELIN_minimized.pdb_190", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "487.55", " logP": "-3.34", " logD": "-7.34", " logSw": "0.3", " tPSA": "238.29", " RotatableB": "16", " RigidB": "10", " Flexibility": "0.62", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "34", " CarbonAtoms": "21", " HeteroAtoms": "13", " ratio_H_by_C": "0.62", " Lipinski_Violation": "2", " Solubility_mg_per_l": "656415.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 487.547", "link_html_complex": "/ACE_complex_html/ACE_ELIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ELIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ELIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ELIN.png", "phi_psi": "/peptide_da/ELIN.pdb", "link_html_peptide": "/Peptide_html/ELIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ELIN.pdb", "link_png_peptide": "/Peptide_pics/ELIN.png"}
{"Peptide_Sequence": "EMPFPK", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "423 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "191", " Ligand_ID": "EMPFPK_minimized.pdb_191", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "747.9", " logP": "-4.45", " logD": "-5.96", " logSw": "-0.33", " tPSA": "288.76", " RotatableB": "21", " RigidB": "28", " Flexibility": "0.43", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "537804.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.902", "link_html_complex": "/ACE_complex_html/ACE_EMPFPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EMPFPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EMPFPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EMPFPK.png", "phi_psi": "/peptide_da/EMPFPK.pdb", "link_html_peptide": "/Peptide_html/EMPFPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EMPFPK.pdb", "link_png_peptide": "/Peptide_pics/EMPFPK.png"}
{"Peptide_Sequence": "ENGLPVHLDQSIFR", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "St. Clair (1987)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Rybak, Susanna M., et al. \"C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.\" Biochemical and biophysical research communications 162.1 (1989): 535-543.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1624.8", "link_html_complex": "/ACE_complex_html/ACE_ENGLPVHLDQSIFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENGLPVHLDQSIFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENGLPVHLDQSIFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENGLPVHLDQSIFR.png", "phi_psi": "/peptide_da/ENGLPVHLDQSIFR.pdb", "link_html_peptide": "/Peptide_html/ENGLPVHLDQSIFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENGLPVHLDQSIFR.pdb", "link_png_peptide": "/Peptide_pics/ENGLPVHLDQSIFR.png"}
{"Peptide_Sequence": "ENGLPVHLDQSIFRR", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "St. Clair (1987)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Rybak, Susanna M., et al. \"C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.\" Biochemical and biophysical research communications 162.1 (1989): 535-543.", " Binding_Energy_kcal_per_mol": "-2.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1780.98", "link_html_complex": "/ACE_complex_html/ACE_ENGLPVHLDQSIFRR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENGLPVHLDQSIFRR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENGLPVHLDQSIFRR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENGLPVHLDQSIFRR.png", "phi_psi": "/peptide_da/ENGLPVHLDQSIFRR.pdb", "link_html_peptide": "/Peptide_html/ENGLPVHLDQSIFRR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENGLPVHLDQSIFRR.pdb", "link_png_peptide": "/Peptide_pics/ENGLPVHLDQSIFRR.png"}
{"Peptide_Sequence": "ENGLPVHLDQSIFRRP", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "St. Clair (1987)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Rybak, Susanna M., et al. \"C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.\" Biochemical and biophysical research communications 162.1 (1989): 535-543.", " Binding_Energy_kcal_per_mol": "3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1878.1", "link_html_complex": "/ACE_complex_html/ACE_ENGLPVHLDQSIFRRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENGLPVHLDQSIFRRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENGLPVHLDQSIFRRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENGLPVHLDQSIFRRP.png", "phi_psi": "/peptide_da/ENGLPVHLDQSIFRRP.pdb", "link_html_peptide": "/Peptide_html/ENGLPVHLDQSIFRRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENGLPVHLDQSIFRRP.pdb", "link_png_peptide": "/Peptide_pics/ENGLPVHLDQSIFRRP.png"}
{"Peptide_Sequence": "ENLHLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "197", " Ligand_ID": "ENLHLP_minimized.pdb_197", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "721.8", " logP": "-5.27", " logD": "-8.67", " logSw": "0.35", " tPSA": "316.38", " RotatableB": "21", " RigidB": "24", " Flexibility": "0.47", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "51", " CarbonAtoms": "32", " HeteroAtoms": "19", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1029064.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 721.802", "link_html_complex": "/ACE_complex_html/ACE_ENLHLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENLHLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENLHLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENLHLP.png", "phi_psi": "/peptide_da/ENLHLP.pdb", "link_html_peptide": "/Peptide_html/ENLHLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENLHLP.pdb", "link_png_peptide": "/Peptide_pics/ENLHLP.png"}
{"Peptide_Sequence": "ENLHLPLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "155", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "196", " Ligand_ID": "ENLHLPLP_minimized.pdb_196", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "932.07", " logP": "-2.47", " logD": "-8.23", " logSw": "-2.37", " tPSA": "365.79", " RotatableB": "26", " RigidB": "33", " Flexibility": "0.44", " HBD": "12", " HBA": "23", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "66", " CarbonAtoms": "43", " HeteroAtoms": "23", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "86768.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 932.074", "link_html_complex": "/ACE_complex_html/ACE_ENLHLPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENLHLPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENLHLPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENLHLPLP.png", "phi_psi": "/peptide_da/ENLHLPLP.pdb", "link_html_peptide": "/Peptide_html/ENLHLPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENLHLPLP.pdb", "link_png_peptide": "/Peptide_pics/ENLHLPLP.png"}
{"Peptide_Sequence": "ENLHLPLPLL", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "250 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "195", " Ligand_ID": "ENLHLPLPLL_minimized.pdb_195", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "1158.39", " logP": "-0.33", " logD": "-6.75", " logSw": "-4.59", " tPSA": "423.99", " RotatableB": "34", " RigidB": "37", " Flexibility": "0.48", " HBD": "14", " HBA": "27", " HBD_HBA": "41", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "82", " CarbonAtoms": "55", " HeteroAtoms": "27", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11743.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1158.39", "link_html_complex": "/ACE_complex_html/ACE_ENLHLPLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENLHLPLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENLHLPLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENLHLPLPLL.png", "phi_psi": "/peptide_da/ENLHLPLPLL.pdb", "link_html_peptide": "/Peptide_html/ENLHLPLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENLHLPLPLL.pdb", "link_png_peptide": "/Peptide_pics/ENLHLPLPLL.png"}
{"Peptide_Sequence": "ENLLRF", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "82.4 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "199", " Ligand_ID": "ENLLRF_minimized.pdb_199", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "790.91", " logP": "-2.89", " logD": "-6.26", " logSw": "-1.18", " tPSA": "360.13", " RotatableB": "27", " RigidB": "21", " Flexibility": "0.56", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "36", " HeteroAtoms": "20", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "243060.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 790.907", "link_html_complex": "/ACE_complex_html/ACE_ENLLRF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENLLRF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENLLRF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENLLRF.png", "phi_psi": "/peptide_da/ENLLRF.pdb", "link_html_peptide": "/Peptide_html/ENLLRF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENLLRF.pdb", "link_png_peptide": "/Peptide_pics/ENLLRF.png"}
{"Peptide_Sequence": "ENLLRFFVAPFPEVFG", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "250 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "3.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1882.16", "link_html_complex": "/ACE_complex_html/ACE_ENLLRFFVAPFPEVFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ENLLRFFVAPFPEVFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ENLLRFFVAPFPEVFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ENLLRFFVAPFPEVFG.png", "phi_psi": "/peptide_da/ENLLRFFVAPFPEVFG.pdb", "link_html_peptide": "/Peptide_html/ENLLRFFVAPFPEVFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ENLLRFFVAPFPEVFG.pdb", "link_png_peptide": "/Peptide_pics/ENLLRFFVAPFPEVFG.png"}
{"Peptide_Sequence": "EP", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1200", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "202", " Ligand_ID": "EP_minimized.pdb_202", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "244.24", " logP": "-3.59", " logD": "-6.91", " logSw": "1.24", " tPSA": "128.21", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "841809.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 244.244", "link_html_complex": "/ACE_complex_html/ACE_EP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EP.png", "phi_psi": "/peptide_da/EP.pdb", "link_html_peptide": "/Peptide_html/EP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EP.pdb", "link_png_peptide": "/Peptide_pics/EP.png"}
{"Peptide_Sequence": "EPIPYGFLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "180", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "200", " Ligand_ID": "EPIPYGFLP_minimized.pdb_200", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1032.19", " logP": "0.44", " logD": "-5.26", " logSw": "-4.93", " tPSA": "334.56", " RotatableB": "25", " RigidB": "45", " Flexibility": "0.36", " HBD": "10", " HBA": "22", " HBD_HBA": "32", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "74", " CarbonAtoms": "52", " HeteroAtoms": "22", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7480.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1032.19", "link_html_complex": "/ACE_complex_html/ACE_EPIPYGFLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EPIPYGFLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EPIPYGFLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EPIPYGFLP.png", "phi_psi": "/peptide_da/EPIPYGFLP.pdb", "link_html_peptide": "/Peptide_html/EPIPYGFLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EPIPYGFLP.pdb", "link_png_peptide": "/Peptide_pics/EPIPYGFLP.png"}
{"Peptide_Sequence": "EPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "380", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "201", " Ligand_ID": "EPKAIP_minimized.pdb_201", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "653.77", " logP": "-5.36", " logD": "-6.94", " logSw": "0.67", " tPSA": "263.46", " RotatableB": "18", " RigidB": "22", " Flexibility": "0.45", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "30", " HeteroAtoms": "16", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1279460.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 653.767", "link_html_complex": "/ACE_complex_html/ACE_EPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EPKAIP.png", "phi_psi": "/peptide_da/EPKAIP.pdb", "link_html_peptide": "/Peptide_html/EPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EPKAIP.pdb", "link_png_peptide": "/Peptide_pics/EPKAIP.png"}
{"Peptide_Sequence": "EPR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "203", " Ligand_ID": "EPR_minimized.pdb_203", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "400.43", " logP": "-5.54", " logD": "-7.09", " logSw": "1.96", " tPSA": "220.95", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2841457.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.43", "link_html_complex": "/ACE_complex_html/ACE_EPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EPR.png", "phi_psi": "/peptide_da/EPR.pdb", "link_html_peptide": "/Peptide_html/EPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EPR.pdb", "link_png_peptide": "/Peptide_pics/EPR.png"}
{"Peptide_Sequence": "EPVLGPVRGPFP", " Origin": "bovine sodium caseinate", " Peptide_Preparation": "fermentatation, Lactobacillus animalis ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Roy et al.(2000)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "137.43 \u03bcM", " Reference": "Hayes, M., et al. \"Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.\" Appl. Environ. Microbiol. 73.14 (2007): 4658-4667.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "204", " Ligand_ID": "EPVLGPVRGPFP_minimized.pdb_204", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1264.47", " logP": "-1.87", " logD": "-7.55", " logSw": "-4.35", " tPSA": "456.48", " RotatableB": "33", " RigidB": "51", " Flexibility": "0.39", " HBD": "15", " HBA": "30", " HBD_HBA": "45", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "90", " CarbonAtoms": "60", " HeteroAtoms": "30", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "16354.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1264.47", "link_html_complex": "/ACE_complex_html/ACE_EPVLGPVRGPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EPVLGPVRGPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EPVLGPVRGPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EPVLGPVRGPFP.png", "phi_psi": "/peptide_da/EPVLGPVRGPFP.pdb", "link_html_peptide": "/Peptide_html/EPVLGPVRGPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EPVLGPVRGPFP.pdb", "link_png_peptide": "/Peptide_pics/EPVLGPVRGPFP.png"}
{"Peptide_Sequence": "EQGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "139.4 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "205", " Ligand_ID": "EQGP_minimized.pdb_205", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "429.42", " logP": "-6.55", " logD": "-9.96", " logSw": "2.42", " tPSA": "229.5", " RotatableB": "12", " RigidB": "15", " Flexibility": "0.44", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "17", " HeteroAtoms": "13", " ratio_H_by_C": "0.76", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4810287.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.425", "link_html_complex": "/ACE_complex_html/ACE_EQGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EQGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EQGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EQGP.png", "phi_psi": "/peptide_da/EQGP.pdb", "link_html_peptide": "/Peptide_html/EQGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EQGP.pdb", "link_png_peptide": "/Peptide_pics/EQGP.png"}
{"Peptide_Sequence": "ER", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "667", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "208", " Ligand_ID": "ER_minimized.pdb_208", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "303.31", " logP": "-4.59", " logD": "-6.79", " logSw": "1.9", " tPSA": "200.64", " RotatableB": "11", " RigidB": "5", " Flexibility": "0.69", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "11", " HeteroAtoms": "10", " ratio_H_by_C": "0.91", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2022154.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.315", "link_html_complex": "/ACE_complex_html/ACE_ER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ER.png", "phi_psi": "/peptide_da/ER.pdb", "link_html_peptide": "/Peptide_html/ER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ER.pdb", "link_png_peptide": "/Peptide_pics/ER.png"}
{"Peptide_Sequence": "ERGDT", " Origin": "Plant derived ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.7\u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "206", " Ligand_ID": "ERGDT_minimized.pdb_206", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "576.56", " logP": "-7.23", " logD": "-13.6", " logSw": "2.46", " tPSA": "348.3", " RotatableB": "20", " RigidB": "12", " Flexibility": "0.63", " HBD": "14", " HBA": "19", " HBD_HBA": "33", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "21", " HeteroAtoms": "19", " ratio_H_by_C": "0.9", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6750139.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 576.558", "link_html_complex": "/ACE_complex_html/ACE_ERGDT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ERGDT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ERGDT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ERGDT.png", "phi_psi": "/peptide_da/ERGDT.pdb", "link_html_peptide": "/Peptide_html/ERGDT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ERGDT.pdb", "link_png_peptide": "/Peptide_pics/ERGDT.png"}
{"Peptide_Sequence": "ERKIKVYL", " Origin": "Oval Albumin(OVA)", " Peptide_Preparation": "hydrolyzed by pepsin, trypsin,\nchymotrypsin, and thermolysin.", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung with minor modification by Yamamoto et al. 1989", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.2 \u03bcM", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "207", " Ligand_ID": "ERKIKVYL_minimized.pdb_207", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "1048.28", " logP": "-4.02", " logD": "-10.7", " logSw": "-1.33", " tPSA": "450.75", " RotatableB": "38", " RigidB": "23", " Flexibility": "0.62", " HBD": "20", " HBA": "25", " HBD_HBA": "45", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "74", " CarbonAtoms": "49", " HeteroAtoms": "25", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "278174.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1048.28", "link_html_complex": "/ACE_complex_html/ACE_ERKIKVYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ERKIKVYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ERKIKVYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ERKIKVYL.png", "phi_psi": "/peptide_da/ERKIKVYL.pdb", "link_html_peptide": "/Peptide_html/ERKIKVYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ERKIKVYL.pdb", "link_png_peptide": "/Peptide_pics/ERKIKVYL.png"}
{"Peptide_Sequence": "ERYL", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "200.3 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "209", " Ligand_ID": "ERYL_minimized.pdb_209", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "579.65", " logP": "-3.13", " logD": "-5.3", " logSw": "-0.26", " tPSA": "279.07", " RotatableB": "19", " RigidB": "15", " Flexibility": "0.56", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "446021.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.646", "link_html_complex": "/ACE_complex_html/ACE_ERYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ERYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ERYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ERYL.png", "phi_psi": "/peptide_da/ERYL.pdb", "link_html_peptide": "/Peptide_html/ERYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ERYL.pdb", "link_png_peptide": "/Peptide_pics/ERYL.png"}
{"Peptide_Sequence": "9.9", " Origin": null, " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "210", " Ligand_ID": "ERYPI_minimized.pdb_210", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "676.76", " logP": "-2.84", " logD": "-5.49", " logSw": "-0.97", " tPSA": "299.38", " RotatableB": "20", " RigidB": "22", " Flexibility": "0.48", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "31", " HeteroAtoms": "17", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "255788.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 676.761", "link_html_complex": "/ACE_complex_html/ACE_ERYPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ERYPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ERYPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ERYPI.png", "phi_psi": "/peptide_da/ERYPI.pdb", "link_html_peptide": "/Peptide_html/ERYPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ERYPI.pdb", "link_png_peptide": "/Peptide_pics/ERYPI.png"}
{"Peptide_Sequence": "ESAGIH", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "371.6 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "211", " Ligand_ID": "ESAGIH_minimized.pdb_211", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "612.63", " logP": "-5.14", " logD": "-10.25", " logSw": "0.81", " tPSA": "302.31", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "25", " HeteroAtoms": "18", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1376176.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 612.633", "link_html_complex": "/ACE_complex_html/ACE_ESAGIH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ESAGIH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ESAGIH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ESAGIH.png", "phi_psi": "/peptide_da/ESAGIH.pdb", "link_html_peptide": "/Peptide_html/ESAGIH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ESAGIH.pdb", "link_png_peptide": "/Peptide_pics/ESAGIH.png"}
{"Peptide_Sequence": "ESI", " Origin": "Egg White", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": ">1000 \u00b5mol/L", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "213", " Ligand_ID": "ESI_minimized.pdb_213", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "347.36", " logP": "-3.82", " logD": "-7.62", " logSw": "1.14", " tPSA": "186.33", " RotatableB": "11", " RigidB": "6", " Flexibility": "0.65", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1084978.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 347.364", "link_html_complex": "/ACE_complex_html/ACE_ESI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ESI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ESI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ESI.png", "phi_psi": "/peptide_da/ESI.pdb", "link_html_peptide": "/Peptide_html/ESI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ESI.pdb", "link_png_peptide": "/Peptide_pics/ESI.png"}
{"Peptide_Sequence": "ESIINF", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "212", " Ligand_ID": "ESIINF_minimized.pdb_212", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "721.8", " logP": "-3.12", " logD": "-7.75", " logSw": "-0.88", " tPSA": "316.72", " RotatableB": "23", " RigidB": "20", " Flexibility": "0.53", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "51", " CarbonAtoms": "33", " HeteroAtoms": "18", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "300866.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 721.798", "link_html_complex": "/ACE_complex_html/ACE_ESIINF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ESIINF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ESIINF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ESIINF.png", "phi_psi": "/peptide_da/ESIINF.pdb", "link_html_peptide": "/Peptide_html/ESIINF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ESIINF.pdb", "link_png_peptide": "/Peptide_pics/ESIINF.png"}
{"Peptide_Sequence": "ETNGQ", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "214", " Ligand_ID": "ETNGQ_minimized.pdb_214", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "547.52", " logP": "-8.22", " logD": "-12.85", " logSw": "3.07", " tPSA": "330.71", " RotatableB": "17", " RigidB": "14", " Flexibility": "0.55", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "38", " CarbonAtoms": "20", " HeteroAtoms": "18", " ratio_H_by_C": "0.9", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11747445.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 547.516", "link_html_complex": "/ACE_complex_html/ACE_ETNGQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ETNGQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ETNGQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ETNGQ.png", "phi_psi": "/peptide_da/ETNGQ.pdb", "link_html_peptide": "/Peptide_html/ETNGQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ETNGQ.pdb", "link_png_peptide": "/Peptide_pics/ETNGQ.png"}
{"Peptide_Sequence": "EV", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": "CoMFA models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "30 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "218", " Ligand_ID": "EV_minimized.pdb_218", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(O)=O", " MW": "246.26", " logP": "-3.88", " logD": "-6.21", " logSw": "1.54", " tPSA": "137", " RotatableB": "7", " RigidB": "4", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1148228.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 246.26", "link_html_complex": "/ACE_complex_html/ACE_EV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EV.png", "phi_psi": "/peptide_da/EV.pdb", "link_html_peptide": "/Peptide_html/EV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EV.pdb", "link_png_peptide": "/Peptide_pics/EV.png"}
{"Peptide_Sequence": "EVLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "215", " Ligand_ID": "EVLP_minimized.pdb_215", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "456.53", " logP": "-3.37", " logD": "-6.04", " logSw": "0.24", " tPSA": "186.41", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "583040.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 456.533", "link_html_complex": "/ACE_complex_html/ACE_EVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EVLP.png", "phi_psi": "/peptide_da/EVLP.pdb", "link_html_peptide": "/Peptide_html/EVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EVLP.pdb", "link_png_peptide": "/Peptide_pics/EVLP.png"}
{"Peptide_Sequence": "EVMAGNLYPG", " Origin": "sauce of fermented blue mussel", " Peptide_Preparation": "", " Isolation_Method": "GFC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.98 \u03bcM", " Reference": "Je, Jae-Young, et al. \"Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis.\" Bioresource technology 96.14 (2005): 1624-1629.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "216", " Ligand_ID": "EVMAGNLYPG_minimized.pdb_216", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "1050.19", " logP": "-3.65", " logD": "-9.86", " logSw": "-2.04", " tPSA": "449.63", " RotatableB": "31", " RigidB": "33", " Flexibility": "0.48", " HBD": "15", " HBA": "26", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "73", " CarbonAtoms": "46", " HeteroAtoms": "27", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "137035.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1050.19", "link_html_complex": "/ACE_complex_html/ACE_EVMAGNLYPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EVMAGNLYPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EVMAGNLYPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EVMAGNLYPG.png", "phi_psi": "/peptide_da/EVMAGNLYPG.pdb", "link_html_peptide": "/Peptide_html/EVMAGNLYPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EVMAGNLYPG.pdb", "link_png_peptide": "/Peptide_pics/EVMAGNLYPG.png"}
{"Peptide_Sequence": "EVMAGNYLPG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2.98 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "217", " Ligand_ID": "EVMAGNYLPG_minimized.pdb_217", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "1050.19", " logP": "-3.65", " logD": "-9.88", " logSw": "-2.04", " tPSA": "449.63", " RotatableB": "31", " RigidB": "33", " Flexibility": "0.48", " HBD": "15", " HBA": "26", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "73", " CarbonAtoms": "46", " HeteroAtoms": "27", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "137035.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1050.19", "link_html_complex": "/ACE_complex_html/ACE_EVMAGNYLPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EVMAGNYLPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EVMAGNYLPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EVMAGNYLPG.png", "phi_psi": "/peptide_da/EVMAGNYLPG.pdb", "link_html_peptide": "/Peptide_html/EVMAGNYLPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EVMAGNYLPG.pdb", "link_png_peptide": "/Peptide_pics/EVMAGNYLPG.png"}
{"Peptide_Sequence": "EVPK", " Origin": "Sweet potato thioredoxin h2 ", " Peptide_Preparation": "expression of thioredoxin h2 in E. coli", " Isolation_Method": "", " ACE_inhibition_assay": " Lee  et  al.(2003) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.73 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Botanical Studies 52.1 (2011).", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "219", " Ligand_ID": "EVPK_minimized.pdb_219", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "471.55", " logP": "-7.03", " logD": "-6.58", " logSw": "2.59", " tPSA": "214.05", " RotatableB": "14", " RigidB": "13", " Flexibility": "0.52", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "6281249.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 471.548", "link_html_complex": "/ACE_complex_html/ACE_EVPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EVPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EVPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EVPK.png", "phi_psi": "/peptide_da/EVPK.pdb", "link_html_peptide": "/Peptide_html/EVPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EVPK.pdb", "link_png_peptide": "/Peptide_pics/EVPK.png"}
{"Peptide_Sequence": "EVSQGRP", " Origin": "sea cucumber (Stichopus horrens)", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": " 0.05 mM", " Reference": "Forghani, Bita, et al. \"Purification and characterization of angiotensin converting enzyme-inhibitory peptides derived from Stichopus horrens: Stability study against the ACE and inhibition kinetics.\" Journal of functional foods 20 (2016): 276-290.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "220", " Ligand_ID": "EVSQGRP_minimized.pdb_220", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "771.82", " logP": "-7.2", " logD": "-11.12", " logSw": "1.56", " tPSA": "400.67", " RotatableB": "25", " RigidB": "22", " Flexibility": "0.53", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "31", " HeteroAtoms": "23", " ratio_H_by_C": "0.74", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3675601.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 771.819", "link_html_complex": "/ACE_complex_html/ACE_EVSQGRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EVSQGRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EVSQGRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EVSQGRP.png", "phi_psi": "/peptide_da/EVSQGRP.pdb", "link_html_peptide": "/Peptide_html/EVSQGRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EVSQGRP.pdb", "link_png_peptide": "/Peptide_pics/EVSQGRP.png"}
{"Peptide_Sequence": "EW", " Origin": "milk", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "221", " Ligand_ID": "EW_minimized.pdb_221", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "333.34", " logP": "-2.65", " logD": "-5.37", " logSw": "0.14", " tPSA": "152.79", " RotatableB": "8", " RigidB": "14", " Flexibility": "0.36", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "381867.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.339", "link_html_complex": "/ACE_complex_html/ACE_EW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EW.png", "phi_psi": "/peptide_da/EW.pdb", "link_html_peptide": "/Peptide_html/EW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EW.pdb", "link_png_peptide": "/Peptide_pics/EW.png"}
{"Peptide_Sequence": "EWPRPQIPP", " Origin": " Human \u03b2-Casein ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "", " Reference": "Wang, Xiaoyu, et al. \"QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors.\" Journal of molecular modeling 17.7 (2011): 1599-1606.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "222", " Ligand_ID": "EWPRPQIPP_minimized.pdb_222", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "1119.27", " logP": "-3.27", " logD": "-7.56", " logSw": "-2.91", " tPSA": "428.06", " RotatableB": "28", " RigidB": "51", " Flexibility": "0.35", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "5", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "80", " CarbonAtoms": "53", " HeteroAtoms": "27", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "60757.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1119.27", "link_html_complex": "/ACE_complex_html/ACE_EWPRPQIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EWPRPQIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EWPRPQIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EWPRPQIPP.png", "phi_psi": "/peptide_da/EWPRPQIPP.pdb", "link_html_peptide": "/Peptide_html/EWPRPQIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EWPRPQIPP.pdb", "link_png_peptide": "/Peptide_pics/EWPRPQIPP.png"}
{"Peptide_Sequence": "EY", " Origin": "shark meat", " Peptide_Preparation": "Protease hydrolysis", " Isolation_Method": "ultrafiltration, gel chromatography, RP-HPLC", " ACE_inhibition_assay": "He et al. (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.68 \u03bcM", " Reference": "Wu, Hao, et al. \"Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate.\" Process Biochemistry 43.4 (2008): 457-461.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "223", " Ligand_ID": "EY_minimized.pdb_223", " Smiles": "N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "310.3", " logP": "-3.77", " logD": "-5.9", " logSw": "1.03", " tPSA": "157.23", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "1", " Solubility_mg_per_l": "867635.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 310.303", "link_html_complex": "/ACE_complex_html/ACE_EY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_EY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_EY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_EY.png", "phi_psi": "/peptide_da/EY.pdb", "link_html_peptide": "/Peptide_html/EY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/EY.pdb", "link_png_peptide": "/Peptide_pics/EY.png"}
{"Peptide_Sequence": "FAL", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "26.3 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "224", " Ligand_ID": "FAL_minimized.pdb_224", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "349.42", " logP": "-1.72", " logD": "-2.37", " logSw": "-0.41", " tPSA": "125.97", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "18", " HeteroAtoms": "7", " ratio_H_by_C": "0.39", " Lipinski_Violation": "0", " Solubility_mg_per_l": "230919.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 349.425", "link_html_complex": "/ACE_complex_html/ACE_FAL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FAL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FAL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FAL.png", "phi_psi": "/peptide_da/FAL.pdb", "link_html_peptide": "/Peptide_html/FAL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FAL.pdb", "link_png_peptide": "/Peptide_pics/FAL.png"}
{"Peptide_Sequence": "FALPC", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "690.9", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "225", " Ligand_ID": "FALPC_minimized.pdb_225", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(O)=O", " MW": "549.68", " logP": "-2.38", " logD": "-3.37", " logSw": "-0.95", " tPSA": "214.18", " RotatableB": "13", " RigidB": "20", " Flexibility": "0.39", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "26", " HeteroAtoms": "12", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "212947.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 549.682", "link_html_complex": "/ACE_complex_html/ACE_FALPC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FALPC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FALPC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FALPC.png", "phi_psi": "/peptide_da/FALPC.pdb", "link_html_peptide": "/Peptide_html/FALPC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FALPC.pdb", "link_png_peptide": "/Peptide_pics/FALPC.png"}
{"Peptide_Sequence": "FALPQY", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.3", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "227", " Ligand_ID": "FALPQY_minimized.pdb_227", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "737.84", " logP": "-2.49", " logD": "-3.81", " logSw": "-1.68", " tPSA": "267.8", " RotatableB": "19", " RigidB": "30", " Flexibility": "0.39", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "37", " HeteroAtoms": "16", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "137885.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 737.842", "link_html_complex": "/ACE_complex_html/ACE_FALPQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FALPQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FALPQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FALPQY.png", "phi_psi": "/peptide_da/FALPQY.pdb", "link_html_peptide": "/Peptide_html/FALPQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FALPQY.pdb", "link_png_peptide": "/Peptide_pics/FALPQY.png"}
{"Peptide_Sequence": "FALPQYLK", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.3", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "226", " Ligand_ID": "FALPQYLK_minimized.pdb_226", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "979.17", " logP": "-1.91", " logD": "-3.35", " logSw": "-2.86", " tPSA": "353.64", " RotatableB": "29", " RigidB": "34", " Flexibility": "0.46", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "70", " CarbonAtoms": "49", " HeteroAtoms": "21", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "56343.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 979.172", "link_html_complex": "/ACE_complex_html/ACE_FALPQYLK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FALPQYLK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FALPQYLK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FALPQYLK.png", "phi_psi": "/peptide_da/FALPQYLK.pdb", "link_html_peptide": "/Peptide_html/FALPQYLK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FALPQYLK.pdb", "link_png_peptide": "/Peptide_pics/FALPQYLK.png"}
{"Peptide_Sequence": "FAP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.8 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "228", " Ligand_ID": "FAP_minimized.pdb_228", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "333.38", " logP": "-1.48", " logD": "-3.4", " logSw": "-0.67", " tPSA": "117.18", " RotatableB": "6", " RigidB": "16", " Flexibility": "0.27", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "170077.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.382", "link_html_complex": "/ACE_complex_html/ACE_FAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FAP.png", "phi_psi": "/peptide_da/FAP.pdb", "link_html_peptide": "/Peptide_html/FAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FAP.pdb", "link_png_peptide": "/Peptide_pics/FAP.png"}
{"Peptide_Sequence": "FAQTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "25", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "229", " Ligand_ID": "FAQTQSLVYP_minimized.pdb_229", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1153.28", " logP": "-3.86", " logD": "-7.89", " logSw": "-2.5", " tPSA": "467.75", " RotatableB": "32", " RigidB": "40", " Flexibility": "0.44", " HBD": "18", " HBA": "28", " HBD_HBA": "46", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "82", " CarbonAtoms": "54", " HeteroAtoms": "28", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "94537.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1153.28", "link_html_complex": "/ACE_complex_html/ACE_FAQTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FAQTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FAQTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FAQTQSLVYP.png", "phi_psi": "/peptide_da/FAQTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/FAQTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FAQTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/FAQTQSLVYP.png"}
{"Peptide_Sequence": "FC", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "478 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "231", " Ligand_ID": "FC_minimized.pdb_231", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(O)=O", " MW": "268.33", " logP": "-2.72", " logD": "-2.19", " logSw": "0.48", " tPSA": "135.67", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "431634.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 268.331", "link_html_complex": "/ACE_complex_html/ACE_FC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FC.png", "phi_psi": "/peptide_da/FC.pdb", "link_html_peptide": "/Peptide_html/FC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FC.pdb", "link_png_peptide": "/Peptide_pics/FC.png"}
{"Peptide_Sequence": "FCF", " Origin": "ovalbumin", " Peptide_Preparation": "pepsin, trypsin, chymotrypsin, and thermolysin", " Isolation_Method": "ODS", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "11", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "230", " Ligand_ID": "FCF_minimized.pdb_230", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "415.51", " logP": "-1.69", " logD": "-1.95", " logSw": "-0.86", " tPSA": "164.77", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "0", " Solubility_mg_per_l": "176552.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.505", "link_html_complex": "/ACE_complex_html/ACE_FCF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FCF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FCF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FCF.png", "phi_psi": "/peptide_da/FCF.pdb", "link_html_peptide": "/Peptide_html/FCF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FCF.pdb", "link_png_peptide": "/Peptide_pics/FCF.png"}
{"Peptide_Sequence": "FCVL", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "19.8 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "232", " Ligand_ID": "FCVL_minimized.pdb_232", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(O)=O", " MW": "480.62", " logP": "-1.65", " logD": "-2.11", " logSw": "-0.99", " tPSA": "193.87", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "179178.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 480.62", "link_html_complex": "/ACE_complex_html/ACE_FCVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FCVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FCVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FCVL.png", "phi_psi": "/peptide_da/FCVL.pdb", "link_html_peptide": "/Peptide_html/FCVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FCVL.pdb", "link_png_peptide": "/Peptide_pics/FCVL.png"}
{"Peptide_Sequence": "FCVLRP", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 12.3 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "233", " Ligand_ID": "FCVLRP_minimized.pdb_233", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "733.92", " logP": "-2.67", " logD": "-5.21", " logSw": "-1.36", " tPSA": "306.92", " RotatableB": "21", " RigidB": "23", " Flexibility": "0.48", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "187598.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 733.921", "link_html_complex": "/ACE_complex_html/ACE_FCVLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FCVLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FCVLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FCVLRP.png", "phi_psi": "/peptide_da/FCVLRP.pdb", "link_html_peptide": "/Peptide_html/FCVLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FCVLRP.pdb", "link_png_peptide": "/Peptide_pics/FCVLRP.png"}
{"Peptide_Sequence": "FDART", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "1900 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "234", " Ligand_ID": "FDART_minimized.pdb_234", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "608.64", " logP": "-4.73", " logD": "-8.87", " logSw": "0.57", " tPSA": "308.17", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1072820.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 608.644", "link_html_complex": "/ACE_complex_html/ACE_FDART.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FDART.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FDART.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FDART.png", "phi_psi": "/peptide_da/FDART.pdb", "link_html_peptide": "/Peptide_html/FDART.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FDART.pdb", "link_png_peptide": "/Peptide_pics/FDART.png"}
{"Peptide_Sequence": "FDAVGVK", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "235", " Ligand_ID": "FDAVGVK_minimized.pdb_235", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "734.84", " logP": "-6.18", " logD": "-7.84", " logSw": "0.97", " tPSA": "310.14", " RotatableB": "23", " RigidB": "20", " Flexibility": "0.53", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "34", " HeteroAtoms": "18", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1945272.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 734.84", "link_html_complex": "/ACE_complex_html/ACE_FDAVGVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FDAVGVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FDAVGVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FDAVGVK.png", "phi_psi": "/peptide_da/FDAVGVK.pdb", "link_html_peptide": "/Peptide_html/FDAVGVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FDAVGVK.pdb", "link_png_peptide": "/Peptide_pics/FDAVGVK.png"}
{"Peptide_Sequence": "FDK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "236", " Ligand_ID": "FDK_minimized.pdb_236", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "408.45", " logP": "-5.33", " logD": "-6.9", " logSw": "1.77", " tPSA": "193.74", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2387469.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 408.449", "link_html_complex": "/ACE_complex_html/ACE_FDK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FDK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FDK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FDK.png", "phi_psi": "/peptide_da/FDK.pdb", "link_html_peptide": "/Peptide_html/FDK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FDK.pdb", "link_png_peptide": "/Peptide_pics/FDK.png"}
{"Peptide_Sequence": "FE", " Origin": "shark meat", " Peptide_Preparation": "Protease hydrolysis", " Isolation_Method": "ultrafiltration, gel chromatography, RP-HPLC", " ACE_inhibition_assay": "He et al. (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.45 \u03bcM", " Reference": "Wu, Hao, et al. \"Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate.\" Process Biochemistry 43.4 (2008): 457-461.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "239", " Ligand_ID": "FE_minimized.pdb_239", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "294.3", " logP": "-3", " logD": "-5.81", " logSw": "0.64", " tPSA": "137", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "557847.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 294.303", "link_html_complex": "/ACE_complex_html/ACE_FE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FE.png", "phi_psi": "/peptide_da/FE.pdb", "link_html_peptide": "/Peptide_html/FE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FE.pdb", "link_png_peptide": "/Peptide_pics/FE.png"}
{"Peptide_Sequence": "FEDYVPLSCF", " Origin": "salmon ", " Peptide_Preparation": "Alcalase, flavourzyme, neutrase, pepsin, protamex and trypsin", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "10.77 \u03bcM", " Reference": "Ahn, Chang-Bum, et al. \"Angiotensin I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis.\" Process Biochemistry 47.12 (2012): 2240-2245.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "237", " Ligand_ID": "FEDYVPLSCF_minimized.pdb_237", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1219.36", " logP": "-0.79", " logD": "-10.44", " logSw": "-4.74", " tPSA": "480.4", " RotatableB": "34", " RigidB": "44", " Flexibility": "0.44", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "86", " CarbonAtoms": "58", " HeteroAtoms": "28", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10660.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1219.36", "link_html_complex": "/ACE_complex_html/ACE_FEDYVPLSCF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FEDYVPLSCF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FEDYVPLSCF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FEDYVPLSCF.png", "phi_psi": "/peptide_da/FEDYVPLSCF.pdb", "link_html_peptide": "/Peptide_html/FEDYVPLSCF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FEDYVPLSCF.pdb", "link_png_peptide": "/Peptide_pics/FEDYVPLSCF.png"}
{"Peptide_Sequence": "FEGTVFENG", " Origin": " pea seed (Pisum sativum L.)", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "Udenigwe, Lin, Hou, & Aluko, 2009", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Aluko, Rotimi E., et al. \"Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides.\" Food Research International 77 (2015): 10-16.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "238", " Ligand_ID": "FEGTVFENG_minimized.pdb_238", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O", " MW": "999.03", " logP": "-4.87", " logD": "-14.78", " logSw": "-0.99", " tPSA": "444.15", " RotatableB": "31", " RigidB": "33", " Flexibility": "0.48", " HBD": "16", " HBA": "26", " HBD_HBA": "42", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "71", " CarbonAtoms": "45", " HeteroAtoms": "26", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "372458.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 999.031", "link_html_complex": "/ACE_complex_html/ACE_FEGTVFENG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FEGTVFENG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FEGTVFENG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FEGTVFENG.png", "phi_psi": "/peptide_da/FEGTVFENG.pdb", "link_html_peptide": "/Peptide_html/FEGTVFENG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FEGTVFENG.pdb", "link_png_peptide": "/Peptide_pics/FEGTVFENG.png"}
{"Peptide_Sequence": "FEP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "240", " Ligand_ID": "FEP_minimized.pdb_240", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "391.42", " logP": "-3.14", " logD": "-6.79", " logSw": "0.22", " tPSA": "157.31", " RotatableB": "9", " RigidB": "17", " Flexibility": "0.35", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "0", " Solubility_mg_per_l": "488534.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.418", "link_html_complex": "/ACE_complex_html/ACE_FEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FEP.png", "phi_psi": "/peptide_da/FEP.pdb", "link_html_peptide": "/Peptide_html/FEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FEP.pdb", "link_png_peptide": "/Peptide_pics/FEP.png"}
{"Peptide_Sequence": "FFGRCVSP", " Origin": "Oval Albumin(OVA)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung with minor modification by Yamamoto et al. (1989)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.2 \u03bcM", " Reference": "Hiroyuki Fujita, Masaaki Yoshikawa, LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein, In Immunopharmacology, Volume 44, Issues 1\u20132, 1999, Pages 123-127.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "241", " Ligand_ID": "FFGRCVSP_minimized.pdb_241", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "912.07", " logP": "-2.68", " logD": "-8.2", " logSw": "-2.16", " tPSA": "385.35", " RotatableB": "26", " RigidB": "33", " Flexibility": "0.44", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "64", " CarbonAtoms": "42", " HeteroAtoms": "22", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "105031.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 912.066", "link_html_complex": "/ACE_complex_html/ACE_FFGRCVSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFGRCVSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFGRCVSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFGRCVSP.png", "phi_psi": "/peptide_da/FFGRCVSP.pdb", "link_html_peptide": "/Peptide_html/FFGRCVSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFGRCVSP.pdb", "link_png_peptide": "/Peptide_pics/FFGRCVSP.png"}
{"Peptide_Sequence": "FFGVRCVSP", " Origin": "ovalbumin", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "0.4 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "242", " Ligand_ID": "FFGVRCVSP_minimized.pdb_242", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1011.2", " logP": "-1.96", " logD": "-7.84", " logSw": "-3.02", " tPSA": "414.45", " RotatableB": "29", " RigidB": "35", " Flexibility": "0.45", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "71", " CarbonAtoms": "47", " HeteroAtoms": "24", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "49170.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1011.2", "link_html_complex": "/ACE_complex_html/ACE_FFGVRCVSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFGVRCVSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFGVRCVSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFGVRCVSP.png", "phi_psi": "/peptide_da/FFGVRCVSP.pdb", "link_html_peptide": "/Peptide_html/FFGVRCVSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFGVRCVSP.pdb", "link_png_peptide": "/Peptide_pics/FFGVRCVSP.png"}
{"Peptide_Sequence": "FFL", " Origin": "soyabean", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "IEC, GF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 37 mM", " Reference": "Wang, Wenyi, and Elvira Gonzalez De Mejia. \"A new frontier in soy bioactive peptides that may prevent age\u2010related chronic diseases.\" Comprehensive reviews in food science and food safety 4.4 (2005): 63-78.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "243", " Ligand_ID": "FFL_minimized.pdb_243", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "425.52", " logP": "-0.67", " logD": "-0.71", " logSw": "-1.47", " tPSA": "125.97", " RotatableB": "11", " RigidB": "17", " Flexibility": "0.39", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "24", " HeteroAtoms": "7", " ratio_H_by_C": "0.29", " Lipinski_Violation": "0", " Solubility_mg_per_l": "97510.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 425.521", "link_html_complex": "/ACE_complex_html/ACE_FFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFL.png", "phi_psi": "/peptide_da/FFL.pdb", "link_html_peptide": "/Peptide_html/FFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFL.pdb", "link_png_peptide": "/Peptide_pics/FFL.png"}
{"Peptide_Sequence": "FFVAP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "246", " Ligand_ID": "FFVAP_minimized.pdb_246", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "579.69", " logP": "0.56", " logD": "-2.15", " logSw": "-3.04", " tPSA": "175.38", " RotatableB": "13", " RigidB": "26", " Flexibility": "0.33", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "31", " HeteroAtoms": "11", " ratio_H_by_C": "0.35", " Lipinski_Violation": "3", " Solubility_mg_per_l": "27844.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.687", "link_html_complex": "/ACE_complex_html/ACE_FFVAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFVAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFVAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFVAP.png", "phi_psi": "/peptide_da/FFVAP.pdb", "link_html_peptide": "/Peptide_html/FFVAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFVAP.pdb", "link_png_peptide": "/Peptide_pics/FFVAP.png"}
{"Peptide_Sequence": "FFVAPFEVFGK", " Origin": "Casein", " Peptide_Preparation": "roteinase from lactic acid bacteria", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "FitzGerald, Richard J., Brian A. Murray, and Daniel J. Walsh. \"Hypotensive peptides from milk proteins.\" The journal of nutrition 134.4 (2004): 980S-988S.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "244", " Ligand_ID": "FFVAPFEVFGK_minimized.pdb_244", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1287.5", " logP": "-0.37", " logD": "-4.46", " logSw": "-5.24", " tPSA": "417.75", " RotatableB": "37", " RigidB": "51", " Flexibility": "0.42", " HBD": "15", " HBA": "26", " HBD_HBA": "41", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "93", " CarbonAtoms": "67", " HeteroAtoms": "26", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6793.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1287.5", "link_html_complex": "/ACE_complex_html/ACE_FFVAPFEVFGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFVAPFEVFGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFVAPFEVFGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFVAPFEVFGK.png", "phi_psi": "/peptide_da/FFVAPFEVFGK.pdb", "link_html_peptide": "/Peptide_html/FFVAPFEVFGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFVAPFEVFGK.pdb", "link_png_peptide": "/Peptide_pics/FFVAPFEVFGK.png"}
{"Peptide_Sequence": "FFVAPFPEVFGK", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "77 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1384.62", "link_html_complex": "/ACE_complex_html/ACE_FFVAPFPEVFGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFVAPFPEVFGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFVAPFPEVFGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFVAPFPEVFGK.png", "phi_psi": "/peptide_da/FFVAPFPEVFGK.pdb", "link_html_peptide": "/Peptide_html/FFVAPFPEVFGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFVAPFPEVFGK.pdb", "link_png_peptide": "/Peptide_pics/FFVAPFPEVFGK.png"}
{"Peptide_Sequence": "FFYY", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.9 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "247", " Ligand_ID": "FFYY_minimized.pdb_247", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "638.71", " logP": "0.92", " logD": "-0.07", " logSw": "-3.6", " tPSA": "195.53", " RotatableB": "15", " RigidB": "31", " Flexibility": "0.33", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "36", " HeteroAtoms": "11", " ratio_H_by_C": "0.31", " Lipinski_Violation": "3", " Solubility_mg_per_l": "17477.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.22", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 638.71", "link_html_complex": "/ACE_complex_html/ACE_FFYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FFYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FFYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FFYY.png", "phi_psi": "/peptide_da/FFYY.pdb", "link_html_peptide": "/Peptide_html/FFYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FFYY.pdb", "link_png_peptide": "/Peptide_pics/FFYY.png"}
{"Peptide_Sequence": "FG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3700 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "252", " Ligand_ID": "FG_minimized.pdb_252", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O", " MW": "222.24", " logP": "-2.5", " logD": "-2.81", " logSw": "0.54", " tPSA": "96.87", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "11", " HeteroAtoms": "5", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "381026.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 222.24", "link_html_complex": "/ACE_complex_html/ACE_FG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FG.png", "phi_psi": "/peptide_da/FG.pdb", "link_html_peptide": "/Peptide_html/FG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FG.pdb", "link_png_peptide": "/Peptide_pics/FG.png"}
{"Peptide_Sequence": "FGASTRGA", " Origin": "Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "pepsin", " Isolation_Method": "IEC, RP-HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "14.7 \u03bcM", " Reference": "Je, Jae-Young, et al. \"A novel angiotensin I converting enzyme inhibitory peptide from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate.\" Journal of agricultural and food chemistry 52.26 (2004): 7842-7845.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "248", " Ligand_ID": "FGASTRGA_minimized.pdb_248", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C)C(O)=O", " MW": "765.81", " logP": "-6.47", " logD": "-12.73", " logSw": "1.03", " tPSA": "375.57", " RotatableB": "24", " RigidB": "22", " Flexibility": "0.52", " HBD": "16", " HBA": "22", " HBD_HBA": "38", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "54", " CarbonAtoms": "32", " HeteroAtoms": "22", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2144592.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 765.814", "link_html_complex": "/ACE_complex_html/ACE_FGASTRGA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FGASTRGA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FGASTRGA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FGASTRGA.png", "phi_psi": "/peptide_da/FGASTRGA.pdb", "link_html_peptide": "/Peptide_html/FGASTRGA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FGASTRGA.pdb", "link_png_peptide": "/Peptide_pics/FGASTRGA.png"}
{"Peptide_Sequence": "FGG", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "82.5", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "250", " Ligand_ID": "FGG_minimized.pdb_250", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(O)=O", " MW": "279.29", " logP": "-3.15", " logD": "-4.84", " logSw": "0.75", " tPSA": "125.97", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "594159.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 279.292", "link_html_complex": "/ACE_complex_html/ACE_FGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FGG.png", "phi_psi": "/peptide_da/FGG.pdb", "link_html_peptide": "/Peptide_html/FGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FGG.pdb", "link_png_peptide": "/Peptide_pics/FGG.png"}
{"Peptide_Sequence": "FGGIDDINQIGQSD", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.070 mg/ml", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1478.52", "link_html_complex": "/ACE_complex_html/ACE_FGGIDDINQIGQSD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FGGIDDINQIGQSD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FGGIDDINQIGQSD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FGGIDDINQIGQSD.png", "phi_psi": "/peptide_da/FGGIDDINQIGQSD.pdb", "link_html_peptide": "/Peptide_html/FGGIDDINQIGQSD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FGGIDDINQIGQSD.pdb", "link_png_peptide": "/Peptide_pics/FGGIDDINQIGQSD.png"}
{"Peptide_Sequence": "FGK", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "160 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "251", " Ligand_ID": "FGK_minimized.pdb_251", " Smiles": "NCCCC[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "350.41", " logP": "-3.33", " logD": "-4.21", " logSw": "0.72", " tPSA": "153.61", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "722988.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 350.413", "link_html_complex": "/ACE_complex_html/ACE_FGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FGK.png", "phi_psi": "/peptide_da/FGK.pdb", "link_html_peptide": "/Peptide_html/FGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FGK.pdb", "link_png_peptide": "/Peptide_pics/FGK.png"}
{"Peptide_Sequence": "FGRCVSP", " Origin": "chicken muscle", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "6.2 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "253", " Ligand_ID": "FGRCVSP_minimized.pdb_253", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "764.89", " logP": "-4.01", " logD": "-9.32", " logSw": "-0.65", " tPSA": "356.25", " RotatableB": "22", " RigidB": "25", " Flexibility": "0.47", " HBD": "13", " HBA": "19", " HBD_HBA": "32", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "400781.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 764.892", "link_html_complex": "/ACE_complex_html/ACE_FGRCVSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FGRCVSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FGRCVSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FGRCVSP.png", "phi_psi": "/peptide_da/FGRCVSP.pdb", "link_html_peptide": "/Peptide_html/FGRCVSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FGRCVSP.pdb", "link_png_peptide": "/Peptide_pics/FGRCVSP.png"}
{"Peptide_Sequence": "FHERDPTHIKWGD", " Origin": "bonito muscle", " Peptide_Preparation": "artificial gastric juice ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifi-cation", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.8 \u03bcM", " Reference": "Hasan, Fida, et al. \"Production kinetics of angiotensin-I converting enzyme inhibitory peptides from bonito meat in artificial gastric juice.\" Process Biochemistry 41.3 (2006): 505-511.", " Binding_Energy_kcal_per_mol": "-4.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1637.75", "link_html_complex": "/ACE_complex_html/ACE_FHERDPTHIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FHERDPTHIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FHERDPTHIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FHERDPTHIKWGD.png", "phi_psi": "/peptide_da/FHERDPTHIKWGD.pdb", "link_html_peptide": "/Peptide_html/FHERDPTHIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FHERDPTHIKWGD.pdb", "link_png_peptide": "/Peptide_pics/FHERDPTHIKWGD.png"}
{"Peptide_Sequence": "FHG", " Origin": "beef sarcoplasmic protein extract ", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Jang, Aera, Cheorun Jo, and Mooha Lee. \"Storage stability of the synthetic angiotensin converting enzyme (ACE) inhibitory peptides separated from beef sarcoplasmic protein extracts at different pH, temperature, and gastric digestion.\" Food Science and Biotechnology 16.4 (2007): 572-575.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "255", " Ligand_ID": "FHG_minimized.pdb_255", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(O)=O", " MW": "359.38", " logP": "-3.53", " logD": "-4.49", " logSw": "0.58", " tPSA": "154.65", " RotatableB": "9", " RigidB": "16", " Flexibility": "0.36", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "639658.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 359.38", "link_html_complex": "/ACE_complex_html/ACE_FHG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FHG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FHG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FHG.png", "phi_psi": "/peptide_da/FHG.pdb", "link_html_peptide": "/Peptide_html/FHG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FHG.pdb", "link_png_peptide": "/Peptide_pics/FHG.png"}
{"Peptide_Sequence": "FHSGIQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "520", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1410.57", "link_html_complex": "/ACE_complex_html/ACE_FHSGIQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FHSGIQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FHSGIQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FHSGIQSEPKAIP.png", "phi_psi": "/peptide_da/FHSGIQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/FHSGIQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FHSGIQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/FHSGIQSEPKAIP.png"}
{"Peptide_Sequence": "FK", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "265 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "259", " Ligand_ID": "FK_minimized.pdb_259", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "293.36", " logP": "-2.73", " logD": "-3.32", " logSw": "0.55", " tPSA": "124.51", " RotatableB": "9", " RigidB": "9", " Flexibility": "0.5", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "15", " HeteroAtoms": "6", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "510584.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 293.361", "link_html_complex": "/ACE_complex_html/ACE_FK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FK.png", "phi_psi": "/peptide_da/FK.pdb", "link_html_peptide": "/Peptide_html/FK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FK.pdb", "link_png_peptide": "/Peptide_pics/FK.png"}
{"Peptide_Sequence": "FKC", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "257", " Ligand_ID": "FKC_minimized.pdb_257", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CS)C(O)=O", " MW": "396.5", " logP": "-2.1", " logD": "-5.17", " logSw": "-0.26", " tPSA": "192.41", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "18", " HeteroAtoms": "9", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "304488.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 396.503", "link_html_complex": "/ACE_complex_html/ACE_FKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FKC.png", "phi_psi": "/peptide_da/FKC.pdb", "link_html_peptide": "/Peptide_html/FKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FKC.pdb", "link_png_peptide": "/Peptide_pics/FKC.png"}
{"Peptide_Sequence": "FKGRYYP", " Origin": "chicken muscle", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "0.5 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "258", " Ligand_ID": "FKGRYYP_minimized.pdb_258", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "930.06", " logP": "-1.61", " logD": "-9.7", " logSw": "-2.91", " tPSA": "365.32", " RotatableB": "27", " RigidB": "37", " Flexibility": "0.42", " HBD": "16", " HBA": "21", " HBD_HBA": "37", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "67", " CarbonAtoms": "46", " HeteroAtoms": "21", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "50537.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 930.06", "link_html_complex": "/ACE_complex_html/ACE_FKGRYYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FKGRYYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FKGRYYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FKGRYYP.png", "phi_psi": "/peptide_da/FKGRYYP.pdb", "link_html_peptide": "/Peptide_html/FKGRYYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FKGRYYP.pdb", "link_png_peptide": "/Peptide_pics/FKGRYYP.png"}
{"Peptide_Sequence": "FKP", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "260", " Ligand_ID": "FKP_minimized.pdb_260", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "390.48", " logP": "-2.87", " logD": "-4.97", " logSw": "0.13", " tPSA": "144.82", " RotatableB": "10", " RigidB": "16", " Flexibility": "0.38", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "444949.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.477", "link_html_complex": "/ACE_complex_html/ACE_FKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FKP.png", "phi_psi": "/peptide_da/FKP.pdb", "link_html_peptide": "/Peptide_html/FKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FKP.pdb", "link_png_peptide": "/Peptide_pics/FKP.png"}
{"Peptide_Sequence": "FKR", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "261", " Ligand_ID": "FKR_minimized.pdb_261", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "449.55", " logP": "-3.56", " logD": "-6.97", " logSw": "0.61", " tPSA": "217.25", " RotatableB": "16", " RigidB": "12", " Flexibility": "0.57", " HBD": "11", " HBA": "11", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "823513.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 449.547", "link_html_complex": "/ACE_complex_html/ACE_FKR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FKR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FKR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FKR.png", "phi_psi": "/peptide_da/FKR.pdb", "link_html_peptide": "/Peptide_html/FKR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FKR.pdb", "link_png_peptide": "/Peptide_pics/FKR.png"}
{"Peptide_Sequence": "FL", " Origin": "defatted canola meal", " Peptide_Preparation": "Alcalase", " Isolation_Method": "GPC", " ACE_inhibition_assay": "Wu, Aluko, & Muir, 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.33 \u03bcM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Alister D. Muir. \"Purification of angiotensin I-converting enzyme-inhibitory peptides from the enzymatic hydrolysate of defatted canola meal.\" Food chemistry 111.4 (2008): 942-950.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "263", " Ligand_ID": "FL_minimized.pdb_263", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "278.35", " logP": "-1.17", " logD": "-0.98", " logSw": "-0.47", " tPSA": "96.87", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "15", " HeteroAtoms": "5", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "173556.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 278.347", "link_html_complex": "/ACE_complex_html/ACE_FL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FL.png", "phi_psi": "/peptide_da/FL.pdb", "link_html_peptide": "/Peptide_html/FL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FL.pdb", "link_png_peptide": "/Peptide_pics/FL.png"}
{"Peptide_Sequence": "FLKPLFNAALKLLP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al. (1979) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 22.19 \u03bcM", " Reference": "Mojallal-Tabatabaei, Zahra, et al. \"ACE-Inhibitory and antioxidant activity of temporin-ra peptide: biochemical characterization and molecular modeling study.\" International Journal of Peptide Research and Therapeutics 20.4 (2014): 493-500.", " Binding_Energy_kcal_per_mol": "-5.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1584.98", "link_html_complex": "/ACE_complex_html/ACE_FLKPLFNAALKLLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FLKPLFNAALKLLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FLKPLFNAALKLLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FLKPLFNAALKLLP.png", "phi_psi": "/peptide_da/FLKPLFNAALKLLP.pdb", "link_html_peptide": "/Peptide_html/FLKPLFNAALKLLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FLKPLFNAALKLLP.pdb", "link_png_peptide": "/Peptide_pics/FLKPLFNAALKLLP.png"}
{"Peptide_Sequence": "FLVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "12 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "264", " Ligand_ID": "FLVPP_minimized.pdb_264", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "571.71", " logP": "0.47", " logD": "-2.27", " logSw": "-2.94", " tPSA": "166.59", " RotatableB": "12", " RigidB": "25", " Flexibility": "0.32", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "30", " HeteroAtoms": "11", " ratio_H_by_C": "0.37", " Lipinski_Violation": "2", " Solubility_mg_per_l": "30214.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 571.708", "link_html_complex": "/ACE_complex_html/ACE_FLVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FLVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FLVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FLVPP.png", "phi_psi": "/peptide_da/FLVPP.pdb", "link_html_peptide": "/Peptide_html/FLVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FLVPP.pdb", "link_png_peptide": "/Peptide_pics/FLVPP.png"}
{"Peptide_Sequence": "FNE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "265", " Ligand_ID": "FNE_minimized.pdb_265", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "408.41", " logP": "-4.78", " logD": "-8.88", " logSw": "1.35", " tPSA": "209.19", " RotatableB": "12", " RigidB": "14", " Flexibility": "0.46", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1571478.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.39", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 408.406", "link_html_complex": "/ACE_complex_html/ACE_FNE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FNE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FNE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FNE.png", "phi_psi": "/peptide_da/FNE.pdb", "link_html_peptide": "/Peptide_html/FNE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FNE.pdb", "link_png_peptide": "/Peptide_pics/FNE.png"}
{"Peptide_Sequence": "FNF", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.9 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "266", " Ligand_ID": "FNF_minimized.pdb_266", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "426.47", " logP": "-3.13", " logD": "-3.47", " logSw": "0.06", " tPSA": "169.06", " RotatableB": "11", " RigidB": "19", " Flexibility": "0.37", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "22", " HeteroAtoms": "9", " ratio_H_by_C": "0.41", " Lipinski_Violation": "1", " Solubility_mg_per_l": "451942.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 426.466", "link_html_complex": "/ACE_complex_html/ACE_FNF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FNF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FNF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FNF.png", "phi_psi": "/peptide_da/FNF.pdb", "link_html_peptide": "/Peptide_html/FNF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FNF.pdb", "link_png_peptide": "/Peptide_pics/FNF.png"}
{"Peptide_Sequence": "FNQ", " Origin": "maize protein \u03b1-Zein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Yamamoto et al.1980", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "355 \u03bcM", " Reference": "Yano, Seiko, Kazumasa Suzuki, and Gunki Funatsu. \"Isolation from \u03b1-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 60.4 (1996): 661-663.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "267", " Ligand_ID": "FNQ_minimized.pdb_267", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "407.42", " logP": "-4.69", " logD": "-6.32", " logSw": "1.23", " tPSA": "212.15", " RotatableB": "11", " RigidB": "15", " Flexibility": "0.42", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1397324.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.39", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 407.421", "link_html_complex": "/ACE_complex_html/ACE_FNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FNQ.png", "phi_psi": "/peptide_da/FNQ.pdb", "link_html_peptide": "/Peptide_html/FNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FNQ.pdb", "link_png_peptide": "/Peptide_pics/FNQ.png"}
{"Peptide_Sequence": "FNVPLYE", " Origin": "salmon ", " Peptide_Preparation": "Alcalase, flavourzyme, neutrase, pepsin, protamex and trypsin", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "7.72 \u03bcM", " Reference": "Ahn, Chang-Bum, et al. \"Angiotensin I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis.\" Process Biochemistry 47.12 (2012): 2240-2245.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "268", " Ligand_ID": "FNVPLYE_minimized.pdb_268", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "880.98", " logP": "-1.14", " logD": "-7.42", " logSw": "-3.07", " tPSA": "337.03", " RotatableB": "24", " RigidB": "33", " Flexibility": "0.42", " HBD": "12", " HBA": "20", " HBD_HBA": "32", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "63", " CarbonAtoms": "43", " HeteroAtoms": "20", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "40810.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 880.983", "link_html_complex": "/ACE_complex_html/ACE_FNVPLYE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FNVPLYE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FNVPLYE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FNVPLYE.png", "phi_psi": "/peptide_da/FNVPLYE.pdb", "link_html_peptide": "/Peptide_html/FNVPLYE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FNVPLYE.pdb", "link_png_peptide": "/Peptide_pics/FNVPLYE.png"}
{"Peptide_Sequence": "FNW", " Origin": "meat-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "269", " Ligand_ID": "FNW_minimized.pdb_269", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "465.5", " logP": "-2.24", " logD": "-3.36", " logSw": "-0.77", " tPSA": "184.85", " RotatableB": "11", " RigidB": "23", " Flexibility": "0.32", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "24", " HeteroAtoms": "10", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "215344.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.25", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 465.502", "link_html_complex": "/ACE_complex_html/ACE_FNW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FNW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FNW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FNW.png", "phi_psi": "/peptide_da/FNW.pdb", "link_html_peptide": "/Peptide_html/FNW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FNW.pdb", "link_png_peptide": "/Peptide_pics/FNW.png"}
{"Peptide_Sequence": "FP", " Origin": "pepsin,trypsin,chymotrypsin, proteinase K, actinase E, thermolysin,and  papain", " Peptide_Preparation": "Proteinase K", " Isolation_Method": "RP-HPLC, GFC", " ACE_inhibition_assay": "  Yamamoto  et  al. 1994 ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "315 \u03bcM", " Reference": "Abubakar, Amhar, et al. \"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.\" Journal of Dairy Science 81.12 (1998): 3131-3138.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "272", " Ligand_ID": "FP_minimized.pdb_272", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "262.3", " logP": "-1.23", " logD": "-1.97", " logSw": "-0.55", " tPSA": "88.08", " RotatableB": "4", " RigidB": "14", " Flexibility": "0.22", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "14", " HeteroAtoms": "5", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "151732.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 262.304", "link_html_complex": "/ACE_complex_html/ACE_FP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FP.png", "phi_psi": "/peptide_da/FP.pdb", "link_html_peptide": "/Peptide_html/FP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FP.pdb", "link_png_peptide": "/Peptide_pics/FP.png"}
{"Peptide_Sequence": "FPEVFGK", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "140", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "270", " Ligand_ID": "FPEVFGK_minimized.pdb_270", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "822.95", " logP": "-3.85", " logD": "-6.51", " logSw": "-1.01", " tPSA": "301.35", " RotatableB": "24", " RigidB": "31", " Flexibility": "0.44", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "41", " HeteroAtoms": "18", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "300132.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 822.947", "link_html_complex": "/ACE_complex_html/ACE_FPEVFGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FPEVFGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FPEVFGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FPEVFGK.png", "phi_psi": "/peptide_da/FPEVFGK.pdb", "link_html_peptide": "/Peptide_html/FPEVFGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FPEVFGK.pdb", "link_png_peptide": "/Peptide_pics/FPEVFGK.png"}
{"Peptide_Sequence": "FPIIV", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "271", " Ligand_ID": "FPIIV_minimized.pdb_271", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "587.75", " logP": "1.14", " logD": "-1.05", " logSw": "-3.26", " tPSA": "175.38", " RotatableB": "15", " RigidB": "20", " Flexibility": "0.43", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "31", " HeteroAtoms": "11", " ratio_H_by_C": "0.35", " Lipinski_Violation": "3", " Solubility_mg_per_l": "22539.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 587.751", "link_html_complex": "/ACE_complex_html/ACE_FPIIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FPIIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FPIIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FPIIV.png", "phi_psi": "/peptide_da/FPIIV.pdb", "link_html_peptide": "/Peptide_html/FPIIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FPIIV.pdb", "link_png_peptide": "/Peptide_pics/FPIIV.png"}
{"Peptide_Sequence": "FPPQS", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "273", " Ligand_ID": "FPPQS_minimized.pdb_273", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "574.63", " logP": "-4.03", " logD": "-6.65", " logSw": "-0.06", " tPSA": "229.91", " RotatableB": "13", " RigidB": "27", " Flexibility": "0.33", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "540089.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 574.626", "link_html_complex": "/ACE_complex_html/ACE_FPPQS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FPPQS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FPPQS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FPPQS.png", "phi_psi": "/peptide_da/FPPQS.pdb", "link_html_peptide": "/Peptide_html/FPPQS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FPPQS.pdb", "link_png_peptide": "/Peptide_pics/FPPQS.png"}
{"Peptide_Sequence": "FPQYLQY", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "14", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-10.9", "Serial_ID": "274", " Ligand_ID": "FPQYLQY_minimized.pdb_274", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "958.07", " logP": "-2.59", " logD": "-4.13", " logSw": "-2.6", " tPSA": "360.22", " RotatableB": "25", " RigidB": "40", " Flexibility": "0.38", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "69", " CarbonAtoms": "48", " HeteroAtoms": "21", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "71214.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 958.067", "link_html_complex": "/ACE_complex_html/ACE_FPQYLQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FPQYLQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FPQYLQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FPQYLQY.png", "phi_psi": "/peptide_da/FPQYLQY.pdb", "link_html_peptide": "/Peptide_html/FPQYLQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FPQYLQY.pdb", "link_png_peptide": "/Peptide_pics/FPQYLQY.png"}
{"Peptide_Sequence": "FQ", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "7400 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "279", " Ligand_ID": "FQ_minimized.pdb_279", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "293.32", " logP": "-3.65", " logD": "-3.4", " logSw": "1.06", " tPSA": "139.96", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "844871.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 293.318", "link_html_complex": "/ACE_complex_html/ACE_FQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQ.png", "phi_psi": "/peptide_da/FQ.pdb", "link_html_peptide": "/Peptide_html/FQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQ.pdb", "link_png_peptide": "/Peptide_pics/FQ.png"}
{"Peptide_Sequence": "FQKPKR", " Origin": "chicken muscle", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "14 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "275", " Ligand_ID": "FQKPKR_minimized.pdb_275", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "802.96", " logP": "-6.34", " logD": "-12.2", " logSw": "0.99", " tPSA": "366.49", " RotatableB": "28", " RigidB": "25", " Flexibility": "0.53", " HBD": "17", " HBA": "20", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2153443.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.964", "link_html_complex": "/ACE_complex_html/ACE_FQKPKR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQKPKR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQKPKR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQKPKR.png", "phi_psi": "/peptide_da/FQKPKR.pdb", "link_html_peptide": "/Peptide_html/FQKPKR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQKPKR.pdb", "link_png_peptide": "/Peptide_pics/FQKPKR.png"}
{"Peptide_Sequence": "FQKVVA", " Origin": "swine hemoglobin", " Peptide_Preparation": "DeLoach et al. (1986)", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "5.8 \u03bcM", " Reference": "Mito, Kazue, et al. \"Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin.\" European journal of pharmacology 304.1-3 (1996): 93-98.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "278", " Ligand_ID": "FQKVVA_minimized.pdb_278", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "690.83", " logP": "-3.38", " logD": "-7.62", " logSw": "-0.58", " tPSA": "284", " RotatableB": "22", " RigidB": "19", " Flexibility": "0.54", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "49", " CarbonAtoms": "33", " HeteroAtoms": "16", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "384920.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 690.831", "link_html_complex": "/ACE_complex_html/ACE_FQKVVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQKVVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQKVVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQKVVA.png", "phi_psi": "/peptide_da/FQKVVA.pdb", "link_html_peptide": "/Peptide_html/FQKVVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQKVVA.pdb", "link_png_peptide": "/Peptide_pics/FQKVVA.png"}
{"Peptide_Sequence": "FQKVVAG", " Origin": "swine hemoglobin", " Peptide_Preparation": "DeLoach et al. (1986)", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "7.4 \u03bcM", " Reference": "Mito, Kazue, et al. \"Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin.\" European journal of pharmacology 304.1-3 (1996): 93-98.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "276", " Ligand_ID": "FQKVVAG_minimized.pdb_276", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(O)=O", " MW": "747.88", " logP": "-3.78", " logD": "-8.76", " logSw": "-0.55", " tPSA": "313.1", " RotatableB": "24", " RigidB": "21", " Flexibility": "0.53", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "430700.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.882", "link_html_complex": "/ACE_complex_html/ACE_FQKVVAG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQKVVAG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQKVVAG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQKVVAG.png", "phi_psi": "/peptide_da/FQKVVAG.pdb", "link_html_peptide": "/Peptide_html/FQKVVAG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQKVVAG.pdb", "link_png_peptide": "/Peptide_pics/FQKVVAG.png"}
{"Peptide_Sequence": "FQKVVAK", " Origin": "swine hemoglobin", " Peptide_Preparation": "DeLoach et al. (1986)", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2.1 \u03bcM", " Reference": "Mito, Kazue, et al. \"Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin.\" European journal of pharmacology 304.1-3 (1996): 93-98.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "277", " Ligand_ID": "FQKVVAK_minimized.pdb_277", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "819", " logP": "-2.63", " logD": "-7.91", " logSw": "-1.45", " tPSA": "340.74", " RotatableB": "28", " RigidB": "21", " Flexibility": "0.57", " HBD": "15", " HBA": "19", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "58", " CarbonAtoms": "39", " HeteroAtoms": "19", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "192358.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 819.003", "link_html_complex": "/ACE_complex_html/ACE_FQKVVAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQKVVAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQKVVAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQKVVAK.png", "phi_psi": "/peptide_da/FQKVVAK.pdb", "link_html_peptide": "/Peptide_html/FQKVVAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQKVVAK.pdb", "link_png_peptide": "/Peptide_pics/FQKVVAK.png"}
{"Peptide_Sequence": "FQP", " Origin": "Dried Bonito", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "12 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "280", " Ligand_ID": "FQP_minimized.pdb_280", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "390.43", " logP": "-3.8", " logD": "-4.57", " logSw": "0.65", " tPSA": "160.27", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "744228.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.434", "link_html_complex": "/ACE_complex_html/ACE_FQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQP.png", "phi_psi": "/peptide_da/FQP.pdb", "link_html_peptide": "/Peptide_html/FQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQP.pdb", "link_png_peptide": "/Peptide_pics/FQP.png"}
{"Peptide_Sequence": "FQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.8", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "281", " Ligand_ID": "FQPQPLIYP_minimized.pdb_281", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1102.28", " logP": "-0.97", " logD": "-4.68", " logSw": "-4.34", " tPSA": "380.61", " RotatableB": "27", " RigidB": "48", " Flexibility": "0.36", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "79", " CarbonAtoms": "55", " HeteroAtoms": "24", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "14409.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1102.28", "link_html_complex": "/ACE_complex_html/ACE_FQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQPQPLIYP.png", "phi_psi": "/peptide_da/FQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/FQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/FQPQPLIYP.png"}
{"Peptide_Sequence": "FQPSF", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "12.56 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "282", " Ligand_ID": "FQPSF_minimized.pdb_282", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "624.68", " logP": "-2.74", " logD": "-5.24", " logSw": "-1.04", " tPSA": "238.7", " RotatableB": "16", " RigidB": "28", " Flexibility": "0.36", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "31", " HeteroAtoms": "14", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "221834.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 624.685", "link_html_complex": "/ACE_complex_html/ACE_FQPSF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FQPSF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FQPSF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FQPSF.png", "phi_psi": "/peptide_da/FQPSF.pdb", "link_html_peptide": "/Peptide_html/FQPSF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FQPSF.pdb", "link_png_peptide": "/Peptide_pics/FQPSF.png"}
{"Peptide_Sequence": "FR", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "288", " Ligand_ID": "FR_minimized.pdb_288", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "321.37", " logP": "-3.31", " logD": "-3.88", " logSw": "0.82", " tPSA": "160.51", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "726953.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 321.375", "link_html_complex": "/ACE_complex_html/ACE_FR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FR.png", "phi_psi": "/peptide_da/FR.pdb", "link_html_peptide": "/Peptide_html/FR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FR.pdb", "link_png_peptide": "/Peptide_pics/FR.png"}
{"Peptide_Sequence": "FRADHPFL", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.2", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "283", " Ligand_ID": "FRADHPFL_minimized.pdb_283", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "1002.13", " logP": "-1.89", " logD": "-11.18", " logSw": "-3.04", " tPSA": "395.13", " RotatableB": "29", " RigidB": "39", " Flexibility": "0.43", " HBD": "15", " HBA": "24", " HBD_HBA": "39", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "72", " CarbonAtoms": "48", " HeteroAtoms": "24", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "47985.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1002.13", "link_html_complex": "/ACE_complex_html/ACE_FRADHPFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FRADHPFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FRADHPFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FRADHPFL.png", "phi_psi": "/peptide_da/FRADHPFL.pdb", "link_html_peptide": "/Peptide_html/FRADHPFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FRADHPFL.pdb", "link_png_peptide": "/Peptide_pics/FRADHPFL.png"}
{"Peptide_Sequence": "FRAHPFL", " Origin": "Ovalbumin ", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.2 \u03bcM", " Reference": "Rao, Sheng-Qi, et al. \"Purification and characterization of angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysate of hen egg white lysozyme.\" Food research international 46.1 (2012): 127-134.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "284", " Ligand_ID": "FRAHPFL_minimized.pdb_284", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "887.04", " logP": "-0.77", " logD": "-6.61", " logSw": "-3.3", " tPSA": "325.9", " RotatableB": "25", " RigidB": "36", " Flexibility": "0.41", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "64", " CarbonAtoms": "44", " HeteroAtoms": "20", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "32573.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 887.039", "link_html_complex": "/ACE_complex_html/ACE_FRAHPFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FRAHPFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FRAHPFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FRAHPFL.png", "phi_psi": "/peptide_da/FRAHPFL.pdb", "link_html_peptide": "/Peptide_html/FRAHPFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FRAHPFL.pdb", "link_png_peptide": "/Peptide_pics/FRAHPFL.png"}
{"Peptide_Sequence": "FRC", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "285", " Ligand_ID": "FRC_minimized.pdb_285", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(O)=O", " MW": "424.52", " logP": "-3.4", " logD": "-5.96", " logSw": "0.45", " tPSA": "228.41", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "1", " Solubility_mg_per_l": "665839.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 424.517", "link_html_complex": "/ACE_complex_html/ACE_FRC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FRC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FRC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FRC.png", "phi_psi": "/peptide_da/FRC.pdb", "link_html_peptide": "/Peptide_html/FRC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FRC.pdb", "link_png_peptide": "/Peptide_pics/FRC.png"}
{"Peptide_Sequence": "FREGD", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "286", " Ligand_ID": "FREGD_minimized.pdb_286", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "622.63", " logP": "-5.03", " logD": "-15.79", " logSw": "0.8", " tPSA": "328.07", " RotatableB": "21", " RigidB": "18", " Flexibility": "0.54", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "44", " CarbonAtoms": "26", " HeteroAtoms": "18", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1386324.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 622.628", "link_html_complex": "/ACE_complex_html/ACE_FREGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FREGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FREGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FREGD.png", "phi_psi": "/peptide_da/FREGD.pdb", "link_html_peptide": "/Peptide_html/FREGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FREGD.pdb", "link_png_peptide": "/Peptide_pics/FREGD.png"}
{"Peptide_Sequence": "FRHEA", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "287", " Ligand_ID": "FRHEA_minimized.pdb_287", " Smiles": "C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "658.71", " logP": "-3.99", " logD": "-12.51", " logSw": "-0.12", " tPSA": "316.62", " RotatableB": "21", " RigidB": "22", " Flexibility": "0.49", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "586715.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 658.706", "link_html_complex": "/ACE_complex_html/ACE_FRHEA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FRHEA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FRHEA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FRHEA.png", "phi_psi": "/peptide_da/FRHEA.pdb", "link_html_peptide": "/Peptide_html/FRHEA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FRHEA.pdb", "link_png_peptide": "/Peptide_pics/FRHEA.png"}
{"Peptide_Sequence": "FRVPTPN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "9.55 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "289", " Ligand_ID": "FRVPTPN_minimized.pdb_289", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "829.94", " logP": "-4.31", " logD": "-10.03", " logSw": "-0.86", " tPSA": "351.75", " RotatableB": "22", " RigidB": "32", " Flexibility": "0.41", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "59", " CarbonAtoms": "38", " HeteroAtoms": "21", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "352617.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 829.943", "link_html_complex": "/ACE_complex_html/ACE_FRVPTPN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FRVPTPN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FRVPTPN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FRVPTPN.png", "phi_psi": "/peptide_da/FRVPTPN.pdb", "link_html_peptide": "/Peptide_html/FRVPTPN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FRVPTPN.pdb", "link_png_peptide": "/Peptide_pics/FRVPTPN.png"}
{"Peptide_Sequence": "FSDKIAK", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "113.6 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "290", " Ligand_ID": "FSDKIAK_minimized.pdb_290", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "807.93", " logP": "-6.28", " logD": "-9.31", " logSw": "0.92", " tPSA": "358.01", " RotatableB": "28", " RigidB": "20", " Flexibility": "0.58", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2022445.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 807.934", "link_html_complex": "/ACE_complex_html/ACE_FSDKIAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FSDKIAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FSDKIAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FSDKIAK.png", "phi_psi": "/peptide_da/FSDKIAK.pdb", "link_html_peptide": "/Peptide_html/FSDKIAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FSDKIAK.pdb", "link_png_peptide": "/Peptide_pics/FSDKIAK.png"}
{"Peptide_Sequence": "FSL", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "172.9", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "291", " Ligand_ID": "FSL_minimized.pdb_291", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "365.42", " logP": "-2.47", " logD": "-3.45", " logSw": "0.03", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "375311.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.424", "link_html_complex": "/ACE_complex_html/ACE_FSL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FSL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FSL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FSL.png", "phi_psi": "/peptide_da/FSL.pdb", "link_html_peptide": "/Peptide_html/FSL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FSL.pdb", "link_png_peptide": "/Peptide_pics/FSL.png"}
{"Peptide_Sequence": "FSY", " Origin": "Northern shrimp (Pandalus borealis)", " Peptide_Preparation": "synthetic", " Isolation_Method": " cation exchange chromatography", " ACE_inhibition_assay": "Vermeirssen et al. 2002", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "2.2 \u03bcM", " Reference": "Gildberg, Asbj\u00f8rn, et al. \"Angiotensin I-converting enzyme inhibitory activity in a hydrolysate of proteins from Northern shrimp (Pandalus borealis) and identification of two novel inhibitory tri-peptides.\" Process biochemistry 46.11 (2011): 2205-2209.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "292", " Ligand_ID": "FSY_minimized.pdb_292", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "415.44", " logP": "-2.98", " logD": "-3.41", " logSw": "-0.04", " tPSA": "166.43", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "399237.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.44", "link_html_complex": "/ACE_complex_html/ACE_FSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FSY.png", "phi_psi": "/peptide_da/FSY.pdb", "link_html_peptide": "/Peptide_html/FSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FSY.pdb", "link_png_peptide": "/Peptide_pics/FSY.png"}
{"Peptide_Sequence": "FTDVDFIK", " Origin": "Sweet potato thioredoxin h2 ", " Peptide_Preparation": "expression of thioredoxin h2 in E. coli", " Isolation_Method": "", " ACE_inhibition_assay": " Lee  et  al.(2003) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.42 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Botanical Studies 52.1 (2011).", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "293", " Ligand_ID": "FTDVDFIK_minimized.pdb_293", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "984.1", " logP": "-4.18", " logD": "-10.19", " logSw": "-1.33", " tPSA": "399.6", " RotatableB": "31", " RigidB": "29", " Flexibility": "0.52", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "70", " CarbonAtoms": "47", " HeteroAtoms": "23", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "261336.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 984.103", "link_html_complex": "/ACE_complex_html/ACE_FTDVDFIK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FTDVDFIK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FTDVDFIK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FTDVDFIK.png", "phi_psi": "/peptide_da/FTDVDFIK.pdb", "link_html_peptide": "/Peptide_html/FTDVDFIK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FTDVDFIK.pdb", "link_png_peptide": "/Peptide_pics/FTDVDFIK.png"}
{"Peptide_Sequence": "FTY", " Origin": "Northern shrimp (Pandalus borealis)", " Peptide_Preparation": "synthetic", " Isolation_Method": " cation exchange chromatography", " ACE_inhibition_assay": "Vermeirssen et al. 2002", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "59 \u03bcM", " Reference": "Gildberg, Asbj\u00f8rn, et al. \"Angiotensin I-converting enzyme inhibitory activity in a hydrolysate of proteins from Northern shrimp (Pandalus borealis) and identification of two novel inhibitory tri-peptides.\" Process biochemistry 46.11 (2011): 2205-2209.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "294", " Ligand_ID": "FTY_minimized.pdb_294", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "429.47", " logP": "-2.55", " logD": "-2.99", " logSw": "-0.39", " tPSA": "166.43", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "22", " HeteroAtoms": "9", " ratio_H_by_C": "0.41", " Lipinski_Violation": "1", " Solubility_mg_per_l": "290978.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.32", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.466", "link_html_complex": "/ACE_complex_html/ACE_FTY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FTY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FTY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FTY.png", "phi_psi": "/peptide_da/FTY.pdb", "link_html_peptide": "/Peptide_html/FTY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FTY.pdb", "link_png_peptide": "/Peptide_pics/FTY.png"}
{"Peptide_Sequence": "FV", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.6 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "299", " Ligand_ID": "FV_minimized.pdb_299", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "264.32", " logP": "-1.68", " logD": "-1.35", " logSw": "-0.14", " tPSA": "96.87", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "14", " HeteroAtoms": "5", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "230195.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 264.32", "link_html_complex": "/ACE_complex_html/ACE_FV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FV.png", "phi_psi": "/peptide_da/FV.pdb", "link_html_peptide": "/Peptide_html/FV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FV.pdb", "link_png_peptide": "/Peptide_pics/FV.png"}
{"Peptide_Sequence": "FVAP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "297", " Ligand_ID": "FVAP_minimized.pdb_297", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "432.51", " logP": "-0.77", " logD": "-3.27", " logSw": "-1.51", " tPSA": "146.28", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "22", " HeteroAtoms": "9", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "95264.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 432.513", "link_html_complex": "/ACE_complex_html/ACE_FVAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVAP.png", "phi_psi": "/peptide_da/FVAP.pdb", "link_html_peptide": "/Peptide_html/FVAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVAP.pdb", "link_png_peptide": "/Peptide_pics/FVAP.png"}
{"Peptide_Sequence": "FVAPFPEV", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "475 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "296", " Ligand_ID": "FVAPFPEV_minimized.pdb_296", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(O)=O", " MW": "905.05", " logP": "0.43", " logD": "-6.16", " logSw": "-4.34", " tPSA": "294.02", " RotatableB": "22", " RigidB": "38", " Flexibility": "0.37", " HBD": "9", " HBA": "19", " HBD_HBA": "28", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "65", " CarbonAtoms": "46", " HeteroAtoms": "19", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11810.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 905.048", "link_html_complex": "/ACE_complex_html/ACE_FVAPFPEV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVAPFPEV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVAPFPEV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVAPFPEV.png", "phi_psi": "/peptide_da/FVAPFPEV.pdb", "link_html_peptide": "/Peptide_html/FVAPFPEV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVAPFPEV.pdb", "link_png_peptide": "/Peptide_pics/FVAPFPEV.png"}
{"Peptide_Sequence": "FVAPFPEVFG", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "650 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "295", " Ligand_ID": "FVAPFPEVFG_minimized.pdb_295", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O", " MW": "1109.27", " logP": "1.11", " logD": "-6.15", " logSw": "-5.65", " tPSA": "352.22", " RotatableB": "28", " RigidB": "48", " Flexibility": "0.37", " HBD": "11", " HBA": "23", " HBD_HBA": "34", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "80", " CarbonAtoms": "57", " HeteroAtoms": "23", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3885.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1109.27", "link_html_complex": "/ACE_complex_html/ACE_FVAPFPEVFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVAPFPEVFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVAPFPEVFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVAPFPEVFG.png", "phi_psi": "/peptide_da/FVAPFPEVFG.pdb", "link_html_peptide": "/Peptide_html/FVAPFPEVFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVAPFPEVFG.pdb", "link_png_peptide": "/Peptide_pics/FVAPFPEVFG.png"}
{"Peptide_Sequence": "FVEPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "298", " Ligand_ID": "FVEPIP_minimized.pdb_298", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "700.82", " logP": "-0.29", " logD": "-6.27", " logSw": "-2.92", " tPSA": "235.82", " RotatableB": "17", " RigidB": "28", " Flexibility": "0.38", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "50", " CarbonAtoms": "35", " HeteroAtoms": "15", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "37649.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 700.822", "link_html_complex": "/ACE_complex_html/ACE_FVEPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVEPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVEPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVEPIP.png", "phi_psi": "/peptide_da/FVEPIP.pdb", "link_html_peptide": "/Peptide_html/FVEPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVEPIP.pdb", "link_png_peptide": "/Peptide_pics/FVEPIP.png"}
{"Peptide_Sequence": "FVNPEAGS", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "6.92 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "300", " Ligand_ID": "FVNPEAGS_minimized.pdb_300", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "819.86", " logP": "-5.4", " logD": "-12.12", " logSw": "-0.04", " tPSA": "366.13", " RotatableB": "23", " RigidB": "29", " Flexibility": "0.44", " HBD": "13", " HBA": "22", " HBD_HBA": "35", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "58", " CarbonAtoms": "36", " HeteroAtoms": "22", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "785255.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 819.859", "link_html_complex": "/ACE_complex_html/ACE_FVNPEAGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVNPEAGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVNPEAGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVNPEAGS.png", "phi_psi": "/peptide_da/FVNPEAGS.pdb", "link_html_peptide": "/Peptide_html/FVNPEAGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVNPEAGS.pdb", "link_png_peptide": "/Peptide_pics/FVNPEAGS.png"}
{"Peptide_Sequence": "FVNPQAGS", " Origin": "Sunflower (Helianthus annuus L.)", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "GFC, RP-HPLC", " ACE_inhibition_assay": "Hayakari et al. (1978)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.9 \u03bcM", " Reference": "Meg\u00edas, Cristina, et al. \"Purification of an ACE inhibitory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates.\" Journal of Agricultural and Food Chemistry 52.7 (2004): 1928-1932.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "301", " Ligand_ID": "FVNPQAGS_minimized.pdb_301", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "818.87", " logP": "-6.05", " logD": "-9.65", " logSw": "0.31", " tPSA": "369.09", " RotatableB": "22", " RigidB": "30", " Flexibility": "0.42", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "58", " CarbonAtoms": "36", " HeteroAtoms": "22", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1112950.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 818.874", "link_html_complex": "/ACE_complex_html/ACE_FVNPQAGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVNPQAGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVNPQAGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVNPQAGS.png", "phi_psi": "/peptide_da/FVNPQAGS.pdb", "link_html_peptide": "/Peptide_html/FVNPQAGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVNPQAGS.pdb", "link_png_peptide": "/Peptide_pics/FVNPQAGS.png"}
{"Peptide_Sequence": "FVP", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10.1 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "303", " Ligand_ID": "FVP_minimized.pdb_303", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "361.44", " logP": "-0.52", " logD": "-2.48", " logSw": "-1.38", " tPSA": "117.18", " RotatableB": "7", " RigidB": "16", " Flexibility": "0.3", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "19", " HeteroAtoms": "7", " ratio_H_by_C": "0.37", " Lipinski_Violation": "0", " Solubility_mg_per_l": "91378.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 361.435", "link_html_complex": "/ACE_complex_html/ACE_FVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVP.png", "phi_psi": "/peptide_da/FVP.pdb", "link_html_peptide": "/Peptide_html/FVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVP.pdb", "link_png_peptide": "/Peptide_pics/FVP.png"}
{"Peptide_Sequence": "FVPAF", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.5 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "302", " Ligand_ID": "FVPAF_minimized.pdb_302", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "579.69", " logP": "-1.27", " logD": "-2.12", " logSw": "-1.88", " tPSA": "175.38", " RotatableB": "13", " RigidB": "26", " Flexibility": "0.33", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "31", " HeteroAtoms": "11", " ratio_H_by_C": "0.35", " Lipinski_Violation": "3", " Solubility_mg_per_l": "88194.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.687", "link_html_complex": "/ACE_complex_html/ACE_FVPAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FVPAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FVPAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FVPAF.png", "phi_psi": "/peptide_da/FVPAF.pdb", "link_html_peptide": "/Peptide_html/FVPAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FVPAF.pdb", "link_png_peptide": "/Peptide_pics/FVPAF.png"}
{"Peptide_Sequence": "FW", " Origin": "plant-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.9 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "304", " Ligand_ID": "FW_minimized.pdb_304", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "351.4", " logP": "-0.47", " logD": "-0.48", " logSw": "-1.5", " tPSA": "112.66", " RotatableB": "7", " RigidB": "19", " Flexibility": "0.27", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "20", " HeteroAtoms": "6", " ratio_H_by_C": "0.3", " Lipinski_Violation": "0", " Solubility_mg_per_l": "78663.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.2", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 351.399", "link_html_complex": "/ACE_complex_html/ACE_FW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FW.png", "phi_psi": "/peptide_da/FW.pdb", "link_html_peptide": "/Peptide_html/FW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FW.pdb", "link_png_peptide": "/Peptide_pics/FW.png"}
{"Peptide_Sequence": "FWN", " Origin": "Sake ", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "18.3", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "305", " Ligand_ID": "FWN_minimized.pdb_305", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "465.5", " logP": "-2.52", " logD": "-3.38", " logSw": "-0.59", " tPSA": "184.85", " RotatableB": "11", " RigidB": "23", " Flexibility": "0.32", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "24", " HeteroAtoms": "10", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "256887.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.25", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 465.502", "link_html_complex": "/ACE_complex_html/ACE_FWN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FWN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FWN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FWN.png", "phi_psi": "/peptide_da/FWN.pdb", "link_html_peptide": "/Peptide_html/FWN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FWN.pdb", "link_png_peptide": "/Peptide_pics/FWN.png"}
{"Peptide_Sequence": "FY", " Origin": "broccoli (Brassica oleracea Italica)", " Peptide_Preparation": "", " Isolation_Method": "column chromatography", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modification", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.74 \u03bcM", " Reference": "Lee, Ju-Eun, et al. \"Tyr-Pro-Lys, an angiotensin I-converting enzyme inhibitory peptide derived from broccoli (Brassica oleracea Italica).\" Food chemistry 99.1 (2006): 143-148.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "306", " Ligand_ID": "FY_minimized.pdb_306", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "328.36", " logP": "-1.68", " logD": "-0.89", " logSw": "-0.56", " tPSA": "117.1", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "18", " HeteroAtoms": "6", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "188077.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.22", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 328.362", "link_html_complex": "/ACE_complex_html/ACE_FY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FY.png", "phi_psi": "/peptide_da/FY.pdb", "link_html_peptide": "/Peptide_html/FY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FY.pdb", "link_png_peptide": "/Peptide_pics/FY.png"}
{"Peptide_Sequence": "FYN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "307", " Ligand_ID": "FYN_minimized.pdb_307", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "442.47", " logP": "-3.85", " logD": "-3.81", " logSw": "0.42", " tPSA": "189.29", " RotatableB": "11", " RigidB": "19", " Flexibility": "0.37", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "670132.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 442.465", "link_html_complex": "/ACE_complex_html/ACE_FYN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FYN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FYN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FYN.png", "phi_psi": "/peptide_da/FYN.pdb", "link_html_peptide": "/Peptide_html/FYN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FYN.pdb", "link_png_peptide": "/Peptide_pics/FYN.png"}
{"Peptide_Sequence": "FYPEL", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.9 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "308", " Ligand_ID": "FYPEL_minimized.pdb_308", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O", " MW": "667.75", " logP": "-1.58", " logD": "-5.73", " logSw": "-1.96", " tPSA": "235.74", " RotatableB": "17", " RigidB": "27", " Flexibility": "0.39", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "48", " CarbonAtoms": "34", " HeteroAtoms": "14", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "94234.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 667.749", "link_html_complex": "/ACE_complex_html/ACE_FYPEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FYPEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FYPEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FYPEL.png", "phi_psi": "/peptide_da/FYPEL.pdb", "link_html_peptide": "/Peptide_html/FYPEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FYPEL.pdb", "link_png_peptide": "/Peptide_pics/FYPEL.png"}
{"Peptide_Sequence": "FYQQ", " Origin": "maize protein \u03b1-Zein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Yamamoto et al.1980", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "25 \u03bcM", " Reference": "Yano, Seiko, Kazumasa Suzuki, and Gunki Funatsu. \"Isolation from \u03b1-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 60.4 (1996): 661-663.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "309", " Ligand_ID": "FYQQ_minimized.pdb_309", " Smiles": "N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "584.62", " logP": "-4.92", " logD": "-5.39", " logSw": "0.58", " tPSA": "261.48", " RotatableB": "16", " RigidB": "23", " Flexibility": "0.41", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "28", " HeteroAtoms": "14", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1041136.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.621", "link_html_complex": "/ACE_complex_html/ACE_FYQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FYQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FYQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FYQQ.png", "phi_psi": "/peptide_da/FYQQ.pdb", "link_html_peptide": "/Peptide_html/FYQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FYQQ.pdb", "link_png_peptide": "/Peptide_pics/FYQQ.png"}
{"Peptide_Sequence": "FYTGG", " Origin": "egg proteins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.8 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "310", " Ligand_ID": "FYTGG_minimized.pdb_310", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)NCC(O)=O", " MW": "543.57", " logP": "-2.9", " logD": "-5.43", " logSw": "-0.58", " tPSA": "224.63", " RotatableB": "14", " RigidB": "21", " Flexibility": "0.4", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "303595.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 543.569", "link_html_complex": "/ACE_complex_html/ACE_FYTGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_FYTGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_FYTGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_FYTGG.png", "phi_psi": "/peptide_da/FYTGG.pdb", "link_html_peptide": "/Peptide_html/FYTGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/FYTGG.pdb", "link_png_peptide": "/Peptide_pics/FYTGG.png"}
{"Peptide_Sequence": "GA", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "2000 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-5.3", "Serial_ID": "313", " Ligand_ID": "GA_minimized.pdb_313", " Smiles": "C[C@H](NC(=O)CN)C(O)=O", " MW": "146.14", " logP": "-3.65", " logD": "-4.45", " logSw": "1.75", " tPSA": "96.87", " RotatableB": "3", " RigidB": "3", " Flexibility": "0.5", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "10", " CarbonAtoms": "5", " HeteroAtoms": "5", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "842185.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 146.144", "link_html_complex": "/ACE_complex_html/ACE_GA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GA.png", "phi_psi": "/peptide_da/GA.pdb", "link_html_peptide": "/Peptide_html/GA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GA.pdb", "link_png_peptide": "/Peptide_pics/GA.png"}
{"Peptide_Sequence": "GAAELPCSADWW", " Origin": "bullfrog (Rana catesbeiana Shaw) muscle protein", " Peptide_Preparation": "Alcalase, \u03b1-chymotrypsin, Neutrase, papain, pepsin, and trypsin", " Isolation_Method": " ion-exchange column, HPLC", " ACE_inhibition_assay": "Cushman and Cheung with slight modifications", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "0.95 \u03bcM", " Reference": "Qian, Zhong-Ji, et al. \"Antihypertensive effect of an angiotensin I-converting enzyme inhibitory peptide from bullfrog (Rana catesbeiana Shaw) muscle protein in spontaneously hypertensive rats.\" Process Biochemistry 42.10 (2007): 1443-1448.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "311", " Ligand_ID": "GAAELPCSADWW_minimized.pdb_311", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "1305.41", " logP": "-3.64", " logD": "-14.54", " logSw": "-3.41", " tPSA": "549.95", " RotatableB": "35", " RigidB": "50", " Flexibility": "0.41", " HBD": "18", " HBA": "32", " HBD_HBA": "50", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "92", " CarbonAtoms": "59", " HeteroAtoms": "33", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "43226.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1305.41", "link_html_complex": "/ACE_complex_html/ACE_GAAELPCSADWW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAAELPCSADWW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAAELPCSADWW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAAELPCSADWW.png", "phi_psi": "/peptide_da/GAAELPCSADWW.pdb", "link_html_peptide": "/Peptide_html/GAAELPCSADWW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAAELPCSADWW.pdb", "link_png_peptide": "/Peptide_pics/GAAELPCSADWW.png"}
{"Peptide_Sequence": "GAGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "98.8 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "312", " Ligand_ID": "GAGP_minimized.pdb_312", " Smiles": "C[C@H](NC(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "300.31", " logP": "-4.26", " logD": "-7", " logSw": "1.38", " tPSA": "146.28", " RotatableB": "6", " RigidB": "12", " Flexibility": "0.33", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1191168.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.311", "link_html_complex": "/ACE_complex_html/ACE_GAGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAGP.png", "phi_psi": "/peptide_da/GAGP.pdb", "link_html_peptide": "/Peptide_html/GAGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAGP.pdb", "link_png_peptide": "/Peptide_pics/GAGP.png"}
{"Peptide_Sequence": "GAP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung modified by Hern\u03bcndez-Ledesmaet al", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.3 \u03bcM", " Reference": "Jing, Tao, et al. \"Rational design of angiotensin\u2010I\u2010converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.\" ChemMedChem 8.7 (2013): 1057-1066.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "316", " Ligand_ID": "GAP_minimized.pdb_316", " Smiles": "C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "243.26", " logP": "-3.36", " logD": "-5.67", " logSw": "1.03", " tPSA": "117.18", " RotatableB": "4", " RigidB": "10", " Flexibility": "0.29", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "683153.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.26", "link_html_complex": "/ACE_complex_html/ACE_GAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAP.png", "phi_psi": "/peptide_da/GAP.pdb", "link_html_peptide": "/Peptide_html/GAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAP.pdb", "link_png_peptide": "/Peptide_pics/GAP.png"}
{"Peptide_Sequence": "GAPGLPGP", " Origin": "chicken", " Peptide_Preparation": " broad substrate proteases", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "29.4 \u00b5M\t", " Reference": "Zhang, Yuhao, et al. \"Effect of pretreatment on enzymatic hydrolysis of bovine collagen and formation of ACE-inhibitory peptides.\" Food Chemistry 141.3 (2013): 2343-2354.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "314", " Ligand_ID": "GAPGLPGP_minimized.pdb_314", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "664.75", " logP": "-3.74", " logD": "-7.97", " logSw": "-0.68", " tPSA": "245.1", " RotatableB": "14", " RigidB": "30", " Flexibility": "0.32", " HBD": "7", " HBA": "17", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "336352.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 664.75", "link_html_complex": "/ACE_complex_html/ACE_GAPGLPGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAPGLPGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAPGLPGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAPGLPGP.png", "phi_psi": "/peptide_da/GAPGLPGP.pdb", "link_html_peptide": "/Peptide_html/GAPGLPGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAPGLPGP.pdb", "link_png_peptide": "/Peptide_pics/GAPGLPGP.png"}
{"Peptide_Sequence": "GAPGPAGPGGIPGERG", " Origin": "chicken", " Peptide_Preparation": " broad substrate proteases", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "45.6 \u00b5M        ", " Reference": "Zhang, Yuhao, et al. \"Effect of pretreatment on enzymatic hydrolysis of bovine collagen and formation of ACE-inhibitory peptides.\" Food Chemistry 141.3 (2013): 2343-2354.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "315", " Ligand_ID": "GAPGPAGPGGIPGERG_minimized.pdb_315", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O", " MW": "1346.45", " logP": "-8.4", " logD": "-20.16", " logSw": "-0.45", " tPSA": "572.88", " RotatableB": "37", " RigidB": "53", " Flexibility": "0.41", " HBD": "19", " HBA": "38", " HBD_HBA": "57", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "95", " CarbonAtoms": "57", " HeteroAtoms": "38", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "855123.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1346.45", "link_html_complex": "/ACE_complex_html/ACE_GAPGPAGPGGIPGERG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAPGPAGPGGIPGERG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAPGPAGPGGIPGERG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAPGPAGPGGIPGERG.png", "phi_psi": "/peptide_da/GAPGPAGPGGIPGERG.pdb", "link_html_peptide": "/Peptide_html/GAPGPAGPGGIPGERG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAPGPAGPGGIPGERG.pdb", "link_png_peptide": "/Peptide_pics/GAPGPAGPGGIPGERG.png"}
{"Peptide_Sequence": "GAW", " Origin": "milk", " Peptide_Preparation": "fermentation with lactic acid bacteria ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) and Wu and Ding (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "240 \u00b5M        ", " Reference": "Chen, Guan-Wen, Jenn-Shou Tsai, and Bonnie Sun Pan. \"Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation.\" International Dairy Journal 17.6 (2007): 641-647.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "317", " Ligand_ID": "GAW_minimized.pdb_317", " Smiles": "C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "332.35", " logP": "-2.86", " logD": "-4.14", " logSw": "0.21", " tPSA": "141.76", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "410773.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 332.354", "link_html_complex": "/ACE_complex_html/ACE_GAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GAW.png", "phi_psi": "/peptide_da/GAW.pdb", "link_html_peptide": "/Peptide_html/GAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GAW.pdb", "link_png_peptide": "/Peptide_pics/GAW.png"}
{"Peptide_Sequence": "GCETR", " Origin": "plant proteins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10\u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "318", " Ligand_ID": "GCETR_minimized.pdb_318", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "564.61", " logP": "-6.44", " logD": "-11.41", " logSw": "1.97", " tPSA": "346.97", " RotatableB": "19", " RigidB": "11", " Flexibility": "0.63", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "20", " HeteroAtoms": "18", " ratio_H_by_C": "0.9", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4051083.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 564.612", "link_html_complex": "/ACE_complex_html/ACE_GCETR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GCETR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GCETR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GCETR.png", "phi_psi": "/peptide_da/GCETR.pdb", "link_html_peptide": "/Peptide_html/GCETR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GCETR.pdb", "link_png_peptide": "/Peptide_pics/GCETR.png"}
{"Peptide_Sequence": "GD", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "9200 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.7", "Serial_ID": "321", " Ligand_ID": "GD_minimized.pdb_321", " Smiles": "NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "190.15", " logP": "-5.14", " logD": "-7.4", " logSw": "2.55", " tPSA": "137", " RotatableB": "5", " RigidB": "4", " Flexibility": "0.56", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "13", " CarbonAtoms": "6", " HeteroAtoms": "7", " ratio_H_by_C": "1.17", " Lipinski_Violation": "0", " Solubility_mg_per_l": "2433484.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 190.154", "link_html_complex": "/ACE_complex_html/ACE_GD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GD.png", "phi_psi": "/peptide_da/GD.pdb", "link_html_peptide": "/Peptide_html/GD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GD.pdb", "link_png_peptide": "/Peptide_pics/GD.png"}
{"Peptide_Sequence": "GDAP", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "22.5", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "319", " Ligand_ID": "GDAP_minimized.pdb_319", " Smiles": "C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "358.35", " logP": "-5.18", " logD": "-9.59", " logSw": "1.73", " tPSA": "186.41", " RotatableB": "8", " RigidB": "13", " Flexibility": "0.38", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "14", " HeteroAtoms": "11", " ratio_H_by_C": "0.79", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2020600.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.347", "link_html_complex": "/ACE_complex_html/ACE_GDAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GDAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GDAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GDAP.png", "phi_psi": "/peptide_da/GDAP.pdb", "link_html_peptide": "/Peptide_html/GDAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GDAP.pdb", "link_png_peptide": "/Peptide_pics/GDAP.png"}
{"Peptide_Sequence": "GDLGKTTTVSNWSPPKYKDTP", " Origin": "tuna", " Peptide_Preparation": "Alcalase,a-chymotrypsin, papain, pepsin, Neutraseand trypsin", " Isolation_Method": "IEC, HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)with slight modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "11.28 \u03bcM", " Reference": "Lee, Sang-Hoon, Zhong-Ji Qian, and Se-Kwon Kim. \"A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats.\" Food Chemistry 118.1 (2010): 96-102.", " Binding_Energy_kcal_per_mol": "", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": "#", "link_html_complex": "/ACE_complex_html/ACE_GDLGKTTTVSNWSPPKYKDTP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GDLGKTTTVSNWSPPKYKDTP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GDLGKTTTVSNWSPPKYKDTP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GDLGKTTTVSNWSPPKYKDTP.png", "phi_psi": "#", "link_html_peptide": "/Peptide_html/GDLGKTTTVSNWSPPKYKDTP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GDLGKTTTVSNWSPPKYKDTP.pdb", "link_png_peptide": "/Peptide_pics/GDLGKTTTVSNWSPPKYKDTP.png"}
{"Peptide_Sequence": "GE", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "5400 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "324", " Ligand_ID": "GE_minimized.pdb_324", " Smiles": "NCC(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "204.18", " logP": "-4.17", " logD": "-8.01", " logSw": "1.92", " tPSA": "137", " RotatableB": "6", " RigidB": "4", " Flexibility": "0.6", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1388785.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 204.181", "link_html_complex": "/ACE_complex_html/ACE_GE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GE.png", "phi_psi": "/peptide_da/GE.pdb", "link_html_peptide": "/Peptide_html/GE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GE.pdb", "link_png_peptide": "/Peptide_pics/GE.png"}
{"Peptide_Sequence": "GEGGP", " Origin": "Korean mushroom (Pholiota adiposa)", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "254 \u03bcM", " Reference": "Koo, Kyo-Chul, et al. \"Production and characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Pholiota adiposa.\" Journal of microbiology and biotechnology 16.5 (2006): 757-763.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "322", " Ligand_ID": "GEGGP_minimized.pdb_322", " Smiles": "NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "415.4", " logP": "-5.42", " logD": "-11.31", " logSw": "1.73", " tPSA": "215.51", " RotatableB": "11", " RigidB": "15", " Flexibility": "0.42", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "16", " HeteroAtoms": "13", " ratio_H_by_C": "0.81", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2331735.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.398", "link_html_complex": "/ACE_complex_html/ACE_GEGGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GEGGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GEGGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GEGGP.png", "phi_psi": "/peptide_da/GEGGP.pdb", "link_html_peptide": "/Peptide_html/GEGGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GEGGP.pdb", "link_png_peptide": "/Peptide_pics/GEGGP.png"}
{"Peptide_Sequence": "GEGSGA", " Origin": "common beans (Phaseolus vulgaris L.) ", " Peptide_Preparation": " synthesized ", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "113.7 \u03bcM", " Reference": "Luna-Vital, Diego A., et al. \"Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity.\" Food & function 6.5 (2015): 1470-1479.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "323", " Ligand_ID": "GEGSGA_minimized.pdb_323", " Smiles": "C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CN)C(O)=O", " MW": "476.44", " logP": "-7.03", " logD": "-13.2", " logSw": "2.62", " tPSA": "273.63", " RotatableB": "15", " RigidB": "12", " Flexibility": "0.56", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "33", " CarbonAtoms": "17", " HeteroAtoms": "16", " ratio_H_by_C": "0.94", " Lipinski_Violation": "2", " Solubility_mg_per_l": "6576909.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 476.438", "link_html_complex": "/ACE_complex_html/ACE_GEGSGA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GEGSGA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GEGSGA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GEGSGA.png", "phi_psi": "/peptide_da/GEGSGA.pdb", "link_html_peptide": "/Peptide_html/GEGSGA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GEGSGA.pdb", "link_png_peptide": "/Peptide_pics/GEGSGA.png"}
{"Peptide_Sequence": "GEP", " Origin": "edible mushroom Tricholoma giganteum", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "modification of the method of Cushman and Cheung", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Lee, Dae Hyoung, et al. \"Isolation and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from the edible mushroom Tricholoma giganteum.\" Peptides 25.4 (2004): 621-627.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "325", " Ligand_ID": "GEP_minimized.pdb_325", " Smiles": "NCC(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "301.3", " logP": "-5.14", " logD": "-9.01", " logSw": "1.99", " tPSA": "157.31", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "0", " Solubility_mg_per_l": "2208919.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.296", "link_html_complex": "/ACE_complex_html/ACE_GEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GEP.png", "phi_psi": "/peptide_da/GEP.pdb", "link_html_peptide": "/Peptide_html/GEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GEP.pdb", "link_png_peptide": "/Peptide_pics/GEP.png"}
{"Peptide_Sequence": "GF", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "630 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "327", " Ligand_ID": "GF_minimized.pdb_327", " Smiles": "NCC(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "222.24", " logP": "-2.26", " logD": "-2.79", " logSw": "0.39", " tPSA": "96.87", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "11", " HeteroAtoms": "5", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "327559.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 222.24", "link_html_complex": "/ACE_complex_html/ACE_GF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GF.png", "phi_psi": "/peptide_da/GF.pdb", "link_html_peptide": "/Peptide_html/GF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GF.pdb", "link_png_peptide": "/Peptide_pics/GF.png"}
{"Peptide_Sequence": "GFHI", " Origin": "beef sarcoplasmic protein extract ", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Jang, Aera, Cheorun Jo, and Mooha Lee. \"Storage stability of the synthetic angiotensin converting enzyme (ACE) inhibitory peptides separated from beef sarcoplasmic protein extracts at different pH, temperature, and gastric digestion.\" Food Science and Biotechnology 16.4 (2007): 572-575.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "326", " Ligand_ID": "GFHI_minimized.pdb_326", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(O)=O", " MW": "472.54", " logP": "-1.48", " logD": "-3.86", " logSw": "-1.1", " tPSA": "183.75", " RotatableB": "13", " RigidB": "18", " Flexibility": "0.42", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "156875.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.537", "link_html_complex": "/ACE_complex_html/ACE_GFHI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GFHI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GFHI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GFHI.png", "phi_psi": "/peptide_da/GFHI.pdb", "link_html_peptide": "/Peptide_html/GFHI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GFHI.pdb", "link_png_peptide": "/Peptide_pics/GFHI.png"}
{"Peptide_Sequence": "GFPGTPGLPGF", " Origin": " Chicken Breast Muscle ", " Peptide_Preparation": "trypsin/chymotrypsin and fresh small intestinal juice", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "436 \u03bcM", " Reference": "Saiga, Ai, et al. \"Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract.\" Journal of Agricultural and Food Chemistry 51.6 (2003): 1741-1745.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "328", " Ligand_ID": "GFPGTPGLPGF_minimized.pdb_328", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1046.18", " logP": "-2.34", " logD": "-7.44", " logSw": "-3.26", " tPSA": "352.63", " RotatableB": "25", " RigidB": "48", " Flexibility": "0.34", " HBD": "11", " HBA": "24", " HBD_HBA": "35", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "75", " CarbonAtoms": "51", " HeteroAtoms": "24", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "40044.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1046.18", "link_html_complex": "/ACE_complex_html/ACE_GFPGTPGLPGF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GFPGTPGLPGF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GFPGTPGLPGF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GFPGTPGLPGF.png", "phi_psi": "/peptide_da/GFPGTPGLPGF.pdb", "link_html_peptide": "/Peptide_html/GFPGTPGLPGF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GFPGTPGLPGF.pdb", "link_png_peptide": "/Peptide_pics/GFPGTPGLPGF.png"}
{"Peptide_Sequence": "GFR", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "94.25 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "329", " Ligand_ID": "GFR_minimized.pdb_329", " Smiles": "NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "378.43", " logP": "-3.73", " logD": "-4.89", " logSw": "0.87", " tPSA": "189.61", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "904973.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 378.426", "link_html_complex": "/ACE_complex_html/ACE_GFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GFR.png", "phi_psi": "/peptide_da/GFR.pdb", "link_html_peptide": "/Peptide_html/GFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GFR.pdb", "link_png_peptide": "/Peptide_pics/GFR.png"}
{"Peptide_Sequence": "GG", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "8670", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-4.6", "Serial_ID": "333", " Ligand_ID": "GG_minimized.pdb_333", " Smiles": "NCC(=O)NCC(O)=O", " MW": "132.12", " logP": "-2.92", " logD": "-5.02", " logSw": "1.38", " tPSA": "96.87", " RotatableB": "3", " RigidB": "3", " Flexibility": "0.5", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "9", " CarbonAtoms": "4", " HeteroAtoms": "5", " ratio_H_by_C": "1.25", " Lipinski_Violation": "0", " Solubility_mg_per_l": "524352.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "0", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 132.118", "link_html_complex": "/ACE_complex_html/ACE_GG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GG.png", "phi_psi": "/peptide_da/GG.pdb", "link_html_peptide": "/Peptide_html/GG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GG.pdb", "link_png_peptide": "/Peptide_pics/GG.png"}
{"Peptide_Sequence": "GGDDL", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "330", " Ligand_ID": "GGDDL_minimized.pdb_330", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)CN)C(O)=O", " MW": "475.45", " logP": "-5.23", " logD": "-14.42", " logSw": "1.5", " tPSA": "264.43", " RotatableB": "15", " RigidB": "11", " Flexibility": "0.58", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "33", " CarbonAtoms": "18", " HeteroAtoms": "15", " ratio_H_by_C": "0.83", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2124666.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 475.45", "link_html_complex": "/ACE_complex_html/ACE_GGDDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGDDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGDDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGDDL.png", "phi_psi": "/peptide_da/GGDDL.pdb", "link_html_peptide": "/Peptide_html/GGDDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGDDL.pdb", "link_png_peptide": "/Peptide_pics/GGDDL.png"}
{"Peptide_Sequence": "GGFIE", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">10000 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "331", " Ligand_ID": "GGFIE_minimized.pdb_331", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CN)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "521.56", " logP": "-2.76", " logD": "-8.45", " logSw": "-0.34", " tPSA": "224.3", " RotatableB": "16", " RigidB": "16", " Flexibility": "0.5", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "371025.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 521.563", "link_html_complex": "/ACE_complex_html/ACE_GGFIE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGFIE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGFIE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGFIE.png", "phi_psi": "/peptide_da/GGFIE.pdb", "link_html_peptide": "/Peptide_html/GGFIE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGFIE.pdb", "link_png_peptide": "/Peptide_pics/GGFIE.png"}
{"Peptide_Sequence": "GGLEPI", " Origin": "Egg White", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": ">1000 \u00b5mol/L", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "332", " Ligand_ID": "GGLEPI_minimized.pdb_332", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CN)C(O)=O", " MW": "584.66", " logP": "-3.11", " logD": "-9.11", " logSw": "-0.38", " tPSA": "244.61", " RotatableB": "17", " RigidB": "17", " Flexibility": "0.5", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "398388.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.662", "link_html_complex": "/ACE_complex_html/ACE_GGLEPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGLEPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGLEPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGLEPI.png", "phi_psi": "/peptide_da/GGLEPI.pdb", "link_html_peptide": "/Peptide_html/GGLEPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGLEPI.pdb", "link_png_peptide": "/Peptide_pics/GGLEPI.png"}
{"Peptide_Sequence": "GGRPTY", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "334", " Ligand_ID": "GGRPTY_minimized.pdb_334", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "649.7", " logP": "-4.97", " logD": "-10.75", " logSw": "0.4", " tPSA": "308.58", " RotatableB": "18", " RigidB": "23", " Flexibility": "0.44", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "28", " HeteroAtoms": "18", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "970296.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 649.696", "link_html_complex": "/ACE_complex_html/ACE_GGRPTY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGRPTY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGRPTY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGRPTY.png", "phi_psi": "/peptide_da/GGRPTY.pdb", "link_html_peptide": "/Peptide_html/GGRPTY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGRPTY.pdb", "link_png_peptide": "/Peptide_pics/GGRPTY.png"}
{"Peptide_Sequence": "GGVIPN", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.74 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "335", " Ligand_ID": "GGVIPN_minimized.pdb_335", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "555.62", " logP": "-4.47", " logD": "-7.36", " logSw": "0.52", " tPSA": "247.57", " RotatableB": "15", " RigidB": "18", " Flexibility": "0.45", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "935724.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 555.624", "link_html_complex": "/ACE_complex_html/ACE_GGVIPN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGVIPN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGVIPN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGVIPN.png", "phi_psi": "/peptide_da/GGVIPN.pdb", "link_html_peptide": "/Peptide_html/GGVIPN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGVIPN.pdb", "link_png_peptide": "/Peptide_pics/GGVIPN.png"}
{"Peptide_Sequence": "GGY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.3", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "336", " Ligand_ID": "GGY_minimized.pdb_336", " Smiles": "NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "295.29", " logP": "-3.85", " logD": "-5.2", " logSw": "1.1", " tPSA": "146.2", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "886972.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 295.291", "link_html_complex": "/ACE_complex_html/ACE_GGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GGY.png", "phi_psi": "/peptide_da/GGY.pdb", "link_html_peptide": "/Peptide_html/GGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GGY.pdb", "link_png_peptide": "/Peptide_pics/GGY.png"}
{"Peptide_Sequence": "GH", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3100 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "341", " Ligand_ID": "GH_minimized.pdb_341", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "212.21", " logP": "-3.89", " logD": "-4.85", " logSw": "1.49", " tPSA": "125.55", " RotatableB": "5", " RigidB": "8", " Flexibility": "0.38", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "8", " HeteroAtoms": "7", " ratio_H_by_C": "0.88", " Lipinski_Violation": "0", " Solubility_mg_per_l": "939683.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 212.206", "link_html_complex": "/ACE_complex_html/ACE_GH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GH.png", "phi_psi": "/peptide_da/GH.pdb", "link_html_peptide": "/Peptide_html/GH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GH.pdb", "link_png_peptide": "/Peptide_pics/GH.png"}
{"Peptide_Sequence": "GHF", " Origin": "Bonito", " Peptide_Preparation": "protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1100", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "337", " Ligand_ID": "GHF_minimized.pdb_337", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "359.38", " logP": "-3.15", " logD": "-4.54", " logSw": "0.34", " tPSA": "154.65", " RotatableB": "9", " RigidB": "16", " Flexibility": "0.36", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "503474.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 359.38", "link_html_complex": "/ACE_complex_html/ACE_GHF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHF.png", "phi_psi": "/peptide_da/GHF.pdb", "link_html_peptide": "/Peptide_html/GHF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHF.pdb", "link_png_peptide": "/Peptide_pics/GHF.png"}
{"Peptide_Sequence": "GHG", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "122", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "338", " Ligand_ID": "GHG_minimized.pdb_338", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(O)=O", " MW": "269.26", " logP": "-4.54", " logD": "-6.78", " logSw": "1.7", " tPSA": "154.65", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "10", " HeteroAtoms": "9", " ratio_H_by_C": "0.9", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1479780.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 269.257", "link_html_complex": "/ACE_complex_html/ACE_GHG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHG.png", "phi_psi": "/peptide_da/GHG.pdb", "link_html_peptide": "/Peptide_html/GHG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHG.pdb", "link_png_peptide": "/Peptide_pics/GHG.png"}
{"Peptide_Sequence": "GHKIATFQER", " Origin": "Baker's yeast", " Peptide_Preparation": "HCl", " Isolation_Method": "GP, RP-HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.4  \u03bcM", " Reference": "KOHAMA, Yasuhiro, et al. \"Production of angiotensin-converting enzyme inhibitors from baker's yeast glyceraldehyde-3-phosphate dehydrogenase.\" Journal of pharmacobio-dynamics 13.12 (1990): 766-771.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "339", " Ligand_ID": "GHKIATFQER_minimized.pdb_339", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1186.32", " logP": "-8.63", " logD": "-13.54", " logSw": "0.9", " tPSA": "553.08", " RotatableB": "41", " RigidB": "34", " Flexibility": "0.55", " HBD": "23", " HBA": "32", " HBD_HBA": "55", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "84", " CarbonAtoms": "52", " HeteroAtoms": "32", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2914877.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1186.32", "link_html_complex": "/ACE_complex_html/ACE_GHKIATFQER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHKIATFQER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHKIATFQER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHKIATFQER.png", "phi_psi": "/peptide_da/GHKIATFQER.pdb", "link_html_peptide": "/Peptide_html/GHKIATFQER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHKIATFQER.pdb", "link_png_peptide": "/Peptide_pics/GHKIATFQER.png"}
{"Peptide_Sequence": "GHKIATFQQR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR model", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.4  \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "340", " Ligand_ID": "GHKIATFQQR_minimized.pdb_340", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1185.34", " logP": "-7", " logD": "-13.49", " logSw": "-0.19", " tPSA": "556.04", " RotatableB": "40", " RigidB": "35", " Flexibility": "0.53", " HBD": "24", " HBA": "32", " HBD_HBA": "56", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "84", " CarbonAtoms": "52", " HeteroAtoms": "32", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "982645.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1185.34", "link_html_complex": "/ACE_complex_html/ACE_GHKIATFQQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHKIATFQQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHKIATFQQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHKIATFQQR.png", "phi_psi": "/peptide_da/GHKIATFQQR.pdb", "link_html_peptide": "/Peptide_html/GHKIATFQQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHKIATFQQR.pdb", "link_png_peptide": "/Peptide_pics/GHKIATFQQR.png"}
{"Peptide_Sequence": "GHP", " Origin": "Bonito", " Peptide_Preparation": "synthetic peptide", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1100", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "342", " Ligand_ID": "GHP_minimized.pdb_342", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "309.32", " logP": "-4.44", " logD": "-5.94", " logSw": "1.35", " tPSA": "145.86", " RotatableB": "6", " RigidB": "15", " Flexibility": "0.29", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1187428.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 309.321", "link_html_complex": "/ACE_complex_html/ACE_GHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHP.png", "phi_psi": "/peptide_da/GHP.pdb", "link_html_peptide": "/Peptide_html/GHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHP.pdb", "link_png_peptide": "/Peptide_pics/GHP.png"}
{"Peptide_Sequence": "GHS", " Origin": "Rapeseed Protein", " Peptide_Preparation": "pepsin orpancreati", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "Holmquist et al (1979)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "500  \u03bcM", " Reference": "He, Rong, et al. \"Glycinyl-histidinyl-serine (GHS), a novel rapeseed protein-derived peptide has blood pressure-lowering effect in spontaneously hypertensive rats.\" Journal of agricultural and food chemistry 61.35 (2013): 8396-8402.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "343", " Ligand_ID": "GHS_minimized.pdb_343", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(O)=O", " MW": "299.28", " logP": "-5.19", " logD": "-7.27", " logSw": "2", " tPSA": "174.88", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "11", " HeteroAtoms": "10", " ratio_H_by_C": "0.91", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2222006.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.283", "link_html_complex": "/ACE_complex_html/ACE_GHS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GHS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GHS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GHS.png", "phi_psi": "/peptide_da/GHS.pdb", "link_html_peptide": "/Peptide_html/GHS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GHS.pdb", "link_png_peptide": "/Peptide_pics/GHS.png"}
{"Peptide_Sequence": "GI", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1300", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "347", " Ligand_ID": "GI_minimized.pdb_347", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(O)=O", " MW": "188.22", " logP": "-3", " logD": "-3.11", " logSw": "1.21", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "633109.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 188.224", "link_html_complex": "/ACE_complex_html/ACE_GI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GI.png", "phi_psi": "/peptide_da/GI.pdb", "link_html_peptide": "/Peptide_html/GI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GI.pdb", "link_png_peptide": "/Peptide_pics/GI.png"}
{"Peptide_Sequence": "GIHETTY", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "25.55 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "344", " Ligand_ID": "GIHETTY_minimized.pdb_344", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "819.86", " logP": "-4.35", " logD": "-11.09", " logSw": "-0.67", " tPSA": "371.87", " RotatableB": "24", " RigidB": "25", " Flexibility": "0.49", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "58", " CarbonAtoms": "36", " HeteroAtoms": "22", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "418708.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 819.859", "link_html_complex": "/ACE_complex_html/ACE_GIHETTY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GIHETTY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GIHETTY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GIHETTY.png", "phi_psi": "/peptide_da/GIHETTY.pdb", "link_html_peptide": "/Peptide_html/GIHETTY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GIHETTY.pdb", "link_png_peptide": "/Peptide_pics/GIHETTY.png"}
{"Peptide_Sequence": "GIL", " Origin": "hen egg white lysozyme", " Peptide_Preparation": " simulated human gastrointestinal digestion", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "53.8", " Reference": "Rao, Shengqi, et al. \"ACE inhibitory peptides and antioxidant peptides derived from in vitro digestion hydrolysate of hen egg white lysozyme.\" Food chemistry 135.3 (2012): 1245-1252.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "345", " Ligand_ID": "GIL_minimized.pdb_345", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "301.38", " logP": "-1.86", " logD": "-3.25", " logSw": "0.06", " tPSA": "125.97", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "319133.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.382", "link_html_complex": "/ACE_complex_html/ACE_GIL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GIL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GIL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GIL.png", "phi_psi": "/peptide_da/GIL.pdb", "link_html_peptide": "/Peptide_html/GIL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GIL.pdb", "link_png_peptide": "/Peptide_pics/GIL.png"}
{"Peptide_Sequence": "GILRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "90.7 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "346", " Ligand_ID": "GILRP_minimized.pdb_346", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "554.68", " logP": "-3.98", " logD": "-6.71", " logSw": "0.35", " tPSA": "239.02", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "787421.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 554.683", "link_html_complex": "/ACE_complex_html/ACE_GILRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GILRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GILRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GILRP.png", "phi_psi": "/peptide_da/GILRP.pdb", "link_html_peptide": "/Peptide_html/GILRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GILRP.pdb", "link_png_peptide": "/Peptide_pics/GILRP.png"}
{"Peptide_Sequence": "GIPGERGPVGPSG", " Origin": "chicken", " Peptide_Preparation": " broad substrate proteases", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "43.4 \u00b5M        ", " Reference": "Zhang, Yuhao, et al. \"Effect of pretreatment on enzymatic hydrolysis of bovine collagen and formation of ACE-inhibitory peptides.\" Food Chemistry 141.3 (2013): 2343-2354.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "348", " Ligand_ID": "GIPGERGPVGPSG_minimized.pdb_348", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(O)=O", " MW": "1179.28", " logP": "-7.23", " logD": "-18.94", " logSw": "-0.35", " tPSA": "514.6", " RotatableB": "34", " RigidB": "42", " Flexibility": "0.45", " HBD": "18", " HBA": "33", " HBD_HBA": "51", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "83", " CarbonAtoms": "50", " HeteroAtoms": "33", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "828823.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1179.28", "link_html_complex": "/ACE_complex_html/ACE_GIPGERGPVGPSG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GIPGERGPVGPSG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GIPGERGPVGPSG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GIPGERGPVGPSG.png", "phi_psi": "/peptide_da/GIPGERGPVGPSG.pdb", "link_html_peptide": "/Peptide_html/GIPGERGPVGPSG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GIPGERGPVGPSG.pdb", "link_png_peptide": "/Peptide_pics/GIPGERGPVGPSG.png"}
{"Peptide_Sequence": "GIQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "430", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "349", " Ligand_ID": "GIQSEPKAIP_minimized.pdb_349", " Smiles": "CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1039.18", " logP": "-7.67", " logD": "-15.31", " logSw": "0.66", " tPSA": "443.18", " RotatableB": "32", " RigidB": "32", " Flexibility": "0.5", " HBD": "16", " HBA": "27", " HBD_HBA": "43", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "73", " CarbonAtoms": "46", " HeteroAtoms": "27", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2012948.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1039.18", "link_html_complex": "/ACE_complex_html/ACE_GIQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GIQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GIQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GIQSEPKAIP.png", "phi_psi": "/peptide_da/GIQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/GIQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GIQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/GIQSEPKAIP.png"}
{"Peptide_Sequence": "GK", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": "CoMFA models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "30 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "353", " Ligand_ID": "GK_minimized.pdb_353", " Smiles": "NCCCC[C@H](NC(=O)CN)C(O)=O", " MW": "203.24", " logP": "-3.89", " logD": "-5.65", " logSw": "1.81", " tPSA": "124.51", " RotatableB": "7", " RigidB": "3", " Flexibility": "0.7", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "14", " CarbonAtoms": "8", " HeteroAtoms": "6", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1245137.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 203.239", "link_html_complex": "/ACE_complex_html/ACE_GK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GK.png", "phi_psi": "/peptide_da/GK.pdb", "link_html_peptide": "/Peptide_html/GK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GK.pdb", "link_png_peptide": "/Peptide_pics/GK.png"}
{"Peptide_Sequence": "GKEIIVKAER", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "75.1 \u03bcg/ml", " Reference": "Mimura, Tsutomu, et al. \"Angiotensin converting enzyme inhibitor.\" U.S. Patent No. 5,098,887. 24 Mar. 1992.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "350", " Ligand_ID": "GKEIIVKAER_minimized.pdb_350", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1142.35", " logP": "-8.95", " logD": "-14.65", " logSw": "1.55", " tPSA": "528.85", " RotatableB": "43", " RigidB": "22", " Flexibility": "0.66", " HBD": "22", " HBA": "30", " HBD_HBA": "52", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "7", " TotalCharge": "1", " HeavyAtoms": "80", " CarbonAtoms": "50", " HeteroAtoms": "30", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5403369.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1142.35", "link_html_complex": "/ACE_complex_html/ACE_GKEIIVKAER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKEIIVKAER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKEIIVKAER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKEIIVKAER.png", "phi_psi": "/peptide_da/GKEIIVKAER.pdb", "link_html_peptide": "/Peptide_html/GKEIIVKAER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKEIIVKAER.pdb", "link_png_peptide": "/Peptide_pics/GKEIIVKAER.png"}
{"Peptide_Sequence": "GKKIATYQER", " Origin": "Baker's yeast", " Peptide_Preparation": "HCl", " Isolation_Method": "GP, RP-HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "KOHAMA, Yasuhiro, et al. \"Production of angiotensin-converting enzyme inhibitors from baker's yeast glyceraldehyde-3-phosphate dehydrogenase.\" Journal of pharmacobio-dynamics 13.12 (1990): 766-771.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "351", " Ligand_ID": "GKKIATYQER_minimized.pdb_351", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1193.35", " logP": "-8.99", " logD": "-15.89", " logSw": "1.24", " tPSA": "572.27", " RotatableB": "43", " RigidB": "29", " Flexibility": "0.6", " HBD": "25", " HBA": "32", " HBD_HBA": "57", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "84", " CarbonAtoms": "52", " HeteroAtoms": "32", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4111820.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1193.35", "link_html_complex": "/ACE_complex_html/ACE_GKKIATYQER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKKIATYQER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKKIATYQER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKKIATYQER.png", "phi_psi": "/peptide_da/GKKIATYQER.pdb", "link_html_peptide": "/Peptide_html/GKKIATYQER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKKIATYQER.pdb", "link_png_peptide": "/Peptide_pics/GKKIATYQER.png"}
{"Peptide_Sequence": "GKKVLQ", " Origin": "swine hemoglobin", " Peptide_Preparation": "DeLoach et al. (1986)", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1.9 \u03bcM", " Reference": "Mito, Kazue, et al. \"Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides derived from hemoglobin.\" European journal of pharmacology 304.1-3 (1996): 93-98.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "352", " Ligand_ID": "GKKVLQ_minimized.pdb_352", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CN)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "671.83", " logP": "-3.8", " logD": "-12.3", " logSw": "0.04", " tPSA": "311.64", " RotatableB": "25", " RigidB": "13", " Flexibility": "0.66", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "698310.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 671.829", "link_html_complex": "/ACE_complex_html/ACE_GKKVLQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKKVLQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKKVLQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKKVLQ.png", "phi_psi": "/peptide_da/GKKVLQ.pdb", "link_html_peptide": "/Peptide_html/GKKVLQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKKVLQ.pdb", "link_png_peptide": "/Peptide_pics/GKKVLQ.png"}
{"Peptide_Sequence": "GKMVKVVSWY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "8.0 \u03bcg/ml", " Reference": "Mimura, Tsutomu, et al. \"Angiotensin converting enzyme inhibitor.\" U.S. Patent No. 5,098,887. 24 Mar. 1992.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "354", " Ligand_ID": "GKMVKVVSWY_minimized.pdb_354", " Smiles": "CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1196.46", " logP": "-0.72", " logD": "-10.08", " logSw": "-4.36", " tPSA": "466.5", " RotatableB": "38", " RigidB": "35", " Flexibility": "0.52", " HBD": "19", " HBA": "26", " HBD_HBA": "45", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "84", " CarbonAtoms": "57", " HeteroAtoms": "27", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "15279.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1196.46", "link_html_complex": "/ACE_complex_html/ACE_GKMVKVVSWY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKMVKVVSWY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKMVKVVSWY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKMVKVVSWY.png", "phi_psi": "/peptide_da/GKMVKVVSWY.pdb", "link_html_peptide": "/Peptide_html/GKMVKVVSWY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKMVKVVSWY.pdb", "link_png_peptide": "/Peptide_pics/GKMVKVVSWY.png"}
{"Peptide_Sequence": "GKP", " Origin": "pepsin,trypsin,chymotrypsin, proteinase K, actinase E, thermolysin,and  papain", " Peptide_Preparation": "Proteinase K", " Isolation_Method": "RP-HPLC, GFC", " ACE_inhibition_assay": "  Yamamoto  et  al. 1994 ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "352 \u03bcM", " Reference": "Abubakar, Amhar, et al. \"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.\" Journal of Dairy Science 81.12 (1998): 3131-3138.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "355", " Ligand_ID": "GKP_minimized.pdb_355", " Smiles": "NCCCC[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "300.35", " logP": "-4.86", " logD": "-7.28", " logSw": "1.89", " tPSA": "144.82", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1983397.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.354", "link_html_complex": "/ACE_complex_html/ACE_GKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKP.png", "phi_psi": "/peptide_da/GKP.pdb", "link_html_peptide": "/Peptide_html/GKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKP.pdb", "link_png_peptide": "/Peptide_pics/GKP.png"}
{"Peptide_Sequence": "GKV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "356", " Ligand_ID": "GKV_minimized.pdb_356", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O", " MW": "302.37", " logP": "-3.18", " logD": "-6.67", " logSw": "0.95", " tPSA": "153.61", " RotatableB": "10", " RigidB": "5", " Flexibility": "0.67", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "780830.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 302.37", "link_html_complex": "/ACE_complex_html/ACE_GKV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GKV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GKV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GKV.png", "phi_psi": "/peptide_da/GKV.pdb", "link_html_peptide": "/Peptide_html/GKV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GKV.pdb", "link_png_peptide": "/Peptide_pics/GKV.png"}
{"Peptide_Sequence": "GL", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2500 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-6.4", "Serial_ID": "359", " Ligand_ID": "GL_minimized.pdb_359", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(O)=O", " MW": "188.22", " logP": "-3.11", " logD": "-3.19", " logSw": "1.28", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "678540.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 188.224", "link_html_complex": "/ACE_complex_html/ACE_GL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GL.png", "phi_psi": "/peptide_da/GL.pdb", "link_html_peptide": "/Peptide_html/GL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GL.pdb", "link_png_peptide": "/Peptide_pics/GL.png"}
{"Peptide_Sequence": "GLDIQK", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "580 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "357", " Ligand_ID": "GLDIQK_minimized.pdb_357", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "672.77", " logP": "-6.57", " logD": "-9.28", " logSw": "1.71", " tPSA": "324.13", " RotatableB": "24", " RigidB": "14", " Flexibility": "0.63", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3726876.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 672.771", "link_html_complex": "/ACE_complex_html/ACE_GLDIQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLDIQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLDIQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLDIQK.png", "phi_psi": "/peptide_da/GLDIQK.pdb", "link_html_peptide": "/Peptide_html/GLDIQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLDIQK.pdb", "link_png_peptide": "/Peptide_pics/GLDIQK.png"}
{"Peptide_Sequence": "GLG", " Origin": "hum salmon head", " Peptide_Preparation": "commercial protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "730 \u03bcM", " Reference": "OHTA, Tomoki, et al. \"Antihypertensive action of the orally administered protease hydrolysates of chum salmon head and their angiotensin I-converting enzyme inhibitory peptides.\" Food Science and Technology International, Tokyo 3.4 (1997): 339-343.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "358", " Ligand_ID": "GLG_minimized.pdb_358", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)NCC(O)=O", " MW": "245.28", " logP": "-3.11", " logD": "-5.21", " logSw": "1.06", " tPSA": "125.97", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "708375.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.275", "link_html_complex": "/ACE_complex_html/ACE_GLG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLG.png", "phi_psi": "/peptide_da/GLG.pdb", "link_html_peptide": "/Peptide_html/GLG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLG.pdb", "link_png_peptide": "/Peptide_pics/GLG.png"}
{"Peptide_Sequence": "GLP", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "1.62 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "361", " Ligand_ID": "GLP_minimized.pdb_361", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "285.34", " logP": "-3.3", " logD": "-4.37", " logSw": "0.87", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "678290.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_GLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLP.png", "phi_psi": "/peptide_da/GLP.pdb", "link_html_peptide": "/Peptide_html/GLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLP.pdb", "link_png_peptide": "/Peptide_pics/GLP.png"}
{"Peptide_Sequence": "GLPGSRGERGLPG", " Origin": "chicken", " Peptide_Preparation": " broad substrate proteases", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "60.8 \u00b5M        ", " Reference": "Zhang, Yuhao, et al. \"Effect of pretreatment on enzymatic hydrolysis of bovine collagen and formation of ACE-inhibitory peptides.\" Food Chemistry 141.3 (2013): 2343-2354.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "360", " Ligand_ID": "GLPGSRGERGLPG_minimized.pdb_360", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "1252.38", " logP": "-8", " logD": "-22.2", " logSw": "0.14", " tPSA": "587.03", " RotatableB": "41", " RigidB": "38", " Flexibility": "0.52", " HBD": "23", " HBA": "36", " HBD_HBA": "59", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "88", " CarbonAtoms": "52", " HeteroAtoms": "36", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1442371.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1252.38", "link_html_complex": "/ACE_complex_html/ACE_GLPGSRGERGLPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLPGSRGERGLPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLPGSRGERGLPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLPGSRGERGLPG.png", "phi_psi": "/peptide_da/GLPGSRGERGLPG.pdb", "link_html_peptide": "/Peptide_html/GLPGSRGERGLPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLPGSRGERGLPG.pdb", "link_png_peptide": "/Peptide_pics/GLPGSRGERGLPG.png"}
{"Peptide_Sequence": "GLPQE", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "362", " Ligand_ID": "GLPQE_minimized.pdb_362", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "542.58", " logP": "-5.97", " logD": "-10.58", " logSw": "1.61", " tPSA": "258.6", " RotatableB": "16", " RigidB": "17", " Flexibility": "0.48", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2722832.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 542.583", "link_html_complex": "/ACE_complex_html/ACE_GLPQE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLPQE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLPQE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLPQE.png", "phi_psi": "/peptide_da/GLPQE.pdb", "link_html_peptide": "/Peptide_html/GLPQE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLPQE.pdb", "link_png_peptide": "/Peptide_pics/GLPQE.png"}
{"Peptide_Sequence": "GLSDGEWQ", " Origin": "beef sarcoplasmic protein extract ", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Jang, Aera, Cheorun Jo, and Mooha Lee. \"Storage stability of the synthetic angiotensin converting enzyme (ACE) inhibitory peptides separated from beef sarcoplasmic protein extracts at different pH, temperature, and gastric digestion.\" Food Science and Biotechnology 16.4 (2007): 572-575.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "363", " Ligand_ID": "GLSDGEWQ_minimized.pdb_363", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "890.89", " logP": "-6.27", " logD": "-16.29", " logSw": "0.38", " tPSA": "430.84", " RotatableB": "28", " RigidB": "29", " Flexibility": "0.49", " HBD": "16", " HBA": "25", " HBD_HBA": "41", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "63", " CarbonAtoms": "38", " HeteroAtoms": "25", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1299666.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 890.893", "link_html_complex": "/ACE_complex_html/ACE_GLSDGEWQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLSDGEWQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLSDGEWQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLSDGEWQ.png", "phi_psi": "/peptide_da/GLSDGEWQ.pdb", "link_html_peptide": "/Peptide_html/GLSDGEWQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLSDGEWQ.pdb", "link_png_peptide": "/Peptide_pics/GLSDGEWQ.png"}
{"Peptide_Sequence": "GLTSK", " Origin": "common beans (Phaseolus vulgaris L.) ", " Peptide_Preparation": " synthesized ", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "65.4 \u03bcM", " Reference": "Luna-Vital, Diego A., et al. \"Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity.\" Food & function 6.5 (2015): 1470-1479.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "364", " Ligand_ID": "GLTSK_minimized.pdb_364", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "504.58", " logP": "-4.78", " logD": "-7.45", " logSw": "1.17", " tPSA": "252.27", " RotatableB": "17", " RigidB": "9", " Flexibility": "0.65", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1617666.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 504.578", "link_html_complex": "/ACE_complex_html/ACE_GLTSK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLTSK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLTSK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLTSK.png", "phi_psi": "/peptide_da/GLTSK.pdb", "link_html_peptide": "/Peptide_html/GLTSK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLTSK.pdb", "link_png_peptide": "/Peptide_pics/GLTSK.png"}
{"Peptide_Sequence": "GLY", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.8 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "365", " Ligand_ID": "GLY_minimized.pdb_365", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "351.4", " logP": "-3.06", " logD": "-3.33", " logSw": "0.41", " tPSA": "146.2", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "531792.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 351.397", "link_html_complex": "/ACE_complex_html/ACE_GLY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLY.png", "phi_psi": "/peptide_da/GLY.pdb", "link_html_peptide": "/Peptide_html/GLY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLY.pdb", "link_png_peptide": "/Peptide_pics/GLY.png"}
{"Peptide_Sequence": "GLYP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "190 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "366", " Ligand_ID": "GLYP_minimized.pdb_366", " Smiles": "CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "448.51", " logP": "-2.99", " logD": "-3.85", " logSw": "-0.15", " tPSA": "166.51", " RotatableB": "10", " RigidB": "18", " Flexibility": "0.36", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "387409.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 448.513", "link_html_complex": "/ACE_complex_html/ACE_GLYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GLYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GLYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GLYP.png", "phi_psi": "/peptide_da/GLYP.pdb", "link_html_peptide": "/Peptide_html/GLYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GLYP.pdb", "link_png_peptide": "/Peptide_pics/GLYP.png"}
{"Peptide_Sequence": "GM", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1400 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.5", "Serial_ID": "368", " Ligand_ID": "GM_minimized.pdb_368", " Smiles": "CSCC[C@H](NC(=O)CN)C(O)=O", " MW": "206.26", " logP": "-3.59", " logD": "-3.8", " logSw": "1.54", " tPSA": "122.17", " RotatableB": "6", " RigidB": "3", " Flexibility": "0.67", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "7", " HeteroAtoms": "6", " ratio_H_by_C": "0.86", " Lipinski_Violation": "0", " Solubility_mg_per_l": "961045.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 206.263", "link_html_complex": "/ACE_complex_html/ACE_GM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GM.png", "phi_psi": "/peptide_da/GM.pdb", "link_html_peptide": "/Peptide_html/GM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GM.pdb", "link_png_peptide": "/Peptide_pics/GM.png"}
{"Peptide_Sequence": "GMKCAF", " Origin": "lizard fish protein", " Peptide_Preparation": "", " Isolation_Method": "magnetic affinity separation, RP-HPLC", " ACE_inhibition_assay": "Wu et al., 2012", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "45.7 \u03bcM", " Reference": "Lan, Xiongdiao, et al. \"Rapid purification and characterization of angiotensin converting enzyme inhibitory peptides from lizard fish protein hydrolysates with magnetic affinity separation.\" Food chemistry 182 (2015): 136-142.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "367", " Ligand_ID": "GMKCAF_minimized.pdb_367", " Smiles": "CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "655.83", " logP": "-2.75", " logD": "-7.8", " logSw": "-0.84", " tPSA": "305.01", " RotatableB": "21", " RigidB": "17", " Flexibility": "0.55", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "283828.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 655.829", "link_html_complex": "/ACE_complex_html/ACE_GMKCAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GMKCAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GMKCAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GMKCAF.png", "phi_psi": "/peptide_da/GMKCAF.pdb", "link_html_peptide": "/Peptide_html/GMKCAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GMKCAF.pdb", "link_png_peptide": "/Peptide_pics/GMKCAF.png"}
{"Peptide_Sequence": "GNGGA", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "369", " Ligand_ID": "GNGGA_minimized.pdb_369", " Smiles": "C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CN)C(O)=O", " MW": "374.35", " logP": "-6.73", " logD": "-9.86", " logSw": "2.8", " tPSA": "227.26", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "13", " HeteroAtoms": "13", " ratio_H_by_C": "1", " Lipinski_Violation": "2", " Solubility_mg_per_l": "6186482.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.35", "link_html_complex": "/ACE_complex_html/ACE_GNGGA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GNGGA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GNGGA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GNGGA.png", "phi_psi": "/peptide_da/GNGGA.pdb", "link_html_peptide": "/Peptide_html/GNGGA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GNGGA.pdb", "link_png_peptide": "/Peptide_pics/GNGGA.png"}
{"Peptide_Sequence": "GP", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "66 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "381", " Ligand_ID": "GP_minimized.pdb_381", " Smiles": "NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "172.18", " logP": "-3.11", " logD": "-4.18", " logSw": "1.18", " tPSA": "88.08", " RotatableB": "2", " RigidB": "8", " Flexibility": "0.2", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "7", " HeteroAtoms": "5", " ratio_H_by_C": "0.71", " Lipinski_Violation": "0", " Solubility_mg_per_l": "562462.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 172.182", "link_html_complex": "/ACE_complex_html/ACE_GP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GP.png", "phi_psi": "/peptide_da/GP.pdb", "link_html_peptide": "/Peptide_html/GP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GP.pdb", "link_png_peptide": "/Peptide_pics/GP.png"}
{"Peptide_Sequence": "GPA", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "405 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "372", " Ligand_ID": "GPA_minimized.pdb_372", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "243.26", " logP": "-4.6", " logD": "-5.66", " logSw": "1.81", " tPSA": "117.18", " RotatableB": "4", " RigidB": "10", " Flexibility": "0.29", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1492069.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.26", "link_html_complex": "/ACE_complex_html/ACE_GPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPA.png", "phi_psi": "/peptide_da/GPA.pdb", "link_html_peptide": "/Peptide_html/GPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPA.pdb", "link_png_peptide": "/Peptide_pics/GPA.png"}
{"Peptide_Sequence": "GPAGAP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.3 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "371", " Ligand_ID": "GPAGAP_minimized.pdb_371", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "468.5", " logP": "-4.92", " logD": "-7.8", " logSw": "0.95", " tPSA": "195.69", " RotatableB": "9", " RigidB": "21", " Flexibility": "0.3", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1210053.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 468.504", "link_html_complex": "/ACE_complex_html/ACE_GPAGAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPAGAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPAGAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPAGAP.png", "phi_psi": "/peptide_da/GPAGAP.pdb", "link_html_peptide": "/Peptide_html/GPAGAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPAGAP.pdb", "link_png_peptide": "/Peptide_pics/GPAGAP.png"}
{"Peptide_Sequence": "GPAGAPGAA", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "37 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "370", " Ligand_ID": "GPAGAPGAA_minimized.pdb_370", " Smiles": "C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "667.71", " logP": "-5.62", " logD": "-9.98", " logSw": "0.55", " tPSA": "282.99", " RotatableB": "15", " RigidB": "27", " Flexibility": "0.36", " HBD": "9", " HBA": "19", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "28", " HeteroAtoms": "19", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1158227.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 667.711", "link_html_complex": "/ACE_complex_html/ACE_GPAGAPGAA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPAGAPGAA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPAGAPGAA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPAGAPGAA.png", "phi_psi": "/peptide_da/GPAGAPGAA.pdb", "link_html_peptide": "/Peptide_html/GPAGAPGAA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPAGAPGAA.pdb", "link_png_peptide": "/Peptide_pics/GPAGAPGAA.png"}
{"Peptide_Sequence": "GPCSR", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "61.67 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "373", " Ligand_ID": "GPCSR_minimized.pdb_373", " Smiles": "NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "518.59", " logP": "-6.06", " logD": "-8.34", " logSw": "1.75", " tPSA": "298.05", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "19", " HeteroAtoms": "16", " ratio_H_by_C": "0.84", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2991905", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 518.587", "link_html_complex": "/ACE_complex_html/ACE_GPCSR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPCSR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPCSR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPCSR.png", "phi_psi": "/peptide_da/GPCSR.pdb", "link_html_peptide": "/Peptide_html/GPCSR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPCSR.pdb", "link_png_peptide": "/Peptide_pics/GPCSR.png"}
{"Peptide_Sequence": "GPFPILV", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "424 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "374", " Ligand_ID": "GPFPILV_minimized.pdb_374", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "741.92", " logP": "0.88", " logD": "-2.59", " logSw": "-3.85", " tPSA": "224.79", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "38", " HeteroAtoms": "15", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "15852.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 741.917", "link_html_complex": "/ACE_complex_html/ACE_GPFPILV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPFPILV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPFPILV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPFPILV.png", "phi_psi": "/peptide_da/GPFPILV.pdb", "link_html_peptide": "/Peptide_html/GPFPILV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPFPILV.pdb", "link_png_peptide": "/Peptide_pics/GPFPILV.png"}
{"Peptide_Sequence": "GPIGPA", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "123.4 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "375", " Ligand_ID": "GPIGPA_minimized.pdb_375", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "510.58", " logP": "-3.14", " logD": "-6.46", " logSw": "-0.3", " tPSA": "195.69", " RotatableB": "11", " RigidB": "21", " Flexibility": "0.34", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "377713.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 510.584", "link_html_complex": "/ACE_complex_html/ACE_GPIGPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPIGPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPIGPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPIGPA.png", "phi_psi": "/peptide_da/GPIGPA.pdb", "link_html_peptide": "/Peptide_html/GPIGPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPIGPA.pdb", "link_png_peptide": "/Peptide_pics/GPIGPA.png"}
{"Peptide_Sequence": "GPIGPP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "123.4 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "376", " Ligand_ID": "GPIGPP_minimized.pdb_376", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "536.62", " logP": "-2.83", " logD": "-6.19", " logSw": "-0.72", " tPSA": "186.9", " RotatableB": "10", " RigidB": "26", " Flexibility": "0.28", " HBD": "5", " HBA": "13", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "260119.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 536.621", "link_html_complex": "/ACE_complex_html/ACE_GPIGPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPIGPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPIGPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPIGPP.png", "phi_psi": "/peptide_da/GPIGPP.pdb", "link_html_peptide": "/Peptide_html/GPIGPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPIGPP.pdb", "link_png_peptide": "/Peptide_pics/GPIGPP.png"}
{"Peptide_Sequence": "GPIGSVGAP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "31.8 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "377", " Ligand_ID": "GPIGSVGAP_minimized.pdb_377", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "753.84", " logP": "-4.39", " logD": "-8.8", " logSw": "-0.49", " tPSA": "303.22", " RotatableB": "19", " RigidB": "27", " Flexibility": "0.41", " HBD": "10", " HBA": "20", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "459921.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 753.843", "link_html_complex": "/ACE_complex_html/ACE_GPIGSVGAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPIGSVGAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPIGSVGAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPIGSVGAP.png", "phi_psi": "/peptide_da/GPIGSVGAP.pdb", "link_html_peptide": "/Peptide_html/GPIGSVGAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPIGSVGAP.pdb", "link_png_peptide": "/Peptide_pics/GPIGSVGAP.png"}
{"Peptide_Sequence": "GPK", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "352 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "378", " Ligand_ID": "GPK_minimized.pdb_378", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "300.35", " logP": "-4.84", " logD": "-5.68", " logSw": "1.88", " tPSA": "144.82", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1958563.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.354", "link_html_complex": "/ACE_complex_html/ACE_GPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPK.png", "phi_psi": "/peptide_da/GPK.pdb", "link_html_peptide": "/Peptide_html/GPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPK.pdb", "link_png_peptide": "/Peptide_pics/GPK.png"}
{"Peptide_Sequence": "GPL", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "2.65 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "380", " Ligand_ID": "GPL_minimized.pdb_380", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "285.34", " logP": "-3.28", " logD": "-4.36", " logSw": "0.85", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "669797.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_GPL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPL.png", "phi_psi": "/peptide_da/GPL.pdb", "link_html_peptide": "/Peptide_html/GPL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPL.pdb", "link_png_peptide": "/Peptide_pics/GPL.png"}
{"Peptide_Sequence": "GPLGLLGFLGPLGLS", " Origin": "Squid  gelatin", " Peptide_Preparation": "Alcalase", " Isolation_Method": "UF, SEC", " ACE_inhibition_assay": " Wu,  Aluko  and  Muir  (2002)withsome modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "90.03 \u03bcM", " Reference": "Alem\u00e1n, Ail\u00e9n, et al. \"Contribution of Leu and Hyp residues to antioxidant and ACE-inhibitory activities of peptide sequences isolated from squid gelatin hydrolysate.\" Food Chemistry 125.2 (2011): 334-341.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1410.7", "link_html_complex": "/ACE_complex_html/ACE_GPLGLLGFLGPLGLS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPLGLLGFLGPLGLS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPLGLLGFLGPLGLS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPLGLLGFLGPLGLS.png", "phi_psi": "/peptide_da/GPLGLLGFLGPLGLS.pdb", "link_html_peptide": "/Peptide_html/GPLGLLGFLGPLGLS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPLGLLGFLGPLGLS.pdb", "link_png_peptide": "/Peptide_pics/GPLGLLGFLGPLGLS.png"}
{"Peptide_Sequence": "GPM", " Origin": "Alaska  pollack  (Theragra chalcogramma)  skin", " Peptide_Preparation": " trypsin, chymotrypsin, and Denazyme AP", " Isolation_Method": "Sephadex G-25 column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "17.13", " Reference": "Byun, H.-G., & Kim, S.-K. (2001). Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochemistry, 36(12), 1155\u20131162. doi:10.1016/s0032-9592(00)00297-1", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "382", " Ligand_ID": "GPM_minimized.pdb_382", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "303.38", " logP": "-3.96", " logD": "-4.99", " logSw": "1.24", " tPSA": "142.48", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1044022.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.378", "link_html_complex": "/ACE_complex_html/ACE_GPM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPM.png", "phi_psi": "/peptide_da/GPM.pdb", "link_html_peptide": "/Peptide_html/GPM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPM.pdb", "link_png_peptide": "/Peptide_pics/GPM.png"}
{"Peptide_Sequence": "GPP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "387", " Ligand_ID": "GPP_minimized.pdb_387", " Smiles": "NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "269.3", " logP": "-3.3", " logD": "-5.39", " logSw": "0.77", " tPSA": "108.39", " RotatableB": "3", " RigidB": "15", " Flexibility": "0.17", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "0", " Solubility_mg_per_l": "580084.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 269.297", "link_html_complex": "/ACE_complex_html/ACE_GPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPP.png", "phi_psi": "/peptide_da/GPP.pdb", "link_html_peptide": "/Peptide_html/GPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPP.pdb", "link_png_peptide": "/Peptide_pics/GPP.png"}
{"Peptide_Sequence": "GPPGAIGP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "146.5 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "383", " Ligand_ID": "GPPGAIGP_minimized.pdb_383", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "664.75", " logP": "-3.74", " logD": "-7.89", " logSw": "-0.68", " tPSA": "245.1", " RotatableB": "14", " RigidB": "30", " Flexibility": "0.32", " HBD": "7", " HBA": "17", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "336352.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 664.75", "link_html_complex": "/ACE_complex_html/ACE_GPPGAIGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPPGAIGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPPGAIGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPPGAIGP.png", "phi_psi": "/peptide_da/GPPGAIGP.pdb", "link_html_peptide": "/Peptide_html/GPPGAIGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPPGAIGP.pdb", "link_png_peptide": "/Peptide_pics/GPPGAIGP.png"}
{"Peptide_Sequence": "GPPGAP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.6 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "384", " Ligand_ID": "GPPGAP_minimized.pdb_384", " Smiles": "C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "494.54", " logP": "-4.15", " logD": "-7.52", " logSw": "0.24", " tPSA": "186.9", " RotatableB": "8", " RigidB": "26", " Flexibility": "0.24", " HBD": "5", " HBA": "13", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "22", " HeteroAtoms": "13", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "626390.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 494.541", "link_html_complex": "/ACE_complex_html/ACE_GPPGAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPPGAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPPGAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPPGAP.png", "phi_psi": "/peptide_da/GPPGAP.pdb", "link_html_peptide": "/Peptide_html/GPPGAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPPGAP.pdb", "link_png_peptide": "/Peptide_pics/GPPGAP.png"}
{"Peptide_Sequence": "GPPGPP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "11.3 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "385", " Ligand_ID": "GPPGPP_minimized.pdb_385", " Smiles": "NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "520.58", " logP": "-3.85", " logD": "-7.25", " logSw": "-0.18", " tPSA": "178.11", " RotatableB": "7", " RigidB": "31", " Flexibility": "0.18", " HBD": "4", " HBA": "13", " HBD_HBA": "17", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "2", " Solubility_mg_per_l": "434785.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 520.579", "link_html_complex": "/ACE_complex_html/ACE_GPPGPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPPGPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPPGPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPPGPP.png", "phi_psi": "/peptide_da/GPPGPP.pdb", "link_html_peptide": "/Peptide_html/GPPGPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPPGPP.pdb", "link_png_peptide": "/Peptide_pics/GPPGPP.png"}
{"Peptide_Sequence": "GPPGTDGAP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "10.5 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "386", " Ligand_ID": "GPPGTDGAP_minimized.pdb_386", " Smiles": "C[C@@H](O)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "767.78", " logP": "-6.8", " logD": "-14.3", " logSw": "0.81", " tPSA": "334.56", " RotatableB": "17", " RigidB": "33", " Flexibility": "0.34", " HBD": "10", " HBA": "22", " HBD_HBA": "32", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "54", " CarbonAtoms": "32", " HeteroAtoms": "22", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1718570.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 767.784", "link_html_complex": "/ACE_complex_html/ACE_GPPGTDGAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPPGTDGAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPPGTDGAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPPGTDGAP.png", "phi_psi": "/peptide_da/GPPGTDGAP.pdb", "link_html_peptide": "/Peptide_html/GPPGTDGAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPPGTDGAP.pdb", "link_png_peptide": "/Peptide_pics/GPPGTDGAP.png"}
{"Peptide_Sequence": "GPR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "388", " Ligand_ID": "GPR_minimized.pdb_388", " Smiles": "NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "328.37", " logP": "-5.43", " logD": "-6.27", " logSw": "2.14", " tPSA": "180.82", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2788209.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 328.367", "link_html_complex": "/ACE_complex_html/ACE_GPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPR.png", "phi_psi": "/peptide_da/GPR.pdb", "link_html_peptide": "/Peptide_html/GPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPR.pdb", "link_png_peptide": "/Peptide_pics/GPR.png"}
{"Peptide_Sequence": "GPSMR", " Origin": "mushroom", " Peptide_Preparation": "centrifugation, precipitation", " Isolation_Method": "precipitation, RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "277.5", " Reference": "Lau, Ching Ching, Noorlidah Abdullah, and Adawiyah Suriza Shuib. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from an edible mushroom, Pleurotus cystidiosus OK Miller identified by LC-MS/MS.\" BMC complementary and alternative medicine 13.1 (2013): 313.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "389", " Ligand_ID": "GPSMR_minimized.pdb_389", " Smiles": "CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "546.64", " logP": "-5.34", " logD": "-7.74", " logSw": "1.26", " tPSA": "284.55", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "21", " HeteroAtoms": "16", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1921418.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 546.641", "link_html_complex": "/ACE_complex_html/ACE_GPSMR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPSMR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPSMR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPSMR.png", "phi_psi": "/peptide_da/GPSMR.pdb", "link_html_peptide": "/Peptide_html/GPSMR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPSMR.pdb", "link_png_peptide": "/Peptide_pics/GPSMR.png"}
{"Peptide_Sequence": "GPV", " Origin": "bovine skin gelatin", " Peptide_Preparation": "Alcalase,Pronase E, and collagenase", " Isolation_Method": "UF, MWCO, RP-HPLC", " ACE_inhibition_assay": "modified Cushman and cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.67 \u03bcM", " Reference": "Kim, Se-Kwon, et al. \"Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate.\" Journal of Agricultural and Food Chemistry 49.6 (2001): 2992-2997.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "392", " Ligand_ID": "GPV_minimized.pdb_392", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(O)=O", " MW": "271.31", " logP": "-3.54", " logD": "-4.75", " logSw": "1.04", " tPSA": "117.18", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "0", " Solubility_mg_per_l": "766115.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 271.313", "link_html_complex": "/ACE_complex_html/ACE_GPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPV.png", "phi_psi": "/peptide_da/GPV.pdb", "link_html_peptide": "/Peptide_html/GPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPV.pdb", "link_png_peptide": "/Peptide_pics/GPV.png"}
{"Peptide_Sequence": "GPVGPA", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "123.4 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "390", " Ligand_ID": "GPVGPA_minimized.pdb_390", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "496.56", " logP": "-3.49", " logD": "-6.91", " logSw": "-0.06", " tPSA": "195.69", " RotatableB": "10", " RigidB": "21", " Flexibility": "0.32", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "22", " HeteroAtoms": "13", " ratio_H_by_C": "0.59", " Lipinski_Violation": "2", " Solubility_mg_per_l": "467661.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 496.557", "link_html_complex": "/ACE_complex_html/ACE_GPVGPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPVGPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPVGPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPVGPA.png", "phi_psi": "/peptide_da/GPVGPA.pdb", "link_html_peptide": "/Peptide_html/GPVGPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPVGPA.pdb", "link_png_peptide": "/Peptide_pics/GPVGPA.png"}
{"Peptide_Sequence": "GPVGPP", " Origin": "gelatin", " Peptide_Preparation": "bacterial collagenase", " Isolation_Method": "TLC, CECC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "123.4 \u03bcM", " Reference": "Oshima, Genichiro, Hirokazu Shimabukuro, and Kinzo Nagasawa. \"Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase.\" Biochimica et Biophysica Acta (BBA)-Enzymology 566.1 (1979): 128-137.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "391", " Ligand_ID": "GPVGPP_minimized.pdb_391", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "522.59", " logP": "-3.19", " logD": "-6.63", " logSw": "-0.48", " tPSA": "186.9", " RotatableB": "9", " RigidB": "26", " Flexibility": "0.26", " HBD": "5", " HBA": "13", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "2", " Solubility_mg_per_l": "324543.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 522.595", "link_html_complex": "/ACE_complex_html/ACE_GPVGPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GPVGPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GPVGPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GPVGPP.png", "phi_psi": "/peptide_da/GPVGPP.pdb", "link_html_peptide": "/Peptide_html/GPVGPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GPVGPP.pdb", "link_png_peptide": "/Peptide_pics/GPVGPP.png"}
{"Peptide_Sequence": "GQ", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "7000 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "393", " Ligand_ID": "GQ_minimized.pdb_393", " Smiles": "NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "203.2", " logP": "-4.82", " logD": "-5.61", " logSw": "2.33", " tPSA": "139.96", " RotatableB": "6", " RigidB": "5", " Flexibility": "0.55", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2094261.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 203.196", "link_html_complex": "/ACE_complex_html/ACE_GQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GQ.png", "phi_psi": "/peptide_da/GQ.pdb", "link_html_peptide": "/Peptide_html/GQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GQ.pdb", "link_png_peptide": "/Peptide_pics/GQ.png"}
{"Peptide_Sequence": "GQP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Structural requirements of angiotensin I-converting enzyme inhibitory activity: quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem., 54, 732-738, 2006", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "394", " Ligand_ID": "GQP_minimized.pdb_394", " Smiles": "NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "300.31", " logP": "-5.79", " logD": "-6.84", " logSw": "2.41", " tPSA": "160.27", " RotatableB": "7", " RigidB": "12", " Flexibility": "0.37", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "3336208.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.311", "link_html_complex": "/ACE_complex_html/ACE_GQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GQP.png", "phi_psi": "/peptide_da/GQP.pdb", "link_html_peptide": "/Peptide_html/GQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GQP.pdb", "link_png_peptide": "/Peptide_pics/GQP.png"}
{"Peptide_Sequence": "GQY", " Origin": "Sweet-potato protein isolate", " Peptide_Preparation": "", " Isolation_Method": "Absorption Chromatography, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "52.3 \u03bcM", " Reference": "Ishiguro, Koji, et al. \"Hypotensive effect of a sweetpotato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides.\" Food chemistry 131.3 (2012): 774-779.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "395", " Ligand_ID": "GQY_minimized.pdb_395", " Smiles": "NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "366.37", " logP": "-4.03", " logD": "-5.78", " logSw": "0.99", " tPSA": "189.29", " RotatableB": "10", " RigidB": "13", " Flexibility": "0.43", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "990839.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 366.369", "link_html_complex": "/ACE_complex_html/ACE_GQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GQY.png", "phi_psi": "/peptide_da/GQY.pdb", "link_html_peptide": "/Peptide_html/GQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GQY.pdb", "link_png_peptide": "/Peptide_pics/GQY.png"}
{"Peptide_Sequence": "GR", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "162.2 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "397", " Ligand_ID": "GR_minimized.pdb_397", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "231.25", " logP": "-4.47", " logD": "-6.21", " logSw": "2.07", " tPSA": "160.51", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "16", " CarbonAtoms": "8", " HeteroAtoms": "8", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1833249.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 231.252", "link_html_complex": "/ACE_complex_html/ACE_GR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GR.png", "phi_psi": "/peptide_da/GR.pdb", "link_html_peptide": "/Peptide_html/GR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GR.pdb", "link_png_peptide": "/Peptide_pics/GR.png"}
{"Peptide_Sequence": "GRC", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "396", " Ligand_ID": "GRC_minimized.pdb_396", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(O)=O", " MW": "334.4", " logP": "-4.81", " logD": "-8.27", " logSw": "1.84", " tPSA": "228.41", " RotatableB": "11", " RigidB": "6", " Flexibility": "0.65", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "22", " CarbonAtoms": "11", " HeteroAtoms": "11", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2111963.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 334.394", "link_html_complex": "/ACE_complex_html/ACE_GRC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRC.png", "phi_psi": "/peptide_da/GRC.pdb", "link_html_peptide": "/Peptide_html/GRC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRC.pdb", "link_png_peptide": "/Peptide_pics/GRC.png"}
{"Peptide_Sequence": "GRP", " Origin": "Sardine muscles", " Peptide_Preparation": "alkakine protease", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "2,4,6-trinitroben-zene sulfonate (TNBS) method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "20", " Reference": "Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., & Osajima, Y. (1994). Angiotensin I-converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58(12), 2244\u20132245. doi:10.1271/bbb.58.2244 ", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "398", " Ligand_ID": "GRP_minimized.pdb_398", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "328.37", " logP": "-5.45", " logD": "-8.17", " logSw": "2.15", " tPSA": "180.82", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2823563.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 328.367", "link_html_complex": "/ACE_complex_html/ACE_GRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRP.png", "phi_psi": "/peptide_da/GRP.pdb", "link_html_peptide": "/Peptide_html/GRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRP.pdb", "link_png_peptide": "/Peptide_pics/GRP.png"}
{"Peptide_Sequence": "GRPR", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "470 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "400", " Ligand_ID": "GRPR_minimized.pdb_400", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "484.55", " logP": "-7.01", " logD": "-10.12", " logSw": "2.63", " tPSA": "273.56", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "13", " HBA": "15", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "34", " CarbonAtoms": "19", " HeteroAtoms": "15", " ratio_H_by_C": "0.79", " Lipinski_Violation": "2", " Solubility_mg_per_l": "6709620.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 484.553", "link_html_complex": "/ACE_complex_html/ACE_GRPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRPR.png", "phi_psi": "/peptide_da/GRPR.pdb", "link_html_peptide": "/Peptide_html/GRPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRPR.pdb", "link_png_peptide": "/Peptide_pics/GRPR.png"}
{"Peptide_Sequence": "GRPRHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "34 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "399", " Ligand_ID": "GRPRHQG_minimized.pdb_399", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "806.87", " logP": "-8.06", " logD": "-16.94", " logSw": "1.98", " tPSA": "432.63", " RotatableB": "27", " RigidB": "27", " Flexibility": "0.5", " HBD": "19", " HBA": "25", " HBD_HBA": "44", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "57", " CarbonAtoms": "32", " HeteroAtoms": "25", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5866541.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 806.873", "link_html_complex": "/ACE_complex_html/ACE_GRPRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRPRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRPRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRPRHQG.png", "phi_psi": "/peptide_da/GRPRHQG.pdb", "link_html_peptide": "/Peptide_html/GRPRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRPRHQG.pdb", "link_png_peptide": "/Peptide_pics/GRPRHQG.png"}
{"Peptide_Sequence": "GRVMP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "250", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "401", " Ligand_ID": "GRVMP_minimized.pdb_401", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "558.69", " logP": "-5.02", " logD": "-8.77", " logSw": "0.98", " tPSA": "264.32", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1489650.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 558.695", "link_html_complex": "/ACE_complex_html/ACE_GRVMP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRVMP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRVMP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRVMP.png", "phi_psi": "/peptide_da/GRVMP.pdb", "link_html_peptide": "/Peptide_html/GRVMP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRVMP.pdb", "link_png_peptide": "/Peptide_pics/GRVMP.png"}
{"Peptide_Sequence": "GRY", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "402", " Ligand_ID": "GRY_minimized.pdb_402", " Smiles": "NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "394.43", " logP": "-4.37", " logD": "-7.1", " logSw": "1.18", " tPSA": "209.84", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1280325.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 394.426", "link_html_complex": "/ACE_complex_html/ACE_GRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GRY.png", "phi_psi": "/peptide_da/GRY.pdb", "link_html_peptide": "/Peptide_html/GRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GRY.pdb", "link_png_peptide": "/Peptide_pics/GRY.png"}
{"Peptide_Sequence": "GS", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "1156.3 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-5.1", "Serial_ID": "405", " Ligand_ID": "GS_minimized.pdb_405", " Smiles": "NCC(=O)N[C@@H](CO)C(O)=O", " MW": "162.14", " logP": "-4.7", " logD": "-5.5", " logSw": "2.38", " tPSA": "117.1", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "11", " CarbonAtoms": "5", " HeteroAtoms": "6", " ratio_H_by_C": "1.2", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1751437.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 162.144", "link_html_complex": "/ACE_complex_html/ACE_GS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GS.png", "phi_psi": "/peptide_da/GS.pdb", "link_html_peptide": "/Peptide_html/GS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GS.pdb", "link_png_peptide": "/Peptide_pics/GS.png"}
{"Peptide_Sequence": "GSAGY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "403", " Ligand_ID": "GSAGY_minimized.pdb_403", " Smiles": "C[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "453.45", " logP": "-4.23", " logD": "-7.54", " logSw": "0.73", " tPSA": "224.63", " RotatableB": "12", " RigidB": "15", " Flexibility": "0.44", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "19", " HeteroAtoms": "13", " ratio_H_by_C": "0.68", " Lipinski_Violation": "2", " Solubility_mg_per_l": "941199.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 453.446", "link_html_complex": "/ACE_complex_html/ACE_GSAGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GSAGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GSAGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GSAGY.png", "phi_psi": "/peptide_da/GSAGY.pdb", "link_html_peptide": "/Peptide_html/GSAGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GSAGY.pdb", "link_png_peptide": "/Peptide_pics/GSAGY.png"}
{"Peptide_Sequence": "GSH", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "404", " Ligand_ID": "GSH_minimized.pdb_404", " Smiles": "NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "299.28", " logP": "-5.19", " logD": "-6.82", " logSw": "2", " tPSA": "174.88", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "11", " HeteroAtoms": "10", " ratio_H_by_C": "0.91", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2222006.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.283", "link_html_complex": "/ACE_complex_html/ACE_GSH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GSH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GSH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GSH.png", "phi_psi": "/peptide_da/GSH.pdb", "link_html_peptide": "/Peptide_html/GSH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GSH.pdb", "link_png_peptide": "/Peptide_pics/GSH.png"}
{"Peptide_Sequence": "GT", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "5700 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "408", " Ligand_ID": "GT_minimized.pdb_408", " Smiles": "C[C@@H](O)[C@H](NC(=O)CN)C(O)=O", " MW": "176.17", " logP": "-4.27", " logD": "-5.08", " logSw": "2.02", " tPSA": "117.1", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "6", " HeteroAtoms": "6", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1330480.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 176.17", "link_html_complex": "/ACE_complex_html/ACE_GT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GT.png", "phi_psi": "/peptide_da/GT.pdb", "link_html_peptide": "/Peptide_html/GT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GT.pdb", "link_png_peptide": "/Peptide_pics/GT.png"}
{"Peptide_Sequence": "GTEKC", " Origin": "Sweet-potato", " Peptide_Preparation": "", " Isolation_Method": "SEC, RP-HPLC, LC-MS/MS", " ACE_inhibition_assay": "ACE inhibitory assay kit (ACE kit-WST, Dojindo Lab", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "61.67 \u03bcM", " Reference": "Lau, Ching Ching, Noorlidah Abdullah, and Adawiyah Suriza Shuib. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from an edible mushroom, Pleurotus cystidiosus OK Miller identified by LC-MS/MS.\" BMC complementary and alternative medicine 13.1 (2013): 313.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "406", " Ligand_ID": "GTEKC_minimized.pdb_406", " Smiles": "C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O", " MW": "536.6", " logP": "-8.14", " logD": "-12.86", " logSw": "3.15", " tPSA": "310.97", " RotatableB": "18", " RigidB": "10", " Flexibility": "0.64", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "20", " HeteroAtoms": "16", " ratio_H_by_C": "0.8", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12513139.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 536.599", "link_html_complex": "/ACE_complex_html/ACE_GTEKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GTEKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GTEKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GTEKC.png", "phi_psi": "/peptide_da/GTEKC.pdb", "link_html_peptide": "/Peptide_html/GTEKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GTEKC.pdb", "link_png_peptide": "/Peptide_pics/GTEKC.png"}
{"Peptide_Sequence": "GTG", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "fermented by Lactobacillus fermentum SM 605", " Isolation_Method": "UF, GF, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "5.54 \u03bcM", " Reference": "Wang, Yu-Kai, et al. \"Production of novel angiotensin I-converting enzyme inhibitory peptides by fermentation of marine shrimp Acetes chinensis with Lactobacillus fermentum SM 605.\" Applied microbiology and biotechnology 79.5 (2008): 785-791.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "407", " Ligand_ID": "GTG_minimized.pdb_407", " Smiles": "C[C@@H](O)[C@H](NC(=O)CN)C(=O)NCC(O)=O", " MW": "233.22", " logP": "-4.93", " logD": "-7.16", " logSw": "2.22", " tPSA": "146.2", " RotatableB": "6", " RigidB": "5", " Flexibility": "0.55", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "8", " HeteroAtoms": "8", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2138617.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 233.222", "link_html_complex": "/ACE_complex_html/ACE_GTG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GTG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GTG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GTG.png", "phi_psi": "/peptide_da/GTG.pdb", "link_html_peptide": "/Peptide_html/GTG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GTG.pdb", "link_png_peptide": "/Peptide_pics/GTG.png"}
{"Peptide_Sequence": "GTQY", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "409", " Ligand_ID": "GTQY_minimized.pdb_409", " Smiles": "C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "467.47", " logP": "-4.71", " logD": "-7.21", " logSw": "1.02", " tPSA": "238.62", " RotatableB": "13", " RigidB": "15", " Flexibility": "0.46", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1290385.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 467.473", "link_html_complex": "/ACE_complex_html/ACE_GTQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GTQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GTQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GTQY.png", "phi_psi": "/peptide_da/GTQY.pdb", "link_html_peptide": "/Peptide_html/GTQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GTQY.pdb", "link_png_peptide": "/Peptide_pics/GTQY.png"}
{"Peptide_Sequence": "GTW", " Origin": "milk", " Peptide_Preparation": "fermentation with lactic acid bacteria ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) and Wu and Ding (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "464.4 \u00b5M        ", " Reference": "Chen, Guan-Wen, Jenn-Shou Tsai, and Bonnie Sun Pan. \"Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation.\" International Dairy Journal 17.6 (2007): 641-647.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "410", " Ligand_ID": "GTW_minimized.pdb_410", " Smiles": "C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "362.38", " logP": "-2.98", " logD": "-4.79", " logSw": "0.18", " tPSA": "161.99", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "433801.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 362.38", "link_html_complex": "/ACE_complex_html/ACE_GTW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GTW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GTW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GTW.png", "phi_psi": "/peptide_da/GTW.pdb", "link_html_peptide": "/Peptide_html/GTW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GTW.pdb", "link_png_peptide": "/Peptide_pics/GTW.png"}
{"Peptide_Sequence": "GV", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "417", " Ligand_ID": "GV_minimized.pdb_417", " Smiles": "CC(C)[C@H](NC(=O)CN)C(O)=O", " MW": "174.2", " logP": "-2.69", " logD": "-3.56", " logSw": "1.04", " tPSA": "96.87", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "7", " HeteroAtoms": "5", " ratio_H_by_C": "0.71", " Lipinski_Violation": "0", " Solubility_mg_per_l": "492190.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 174.198", "link_html_complex": "/ACE_complex_html/ACE_GV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GV.png", "phi_psi": "/peptide_da/GV.pdb", "link_html_peptide": "/Peptide_html/GV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GV.pdb", "link_png_peptide": "/Peptide_pics/GV.png"}
{"Peptide_Sequence": "GVDNPGHPF", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "411", " Ligand_ID": "GVDNPGHPF_minimized.pdb_411", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "938.98", " logP": "-5.29", " logD": "-12.67", " logSw": "-0.81", " tPSA": "394.89", " RotatableB": "24", " RigidB": "41", " Flexibility": "0.37", " HBD": "13", " HBA": "25", " HBD_HBA": "38", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "67", " CarbonAtoms": "42", " HeteroAtoms": "25", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "417667.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 938.983", "link_html_complex": "/ACE_complex_html/ACE_GVDNPGHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVDNPGHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVDNPGHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVDNPGHPF.png", "phi_psi": "/peptide_da/GVDNPGHPF.pdb", "link_html_peptide": "/Peptide_html/GVDNPGHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVDNPGHPF.pdb", "link_png_peptide": "/Peptide_pics/GVDNPGHPF.png"}
{"Peptide_Sequence": "GVGAGY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "4.07 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "412", " Ligand_ID": "GVGAGY_minimized.pdb_412", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "522.55", " logP": "-4", " logD": "-6.71", " logSw": "0.3", " tPSA": "233.5", " RotatableB": "14", " RigidB": "17", " Flexibility": "0.45", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "23", " HeteroAtoms": "14", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "706532.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 522.551", "link_html_complex": "/ACE_complex_html/ACE_GVGAGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVGAGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVGAGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVGAGY.png", "phi_psi": "/peptide_da/GVGAGY.pdb", "link_html_peptide": "/Peptide_html/GVGAGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVGAGY.pdb", "link_png_peptide": "/Peptide_pics/GVGAGY.png"}
{"Peptide_Sequence": "GVGY", " Origin": "Silkworm fibroin", " Peptide_Preparation": "", " Isolation_Method": "HPLC, LC/MS/MS", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "35 \u03bcM", " Reference": "Mart\u00ednez-Maqueda, Daniel, et al. \"Antihypertensive peptides from food proteins: a review.\" Food & Function 3.4 (2012): 350-361.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "413", " Ligand_ID": "GVGY_minimized.pdb_413", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "394.42", " logP": "-3.09", " logD": "-5.1", " logSw": "0.24", " tPSA": "175.3", " RotatableB": "10", " RigidB": "13", " Flexibility": "0.43", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "500937.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 394.422", "link_html_complex": "/ACE_complex_html/ACE_GVGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVGY.png", "phi_psi": "/peptide_da/GVGY.pdb", "link_html_peptide": "/Peptide_html/GVGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVGY.pdb", "link_png_peptide": "/Peptide_pics/GVGY.png"}
{"Peptide_Sequence": "GVHGV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "414", " Ligand_ID": "GVHGV_minimized.pdb_414", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(O)=O", " MW": "467.52", " logP": "-3.12", " logD": "-6.53", " logSw": "0.03", " tPSA": "212.85", " RotatableB": "13", " RigidB": "14", " Flexibility": "0.48", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "481237.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 467.519", "link_html_complex": "/ACE_complex_html/ACE_GVHGV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVHGV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVHGV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVHGV.png", "phi_psi": "/peptide_da/GVHGV.pdb", "link_html_peptide": "/Peptide_html/GVHGV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVHGV.pdb", "link_png_peptide": "/Peptide_pics/GVHGV.png"}
{"Peptide_Sequence": "GVHHA", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "71.8", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "415", " Ligand_ID": "GVHHA_minimized.pdb_415", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(O)=O", " MW": "519.55", " logP": "-3.92", " logD": "-7", " logSw": "0.23", " tPSA": "241.53", " RotatableB": "14", " RigidB": "19", " Flexibility": "0.42", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "22", " HeteroAtoms": "15", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "651724", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 519.554", "link_html_complex": "/ACE_complex_html/ACE_GVHHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVHHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVHHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVHHA.png", "phi_psi": "/peptide_da/GVHHA.pdb", "link_html_peptide": "/Peptide_html/GVHHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVHHA.pdb", "link_png_peptide": "/Peptide_pics/GVHHA.png"}
{"Peptide_Sequence": "8 (2017): 10482-10488.\"", " Origin": "-9.3", " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "416", " Ligand_ID": "GVLY_minimized.pdb_416", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "450.53", " logP": "-2.33", " logD": "-3.23", " logSw": "-0.44", " tPSA": "175.3", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "289968.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 450.529", "link_html_complex": "/ACE_complex_html/ACE_GVLY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVLY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVLY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVLY.png", "phi_psi": "/peptide_da/GVLY.pdb", "link_html_peptide": "/Peptide_html/GVLY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVLY.pdb", "link_png_peptide": "/Peptide_pics/GVLY.png"}
{"Peptide_Sequence": "GVPKVKETMVPK", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "376.1 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "419", " Ligand_ID": "GVPKVKETMVPK_minimized.pdb_419", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1312.62", " logP": "-6.16", " logD": "-13.6", " logSw": "-1.26", " tPSA": "538.87", " RotatableB": "43", " RigidB": "34", " Flexibility": "0.56", " HBD": "20", " HBA": "31", " HBD_HBA": "51", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "91", " CarbonAtoms": "59", " HeteroAtoms": "32", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "372535.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1312.62", "link_html_complex": "/ACE_complex_html/ACE_GVPKVKETMVPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVPKVKETMVPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVPKVKETMVPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVPKVKETMVPK.png", "phi_psi": "/peptide_da/GVPKVKETMVPK.pdb", "link_html_peptide": "/Peptide_html/GVPKVKETMVPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVPKVKETMVPK.pdb", "link_png_peptide": "/Peptide_pics/GVPKVKETMVPK.png"}
{"Peptide_Sequence": "GVPKVKETMVPKH", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "223.2 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-4.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1449.76", "link_html_complex": "/ACE_complex_html/ACE_GVPKVKETMVPKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVPKVKETMVPKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVPKVKETMVPKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVPKVKETMVPKH.png", "phi_psi": "/peptide_da/GVPKVKETMVPKH.pdb", "link_html_peptide": "/Peptide_html/GVPKVKETMVPKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVPKVKETMVPKH.pdb", "link_png_peptide": "/Peptide_pics/GVPKVKETMVPKH.png"}
{"Peptide_Sequence": "GVQGPM", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "736.7", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "420", " Ligand_ID": "GVQGPM_minimized.pdb_420", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(O)=O", " MW": "587.69", " logP": "-4.32", " logD": "-7.67", " logSw": "0.36", " tPSA": "272.87", " RotatableB": "17", " RigidB": "18", " Flexibility": "0.49", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "842289.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 587.689", "link_html_complex": "/ACE_complex_html/ACE_GVQGPM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVQGPM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVQGPM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVQGPM.png", "phi_psi": "/peptide_da/GVQGPM.pdb", "link_html_peptide": "/Peptide_html/GVQGPM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVQGPM.pdb", "link_png_peptide": "/Peptide_pics/GVQGPM.png"}
{"Peptide_Sequence": "GVSLPEW", " Origin": "Alpha-Lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "SEC, RP-HPLC, LC-MS/MS", " ACE_inhibition_assay": "Shalaby et al. (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "30 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "421", " Ligand_ID": "GVSLPEW_minimized.pdb_421", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "786.87", " logP": "-2.18", " logD": "-8.8", " logSw": "-2.02", " tPSA": "309.73", " RotatableB": "21", " RigidB": "29", " Flexibility": "0.42", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "56", " CarbonAtoms": "37", " HeteroAtoms": "19", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "104408.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 786.872", "link_html_complex": "/ACE_complex_html/ACE_GVSLPEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVSLPEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVSLPEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVSLPEW.png", "phi_psi": "/peptide_da/GVSLPEW.pdb", "link_html_peptide": "/Peptide_html/GVSLPEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVSLPEW.pdb", "link_png_peptide": "/Peptide_pics/GVSLPEW.png"}
{"Peptide_Sequence": "GVW", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "270 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "422", " Ligand_ID": "GVW_minimized.pdb_422", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "360.41", " logP": "-1.81", " logD": "-3.23", " logSw": "-0.54", " tPSA": "141.76", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "210147.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.39", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 360.408", "link_html_complex": "/ACE_complex_html/ACE_GVW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVW.png", "phi_psi": "/peptide_da/GVW.pdb", "link_html_peptide": "/Peptide_html/GVW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVW.pdb", "link_png_peptide": "/Peptide_pics/GVW.png"}
{"Peptide_Sequence": "GVY", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1992", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "400 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "423", " Ligand_ID": "GVY_minimized.pdb_423", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "337.37", " logP": "-2.66", " logD": "-3.71", " logSw": "0.18", " tPSA": "146.2", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "402951.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 337.371", "link_html_complex": "/ACE_complex_html/ACE_GVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVY.png", "phi_psi": "/peptide_da/GVY.pdb", "link_html_peptide": "/Peptide_html/GVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVY.pdb", "link_png_peptide": "/Peptide_pics/GVY.png"}
{"Peptide_Sequence": "GVYPH", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2511.89 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "425", " Ligand_ID": "GVYPH_minimized.pdb_425", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "571.63", " logP": "-2.15", " logD": "-4.38", " logSw": "-1.28", " tPSA": "224.29", " RotatableB": "13", " RigidB": "25", " Flexibility": "0.34", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "159580.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 571.625", "link_html_complex": "/ACE_complex_html/ACE_GVYPH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVYPH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVYPH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVYPH.png", "phi_psi": "/peptide_da/GVYPH.pdb", "link_html_peptide": "/Peptide_html/GVYPH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVYPH.pdb", "link_png_peptide": "/Peptide_pics/GVYPH.png"}
{"Peptide_Sequence": "GVYPHK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.6 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "424", " Ligand_ID": "GVYPHK_minimized.pdb_424", " Smiles": "CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "699.8", " logP": "-2.63", " logD": "-5.54", " logSw": "-1.35", " tPSA": "281.03", " RotatableB": "19", " RigidB": "27", " Flexibility": "0.41", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "50", " CarbonAtoms": "33", " HeteroAtoms": "17", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "181403.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 699.798", "link_html_complex": "/ACE_complex_html/ACE_GVYPHK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GVYPHK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GVYPHK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GVYPHK.png", "phi_psi": "/peptide_da/GVYPHK.pdb", "link_html_peptide": "/Peptide_html/GVYPHK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GVYPHK.pdb", "link_png_peptide": "/Peptide_pics/GVYPHK.png"}
{"Peptide_Sequence": "GW", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "30 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "427", " Ligand_ID": "GW_minimized.pdb_427", " Smiles": "NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "261.28", " logP": "-2.11", " logD": "-2.69", " logSw": "0", " tPSA": "112.66", " RotatableB": "5", " RigidB": "13", " Flexibility": "0.28", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "13", " HeteroAtoms": "6", " ratio_H_by_C": "0.46", " Lipinski_Violation": "0", " Solubility_mg_per_l": "262193.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.23", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 261.276", "link_html_complex": "/ACE_complex_html/ACE_GW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GW.png", "phi_psi": "/peptide_da/GW.pdb", "link_html_peptide": "/Peptide_html/GW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GW.pdb", "link_png_peptide": "/Peptide_pics/GW.png"}
{"Peptide_Sequence": "GWAP", " Origin": "Sardine Muscle ", " Peptide_Preparation": "Alkaline Protease Hydrolyzate", " Isolation_Method": "GPC with reversed-phase columns", " ACE_inhibition_assay": "2,4,6-trinitroben-zenesulfonate(TNBS)method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.86", " Reference": "Matsui T, Matsufuji H, Seki E, Osajima K, Nakashima M, Osajima Y. Angiotensin I\u2013converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci Biotech Biochem 1994;58:2244\u20135.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "426", " Ligand_ID": "GWAP_minimized.pdb_426", " Smiles": "C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "429.47", " logP": "-1.89", " logD": "-4.69", " logSw": "-0.9", " tPSA": "162.07", " RotatableB": "8", " RigidB": "22", " Flexibility": "0.27", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "21", " HeteroAtoms": "10", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "174812.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.47", "link_html_complex": "/ACE_complex_html/ACE_GWAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GWAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GWAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GWAP.png", "phi_psi": "/peptide_da/GWAP.pdb", "link_html_peptide": "/Peptide_html/GWAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GWAP.pdb", "link_png_peptide": "/Peptide_pics/GWAP.png"}
{"Peptide_Sequence": "GY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "259", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "429", " Ligand_ID": "GY_minimized.pdb_429", " Smiles": "NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "238.24", " logP": "-1.87", " logD": "-3.1", " logSw": "0.05", " tPSA": "117.1", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "11", " HeteroAtoms": "6", " ratio_H_by_C": "0.55", " Lipinski_Violation": "0", " Solubility_mg_per_l": "249901.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 238.24", "link_html_complex": "/ACE_complex_html/ACE_GY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GY.png", "phi_psi": "/peptide_da/GY.pdb", "link_html_peptide": "/Peptide_html/GY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GY.pdb", "link_png_peptide": "/Peptide_pics/GY.png"}
{"Peptide_Sequence": "GYALPHA", " Origin": "Mantle Muscle", " Peptide_Preparation": "autolysate", " Isolation_Method": "RT-HPLC", " ACE_inhibition_assay": "Ukeda et al.", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "27.3", " Reference": "Wako Y, Ishikawa S, Muramoto K. Angiotensin I\u2013converting enzyme inhibitors in autolysates of liver and mantle muscle. Biosci Biotech Biochem 1996;60:1353\u20135.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "428", " Ligand_ID": "GYALPHA_minimized.pdb_428", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(O)=O", " MW": "727.81", " logP": "-2.3", " logD": "-5.61", " logSw": "-1.8", " tPSA": "282.49", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "34", " HeteroAtoms": "18", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "120787.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 727.808", "link_html_complex": "/ACE_complex_html/ACE_GYALPHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_GYALPHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_GYALPHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_GYALPHA.png", "phi_psi": "/peptide_da/GYALPHA.pdb", "link_html_peptide": "/Peptide_html/GYALPHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/GYALPHA.pdb", "link_png_peptide": "/Peptide_pics/GYALPHA.png"}
{"Peptide_Sequence": "HA", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "431", " Ligand_ID": "HA_minimized.pdb_431", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "226.23", " logP": "-3.76", " logD": "-4.36", " logSw": "1.33", " tPSA": "125.55", " RotatableB": "5", " RigidB": "8", " Flexibility": "0.38", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "9", " HeteroAtoms": "7", " ratio_H_by_C": "0.78", " Lipinski_Violation": "0", " Solubility_mg_per_l": "857815.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 226.232", "link_html_complex": "/ACE_complex_html/ACE_HA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HA.png", "phi_psi": "/peptide_da/HA.pdb", "link_html_peptide": "/Peptide_html/HA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HA.pdb", "link_png_peptide": "/Peptide_pics/HA.png"}
{"Peptide_Sequence": "HAEIN", " Origin": "Egg", " Peptide_Preparation": "Alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Yu, Zhipeng, et al. \"QIGLF, a novel angiotensin I\u2010converting enzyme\u2010inhibitory peptide from egg white protein.\" Journal of the Science of Food and Agriculture 91.5 (2011): 921-926.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "430", " Ligand_ID": "HAEIN_minimized.pdb_430", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "582.61", " logP": "-4.96", " logD": "-10.67", " logSw": "0.81", " tPSA": "296.07", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "24", " HeteroAtoms": "17", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1314636.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 582.607", "link_html_complex": "/ACE_complex_html/ACE_HAEIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HAEIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HAEIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HAEIN.png", "phi_psi": "/peptide_da/HAEIN.pdb", "link_html_peptide": "/Peptide_html/HAEIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HAEIN.pdb", "link_png_peptide": "/Peptide_pics/HAEIN.png"}
{"Peptide_Sequence": "HANENIF", " Origin": "egg white", " Peptide_Preparation": "Alcalase", " Isolation_Method": "LC/MS/MS, TMS", " ACE_inhibition_assay": "Liu et al., 2010", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Yu, Zhipeng, et al. \"Primary and secondary structure of novel ACE-inhibitory peptides from egg white protein.\" Food chemistry 133.2 (2012): 315-322.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "432", " Ligand_ID": "HANENIF_minimized.pdb_432", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "843.88", " logP": "-5.39", " logD": "-11.57", " logSw": "-0.1", " tPSA": "397.36", " RotatableB": "25", " RigidB": "29", " Flexibility": "0.46", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "60", " CarbonAtoms": "37", " HeteroAtoms": "23", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "764791.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 843.883", "link_html_complex": "/ACE_complex_html/ACE_HANENIF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HANENIF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HANENIF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HANENIF.png", "phi_psi": "/peptide_da/HANENIF.pdb", "link_html_peptide": "/Peptide_html/HANENIF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HANENIF.pdb", "link_png_peptide": "/Peptide_pics/HANENIF.png"}
{"Peptide_Sequence": "HDHM", " Origin": "Sweet-potato tuber trypsin inhibitor", " Peptide_Preparation": " trypsin_x005F_x0007_Sepharose-4B affinity column", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist et al., 1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "276.2 \u03bcM", " Reference": "Pihlanto, Anne, and Sari Ma\u0308kinen. \"Antihypertensive properties of plant protein derived peptides.\" Bioactive food peptides in health and disease. IntechOpen, 2013.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "433", " Ligand_ID": "HDHM_minimized.pdb_433", " Smiles": "CSCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "538.58", " logP": "-4.46", " logD": "-9.4", " logSw": "0.58", " tPSA": "277.86", " RotatableB": "16", " RigidB": "18", " Flexibility": "0.47", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "37", " CarbonAtoms": "21", " HeteroAtoms": "16", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "958245.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 538.577", "link_html_complex": "/ACE_complex_html/ACE_HDHM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HDHM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HDHM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HDHM.png", "phi_psi": "/peptide_da/HDHM.pdb", "link_html_peptide": "/Peptide_html/HDHM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HDHM.pdb", "link_png_peptide": "/Peptide_pics/HDHM.png"}
{"Peptide_Sequence": "HERDPTHIKWGD", " Origin": "bonito muscle", " Peptide_Preparation": "artificial gastric juice ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifi-cation", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8 \u03bcM", " Reference": "Hasan, Fida, et al. \"Production kinetics of angiotensin-I converting enzyme inhibitory peptides from bonito meat in artificial gastric juice.\" Process Biochemistry 41.3 (2006): 505-511.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1490.58", "link_html_complex": "/ACE_complex_html/ACE_HERDPTHIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HERDPTHIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HERDPTHIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HERDPTHIKWGD.png", "phi_psi": "/peptide_da/HERDPTHIKWGD.pdb", "link_html_peptide": "/Peptide_html/HERDPTHIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HERDPTHIKWGD.pdb", "link_png_peptide": "/Peptide_pics/HERDPTHIKWGD.png"}
{"Peptide_Sequence": "HFEAMR", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "192.3 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "435", " Ligand_ID": "HFEAMR_minimized.pdb_435", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "789.9", " logP": "-3.6", " logD": "-8.94", " logSw": "-0.83", " tPSA": "371.02", " RotatableB": "26", " RigidB": "24", " Flexibility": "0.52", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "34", " HeteroAtoms": "21", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "344372.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 789.902", "link_html_complex": "/ACE_complex_html/ACE_HFEAMR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HFEAMR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HFEAMR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HFEAMR.png", "phi_psi": "/peptide_da/HFEAMR.pdb", "link_html_peptide": "/Peptide_html/HFEAMR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HFEAMR.pdb", "link_png_peptide": "/Peptide_pics/HFEAMR.png"}
{"Peptide_Sequence": "HG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "6300 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "436", " Ligand_ID": "HG_minimized.pdb_436", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)NCC(O)=O", " MW": "212.21", " logP": "-4.17", " logD": "-4.93", " logSw": "1.66", " tPSA": "125.55", " RotatableB": "5", " RigidB": "8", " Flexibility": "0.38", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "8", " HeteroAtoms": "7", " ratio_H_by_C": "0.88", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1120963.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 212.206", "link_html_complex": "/ACE_complex_html/ACE_HG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HG.png", "phi_psi": "/peptide_da/HG.pdb", "link_html_peptide": "/Peptide_html/HG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HG.pdb", "link_png_peptide": "/Peptide_pics/HG.png"}
{"Peptide_Sequence": "HHL", " Origin": "fermented soyabean paste", " Peptide_Preparation": "", " Isolation_Method": "SEC, HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "2.2 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "437", " Ligand_ID": "HHL_minimized.pdb_437", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "405.45", " logP": "-2.65", " logD": "-4.69", " logSw": "-0.09", " tPSA": "183.33", " RotatableB": "11", " RigidB": "15", " Flexibility": "0.42", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "370390.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 405.451", "link_html_complex": "/ACE_complex_html/ACE_HHL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HHL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HHL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HHL.png", "phi_psi": "/peptide_da/HHL.pdb", "link_html_peptide": "/Peptide_html/HHL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HHL.pdb", "link_png_peptide": "/Peptide_pics/HHL.png"}
{"Peptide_Sequence": "HHT", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "800 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "439", " Ligand_ID": "HHT_minimized.pdb_439", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "393.4", " logP": "-4.59", " logD": "-6.59", " logSw": "1.13", " tPSA": "203.56", " RotatableB": "10", " RigidB": "15", " Flexibility": "0.4", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1214827.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.398", "link_html_complex": "/ACE_complex_html/ACE_HHT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HHT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HHT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HHT.png", "phi_psi": "/peptide_da/HHT.pdb", "link_html_peptide": "/Peptide_html/HHT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HHT.pdb", "link_png_peptide": "/Peptide_pics/HHT.png"}
{"Peptide_Sequence": "HHTF", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "84 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "438", " Ligand_ID": "HHTF_minimized.pdb_438", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "540.57", " logP": "-3.26", " logD": "-5.85", " logSw": "-0.38", " tPSA": "232.66", " RotatableB": "14", " RigidB": "23", " Flexibility": "0.38", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "369489.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 540.572", "link_html_complex": "/ACE_complex_html/ACE_HHTF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HHTF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HHTF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HHTF.png", "phi_psi": "/peptide_da/HHTF.pdb", "link_html_peptide": "/Peptide_html/HHTF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HHTF.pdb", "link_png_peptide": "/Peptide_pics/HHTF.png"}
{"Peptide_Sequence": "HIK", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "440", " Ligand_ID": "HIK_minimized.pdb_440", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "396.48", " logP": "-2.66", " logD": "-4.31", " logSw": "0.17", " tPSA": "182.29", " RotatableB": "13", " RigidB": "10", " Flexibility": "0.57", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "471805.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 396.484", "link_html_complex": "/ACE_complex_html/ACE_HIK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HIK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HIK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HIK.png", "phi_psi": "/peptide_da/HIK.pdb", "link_html_peptide": "/Peptide_html/HIK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HIK.pdb", "link_png_peptide": "/Peptide_pics/HIK.png"}
{"Peptide_Sequence": "HIKW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "442", " Ligand_ID": "HIKW_minimized.pdb_442", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "582.69", " logP": "-2.53", " logD": "-4.7", " logSw": "-0.86", " tPSA": "227.18", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "246540.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 582.694", "link_html_complex": "/ACE_complex_html/ACE_HIKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HIKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HIKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HIKW.png", "phi_psi": "/peptide_da/HIKW.pdb", "link_html_peptide": "/Peptide_html/HIKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HIKW.pdb", "link_png_peptide": "/Peptide_pics/HIKW.png"}
{"Peptide_Sequence": "HIKWGD", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "50 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "441", " Ligand_ID": "HIKWGD_minimized.pdb_441", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "754.83", " logP": "-5.64", " logD": "-11.04", " logSw": "0.45", " tPSA": "325.51", " RotatableB": "23", " RigidB": "27", " Flexibility": "0.46", " HBD": "13", " HBA": "19", " HBD_HBA": "32", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "35", " HeteroAtoms": "19", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1185732.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 754.833", "link_html_complex": "/ACE_complex_html/ACE_HIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HIKWGD.png", "phi_psi": "/peptide_da/HIKWGD.pdb", "link_html_peptide": "/Peptide_html/HIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HIKWGD.pdb", "link_png_peptide": "/Peptide_pics/HIKWGD.png"}
{"Peptide_Sequence": "HIR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "444", " Ligand_ID": "HIR_minimized.pdb_444", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "424.5", " logP": "-3.24", " logD": "-4.9", " logSw": "0.43", " tPSA": "218.29", " RotatableB": "14", " RigidB": "11", " Flexibility": "0.56", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "654939.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 424.498", "link_html_complex": "/ACE_complex_html/ACE_HIR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HIR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HIR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HIR.png", "phi_psi": "/peptide_da/HIR.pdb", "link_html_peptide": "/Peptide_html/HIR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HIR.pdb", "link_png_peptide": "/Peptide_pics/HIR.png"}
{"Peptide_Sequence": "HIRL", " Origin": "Alpha-lactalbumin and alpha-lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "(Chiba and Yoshikawa,  1991", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1153.2 \u03bcM", " Reference": "Mullally, Margaret M., Hans Meisel, and Richard J. FitzGerald. \"Synthetic peptides corresponding to a-lactalbumin and b-lactoglobulin sequences with angiotensin-1-converting enzyme inhibitory activity.\" Biological Chemistry-Hoppe Seyler 377.4 (1996): 259-260.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "443", " Ligand_ID": "HIRL_minimized.pdb_443", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "537.66", " logP": "-2.17", " logD": "-6.13", " logSw": "-0.66", " tPSA": "247.39", " RotatableB": "18", " RigidB": "13", " Flexibility": "0.58", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "276766.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 537.655", "link_html_complex": "/ACE_complex_html/ACE_HIRL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HIRL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HIRL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HIRL.png", "phi_psi": "/peptide_da/HIRL.pdb", "link_html_peptide": "/Peptide_html/HIRL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HIRL.pdb", "link_png_peptide": "/Peptide_pics/HIRL.png"}
{"Peptide_Sequence": "HK", " Origin": "milk proteins hydrolysate", " Peptide_Preparation": "synthesized", " Isolation_Method": "hydrophilic interaction liquid chromatography (HILIC)", " ACE_inhibition_assay": "Nakamura Y (1995)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "446", " Ligand_ID": "HK_minimized.pdb_446", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "283.33", " logP": "-3.72", " logD": "-5.29", " logSw": "1.25", " tPSA": "153.19", " RotatableB": "9", " RigidB": "8", " Flexibility": "0.53", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "989629.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 283.327", "link_html_complex": "/ACE_complex_html/ACE_HK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HK.png", "phi_psi": "/peptide_da/HK.pdb", "link_html_peptide": "/Peptide_html/HK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HK.pdb", "link_png_peptide": "/Peptide_pics/HK.png"}
{"Peptide_Sequence": "HKEMPFPKY", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "445", " Ligand_ID": "HKEMPFPKY_minimized.pdb_445", " Smiles": "CSCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1176.39", " logP": "-4.45", " logD": "-11.41", " logSw": "-2.1", " tPSA": "452.61", " RotatableB": "35", " RigidB": "45", " Flexibility": "0.44", " HBD": "16", " HBA": "26", " HBD_HBA": "42", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "83", " CarbonAtoms": "56", " HeteroAtoms": "27", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "144517.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1176.39", "link_html_complex": "/ACE_complex_html/ACE_HKEMPFPKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HKEMPFPKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HKEMPFPKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HKEMPFPKY.png", "phi_psi": "/peptide_da/HKEMPFPKY.pdb", "link_html_peptide": "/Peptide_html/HKEMPFPKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HKEMPFPKY.pdb", "link_png_peptide": "/Peptide_pics/HKEMPFPKY.png"}
{"Peptide_Sequence": "HLFGPPGKKDPV", " Origin": "fertilized egg", " Peptide_Preparation": "", " Isolation_Method": "centrifugation, membrane filteration, UF", " ACE_inhibition_assay": "Terashima et al (2011)", " In-vivo_or_in-vitro": "in-vitro, in-vivo\n", " IC50_micromol_per_L": "125 \u03bcM", " Reference": "Duan, Xiang, et al. \"Naturally occurring angiotensin I-converting enzyme inhibitory peptide from a fertilized egg and its inhibitory mechanism.\" Journal of agricultural and food chemistry 62.24 (2014): 5500-5506.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "447", " Ligand_ID": "HLFGPPGKKDPV_minimized.pdb_447", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "1291.5", " logP": "-5.66", " logD": "-15.47", " logSw": "-1.88", " tPSA": "485.59", " RotatableB": "37", " RigidB": "50", " Flexibility": "0.43", " HBD": "17", " HBA": "31", " HBD_HBA": "48", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "92", " CarbonAtoms": "61", " HeteroAtoms": "31", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "196430.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1291.5", "link_html_complex": "/ACE_complex_html/ACE_HLFGPPGKKDPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HLFGPPGKKDPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HLFGPPGKKDPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HLFGPPGKKDPV.png", "phi_psi": "/peptide_da/HLFGPPGKKDPV.pdb", "link_html_peptide": "/Peptide_html/HLFGPPGKKDPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HLFGPPGKKDPV.pdb", "link_png_peptide": "/Peptide_pics/HLFGPPGKKDPV.png"}
{"Peptide_Sequence": "HLPLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "41", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "449", " Ligand_ID": "HLPLP_minimized.pdb_449", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "575.7", " logP": "-1", " logD": "-3.86", " logSw": "-1.96", " tPSA": "195.27", " RotatableB": "13", " RigidB": "24", " Flexibility": "0.35", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "80739.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 575.7", "link_html_complex": "/ACE_complex_html/ACE_HLPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HLPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HLPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HLPLP.png", "phi_psi": "/peptide_da/HLPLP.pdb", "link_html_peptide": "/Peptide_html/HLPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HLPLP.pdb", "link_png_peptide": "/Peptide_pics/HLPLP.png"}
{"Peptide_Sequence": "HLPLPLL", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "34.4 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "448", " Ligand_ID": "HLPLPLL_minimized.pdb_448", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(O)=O", " MW": "802.02", " logP": "1.14", " logD": "-2.38", " logSw": "-4.17", " tPSA": "253.47", " RotatableB": "21", " RigidB": "28", " Flexibility": "0.43", " HBD": "8", " HBA": "17", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12336.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.015", "link_html_complex": "/ACE_complex_html/ACE_HLPLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HLPLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HLPLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HLPLPLL.png", "phi_psi": "/peptide_da/HLPLPLL.pdb", "link_html_peptide": "/Peptide_html/HLPLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HLPLPLL.pdb", "link_png_peptide": "/Peptide_pics/HLPLPLL.png"}
{"Peptide_Sequence": "HLPPPV", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": ">>1000", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "450", " Ligand_ID": "HLPPPV_minimized.pdb_450", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "658.79", " logP": "-1.3", " logD": "-4.51", " logSw": "-2.29", " tPSA": "215.58", " RotatableB": "13", " RigidB": "31", " Flexibility": "0.3", " HBD": "6", " HBA": "15", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67005.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 658.789", "link_html_complex": "/ACE_complex_html/ACE_HLPPPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HLPPPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HLPPPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HLPPPV.png", "phi_psi": "/peptide_da/HLPPPV.pdb", "link_html_peptide": "/Peptide_html/HLPPPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HLPPPV.pdb", "link_png_peptide": "/Peptide_pics/HLPPPV.png"}
{"Peptide_Sequence": "HNW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "126 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "451", " Ligand_ID": "HNW_minimized.pdb_451", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "455.47", " logP": "-4.22", " logD": "-5.42", " logSw": "0.54", " tPSA": "213.53", " RotatableB": "11", " RigidB": "22", " Flexibility": "0.33", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "783214.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.467", "link_html_complex": "/ACE_complex_html/ACE_HNW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HNW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HNW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HNW.png", "phi_psi": "/peptide_da/HNW.pdb", "link_html_peptide": "/Peptide_html/HNW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HNW.pdb", "link_png_peptide": "/Peptide_pics/HNW.png"}
{"Peptide_Sequence": "HP", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "456", " Ligand_ID": "HP_minimized.pdb_456", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "252.27", " logP": "-2.95", " logD": "-4.08", " logSw": "0.61", " tPSA": "116.76", " RotatableB": "4", " RigidB": "13", " Flexibility": "0.24", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "464101.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 252.27", "link_html_complex": "/ACE_complex_html/ACE_HP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HP.png", "phi_psi": "/peptide_da/HP.pdb", "link_html_peptide": "/Peptide_html/HP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HP.pdb", "link_png_peptide": "/Peptide_pics/HP.png"}
{"Peptide_Sequence": "HPFAQ", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "465 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "452", " Ligand_ID": "HPFAQ_minimized.pdb_452", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "598.65", " logP": "-3.52", " logD": "-6.18", " logSw": "-0.44", " tPSA": "247.15", " RotatableB": "15", " RigidB": "27", " Flexibility": "0.36", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "28", " HeteroAtoms": "15", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "383810.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 598.651", "link_html_complex": "/ACE_complex_html/ACE_HPFAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HPFAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HPFAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HPFAQ.png", "phi_psi": "/peptide_da/HPFAQ.pdb", "link_html_peptide": "/Peptide_html/HPFAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HPFAQ.pdb", "link_png_peptide": "/Peptide_pics/HPFAQ.png"}
{"Peptide_Sequence": "HPFAQTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "26", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "453", " Ligand_ID": "HPFAQTQSLVYP_minimized.pdb_453", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1387.54", " logP": "-4.3", " logD": "-9.03", " logSw": "-3.36", " tPSA": "546.76", " RotatableB": "37", " RigidB": "54", " Flexibility": "0.41", " HBD": "20", " HBA": "34", " HBD_HBA": "54", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "99", " CarbonAtoms": "65", " HeteroAtoms": "34", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "48345.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1387.54", "link_html_complex": "/ACE_complex_html/ACE_HPFAQTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HPFAQTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HPFAQTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HPFAQTQSLVYP.png", "phi_psi": "/peptide_da/HPFAQTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/HPFAQTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HPFAQTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/HPFAQTQSLVYP.png"}
{"Peptide_Sequence": "HPHPHLSF", " Origin": "ovine milk proteins", " Peptide_Preparation": "epsin,  trypsin,  and  chymotrypsin.", " Isolation_Method": "Ultrafiltration, RP-HPLC", " ACE_inhibition_assay": "Cushman  and  Cheung  with  some  modifications.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "28.9 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "454", " Ligand_ID": "HPHPHLSF_minimized.pdb_454", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "971.07", " logP": "-3.01", " logD": "-7.1", " logSw": "-2.5", " tPSA": "360.16", " RotatableB": "24", " RigidB": "46", " Flexibility": "0.34", " HBD": "12", " HBA": "24", " HBD_HBA": "36", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "70", " CarbonAtoms": "46", " HeteroAtoms": "24", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "79864.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 971.072", "link_html_complex": "/ACE_complex_html/ACE_HPHPHLSF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HPHPHLSF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HPHPHLSF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HPHPHLSF.png", "phi_psi": "/peptide_da/HPHPHLSF.pdb", "link_html_peptide": "/Peptide_html/HPHPHLSF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HPHPHLSF.pdb", "link_png_peptide": "/Peptide_pics/HPHPHLSF.png"}
{"Peptide_Sequence": "HPIKH", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "1258.9 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "455", " Ligand_ID": "HPIKH_minimized.pdb_455", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "630.74", " logP": "-3.09", " logD": "-7.13", " logSw": "-0.7", " tPSA": "260.38", " RotatableB": "18", " RigidB": "24", " Flexibility": "0.43", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "314093.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 630.739", "link_html_complex": "/ACE_complex_html/ACE_HPIKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HPIKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HPIKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HPIKH.png", "phi_psi": "/peptide_da/HPIKH.pdb", "link_html_peptide": "/Peptide_html/HPIKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HPIKH.pdb", "link_png_peptide": "/Peptide_pics/HPIKH.png"}
{"Peptide_Sequence": "HQAAGW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "60 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "457", " Ligand_ID": "HQAAGW_minimized.pdb_457", " Smiles": "C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "668.7", " logP": "-4.49", " logD": "-7.38", " logSw": "-0.09", " tPSA": "300.83", " RotatableB": "18", " RigidB": "28", " Flexibility": "0.39", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "30", " HeteroAtoms": "18", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "612999.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 668.701", "link_html_complex": "/ACE_complex_html/ACE_HQAAGW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HQAAGW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HQAAGW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HQAAGW.png", "phi_psi": "/peptide_da/HQAAGW.pdb", "link_html_peptide": "/Peptide_html/HQAAGW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HQAAGW.pdb", "link_png_peptide": "/Peptide_pics/HQAAGW.png"}
{"Peptide_Sequence": "HQDF", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "458", " Ligand_ID": "HQDF_minimized.pdb_458", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "545.55", " logP": "-4.44", " logD": "-9.88", " logSw": "0.51", " tPSA": "266.97", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "912620.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 545.545", "link_html_complex": "/ACE_complex_html/ACE_HQDF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HQDF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HQDF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HQDF.png", "phi_psi": "/peptide_da/HQDF.pdb", "link_html_peptide": "/Peptide_html/HQDF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HQDF.pdb", "link_png_peptide": "/Peptide_pics/HQDF.png"}
{"Peptide_Sequence": "HQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "745 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "459", " Ligand_ID": "HQG_minimized.pdb_459", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "340.34", " logP": "-5.3", " logD": "-7.49", " logSw": "1.96", " tPSA": "197.74", " RotatableB": "10", " RigidB": "12", " Flexibility": "0.45", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "13", " HeteroAtoms": "11", " ratio_H_by_C": "0.85", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2427851.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 340.335", "link_html_complex": "/ACE_complex_html/ACE_HQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HQG.png", "phi_psi": "/peptide_da/HQG.pdb", "link_html_peptide": "/Peptide_html/HQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HQG.pdb", "link_png_peptide": "/Peptide_pics/HQG.png"}
{"Peptide_Sequence": "HQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "110", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "460", " Ligand_ID": "HQIYP_minimized.pdb_460", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "656.73", " logP": "-2.55", " logD": "-5.18", " logSw": "-1.27", " tPSA": "267.38", " RotatableB": "17", " RigidB": "27", " Flexibility": "0.39", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "31", " HeteroAtoms": "16", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "183937.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 656.73", "link_html_complex": "/ACE_complex_html/ACE_HQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HQIYP.png", "phi_psi": "/peptide_da/HQIYP.pdb", "link_html_peptide": "/Peptide_html/HQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HQIYP.pdb", "link_png_peptide": "/Peptide_pics/HQIYP.png"}
{"Peptide_Sequence": "HSGIQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "461", " Ligand_ID": "HSGIQSEPKAIP_minimized.pdb_461", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1263.4", " logP": "-9.46", " logD": "-17.68", " logSw": "0.84", " tPSA": "555.11", " RotatableB": "39", " RigidB": "41", " Flexibility": "0.49", " HBD": "20", " HBA": "34", " HBD_HBA": "54", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "0", " HeavyAtoms": "89", " CarbonAtoms": "55", " HeteroAtoms": "34", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2926651.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1263.4", "link_html_complex": "/ACE_complex_html/ACE_HSGIQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HSGIQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HSGIQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HSGIQSEPKAIP.png", "phi_psi": "/peptide_da/HSGIQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/HSGIQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HSGIQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/HSGIQSEPKAIP.png"}
{"Peptide_Sequence": "HWTTQR", " Origin": "seaweed pipefish (Syngnathus schlegeli) ", " Peptide_Preparation": "alcalase, neutrase, pepsin, papain, pronase and trypsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with slight modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.44 mg/ml ", " Reference": "Wijesekara, Isuru, et al. \"Purification and identification of antihypertensive peptides from seaweed pipefish (Syngnathus schlegeli) muscle protein hydrolysate.\" Food research international 44.3 (2011): 703-707.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "462", " Ligand_ID": "HWTTQR_minimized.pdb_462", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "827.89", " logP": "-6", " logD": "-8.51", " logSw": "0.36", " tPSA": "404.93", " RotatableB": "25", " RigidB": "29", " Flexibility": "0.46", " HBD": "18", " HBA": "23", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "59", " CarbonAtoms": "36", " HeteroAtoms": "23", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1192105.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 827.887", "link_html_complex": "/ACE_complex_html/ACE_HWTTQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HWTTQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HWTTQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HWTTQR.png", "phi_psi": "/peptide_da/HWTTQR.pdb", "link_html_peptide": "/Peptide_html/HWTTQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HWTTQR.pdb", "link_png_peptide": "/Peptide_pics/HWTTQR.png"}
{"Peptide_Sequence": "HY", " Origin": "Sake", " Peptide_Preparation": "Solid Phase Peptide Synthesis with peptide synthesizer", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung method", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "26.1", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "463", " Ligand_ID": "HY_minimized.pdb_463", " Smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "318.33", " logP": "-3.5", " logD": "-3.01", " logSw": "0.65", " tPSA": "145.78", " RotatableB": "7", " RigidB": "14", " Flexibility": "0.33", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "612722.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 318.328", "link_html_complex": "/ACE_complex_html/ACE_HY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HY.png", "phi_psi": "/peptide_da/HY.pdb", "link_html_peptide": "/Peptide_html/HY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HY.pdb", "link_png_peptide": "/Peptide_pics/HY.png"}
{"Peptide_Sequence": "HYVPV", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "998", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "464", " Ligand_ID": "HYVPV_minimized.pdb_464", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)C(O)=O", " MW": "613.71", " logP": "-0.78", " logD": "-3.54", " logSw": "-2.32", " tPSA": "224.29", " RotatableB": "14", " RigidB": "25", " Flexibility": "0.36", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "60122.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 613.705", "link_html_complex": "/ACE_complex_html/ACE_HYVPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_HYVPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_HYVPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_HYVPV.png", "phi_psi": "/peptide_da/HYVPV.pdb", "link_html_peptide": "/Peptide_html/HYVPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/HYVPV.pdb", "link_png_peptide": "/Peptide_pics/HYVPV.png"}
{"Peptide_Sequence": "IA", " Origin": "soyabean", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "IEC, GF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "153 mM", " Reference": "Wang, Wenyi, and Elvira Gonzalez De Mejia. \"A new frontier in soy bioactive peptides that may prevent age\u2010related chronic diseases.\" Comprehensive reviews in food science and food safety 4.4 (2005): 63-78.", " Binding_Energy_kcal_per_mol": "-5.8", "Serial_ID": "470", " Ligand_ID": "IA_minimized.pdb_470", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(O)=O", " MW": "202.25", " logP": "-3.14", " logD": "-2.51", " logSw": "1.21", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "9", " HeteroAtoms": "5", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "681130.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 202.251", "link_html_complex": "/ACE_complex_html/ACE_IA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IA.png", "phi_psi": "/peptide_da/IA.pdb", "link_html_peptide": "/Peptide_html/IA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IA.pdb", "link_png_peptide": "/Peptide_pics/IA.png"}
{"Peptide_Sequence": "IAE", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "34.7 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "465", " Ligand_ID": "IAE_minimized.pdb_465", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "331.36", " logP": "-3.06", " logD": "-7.84", " logSw": "0.69", " tPSA": "166.1", " RotatableB": "10", " RigidB": "6", " Flexibility": "0.63", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "662856.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 331.365", "link_html_complex": "/ACE_complex_html/ACE_IAE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAE.png", "phi_psi": "/peptide_da/IAE.pdb", "link_html_peptide": "/Peptide_html/IAE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAE.pdb", "link_png_peptide": "/Peptide_pics/IAE.png"}
{"Peptide_Sequence": "IAGRP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "25.94 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "466", " Ligand_ID": "IAGRP_minimized.pdb_466", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "512.6", " logP": "-3.61", " logD": "-8.25", " logSw": "0.25", " tPSA": "239.02", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "22", " HeteroAtoms": "14", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "655673.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.603", "link_html_complex": "/ACE_complex_html/ACE_IAGRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAGRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAGRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAGRP.png", "phi_psi": "/peptide_da/IAGRP.pdb", "link_html_peptide": "/Peptide_html/IAGRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAGRP.pdb", "link_png_peptide": "/Peptide_pics/IAGRP.png"}
{"Peptide_Sequence": "IAIP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "470", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "467", " Ligand_ID": "IAIP_minimized.pdb_467", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "412.52", " logP": "-0.98", " logD": "-3.41", " logSw": "-1.12", " tPSA": "146.28", " RotatableB": "10", " RigidB": "12", " Flexibility": "0.45", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "134564.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 412.524", "link_html_complex": "/ACE_complex_html/ACE_IAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAIP.png", "phi_psi": "/peptide_da/IAIP.pdb", "link_html_peptide": "/Peptide_html/IAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAIP.pdb", "link_png_peptide": "/Peptide_pics/IAIP.png"}
{"Peptide_Sequence": "IAIPP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "600", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "468", " Ligand_ID": "IAIPP_minimized.pdb_468", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "509.64", " logP": "-0.76", " logD": "-3.79", " logSw": "-1.79", " tPSA": "166.59", " RotatableB": "11", " RigidB": "19", " Flexibility": "0.37", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "25", " HeteroAtoms": "11", " ratio_H_by_C": "0.44", " Lipinski_Violation": "2", " Solubility_mg_per_l": "84668.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.639", "link_html_complex": "/ACE_complex_html/ACE_IAIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAIPP.png", "phi_psi": "/peptide_da/IAIPP.pdb", "link_html_peptide": "/Peptide_html/IAIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAIPP.pdb", "link_png_peptide": "/Peptide_pics/IAIPP.png"}
{"Peptide_Sequence": "IAK", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "15.7 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "469", " Ligand_ID": "IAK_minimized.pdb_469", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "330.42", " logP": "-2.79", " logD": "-4.35", " logSw": "0.6", " tPSA": "153.61", " RotatableB": "11", " RigidB": "5", " Flexibility": "0.69", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "599113.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.423", "link_html_complex": "/ACE_complex_html/ACE_IAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAK.png", "phi_psi": "/peptide_da/IAK.pdb", "link_html_peptide": "/Peptide_html/IAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAK.pdb", "link_png_peptide": "/Peptide_pics/IAK.png"}
{"Peptide_Sequence": "IAP", " Origin": "Wheat gliadin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "2.7 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "472", " Ligand_ID": "IAP_minimized.pdb_472", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "299.37", " logP": "-2.04", " logD": "-3.9", " logSw": "-0.01", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "294947.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.366", "link_html_complex": "/ACE_complex_html/ACE_IAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAP.png", "phi_psi": "/peptide_da/IAP.pdb", "link_html_peptide": "/Peptide_html/IAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAP.pdb", "link_png_peptide": "/Peptide_pics/IAP.png"}
{"Peptide_Sequence": "IAPG", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "11.4 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "471", " Ligand_ID": "IAPG_minimized.pdb_471", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "356.42", " logP": "-3.01", " logD": "-5.38", " logSw": "0.37", " tPSA": "146.28", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "518331.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.417", "link_html_complex": "/ACE_complex_html/ACE_IAPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAPG.png", "phi_psi": "/peptide_da/IAPG.pdb", "link_html_peptide": "/Peptide_html/IAPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAPG.pdb", "link_png_peptide": "/Peptide_pics/IAPG.png"}
{"Peptide_Sequence": "IAQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "473", " Ligand_ID": "IAQ_minimized.pdb_473", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "330.38", " logP": "-3.71", " logD": "-5.34", " logSw": "1.11", " tPSA": "169.06", " RotatableB": "10", " RigidB": "7", " Flexibility": "0.59", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1001433.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.38", "link_html_complex": "/ACE_complex_html/ACE_IAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAQ.png", "phi_psi": "/peptide_da/IAQ.pdb", "link_html_peptide": "/Peptide_html/IAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAQ.pdb", "link_png_peptide": "/Peptide_pics/IAQ.png"}
{"Peptide_Sequence": "IAV", " Origin": "Cuttlefish (Sepia officinalis) Muscle Proteins", " Peptide_Preparation": "Proteolytic Enzymes", " Isolation_Method": "centrifugation, filteration, Chromatography, RP-HPLC", " ACE_inhibition_assay": "Nakamura et. al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "153.4 \u03bcM", " Reference": "Balti, Rafik, et al. \"Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of cuttlefish (Sepia officinalis) muscle proteins.\" Journal of agricultural and food chemistry 58.6 (2010): 3840-3846.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "474", " Ligand_ID": "IAV_minimized.pdb_474", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "301.38", " logP": "-2.92", " logD": "-3.28", " logSw": "0.66", " tPSA": "125.97", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "582547.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.382", "link_html_complex": "/ACE_complex_html/ACE_IAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAV.png", "phi_psi": "/peptide_da/IAV.pdb", "link_html_peptide": "/Peptide_html/IAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAV.pdb", "link_png_peptide": "/Peptide_pics/IAV.png"}
{"Peptide_Sequence": "IAY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "477", " Ligand_ID": "IAY_minimized.pdb_477", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "365.42", " logP": "-2.73", " logD": "-2.84", " logSw": "0.12", " tPSA": "146.2", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "413871.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.424", "link_html_complex": "/ACE_complex_html/ACE_IAY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAY.png", "phi_psi": "/peptide_da/IAY.pdb", "link_html_peptide": "/Peptide_html/IAY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAY.pdb", "link_png_peptide": "/Peptide_pics/IAY.png"}
{"Peptide_Sequence": "IAYKP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2.93 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "476", " Ligand_ID": "IAYKP_minimized.pdb_476", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "590.71", " logP": "-1.39", " logD": "-5.41", " logSw": "-1.62", " tPSA": "223.25", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "116764.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 590.712", "link_html_complex": "/ACE_complex_html/ACE_IAYKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAYKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAYKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAYKP.png", "phi_psi": "/peptide_da/IAYKP.pdb", "link_html_peptide": "/Peptide_html/IAYKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAYKP.pdb", "link_png_peptide": "/Peptide_pics/IAYKP.png"}
{"Peptide_Sequence": "IAYKPAG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "4.17 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "475", " Ligand_ID": "IAYKPAG_minimized.pdb_475", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(O)=O", " MW": "718.84", " logP": "-2.3", " logD": "-8.46", " logSw": "-1.57", " tPSA": "281.45", " RotatableB": "20", " RigidB": "24", " Flexibility": "0.45", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "149536.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 718.841", "link_html_complex": "/ACE_complex_html/ACE_IAYKPAG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IAYKPAG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IAYKPAG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IAYKPAG.png", "phi_psi": "/peptide_da/IAYKPAG.pdb", "link_html_peptide": "/Peptide_html/IAYKPAG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IAYKPAG.pdb", "link_png_peptide": "/Peptide_pics/IAYKPAG.png"}
{"Peptide_Sequence": "ICRDL", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "478", " Ligand_ID": "ICRDL_minimized.pdb_478", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "618.75", " logP": "-3.14", " logD": "-11.16", " logSw": "-0.31", " tPSA": "326.74", " RotatableB": "21", " RigidB": "11", " Flexibility": "0.66", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "25", " HeteroAtoms": "17", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "452898.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.746", "link_html_complex": "/ACE_complex_html/ACE_ICRDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ICRDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ICRDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ICRDL.png", "phi_psi": "/peptide_da/ICRDL.pdb", "link_html_peptide": "/Peptide_html/ICRDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ICRDL.pdb", "link_png_peptide": "/Peptide_pics/ICRDL.png"}
{"Peptide_Sequence": "IDALNENK", " Origin": "milk", " Peptide_Preparation": "Tryptic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Kimand Chung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "71.2 \u03bcM        ", " Reference": "Chobert, Jean-Marc, et al. \"Angiotensin I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine $\\beta $-lactoglobulin and of milk yoghurts obtained by using different starters.\" Le Lait 85.3 (2005): 141-152.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "479", " Ligand_ID": "IDALNENK_minimized.pdb_479", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "915.99", " logP": "-9.06", " logD": "-14.97", " logSw": "2.23", " tPSA": "465.55", " RotatableB": "31", " RigidB": "21", " Flexibility": "0.6", " HBD": "18", " HBA": "26", " HBD_HBA": "44", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "64", " CarbonAtoms": "38", " HeteroAtoms": "26", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8558504.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 915.987", "link_html_complex": "/ACE_complex_html/ACE_IDALNENK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IDALNENK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IDALNENK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IDALNENK.png", "phi_psi": "/peptide_da/IDALNENK.pdb", "link_html_peptide": "/Peptide_html/IDALNENK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IDALNENK.pdb", "link_png_peptide": "/Peptide_pics/IDALNENK.png"}
{"Peptide_Sequence": "IDPNG", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " QSAR models (Hellberg et al., 1991, Wu et al., 2006a, Wu et al., 2006b)", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "8.4 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "480", " Ligand_ID": "IDPNG_minimized.pdb_480", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O", " MW": "514.53", " logP": "-5.18", " logD": "-10.27", " logSw": "1.16", " tPSA": "258.6", " RotatableB": "14", " RigidB": "17", " Flexibility": "0.45", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "36", " CarbonAtoms": "21", " HeteroAtoms": "15", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1636917.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 514.529", "link_html_complex": "/ACE_complex_html/ACE_IDPNG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IDPNG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IDPNG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IDPNG.png", "phi_psi": "/peptide_da/IDPNG.pdb", "link_html_peptide": "/Peptide_html/IDPNG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IDPNG.pdb", "link_png_peptide": "/Peptide_pics/IDPNG.png"}
{"Peptide_Sequence": "IE", " Origin": "milk", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "484", " Ligand_ID": "IE_minimized.pdb_484", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "260.29", " logP": "-3.55", " logD": "-6", " logSw": "1.31", " tPSA": "137", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "965364.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 260.287", "link_html_complex": "/ACE_complex_html/ACE_IE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IE.png", "phi_psi": "/peptide_da/IE.pdb", "link_html_peptide": "/Peptide_html/IE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IE.pdb", "link_png_peptide": "/Peptide_pics/IE.png"}
{"Peptide_Sequence": "IEF", " Origin": "Chicken muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " QSAR models (Hellberg et al., 1991, Wu et al., 2006a, Wu et al., 2006b)", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.8 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "482", " Ligand_ID": "IEF_minimized.pdb_482", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "407.46", " logP": "-1.45", " logD": "-5.76", " logSw": "-0.74", " tPSA": "166.1", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "194929.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 407.461", "link_html_complex": "/ACE_complex_html/ACE_IEF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEF.png", "phi_psi": "/peptide_da/IEF.pdb", "link_html_peptide": "/Peptide_html/IEF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEF.pdb", "link_png_peptide": "/Peptide_pics/IEF.png"}
{"Peptide_Sequence": "IEFEQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "481", " Ligand_ID": "IEFEQ_minimized.pdb_481", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "664.7", " logP": "-4.67", " logD": "-11.75", " logSw": "0.38", " tPSA": "307.52", " RotatableB": "22", " RigidB": "19", " Flexibility": "0.54", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "976022.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 664.704", "link_html_complex": "/ACE_complex_html/ACE_IEFEQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEFEQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEFEQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEFEQ.png", "phi_psi": "/peptide_da/IEFEQ.pdb", "link_html_peptide": "/Peptide_html/IEFEQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEFEQ.pdb", "link_png_peptide": "/Peptide_pics/IEFEQ.png"}
{"Peptide_Sequence": "IELPLG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "72.4 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "483", " Ligand_ID": "IELPLG_minimized.pdb_483", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O", " MW": "640.77", " logP": "-2.42", " logD": "-6.87", " logSw": "-1.03", " tPSA": "244.61", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "227807.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 640.769", "link_html_complex": "/ACE_complex_html/ACE_IELPLG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IELPLG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IELPLG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IELPLG.png", "phi_psi": "/peptide_da/IELPLG.pdb", "link_html_peptide": "/Peptide_html/IELPLG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IELPLG.pdb", "link_png_peptide": "/Peptide_pics/IELPLG.png"}
{"Peptide_Sequence": "IEP", " Origin": "arachin", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "18 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure\u2013activity relationship.\" Peptides 31.6 (2010): 1165-1176.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "485", " Ligand_ID": "IEP_minimized.pdb_485", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "357.4", " logP": "-3.41", " logD": "-7.14", " logSw": "0.69", " tPSA": "157.31", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "710002.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 357.402", "link_html_complex": "/ACE_complex_html/ACE_IEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEP.png", "phi_psi": "/peptide_da/IEP.pdb", "link_html_peptide": "/Peptide_html/IEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEP.pdb", "link_png_peptide": "/Peptide_pics/IEP.png"}
{"Peptide_Sequence": "IETWNPNNQ", " Origin": "Arachin", " Peptide_Preparation": "Proteases trypsin, chymotrypsin, pepsin and pancreatin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "72 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion.\" Food chemistry 125.2 (2011): 561-569.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "486", " Ligand_ID": "IETWNPNNQ_minimized.pdb_486", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1115.15", " logP": "-8.53", " logD": "-14.84", " logSw": "0.56", " tPSA": "540.29", " RotatableB": "30", " RigidB": "41", " Flexibility": "0.42", " HBD": "21", " HBA": "31", " HBD_HBA": "52", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "79", " CarbonAtoms": "48", " HeteroAtoms": "31", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1943023.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1115.15", "link_html_complex": "/ACE_complex_html/ACE_IETWNPNNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IETWNPNNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IETWNPNNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IETWNPNNQ.png", "phi_psi": "/peptide_da/IETWNPNNQ.pdb", "link_html_peptide": "/Peptide_html/IETWNPNNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IETWNPNNQ.pdb", "link_png_peptide": "/Peptide_pics/IETWNPNNQ.png"}
{"Peptide_Sequence": "IEW", " Origin": "arachin", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "104 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure\u2013activity relationship.\" Peptides 31.6 (2010): 1165-1176.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "488", " Ligand_ID": "IEW_minimized.pdb_488", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "446.5", " logP": "-1.58", " logD": "-5.61", " logSw": "-0.93", " tPSA": "181.89", " RotatableB": "12", " RigidB": "16", " Flexibility": "0.43", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "176466.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 446.497", "link_html_complex": "/ACE_complex_html/ACE_IEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEW.png", "phi_psi": "/peptide_da/IEW.pdb", "link_html_peptide": "/Peptide_html/IEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEW.pdb", "link_png_peptide": "/Peptide_pics/IEW.png"}
{"Peptide_Sequence": "IEWEG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "487", " Ligand_ID": "IEWEG_minimized.pdb_487", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O", " MW": "632.66", " logP": "-3.73", " logD": "-11.04", " logSw": "-0.24", " tPSA": "280.22", " RotatableB": "19", " RigidB": "21", " Flexibility": "0.47", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "499185.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 632.662", "link_html_complex": "/ACE_complex_html/ACE_IEWEG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEWEG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEWEG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEWEG.png", "phi_psi": "/peptide_da/IEWEG.pdb", "link_html_peptide": "/Peptide_html/IEWEG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEWEG.pdb", "link_png_peptide": "/Peptide_pics/IEWEG.png"}
{"Peptide_Sequence": "IEY", " Origin": "arachin", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "182 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure\u2013activity relationship.\" Peptides 31.6 (2010): 1165-1176.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "489", " Ligand_ID": "IEY_minimized.pdb_489", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "423.46", " logP": "-3.25", " logD": "-6.1", " logSw": "0.3", " tPSA": "186.33", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "570921.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 423.46", "link_html_complex": "/ACE_complex_html/ACE_IEY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IEY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IEY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IEY.png", "phi_psi": "/peptide_da/IEY.pdb", "link_html_peptide": "/Peptide_html/IEY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IEY.pdb", "link_png_peptide": "/Peptide_pics/IEY.png"}
{"Peptide_Sequence": "IF", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "930 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "492", " Ligand_ID": "IF_minimized.pdb_492", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "278.35", " logP": "-1.81", " logD": "-0.86", " logSw": "-0.07", " tPSA": "96.87", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "15", " HeteroAtoms": "5", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "259745.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 278.347", "link_html_complex": "/ACE_complex_html/ACE_IF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IF.png", "phi_psi": "/peptide_da/IF.pdb", "link_html_peptide": "/Peptide_html/IF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IF.pdb", "link_png_peptide": "/Peptide_pics/IF.png"}
{"Peptide_Sequence": "IFENLQN", " Origin": " pea seed (Pisum sativum L.)", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "Udenigwe, Lin, Hou, & Aluko, 2009", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Aluko, Rotimi E., et al. \"Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides.\" Food Research International 77 (2015): 10-16.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "490", " Ligand_ID": "IFENLQN_minimized.pdb_490", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "876.95", " logP": "-5", " logD": "-11.6", " logSw": "-0.38", " tPSA": "411.77", " RotatableB": "27", " RigidB": "26", " Flexibility": "0.51", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "62", " CarbonAtoms": "39", " HeteroAtoms": "23", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "598814.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 876.953", "link_html_complex": "/ACE_complex_html/ACE_IFENLQN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IFENLQN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IFENLQN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IFENLQN.png", "phi_psi": "/peptide_da/IFENLQN.pdb", "link_html_peptide": "/Peptide_html/IFENLQN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IFENLQN.pdb", "link_png_peptide": "/Peptide_pics/IFENLQN.png"}
{"Peptide_Sequence": "IFL", " Origin": "Soybean (Tofoyu)", " Peptide_Preparation": "pepsin, chymotrypsin, trypsin", " Isolation_Method": "RPC, IEC, RP-HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "44.8 \u03bcM", " Reference": "Kuba, Megumi, et al. \"Angiotensin I-converting enzyme inhibitory peptides isolated from tofuyo fermented soybean food.\" Bioscience, biotechnology, and biochemistry 67.6 (2003): 1278-1283.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "491", " Ligand_ID": "IFL_minimized.pdb_491", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "391.5", " logP": "-1.06", " logD": "-1.24", " logSw": "-0.95", " tPSA": "125.97", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "21", " HeteroAtoms": "7", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "151969.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.504", "link_html_complex": "/ACE_complex_html/ACE_IFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IFL.png", "phi_psi": "/peptide_da/IFL.pdb", "link_html_peptide": "/Peptide_html/IFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IFL.pdb", "link_png_peptide": "/Peptide_pics/IFL.png"}
{"Peptide_Sequence": "IFVPA", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.9 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "494", " Ligand_ID": "IFVPA_minimized.pdb_494", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "545.67", " logP": "-1.54", " logD": "-2.86", " logSw": "-1.45", " tPSA": "175.38", " RotatableB": "13", " RigidB": "20", " Flexibility": "0.39", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "28", " HeteroAtoms": "11", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "128112.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 545.671", "link_html_complex": "/ACE_complex_html/ACE_IFVPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IFVPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IFVPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IFVPA.png", "phi_psi": "/peptide_da/IFVPA.pdb", "link_html_peptide": "/Peptide_html/IFVPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IFVPA.pdb", "link_png_peptide": "/Peptide_pics/IFVPA.png"}
{"Peptide_Sequence": "IFVPAF", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.4 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "493", " Ligand_ID": "IFVPAF_minimized.pdb_493", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "692.84", " logP": "-0.2", " logD": "-1.71", " logSw": "-2.97", " tPSA": "204.48", " RotatableB": "17", " RigidB": "28", " Flexibility": "0.38", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "37", " HeteroAtoms": "13", " ratio_H_by_C": "0.35", " Lipinski_Violation": "3", " Solubility_mg_per_l": "35378.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 692.845", "link_html_complex": "/ACE_complex_html/ACE_IFVPAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IFVPAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IFVPAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IFVPAF.png", "phi_psi": "/peptide_da/IFVPAF.pdb", "link_html_peptide": "/Peptide_html/IFVPAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IFVPAF.pdb", "link_png_peptide": "/Peptide_pics/IFVPAF.png"}
{"Peptide_Sequence": "IG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1200 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "498", " Ligand_ID": "IG_minimized.pdb_498", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(O)=O", " MW": "188.22", " logP": "-2.5", " logD": "-3.08", " logSw": "0.9", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "462036.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 188.224", "link_html_complex": "/ACE_complex_html/ACE_IG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IG.png", "phi_psi": "/peptide_da/IG.pdb", "link_html_peptide": "/Peptide_html/IG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IG.pdb", "link_png_peptide": "/Peptide_pics/IG.png"}
{"Peptide_Sequence": "IGDEPLANYL", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.070 mg/ml", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "495", " Ligand_ID": "IGDEPLANYL_minimized.pdb_495", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "1104.21", " logP": "-3.08", " logD": "-13.74", " logSw": "-2.6", " tPSA": "464.46", " RotatableB": "33", " RigidB": "34", " Flexibility": "0.49", " HBD": "16", " HBA": "28", " HBD_HBA": "44", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "78", " CarbonAtoms": "50", " HeteroAtoms": "28", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "82313.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1104.21", "link_html_complex": "/ACE_complex_html/ACE_IGDEPLANYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGDEPLANYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGDEPLANYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGDEPLANYL.png", "phi_psi": "/peptide_da/IGDEPLANYL.pdb", "link_html_peptide": "/Peptide_html/IGDEPLANYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGDEPLANYL.pdb", "link_png_peptide": "/Peptide_pics/IGDEPLANYL.png"}
{"Peptide_Sequence": "IGGSI", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "496", " Ligand_ID": "IGGSI_minimized.pdb_496", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O", " MW": "445.51", " logP": "-3.95", " logD": "-6.47", " logSw": "0.81", " tPSA": "204.4", " RotatableB": "14", " RigidB": "9", " Flexibility": "0.61", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "19", " HeteroAtoms": "12", " ratio_H_by_C": "0.63", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1001802.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 445.51", "link_html_complex": "/ACE_complex_html/ACE_IGGSI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGGSI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGGSI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGGSI.png", "phi_psi": "/peptide_da/IGGSI.pdb", "link_html_peptide": "/Peptide_html/IGGSI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGGSI.pdb", "link_png_peptide": "/Peptide_pics/IGGSI.png"}
{"Peptide_Sequence": "IGKGG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "497", " Ligand_ID": "IGKGG_minimized.pdb_497", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(O)=O", " MW": "430.5", " logP": "-4.13", " logD": "-10.14", " logSw": "1.08", " tPSA": "211.81", " RotatableB": "15", " RigidB": "9", " Flexibility": "0.63", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1271243.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 430.499", "link_html_complex": "/ACE_complex_html/ACE_IGKGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGKGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGKGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGKGG.png", "phi_psi": "/peptide_da/IGKGG.pdb", "link_html_peptide": "/Peptide_html/IGKGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGKGG.pdb", "link_png_peptide": "/Peptide_pics/IGKGG.png"}
{"Peptide_Sequence": "IGSENSEKTTMP", " Origin": "bovine sodium caseinate", " Peptide_Preparation": "fermentatation, Lactobacillus animalis ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Roy et al.(2000)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "51.37 \u03bcM", " Reference": "Hayes, M., et al. \"Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.\" Appl. Environ. Microbiol. 73.14 (2007): 4658-4667.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "499", " Ligand_ID": "IGSENSEKTTMP_minimized.pdb_499", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1293.4", " logP": "-12.32", " logD": "-23.98", " logSw": "2.74", " tPSA": "636.29", " RotatableB": "43", " RigidB": "32", " Flexibility": "0.57", " HBD": "23", " HBA": "36", " HBD_HBA": "59", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "89", " CarbonAtoms": "52", " HeteroAtoms": "37", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "20041206.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "14", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1293.4", "link_html_complex": "/ACE_complex_html/ACE_IGSENSEKTTMP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGSENSEKTTMP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGSENSEKTTMP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGSENSEKTTMP.png", "phi_psi": "/peptide_da/IGSENSEKTTMP.pdb", "link_html_peptide": "/Peptide_html/IGSENSEKTTMP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGSENSEKTTMP.pdb", "link_png_peptide": "/Peptide_pics/IGSENSEKTTMP.png"}
{"Peptide_Sequence": "IGW", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "500", " Ligand_ID": "IGW_minimized.pdb_500", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "374.43", " logP": "-1.26", " logD": "-2.97", " logSw": "-0.9", " tPSA": "141.76", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "152332.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.434", "link_html_complex": "/ACE_complex_html/ACE_IGW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGW.png", "phi_psi": "/peptide_da/IGW.pdb", "link_html_peptide": "/Peptide_html/IGW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGW.pdb", "link_png_peptide": "/Peptide_pics/IGW.png"}
{"Peptide_Sequence": "IGYNQ", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "501", " Ligand_ID": "IGYNQ_minimized.pdb_501", " Smiles": "CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "593.63", " logP": "-5.93", " logD": "-7.51", " logSw": "1.28", " tPSA": "290.58", " RotatableB": "17", " RigidB": "19", " Flexibility": "0.47", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "26", " HeteroAtoms": "16", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2140593.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 593.629", "link_html_complex": "/ACE_complex_html/ACE_IGYNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IGYNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IGYNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IGYNQ.png", "phi_psi": "/peptide_da/IGYNQ.pdb", "link_html_peptide": "/Peptide_html/IGYNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IGYNQ.pdb", "link_png_peptide": "/Peptide_pics/IGYNQ.png"}
{"Peptide_Sequence": "IHF", " Origin": "milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "502", " Ligand_ID": "IHF_minimized.pdb_502", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "415.49", " logP": "-2.61", " logD": "-2.83", " logSw": "-0.18", " tPSA": "154.65", " RotatableB": "11", " RigidB": "16", " Flexibility": "0.41", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "345768.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.486", "link_html_complex": "/ACE_complex_html/ACE_IHF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IHF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IHF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IHF.png", "phi_psi": "/peptide_da/IHF.pdb", "link_html_peptide": "/Peptide_html/IHF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IHF.pdb", "link_png_peptide": "/Peptide_pics/IHF.png"}
{"Peptide_Sequence": "IHP", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "505", " Ligand_ID": "IHP_minimized.pdb_505", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "365.43", " logP": "-2.72", " logD": "-4.22", " logSw": "0.07", " tPSA": "145.86", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "390413.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.427", "link_html_complex": "/ACE_complex_html/ACE_IHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IHP.png", "phi_psi": "/peptide_da/IHP.pdb", "link_html_peptide": "/Peptide_html/IHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IHP.pdb", "link_png_peptide": "/Peptide_pics/IHP.png"}
{"Peptide_Sequence": "IHPF", " Origin": "Normotensive human plasma", " Peptide_Preparation": "", " Isolation_Method": "UF, HPLC", " ACE_inhibition_assay": "H. matsufugi et al. 1995", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Matsui, Toshiro, et al. \"Determination of endogenous peptides with in vitro ACE inhibitory activity in normotensive human plasma by the fluorometric HPLC method.\" Bioscience, biotechnology, and biochemistry 61.6 (1997): 1052-1054.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "504", " Ligand_ID": "IHPF_minimized.pdb_504", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "512.6", " logP": "-0.78", " logD": "-3.64", " logSw": "-1.85", " tPSA": "174.96", " RotatableB": "12", " RigidB": "23", " Flexibility": "0.34", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "26", " HeteroAtoms": "11", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "80904.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.601", "link_html_complex": "/ACE_complex_html/ACE_IHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IHPF.png", "phi_psi": "/peptide_da/IHPF.pdb", "link_html_peptide": "/Peptide_html/IHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IHPF.pdb", "link_png_peptide": "/Peptide_pics/IHPF.png"}
{"Peptide_Sequence": "IHPFAQTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "19", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1500.7", "link_html_complex": "/ACE_complex_html/ACE_IHPFAQTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IHPFAQTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IHPFAQTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IHPFAQTQSLVYP.png", "phi_psi": "/peptide_da/IHPFAQTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/IHPFAQTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IHPFAQTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/IHPFAQTQSLVYP.png"}
{"Peptide_Sequence": "IHY", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "506", " Ligand_ID": "IHY_minimized.pdb_506", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "431.49", " logP": "-2.97", " logD": "-3.15", " logSw": "-0.05", " tPSA": "174.88", " RotatableB": "11", " RigidB": "16", " Flexibility": "0.41", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "21", " HeteroAtoms": "10", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "408894.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 431.485", "link_html_complex": "/ACE_complex_html/ACE_IHY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IHY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IHY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IHY.png", "phi_psi": "/peptide_da/IHY.pdb", "link_html_peptide": "/Peptide_html/IHY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IHY.pdb", "link_png_peptide": "/Peptide_pics/IHY.png"}
{"Peptide_Sequence": "IIAEK", " Origin": "bovine \u03b2-lactoglobulin", " Peptide_Preparation": "trypsin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "63.70 \u03bcM", " Reference": "Power, O., et al. \"Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of \u03b2-lactoglobulin.\" journal of functional foods 9 (2014): 38-47.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "507", " Ligand_ID": "IIAEK_minimized.pdb_507", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "572.69", " logP": "-6.1", " logD": "-6.64", " logSw": "1.77", " tPSA": "251.94", " RotatableB": "20", " RigidB": "10", " Flexibility": "0.67", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "26", " HeteroAtoms": "14", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3369924.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 572.695", "link_html_complex": "/ACE_complex_html/ACE_IIAEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IIAEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IIAEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IIAEK.png", "phi_psi": "/peptide_da/IIAEK.pdb", "link_html_peptide": "/Peptide_html/IIAEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IIAEK.pdb", "link_png_peptide": "/Peptide_pics/IIAEK.png"}
{"Peptide_Sequence": "IIAMK", " Origin": "Buffalo colostrum Beta Lactoglobulin", " Peptide_Preparation": "trypsin", " Isolation_Method": "HPLC, LC-MS", " ACE_inhibition_assay": "Jimsheena and Gowda (2009)", " In-vivo_or_in-vitro": "in-vitro. in-silico", " IC50_micromol_per_L": "498 \u03bcM", " Reference": "Rohit, A. C., K. Sathisha, and H. S. Aparna. \"A variant peptide of buffalo colostrum \u03b2-lactoglobulin inhibits angiotensin I-converting enzyme activity.\" European journal of medicinal chemistry 53 (2012): 211-219.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "508", " Ligand_ID": "IIAMK_minimized.pdb_508", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "574.78", " logP": "-2.67", " logD": "-3.44", " logSw": "-0.4", " tPSA": "237.11", " RotatableB": "20", " RigidB": "9", " Flexibility": "0.69", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "384700.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 574.777", "link_html_complex": "/ACE_complex_html/ACE_IIAMK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IIAMK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IIAMK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IIAMK.png", "phi_psi": "/peptide_da/IIAMK.pdb", "link_html_peptide": "/Peptide_html/IIAMK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IIAMK.pdb", "link_png_peptide": "/Peptide_pics/IIAMK.png"}
{"Peptide_Sequence": "IIP", " Origin": "Sweet-potato protein isolate", " Peptide_Preparation": "", " Isolation_Method": "Absorption Chromatography, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "80.8 \u03bcM", " Reference": "Ishiguro, Koji, et al. \"Hypotensive effect of a sweetpotato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides.\" Food chemistry 131.3 (2012): 774-779.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "510", " Ligand_ID": "IIP_minimized.pdb_510", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "341.45", " logP": "-0.72", " logD": "-2.55", " logSw": "-0.98", " tPSA": "117.18", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "128743.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 341.446", "link_html_complex": "/ACE_complex_html/ACE_IIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IIP.png", "phi_psi": "/peptide_da/IIP.pdb", "link_html_peptide": "/Peptide_html/IIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IIP.pdb", "link_png_peptide": "/Peptide_pics/IIP.png"}
{"Peptide_Sequence": "IIPLEN", " Origin": " pea seed (Pisum sativum L.)", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "Udenigwe, Lin, Hou, & Aluko, 2009", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Aluko, Rotimi E., et al. \"Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides.\" Food Research International 77 (2015): 10-16.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "509", " Ligand_ID": "IIPLEN_minimized.pdb_509", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "697.82", " logP": "-3.73", " logD": "-8.54", " logSw": "-0.43", " tPSA": "287.7", " RotatableB": "21", " RigidB": "19", " Flexibility": "0.53", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "49", " CarbonAtoms": "32", " HeteroAtoms": "17", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "453673.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 697.82", "link_html_complex": "/ACE_complex_html/ACE_IIPLEN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IIPLEN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IIPLEN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IIPLEN.png", "phi_psi": "/peptide_da/IIPLEN.pdb", "link_html_peptide": "/Peptide_html/IIPLEN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IIPLEN.pdb", "link_png_peptide": "/Peptide_pics/IIPLEN.png"}
{"Peptide_Sequence": "IITNW", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "30.96 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "511", " Ligand_ID": "IITNW_minimized.pdb_511", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "645.75", " logP": "-2.19", " logD": "-4.65", " logSw": "-1.35", " tPSA": "263.28", " RotatableB": "18", " RigidB": "21", " Flexibility": "0.46", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "167815.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 645.747", "link_html_complex": "/ACE_complex_html/ACE_IITNW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IITNW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IITNW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IITNW.png", "phi_psi": "/peptide_da/IITNW.pdb", "link_html_peptide": "/Peptide_html/IITNW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IITNW.pdb", "link_png_peptide": "/Peptide_pics/IITNW.png"}
{"Peptide_Sequence": "IKD", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "512", " Ligand_ID": "IKD_minimized.pdb_512", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "374.43", " logP": "-5.57", " logD": "-8.81", " logSw": "2.21", " tPSA": "193.74", " RotatableB": "13", " RigidB": "6", " Flexibility": "0.68", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "3398296.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.433", "link_html_complex": "/ACE_complex_html/ACE_IKD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKD.png", "phi_psi": "/peptide_da/IKD.pdb", "link_html_peptide": "/Peptide_html/IKD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKD.pdb", "link_png_peptide": "/Peptide_pics/IKD.png"}
{"Peptide_Sequence": "IKELQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "513", " Ligand_ID": "IKELQ_minimized.pdb_513", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "629.75", " logP": "-5.56", " logD": "-11.82", " logSw": "1.28", " tPSA": "295.03", " RotatableB": "23", " RigidB": "12", " Flexibility": "0.66", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2256772.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 629.746", "link_html_complex": "/ACE_complex_html/ACE_IKELQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKELQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKELQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKELQ.png", "phi_psi": "/peptide_da/IKELQ.pdb", "link_html_peptide": "/Peptide_html/IKELQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKELQ.pdb", "link_png_peptide": "/Peptide_pics/IKELQ.png"}
{"Peptide_Sequence": "IKF", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "514", " Ligand_ID": "IKF_minimized.pdb_514", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "406.52", " logP": "-1.23", " logD": "-4.28", " logSw": "-0.8", " tPSA": "153.61", " RotatableB": "13", " RigidB": "11", " Flexibility": "0.54", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "183027.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.519", "link_html_complex": "/ACE_complex_html/ACE_IKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKF.png", "phi_psi": "/peptide_da/IKF.pdb", "link_html_peptide": "/Peptide_html/IKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKF.pdb", "link_png_peptide": "/Peptide_pics/IKF.png"}
{"Peptide_Sequence": "IKH", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "515", " Ligand_ID": "IKH_minimized.pdb_515", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "396.48", " logP": "-2.66", " logD": "-6.36", " logSw": "0.17", " tPSA": "182.29", " RotatableB": "13", " RigidB": "10", " Flexibility": "0.57", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "471805.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 396.484", "link_html_complex": "/ACE_complex_html/ACE_IKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKH.png", "phi_psi": "/peptide_da/IKH.pdb", "link_html_peptide": "/Peptide_html/IKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKH.pdb", "link_png_peptide": "/Peptide_pics/IKH.png"}
{"Peptide_Sequence": "IKL", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "516", " Ligand_ID": "IKL_minimized.pdb_516", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "372.5", " logP": "-1.47", " logD": "-4.68", " logSw": "-0.37", " tPSA": "153.61", " RotatableB": "13", " RigidB": "5", " Flexibility": "0.72", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "258482.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 372.503", "link_html_complex": "/ACE_complex_html/ACE_IKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKL.png", "phi_psi": "/peptide_da/IKL.pdb", "link_html_peptide": "/Peptide_html/IKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKL.pdb", "link_png_peptide": "/Peptide_pics/IKL.png"}
{"Peptide_Sequence": "IKLPP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "193.9 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "517", " Ligand_ID": "IKLPP_minimized.pdb_517", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "566.73", " logP": "-2.69", " logD": "-6.6", " logSw": "-0.67", " tPSA": "194.23", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "28", " HeteroAtoms": "12", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "290279.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 566.733", "link_html_complex": "/ACE_complex_html/ACE_IKLPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKLPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKLPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKLPP.png", "phi_psi": "/peptide_da/IKLPP.pdb", "link_html_peptide": "/Peptide_html/IKLPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKLPP.pdb", "link_png_peptide": "/Peptide_pics/IKLPP.png"}
{"Peptide_Sequence": "IKN", " Origin": "milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "518", " Ligand_ID": "IKN_minimized.pdb_518", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "373.45", " logP": "-3.94", " logD": "-7.39", " logSw": "1.18", " tPSA": "196.7", " RotatableB": "13", " RigidB": "7", " Flexibility": "0.65", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1221215.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 373.448", "link_html_complex": "/ACE_complex_html/ACE_IKN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKN.png", "phi_psi": "/peptide_da/IKN.pdb", "link_html_peptide": "/Peptide_html/IKN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKN.pdb", "link_png_peptide": "/Peptide_pics/IKN.png"}
{"Peptide_Sequence": "IKP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.7 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "521", " Ligand_ID": "IKP_minimized.pdb_521", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.46", " logP": "-3.14", " logD": "-5.66", " logSw": "0.59", " tPSA": "144.82", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "641859.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.46", "link_html_complex": "/ACE_complex_html/ACE_IKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKP.png", "phi_psi": "/peptide_da/IKP.pdb", "link_html_peptide": "/Peptide_html/IKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKP.pdb", "link_png_peptide": "/Peptide_pics/IKP.png"}
{"Peptide_Sequence": "IKPLDY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "42.6 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "519", " Ligand_ID": "IKPLDY_minimized.pdb_519", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "747.88", " logP": "-3.47", " logD": "-10.06", " logSw": "-0.88", " tPSA": "292.48", " RotatableB": "22", " RigidB": "23", " Flexibility": "0.49", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "310483.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.879", "link_html_complex": "/ACE_complex_html/ACE_IKPLDY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKPLDY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKPLDY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKPLDY.png", "phi_psi": "/peptide_da/IKPLDY.pdb", "link_html_peptide": "/Peptide_html/IKPLDY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKPLDY.pdb", "link_png_peptide": "/Peptide_pics/IKPLDY.png"}
{"Peptide_Sequence": "IKPLNY", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "43 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "520", " Ligand_ID": "IKPLNY_minimized.pdb_520", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "746.89", " logP": "-1.84", " logD": "-7.55", " logSw": "-1.9", " tPSA": "295.44", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "111763.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 746.894", "link_html_complex": "/ACE_complex_html/ACE_IKPLNY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKPLNY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKPLNY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKPLNY.png", "phi_psi": "/peptide_da/IKPLNY.pdb", "link_html_peptide": "/Peptide_html/IKPLNY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKPLNY.pdb", "link_png_peptide": "/Peptide_pics/IKPLNY.png"}
{"Peptide_Sequence": "IKPVQ", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung modified by Hern\u03bcndez-Ledesmaet al", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "33.5 \u03bcM", " Reference": "Jing, Tao, et al. \"Rational design of angiotensin\u2010I\u2010converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.\" ChemMedChem 8.7 (2013): 1057-1066.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "522", " Ligand_ID": "IKPVQ_minimized.pdb_522", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "583.72", " logP": "-4.53", " logD": "-8.41", " logSw": "0.58", " tPSA": "246.11", " RotatableB": "18", " RigidB": "16", " Flexibility": "0.53", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1045504.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 583.721", "link_html_complex": "/ACE_complex_html/ACE_IKPVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKPVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKPVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKPVQ.png", "phi_psi": "/peptide_da/IKPVQ.pdb", "link_html_peptide": "/Peptide_html/IKPVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKPVQ.pdb", "link_png_peptide": "/Peptide_pics/IKPVQ.png"}
{"Peptide_Sequence": "IKW", " Origin": "chicken muscle", " Peptide_Preparation": "creatine kinase, thermolysin", " Isolation_Method": "ODS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.21", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "524", " Ligand_ID": "IKW_minimized.pdb_524", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "445.56", " logP": "-1.31", " logD": "-4.18", " logSw": "-1.02", " tPSA": "169.4", " RotatableB": "13", " RigidB": "15", " Flexibility": "0.46", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "23", " HeteroAtoms": "9", " ratio_H_by_C": "0.39", " Lipinski_Violation": "1", " Solubility_mg_per_l": "160898.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 445.555", "link_html_complex": "/ACE_complex_html/ACE_IKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKW.png", "phi_psi": "/peptide_da/IKW.pdb", "link_html_peptide": "/Peptide_html/IKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKW.pdb", "link_png_peptide": "/Peptide_pics/IKW.png"}
{"Peptide_Sequence": "IKWGD", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "523", " Ligand_ID": "IKWGD_minimized.pdb_523", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "617.69", " logP": "-6.09", " logD": "-10.54", " logSw": "1.34", " tPSA": "267.73", " RotatableB": "19", " RigidB": "20", " Flexibility": "0.49", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "29", " HeteroAtoms": "15", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2369512.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.694", "link_html_complex": "/ACE_complex_html/ACE_IKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKWGD.png", "phi_psi": "/peptide_da/IKWGD.pdb", "link_html_peptide": "/Peptide_html/IKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKWGD.pdb", "link_png_peptide": "/Peptide_pics/IKWGD.png"}
{"Peptide_Sequence": "IKY", " Origin": "arachin", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "34 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure\u2013activity relationship.\" Peptides 31.6 (2010): 1165-1176.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "525", " Ligand_ID": "IKY_minimized.pdb_525", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "422.52", " logP": "-2.97", " logD": "-4.59", " logSw": "0.2", " tPSA": "173.84", " RotatableB": "13", " RigidB": "11", " Flexibility": "0.54", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "516122.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.518", "link_html_complex": "/ACE_complex_html/ACE_IKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IKY.png", "phi_psi": "/peptide_da/IKY.pdb", "link_html_peptide": "/Peptide_html/IKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IKY.pdb", "link_png_peptide": "/Peptide_pics/IKY.png"}
{"Peptide_Sequence": "IL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "526", " Ligand_ID": "IL_minimized.pdb_526", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "244.33", " logP": "-1.71", " logD": "-1.26", " logSw": "0.18", " tPSA": "96.87", " RotatableB": "7", " RigidB": "3", " Flexibility": "0.7", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "12", " HeteroAtoms": "5", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "293821.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 244.33", "link_html_complex": "/ACE_complex_html/ACE_IL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IL.png", "phi_psi": "/peptide_da/IL.pdb", "link_html_peptide": "/Peptide_html/IL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IL.pdb", "link_png_peptide": "/Peptide_pics/IL.png"}
{"Peptide_Sequence": "ILP", " Origin": "Bonito", " Peptide_Preparation": "synthetic peptide", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.5", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "527", " Ligand_ID": "ILP_minimized.pdb_527", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "341.45", " logP": "-1.58", " logD": "-2.63", " logSw": "-0.43", " tPSA": "117.18", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "221323.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 341.446", "link_html_complex": "/ACE_complex_html/ACE_ILP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ILP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ILP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ILP.png", "phi_psi": "/peptide_da/ILP.pdb", "link_html_peptide": "/Peptide_html/ILP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ILP.pdb", "link_png_peptide": "/Peptide_pics/ILP.png"}
{"Peptide_Sequence": "IMVAEAR", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "84.12 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "528", " Ligand_ID": "IMVAEAR_minimized.pdb_528", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "788.96", " logP": "-2.93", " logD": "-8.48", " logSw": "-1.1", " tPSA": "371.44", " RotatableB": "27", " RigidB": "15", " Flexibility": "0.64", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "33", " HeteroAtoms": "21", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "261670.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 788.956", "link_html_complex": "/ACE_complex_html/ACE_IMVAEAR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IMVAEAR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IMVAEAR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IMVAEAR.png", "phi_psi": "/peptide_da/IMVAEAR.pdb", "link_html_peptide": "/Peptide_html/IMVAEAR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IMVAEAR.pdb", "link_png_peptide": "/Peptide_pics/IMVAEAR.png"}
{"Peptide_Sequence": "IMY", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.8 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "529", " Ligand_ID": "IMY_minimized.pdb_529", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "425.54", " logP": "-2.09", " logD": "-2.18", " logSw": "-0.44", " tPSA": "171.5", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "273062.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 425.542", "link_html_complex": "/ACE_complex_html/ACE_IMY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IMY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IMY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IMY.png", "phi_psi": "/peptide_da/IMY.pdb", "link_html_peptide": "/Peptide_html/IMY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IMY.pdb", "link_png_peptide": "/Peptide_pics/IMY.png"}
{"Peptide_Sequence": "INDPF", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "530", " Ligand_ID": "INDPF_minimized.pdb_530", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "604.65", " logP": "-3.19", " logD": "-8.99", " logSw": "-0.58", " tPSA": "258.6", " RotatableB": "16", " RigidB": "23", " Flexibility": "0.41", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "28", " HeteroAtoms": "15", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "339684.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 604.652", "link_html_complex": "/ACE_complex_html/ACE_INDPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_INDPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_INDPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_INDPF.png", "phi_psi": "/peptide_da/INDPF.pdb", "link_html_peptide": "/Peptide_html/INDPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/INDPF.pdb", "link_png_peptide": "/Peptide_pics/INDPF.png"}
{"Peptide_Sequence": "INF", " Origin": "milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "531", " Ligand_ID": "INF_minimized.pdb_531", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "392.45", " logP": "-2.64", " logD": "-3.97", " logSw": "0.04", " tPSA": "169.06", " RotatableB": "11", " RigidB": "13", " Flexibility": "0.46", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "407131.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.449", "link_html_complex": "/ACE_complex_html/ACE_INF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_INF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_INF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_INF.png", "phi_psi": "/peptide_da/INF.pdb", "link_html_peptide": "/Peptide_html/INF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/INF.pdb", "link_png_peptide": "/Peptide_pics/INF.png"}
{"Peptide_Sequence": "INP", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "532", " Ligand_ID": "INP_minimized.pdb_532", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "342.39", " logP": "-3.56", " logD": "-5.36", " logSw": "0.81", " tPSA": "160.27", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "768107.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 342.391", "link_html_complex": "/ACE_complex_html/ACE_INP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_INP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_INP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_INP.png", "phi_psi": "/peptide_da/INP.pdb", "link_html_peptide": "/Peptide_html/INP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/INP.pdb", "link_png_peptide": "/Peptide_pics/INP.png"}
{"Peptide_Sequence": "INSQ", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "629 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "533", " Ligand_ID": "INSQ_minimized.pdb_533", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "460.48", " logP": "-6.54", " logD": "-8.8", " logSw": "2.35", " tPSA": "261.48", " RotatableB": "14", " RigidB": "11", " Flexibility": "0.56", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "18", " HeteroAtoms": "14", " ratio_H_by_C": "0.78", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4824609.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 460.482", "link_html_complex": "/ACE_complex_html/ACE_INSQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_INSQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_INSQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_INSQ.png", "phi_psi": "/peptide_da/INSQ.pdb", "link_html_peptide": "/Peptide_html/INSQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/INSQ.pdb", "link_png_peptide": "/Peptide_pics/INSQ.png"}
{"Peptide_Sequence": "INYWL", " Origin": "Whey (Whole whey protein)", " Peptide_Preparation": "", " Isolation_Method": "IEC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "11 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "534", " Ligand_ID": "INYWL_minimized.pdb_534", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "707.82", " logP": "-1.27", " logD": "-2.66", " logSw": "-2.29", " tPSA": "263.28", " RotatableB": "19", " RigidB": "27", " Flexibility": "0.41", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "36", " HeteroAtoms": "15", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "72011.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 707.816", "link_html_complex": "/ACE_complex_html/ACE_INYWL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_INYWL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_INYWL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_INYWL.png", "phi_psi": "/peptide_da/INYWL.pdb", "link_html_peptide": "/Peptide_html/INYWL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/INYWL.pdb", "link_png_peptide": "/Peptide_pics/INYWL.png"}
{"Peptide_Sequence": "IP", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "130  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-6.4", "Serial_ID": "541", " Ligand_ID": "IP_minimized.pdb_541", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "228.29", " logP": "-1.79", " logD": "-2.24", " logSw": "0.14", " tPSA": "88.08", " RotatableB": "4", " RigidB": "8", " Flexibility": "0.33", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "11", " HeteroAtoms": "5", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "261627.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 228.288", "link_html_complex": "/ACE_complex_html/ACE_IP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IP.png", "phi_psi": "/peptide_da/IP.pdb", "link_html_peptide": "/Peptide_html/IP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IP.pdb", "link_png_peptide": "/Peptide_pics/IP.png"}
{"Peptide_Sequence": "IPA", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "141 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "537", " Ligand_ID": "IPA_minimized.pdb_537", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "299.37", " logP": "-2.04", " logD": "-3.9", " logSw": "-0.01", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "294947.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.366", "link_html_complex": "/ACE_complex_html/ACE_IPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPA.png", "phi_psi": "/peptide_da/IPA.pdb", "link_html_peptide": "/Peptide_html/IPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPA.pdb", "link_png_peptide": "/Peptide_pics/IPA.png"}
{"Peptide_Sequence": "IPAIN", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "432.6 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "535", " Ligand_ID": "IPAIN_minimized.pdb_535", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "526.63", " logP": "-3.06", " logD": "-5.44", " logSw": "-0.25", " tPSA": "218.47", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "408792.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 526.626", "link_html_complex": "/ACE_complex_html/ACE_IPAIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPAIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPAIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPAIN.png", "phi_psi": "/peptide_da/IPAIN.pdb", "link_html_peptide": "/Peptide_html/IPAIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPAIN.pdb", "link_png_peptide": "/Peptide_pics/IPAIN.png"}
{"Peptide_Sequence": "IPALLKR", " Origin": " wheat gluten protein", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al. (1979) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "43", " Reference": "Asoodeh, Ahmad, et al. \"Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: biochemical characterization and molecular docking study.\" Journal of Cereal Science 60.1 (2014): 92-98.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "536", " Ligand_ID": "IPALLKR_minimized.pdb_536", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "810.04", " logP": "-3.01", " logD": "-7.04", " logSw": "-1.18", " tPSA": "324.86", " RotatableB": "27", " RigidB": "19", " Flexibility": "0.59", " HBD": "14", " HBA": "19", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "57", " CarbonAtoms": "38", " HeteroAtoms": "19", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "247928.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 810.039", "link_html_complex": "/ACE_complex_html/ACE_IPALLKR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPALLKR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPALLKR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPALLKR.png", "phi_psi": "/peptide_da/IPALLKR.pdb", "link_html_peptide": "/Peptide_html/IPALLKR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPALLKR.pdb", "link_png_peptide": "/Peptide_pics/IPALLKR.png"}
{"Peptide_Sequence": "IPAQK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "260 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "538", " Ligand_ID": "IPAQK_minimized.pdb_538", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "555.67", " logP": "-5.49", " logD": "-6.31", " logSw": "1.3", " tPSA": "246.11", " RotatableB": "17", " RigidB": "16", " Flexibility": "0.52", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2029879.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 555.667", "link_html_complex": "/ACE_complex_html/ACE_IPAQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPAQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPAQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPAQK.png", "phi_psi": "/peptide_da/IPAQK.pdb", "link_html_peptide": "/Peptide_html/IPAQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPAQK.pdb", "link_png_peptide": "/Peptide_pics/IPAQK.png"}
{"Peptide_Sequence": "IPAVFK", " Origin": "bovine \u03b2-lactoglobulin", " Peptide_Preparation": "trypsin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "144.8 \u03bcM", " Reference": "Power, O., et al. \"Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of \u03b2-lactoglobulin.\" journal of functional foods 9 (2014): 38-47.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "539", " Ligand_ID": "IPAVFK_minimized.pdb_539", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "673.84", " logP": "-2.03", " logD": "-3.14", " logSw": "-1.53", " tPSA": "232.12", " RotatableB": "19", " RigidB": "22", " Flexibility": "0.46", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "34", " HeteroAtoms": "14", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "146198.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 673.843", "link_html_complex": "/ACE_complex_html/ACE_IPAVFK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPAVFK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPAVFK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPAVFK.png", "phi_psi": "/peptide_da/IPAVFK.pdb", "link_html_peptide": "/Peptide_html/IPAVFK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPAVFK.pdb", "link_png_peptide": "/Peptide_pics/IPAVFK.png"}
{"Peptide_Sequence": "", " Origin": "-9", " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "540", " Ligand_ID": "IPF_minimized.pdb_540", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "375.46", " logP": "-0.64", " logD": "-2.23", " logSw": "-1.32", " tPSA": "117.18", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "20", " HeteroAtoms": "7", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "100706.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 375.462", "link_html_complex": "/ACE_complex_html/ACE_IPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPF.png", "phi_psi": "/peptide_da/IPF.pdb", "link_html_peptide": "/Peptide_html/IPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPF.pdb", "link_png_peptide": "/Peptide_pics/IPF.png"}
{"Peptide_Sequence": "IPP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "5 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "543", " Ligand_ID": "IPP_minimized.pdb_543", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "325.4", " logP": "-1.74", " logD": "-3.63", " logSw": "-0.43", " tPSA": "108.39", " RotatableB": "5", " RigidB": "15", " Flexibility": "0.25", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "211402.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 325.403", "link_html_complex": "/ACE_complex_html/ACE_IPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPP.png", "phi_psi": "/peptide_da/IPP.pdb", "link_html_peptide": "/Peptide_html/IPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPP.pdb", "link_png_peptide": "/Peptide_pics/IPP.png"}
{"Peptide_Sequence": "IPPGVPYWT", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "64 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "542", " Ligand_ID": "IPPGVPYWT_minimized.pdb_542", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "1029.19", " logP": "-0.24", " logD": "-4.17", " logSw": "-4.69", " tPSA": "330.45", " RotatableB": "22", " RigidB": "48", " Flexibility": "0.31", " HBD": "11", " HBA": "22", " HBD_HBA": "33", " Rings": "5", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "74", " CarbonAtoms": "52", " HeteroAtoms": "22", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9419.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1029.19", "link_html_complex": "/ACE_complex_html/ACE_IPPGVPYWT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPPGVPYWT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPPGVPYWT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPPGVPYWT.png", "phi_psi": "/peptide_da/IPPGVPYWT.pdb", "link_html_peptide": "/Peptide_html/IPPGVPYWT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPPGVPYWT.pdb", "link_png_peptide": "/Peptide_pics/IPPGVPYWT.png"}
{"Peptide_Sequence": "IPPVPP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Wu & Ding (2002)", " In-vivo_or_in-vitro": " in vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Ding, Fengyun, et al. \"VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity.\" PloS one 8.4 (2013): e62384.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "544", " Ligand_ID": "IPPVPP_minimized.pdb_544", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "618.76", " logP": "-0.76", " logD": "-4.22", " logSw": "-2.54", " tPSA": "178.11", " RotatableB": "10", " RigidB": "31", " Flexibility": "0.24", " HBD": "4", " HBA": "13", " HBD_HBA": "17", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "2", " Solubility_mg_per_l": "48919.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.765", "link_html_complex": "/ACE_complex_html/ACE_IPPVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPPVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPPVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPPVPP.png", "phi_psi": "/peptide_da/IPPVPP.pdb", "link_html_peptide": "/Peptide_html/IPPVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPPVPP.pdb", "link_png_peptide": "/Peptide_pics/IPPVPP.png"}
{"Peptide_Sequence": "IPQEVLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "690", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "545", " Ligand_ID": "IPQEVLP_minimized.pdb_545", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "794.94", " logP": "-3.68", " logD": "-8.76", " logSw": "-1", " tPSA": "308.01", " RotatableB": "22", " RigidB": "26", " Flexibility": "0.46", " HBD": "10", " HBA": "19", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "56", " CarbonAtoms": "37", " HeteroAtoms": "19", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "292967.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 794.935", "link_html_complex": "/ACE_complex_html/ACE_IPQEVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPQEVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPQEVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPQEVLP.png", "phi_psi": "/peptide_da/IPQEVLP.pdb", "link_html_peptide": "/Peptide_html/IPQEVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPQEVLP.pdb", "link_png_peptide": "/Peptide_pics/IPQEVLP.png"}
{"Peptide_Sequence": "IPY", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "206 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "546", " Ligand_ID": "IPY_minimized.pdb_546", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "391.46", " logP": "-1", " logD": "-2.56", " logSw": "-1.19", " tPSA": "137.41", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "119454.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.461", "link_html_complex": "/ACE_complex_html/ACE_IPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IPY.png", "phi_psi": "/peptide_da/IPY.pdb", "link_html_peptide": "/Peptide_html/IPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IPY.pdb", "link_png_peptide": "/Peptide_pics/IPY.png"}
{"Peptide_Sequence": "IQF", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "547", " Ligand_ID": "IQF_minimized.pdb_547", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "406.48", " logP": "-2.1", " logD": "-3.67", " logSw": "-0.32", " tPSA": "169.06", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "295042.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.476", "link_html_complex": "/ACE_complex_html/ACE_IQF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQF.png", "phi_psi": "/peptide_da/IQF.pdb", "link_html_peptide": "/Peptide_html/IQF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQF.pdb", "link_png_peptide": "/Peptide_pics/IQF.png"}
{"Peptide_Sequence": "IQHST", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "548", " Ligand_ID": "IQHST_minimized.pdb_548", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "584.62", " logP": "-5.76", " logD": "-9.02", " logSw": "1.31", " tPSA": "296.4", " RotatableB": "18", " RigidB": "16", " Flexibility": "0.53", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "24", " HeteroAtoms": "17", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2159058.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.623", "link_html_complex": "/ACE_complex_html/ACE_IQHST.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQHST.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQHST.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQHST.png", "phi_psi": "/peptide_da/IQHST.pdb", "link_html_peptide": "/Peptide_html/IQHST.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQHST.pdb", "link_png_peptide": "/Peptide_pics/IQHST.png"}
{"Peptide_Sequence": "IQP", " Origin": "wheat bran", " Peptide_Preparation": "heating, centrifuge", " Isolation_Method": "HPLC", " ACE_inhibition_assay": " modified Lieberman\u2019s method (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.8\u03bcmol/L", " Reference": "Nogata, Yoichi, et al. \"Angiotensin I converting enzyme inhibitory peptides produced by autolysis reactions from wheat bran.\" Journal of agricultural and food chemistry 57.15 (2009): 6618-6622.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "549", " Ligand_ID": "IQP_minimized.pdb_549", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.42", " logP": "-4.06", " logD": "-5.07", " logSw": "1.1", " tPSA": "160.27", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1072893.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.417", "link_html_complex": "/ACE_complex_html/ACE_IQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQP.png", "phi_psi": "/peptide_da/IQP.pdb", "link_html_peptide": "/Peptide_html/IQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQP.pdb", "link_png_peptide": "/Peptide_pics/IQP.png"}
{"Peptide_Sequence": "IQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "570", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "550", " Ligand_ID": "IQSEPKAIP_minimized.pdb_550", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "982.13", " logP": "-7.01", " logD": "-14.5", " logSw": "0.47", " tPSA": "414.08", " RotatableB": "30", " RigidB": "30", " Flexibility": "0.5", " HBD": "15", " HBA": "25", " HBD_HBA": "40", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "69", " CarbonAtoms": "44", " HeteroAtoms": "25", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1566829.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 982.132", "link_html_complex": "/ACE_complex_html/ACE_IQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQSEPKAIP.png", "phi_psi": "/peptide_da/IQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/IQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/IQSEPKAIP.png"}
{"Peptide_Sequence": "IQSQPQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "630", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "551", " Ligand_ID": "IQSQPQAFP_minimized.pdb_551", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1015.12", " logP": "-6.04", " logD": "-10.07", " logSw": "-0.58", " tPSA": "432.49", " RotatableB": "27", " RigidB": "39", " Flexibility": "0.41", " HBD": "16", " HBA": "26", " HBD_HBA": "42", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "72", " CarbonAtoms": "46", " HeteroAtoms": "26", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "569609.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1015.12", "link_html_complex": "/ACE_complex_html/ACE_IQSQPQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQSQPQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQSQPQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQSQPQAFP.png", "phi_psi": "/peptide_da/IQSQPQAFP.pdb", "link_html_peptide": "/Peptide_html/IQSQPQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQSQPQAFP.pdb", "link_png_peptide": "/Peptide_pics/IQSQPQAFP.png"}
{"Peptide_Sequence": "IQW", " Origin": "Egg protein-\novotransferrin\n", " Peptide_Preparation": "\nThermolysin followed by pepsin digestion\n", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.6", " Reference": " K. Majumder and J. Wu, Food Res. Int., 2010, 43, 1371\u2013\n1378", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "552", " Ligand_ID": "IQW_minimized.pdb_552", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "445.51", " logP": "-2.23", " logD": "-3.57", " logSw": "-0.51", " tPSA": "184.85", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "267263.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 445.512", "link_html_complex": "/ACE_complex_html/ACE_IQW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQW.png", "phi_psi": "/peptide_da/IQW.pdb", "link_html_peptide": "/Peptide_html/IQW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQW.pdb", "link_png_peptide": "/Peptide_pics/IQW.png"}
{"Peptide_Sequence": "IQY", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "70.4 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "554", " Ligand_ID": "IQY_minimized.pdb_554", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "422.48", " logP": "-3.9", " logD": "-4", " logSw": "0.72", " tPSA": "189.29", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "864182.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.475", "link_html_complex": "/ACE_complex_html/ACE_IQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQY.png", "phi_psi": "/peptide_da/IQY.pdb", "link_html_peptide": "/Peptide_html/IQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQY.pdb", "link_png_peptide": "/Peptide_pics/IQY.png"}
{"Peptide_Sequence": "IQYCA", " Origin": "egg proteins", " Peptide_Preparation": "thermolysin, pepsin", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR, Cushman and Cheung with slight modifications byMajumder & Wu, 2009", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "", " Reference": "Majumder, Kaustav, and Jianping Wu. \"A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics.\" Food Research International 43.5 (2010): 1371-1378.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "553", " Ligand_ID": "IQYCA_minimized.pdb_553", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O", " MW": "596.7", " logP": "-4.48", " logD": "-5.4", " logSw": "0.35", " tPSA": "286.29", " RotatableB": "17", " RigidB": "17", " Flexibility": "0.5", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "846810.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 596.695", "link_html_complex": "/ACE_complex_html/ACE_IQYCA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IQYCA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IQYCA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IQYCA.png", "phi_psi": "/peptide_da/IQYCA.pdb", "link_html_peptide": "/Peptide_html/IQYCA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IQYCA.pdb", "link_png_peptide": "/Peptide_pics/IQYCA.png"}
{"Peptide_Sequence": "IR", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "695 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "559", " Ligand_ID": "IR_minimized.pdb_559", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "287.36", " logP": "-3.86", " logD": "-4.62", " logSw": "1.47", " tPSA": "160.51", " RotatableB": "10", " RigidB": "4", " Flexibility": "0.71", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1250010.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.359", "link_html_complex": "/ACE_complex_html/ACE_IR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IR.png", "phi_psi": "/peptide_da/IR.pdb", "link_html_peptide": "/Peptide_html/IR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IR.pdb", "link_png_peptide": "/Peptide_pics/IR.png"}
{"Peptide_Sequence": "IRA", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.4", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "555", " Ligand_ID": "IRA_minimized.pdb_555", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O", " MW": "358.44", " logP": "-3.01", " logD": "-6.81", " logSw": "0.63", " tPSA": "189.61", " RotatableB": "12", " RigidB": "6", " Flexibility": "0.67", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "15", " HeteroAtoms": "10", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "670313.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.436", "link_html_complex": "/ACE_complex_html/ACE_IRA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRA.png", "phi_psi": "/peptide_da/IRA.pdb", "link_html_peptide": "/Peptide_html/IRA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRA.pdb", "link_png_peptide": "/Peptide_pics/IRA.png"}
{"Peptide_Sequence": "IRAQQ", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "160", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "556", " Ligand_ID": "IRAQQ_minimized.pdb_556", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "614.69", " logP": "-5.84", " logD": "-11.29", " logSw": "1.41", " tPSA": "333.99", " RotatableB": "21", " RigidB": "14", " Flexibility": "0.6", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "25", " HeteroAtoms": "18", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2528085.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 614.695", "link_html_complex": "/ACE_complex_html/ACE_IRAQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRAQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRAQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRAQQ.png", "phi_psi": "/peptide_da/IRAQQ.pdb", "link_html_peptide": "/Peptide_html/IRAQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRAQQ.pdb", "link_png_peptide": "/Peptide_pics/IRAQQ.png"}
{"Peptide_Sequence": "IRD", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "557", " Ligand_ID": "IRD_minimized.pdb_557", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "402.45", " logP": "-3.87", " logD": "-9.24", " logSw": "1.03", " tPSA": "229.74", " RotatableB": "14", " RigidB": "7", " Flexibility": "0.67", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1123827.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 402.446", "link_html_complex": "/ACE_complex_html/ACE_IRD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRD.png", "phi_psi": "/peptide_da/IRD.pdb", "link_html_peptide": "/Peptide_html/IRD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRD.pdb", "link_png_peptide": "/Peptide_pics/IRD.png"}
{"Peptide_Sequence": "IRH", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "558", " Ligand_ID": "IRH_minimized.pdb_558", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "424.5", " logP": "-3.24", " logD": "-7.29", " logSw": "0.43", " tPSA": "218.29", " RotatableB": "14", " RigidB": "11", " Flexibility": "0.56", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "654939.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 424.498", "link_html_complex": "/ACE_complex_html/ACE_IRH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRH.png", "phi_psi": "/peptide_da/IRH.pdb", "link_html_peptide": "/Peptide_html/IRH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRH.pdb", "link_png_peptide": "/Peptide_pics/IRH.png"}
{"Peptide_Sequence": "IRN", " Origin": "meat, milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "560", " Ligand_ID": "IRN_minimized.pdb_560", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "401.46", " logP": "-4.52", " logD": "-8.26", " logSw": "1.44", " tPSA": "232.7", " RotatableB": "14", " RigidB": "8", " Flexibility": "0.64", " HBD": "11", " HBA": "12", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1698755.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 401.461", "link_html_complex": "/ACE_complex_html/ACE_IRN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRN.png", "phi_psi": "/peptide_da/IRN.pdb", "link_html_peptide": "/Peptide_html/IRN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRN.pdb", "link_png_peptide": "/Peptide_pics/IRN.png"}
{"Peptide_Sequence": "IRP", " Origin": "Bonito", " Peptide_Preparation": "synthetic peptide", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.8", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "561", " Ligand_ID": "IRP_minimized.pdb_561", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "384.47", " logP": "-3.72", " logD": "-6.54", " logSw": "0.85", " tPSA": "180.82", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "895818.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 384.474", "link_html_complex": "/ACE_complex_html/ACE_IRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRP.png", "phi_psi": "/peptide_da/IRP.pdb", "link_html_peptide": "/Peptide_html/IRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRP.pdb", "link_png_peptide": "/Peptide_pics/IRP.png"}
{"Peptide_Sequence": "IRPV", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "31 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "562", " Ligand_ID": "IRPV_minimized.pdb_562", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "483.6", " logP": "-3.7", " logD": "-7.24", " logSw": "0.42", " tPSA": "209.92", " RotatableB": "14", " RigidB": "13", " Flexibility": "0.52", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "733566.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 483.605", "link_html_complex": "/ACE_complex_html/ACE_IRPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRPV.png", "phi_psi": "/peptide_da/IRPV.pdb", "link_html_peptide": "/Peptide_html/IRPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRPV.pdb", "link_png_peptide": "/Peptide_pics/IRPV.png"}
{"Peptide_Sequence": "IRPVQ", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.4 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "563", " Ligand_ID": "IRPVQ_minimized.pdb_563", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "611.73", " logP": "-5.11", " logD": "-8.98", " logSw": "0.84", " tPSA": "282.11", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "27", " HeteroAtoms": "16", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1417778.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 611.734", "link_html_complex": "/ACE_complex_html/ACE_IRPVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRPVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRPVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRPVQ.png", "phi_psi": "/peptide_da/IRPVQ.pdb", "link_html_peptide": "/Peptide_html/IRPVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRPVQ.pdb", "link_png_peptide": "/Peptide_pics/IRPVQ.png"}
{"Peptide_Sequence": "IRRGQ", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "564", " Ligand_ID": "IRRGQ_minimized.pdb_564", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "628.72", " logP": "-5.9", " logD": "-14.05", " logSw": "1.56", " tPSA": "354.54", " RotatableB": "24", " RigidB": "13", " Flexibility": "0.65", " HBD": "17", " HBA": "19", " HBD_HBA": "36", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "44", " CarbonAtoms": "25", " HeteroAtoms": "19", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3000696.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 628.725", "link_html_complex": "/ACE_complex_html/ACE_IRRGQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRRGQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRRGQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRRGQ.png", "phi_psi": "/peptide_da/IRRGQ.pdb", "link_html_peptide": "/Peptide_html/IRRGQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRRGQ.pdb", "link_png_peptide": "/Peptide_pics/IRRGQ.png"}
{"Peptide_Sequence": "IRW", " Origin": "egg", " Peptide_Preparation": "Enzymatic digestion", " Isolation_Method": "", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "0.6", " Reference": "S. Bejjani and J. Wu, J. Agric. Food Chem., 2013, 61, 1487\u2013\n 1492; K. Majumder and J. Wu, Food Res. Int., 2010, 43, 1371\u2013\n 1378", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "566", " Ligand_ID": "IRW_minimized.pdb_566", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "473.57", " logP": "-1.89", " logD": "-5.05", " logSw": "-0.76", " tPSA": "205.4", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "221927.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.568", "link_html_complex": "/ACE_complex_html/ACE_IRW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRW.png", "phi_psi": "/peptide_da/IRW.pdb", "link_html_peptide": "/Peptide_html/IRW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRW.pdb", "link_png_peptide": "/Peptide_pics/IRW.png"}
{"Peptide_Sequence": "IRWCT", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "565", " Ligand_ID": "IRWCT_minimized.pdb_565", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "677.82", " logP": "-2.49", " logD": "-7.29", " logSw": "-1.22", " tPSA": "322.63", " RotatableB": "20", " RigidB": "20", " Flexibility": "0.5", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "199191.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 677.814", "link_html_complex": "/ACE_complex_html/ACE_IRWCT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRWCT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRWCT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRWCT.png", "phi_psi": "/peptide_da/IRWCT.pdb", "link_html_peptide": "/Peptide_html/IRWCT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRWCT.pdb", "link_png_peptide": "/Peptide_pics/IRWCT.png"}
{"Peptide_Sequence": "IRY", " Origin": "egg proteins", " Peptide_Preparation": "thermolysin, pepsin", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR, Cushman and Cheung with slight modifications byMajumder & Wu, 2010", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "0.6 \u03bcM", " Reference": "Majumder, Kaustav, and Jianping Wu. \"A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics.\" Food Research International 43.5 (2010): 1371-1378.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "568", " Ligand_ID": "IRY_minimized.pdb_568", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "450.53", " logP": "-3.56", " logD": "-5.46", " logSw": "0.47", " tPSA": "209.84", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "718135.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 450.532", "link_html_complex": "/ACE_complex_html/ACE_IRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRY.png", "phi_psi": "/peptide_da/IRY.pdb", "link_html_peptide": "/Peptide_html/IRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRY.pdb", "link_png_peptide": "/Peptide_pics/IRY.png"}
{"Peptide_Sequence": "IRYCT", " Origin": "egg proteins", " Peptide_Preparation": "thermolysin, pepsin", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR, Cushman and Cheung with slight modifications byMajumder & Wu, 2010", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "", " Reference": "Majumder, Kaustav, and Jianping Wu. \"A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics.\" Food Research International 43.5 (2010): 1371-1378.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "567", " Ligand_ID": "IRYCT_minimized.pdb_567", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "654.78", " logP": "-3.79", " logD": "-7.67", " logSw": "-0.24", " tPSA": "327.07", " RotatableB": "20", " RigidB": "16", " Flexibility": "0.56", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "28", " HeteroAtoms": "17", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "514697.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 654.778", "link_html_complex": "/ACE_complex_html/ACE_IRYCT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IRYCT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IRYCT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IRYCT.png", "phi_psi": "/peptide_da/IRYCT.pdb", "link_html_peptide": "/Peptide_html/IRYCT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IRYCT.pdb", "link_png_peptide": "/Peptide_pics/IRYCT.png"}
{"Peptide_Sequence": "ISHIYVWK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.77 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "569", " Ligand_ID": "ISHIYVWK_minimized.pdb_569", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1045.23", " logP": "0.26", " logD": "-3.24", " logSw": "-4.54", " tPSA": "384.04", " RotatableB": "31", " RigidB": "36", " Flexibility": "0.46", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "75", " CarbonAtoms": "52", " HeteroAtoms": "23", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11197.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1045.23", "link_html_complex": "/ACE_complex_html/ACE_ISHIYVWK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ISHIYVWK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ISHIYVWK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ISHIYVWK.png", "phi_psi": "/peptide_da/ISHIYVWK.pdb", "link_html_peptide": "/Peptide_html/ISHIYVWK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ISHIYVWK.pdb", "link_png_peptide": "/Peptide_pics/ISHIYVWK.png"}
{"Peptide_Sequence": "ISP", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "570", " Ligand_ID": "ISP_minimized.pdb_570", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "315.37", " logP": "-3.09", " logD": "-4.96", " logSw": "0.61", " tPSA": "137.41", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "0", " Solubility_mg_per_l": "582405.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 315.365", "link_html_complex": "/ACE_complex_html/ACE_ISP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ISP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ISP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ISP.png", "phi_psi": "/peptide_da/ISP.pdb", "link_html_peptide": "/Peptide_html/ISP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ISP.pdb", "link_png_peptide": "/Peptide_pics/ISP.png"}
{"Peptide_Sequence": "ISSSK", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "571", " Ligand_ID": "ISSSK_minimized.pdb_571", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "520.58", " logP": "-6.45", " logD": "-8.56", " logSw": "2.18", " tPSA": "272.5", " RotatableB": "18", " RigidB": "9", " Flexibility": "0.67", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "21", " HeteroAtoms": "15", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4623281.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 520.577", "link_html_complex": "/ACE_complex_html/ACE_ISSSK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ISSSK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ISSSK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ISSSK.png", "phi_psi": "/peptide_da/ISSSK.pdb", "link_html_peptide": "/Peptide_html/ISSSK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ISSSK.pdb", "link_png_peptide": "/Peptide_pics/ISSSK.png"}
{"Peptide_Sequence": "ISW", " Origin": "milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "572", " Ligand_ID": "ISW_minimized.pdb_572", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "404.46", " logP": "-2.19", " logD": "-3.46", " logSw": "-0.42", " tPSA": "161.99", " RotatableB": "10", " RigidB": "15", " Flexibility": "0.4", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "264478.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 404.46", "link_html_complex": "/ACE_complex_html/ACE_ISW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ISW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ISW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ISW.png", "phi_psi": "/peptide_da/ISW.pdb", "link_html_peptide": "/Peptide_html/ISW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ISW.pdb", "link_png_peptide": "/Peptide_pics/ISW.png"}
{"Peptide_Sequence": "ITC", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "573", " Ligand_ID": "ITC_minimized.pdb_573", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(O)=O", " MW": "335.42", " logP": "-3.63", " logD": "-4.76", " logSw": "0.96", " tPSA": "185", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "1", " Solubility_mg_per_l": "877152.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 335.419", "link_html_complex": "/ACE_complex_html/ACE_ITC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITC.png", "phi_psi": "/peptide_da/ITC.pdb", "link_html_peptide": "/Peptide_html/ITC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITC.pdb", "link_png_peptide": "/Peptide_pics/ITC.png"}
{"Peptide_Sequence": "ITF", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "629 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "574", " Ligand_ID": "ITF_minimized.pdb_574", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "379.45", " logP": "-1.95", " logD": "-3.14", " logSw": "-0.38", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "258616.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 379.451", "link_html_complex": "/ACE_complex_html/ACE_ITF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITF.png", "phi_psi": "/peptide_da/ITF.pdb", "link_html_peptide": "/Peptide_html/ITF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITF.pdb", "link_png_peptide": "/Peptide_pics/ITF.png"}
{"Peptide_Sequence": "ITMIAPSAF", " Origin": "Chemical synthesis", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung with modification described by Miguel et. al. 2004", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.24 \u03bcmol/L", " Reference": "Eckert, Ewelina, et al. \"Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia).\" Journal of proteomics 110 (2014): 107-116.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "575", " Ligand_ID": "ITMIAPSAF_minimized.pdb_575", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "950.15", " logP": "-1.52", " logD": "-5.54", " logSw": "-3.02", " tPSA": "357.54", " RotatableB": "27", " RigidB": "28", " Flexibility": "0.49", " HBD": "12", " HBA": "21", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "66", " CarbonAtoms": "44", " HeteroAtoms": "22", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "46194.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 950.153", "link_html_complex": "/ACE_complex_html/ACE_ITMIAPSAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITMIAPSAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITMIAPSAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITMIAPSAF.png", "phi_psi": "/peptide_da/ITMIAPSAF.pdb", "link_html_peptide": "/Peptide_html/ITMIAPSAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITMIAPSAF.pdb", "link_png_peptide": "/Peptide_pics/ITMIAPSAF.png"}
{"Peptide_Sequence": "ITP", " Origin": "Sweet-potato protein isolate", " Peptide_Preparation": "", " Isolation_Method": "Absorption Chromatography, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "9.5 \u03bcM", " Reference": "Ishiguro, Koji, et al. \"Hypotensive effect of a sweetpotato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides.\" Food chemistry 131.3 (2012): 774-779.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "576", " Ligand_ID": "ITP_minimized.pdb_576", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "329.39", " logP": "-2.66", " logD": "-4.54", " logSw": "0.26", " tPSA": "137.41", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "425309.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 329.392", "link_html_complex": "/ACE_complex_html/ACE_ITP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITP.png", "phi_psi": "/peptide_da/ITP.pdb", "link_html_peptide": "/Peptide_html/ITP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITP.pdb", "link_png_peptide": "/Peptide_pics/ITP.png"}
{"Peptide_Sequence": "ITRTQ", " Origin": "meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "577", " Ligand_ID": "ITRTQ_minimized.pdb_577", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "617.7", " logP": "-5.91", " logD": "-11.43", " logSw": "1.44", " tPSA": "331.36", " RotatableB": "21", " RigidB": "12", " Flexibility": "0.64", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "25", " HeteroAtoms": "18", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2606029.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.696", "link_html_complex": "/ACE_complex_html/ACE_ITRTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITRTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITRTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITRTQ.png", "phi_psi": "/peptide_da/ITRTQ.pdb", "link_html_peptide": "/Peptide_html/ITRTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITRTQ.pdb", "link_png_peptide": "/Peptide_pics/ITRTQ.png"}
{"Peptide_Sequence": "ITRY", " Origin": "Antarctic krill (Euphausia superba) tail meat", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "236.9 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "578", " Ligand_ID": "ITRY_minimized.pdb_578", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "551.64", " logP": "-3.46", " logD": "-6.71", " logSw": "-0.01", " tPSA": "259.17", " RotatableB": "17", " RigidB": "14", " Flexibility": "0.55", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "544052.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 551.636", "link_html_complex": "/ACE_complex_html/ACE_ITRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITRY.png", "phi_psi": "/peptide_da/ITRY.pdb", "link_html_peptide": "/Peptide_html/ITRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITRY.pdb", "link_png_peptide": "/Peptide_pics/ITRY.png"}
{"Peptide_Sequence": "ITT", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "678", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "579", " Ligand_ID": "ITT_minimized.pdb_579", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "333.38", " logP": "-4.17", " logD": "-5.45", " logSw": "1.31", " tPSA": "166.43", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1240692.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.381", "link_html_complex": "/ACE_complex_html/ACE_ITT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITT.png", "phi_psi": "/peptide_da/ITT.pdb", "link_html_peptide": "/Peptide_html/ITT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITT.pdb", "link_png_peptide": "/Peptide_pics/ITT.png"}
{"Peptide_Sequence": "ITTNP", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "549", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "580", " Ligand_ID": "ITTNP_minimized.pdb_580", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "544.6", " logP": "-5.3", " logD": "-8.14", " logSw": "1.05", " tPSA": "258.93", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1550818.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 544.598", "link_html_complex": "/ACE_complex_html/ACE_ITTNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ITTNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ITTNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ITTNP.png", "phi_psi": "/peptide_da/ITTNP.pdb", "link_html_peptide": "/Peptide_html/ITTNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ITTNP.pdb", "link_png_peptide": "/Peptide_pics/ITTNP.png"}
{"Peptide_Sequence": "IVF", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "33.9", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "581", " Ligand_ID": "IVF_minimized.pdb_581", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "377.48", " logP": "-1.41", " logD": "-1.61", " logSw": "-0.71", " tPSA": "125.97", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "20", " HeteroAtoms": "7", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "185842.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 377.478", "link_html_complex": "/ACE_complex_html/ACE_IVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVF.png", "phi_psi": "/peptide_da/IVF.pdb", "link_html_peptide": "/Peptide_html/IVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVF.pdb", "link_png_peptide": "/Peptide_pics/IVF.png"}
{"Peptide_Sequence": "IVGRPR", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "300 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "583", " Ligand_ID": "IVGRPR_minimized.pdb_583", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "696.84", " logP": "-4.2", " logD": "-9.28", " logSw": "0", " tPSA": "331.76", " RotatableB": "23", " RigidB": "18", " Flexibility": "0.56", " HBD": "15", " HBA": "19", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "49", " CarbonAtoms": "30", " HeteroAtoms": "19", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "699341.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 696.842", "link_html_complex": "/ACE_complex_html/ACE_IVGRPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVGRPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVGRPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVGRPR.png", "phi_psi": "/peptide_da/IVGRPR.pdb", "link_html_peptide": "/Peptide_html/IVGRPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVGRPR.pdb", "link_png_peptide": "/Peptide_pics/IVGRPR.png"}
{"Peptide_Sequence": "IVGRPRHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.2 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "582", " Ligand_ID": "IVGRPRHQG_minimized.pdb_582", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "1019.16", " logP": "-6.28", " logD": "-16.11", " logSw": "0.02", " tPSA": "490.83", " RotatableB": "34", " RigidB": "31", " Flexibility": "0.52", " HBD": "21", " HBA": "29", " HBD_HBA": "50", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "72", " CarbonAtoms": "43", " HeteroAtoms": "29", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1035863.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1019.16", "link_html_complex": "/ACE_complex_html/ACE_IVGRPRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVGRPRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVGRPRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVGRPRHQG.png", "phi_psi": "/peptide_da/IVGRPRHQG.pdb", "link_html_peptide": "/Peptide_html/IVGRPRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVGRPRHQG.pdb", "link_png_peptide": "/Peptide_pics/IVGRPRHQG.png"}
{"Peptide_Sequence": "IVGRRRHQG", " Origin": "Chicken muscle", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "14 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "584", " Ligand_ID": "IVGRRRHQG_minimized.pdb_584", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "1078.23", " logP": "-7.4", " logD": "-19.71", " logSw": "0.75", " tPSA": "563.26", " RotatableB": "40", " RigidB": "27", " Flexibility": "0.6", " HBD": "26", " HBA": "32", " HBD_HBA": "58", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "76", " CarbonAtoms": "44", " HeteroAtoms": "32", " ratio_H_by_C": "0.73", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2289680.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1078.23", "link_html_complex": "/ACE_complex_html/ACE_IVGRRRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVGRRRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVGRRRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVGRRRHQG.png", "phi_psi": "/peptide_da/IVGRRRHQG.pdb", "link_html_peptide": "/Peptide_html/IVGRRRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVGRRRHQG.pdb", "link_png_peptide": "/Peptide_pics/IVGRRRHQG.png"}
{"Peptide_Sequence": "IVQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "585", " Ligand_ID": "IVQ_minimized.pdb_585", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "358.43", " logP": "-2.75", " logD": "-4.44", " logSw": "0.4", " tPSA": "169.06", " RotatableB": "11", " RigidB": "7", " Flexibility": "0.61", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "532698.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.433", "link_html_complex": "/ACE_complex_html/ACE_IVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVQ.png", "phi_psi": "/peptide_da/IVQ.pdb", "link_html_peptide": "/Peptide_html/IVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVQ.pdb", "link_png_peptide": "/Peptide_pics/IVQ.png"}
{"Peptide_Sequence": "IVR", " Origin": " latex of Ficus carica", " Peptide_Preparation": "", " Isolation_Method": "ultrafilteration, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified  by Maruyama et. al. (1985).", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "14 \u03bcM", " Reference": "Maruyama, Susumu, Shinsuke Miyoshi, and Hideoki Tanaka. \"Angiotensin I-converting enzyme inhibitors derived from Ficus carica.\" Agricultural and biological chemistry 53.10 (1989): 2763-2767.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "587", " Ligand_ID": "IVR_minimized.pdb_587", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "386.49", " logP": "-2.41", " logD": "-4.06", " logSw": "0.14", " tPSA": "189.61", " RotatableB": "13", " RigidB": "6", " Flexibility": "0.68", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "444597.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 386.49", "link_html_complex": "/ACE_complex_html/ACE_IVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVR.png", "phi_psi": "/peptide_da/IVR.pdb", "link_html_peptide": "/Peptide_html/IVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVR.pdb", "link_png_peptide": "/Peptide_pics/IVR.png"}
{"Peptide_Sequence": "IVRDPNGMGAW", " Origin": "Chinesesoft-shelled turtle egg white", " Peptide_Preparation": "synthetic", " Isolation_Method": "MWCO", " ACE_inhibition_assay": "Cushman et al.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.39 \u03bcM", " Reference": "Rawendra, Reynetha DS, et al. \"A novel angiotensin converting enzyme inhibitory peptide derived from proteolytic digest of Chinese soft-shelled turtle egg white proteins.\" Journal of proteomics 94 (2013): 359-369.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "586", " Ligand_ID": "IVRDPNGMGAW_minimized.pdb_586", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "1215.38", " logP": "-4.6", " logD": "-14.92", " logSw": "-2.08", " tPSA": "537.93", " RotatableB": "37", " RigidB": "40", " Flexibility": "0.48", " HBD": "20", " HBA": "31", " HBD_HBA": "51", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "53", " HeteroAtoms": "32", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "152561.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1215.38", "link_html_complex": "/ACE_complex_html/ACE_IVRDPNGMGAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVRDPNGMGAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVRDPNGMGAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVRDPNGMGAW.png", "phi_psi": "/peptide_da/IVRDPNGMGAW.pdb", "link_html_peptide": "/Peptide_html/IVRDPNGMGAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVRDPNGMGAW.pdb", "link_png_peptide": "/Peptide_pics/IVRDPNGMGAW.png"}
{"Peptide_Sequence": "IVVE", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "315.3 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "588", " Ligand_ID": "IVVE_minimized.pdb_588", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "458.55", " logP": "-3.24", " logD": "-6.94", " logSw": "0.28", " tPSA": "195.2", " RotatableB": "14", " RigidB": "8", " Flexibility": "0.64", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "608053.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 458.549", "link_html_complex": "/ACE_complex_html/ACE_IVVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVVE.png", "phi_psi": "/peptide_da/IVVE.pdb", "link_html_peptide": "/Peptide_html/IVVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVVE.pdb", "link_png_peptide": "/Peptide_pics/IVVE.png"}
{"Peptide_Sequence": "IVY", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "0.48 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "589", " Ligand_ID": "IVY_minimized.pdb_589", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "393.48", " logP": "-1.77", " logD": "-1.94", " logSw": "-0.58", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "220370.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.477", "link_html_complex": "/ACE_complex_html/ACE_IVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IVY.png", "phi_psi": "/peptide_da/IVY.pdb", "link_html_peptide": "/Peptide_html/IVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IVY.pdb", "link_png_peptide": "/Peptide_pics/IVY.png"}
{"Peptide_Sequence": "IW", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "593", " Ligand_ID": "IW_minimized.pdb_593", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "317.38", " logP": "-0.89", " logD": "-0.76", " logSw": "-0.93", " tPSA": "112.66", " RotatableB": "7", " RigidB": "13", " Flexibility": "0.35", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "17", " HeteroAtoms": "6", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "125242.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 317.383", "link_html_complex": "/ACE_complex_html/ACE_IW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IW.png", "phi_psi": "/peptide_da/IW.pdb", "link_html_peptide": "/Peptide_html/IW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IW.pdb", "link_png_peptide": "/Peptide_pics/IW.png"}
{"Peptide_Sequence": "IWH", " Origin": "Bonito", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung with minor modification by Yamamoto et al. (1989) ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3.5 \u03bcM", " Reference": "Fujita, Hiroyuki, and Masaaki Yoshikawa. \"LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein.\" Immunopharmacology 44.1-2 (1999): 123-127.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "592", " Ligand_ID": "IWH_minimized.pdb_592", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "454.52", " logP": "-2.03", " logD": "-2.37", " logSw": "-0.82", " tPSA": "170.44", " RotatableB": "11", " RigidB": "20", " Flexibility": "0.35", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "200670.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.39", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 454.522", "link_html_complex": "/ACE_complex_html/ACE_IWH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IWH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IWH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IWH.png", "phi_psi": "/peptide_da/IWH.pdb", "link_html_peptide": "/Peptide_html/IWH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IWH.pdb", "link_png_peptide": "/Peptide_pics/IWH.png"}
{"Peptide_Sequence": "IWHHT", " Origin": "dried bonito", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "5.8 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "591", " Ligand_ID": "IWHHT_minimized.pdb_591", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "692.77", " logP": "-3.39", " logD": "-5.16", " logSw": "-0.96", " tPSA": "277.55", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "33", " HeteroAtoms": "17", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "264984.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 692.765", "link_html_complex": "/ACE_complex_html/ACE_IWHHT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IWHHT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IWHHT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IWHHT.png", "phi_psi": "/peptide_da/IWHHT.pdb", "link_html_peptide": "/Peptide_html/IWHHT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IWHHT.pdb", "link_png_peptide": "/Peptide_pics/IWHHT.png"}
{"Peptide_Sequence": "IWHHTF", " Origin": "Dried Bonito", " Peptide_Preparation": "Solid phase method with peptide synthesizer", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.5", " Reference": "Yamamoto, N., Ejiri, M., & Mizuno, S. (2003). Biogenic Peptides and Their Potential Use. Current Pharmaceutical Design, 9(16), 1345\u20131355. doi:10.2174/1381612033454801", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "590", " Ligand_ID": "IWHHTF_minimized.pdb_590", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "839.94", " logP": "-2.06", " logD": "-4.36", " logSw": "-2.46", " tPSA": "306.65", " RotatableB": "22", " RigidB": "37", " Flexibility": "0.37", " HBD": "12", " HBA": "19", " HBD_HBA": "31", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "42", " HeteroAtoms": "19", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "71752.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 839.939", "link_html_complex": "/ACE_complex_html/ACE_IWHHTF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IWHHTF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IWHHTF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IWHHTF.png", "phi_psi": "/peptide_da/IWHHTF.pdb", "link_html_peptide": "/Peptide_html/IWHHTF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IWHHTF.pdb", "link_png_peptide": "/Peptide_pics/IWHHTF.png"}
{"Peptide_Sequence": "IY", " Origin": "rapeseed", " Peptide_Preparation": "proteolytic enzymes", " Isolation_Method": "octadecyl silica (ODS) column, cyanopropyl silica (CN) column, phenetyl silica and nitrophenetyl column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with modification by Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "3.7", " Reference": "Marczak, Ewa D., et al. \"New antihypertensive peptides isolated from rapeseed.\" Peptides 24.6 (2003): 791-798.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "597", " Ligand_ID": "IY_minimized.pdb_597", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "294.35", " logP": "-2.16", " logD": "-1.17", " logSw": "0.05", " tPSA": "117.1", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "15", " HeteroAtoms": "6", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "310863.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 294.346", "link_html_complex": "/ACE_complex_html/ACE_IY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IY.png", "phi_psi": "/peptide_da/IY.pdb", "link_html_peptide": "/Peptide_html/IY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IY.pdb", "link_png_peptide": "/Peptide_pics/IY.png"}
{"Peptide_Sequence": "IYEGY", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "79.42 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "594", " Ligand_ID": "IYEGY_minimized.pdb_594", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "643.68", " logP": "-1.63", " logD": "-7.23", " logSw": "-1.72", " tPSA": "264.76", " RotatableB": "18", " RigidB": "22", " Flexibility": "0.45", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "115491.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 643.685", "link_html_complex": "/ACE_complex_html/ACE_IYEGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYEGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYEGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYEGY.png", "phi_psi": "/peptide_da/IYEGY.pdb", "link_html_peptide": "/Peptide_html/IYEGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYEGY.pdb", "link_png_peptide": "/Peptide_pics/IYEGY.png"}
{"Peptide_Sequence": "IYK", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "177", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "595", " Ligand_ID": "IYK_minimized.pdb_595", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "422.52", " logP": "-2.97", " logD": "-3", " logSw": "0.2", " tPSA": "173.84", " RotatableB": "13", " RigidB": "11", " Flexibility": "0.54", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "516122.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.518", "link_html_complex": "/ACE_complex_html/ACE_IYK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYK.png", "phi_psi": "/peptide_da/IYK.pdb", "link_html_peptide": "/Peptide_html/IYK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYK.pdb", "link_png_peptide": "/Peptide_pics/IYK.png"}
{"Peptide_Sequence": "IYLL", " Origin": "soyabean", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "IEC, GF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "42 mM", " Reference": "Wang, Wenyi, and Elvira Gonzalez De Mejia. \"A new frontier in soy bioactive peptides that may prevent age\u2010related chronic diseases.\" Comprehensive reviews in food science and food safety 4.4 (2005): 63-78.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "596", " Ligand_ID": "IYLL_minimized.pdb_596", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "520.66", " logP": "-0.35", " logD": "-1.12", " logSw": "-1.91", " tPSA": "175.3", " RotatableB": "15", " RigidB": "13", " Flexibility": "0.54", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "27", " HeteroAtoms": "10", " ratio_H_by_C": "0.37", " Lipinski_Violation": "2", " Solubility_mg_per_l": "76913.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 520.661", "link_html_complex": "/ACE_complex_html/ACE_IYLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYLL.png", "phi_psi": "/peptide_da/IYLL.pdb", "link_html_peptide": "/Peptide_html/IYLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYLL.pdb", "link_png_peptide": "/Peptide_pics/IYLL.png"}
{"Peptide_Sequence": "IYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "61", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "598", " Ligand_ID": "IYP_minimized.pdb_598", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "391.46", " logP": "-0.96", " logD": "-2.56", " logSw": "-1.21", " tPSA": "137.41", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "116481.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.461", "link_html_complex": "/ACE_complex_html/ACE_IYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYP.png", "phi_psi": "/peptide_da/IYP.pdb", "link_html_peptide": "/Peptide_html/IYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYP.pdb", "link_png_peptide": "/Peptide_pics/IYP.png"}
{"Peptide_Sequence": "IYPR", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "599", " Ligand_ID": "IYPR_minimized.pdb_599", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "547.65", " logP": "-2.07", " logD": "-3.86", " logSw": "-1", " tPSA": "230.15", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "202111.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 547.647", "link_html_complex": "/ACE_complex_html/ACE_IYPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYPR.png", "phi_psi": "/peptide_da/IYPR.pdb", "link_html_peptide": "/Peptide_html/IYPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYPR.pdb", "link_png_peptide": "/Peptide_pics/IYPR.png"}
{"Peptide_Sequence": "IYPRY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "8.5", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "600", " Ligand_ID": "IYPRY_minimized.pdb_600", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "710.82", " logP": "-0.74", " logD": "-4.99", " logSw": "-2.61", " tPSA": "279.48", " RotatableB": "19", " RigidB": "27", " Flexibility": "0.41", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "35", " HeteroAtoms": "16", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "52019.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 710.82", "link_html_complex": "/ACE_complex_html/ACE_IYPRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYPRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYPRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYPRY.png", "phi_psi": "/peptide_da/IYPRY.pdb", "link_html_peptide": "/Peptide_html/IYPRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYPRY.pdb", "link_png_peptide": "/Peptide_pics/IYPRY.png"}
{"Peptide_Sequence": "IYPSFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "7.6", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1562.81", "link_html_complex": "/ACE_complex_html/ACE_IYPSFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYPSFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYPSFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYPSFQPQPLIYP.png", "phi_psi": "/peptide_da/IYPSFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/IYPSFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYPSFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/IYPSFQPQPLIYP.png"}
{"Peptide_Sequence": "IYSNN", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "602", " Ligand_ID": "IYSNN_minimized.pdb_602", " Smiles": "CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "609.63", " logP": "-7.33", " logD": "-8.3", " logSw": "2.07", " tPSA": "310.81", " RotatableB": "17", " RigidB": "19", " Flexibility": "0.47", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4812180.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 609.629", "link_html_complex": "/ACE_complex_html/ACE_IYSNN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_IYSNN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_IYSNN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_IYSNN.png", "phi_psi": "/peptide_da/IYSNN.pdb", "link_html_peptide": "/Peptide_html/IYSNN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/IYSNN.pdb", "link_png_peptide": "/Peptide_pics/IYSNN.png"}
{"Peptide_Sequence": "KA", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "31.5 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "609", " Ligand_ID": "KA_minimized.pdb_609", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "217.27", " logP": "-3.49", " logD": "-6.44", " logSw": "1.47", " tPSA": "124.51", " RotatableB": "7", " RigidB": "3", " Flexibility": "0.7", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "15", " CarbonAtoms": "9", " HeteroAtoms": "6", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "948397.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 217.265", "link_html_complex": "/ACE_complex_html/ACE_KA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KA.png", "phi_psi": "/peptide_da/KA.pdb", "link_html_peptide": "/Peptide_html/KA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KA.pdb", "link_png_peptide": "/Peptide_pics/KA.png"}
{"Peptide_Sequence": "KAAAAP", " Origin": "Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "19.79 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "603", " Ligand_ID": "KAAAAP_minimized.pdb_603", " Smiles": "C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "527.61", " logP": "-5.89", " logD": "-9.92", " logSw": "1.52", " tPSA": "232.12", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "23", " HeteroAtoms": "14", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2420808.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 527.614", "link_html_complex": "/ACE_complex_html/ACE_KAAAAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAAAAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAAAAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAAAAP.png", "phi_psi": "/peptide_da/KAAAAP.pdb", "link_html_peptide": "/Peptide_html/KAAAAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAAAAP.pdb", "link_png_peptide": "/Peptide_pics/KAAAAP.png"}
{"Peptide_Sequence": "KAAAATP", " Origin": "Dry-cured ham", " Peptide_Preparation": "Artifically synthesized", " Isolation_Method": "solid phase extraction", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "25.64 \u03bcM", " Reference": "Escudero, E., Mora, L., & Toldr\u00e1, F. (2014). Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chemistry, 161, 305\u2013311. doi:10.1016/j.foodchem.2014.03.117", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "604", " Ligand_ID": "KAAAATP_minimized.pdb_604", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "628.72", " logP": "-6.76", " logD": "-11.1", " logSw": "1.64", " tPSA": "281.45", " RotatableB": "17", " RigidB": "18", " Flexibility": "0.49", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "27", " HeteroAtoms": "17", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3250064.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 628.718", "link_html_complex": "/ACE_complex_html/ACE_KAAAATP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAAAATP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAAAATP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAAAATP.png", "phi_psi": "/peptide_da/KAAAATP.pdb", "link_html_peptide": "/Peptide_html/KAAAATP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAAAATP.pdb", "link_png_peptide": "/Peptide_pics/KAAAATP.png"}
{"Peptide_Sequence": "KAEEEYPDL", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "605", " Ligand_ID": "KAEEEYPDL_minimized.pdb_605", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "1093.14", " logP": "-7.09", " logD": "-23.87", " logSw": "0.13", " tPSA": "500.17", " RotatableB": "35", " RigidB": "32", " Flexibility": "0.52", " HBD": "17", " HBA": "29", " HBD_HBA": "46", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "7", " TotalCharge": "-3", " HeavyAtoms": "77", " CarbonAtoms": "48", " HeteroAtoms": "29", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1244187.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1093.14", "link_html_complex": "/ACE_complex_html/ACE_KAEEEYPDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAEEEYPDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAEEEYPDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAEEEYPDL.png", "phi_psi": "/peptide_da/KAEEEYPDL.pdb", "link_html_peptide": "/Peptide_html/KAEEEYPDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAEEEYPDL.pdb", "link_png_peptide": "/Peptide_pics/KAEEEYPDL.png"}
{"Peptide_Sequence": "KAFR", " Origin": "Legume (Peanut (Arachis hypogaea))", " Peptide_Preparation": "Alcalase", " Isolation_Method": "RP-HPLC, UF, MWCO", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "16.9 \u03bcg/ml", " Reference": "Guang, Cuie, and Robert D. Phillips. \"Purification, activity and sequence of angiotensin I converting enzyme inhibitory peptide from alcalase hydrolysate of peanut flour.\" Journal of agricultural and food chemistry 57.21 (2009): 10102-10106.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "606", " Ligand_ID": "KAFR_minimized.pdb_606", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "520.63", " logP": "-3.81", " logD": "-7.84", " logSw": "0.46", " tPSA": "246.35", " RotatableB": "18", " RigidB": "14", " Flexibility": "0.56", " HBD": "12", " HBA": "13", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "826990.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 520.625", "link_html_complex": "/ACE_complex_html/ACE_KAFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAFR.png", "phi_psi": "/peptide_da/KAFR.pdb", "link_html_peptide": "/Peptide_html/KAFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAFR.pdb", "link_png_peptide": "/Peptide_pics/KAFR.png"}
{"Peptide_Sequence": "KAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "330", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "607", " Ligand_ID": "KAIP_minimized.pdb_607", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "427.54", " logP": "-4.06", " logD": "-7.46", " logSw": "0.86", " tPSA": "173.92", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1009395.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 427.538", "link_html_complex": "/ACE_complex_html/ACE_KAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAIP.png", "phi_psi": "/peptide_da/KAIP.pdb", "link_html_peptide": "/Peptide_html/KAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAIP.pdb", "link_png_peptide": "/Peptide_pics/KAIP.png"}
{"Peptide_Sequence": "KALPMHIRLAF", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "11 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "608", " Ligand_ID": "KALPMHIRLAF_minimized.pdb_608", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1296.63", " logP": "-0.33", " logD": "-10.26", " logSw": "-4.94", " tPSA": "495.24", " RotatableB": "42", " RigidB": "38", " Flexibility": "0.53", " HBD": "19", " HBA": "29", " HBD_HBA": "48", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "91", " CarbonAtoms": "61", " HeteroAtoms": "30", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9262.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1296.63", "link_html_complex": "/ACE_complex_html/ACE_KALPMHIRLAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KALPMHIRLAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KALPMHIRLAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KALPMHIRLAF.png", "phi_psi": "/peptide_da/KALPMHIRLAF.pdb", "link_html_peptide": "/Peptide_html/KALPMHIRLAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KALPMHIRLAF.pdb", "link_png_peptide": "/Peptide_pics/KALPMHIRLAF.png"}
{"Peptide_Sequence": "KAPVA", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "610", " Ligand_ID": "KAPVA_minimized.pdb_610", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(O)=O", " MW": "484.59", " logP": "-4.68", " logD": "-8.52", " logSw": "0.96", " tPSA": "203.02", " RotatableB": "13", " RigidB": "14", " Flexibility": "0.48", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1268064.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 484.59", "link_html_complex": "/ACE_complex_html/ACE_KAPVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KAPVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KAPVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KAPVA.png", "phi_psi": "/peptide_da/KAPVA.pdb", "link_html_peptide": "/Peptide_html/KAPVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KAPVA.pdb", "link_png_peptide": "/Peptide_pics/KAPVA.png"}
{"Peptide_Sequence": "KDERF", " Origin": "ovine milk", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "UF, FPLC, RP-HPLC, IT-MS (CE-MS)", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "848 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "611", " Ligand_ID": "KDERF_minimized.pdb_611", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "693.75", " logP": "-7.14", " logD": "-11.66", " logSw": "1.96", " tPSA": "355.71", " RotatableB": "25", " RigidB": "18", " Flexibility": "0.58", " HBD": "15", " HBA": "19", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "30", " HeteroAtoms": "19", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4928642.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 693.749", "link_html_complex": "/ACE_complex_html/ACE_KDERF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KDERF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KDERF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KDERF.png", "phi_psi": "/peptide_da/KDERF.pdb", "link_html_peptide": "/Peptide_html/KDERF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KDERF.pdb", "link_png_peptide": "/Peptide_pics/KDERF.png"}
{"Peptide_Sequence": "KDQGSYEDF", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "612", " Ligand_ID": "KDQGSYEDF_minimized.pdb_612", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1088.08", " logP": "-9.58", " logD": "-19.19", " logSw": "1.76", " tPSA": "532.15", " RotatableB": "36", " RigidB": "34", " Flexibility": "0.51", " HBD": "20", " HBA": "30", " HBD_HBA": "50", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "-2", " HeavyAtoms": "77", " CarbonAtoms": "47", " HeteroAtoms": "30", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6341888.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1088.08", "link_html_complex": "/ACE_complex_html/ACE_KDQGSYEDF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KDQGSYEDF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KDQGSYEDF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KDQGSYEDF.png", "phi_psi": "/peptide_da/KDQGSYEDF.pdb", "link_html_peptide": "/Peptide_html/KDQGSYEDF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KDQGSYEDF.pdb", "link_png_peptide": "/Peptide_pics/KDQGSYEDF.png"}
{"Peptide_Sequence": "KDYRL", " Origin": "Mung bean protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "26.5 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "613", " Ligand_ID": "KDYRL_minimized.pdb_613", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "693.79", " logP": "-5.66", " logD": "-9.93", " logSw": "0.96", " tPSA": "335.81", " RotatableB": "24", " RigidB": "17", " Flexibility": "0.59", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "49", " CarbonAtoms": "31", " HeteroAtoms": "18", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1819039.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 693.792", "link_html_complex": "/ACE_complex_html/ACE_KDYRL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KDYRL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KDYRL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KDYRL.png", "phi_psi": "/peptide_da/KDYRL.pdb", "link_html_peptide": "/Peptide_html/KDYRL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KDYRL.pdb", "link_png_peptide": "/Peptide_pics/KDYRL.png"}
{"Peptide_Sequence": "KE", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": "CoMFA models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "18 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-5.7", "Serial_ID": "616", " Ligand_ID": "KE_minimized.pdb_616", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "275.3", " logP": "-6.28", " logD": "-7.06", " logSw": "3.07", " tPSA": "164.64", " RotatableB": "10", " RigidB": "4", " Flexibility": "0.71", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "5927734.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 275.302", "link_html_complex": "/ACE_complex_html/ACE_KE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KE.png", "phi_psi": "/peptide_da/KE.pdb", "link_html_peptide": "/Peptide_html/KE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KE.pdb", "link_png_peptide": "/Peptide_pics/KE.png"}
{"Peptide_Sequence": "KEDDEEEEQGEEE", " Origin": " pea proteins", " Peptide_Preparation": "fermented with L. plantarum 299v", " Isolation_Method": "GFC, HPLC", " ACE_inhibition_assay": " Chang et al. (2001) with slight modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "64.04 \u03bcg/ml", " Reference": "Jakubczyk, Anna, et al. \"The impact of fermentation and in vitro digestion on formation angiotensin converting enzyme (ACE) inhibitory peptides from pea proteins.\" Food chemistry 141.4 (2013): 3774-3780.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1594.45", "link_html_complex": "/ACE_complex_html/ACE_KEDDEEEEQGEEE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KEDDEEEEQGEEE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KEDDEEEEQGEEE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KEDDEEEEQGEEE.png", "phi_psi": "/peptide_da/KEDDEEEEQGEEE.pdb", "link_html_peptide": "/Peptide_html/KEDDEEEEQGEEE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KEDDEEEEQGEEE.pdb", "link_png_peptide": "/Peptide_pics/KEDDEEEEQGEEE.png"}
{"Peptide_Sequence": "KEDVPSE", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "615", " Ligand_ID": "KEDVPSE_minimized.pdb_615", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "802.83", " logP": "-8.71", " logD": "-18.8", " logSw": "2.39", " tPSA": "401.84", " RotatableB": "26", " RigidB": "21", " Flexibility": "0.55", " HBD": "14", " HBA": "23", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "-2", " HeavyAtoms": "56", " CarbonAtoms": "33", " HeteroAtoms": "23", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8724710.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.827", "link_html_complex": "/ACE_complex_html/ACE_KEDVPSE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KEDVPSE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KEDVPSE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KEDVPSE.png", "phi_psi": "/peptide_da/KEDVPSE.pdb", "link_html_peptide": "/Peptide_html/KEDVPSE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KEDVPSE.pdb", "link_png_peptide": "/Peptide_pics/KEDVPSE.png"}
{"Peptide_Sequence": "KF", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "28", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "619", " Ligand_ID": "KF_minimized.pdb_619", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "293.36", " logP": "-2.71", " logD": "-4.79", " logSw": "0.54", " tPSA": "124.51", " RotatableB": "9", " RigidB": "9", " Flexibility": "0.5", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "15", " HeteroAtoms": "6", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "504191.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 293.361", "link_html_complex": "/ACE_complex_html/ACE_KF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KF.png", "phi_psi": "/peptide_da/KF.pdb", "link_html_peptide": "/Peptide_html/KF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KF.pdb", "link_png_peptide": "/Peptide_pics/KF.png"}
{"Peptide_Sequence": "KFAWPQ", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "177.1 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "617", " Ligand_ID": "KFAWPQ_minimized.pdb_617", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "775.89", " logP": "-2.4", " logD": "-7.7", " logSw": "-1.85", " tPSA": "291", " RotatableB": "21", " RigidB": "34", " Flexibility": "0.38", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "56", " CarbonAtoms": "39", " HeteroAtoms": "17", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "121466.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 775.894", "link_html_complex": "/ACE_complex_html/ACE_KFAWPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KFAWPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KFAWPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KFAWPQ.png", "phi_psi": "/peptide_da/KFAWPQ.pdb", "link_html_peptide": "/Peptide_html/KFAWPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KFAWPQ.pdb", "link_png_peptide": "/Peptide_pics/KFAWPQ.png"}
{"Peptide_Sequence": "KFHSGIQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1538.75", "link_html_complex": "/ACE_complex_html/ACE_KFHSGIQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KFHSGIQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KFHSGIQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KFHSGIQSEPKAIP.png", "phi_psi": "/peptide_da/KFHSGIQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/KFHSGIQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KFHSGIQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/KFHSGIQSEPKAIP.png"}
{"Peptide_Sequence": "KFY", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "45", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "621", " Ligand_ID": "KFY_minimized.pdb_621", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "456.53", " logP": "-2.7", " logD": "-5.23", " logSw": "-0.25", " tPSA": "173.84", " RotatableB": "13", " RigidB": "17", " Flexibility": "0.43", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "24", " HeteroAtoms": "9", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "356214.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 456.535", "link_html_complex": "/ACE_complex_html/ACE_KFY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KFY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KFY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KFY.png", "phi_psi": "/peptide_da/KFY.pdb", "link_html_peptide": "/Peptide_html/KFY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KFY.pdb", "link_png_peptide": "/Peptide_pics/KFY.png"}
{"Peptide_Sequence": "KFYG", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "90", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "620", " Ligand_ID": "KFYG_minimized.pdb_620", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O", " MW": "513.59", " logP": "-1.7", " logD": "-6.72", " logSw": "-1.09", " tPSA": "202.94", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "26", " HeteroAtoms": "11", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "173269.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 513.586", "link_html_complex": "/ACE_complex_html/ACE_KFYG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KFYG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KFYG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KFYG.png", "phi_psi": "/peptide_da/KFYG.pdb", "link_html_peptide": "/Peptide_html/KFYG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KFYG.pdb", "link_png_peptide": "/Peptide_pics/KFYG.png"}
{"Peptide_Sequence": "KG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3200 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.8", "Serial_ID": "623", " Ligand_ID": "KG_minimized.pdb_623", " Smiles": "NCCCC[C@H](N)C(=O)NCC(O)=O", " MW": "203.24", " logP": "-3.89", " logD": "-7.01", " logSw": "1.81", " tPSA": "124.51", " RotatableB": "7", " RigidB": "3", " Flexibility": "0.7", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "14", " CarbonAtoms": "8", " HeteroAtoms": "6", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1245137.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 203.239", "link_html_complex": "/ACE_complex_html/ACE_KG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KG.png", "phi_psi": "/peptide_da/KG.pdb", "link_html_peptide": "/Peptide_html/KG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KG.pdb", "link_png_peptide": "/Peptide_pics/KG.png"}
{"Peptide_Sequence": "KGLWE", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "no activity", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "622", " Ligand_ID": "KGLWE_minimized.pdb_622", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "631.72", " logP": "-4.54", " logD": "-10.91", " logSw": "0.35", " tPSA": "267.73", " RotatableB": "20", " RigidB": "20", " Flexibility": "0.5", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "896035.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 631.72", "link_html_complex": "/ACE_complex_html/ACE_KGLWE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KGLWE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KGLWE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KGLWE.png", "phi_psi": "/peptide_da/KGLWE.pdb", "link_html_peptide": "/Peptide_html/KGLWE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KGLWE.pdb", "link_png_peptide": "/Peptide_pics/KGLWE.png"}
{"Peptide_Sequence": "KGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "172 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "624", " Ligand_ID": "KGP_minimized.pdb_624", " Smiles": "NCCCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "300.35", " logP": "-3.84", " logD": "-8.53", " logSw": "1.25", " tPSA": "144.82", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1043115.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.354", "link_html_complex": "/ACE_complex_html/ACE_KGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KGP.png", "phi_psi": "/peptide_da/KGP.pdb", "link_html_peptide": "/Peptide_html/KGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KGP.pdb", "link_png_peptide": "/Peptide_pics/KGP.png"}
{"Peptide_Sequence": "KGYGGVSL", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "300.9 \u03bcM", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "625", " Ligand_ID": "KGYGGVSL_minimized.pdb_625", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O", " MW": "779.88", " logP": "-5.14", " logD": "-10.56", " logSw": "0.17", " tPSA": "339.57", " RotatableB": "25", " RigidB": "21", " Flexibility": "0.54", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "55", " CarbonAtoms": "35", " HeteroAtoms": "20", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "927448.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 779.881", "link_html_complex": "/ACE_complex_html/ACE_KGYGGVSL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KGYGGVSL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KGYGGVSL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KGYGGVSL.png", "phi_psi": "/peptide_da/KGYGGVSL.pdb", "link_html_peptide": "/Peptide_html/KGYGGVSL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KGYGGVSL.pdb", "link_png_peptide": "/Peptide_pics/KGYGGVSL.png"}
{"Peptide_Sequence": "KGYGGVSLPEW", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.70 \u03bcM", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "626", " Ligand_ID": "KGYGGVSLPEW_minimized.pdb_626", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "1192.32", " logP": "-5.62", " logD": "-13.78", " logSw": "-1.45", " tPSA": "474", " RotatableB": "35", " RigidB": "43", " Flexibility": "0.45", " HBD": "18", " HBA": "29", " HBD_HBA": "47", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "56", " HeteroAtoms": "29", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "280060.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1192.32", "link_html_complex": "/ACE_complex_html/ACE_KGYGGVSLPEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KGYGGVSLPEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KGYGGVSLPEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KGYGGVSLPEW.png", "phi_psi": "/peptide_da/KGYGGVSLPEW.pdb", "link_html_peptide": "/Peptide_html/KGYGGVSLPEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KGYGGVSLPEW.pdb", "link_png_peptide": "/Peptide_pics/KGYGGVSLPEW.png"}
{"Peptide_Sequence": "KHQDFF", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "627", " Ligand_ID": "KHQDFF_minimized.pdb_627", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "820.89", " logP": "-5.87", " logD": "-12.51", " logSw": "0.37", " tPSA": "352.81", " RotatableB": "26", " RigidB": "31", " Flexibility": "0.46", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "39", " HeteroAtoms": "20", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1189908.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 820.891", "link_html_complex": "/ACE_complex_html/ACE_KHQDFF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KHQDFF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KHQDFF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KHQDFF.png", "phi_psi": "/peptide_da/KHQDFF.pdb", "link_html_peptide": "/Peptide_html/KHQDFF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KHQDFF.pdb", "link_png_peptide": "/Peptide_pics/KHQDFF.png"}
{"Peptide_Sequence": "KIEL", " Origin": "Sweet-potato tuber trypsin inhibitor", " Peptide_Preparation": " trypsin_x005F_x0007_Sepharose-4B affinity column", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist et al., 1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "849.7 \u03bcM", " Reference": "Pihlanto, Anne, and Sari Ma\u0308kinen. \"Antihypertensive properties of plant protein derived peptides.\" Bioactive food peptides in health and disease. IntechOpen, 2013.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "628", " Ligand_ID": "KIEL_minimized.pdb_628", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "501.62", " logP": "-4.58", " logD": "-10.17", " logSw": "1.12", " tPSA": "222.84", " RotatableB": "18", " RigidB": "8", " Flexibility": "0.69", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "23", " HeteroAtoms": "12", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1542580.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 501.617", "link_html_complex": "/ACE_complex_html/ACE_KIEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KIEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KIEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KIEL.png", "phi_psi": "/peptide_da/KIEL.pdb", "link_html_peptide": "/Peptide_html/KIEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KIEL.pdb", "link_png_peptide": "/Peptide_pics/KIEL.png"}
{"Peptide_Sequence": "KIHPFAQAQ", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "132.6 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "629", " Ligand_ID": "KIHPFAQAQ_minimized.pdb_629", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1039.19", " logP": "-4.61", " logD": "-11.38", " logSw": "-1.39", " tPSA": "434.28", " RotatableB": "31", " RigidB": "37", " Flexibility": "0.46", " HBD": "17", " HBA": "26", " HBD_HBA": "43", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "74", " CarbonAtoms": "48", " HeteroAtoms": "26", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "259441.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1039.19", "link_html_complex": "/ACE_complex_html/ACE_KIHPFAQAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KIHPFAQAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KIHPFAQAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KIHPFAQAQ.png", "phi_psi": "/peptide_da/KIHPFAQAQ.pdb", "link_html_peptide": "/Peptide_html/KIHPFAQAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KIHPFAQAQ.pdb", "link_png_peptide": "/Peptide_pics/KIHPFAQAQ.png"}
{"Peptide_Sequence": "KIHPFAQTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "39", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-5.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1628.87", "link_html_complex": "/ACE_complex_html/ACE_KIHPFAQTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KIHPFAQTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KIHPFAQTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KIHPFAQTQSLVYP.png", "phi_psi": "/peptide_da/KIHPFAQTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/KIHPFAQTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KIHPFAQTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/KIHPFAQTQSLVYP.png"}
{"Peptide_Sequence": "KIYPSFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "8.6", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-2.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1690.98", "link_html_complex": "/ACE_complex_html/ACE_KIYPSFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KIYPSFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KIYPSFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KIYPSFQPQPLIYP.png", "phi_psi": "/peptide_da/KIYPSFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/KIYPSFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KIYPSFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/KIYPSFQPQPLIYP.png"}
{"Peptide_Sequence": "KKIATYQER", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "632", " Ligand_ID": "KKIATYQER_minimized.pdb_632", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1136.3", " logP": "-8.33", " logD": "-15.02", " logSw": "1.04", " tPSA": "543.17", " RotatableB": "41", " RigidB": "27", " Flexibility": "0.6", " HBD": "24", " HBA": "30", " HBD_HBA": "54", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "80", " CarbonAtoms": "50", " HeteroAtoms": "30", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3221028.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1136.3", "link_html_complex": "/ACE_complex_html/ACE_KKIATYQER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KKIATYQER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KKIATYQER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KKIATYQER.png", "phi_psi": "/peptide_da/KKIATYQER.pdb", "link_html_peptide": "/Peptide_html/KKIATYQER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KKIATYQER.pdb", "link_png_peptide": "/Peptide_pics/KKIATYQER.png"}
{"Peptide_Sequence": "KKYNVPQ", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "716.9 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "634", " Ligand_ID": "KKYNVPQ_minimized.pdb_634", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "876.01", " logP": "-5.17", " logD": "-13.62", " logSw": "-0.27", " tPSA": "395.27", " RotatableB": "27", " RigidB": "28", " Flexibility": "0.49", " HBD": "17", " HBA": "22", " HBD_HBA": "39", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "62", " CarbonAtoms": "40", " HeteroAtoms": "22", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "670650.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 876.011", "link_html_complex": "/ACE_complex_html/ACE_KKYNVPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KKYNVPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KKYNVPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KKYNVPQ.png", "phi_psi": "/peptide_da/KKYNVPQ.pdb", "link_html_peptide": "/Peptide_html/KKYNVPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KKYNVPQ.pdb", "link_png_peptide": "/Peptide_pics/KKYNVPQ.png"}
{"Peptide_Sequence": "KKYNVPQL", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "77.1 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "633", " Ligand_ID": "KKYNVPQL_minimized.pdb_633", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O", " MW": "989.17", " logP": "-4.1", " logD": "-12.87", " logSw": "-1.37", " tPSA": "424.37", " RotatableB": "31", " RigidB": "30", " Flexibility": "0.51", " HBD": "18", " HBA": "24", " HBD_HBA": "42", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "70", " CarbonAtoms": "46", " HeteroAtoms": "24", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "250286.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 989.169", "link_html_complex": "/ACE_complex_html/ACE_KKYNVPQL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KKYNVPQL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KKYNVPQL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KKYNVPQL.png", "phi_psi": "/peptide_da/KKYNVPQL.pdb", "link_html_peptide": "/Peptide_html/KKYNVPQL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KKYNVPQL.pdb", "link_png_peptide": "/Peptide_pics/KKYNVPQL.png"}
{"Peptide_Sequence": "KL", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "213", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "637", " Ligand_ID": "KL_minimized.pdb_637", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "259.35", " logP": "-3.03", " logD": "-5.19", " logSw": "1.05", " tPSA": "124.51", " RotatableB": "9", " RigidB": "3", " Flexibility": "0.75", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "744803", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 259.345", "link_html_complex": "/ACE_complex_html/ACE_KL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KL.png", "phi_psi": "/peptide_da/KL.pdb", "link_html_peptide": "/Peptide_html/KL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KL.pdb", "link_png_peptide": "/Peptide_pics/KL.png"}
{"Peptide_Sequence": "KLEK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "635", " Ligand_ID": "KLEK_minimized.pdb_635", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "516.63", " logP": "-5.7", " logD": "-8.42", " logSw": "1.87", " tPSA": "250.48", " RotatableB": "20", " RigidB": "8", " Flexibility": "0.71", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3344975.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 516.631", "link_html_complex": "/ACE_complex_html/ACE_KLEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLEK.png", "phi_psi": "/peptide_da/KLEK.pdb", "link_html_peptide": "/Peptide_html/KLEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLEK.pdb", "link_png_peptide": "/Peptide_pics/KLEK.png"}
{"Peptide_Sequence": "KLKFV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "30.2 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "636", " Ligand_ID": "KLKFV_minimized.pdb_636", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "633.82", " logP": "-2.3", " logD": "-8.58", " logSw": "-0.91", " tPSA": "239.45", " RotatableB": "22", " RigidB": "15", " Flexibility": "0.59", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "45", " CarbonAtoms": "32", " HeteroAtoms": "13", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "254339.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 633.822", "link_html_complex": "/ACE_complex_html/ACE_KLKFV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLKFV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLKFV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLKFV.png", "phi_psi": "/peptide_da/KLKFV.pdb", "link_html_peptide": "/Peptide_html/KLKFV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLKFV.pdb", "link_png_peptide": "/Peptide_pics/KLKFV.png"}
{"Peptide_Sequence": "KLP", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "500", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "639", " Ligand_ID": "KLP_minimized.pdb_639", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.46", " logP": "-3.14", " logD": "-6.67", " logSw": "0.59", " tPSA": "144.82", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "641859.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.46", "link_html_complex": "/ACE_complex_html/ACE_KLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLP.png", "phi_psi": "/peptide_da/KLP.pdb", "link_html_peptide": "/Peptide_html/KLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLP.pdb", "link_png_peptide": "/Peptide_pics/KLP.png"}
{"Peptide_Sequence": "KLPAGTLF", " Origin": "Mung bean protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "13.4 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "638", " Ligand_ID": "KLPAGTLF_minimized.pdb_638", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "846.02", " logP": "-1.49", " logD": "-8.03", " logSw": "-2.53", " tPSA": "310.55", " RotatableB": "25", " RigidB": "26", " Flexibility": "0.49", " HBD": "12", " HBA": "19", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "60", " CarbonAtoms": "41", " HeteroAtoms": "19", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67284.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 846.025", "link_html_complex": "/ACE_complex_html/ACE_KLPAGTLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLPAGTLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLPAGTLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLPAGTLF.png", "phi_psi": "/peptide_da/KLPAGTLF.pdb", "link_html_peptide": "/Peptide_html/KLPAGTLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLPAGTLF.pdb", "link_png_peptide": "/Peptide_pics/KLPAGTLF.png"}
{"Peptide_Sequence": "KLRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "91.6 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "640", " Ligand_ID": "KLRP_minimized.pdb_640", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "512.65", " logP": "-4.88", " logD": "-9.91", " logSw": "1.18", " tPSA": "237.56", " RotatableB": "17", " RigidB": "13", " Flexibility": "0.57", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1664999.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.646", "link_html_complex": "/ACE_complex_html/ACE_KLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLRP.png", "phi_psi": "/peptide_da/KLRP.pdb", "link_html_peptide": "/Peptide_html/KLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLRP.pdb", "link_png_peptide": "/Peptide_pics/KLRP.png"}
{"Peptide_Sequence": "KLSDW", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "no activity", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "641", " Ligand_ID": "KLSDW_minimized.pdb_641", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "647.72", " logP": "-6.35", " logD": "-11.71", " logSw": "1.39", " tPSA": "287.96", " RotatableB": "20", " RigidB": "20", " Flexibility": "0.5", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "30", " HeteroAtoms": "16", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2604272.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 647.72", "link_html_complex": "/ACE_complex_html/ACE_KLSDW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLSDW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLSDW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLSDW.png", "phi_psi": "/peptide_da/KLSDW.pdb", "link_html_peptide": "/Peptide_html/KLSDW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLSDW.pdb", "link_png_peptide": "/Peptide_pics/KLSDW.png"}
{"Peptide_Sequence": "KLYMRP", " Origin": "Peanut", " Peptide_Preparation": "alcalase", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung\u2019s method with slight modification", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.42 \u03bcM", " Reference": "Shi, Aimin, et al. \"Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide.\" PloS one 9.10 (2014): e111188.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "642", " Ligand_ID": "KLYMRP_minimized.pdb_642", " Smiles": "CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "807.02", " logP": "-3.51", " logD": "-8.98", " logSw": "-0.95", " tPSA": "341.29", " RotatableB": "26", " RigidB": "23", " Flexibility": "0.53", " HBD": "14", " HBA": "18", " HBD_HBA": "32", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "56", " CarbonAtoms": "37", " HeteroAtoms": "19", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "310915.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 807.015", "link_html_complex": "/ACE_complex_html/ACE_KLYMRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KLYMRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KLYMRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KLYMRP.png", "phi_psi": "/peptide_da/KLYMRP.pdb", "link_html_peptide": "/Peptide_html/KLYMRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KLYMRP.pdb", "link_png_peptide": "/Peptide_pics/KLYMRP.png"}
{"Peptide_Sequence": "KNGDGY", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "51.63 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "643", " Ligand_ID": "KNGDGY_minimized.pdb_643", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "652.65", " logP": "-8.74", " logD": "-15.52", " logSw": "2.95", " tPSA": "344.36", " RotatableB": "21", " RigidB": "20", " Flexibility": "0.51", " HBD": "14", " HBA": "19", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "27", " HeteroAtoms": "19", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12521053.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 652.653", "link_html_complex": "/ACE_complex_html/ACE_KNGDGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KNGDGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KNGDGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KNGDGY.png", "phi_psi": "/peptide_da/KNGDGY.pdb", "link_html_peptide": "/Peptide_html/KNGDGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KNGDGY.pdb", "link_png_peptide": "/Peptide_pics/KNGDGY.png"}
{"Peptide_Sequence": "KP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": "CoMFA models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "11 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "645", " Ligand_ID": "KP_minimized.pdb_645", " Smiles": "NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "243.3", " logP": "-3.32", " logD": "-6.17", " logSw": "1.14", " tPSA": "115.72", " RotatableB": "6", " RigidB": "8", " Flexibility": "0.43", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "17", " CarbonAtoms": "11", " HeteroAtoms": "6", " ratio_H_by_C": "0.55", " Lipinski_Violation": "0", " Solubility_mg_per_l": "760084.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.303", "link_html_complex": "/ACE_complex_html/ACE_KP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KP.png", "phi_psi": "/peptide_da/KP.pdb", "link_html_peptide": "/Peptide_html/KP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KP.pdb", "link_png_peptide": "/Peptide_pics/KP.png"}
{"Peptide_Sequence": "KPGRP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "67.08 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "644", " Ligand_ID": "KPGRP_minimized.pdb_644", " Smiles": "NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "553.65", " logP": "-4.86", " logD": "-11.99", " logSw": "0.85", " tPSA": "257.87", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1289076.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 553.655", "link_html_complex": "/ACE_complex_html/ACE_KPGRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KPGRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KPGRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KPGRP.png", "phi_psi": "/peptide_da/KPGRP.pdb", "link_html_peptide": "/Peptide_html/KPGRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KPGRP.pdb", "link_png_peptide": "/Peptide_pics/KPGRP.png"}
{"Peptide_Sequence": "KPPETV", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "24.1 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "646", " Ligand_ID": "KPPETV_minimized.pdb_646", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(O)=O", " MW": "669.77", " logP": "-6.34", " logD": "-13.07", " logSw": "1.19", " tPSA": "283.69", " RotatableB": "18", " RigidB": "22", " Flexibility": "0.45", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2200797.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 669.767", "link_html_complex": "/ACE_complex_html/ACE_KPPETV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KPPETV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KPPETV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KPPETV.png", "phi_psi": "/peptide_da/KPPETV.pdb", "link_html_peptide": "/Peptide_html/KPPETV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KPPETV.pdb", "link_png_peptide": "/Peptide_pics/KPPETV.png"}
{"Peptide_Sequence": "KPVAAP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "12.37", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "647", " Ligand_ID": "KPVAAP_minimized.pdb_647", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "581.7", " logP": "-2.93", " logD": "-8.75", " logSw": "-0.68", " tPSA": "223.33", " RotatableB": "14", " RigidB": "21", " Flexibility": "0.4", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "295684.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 581.705", "link_html_complex": "/ACE_complex_html/ACE_KPVAAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KPVAAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KPVAAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KPVAAP.png", "phi_psi": "/peptide_da/KPVAAP.pdb", "link_html_peptide": "/Peptide_html/KPVAAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KPVAAP.pdb", "link_png_peptide": "/Peptide_pics/KPVAAP.png"}
{"Peptide_Sequence": "KR", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "380 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "648", " Ligand_ID": "KR_minimized.pdb_648", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "302.37", " logP": "-4.31", " logD": "-8.63", " logSw": "1.79", " tPSA": "188.15", " RotatableB": "12", " RigidB": "4", " Flexibility": "0.75", " HBD": "10", " HBA": "9", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1815739.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 302.373", "link_html_complex": "/ACE_complex_html/ACE_KR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KR.png", "phi_psi": "/peptide_da/KR.pdb", "link_html_peptide": "/Peptide_html/KR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KR.pdb", "link_png_peptide": "/Peptide_pics/KR.png"}
{"Peptide_Sequence": "KRQKYDI", " Origin": "Porcine Skeletal Muscle Troponin", " Peptide_Preparation": "Katayama et al (2003)", " Isolation_Method": "AEC, RP-HPLC, GF", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "26.2 \u03bcM", " Reference": "Katayama, Kazunori, et al. \"Porcine skeletal muscle troponin is a good source of peptides with angiotensin-I converting enzyme inhibitory activity and antihypertensive effects in spontaneously hypertensive rats.\" Journal of Agricultural and Food Chemistry 56.2 (2007): 355-360.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "649", " Ligand_ID": "KRQKYDI_minimized.pdb_649", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "950.09", " logP": "-7.57", " logD": "-19.22", " logSw": "1.32", " tPSA": "464.74", " RotatableB": "35", " RigidB": "23", " Flexibility": "0.6", " HBD": "21", " HBA": "25", " HBD_HBA": "46", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "67", " CarbonAtoms": "42", " HeteroAtoms": "25", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3543637.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 950.093", "link_html_complex": "/ACE_complex_html/ACE_KRQKYDI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KRQKYDI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KRQKYDI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KRQKYDI.png", "phi_psi": "/peptide_da/KRQKYDI.pdb", "link_html_peptide": "/Peptide_html/KRQKYDI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KRQKYDI.pdb", "link_png_peptide": "/Peptide_pics/KRQKYDI.png"}
{"Peptide_Sequence": "KRVIQY", " Origin": "Porcine myosin B", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "6.1 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "650", " Ligand_ID": "KRVIQY_minimized.pdb_650", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "805.96", " logP": "-2.96", " logD": "-11.15", " logSw": "-1.16", " tPSA": "367.87", " RotatableB": "28", " RigidB": "20", " Flexibility": "0.58", " HBD": "17", " HBA": "20", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "252360.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 805.964", "link_html_complex": "/ACE_complex_html/ACE_KRVIQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KRVIQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KRVIQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KRVIQY.png", "phi_psi": "/peptide_da/KRVIQY.pdb", "link_html_peptide": "/Peptide_html/KRVIQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KRVIQY.pdb", "link_png_peptide": "/Peptide_pics/KRVIQY.png"}
{"Peptide_Sequence": "KTAP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "37", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "651", " Ligand_ID": "KTAP_minimized.pdb_651", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "415.48", " logP": "-6", " logD": "-9.53", " logSw": "2.09", " tPSA": "194.15", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3359143.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.485", "link_html_complex": "/ACE_complex_html/ACE_KTAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KTAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KTAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KTAP.png", "phi_psi": "/peptide_da/KTAP.pdb", "link_html_peptide": "/Peptide_html/KTAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KTAP.pdb", "link_png_peptide": "/Peptide_pics/KTAP.png"}
{"Peptide_Sequence": "KTEIPTIN", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity\n", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "652", " Ligand_ID": "KTEIPTIN_minimized.pdb_652", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "915.04", " logP": "-7.61", " logD": "-14.69", " logSw": "1.2", " tPSA": "414", " RotatableB": "29", " RigidB": "23", " Flexibility": "0.56", " HBD": "16", " HBA": "24", " HBD_HBA": "40", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "40", " HeteroAtoms": "24", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3023007.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 915.042", "link_html_complex": "/ACE_complex_html/ACE_KTEIPTIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KTEIPTIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KTEIPTIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KTEIPTIN.png", "phi_psi": "/peptide_da/KTEIPTIN.pdb", "link_html_peptide": "/Peptide_html/KTEIPTIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KTEIPTIN.pdb", "link_png_peptide": "/Peptide_pics/KTEIPTIN.png"}
{"Peptide_Sequence": "KVAGPK", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "304.9", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "653", " Ligand_ID": "KVAGPK_minimized.pdb_653", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "598.74", " logP": "-5.57", " logD": "-9.38", " logSw": "1.21", " tPSA": "259.76", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2009740.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 598.735", "link_html_complex": "/ACE_complex_html/ACE_KVAGPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVAGPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVAGPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVAGPK.png", "phi_psi": "/peptide_da/KVAGPK.pdb", "link_html_peptide": "/Peptide_html/KVAGPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVAGPK.pdb", "link_png_peptide": "/Peptide_pics/KVAGPK.png"}
{"Peptide_Sequence": "KVF", " Origin": "hen egg white lysozyme", " Peptide_Preparation": " simulated human gastrointestinal digestion", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "14", " Reference": "Rao, Shengqi, et al. \"ACE inhibitory peptides and antioxidant peptides derived from in vitro digestion hydrolysate of hen egg white lysozyme.\" Food chemistry 135.3 (2012): 1245-1252.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "654", " Ligand_ID": "KVF_minimized.pdb_654", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "392.49", " logP": "-2.87", " logD": "-5.65", " logSw": "0.25", " tPSA": "153.61", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "505305.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.493", "link_html_complex": "/ACE_complex_html/ACE_KVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVF.png", "phi_psi": "/peptide_da/KVF.pdb", "link_html_peptide": "/Peptide_html/KVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVF.pdb", "link_png_peptide": "/Peptide_pics/KVF.png"}
{"Peptide_Sequence": "KVGTKCCAKP", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "30 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "655", " Ligand_ID": "KVGTKCCAKP_minimized.pdb_655", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1034.3", " logP": "-5.89", " logD": "-16.11", " logSw": "-0.3", " tPSA": "501.63", " RotatableB": "34", " RigidB": "24", " Flexibility": "0.59", " HBD": "18", " HBA": "25", " HBD_HBA": "43", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "70", " CarbonAtoms": "43", " HeteroAtoms": "27", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "767804", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1034.3", "link_html_complex": "/ACE_complex_html/ACE_KVGTKCCAKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVGTKCCAKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVGTKCCAKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVGTKCCAKP.png", "phi_psi": "/peptide_da/KVGTKCCAKP.pdb", "link_html_peptide": "/Peptide_html/KVGTKCCAKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVGTKCCAKP.pdb", "link_png_peptide": "/Peptide_pics/KVGTKCCAKP.png"}
{"Peptide_Sequence": "KVHSSIQSQPQAFT", " Origin": "mouse", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1001 \u03bcM", " Reference": "ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1557.71", "link_html_complex": "/ACE_complex_html/ACE_KVHSSIQSQPQAFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVHSSIQSQPQAFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVHSSIQSQPQAFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVHSSIQSQPQAFT.png", "phi_psi": "/peptide_da/KVHSSIQSQPQAFT.pdb", "link_html_peptide": "/Peptide_html/KVHSSIQSQPQAFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVHSSIQSQPQAFT.pdb", "link_png_peptide": "/Peptide_pics/KVHSSIQSQPQAFT.png"}
{"Peptide_Sequence": "KVLAGM", " Origin": "Sardine Meat", " Peptide_Preparation": "peptic hydrolysis", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "30 \u03bcM", " Reference": "Ukeda, Hiroyuki, et al. \"Peptides from peptic hydrolyzate of heated sardine meat that inhibit angiotensin I converting enzyme.\" Nippon Nogeikagaku Kaishi 66.1 (1992): 25-29.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "657", " Ligand_ID": "KVLAGM_minimized.pdb_657", " Smiles": "CSCC[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O", " MW": "617.8", " logP": "-3.18", " logD": "-7.96", " logSw": "-0.28", " tPSA": "266.21", " RotatableB": "21", " RigidB": "11", " Flexibility": "0.66", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "466471.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.802", "link_html_complex": "/ACE_complex_html/ACE_KVLAGM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLAGM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLAGM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLAGM.png", "phi_psi": "/peptide_da/KVLAGM.pdb", "link_html_peptide": "/Peptide_html/KVLAGM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLAGM.pdb", "link_png_peptide": "/Peptide_pics/KVLAGM.png"}
{"Peptide_Sequence": "KVLILA", " Origin": "Milk casein", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "20.85 \u03bcM", " Reference": "Wang, Zhan-Li, et al. \"A novel angiotensin I converting enzyme inhibitory peptide from the milk casein: virtual screening and docking studies.\" Agricultural sciences in China 10.3 (2011): 463-467.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "658", " Ligand_ID": "KVLILA_minimized.pdb_658", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "655.87", " logP": "-0.06", " logD": "-5.47", " logSw": "-2.42", " tPSA": "240.91", " RotatableB": "22", " RigidB": "11", " Flexibility": "0.67", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "32", " HeteroAtoms": "14", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "58520.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 655.869", "link_html_complex": "/ACE_complex_html/ACE_KVLILA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLILA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLILA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLILA.png", "phi_psi": "/peptide_da/KVLILA.pdb", "link_html_peptide": "/Peptide_html/KVLILA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLILA.pdb", "link_png_peptide": "/Peptide_pics/KVLILA.png"}
{"Peptide_Sequence": "KVLPG", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "265.44 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "659", " Ligand_ID": "KVLPG_minimized.pdb_659", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "512.64", " logP": "-3.76", " logD": "-7.84", " logSw": "0.34", " tPSA": "203.02", " RotatableB": "15", " RigidB": "14", " Flexibility": "0.52", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "24", " HeteroAtoms": "12", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "720535.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.643", "link_html_complex": "/ACE_complex_html/ACE_KVLPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLPG.png", "phi_psi": "/peptide_da/KVLPG.pdb", "link_html_peptide": "/Peptide_html/KVLPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLPG.pdb", "link_png_peptide": "/Peptide_pics/KVLPG.png"}
{"Peptide_Sequence": "KVLPVP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "661", " Ligand_ID": "KVLPVP_minimized.pdb_661", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "651.84", " logP": "-2.35", " logD": "-6.64", " logSw": "-1.28", " tPSA": "223.33", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "32", " HeteroAtoms": "14", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "181435.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 651.838", "link_html_complex": "/ACE_complex_html/ACE_KVLPVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLPVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLPVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLPVP.png", "phi_psi": "/peptide_da/KVLPVP.pdb", "link_html_peptide": "/Peptide_html/KVLPVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLPVP.pdb", "link_png_peptide": "/Peptide_pics/KVLPVP.png"}
{"Peptide_Sequence": "KVLPVPE", " Origin": "Fermented Milks", " Peptide_Preparation": "Lactobacillus delbrueckii subsp. bulgaricus SS1 and L. lactis subsp. cremoris FT4", " Isolation_Method": "RP-FPLC,  gel filtration ", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 5 \u03bcM", " Reference": "Gobbetti, Marco, et al. \"Production of Angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckiisubsp. bulgaricus SS1 and Lactococcus lactissubsp. cremoris FT4.\" Appl. Environ. Microbiol. 66.9 (2000): 3898-3904.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "660", " Ligand_ID": "KVLPVPE_minimized.pdb_660", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "780.95", " logP": "-5.39", " logD": "-10.89", " logSw": "0.17", " tPSA": "292.56", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "37", " HeteroAtoms": "18", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "921785.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 780.952", "link_html_complex": "/ACE_complex_html/ACE_KVLPVPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLPVPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLPVPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLPVPE.png", "phi_psi": "/peptide_da/KVLPVPE.pdb", "link_html_peptide": "/Peptide_html/KVLPVPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLPVPE.pdb", "link_png_peptide": "/Peptide_pics/KVLPVPE.png"}
{"Peptide_Sequence": "KVLPVPQ", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "662", " Ligand_ID": "KVLPVPQ_minimized.pdb_662", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "779.97", " logP": "-3.76", " logD": "-8.37", " logSw": "-0.85", " tPSA": "295.52", " RotatableB": "22", " RigidB": "25", " Flexibility": "0.47", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "55", " CarbonAtoms": "37", " HeteroAtoms": "18", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "331708.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 779.967", "link_html_complex": "/ACE_complex_html/ACE_KVLPVPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVLPVPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVLPVPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVLPVPQ.png", "phi_psi": "/peptide_da/KVLPVPQ.pdb", "link_html_peptide": "/Peptide_html/KVLPVPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVLPVPQ.pdb", "link_png_peptide": "/Peptide_pics/KVLPVPQ.png"}
{"Peptide_Sequence": "KVREGT", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "7.59 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "663", " Ligand_ID": "KVREGT_minimized.pdb_663", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "688.77", " logP": "-8.17", " logD": "-17.6", " logSw": "2.69", " tPSA": "364.91", " RotatableB": "25", " RigidB": "13", " Flexibility": "0.66", " HBD": "16", " HBA": "20", " HBD_HBA": "36", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "28", " HeteroAtoms": "20", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10113403.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 688.774", "link_html_complex": "/ACE_complex_html/ACE_KVREGT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVREGT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVREGT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVREGT.png", "phi_psi": "/peptide_da/KVREGT.pdb", "link_html_peptide": "/Peptide_html/KVREGT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVREGT.pdb", "link_png_peptide": "/Peptide_pics/KVREGT.png"}
{"Peptide_Sequence": "KVREGTTY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "102.8 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "664", " Ligand_ID": "KVREGTTY_minimized.pdb_664", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "953.05", " logP": "-8.08", " logD": "-17.97", " logSw": "1.42", " tPSA": "463.57", " RotatableB": "32", " RigidB": "23", " Flexibility": "0.58", " HBD": "20", " HBA": "26", " HBD_HBA": "46", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "67", " CarbonAtoms": "41", " HeteroAtoms": "26", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3945240.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 953.051", "link_html_complex": "/ACE_complex_html/ACE_KVREGTTY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KVREGTTY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KVREGTTY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KVREGTTY.png", "phi_psi": "/peptide_da/KVREGTTY.pdb", "link_html_peptide": "/Peptide_html/KVREGTTY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KVREGTTY.pdb", "link_png_peptide": "/Peptide_pics/KVREGTTY.png"}
{"Peptide_Sequence": "KW", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "1.63 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "667", " Ligand_ID": "KW_minimized.pdb_667", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "332.4", " logP": "-2.38", " logD": "-4.69", " logSw": "0.05", " tPSA": "140.3", " RotatableB": "9", " RigidB": "13", " Flexibility": "0.41", " HBD": "7", " HBA": "7", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "1", " Solubility_mg_per_l": "350765.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 332.397", "link_html_complex": "/ACE_complex_html/ACE_KW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KW.png", "phi_psi": "/peptide_da/KW.pdb", "link_html_peptide": "/Peptide_html/KW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KW.pdb", "link_png_peptide": "/Peptide_pics/KW.png"}
{"Peptide_Sequence": "KWL", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "43.6  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "665", " Ligand_ID": "KWL_minimized.pdb_665", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(O)=O", " MW": "445.56", " logP": "-1.22", " logD": "-5.19", " logSw": "-1.08", " tPSA": "169.4", " RotatableB": "13", " RigidB": "15", " Flexibility": "0.46", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "23", " HeteroAtoms": "9", " ratio_H_by_C": "0.39", " Lipinski_Violation": "1", " Solubility_mg_per_l": "152029.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 445.555", "link_html_complex": "/ACE_complex_html/ACE_KWL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KWL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KWL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KWL.png", "phi_psi": "/peptide_da/KWL.pdb", "link_html_peptide": "/Peptide_html/KWL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KWL.pdb", "link_png_peptide": "/Peptide_pics/KWL.png"}
{"Peptide_Sequence": "KWLP", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "5.0  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "666", " Ligand_ID": "KWLP_minimized.pdb_666", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "542.67", " logP": "-0.4", " logD": "-5.81", " logSw": "-2.11", " tPSA": "189.71", " RotatableB": "14", " RigidB": "22", " Flexibility": "0.39", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "28", " HeteroAtoms": "11", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "65741.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 542.67", "link_html_complex": "/ACE_complex_html/ACE_KWLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KWLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KWLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KWLP.png", "phi_psi": "/peptide_da/KWLP.pdb", "link_html_peptide": "/Peptide_html/KWLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KWLP.pdb", "link_png_peptide": "/Peptide_pics/KWLP.png"}
{"Peptide_Sequence": "KY", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "13", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "668", " Ligand_ID": "KY_minimized.pdb_668", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "309.36", " logP": "-3.5", " logD": "-5.1", " logSw": "0.94", " tPSA": "144.74", " RotatableB": "9", " RigidB": "9", " Flexibility": "0.5", " HBD": "7", " HBA": "7", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "22", " CarbonAtoms": "15", " HeteroAtoms": "7", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "793778.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 309.361", "link_html_complex": "/ACE_complex_html/ACE_KY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KY.png", "phi_psi": "/peptide_da/KY.pdb", "link_html_peptide": "/Peptide_html/KY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KY.pdb", "link_png_peptide": "/Peptide_pics/KY.png"}
{"Peptide_Sequence": "KYPVQPFTESQSLTL", " Origin": "beta-casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "93", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "-4.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1737.95", "link_html_complex": "/ACE_complex_html/ACE_KYPVQPFTESQSLTL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KYPVQPFTESQSLTL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KYPVQPFTESQSLTL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KYPVQPFTESQSLTL.png", "phi_psi": "/peptide_da/KYPVQPFTESQSLTL.pdb", "link_html_peptide": "/Peptide_html/KYPVQPFTESQSLTL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KYPVQPFTESQSLTL.pdb", "link_png_peptide": "/Peptide_pics/KYPVQPFTESQSLTL.png"}
{"Peptide_Sequence": "KYY", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "79", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "670", " Ligand_ID": "KYY_minimized.pdb_670", " Smiles": "NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "472.53", " logP": "-3.06", " logD": "-5.54", " logSw": "-0.12", " tPSA": "194.07", " RotatableB": "13", " RigidB": "17", " Flexibility": "0.43", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "24", " HeteroAtoms": "10", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "419747.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.534", "link_html_complex": "/ACE_complex_html/ACE_KYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_KYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_KYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_KYY.png", "phi_psi": "/peptide_da/KYY.pdb", "link_html_peptide": "/Peptide_html/KYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/KYY.pdb", "link_png_peptide": "/Peptide_pics/KYY.png"}
{"Peptide_Sequence": "LAA", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "13", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "671", " Ligand_ID": "LAA_minimized.pdb_671", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O", " MW": "273.33", " logP": "-3.35", " logD": "-4.22", " logSw": "1.04", " tPSA": "125.97", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "0", " Solubility_mg_per_l": "771654.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 273.329", "link_html_complex": "/ACE_complex_html/ACE_LAA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAA.png", "phi_psi": "/peptide_da/LAA.pdb", "link_html_peptide": "/Peptide_html/LAA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAA.pdb", "link_png_peptide": "/Peptide_pics/LAA.png"}
{"Peptide_Sequence": "LAHKAL", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "621 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "672", " Ligand_ID": "LAHKAL_minimized.pdb_672", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "651.8", " logP": "-2.09", " logD": "-8.14", " logSw": "-1.22", " tPSA": "269.59", " RotatableB": "21", " RigidB": "16", " Flexibility": "0.57", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "30", " HeteroAtoms": "16", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "193236.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 651.798", "link_html_complex": "/ACE_complex_html/ACE_LAHKAL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAHKAL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAHKAL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAHKAL.png", "phi_psi": "/peptide_da/LAHKAL.pdb", "link_html_peptide": "/Peptide_html/LAHKAL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAHKAL.pdb", "link_png_peptide": "/Peptide_pics/LAHKAL.png"}
{"Peptide_Sequence": "LAIPVNKP", " Origin": "Soybean ((\u03b2-conglycinin and glycinin)", " Peptide_Preparation": "acid proteinase from Monascus purpureus", " Isolation_Method": "IEC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "70 \u03bcM", " Reference": "Kuba, M., et al. \"Production of angiotensin I-converting enzyme inhibitory peptides from soybean protein with Monascus purpureus acid proteinase.\" Process Biochemistry 40.6 (2005): 2191-2196.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "673", " Ligand_ID": "LAIPVNKP_minimized.pdb_673", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "851.04", " logP": "-2.31", " logD": "-7.34", " logSw": "-2.08", " tPSA": "324.62", " RotatableB": "24", " RigidB": "27", " Flexibility": "0.47", " HBD": "12", " HBA": "20", " HBD_HBA": "32", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "60", " CarbonAtoms": "40", " HeteroAtoms": "20", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "106621.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 851.045", "link_html_complex": "/ACE_complex_html/ACE_LAIPVNKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAIPVNKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAIPVNKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAIPVNKP.png", "phi_psi": "/peptide_da/LAIPVNKP.pdb", "link_html_peptide": "/Peptide_html/LAIPVNKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAIPVNKP.pdb", "link_png_peptide": "/Peptide_pics/LAIPVNKP.png"}
{"Peptide_Sequence": "LALPP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "790", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "674", " Ligand_ID": "LALPP_minimized.pdb_674", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "509.64", " logP": "-2.45", " logD": "-3.86", " logSw": "-0.73", " tPSA": "166.59", " RotatableB": "11", " RigidB": "19", " Flexibility": "0.37", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "25", " HeteroAtoms": "11", " ratio_H_by_C": "0.44", " Lipinski_Violation": "2", " Solubility_mg_per_l": "245535.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.639", "link_html_complex": "/ACE_complex_html/ACE_LALPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LALPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LALPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LALPP.png", "phi_psi": "/peptide_da/LALPP.pdb", "link_html_peptide": "/Peptide_html/LALPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LALPP.pdb", "link_png_peptide": "/Peptide_pics/LALPP.png"}
{"Peptide_Sequence": "LALR", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "  1268 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "675", " Ligand_ID": "LALR_minimized.pdb_675", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "471.59", " logP": "-3.1", " logD": "-4.24", " logSw": "0.25", " tPSA": "218.71", " RotatableB": "16", " RigidB": "8", " Flexibility": "0.67", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "602588.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 471.594", "link_html_complex": "/ACE_complex_html/ACE_LALR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LALR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LALR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LALR.png", "phi_psi": "/peptide_da/LALR.pdb", "link_html_peptide": "/Peptide_html/LALR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LALR.pdb", "link_png_peptide": "/Peptide_pics/LALR.png"}
{"Peptide_Sequence": "LAMA", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1062", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "676", " Ligand_ID": "LAMA_minimized.pdb_676", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "404.52", " logP": "-2.38", " logD": "-4.41", " logSw": "-0.06", " tPSA": "180.37", " RotatableB": "12", " RigidB": "7", " Flexibility": "0.63", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "382244.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 404.525", "link_html_complex": "/ACE_complex_html/ACE_LAMA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAMA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAMA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAMA.png", "phi_psi": "/peptide_da/LAMA.pdb", "link_html_peptide": "/Peptide_html/LAMA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAMA.pdb", "link_png_peptide": "/Peptide_pics/LAMA.png"}
{"Peptide_Sequence": "LAP", " Origin": "chicken muscle", " Peptide_Preparation": "thermolysin", " Isolation_Method": "ODS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.5", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "677", " Ligand_ID": "LAP_minimized.pdb_677", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "299.37", " logP": "-2.9", " logD": "-3.95", " logSw": "0.53", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "507043.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 299.366", "link_html_complex": "/ACE_complex_html/ACE_LAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAP.png", "phi_psi": "/peptide_da/LAP.pdb", "link_html_peptide": "/Peptide_html/LAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAP.pdb", "link_png_peptide": "/Peptide_pics/LAP.png"}
{"Peptide_Sequence": "LAPSLPGKPKPD", " Origin": "egg yolk", " Peptide_Preparation": "unconventional proteinase from Asian pumpkin", " Isolation_Method": "ultrafiltration, HPLC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung with modification described by Miguel et. al. 2004", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.97 \u03bcmol/L", " Reference": "Eckert, Ewelina, et al. \"Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia).\" Journal of proteomics 110 (2014): 107-116.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "678", " Ligand_ID": "LAPSLPGKPKPD_minimized.pdb_678", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "1219.43", " logP": "-7", " logD": "-17.38", " logSw": "-0.75", " tPSA": "468.35", " RotatableB": "34", " RigidB": "44", " Flexibility": "0.44", " HBD": "16", " HBA": "30", " HBD_HBA": "46", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "86", " CarbonAtoms": "56", " HeteroAtoms": "30", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "578057.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1219.43", "link_html_complex": "/ACE_complex_html/ACE_LAPSLPGKPKPD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAPSLPGKPKPD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAPSLPGKPKPD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAPSLPGKPKPD.png", "phi_psi": "/peptide_da/LAPSLPGKPKPD.pdb", "link_html_peptide": "/Peptide_html/LAPSLPGKPKPD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAPSLPGKPKPD.pdb", "link_png_peptide": "/Peptide_pics/LAPSLPGKPKPD.png"}
{"Peptide_Sequence": "LASPTM", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "679", " Ligand_ID": "LASPTM_minimized.pdb_679", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(O)=O", " MW": "618.74", " logP": "-5.18", " logD": "-6.97", " logSw": "0.71", " tPSA": "270.24", " RotatableB": "17", " RigidB": "16", " Flexibility": "0.52", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "26", " HeteroAtoms": "16", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1257501.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.743", "link_html_complex": "/ACE_complex_html/ACE_LASPTM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LASPTM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LASPTM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LASPTM.png", "phi_psi": "/peptide_da/LASPTM.pdb", "link_html_peptide": "/Peptide_html/LASPTM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LASPTM.pdb", "link_png_peptide": "/Peptide_pics/LASPTM.png"}
{"Peptide_Sequence": "LAY", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.9", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "681", " Ligand_ID": "LAY_minimized.pdb_681", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "365.42", " logP": "-2.66", " logD": "-2.89", " logSw": "0.08", " tPSA": "146.2", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "396016.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.424", "link_html_complex": "/ACE_complex_html/ACE_LAY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAY.png", "phi_psi": "/peptide_da/LAY.pdb", "link_html_peptide": "/Peptide_html/LAY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAY.pdb", "link_png_peptide": "/Peptide_pics/LAY.png"}
{"Peptide_Sequence": "LAYFYP", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "580 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "680", " Ligand_ID": "LAYFYP_minimized.pdb_680", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "772.89", " logP": "-0.27", " logD": "-1.58", " logSw": "-3.4", " tPSA": "244.94", " RotatableB": "18", " RigidB": "34", " Flexibility": "0.35", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "41", " HeteroAtoms": "15", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "25867.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 772.886", "link_html_complex": "/ACE_complex_html/ACE_LAYFYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LAYFYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LAYFYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LAYFYP.png", "phi_psi": "/peptide_da/LAYFYP.pdb", "link_html_peptide": "/Peptide_html/LAYFYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LAYFYP.pdb", "link_png_peptide": "/Peptide_pics/LAYFYP.png"}
{"Peptide_Sequence": "LCNGS", " Origin": "Oats", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "682", " Ligand_ID": "LCNGS_minimized.pdb_682", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "492.55", " logP": "-5.74", " logD": "-8.72", " logSw": "1.71", " tPSA": "286.29", " RotatableB": "15", " RigidB": "11", " Flexibility": "0.58", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "18", " HeteroAtoms": "15", " ratio_H_by_C": "0.83", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2729839.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 492.546", "link_html_complex": "/ACE_complex_html/ACE_LCNGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LCNGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LCNGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LCNGS.png", "phi_psi": "/peptide_da/LCNGS.pdb", "link_html_peptide": "/Peptide_html/LCNGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LCNGS.pdb", "link_png_peptide": "/Peptide_pics/LCNGS.png"}
{"Peptide_Sequence": "LDAQSAPLR", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "635", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "683", " Ligand_ID": "LDAQSAPLR_minimized.pdb_683", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "970.08", " logP": "-5.98", " logD": "-11.35", " logSw": "-0.04", " tPSA": "458.87", " RotatableB": "31", " RigidB": "26", " Flexibility": "0.54", " HBD": "18", " HBA": "27", " HBD_HBA": "45", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "68", " CarbonAtoms": "41", " HeteroAtoms": "27", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "931016.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 970.081", "link_html_complex": "/ACE_complex_html/ACE_LDAQSAPLR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LDAQSAPLR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LDAQSAPLR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LDAQSAPLR.png", "phi_psi": "/peptide_da/LDAQSAPLR.pdb", "link_html_peptide": "/Peptide_html/LDAQSAPLR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LDAQSAPLR.pdb", "link_png_peptide": "/Peptide_pics/LDAQSAPLR.png"}
{"Peptide_Sequence": "LDIQK", " Origin": "Whey protein (Beta Lactoglobulin)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "27.6 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "684", " Ligand_ID": "LDIQK_minimized.pdb_684", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "615.72", " logP": "-5.92", " logD": "-8.15", " logSw": "1.52", " tPSA": "295.03", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "27", " HeteroAtoms": "16", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2826885.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 615.719", "link_html_complex": "/ACE_complex_html/ACE_LDIQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LDIQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LDIQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LDIQK.png", "phi_psi": "/peptide_da/LDIQK.pdb", "link_html_peptide": "/Peptide_html/LDIQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LDIQK.pdb", "link_png_peptide": "/Peptide_pics/LDIQK.png"}
{"Peptide_Sequence": "LDY", " Origin": " dulse Palmaria palmata", " Peptide_Preparation": "pepsin, trypsin, chymptrypsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": " Cushman and Cheung\u2019s method with slight modification", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "6.1 \u03bcM", " Reference": "Furuta, Tomoe, et al. \"Angiotensin I converting enzyme inhibitory peptides derived from phycobiliproteins of dulse Palmaria palmata.\" Marine drugs 14.2 (2016): 32.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "685", " Ligand_ID": "LDY_minimized.pdb_685", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "409.43", " logP": "-3.53", " logD": "-6.13", " logSw": "0.49", " tPSA": "186.33", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "669747.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 409.434", "link_html_complex": "/ACE_complex_html/ACE_LDY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LDY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LDY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LDY.png", "phi_psi": "/peptide_da/LDY.pdb", "link_html_peptide": "/Peptide_html/LDY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LDY.pdb", "link_png_peptide": "/Peptide_pics/LDY.png"}
{"Peptide_Sequence": "LEE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "686", " Ligand_ID": "LEE_minimized.pdb_686", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "389.4", " logP": "-4.61", " logD": "-11.17", " logSw": "1.51", " tPSA": "206.23", " RotatableB": "13", " RigidB": "7", " Flexibility": "0.65", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "27", " CarbonAtoms": "16", " HeteroAtoms": "11", " ratio_H_by_C": "0.69", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1759216.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 389.401", "link_html_complex": "/ACE_complex_html/ACE_LEE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEE.png", "phi_psi": "/peptide_da/LEE.pdb", "link_html_peptide": "/Peptide_html/LEE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEE.pdb", "link_png_peptide": "/Peptide_pics/LEE.png"}
{"Peptide_Sequence": "LEF", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "687", " Ligand_ID": "LEF_minimized.pdb_687", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "407.46", " logP": "-2.18", " logD": "-5.84", " logSw": "-0.28", " tPSA": "166.1", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "308751.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 407.461", "link_html_complex": "/ACE_complex_html/ACE_LEF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEF.png", "phi_psi": "/peptide_da/LEF.pdb", "link_html_peptide": "/Peptide_html/LEF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEF.pdb", "link_png_peptide": "/Peptide_pics/LEF.png"}
{"Peptide_Sequence": "LEFNQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "688", " Ligand_ID": "LEFNQ_minimized.pdb_688", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "649.69", " logP": "-5.85", " logD": "-9.63", " logSw": "1.09", " tPSA": "310.48", " RotatableB": "20", " RigidB": "20", " Flexibility": "0.5", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "46", " CarbonAtoms": "29", " HeteroAtoms": "17", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1927573.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 649.693", "link_html_complex": "/ACE_complex_html/ACE_LEFNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEFNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEFNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEFNQ.png", "phi_psi": "/peptide_da/LEFNQ.pdb", "link_html_peptide": "/Peptide_html/LEFNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEFNQ.pdb", "link_png_peptide": "/Peptide_pics/LEFNQ.png"}
{"Peptide_Sequence": "LEGR", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "1090 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "689", " Ligand_ID": "LEGR_minimized.pdb_689", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "473.52", " logP": "-4.17", " logD": "-9.05", " logSw": "0.97", " tPSA": "258.84", " RotatableB": "17", " RigidB": "9", " Flexibility": "0.65", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "19", " HeteroAtoms": "14", " ratio_H_by_C": "0.74", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1253198.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.524", "link_html_complex": "/ACE_complex_html/ACE_LEGR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEGR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEGR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEGR.png", "phi_psi": "/peptide_da/LEGR.pdb", "link_html_peptide": "/Peptide_html/LEGR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEGR.pdb", "link_png_peptide": "/Peptide_pics/LEGR.png"}
{"Peptide_Sequence": "LEIVPK", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "690", " Ligand_ID": "LEIVPK_minimized.pdb_690", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "697.86", " logP": "-5.09", " logD": "-6.1", " logSw": "0.49", " tPSA": "272.25", " RotatableB": "22", " RigidB": "17", " Flexibility": "0.56", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "33", " HeteroAtoms": "16", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1141355.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 697.863", "link_html_complex": "/ACE_complex_html/ACE_LEIVPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEIVPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEIVPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEIVPK.png", "phi_psi": "/peptide_da/LEIVPK.pdb", "link_html_peptide": "/Peptide_html/LEIVPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEIVPK.pdb", "link_png_peptide": "/Peptide_pics/LEIVPK.png"}
{"Peptide_Sequence": "LEK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "800 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "691", " Ligand_ID": "LEK_minimized.pdb_691", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "388.46", " logP": "-6.61", " logD": "-6.98", " logSw": "2.84", " tPSA": "193.74", " RotatableB": "14", " RigidB": "6", " Flexibility": "0.7", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "6647799.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 388.459", "link_html_complex": "/ACE_complex_html/ACE_LEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEK.png", "phi_psi": "/peptide_da/LEK.pdb", "link_html_peptide": "/Peptide_html/LEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEK.pdb", "link_png_peptide": "/Peptide_pics/LEK.png"}
{"Peptide_Sequence": "LEKTG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "692", " Ligand_ID": "LEKTG_minimized.pdb_692", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O", " MW": "546.61", " logP": "-6.74", " logD": "-10.16", " logSw": "2.27", " tPSA": "272.17", " RotatableB": "19", " RigidB": "10", " Flexibility": "0.66", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5297204.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 546.614", "link_html_complex": "/ACE_complex_html/ACE_LEKTG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEKTG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEKTG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEKTG.png", "phi_psi": "/peptide_da/LEKTG.pdb", "link_html_peptide": "/Peptide_html/LEKTG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEKTG.pdb", "link_png_peptide": "/Peptide_pics/LEKTG.png"}
{"Peptide_Sequence": "LELNQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "693", " Ligand_ID": "LELNQ_minimized.pdb_693", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "615.68", " logP": "-4.56", " logD": "-10.04", " logSw": "0.54", " tPSA": "310.48", " RotatableB": "20", " RigidB": "14", " Flexibility": "0.59", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1051873.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 615.676", "link_html_complex": "/ACE_complex_html/ACE_LELNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LELNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LELNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LELNQ.png", "phi_psi": "/peptide_da/LELNQ.pdb", "link_html_peptide": "/Peptide_html/LELNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LELNQ.pdb", "link_png_peptide": "/Peptide_pics/LELNQ.png"}
{"Peptide_Sequence": "LENLHLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "695", " Ligand_ID": "LENLHLP_minimized.pdb_695", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "834.96", " logP": "-4.21", " logD": "-8.84", " logSw": "-0.75", " tPSA": "345.48", " RotatableB": "25", " RigidB": "26", " Flexibility": "0.49", " HBD": "12", " HBA": "21", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "59", " CarbonAtoms": "38", " HeteroAtoms": "21", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "396373.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 834.959", "link_html_complex": "/ACE_complex_html/ACE_LENLHLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LENLHLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LENLHLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LENLHLP.png", "phi_psi": "/peptide_da/LENLHLP.pdb", "link_html_peptide": "/Peptide_html/LENLHLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LENLHLP.pdb", "link_png_peptide": "/Peptide_pics/LENLHLP.png"}
{"Peptide_Sequence": "LENLHLPLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "86", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "694", " Ligand_ID": "LENLHLPLP_minimized.pdb_694", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1045.23", " logP": "-1.4", " logD": "-8.4", " logSw": "-3.48", " tPSA": "394.89", " RotatableB": "30", " RigidB": "35", " Flexibility": "0.46", " HBD": "13", " HBA": "25", " HBD_HBA": "38", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "74", " CarbonAtoms": "49", " HeteroAtoms": "25", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "32121.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1045.23", "link_html_complex": "/ACE_complex_html/ACE_LENLHLPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LENLHLPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LENLHLPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LENLHLPLP.png", "phi_psi": "/peptide_da/LENLHLPLP.pdb", "link_html_peptide": "/Peptide_html/LENLHLPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LENLHLPLP.pdb", "link_png_peptide": "/Peptide_pics/LENLHLPLP.png"}
{"Peptide_Sequence": "LEP", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "696", " Ligand_ID": "LEP_minimized.pdb_696", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "357.4", " logP": "-3.41", " logD": "-7.23", " logSw": "0.69", " tPSA": "157.31", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "710002.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 357.402", "link_html_complex": "/ACE_complex_html/ACE_LEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEP.png", "phi_psi": "/peptide_da/LEP.pdb", "link_html_peptide": "/Peptide_html/LEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEP.pdb", "link_png_peptide": "/Peptide_pics/LEP.png"}
{"Peptide_Sequence": "LEPP", " Origin": "soya milk", " Peptide_Preparation": " End-type neutral proteases", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "100.1 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "697", " Ligand_ID": "LEPP_minimized.pdb_697", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "454.52", " logP": "-3.36", " logD": "-7.56", " logSw": "0.12", " tPSA": "177.62", " RotatableB": "10", " RigidB": "18", " Flexibility": "0.36", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "1", " Solubility_mg_per_l": "511848.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 454.517", "link_html_complex": "/ACE_complex_html/ACE_LEPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEPP.png", "phi_psi": "/peptide_da/LEPP.pdb", "link_html_peptide": "/Peptide_html/LEPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEPP.pdb", "link_png_peptide": "/Peptide_pics/LEPP.png"}
{"Peptide_Sequence": "LEY", " Origin": "Legume (Pea proteins), Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "698", " Ligand_ID": "LEY_minimized.pdb_698", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "423.46", " logP": "-3.17", " logD": "-6.19", " logSw": "0.25", " tPSA": "186.33", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "542860.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 423.46", "link_html_complex": "/ACE_complex_html/ACE_LEY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LEY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LEY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LEY.png", "phi_psi": "/peptide_da/LEY.pdb", "link_html_peptide": "/Peptide_html/LEY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LEY.pdb", "link_png_peptide": "/Peptide_pics/LEY.png"}
{"Peptide_Sequence": "LF", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "349 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "699", " Ligand_ID": "LF_minimized.pdb_699", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "278.35", " logP": "-1.15", " logD": "-0.94", " logSw": "-0.48", " tPSA": "96.87", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "15", " HeteroAtoms": "5", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "171383.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 278.347", "link_html_complex": "/ACE_complex_html/ACE_LF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LF.png", "phi_psi": "/peptide_da/LF.pdb", "link_html_peptide": "/Peptide_html/LF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LF.pdb", "link_png_peptide": "/Peptide_pics/LF.png"}
{"Peptide_Sequence": "LFR", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "700", " Ligand_ID": "LFR_minimized.pdb_700", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "434.53", " logP": "-2", " logD": "-3.3", " logSw": "-0.42", " tPSA": "189.61", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "21", " HeteroAtoms": "10", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "285962.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 434.532", "link_html_complex": "/ACE_complex_html/ACE_LFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LFR.png", "phi_psi": "/peptide_da/LFR.pdb", "link_html_peptide": "/Peptide_html/LFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LFR.pdb", "link_png_peptide": "/Peptide_pics/LFR.png"}
{"Peptide_Sequence": "LFRQ", " Origin": " as1-CN (136-139)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "17 \u03bcM", " Reference": "ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "701", " Ligand_ID": "LFRQ_minimized.pdb_701", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "562.66", " logP": "-3.42", " logD": "-6.94", " logSw": "0.03", " tPSA": "261.8", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "26", " HeteroAtoms": "14", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "577454.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 562.662", "link_html_complex": "/ACE_complex_html/ACE_LFRQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LFRQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LFRQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LFRQ.png", "phi_psi": "/peptide_da/LFRQ.pdb", "link_html_peptide": "/Peptide_html/LFRQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LFRQ.pdb", "link_png_peptide": "/Peptide_pics/LFRQ.png"}
{"Peptide_Sequence": "LFSGGES", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "702", " Ligand_ID": "LFSGGES_minimized.pdb_702", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "695.72", " logP": "-5.52", " logD": "-12.06", " logSw": "0.73", " tPSA": "322.96", " RotatableB": "22", " RigidB": "20", " Flexibility": "0.52", " HBD": "12", " HBA": "19", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "49", " CarbonAtoms": "30", " HeteroAtoms": "19", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1442104.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 695.718", "link_html_complex": "/ACE_complex_html/ACE_LFSGGES.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LFSGGES.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LFSGGES.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LFSGGES.png", "phi_psi": "/peptide_da/LFSGGES.pdb", "link_html_peptide": "/Peptide_html/LFSGGES.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LFSGGES.pdb", "link_png_peptide": "/Peptide_pics/LFSGGES.png"}
{"Peptide_Sequence": "LFVAAP", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "703", " Ligand_ID": "LFVAAP_minimized.pdb_703", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "616.75", " logP": "-1.78", " logD": "-3.35", " logSw": "-1.6", " tPSA": "204.48", " RotatableB": "15", " RigidB": "22", " Flexibility": "0.41", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "124431.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 616.749", "link_html_complex": "/ACE_complex_html/ACE_LFVAAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LFVAAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LFVAAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LFVAAP.png", "phi_psi": "/peptide_da/LFVAAP.pdb", "link_html_peptide": "/Peptide_html/LFVAAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LFVAAP.pdb", "link_png_peptide": "/Peptide_pics/LFVAAP.png"}
{"Peptide_Sequence": "LG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "8800 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "709", " Ligand_ID": "LG_minimized.pdb_709", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(O)=O", " MW": "188.22", " logP": "-2.33", " logD": "-3.17", " logSw": "0.79", " tPSA": "96.87", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "8", " HeteroAtoms": "5", " ratio_H_by_C": "0.63", " Lipinski_Violation": "0", " Solubility_mg_per_l": "415110.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 188.224", "link_html_complex": "/ACE_complex_html/ACE_LG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LG.png", "phi_psi": "/peptide_da/LG.pdb", "link_html_peptide": "/Peptide_html/LG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LG.pdb", "link_png_peptide": "/Peptide_pics/LG.png"}
{"Peptide_Sequence": "LGALPF", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "2690 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "704", " Ligand_ID": "LGALPF_minimized.pdb_704", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "616.75", " logP": "-1.64", " logD": "-3.55", " logSw": "-1.62", " tPSA": "204.48", " RotatableB": "16", " RigidB": "22", " Flexibility": "0.42", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "121699.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 616.749", "link_html_complex": "/ACE_complex_html/ACE_LGALPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGALPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGALPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGALPF.png", "phi_psi": "/peptide_da/LGALPF.pdb", "link_html_peptide": "/Peptide_html/LGALPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGALPF.pdb", "link_png_peptide": "/Peptide_pics/LGALPF.png"}
{"Peptide_Sequence": "LGECGGR", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "  232.8 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "705", " Ligand_ID": "LGECGGR_minimized.pdb_705", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "690.77", " logP": "-5.81", " logD": "-11.76", " logSw": "1.12", " tPSA": "384.94", " RotatableB": "24", " RigidB": "15", " Flexibility": "0.62", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "26", " HeteroAtoms": "21", " ratio_H_by_C": "0.81", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2120348.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 690.768", "link_html_complex": "/ACE_complex_html/ACE_LGECGGR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGECGGR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGECGGR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGECGGR.png", "phi_psi": "/peptide_da/LGECGGR.pdb", "link_html_peptide": "/Peptide_html/LGECGGR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGECGGR.pdb", "link_png_peptide": "/Peptide_pics/LGECGGR.png"}
{"Peptide_Sequence": "LGFPTTKTYFPHF", " Origin": "porcine hemoglobin", " Peptide_Preparation": "pepsin (porcine stomach mucosa), trypsin (bovine pancreas), papain (pawpaw sap) ", " Isolation_Method": "GEC", " ACE_inhibition_assay": "modification of the method of Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.92 \u03bcM", " Reference": "Yu, Yike, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin.\" Peptides 27.11 (2006): 2950-2956.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1555.77", "link_html_complex": "/ACE_complex_html/ACE_LGFPTTKTYFPHF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGFPTTKTYFPHF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGFPTTKTYFPHF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGFPTTKTYFPHF.png", "phi_psi": "/peptide_da/LGFPTTKTYFPHF.pdb", "link_html_peptide": "/Peptide_html/LGFPTTKTYFPHF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGFPTTKTYFPHF.pdb", "link_png_peptide": "/Peptide_pics/LGFPTTKTYFPHF.png"}
{"Peptide_Sequence": "LGGC", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "707", " Ligand_ID": "LGGC_minimized.pdb_707", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(O)=O", " MW": "348.42", " logP": "-3.32", " logD": "-6.23", " logSw": "0.75", " tPSA": "193.87", " RotatableB": "10", " RigidB": "7", " Flexibility": "0.59", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "738639.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 348.417", "link_html_complex": "/ACE_complex_html/ACE_LGGC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGGC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGGC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGGC.png", "phi_psi": "/peptide_da/LGGC.pdb", "link_html_peptide": "/Peptide_html/LGGC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGGC.pdb", "link_png_peptide": "/Peptide_pics/LGGC.png"}
{"Peptide_Sequence": "LGI", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "629 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "708", " Ligand_ID": "LGI_minimized.pdb_708", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(O)=O", " MW": "301.38", " logP": "-2.29", " logD": "-3.44", " logSw": "0.33", " tPSA": "125.97", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "418430.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.382", "link_html_complex": "/ACE_complex_html/ACE_LGI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGI.png", "phi_psi": "/peptide_da/LGI.pdb", "link_html_peptide": "/Peptide_html/LGI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGI.pdb", "link_png_peptide": "/Peptide_pics/LGI.png"}
{"Peptide_Sequence": "LGP", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "0.7 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "711", " Ligand_ID": "LGP_minimized.pdb_711", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "285.34", " logP": "-2.41", " logD": "-4.53", " logSw": "0.31", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "387174.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_LGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGP.png", "phi_psi": "/peptide_da/LGP.pdb", "link_html_peptide": "/Peptide_html/LGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGP.pdb", "link_png_peptide": "/Peptide_pics/LGP.png"}
{"Peptide_Sequence": "LGPLGHQ", " Origin": "Fish (Skin gelatin of skate (Okamejei kenojei))", " Peptide_Preparation": "Alcalase, flavourzyme, protamex, Neutrase, protease, \u03b1-chymotrypsin", " Isolation_Method": "FPLC, DEAE FF anion exchange column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with slight modifications.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.22 \u03bcM", " Reference": "Ngo, Dai-Hung, BoMi Ryu, and Se-Kwon Kim. \"Active peptides from skate (Okamejei kenojei) skin gelatin diminish angiotensin-I converting enzyme activity and intracellular free radical-mediated oxidation.\" Food chemistry 143 (2014): 246-255.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "710", " Ligand_ID": "LGPLGHQ_minimized.pdb_710", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "720.82", " logP": "-3.77", " logD": "-7.66", " logSw": "-0.58", " tPSA": "305.35", " RotatableB": "21", " RigidB": "25", " Flexibility": "0.46", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "32", " HeteroAtoms": "19", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "402018.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 720.817", "link_html_complex": "/ACE_complex_html/ACE_LGPLGHQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGPLGHQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGPLGHQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGPLGHQ.png", "phi_psi": "/peptide_da/LGPLGHQ.pdb", "link_html_peptide": "/Peptide_html/LGPLGHQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGPLGHQ.pdb", "link_png_peptide": "/Peptide_pics/LGPLGHQ.png"}
{"Peptide_Sequence": "LGPVRGPFP", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "712", " Ligand_ID": "LGPVRGPFP_minimized.pdb_712", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "939.11", " logP": "-1.86", " logD": "-8.93", " logSw": "-2.94", " tPSA": "337.84", " RotatableB": "24", " RigidB": "39", " Flexibility": "0.38", " HBD": "12", " HBA": "22", " HBD_HBA": "34", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "67", " CarbonAtoms": "45", " HeteroAtoms": "22", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "49691.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 939.112", "link_html_complex": "/ACE_complex_html/ACE_LGPVRGPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGPVRGPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGPVRGPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGPVRGPFP.png", "phi_psi": "/peptide_da/LGPVRGPFP.pdb", "link_html_peptide": "/Peptide_html/LGPVRGPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGPVRGPFP.pdb", "link_png_peptide": "/Peptide_pics/LGPVRGPFP.png"}
{"Peptide_Sequence": "LGV", " Origin": "Hemp Seed (Cannabis sativa L.)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "145  \u00b5M        ", " Reference": "Orio, Lara P., et al. \"New ACE-inhibitory peptides from hemp seed (Cannabis sativa L.) proteins.\" Journal of agricultural and food chemistry 65.48 (2017): 10482-10488.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "713", " Ligand_ID": "LGV_minimized.pdb_713", " Smiles": "CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O", " MW": "287.36", " logP": "-2.7", " logD": "-3.89", " logSw": "0.61", " tPSA": "125.97", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "527482.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.355", "link_html_complex": "/ACE_complex_html/ACE_LGV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LGV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LGV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LGV.png", "phi_psi": "/peptide_da/LGV.pdb", "link_html_peptide": "/Peptide_html/LGV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LGV.pdb", "link_png_peptide": "/Peptide_pics/LGV.png"}
{"Peptide_Sequence": "LHEPG", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "714", " Ligand_ID": "LHEPG_minimized.pdb_714", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "551.59", " logP": "-3.54", " logD": "-10.06", " logSw": "-0.09", " tPSA": "244.19", " RotatableB": "15", " RigidB": "20", " Flexibility": "0.43", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "504945.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 551.593", "link_html_complex": "/ACE_complex_html/ACE_LHEPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHEPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHEPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHEPG.png", "phi_psi": "/peptide_da/LHEPG.pdb", "link_html_peptide": "/Peptide_html/LHEPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHEPG.pdb", "link_png_peptide": "/Peptide_pics/LHEPG.png"}
{"Peptide_Sequence": "LHGPYP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung modified by Hern\u03bcndez-Ledesmaet al", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "75.4 \u03bcM", " Reference": "Jing, Tao, et al. \"Rational design of angiotensin\u2010I\u2010converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.\" ChemMedChem 8.7 (2013): 1057-1066.", " Binding_Energy_kcal_per_mol": "-11.2", "Serial_ID": "715", " Ligand_ID": "LHGPYP_minimized.pdb_715", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "682.77", " logP": "-1.74", " logD": "-5.39", " logSw": "-2.07", " tPSA": "244.6", " RotatableB": "15", " RigidB": "32", " Flexibility": "0.32", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "33", " HeteroAtoms": "16", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "85928.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 682.767", "link_html_complex": "/ACE_complex_html/ACE_LHGPYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHGPYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHGPYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHGPYP.png", "phi_psi": "/peptide_da/LHGPYP.pdb", "link_html_peptide": "/Peptide_html/LHGPYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHGPYP.pdb", "link_png_peptide": "/Peptide_pics/LHGPYP.png"}
{"Peptide_Sequence": "LHLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "410", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "722", " Ligand_ID": "LHLP_minimized.pdb_722", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "478.59", " logP": "-2.74", " logD": "-4.04", " logSw": "-0.34", " tPSA": "174.96", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "340500.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 478.585", "link_html_complex": "/ACE_complex_html/ACE_LHLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLP.png", "phi_psi": "/peptide_da/LHLP.pdb", "link_html_peptide": "/Peptide_html/LHLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLP.pdb", "link_png_peptide": "/Peptide_pics/LHLP.png"}
{"Peptide_Sequence": "LHLPAP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.0 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "716", " Ligand_ID": "LHLPAP_minimized.pdb_716", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "646.78", " logP": "-1.25", " logD": "-4.91", " logSw": "-2.11", " tPSA": "224.37", " RotatableB": "15", " RigidB": "26", " Flexibility": "0.37", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "78330.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 646.778", "link_html_complex": "/ACE_complex_html/ACE_LHLPAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPAP.png", "phi_psi": "/peptide_da/LHLPAP.pdb", "link_html_peptide": "/Peptide_html/LHLPAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPAP.pdb", "link_png_peptide": "/Peptide_pics/LHLPAP.png"}
{"Peptide_Sequence": "LHLPGP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.9 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "717", " Ligand_ID": "LHLPGP_minimized.pdb_717", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "632.75", " logP": "-1.65", " logD": "-5.49", " logSw": "-1.77", " tPSA": "224.37", " RotatableB": "15", " RigidB": "26", " Flexibility": "0.37", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "107418.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 632.751", "link_html_complex": "/ACE_complex_html/ACE_LHLPGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPGP.png", "phi_psi": "/peptide_da/LHLPGP.pdb", "link_html_peptide": "/Peptide_html/LHLPGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPGP.pdb", "link_png_peptide": "/Peptide_pics/LHLPGP.png"}
{"Peptide_Sequence": "LHLPLL", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.5 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "718", " Ligand_ID": "LHLPLL_minimized.pdb_718", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "704.9", " logP": "-0.42", " logD": "-2.57", " logSw": "-2.66", " tPSA": "233.16", " RotatableB": "20", " RigidB": "21", " Flexibility": "0.49", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "35", " HeteroAtoms": "15", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "49335.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 704.9", "link_html_complex": "/ACE_complex_html/ACE_LHLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPLL.png", "phi_psi": "/peptide_da/LHLPLL.pdb", "link_html_peptide": "/Peptide_html/LHLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPLL.pdb", "link_png_peptide": "/Peptide_pics/LHLPLL.png"}
{"Peptide_Sequence": "LHLPLP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.7 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "720", " Ligand_ID": "LHLPLP_minimized.pdb_720", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "688.86", " logP": "-1.62", " logD": "-3.6", " logSw": "-2", " tPSA": "224.37", " RotatableB": "17", " RigidB": "26", " Flexibility": "0.4", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "34", " HeteroAtoms": "15", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "92895.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 688.858", "link_html_complex": "/ACE_complex_html/ACE_LHLPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPLP.png", "phi_psi": "/peptide_da/LHLPLP.pdb", "link_html_peptide": "/Peptide_html/LHLPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPLP.pdb", "link_png_peptide": "/Peptide_pics/LHLPLP.png"}
{"Peptide_Sequence": "LHLPLPL", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.9", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "719", " Ligand_ID": "LHLPLPL_minimized.pdb_719", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "802.02", " logP": "-0.37", " logD": "-2.85", " logSw": "-3.22", " tPSA": "253.47", " RotatableB": "21", " RigidB": "28", " Flexibility": "0.43", " HBD": "8", " HBA": "17", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "31941.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.015", "link_html_complex": "/ACE_complex_html/ACE_LHLPLPL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPLPL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPLPL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPLPL.png", "phi_psi": "/peptide_da/LHLPLPL.pdb", "link_html_peptide": "/Peptide_html/LHLPLPL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPLPL.pdb", "link_png_peptide": "/Peptide_pics/LHLPLPL.png"}
{"Peptide_Sequence": "LHLPLR", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.8 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "721", " Ligand_ID": "LHLPLR_minimized.pdb_721", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "747.93", " logP": "-2.56", " logD": "-4.27", " logSw": "-1.38", " tPSA": "296.8", " RotatableB": "23", " RigidB": "22", " Flexibility": "0.51", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "188386.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.928", "link_html_complex": "/ACE_complex_html/ACE_LHLPLR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPLR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPLR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPLR.png", "phi_psi": "/peptide_da/LHLPLR.pdb", "link_html_peptide": "/Peptide_html/LHLPLR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPLR.pdb", "link_png_peptide": "/Peptide_pics/LHLPLR.png"}
{"Peptide_Sequence": "LHLPYP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.3 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "723", " Ligand_ID": "LHLPYP_minimized.pdb_723", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "738.87", " logP": "-0.02", " logD": "-3.56", " logSw": "-3.36", " tPSA": "244.6", " RotatableB": "17", " RigidB": "32", " Flexibility": "0.35", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "37", " HeteroAtoms": "16", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "25601.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 738.873", "link_html_complex": "/ACE_complex_html/ACE_LHLPYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLPYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLPYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLPYP.png", "phi_psi": "/peptide_da/LHLPYP.pdb", "link_html_peptide": "/Peptide_html/LHLPYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLPYP.pdb", "link_png_peptide": "/Peptide_pics/LHLPYP.png"}
{"Peptide_Sequence": "LHLWLP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.0 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "724", " Ligand_ID": "LHLWLP_minimized.pdb_724", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "777.95", " logP": "1.73", " logD": "-2.09", " logSw": "-4.52", " tPSA": "248.95", " RotatableB": "20", " RigidB": "31", " Flexibility": "0.39", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "40", " HeteroAtoms": "16", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8443.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 777.952", "link_html_complex": "/ACE_complex_html/ACE_LHLWLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLWLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLWLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLWLP.png", "phi_psi": "/peptide_da/LHLWLP.pdb", "link_html_peptide": "/Peptide_html/LHLWLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLWLP.pdb", "link_png_peptide": "/Peptide_pics/LHLWLP.png"}
{"Peptide_Sequence": "LHLYLP", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "18.9 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "725", " Ligand_ID": "LHLYLP_minimized.pdb_725", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "754.92", " logP": "-0.69", " logD": "-2.48", " logSw": "-2.84", " tPSA": "253.39", " RotatableB": "20", " RigidB": "27", " Flexibility": "0.43", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "38", " HeteroAtoms": "16", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "44174.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 754.916", "link_html_complex": "/ACE_complex_html/ACE_LHLYLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHLYLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHLYLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHLYLP.png", "phi_psi": "/peptide_da/LHLYLP.pdb", "link_html_peptide": "/Peptide_html/LHLYLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHLYLP.pdb", "link_png_peptide": "/Peptide_pics/LHLYLP.png"}
{"Peptide_Sequence": "LHP", " Origin": "Marine shrimp (Acetes chinensis)", " Peptide_Preparation": "Pepsin", " Isolation_Method": "SEC, RP-HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) with some modification. ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1.6 \u03bcM", " Reference": "Cao, Wenhong, et al. \"Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats.\" International journal of food science & technology 45.5 (2010): 959-965.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "727", " Ligand_ID": "LHP_minimized.pdb_727", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "365.43", " logP": "-3.14", " logD": "-4.26", " logSw": "0.33", " tPSA": "145.86", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "508673.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.427", "link_html_complex": "/ACE_complex_html/ACE_LHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHP.png", "phi_psi": "/peptide_da/LHP.pdb", "link_html_peptide": "/Peptide_html/LHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHP.pdb", "link_png_peptide": "/Peptide_pics/LHP.png"}
{"Peptide_Sequence": "LHPGDAQR", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10.3 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "726", " Ligand_ID": "LHPGDAQR_minimized.pdb_726", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "892.96", " logP": "-6.64", " logD": "-12.87", " logSw": "0.62", " tPSA": "438.22", " RotatableB": "28", " RigidB": "29", " Flexibility": "0.49", " HBD": "17", " HBA": "26", " HBD_HBA": "43", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "63", " CarbonAtoms": "37", " HeteroAtoms": "26", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1667889.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 892.959", "link_html_complex": "/ACE_complex_html/ACE_LHPGDAQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHPGDAQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHPGDAQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHPGDAQR.png", "phi_psi": "/peptide_da/LHPGDAQR.pdb", "link_html_peptide": "/Peptide_html/LHPGDAQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHPGDAQR.pdb", "link_png_peptide": "/Peptide_pics/LHPGDAQR.png"}
{"Peptide_Sequence": "LHREN", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "728", " Ligand_ID": "LHREN_minimized.pdb_728", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "667.71", " logP": "-5.78", " logD": "-14.7", " logSw": "1.14", " tPSA": "359.71", " RotatableB": "23", " RigidB": "18", " Flexibility": "0.56", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "27", " HeteroAtoms": "20", " ratio_H_by_C": "0.74", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2086437.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 667.714", "link_html_complex": "/ACE_complex_html/ACE_LHREN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LHREN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LHREN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LHREN.png", "phi_psi": "/peptide_da/LHREN.pdb", "link_html_peptide": "/Peptide_html/LHREN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LHREN.pdb", "link_png_peptide": "/Peptide_pics/LHREN.png"}
{"Peptide_Sequence": "LIPPGVPY", " Origin": "wine", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "17.5 \u03bcM", " Reference": "Garc\u00eda, M. C., et al. \"Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities.\" Talanta 106 (2013): 328-349.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "729", " Ligand_ID": "LIPPGVPY_minimized.pdb_729", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "855.03", " logP": "0.58", " logD": "-3.49", " logSw": "-4.29", " tPSA": "265.33", " RotatableB": "19", " RigidB": "36", " Flexibility": "0.35", " HBD": "8", " HBA": "18", " HBD_HBA": "26", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "43", " HeteroAtoms": "18", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11746.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 855.032", "link_html_complex": "/ACE_complex_html/ACE_LIPPGVPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIPPGVPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIPPGVPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIPPGVPY.png", "phi_psi": "/peptide_da/LIPPGVPY.pdb", "link_html_peptide": "/Peptide_html/LIPPGVPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIPPGVPY.pdb", "link_png_peptide": "/Peptide_pics/LIPPGVPY.png"}
{"Peptide_Sequence": "LIVT", " Origin": "Soy ", " Peptide_Preparation": "fermentation", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.110 \u03bcM", " Reference": "Vallabha, Vishwanath S., and Purnima Kaul Tiku. \"Antihypertensive peptides derived from soy protein by fermentation.\" International Journal of Peptide Research and Therapeutics 20.2 (2014): 161-168.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "730", " Ligand_ID": "LIVT_minimized.pdb_730", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "444.57", " logP": "-1.43", " logD": "-3.55", " logSw": "-0.84", " tPSA": "175.3", " RotatableB": "13", " RigidB": "7", " Flexibility": "0.65", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "21", " HeteroAtoms": "10", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "192422.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 444.565", "link_html_complex": "/ACE_complex_html/ACE_LIVT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIVT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIVT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIVT.png", "phi_psi": "/peptide_da/LIVT.pdb", "link_html_peptide": "/Peptide_html/LIVT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIVT.pdb", "link_png_peptide": "/Peptide_pics/LIVT.png"}
{"Peptide_Sequence": "LIVTQ", " Origin": "Soy ", " Peptide_Preparation": "fermentation", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.087 \u03bcM", " Reference": "Vallabha, Vishwanath S., and Purnima Kaul Tiku. \"Antihypertensive peptides derived from soy protein by fermentation.\" International Journal of Peptide Research and Therapeutics 20.2 (2014): 161-168.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "731", " Ligand_ID": "LIVTQ_minimized.pdb_731", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "572.69", " logP": "-3", " logD": "-5.28", " logSw": "-0.31", " tPSA": "247.49", " RotatableB": "18", " RigidB": "11", " Flexibility": "0.62", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "26", " HeteroAtoms": "14", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "418905.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 572.695", "link_html_complex": "/ACE_complex_html/ACE_LIVTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIVTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIVTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIVTQ.png", "phi_psi": "/peptide_da/LIVTQ.pdb", "link_html_peptide": "/Peptide_html/LIVTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIVTQ.pdb", "link_png_peptide": "/Peptide_pics/LIVTQ.png"}
{"Peptide_Sequence": "LIWKL", " Origin": "bovine lactoferrin", " Peptide_Preparation": " porcine pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo, ex-vivo", " IC50_micromol_per_L": "\t0.47 \u03bcM", " Reference": "Ruiz-Gim\u00e9nez, Pedro, et al. \"Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides.\" Food Chemistry 131.1 (2012): 266-273.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "732", " Ligand_ID": "LIWKL_minimized.pdb_732", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "671.87", " logP": "0.1", " logD": "-2.71", " logSw": "-2.75", " tPSA": "227.6", " RotatableB": "21", " RigidB": "19", " Flexibility": "0.53", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "35", " HeteroAtoms": "13", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "43122.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 671.87", "link_html_complex": "/ACE_complex_html/ACE_LIWKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIWKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIWKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIWKL.png", "phi_psi": "/peptide_da/LIWKL.pdb", "link_html_peptide": "/Peptide_html/LIWKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIWKL.pdb", "link_png_peptide": "/Peptide_pics/LIWKL.png"}
{"Peptide_Sequence": "LIY", " Origin": "Human Plasma", " Peptide_Preparation": " solid  phase  Fmoc  method on  apeptide synthesizer", " Isolation_Method": "reversed-phase  iso-cratic  HPLC. ", " ACE_inhibition_assay": "Cushman  and  Cheung  as  described  by  Maruyama  et  al", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": " 0.82 umol/l.", " Reference": "Nakagomi K, Yamada R, Ebisu H, Sadkane Y, Akizawa T, Tanimura T. Isolation of acein-2, a novel angiotensin I\u2013converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma. FEBS Lett 2000;467:235\u20138.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "733", " Ligand_ID": "LIY_minimized.pdb_733", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "407.5", " logP": "-0.72", " logD": "-1.54", " logSw": "-1.26", " tPSA": "146.2", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "115759.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 407.504", "link_html_complex": "/ACE_complex_html/ACE_LIY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIY.png", "phi_psi": "/peptide_da/LIY.pdb", "link_html_peptide": "/Peptide_html/LIY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIY.pdb", "link_png_peptide": "/Peptide_pics/LIY.png"}
{"Peptide_Sequence": "LIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "734", " Ligand_ID": "LIYP_minimized.pdb_734", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "504.62", " logP": "-1.27", " logD": "-2.2", " logSw": "-1.43", " tPSA": "166.51", " RotatableB": "12", " RigidB": "18", " Flexibility": "0.4", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "26", " HeteroAtoms": "10", " ratio_H_by_C": "0.38", " Lipinski_Violation": "2", " Solubility_mg_per_l": "120162.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 504.619", "link_html_complex": "/ACE_complex_html/ACE_LIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LIYP.png", "phi_psi": "/peptide_da/LIYP.pdb", "link_html_peptide": "/Peptide_html/LIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LIYP.pdb", "link_png_peptide": "/Peptide_pics/LIYP.png"}
{"Peptide_Sequence": "LK", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "747", " Ligand_ID": "LK_minimized.pdb_747", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "259.35", " logP": "-3.03", " logD": "-4.07", " logSw": "1.05", " tPSA": "124.51", " RotatableB": "9", " RigidB": "3", " Flexibility": "0.75", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "744803", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 259.345", "link_html_complex": "/ACE_complex_html/ACE_LK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LK.png", "phi_psi": "/peptide_da/LK.pdb", "link_html_peptide": "/Peptide_html/LK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LK.pdb", "link_png_peptide": "/Peptide_pics/LK.png"}
{"Peptide_Sequence": "LKA", " Origin": "chicken muscle", " Peptide_Preparation": "creatine kinase", " Isolation_Method": "ODS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.5", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "735", " Ligand_ID": "LKA_minimized.pdb_735", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O", " MW": "330.42", " logP": "-3.59", " logD": "-5.95", " logSw": "1.1", " tPSA": "153.61", " RotatableB": "11", " RigidB": "5", " Flexibility": "0.69", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "991729.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.423", "link_html_complex": "/ACE_complex_html/ACE_LKA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKA.png", "phi_psi": "/peptide_da/LKA.pdb", "link_html_peptide": "/Peptide_html/LKA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKA.pdb", "link_png_peptide": "/Peptide_pics/LKA.png"}
{"Peptide_Sequence": "LKC", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "736", " Ligand_ID": "LKC_minimized.pdb_736", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O", " MW": "362.49", " logP": "-2.93", " logD": "-5.88", " logSw": "0.55", " tPSA": "192.41", " RotatableB": "12", " RigidB": "5", " Flexibility": "0.71", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "628581.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 362.487", "link_html_complex": "/ACE_complex_html/ACE_LKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKC.png", "phi_psi": "/peptide_da/LKC.pdb", "link_html_peptide": "/Peptide_html/LKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKC.pdb", "link_png_peptide": "/Peptide_pics/LKC.png"}
{"Peptide_Sequence": "LKD", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "738", " Ligand_ID": "LKD_minimized.pdb_738", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "374.43", " logP": "-5.57", " logD": "-8.86", " logSw": "2.21", " tPSA": "193.74", " RotatableB": "13", " RigidB": "6", " Flexibility": "0.68", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "3398296.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.433", "link_html_complex": "/ACE_complex_html/ACE_LKD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKD.png", "phi_psi": "/peptide_da/LKD.pdb", "link_html_peptide": "/Peptide_html/LKD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKD.pdb", "link_png_peptide": "/Peptide_pics/LKD.png"}
{"Peptide_Sequence": "LKDAQ", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "737", " Ligand_ID": "LKDAQ_minimized.pdb_737", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "573.64", " logP": "-7.24", " logD": "-12.56", " logSw": "2.48", " tPSA": "295.03", " RotatableB": "20", " RigidB": "12", " Flexibility": "0.63", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6881798.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 573.64", "link_html_complex": "/ACE_complex_html/ACE_LKDAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKDAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKDAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKDAQ.png", "phi_psi": "/peptide_da/LKDAQ.pdb", "link_html_peptide": "/Peptide_html/LKDAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKDAQ.pdb", "link_png_peptide": "/Peptide_pics/LKDAQ.png"}
{"Peptide_Sequence": "LKDTQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "739", " Ligand_ID": "LKDTQ_minimized.pdb_739", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "603.67", " logP": "-7.86", " logD": "-13.19", " logSw": "2.76", " tPSA": "315.26", " RotatableB": "21", " RigidB": "12", " Flexibility": "0.64", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "25", " HeteroAtoms": "17", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9490942.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 603.666", "link_html_complex": "/ACE_complex_html/ACE_LKDTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKDTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKDTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKDTQ.png", "phi_psi": "/peptide_da/LKDTQ.pdb", "link_html_peptide": "/Peptide_html/LKDTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKDTQ.pdb", "link_png_peptide": "/Peptide_pics/LKDTQ.png"}
{"Peptide_Sequence": "LKELQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "740", " Ligand_ID": "LKELQ_minimized.pdb_740", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "629.75", " logP": "-5.56", " logD": "-11.85", " logSw": "1.28", " tPSA": "295.03", " RotatableB": "23", " RigidB": "12", " Flexibility": "0.66", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2256772.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 629.746", "link_html_complex": "/ACE_complex_html/ACE_LKELQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKELQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKELQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKELQ.png", "phi_psi": "/peptide_da/LKELQ.pdb", "link_html_peptide": "/Peptide_html/LKELQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKELQ.pdb", "link_png_peptide": "/Peptide_pics/LKELQ.png"}
{"Peptide_Sequence": "LKGYGGVSLPEW", " Origin": "Alpha-Lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "SEC, RP-HPLC, LC-MS/MS", " ACE_inhibition_assay": "Shalaby et al. (2006)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "83 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "741", " Ligand_ID": "LKGYGGVSLPEW_minimized.pdb_741", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "1305.48", " logP": "-4.55", " logD": "-13.05", " logSw": "-2.55", " tPSA": "503.1", " RotatableB": "39", " RigidB": "45", " Flexibility": "0.46", " HBD": "19", " HBA": "31", " HBD_HBA": "50", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "93", " CarbonAtoms": "62", " HeteroAtoms": "31", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "101581.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1305.48", "link_html_complex": "/ACE_complex_html/ACE_LKGYGGVSLPEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKGYGGVSLPEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKGYGGVSLPEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKGYGGVSLPEW.png", "phi_psi": "/peptide_da/LKGYGGVSLPEW.pdb", "link_html_peptide": "/Peptide_html/LKGYGGVSLPEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKGYGGVSLPEW.pdb", "link_png_peptide": "/Peptide_pics/LKGYGGVSLPEW.png"}
{"Peptide_Sequence": "LKIPLY", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "5.57 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "742", " Ligand_ID": "LKIPLY_minimized.pdb_742", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "745.95", " logP": "-0.51", " logD": "-4.76", " logSw": "-2.73", " tPSA": "252.35", " RotatableB": "22", " RigidB": "22", " Flexibility": "0.5", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "38", " HeteroAtoms": "15", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "48657.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 745.949", "link_html_complex": "/ACE_complex_html/ACE_LKIPLY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKIPLY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKIPLY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKIPLY.png", "phi_psi": "/peptide_da/LKIPLY.pdb", "link_html_peptide": "/Peptide_html/LKIPLY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKIPLY.pdb", "link_png_peptide": "/Peptide_pics/LKIPLY.png"}
{"Peptide_Sequence": "LKIPVA", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "6.07 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "743", " Ligand_ID": "LKIPVA_minimized.pdb_743", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "639.83", " logP": "-2.3", " logD": "-6.46", " logSw": "-1.1", " tPSA": "232.12", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "31", " HeteroAtoms": "14", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "212145.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 639.827", "link_html_complex": "/ACE_complex_html/ACE_LKIPVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKIPVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKIPVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKIPVA.png", "phi_psi": "/peptide_da/LKIPVA.pdb", "link_html_peptide": "/Peptide_html/LKIPVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKIPVA.pdb", "link_png_peptide": "/Peptide_pics/LKIPVA.png"}
{"Peptide_Sequence": "LKKISQ", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.6\u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "744", " Ligand_ID": "LKKISQ_minimized.pdb_744", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "715.88", " logP": "-4.31", " logD": "-12.62", " logSw": "0.22", " tPSA": "331.87", " RotatableB": "27", " RigidB": "13", " Flexibility": "0.68", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "50", " CarbonAtoms": "32", " HeteroAtoms": "18", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "891003.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 715.882", "link_html_complex": "/ACE_complex_html/ACE_LKKISQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKKISQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKKISQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKKISQ.png", "phi_psi": "/peptide_da/LKKISQ.pdb", "link_html_peptide": "/Peptide_html/LKKISQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKKISQ.pdb", "link_png_peptide": "/Peptide_pics/LKKISQ.png"}
{"Peptide_Sequence": "LKL", " Origin": "Sardine Meat", " Peptide_Preparation": "peptic hydrolysis", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "188 \u03bcM", " Reference": "Ukeda, Hiroyuki, et al. \"Peptides from peptic hydrolyzate of heated sardine meat that inhibit angiotensin I converting enzyme.\" Nippon Nogeikagaku Kaishi 66.1 (1992): 25-29.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "745", " Ligand_ID": "LKL_minimized.pdb_745", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "372.5", " logP": "-2.5", " logD": "-4.7", " logSw": "0.28", " tPSA": "153.61", " RotatableB": "13", " RigidB": "5", " Flexibility": "0.72", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "18", " HeteroAtoms": "8", " ratio_H_by_C": "0.44", " Lipinski_Violation": "1", " Solubility_mg_per_l": "494588.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 372.503", "link_html_complex": "/ACE_complex_html/ACE_LKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKL.png", "phi_psi": "/peptide_da/LKL.pdb", "link_html_peptide": "/Peptide_html/LKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKL.pdb", "link_png_peptide": "/Peptide_pics/LKL.png"}
{"Peptide_Sequence": "LKLP", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "367 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "746", " Ligand_ID": "LKLP_minimized.pdb_746", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "469.62", " logP": "-2.74", " logD": "-6.31", " logSw": "-0.1", " tPSA": "173.92", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "424320.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 469.618", "link_html_complex": "/ACE_complex_html/ACE_LKLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKLP.png", "phi_psi": "/peptide_da/LKLP.pdb", "link_html_peptide": "/Peptide_html/LKLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKLP.pdb", "link_png_peptide": "/Peptide_pics/LKLP.png"}
{"Peptide_Sequence": "LKN", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "748", " Ligand_ID": "LKN_minimized.pdb_748", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "373.45", " logP": "-3.94", " logD": "-7.4", " logSw": "1.18", " tPSA": "196.7", " RotatableB": "13", " RigidB": "7", " Flexibility": "0.65", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1221215.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 373.448", "link_html_complex": "/ACE_complex_html/ACE_LKN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKN.png", "phi_psi": "/peptide_da/LKN.pdb", "link_html_peptide": "/Peptide_html/LKN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKN.pdb", "link_png_peptide": "/Peptide_pics/LKN.png"}
{"Peptide_Sequence": "LKP", " Origin": "chicken muscle", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "0.32 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "751", " Ligand_ID": "LKP_minimized.pdb_751", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.46", " logP": "-3.14", " logD": "-5.68", " logSw": "0.59", " tPSA": "144.82", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "641859.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.46", "link_html_complex": "/ACE_complex_html/ACE_LKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKP.png", "phi_psi": "/peptide_da/LKP.pdb", "link_html_peptide": "/Peptide_html/LKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKP.pdb", "link_png_peptide": "/Peptide_pics/LKP.png"}
{"Peptide_Sequence": "LKPDM", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "9.69 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "749", " Ligand_ID": "LKPDM_minimized.pdb_749", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(O)=O", " MW": "602.74", " logP": "-6.64", " logD": "-11.52", " logSw": "1.86", " tPSA": "268.45", " RotatableB": "19", " RigidB": "15", " Flexibility": "0.56", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3872596.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 602.744", "link_html_complex": "/ACE_complex_html/ACE_LKPDM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKPDM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKPDM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKPDM.png", "phi_psi": "/peptide_da/LKPDM.pdb", "link_html_peptide": "/Peptide_html/LKPDM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKPDM.pdb", "link_png_peptide": "/Peptide_pics/LKPDM.png"}
{"Peptide_Sequence": "LKPI", " Origin": "egg proteins", " Peptide_Preparation": "thermolysin, pepsin", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR, Cushman and Cheung with slight modifications byMajumder & Wu, 2010", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "", " Reference": "Majumder, Kaustav, and Jianping Wu. \"A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics.\" Food Research International 43.5 (2010): 1371-1378.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "750", " Ligand_ID": "LKPI_minimized.pdb_750", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(O)=O", " MW": "469.62", " logP": "-2.56", " logD": "-6.23", " logSw": "-0.21", " tPSA": "173.92", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "378830.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.83", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 469.618", "link_html_complex": "/ACE_complex_html/ACE_LKPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKPI.png", "phi_psi": "/peptide_da/LKPI.pdb", "link_html_peptide": "/Peptide_html/LKPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKPI.pdb", "link_png_peptide": "/Peptide_pics/LKPI.png"}
{"Peptide_Sequence": "LKPMN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "9.79 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "752", " Ligand_ID": "LKPMN_minimized.pdb_752", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "601.76", " logP": "-5.01", " logD": "-8.97", " logSw": "0.84", " tPSA": "271.41", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1393050", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 601.759", "link_html_complex": "/ACE_complex_html/ACE_LKPMN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKPMN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKPMN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKPMN.png", "phi_psi": "/peptide_da/LKPMN.pdb", "link_html_peptide": "/Peptide_html/LKPMN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKPMN.pdb", "link_png_peptide": "/Peptide_pics/LKPMN.png"}
{"Peptide_Sequence": "LKPNM", " Origin": "dried bonito", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "2.4 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "753", " Ligand_ID": "LKPNM_minimized.pdb_753", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(O)=O", " MW": "601.76", " logP": "-5.01", " logD": "-8.97", " logSw": "0.84", " tPSA": "271.41", " RotatableB": "19", " RigidB": "16", " Flexibility": "0.54", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1393050", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 601.759", "link_html_complex": "/ACE_complex_html/ACE_LKPNM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKPNM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKPNM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKPNM.png", "phi_psi": "/peptide_da/LKPNM.pdb", "link_html_peptide": "/Peptide_html/LKPNM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKPNM.pdb", "link_png_peptide": "/Peptide_pics/LKPNM.png"}
{"Peptide_Sequence": "LKPTPEGN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2691.5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "754", " Ligand_ID": "LKPTPEGN_minimized.pdb_754", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "854.95", " logP": "-8.41", " logD": "-15.87", " logSw": "1.81", " tPSA": "384.98", " RotatableB": "25", " RigidB": "28", " Flexibility": "0.47", " HBD": "14", " HBA": "23", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "60", " CarbonAtoms": "37", " HeteroAtoms": "23", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5211724.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 854.947", "link_html_complex": "/ACE_complex_html/ACE_LKPTPEGN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKPTPEGN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKPTPEGN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKPTPEGN.png", "phi_psi": "/peptide_da/LKPTPEGN.pdb", "link_html_peptide": "/Peptide_html/LKPTPEGN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKPTPEGN.pdb", "link_png_peptide": "/Peptide_pics/LKPTPEGN.png"}
{"Peptide_Sequence": "LKSQQ", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "755", " Ligand_ID": "LKSQQ_minimized.pdb_755", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "602.68", " logP": "-6.74", " logD": "-11.82", " logSw": "2.06", " tPSA": "318.22", " RotatableB": "21", " RigidB": "13", " Flexibility": "0.62", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "25", " HeteroAtoms": "17", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4707753.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 602.681", "link_html_complex": "/ACE_complex_html/ACE_LKSQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKSQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKSQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKSQQ.png", "phi_psi": "/peptide_da/LKSQQ.pdb", "link_html_peptide": "/Peptide_html/LKSQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKSQQ.pdb", "link_png_peptide": "/Peptide_pics/LKSQQ.png"}
{"Peptide_Sequence": "LKVGVKQY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "11 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "756", " Ligand_ID": "LKVGVKQY_minimized.pdb_756", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "934.13", " logP": "-3.72", " logD": "-11.4", " logSw": "-1.21", " tPSA": "390.07", " RotatableB": "32", " RigidB": "23", " Flexibility": "0.58", " HBD": "17", " HBA": "22", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "66", " CarbonAtoms": "44", " HeteroAtoms": "22", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "279248.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 934.133", "link_html_complex": "/ACE_complex_html/ACE_LKVGVKQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKVGVKQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKVGVKQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKVGVKQY.png", "phi_psi": "/peptide_da/LKVGVKQY.pdb", "link_html_peptide": "/Peptide_html/LKVGVKQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKVGVKQY.pdb", "link_png_peptide": "/Peptide_pics/LKVGVKQY.png"}
{"Peptide_Sequence": "LKY", " Origin": "Antarctic krill (Euphausia superba) tail meat", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "10.1 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "757", " Ligand_ID": "LKY_minimized.pdb_757", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "422.52", " logP": "-2.9", " logD": "-4.61", " logSw": "0.16", " tPSA": "173.84", " RotatableB": "13", " RigidB": "11", " Flexibility": "0.54", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "493855.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.518", "link_html_complex": "/ACE_complex_html/ACE_LKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKY.png", "phi_psi": "/peptide_da/LKY.pdb", "link_html_peptide": "/Peptide_html/LKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKY.pdb", "link_png_peptide": "/Peptide_pics/LKY.png"}
{"Peptide_Sequence": "LKYPI", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "27.07 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "758", " Ligand_ID": "LKYPI_minimized.pdb_758", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(O)=O", " MW": "632.79", " logP": "-0.42", " logD": "-5.41", " logSw": "-2.36", " tPSA": "223.25", " RotatableB": "18", " RigidB": "20", " Flexibility": "0.47", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "32", " HeteroAtoms": "13", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "59959.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 632.791", "link_html_complex": "/ACE_complex_html/ACE_LKYPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LKYPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LKYPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LKYPI.png", "phi_psi": "/peptide_da/LKYPI.pdb", "link_html_peptide": "/Peptide_html/LKYPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LKYPI.pdb", "link_png_peptide": "/Peptide_pics/LKYPI.png"}
{"Peptide_Sequence": "LLF", " Origin": "ovine and caprine \u03b2-lactoglobulin", " Peptide_Preparation": "trypsin, Chymotrypsin, proteinase K and thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971) as modified by Kim, Yoon, Yu, L\u00f6nnerdal, and Chung (1999)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "79.8 \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"Preparation of ovine and caprine \u03b2-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine \u03b2-lactoglobulin hydrolysed with thermolysin.\" International Dairy Journal 12.10 (2002): 805-812.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "759", " Ligand_ID": "LLF_minimized.pdb_759", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "391.5", " logP": "-0.98", " logD": "-1.27", " logSw": "-1", " tPSA": "125.97", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "21", " HeteroAtoms": "7", " ratio_H_by_C": "0.33", " Lipinski_Violation": "0", " Solubility_mg_per_l": "144500.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.504", "link_html_complex": "/ACE_complex_html/ACE_LLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLF.png", "phi_psi": "/peptide_da/LLF.pdb", "link_html_peptide": "/Peptide_html/LLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLF.pdb", "link_png_peptide": "/Peptide_pics/LLF.png"}
{"Peptide_Sequence": "LLHSPP", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "  222 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "760", " Ligand_ID": "LLHSPP_minimized.pdb_760", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "662.78", " logP": "-2.3", " logD": "-5.94", " logSw": "-1.48", " tPSA": "244.6", " RotatableB": "16", " RigidB": "26", " Flexibility": "0.38", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "31", " HeteroAtoms": "16", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "150516.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 662.777", "link_html_complex": "/ACE_complex_html/ACE_LLHSPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLHSPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLHSPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLHSPP.png", "phi_psi": "/peptide_da/LLHSPP.pdb", "link_html_peptide": "/Peptide_html/LLHSPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLHSPP.pdb", "link_png_peptide": "/Peptide_pics/LLHSPP.png"}
{"Peptide_Sequence": "LLLAHLL", " Origin": "P-CN", " Peptide_Preparation": "", " Isolation_Method": "UF, HPLC", " ACE_inhibition_assay": "HPLC method by Mao et al., 2007", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "5.19 \u03bcM", " Reference": "Chen, Y., et al. \"Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk.\" Journal of dairy science 93.3 (2010): 884-892.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "761", " Ligand_ID": "LLLAHLL_minimized.pdb_761", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "792.02", " logP": "1.85", " logD": "-2.11", " logSw": "-4.3", " tPSA": "271.05", " RotatableB": "25", " RigidB": "18", " Flexibility": "0.58", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "39", " HeteroAtoms": "17", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10793.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 792.02", "link_html_complex": "/ACE_complex_html/ACE_LLLAHLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLLAHLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLLAHLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLLAHLL.png", "phi_psi": "/peptide_da/LLLAHLL.pdb", "link_html_peptide": "/Peptide_html/LLLAHLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLLAHLL.pdb", "link_png_peptide": "/Peptide_pics/LLLAHLL.png"}
{"Peptide_Sequence": "LLLLR", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "762", " Ligand_ID": "LLLLR_minimized.pdb_762", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "626.83", " logP": "-0.95", " logD": "-2.27", " logSw": "-1.68", " tPSA": "247.81", " RotatableB": "22", " RigidB": "10", " Flexibility": "0.69", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "117310.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 626.831", "link_html_complex": "/ACE_complex_html/ACE_LLLLR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLLLR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLLLR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLLLR.png", "phi_psi": "/peptide_da/LLLLR.pdb", "link_html_peptide": "/Peptide_html/LLLLR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLLLR.pdb", "link_png_peptide": "/Peptide_pics/LLLLR.png"}
{"Peptide_Sequence": "LLMLDNDLPP", " Origin": "Pacific cod (Gadus macrocephalus) skin", " Peptide_Preparation": "gastric endopeptidases with pepsin, trypsin and \u03b1-chymotrypsin", " Isolation_Method": "FPLC, RP-HPLC", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 35.7 \u03bcM", " Reference": "Himaya, S. W. A., et al. \"An active peptide purified from gastrointestinal enzyme hydrolysate of Pacific cod skin gelatin attenuates angiotensin-1 converting enzyme (ACE) activity and cellular oxidative stress.\" Food Chemistry 132.4 (2012): 1872-1882.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "763", " Ligand_ID": "LLMLDNDLPP_minimized.pdb_763", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "1140.35", " logP": "-2", " logD": "-12.69", " logSw": "-3.41", " tPSA": "460.74", " RotatableB": "34", " RigidB": "33", " Flexibility": "0.51", " HBD": "14", " HBA": "27", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "79", " CarbonAtoms": "51", " HeteroAtoms": "28", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "37823.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1140.35", "link_html_complex": "/ACE_complex_html/ACE_LLMLDNDLPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLMLDNDLPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLMLDNDLPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLMLDNDLPP.png", "phi_psi": "/peptide_da/LLMLDNDLPP.pdb", "link_html_peptide": "/Peptide_html/LLMLDNDLPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLMLDNDLPP.pdb", "link_png_peptide": "/Peptide_pics/LLMLDNDLPP.png"}
{"Peptide_Sequence": "LLMPK", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "  686.2 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "764", " Ligand_ID": "LLMPK_minimized.pdb_764", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "600.81", " logP": "-2.17", " logD": "-3.26", " logSw": "-0.94", " tPSA": "228.32", " RotatableB": "19", " RigidB": "14", " Flexibility": "0.58", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "233770.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 600.814", "link_html_complex": "/ACE_complex_html/ACE_LLMPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLMPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLMPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLMPK.png", "phi_psi": "/peptide_da/LLMPK.pdb", "link_html_peptide": "/Peptide_html/LLMPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLMPK.pdb", "link_png_peptide": "/Peptide_pics/LLMPK.png"}
{"Peptide_Sequence": "LLNP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "765", " Ligand_ID": "LLNP_minimized.pdb_765", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "455.55", " logP": "-4.02", " logD": "-5.07", " logSw": "0.66", " tPSA": "189.37", " RotatableB": "12", " RigidB": "14", " Flexibility": "0.46", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "881567.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.548", "link_html_complex": "/ACE_complex_html/ACE_LLNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLNP.png", "phi_psi": "/peptide_da/LLNP.pdb", "link_html_peptide": "/Peptide_html/LLNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLNP.pdb", "link_png_peptide": "/Peptide_pics/LLNP.png"}
{"Peptide_Sequence": "LLNPPHQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "9.6", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "766", " Ligand_ID": "LLNPPHQIYP_minimized.pdb_766", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1191.38", " logP": "-2.08", " logD": "-6.71", " logSw": "-3.98", " tPSA": "438.39", " RotatableB": "30", " RigidB": "49", " Flexibility": "0.38", " HBD": "15", " HBA": "28", " HBD_HBA": "43", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "57", " HeteroAtoms": "28", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "22178.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1191.38", "link_html_complex": "/ACE_complex_html/ACE_LLNPPHQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLNPPHQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLNPPHQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLNPPHQIYP.png", "phi_psi": "/peptide_da/LLNPPHQIYP.pdb", "link_html_peptide": "/Peptide_html/LLNPPHQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLNPPHQIYP.pdb", "link_png_peptide": "/Peptide_pics/LLNPPHQIYP.png"}
{"Peptide_Sequence": "LLP", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "57", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "767", " Ligand_ID": "LLP_minimized.pdb_767", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "341.45", " logP": "-1.58", " logD": "-2.67", " logSw": "-0.43", " tPSA": "117.18", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "221323.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 341.446", "link_html_complex": "/ACE_complex_html/ACE_LLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLP.png", "phi_psi": "/peptide_da/LLP.pdb", "link_html_peptide": "/Peptide_html/LLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLP.pdb", "link_png_peptide": "/Peptide_pics/LLP.png"}
{"Peptide_Sequence": "LLPSY", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "768", " Ligand_ID": "LLPSY_minimized.pdb_768", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "591.7", " logP": "-2.39", " logD": "-3.89", " logSw": "-1.06", " tPSA": "215.84", " RotatableB": "15", " RigidB": "20", " Flexibility": "0.43", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "204208.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 591.696", "link_html_complex": "/ACE_complex_html/ACE_LLPSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLPSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLPSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLPSY.png", "phi_psi": "/peptide_da/LLPSY.pdb", "link_html_peptide": "/Peptide_html/LLPSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLPSY.pdb", "link_png_peptide": "/Peptide_pics/LLPSY.png"}
{"Peptide_Sequence": "LLRH", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "  307 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "769", " Ligand_ID": "LLRH_minimized.pdb_769", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "537.66", " logP": "-2.17", " logD": "-6.67", " logSw": "-0.66", " tPSA": "247.39", " RotatableB": "18", " RigidB": "13", " Flexibility": "0.58", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "276766.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 537.655", "link_html_complex": "/ACE_complex_html/ACE_LLRH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLRH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLRH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLRH.png", "phi_psi": "/peptide_da/LLRH.pdb", "link_html_peptide": "/Peptide_html/LLRH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLRH.pdb", "link_png_peptide": "/Peptide_pics/LLRH.png"}
{"Peptide_Sequence": "LLYQQPV", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "771", " Ligand_ID": "LLYQQPV_minimized.pdb_771", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "860.01", " logP": "-3.21", " logD": "-5.26", " logSw": "-1.6", " tPSA": "339.99", " RotatableB": "24", " RigidB": "28", " Flexibility": "0.46", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "41", " HeteroAtoms": "20", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "173460.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 860.008", "link_html_complex": "/ACE_complex_html/ACE_LLYQQPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLYQQPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLYQQPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLYQQPV.png", "phi_psi": "/peptide_da/LLYQQPV.pdb", "link_html_peptide": "/Peptide_html/LLYQQPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLYQQPV.pdb", "link_png_peptide": "/Peptide_pics/LLYQQPV.png"}
{"Peptide_Sequence": "LLYQQPVLGPVRGPFPIIV", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "21 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "32.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2106.55", "link_html_complex": "/ACE_complex_html/ACE_LLYQQPVLGPVRGPFPIIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LLYQQPVLGPVRGPFPIIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LLYQQPVLGPVRGPFPIIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LLYQQPVLGPVRGPFPIIV.png", "phi_psi": "/peptide_da/LLYQQPVLGPVRGPFPIIV.pdb", "link_html_peptide": "/Peptide_html/LLYQQPVLGPVRGPFPIIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LLYQQPVLGPVRGPFPIIV.pdb", "link_png_peptide": "/Peptide_pics/LLYQQPVLGPVRGPFPIIV.png"}
{"Peptide_Sequence": "LMGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "377.5 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "772", " Ligand_ID": "LMGP_minimized.pdb_772", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "416.54", " logP": "-2.92", " logD": "-4.79", " logSw": "0.14", " tPSA": "171.58", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "18", " HeteroAtoms": "10", " ratio_H_by_C": "0.56", " Lipinski_Violation": "0", " Solubility_mg_per_l": "480607.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 416.535", "link_html_complex": "/ACE_complex_html/ACE_LMGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LMGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LMGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LMGP.png", "phi_psi": "/peptide_da/LMGP.pdb", "link_html_peptide": "/Peptide_html/LMGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LMGP.pdb", "link_png_peptide": "/Peptide_pics/LMGP.png"}
{"Peptide_Sequence": "LMSPH", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "773", " Ligand_ID": "LMSPH_minimized.pdb_773", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "583.7", " logP": "-4.54", " logD": "-5.42", " logSw": "0.41", " tPSA": "249.59", " RotatableB": "16", " RigidB": "19", " Flexibility": "0.46", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "880918.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 583.701", "link_html_complex": "/ACE_complex_html/ACE_LMSPH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LMSPH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LMSPH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LMSPH.png", "phi_psi": "/peptide_da/LMSPH.pdb", "link_html_peptide": "/Peptide_html/LMSPH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LMSPH.pdb", "link_png_peptide": "/Peptide_pics/LMSPH.png"}
{"Peptide_Sequence": "LN", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "779", " Ligand_ID": "LN_minimized.pdb_779", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "245.28", " logP": "-4.53", " logD": "-4.05", " logSw": "1.96", " tPSA": "139.96", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1732938.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.275", "link_html_complex": "/ACE_complex_html/ACE_LN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LN.png", "phi_psi": "/peptide_da/LN.pdb", "link_html_peptide": "/Peptide_html/LN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LN.pdb", "link_png_peptide": "/Peptide_pics/LN.png"}
{"Peptide_Sequence": "LNECQ", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "774", " Ligand_ID": "LNECQ_minimized.pdb_774", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "605.66", " logP": "-5.96", " logD": "-11.93", " logSw": "1.41", " tPSA": "349.28", " RotatableB": "19", " RigidB": "14", " Flexibility": "0.58", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2489953.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 605.661", "link_html_complex": "/ACE_complex_html/ACE_LNECQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNECQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNECQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNECQ.png", "phi_psi": "/peptide_da/LNECQ.pdb", "link_html_peptide": "/Peptide_html/LNECQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNECQ.pdb", "link_png_peptide": "/Peptide_pics/LNECQ.png"}
{"Peptide_Sequence": "LNENLLRFFVAPFPEVFG", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "280 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "17.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2109.42", "link_html_complex": "/ACE_complex_html/ACE_LNENLLRFFVAPFPEVFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNENLLRFFVAPFPEVFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNENLLRFFVAPFPEVFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNENLLRFFVAPFPEVFG.png", "phi_psi": "/peptide_da/LNENLLRFFVAPFPEVFG.pdb", "link_html_peptide": "/Peptide_html/LNENLLRFFVAPFPEVFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNENLLRFFVAPFPEVFG.pdb", "link_png_peptide": "/Peptide_pics/LNENLLRFFVAPFPEVFG.png"}
{"Peptide_Sequence": "LNF", " Origin": "Soy ", " Peptide_Preparation": "Thermolysin,pepsin and trypsin", " Isolation_Method": "RP-UPLC\u2013MS/MS", " ACE_inhibition_assay": "Wu, Aluko, & Muir, 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "511.4 \u03bcM", " Reference": "Gu, Yuchen, and Jianping Wu. \"LC\u2013MS/MS coupled with QSAR modeling in characterising of angiotensin I-converting enzyme inhibitory peptides from soybean proteins.\" Food chemistry 141.3 (2013): 2682-2690.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "776", " Ligand_ID": "LNF_minimized.pdb_776", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "392.45", " logP": "-2.92", " logD": "-4.02", " logSw": "0.21", " tPSA": "169.06", " RotatableB": "11", " RigidB": "13", " Flexibility": "0.46", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "485672.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.449", "link_html_complex": "/ACE_complex_html/ACE_LNF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNF.png", "phi_psi": "/peptide_da/LNF.pdb", "link_html_peptide": "/Peptide_html/LNF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNF.pdb", "link_png_peptide": "/Peptide_pics/LNF.png"}
{"Peptide_Sequence": "LNLQDF", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.51\u2009\u00b5M", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "777", " Ligand_ID": "LNLQDF_minimized.pdb_777", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "748.82", " logP": "-5.14", " logD": "-9.89", " logSw": "0.23", " tPSA": "339.58", " RotatableB": "23", " RigidB": "22", " Flexibility": "0.51", " HBD": "13", " HBA": "19", " HBD_HBA": "32", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "34", " HeteroAtoms": "19", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "943608.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 748.824", "link_html_complex": "/ACE_complex_html/ACE_LNLQDF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNLQDF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNLQDF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNLQDF.png", "phi_psi": "/peptide_da/LNLQDF.pdb", "link_html_peptide": "/Peptide_html/LNLQDF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNLQDF.pdb", "link_png_peptide": "/Peptide_pics/LNLQDF.png"}
{"Peptide_Sequence": "LNLQDFR", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.85\u2009\u00b5M", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "778", " Ligand_ID": "LNLQDFR_minimized.pdb_778", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "905.01", " logP": "-4.66", " logD": "-10.09", " logSw": "-0.57", " tPSA": "432.32", " RotatableB": "30", " RigidB": "25", " Flexibility": "0.55", " HBD": "18", " HBA": "24", " HBD_HBA": "42", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "40", " HeteroAtoms": "24", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "511833.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 905.009", "link_html_complex": "/ACE_complex_html/ACE_LNLQDFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNLQDFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNLQDFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNLQDFR.png", "phi_psi": "/peptide_da/LNLQDFR.pdb", "link_html_peptide": "/Peptide_html/LNLQDFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNLQDFR.pdb", "link_png_peptide": "/Peptide_pics/LNLQDFR.png"}
{"Peptide_Sequence": "LNNSRAP", " Origin": "bovine lactoferrin", " Peptide_Preparation": " porcine pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo, ex-vivo", " IC50_micromol_per_L": "        105.3 \u03bcM", " Reference": "Ruiz-Gim\u00e9nez, Pedro, et al. \"Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides.\" Food Chemistry 131.1 (2012): 266-273.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "780", " Ligand_ID": "LNNSRAP_minimized.pdb_780", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "770.83", " logP": "-9.49", " logD": "-13.75", " logSw": "2.88", " tPSA": "403.63", " RotatableB": "23", " RigidB": "23", " Flexibility": "0.5", " HBD": "17", " HBA": "23", " HBD_HBA": "40", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "54", " CarbonAtoms": "31", " HeteroAtoms": "23", " ratio_H_by_C": "0.74", " Lipinski_Violation": "3", " Solubility_mg_per_l": "13697943.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 770.834", "link_html_complex": "/ACE_complex_html/ACE_LNNSRAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNNSRAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNNSRAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNNSRAP.png", "phi_psi": "/peptide_da/LNNSRAP.pdb", "link_html_peptide": "/Peptide_html/LNNSRAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNNSRAP.pdb", "link_png_peptide": "/Peptide_pics/LNNSRAP.png"}
{"Peptide_Sequence": "LNP", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "43", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "782", " Ligand_ID": "LNP_minimized.pdb_782", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "342.39", " logP": "-4.42", " logD": "-5.41", " logSw": "1.35", " tPSA": "160.27", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1320452.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 342.391", "link_html_complex": "/ACE_complex_html/ACE_LNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNP.png", "phi_psi": "/peptide_da/LNP.pdb", "link_html_peptide": "/Peptide_html/LNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNP.pdb", "link_png_peptide": "/Peptide_pics/LNP.png"}
{"Peptide_Sequence": "LNPA", " Origin": "maize protein \u03b1-Zein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Yamamoto et al.1980", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "312 \u03bcM", " Reference": "Yano, Seiko, Kazumasa Suzuki, and Gunki Funatsu. \"Isolation from \u03b1-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 60.4 (1996): 661-663.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "781", " Ligand_ID": "LNPA_minimized.pdb_781", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "413.47", " logP": "-5.16", " logD": "-6.29", " logSw": "1.51", " tPSA": "189.37", " RotatableB": "10", " RigidB": "14", " Flexibility": "0.42", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1866604.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 413.469", "link_html_complex": "/ACE_complex_html/ACE_LNPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNPA.png", "phi_psi": "/peptide_da/LNPA.pdb", "link_html_peptide": "/Peptide_html/LNPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNPA.pdb", "link_png_peptide": "/Peptide_pics/LNPA.png"}
{"Peptide_Sequence": "LNPPHQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "25", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "783", " Ligand_ID": "LNPPHQIYP_minimized.pdb_783", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1078.22", " logP": "-3.15", " logD": "-7.43", " logSw": "-2.88", " tPSA": "409.29", " RotatableB": "26", " RigidB": "47", " Flexibility": "0.36", " HBD": "14", " HBA": "26", " HBD_HBA": "40", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "77", " CarbonAtoms": "51", " HeteroAtoms": "26", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "60645.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1078.22", "link_html_complex": "/ACE_complex_html/ACE_LNPPHQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNPPHQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNPPHQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNPPHQIYP.png", "phi_psi": "/peptide_da/LNPPHQIYP.pdb", "link_html_peptide": "/Peptide_html/LNPPHQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNPPHQIYP.pdb", "link_png_peptide": "/Peptide_pics/LNPPHQIYP.png"}
{"Peptide_Sequence": "LNSLT", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "784", " Ligand_ID": "LNSLT_minimized.pdb_784", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "546.61", " logP": "-4.99", " logD": "-7.53", " logSw": "1.04", " tPSA": "267.72", " RotatableB": "17", " RigidB": "11", " Flexibility": "0.61", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1541381.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 546.614", "link_html_complex": "/ACE_complex_html/ACE_LNSLT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNSLT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNSLT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNSLT.png", "phi_psi": "/peptide_da/LNSLT.pdb", "link_html_peptide": "/Peptide_html/LNSLT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNSLT.pdb", "link_png_peptide": "/Peptide_pics/LNSLT.png"}
{"Peptide_Sequence": "LNVPGEIVE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "300 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "785", " Ligand_ID": "LNVPGEIVE_minimized.pdb_785", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "969.09", " logP": "-3.57", " logD": "-13.71", " logSw": "-1.62", " tPSA": "415.13", " RotatableB": "30", " RigidB": "26", " Flexibility": "0.54", " HBD": "14", " HBA": "25", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "68", " CarbonAtoms": "43", " HeteroAtoms": "25", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "191924.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 969.09", "link_html_complex": "/ACE_complex_html/ACE_LNVPGEIVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNVPGEIVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNVPGEIVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNVPGEIVE.png", "phi_psi": "/peptide_da/LNVPGEIVE.pdb", "link_html_peptide": "/Peptide_html/LNVPGEIVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNVPGEIVE.pdb", "link_png_peptide": "/Peptide_pics/LNVPGEIVE.png"}
{"Peptide_Sequence": "LNVVGETVE", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "786", " Ligand_ID": "LNVVGETVE_minimized.pdb_786", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "959.05", " logP": "-4.37", " logD": "-15.09", " logSw": "-0.99", " tPSA": "444.15", " RotatableB": "31", " RigidB": "21", " Flexibility": "0.6", " HBD": "16", " HBA": "26", " HBD_HBA": "42", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "67", " CarbonAtoms": "41", " HeteroAtoms": "26", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "357424.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 959.052", "link_html_complex": "/ACE_complex_html/ACE_LNVVGETVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNVVGETVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNVVGETVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNVVGETVE.png", "phi_psi": "/peptide_da/LNVVGETVE.pdb", "link_html_peptide": "/Peptide_html/LNVVGETVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNVVGETVE.pdb", "link_png_peptide": "/Peptide_pics/LNVVGETVE.png"}
{"Peptide_Sequence": "LNY", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "81 \u03bcM", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "787", " Ligand_ID": "LNY_minimized.pdb_787", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "408.45", " logP": "-4.18", " logD": "-4.34", " logSw": "0.91", " tPSA": "189.29", " RotatableB": "11", " RigidB": "13", " Flexibility": "0.46", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1013828.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 408.449", "link_html_complex": "/ACE_complex_html/ACE_LNY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LNY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LNY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LNY.png", "phi_psi": "/peptide_da/LNY.pdb", "link_html_peptide": "/Peptide_html/LNY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LNY.pdb", "link_png_peptide": "/Peptide_pics/LNY.png"}
{"Peptide_Sequence": "LPAGA", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "788", " Ligand_ID": "LPAGA_minimized.pdb_788", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(O)=O", " MW": "427.5", " logP": "-4.22", " logD": "-5.94", " logSw": "0.83", " tPSA": "175.38", " RotatableB": "10", " RigidB": "14", " Flexibility": "0.42", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "19", " HeteroAtoms": "11", " ratio_H_by_C": "0.58", " Lipinski_Violation": "2", " Solubility_mg_per_l": "978550.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 427.495", "link_html_complex": "/ACE_complex_html/ACE_LPAGA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPAGA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPAGA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPAGA.png", "phi_psi": "/peptide_da/LPAGA.pdb", "link_html_peptide": "/Peptide_html/LPAGA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPAGA.pdb", "link_png_peptide": "/Peptide_pics/LPAGA.png"}
{"Peptide_Sequence": "LPF", " Origin": "egg", " Peptide_Preparation": "pepsin-pancreatin digest", " Isolation_Method": " ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10.59", " Reference": "Majumder, K., & Wu, J. (2009). Angiotensin I Converting Enzyme Inhibitory Peptides from Simulatedin VitroGastrointestinal Digestion of Cooked Eggs. Journal of Agricultural and Food Chemistry, 57(2), 471\u2013477. doi:10.1021/jf8028557", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "789", " Ligand_ID": "LPF_minimized.pdb_789", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "375.46", " logP": "-1.29", " logD": "-2.27", " logSw": "-0.91", " tPSA": "117.18", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "20", " HeteroAtoms": "7", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "151670.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 375.462", "link_html_complex": "/ACE_complex_html/ACE_LPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPF.png", "phi_psi": "/peptide_da/LPF.pdb", "link_html_peptide": "/Peptide_html/LPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPF.pdb", "link_png_peptide": "/Peptide_pics/LPF.png"}
{"Peptide_Sequence": "LPG", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "5.73 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "790", " Ligand_ID": "LPG_minimized.pdb_790", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "285.34", " logP": "-2.41", " logD": "-4.52", " logSw": "0.31", " tPSA": "117.18", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "387174.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_LPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPG.png", "phi_psi": "/peptide_da/LPG.pdb", "link_html_peptide": "/Peptide_html/LPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPG.pdb", "link_png_peptide": "/Peptide_pics/LPG.png"}
{"Peptide_Sequence": "LPHA", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "560 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "791", " Ligand_ID": "LPHA_minimized.pdb_791", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(O)=O", " MW": "436.51", " logP": "-3.8", " logD": "-5", " logSw": "0.45", " tPSA": "174.96", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "683849.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 436.505", "link_html_complex": "/ACE_complex_html/ACE_LPHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPHA.png", "phi_psi": "/peptide_da/LPHA.pdb", "link_html_peptide": "/Peptide_html/LPHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPHA.pdb", "link_png_peptide": "/Peptide_pics/LPHA.png"}
{"Peptide_Sequence": "LPHF", " Origin": "Soybean ((\u03b2-conglycinin and glycinin)", " Peptide_Preparation": "acid proteinase from Monascus purpureus", " Isolation_Method": "IEC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "670 \u03bcM", " Reference": "Kuba, M., et al. \"Production of angiotensin I-converting enzyme inhibitory peptides from soybean protein with Monascus purpureus acid proteinase.\" Process Biochemistry 40.6 (2005): 2191-2196.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "792", " Ligand_ID": "LPHF_minimized.pdb_792", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "512.6", " logP": "-2.21", " logD": "-3.33", " logSw": "-0.95", " tPSA": "174.96", " RotatableB": "12", " RigidB": "23", " Flexibility": "0.34", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "26", " HeteroAtoms": "11", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "199170.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.601", "link_html_complex": "/ACE_complex_html/ACE_LPHF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPHF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPHF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPHF.png", "phi_psi": "/peptide_da/LPHF.pdb", "link_html_peptide": "/Peptide_html/LPHF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPHF.pdb", "link_png_peptide": "/Peptide_pics/LPHF.png"}
{"Peptide_Sequence": "LPLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "720", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "793", " Ligand_ID": "LPLP_minimized.pdb_793", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "438.56", " logP": "-1.51", " logD": "-3.3", " logSw": "-1.01", " tPSA": "137.49", " RotatableB": "9", " RigidB": "17", " Flexibility": "0.35", " HBD": "4", " HBA": "9", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "22", " HeteroAtoms": "9", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "159129.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 438.561", "link_html_complex": "/ACE_complex_html/ACE_LPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPLP.png", "phi_psi": "/peptide_da/LPLP.pdb", "link_html_peptide": "/Peptide_html/LPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPLP.pdb", "link_png_peptide": "/Peptide_pics/LPLP.png"}
{"Peptide_Sequence": "LPP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "9.6", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "794", " Ligand_ID": "LPP_minimized.pdb_794", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "325.4", " logP": "-1.71", " logD": "-3.67", " logSw": "-0.45", " tPSA": "108.39", " RotatableB": "5", " RigidB": "15", " Flexibility": "0.25", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "207444.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 325.403", "link_html_complex": "/ACE_complex_html/ACE_LPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPP.png", "phi_psi": "/peptide_da/LPP.pdb", "link_html_peptide": "/Peptide_html/LPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPP.pdb", "link_png_peptide": "/Peptide_pics/LPP.png"}
{"Peptide_Sequence": "LPPP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "795", " Ligand_ID": "LPPP_minimized.pdb_795", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "422.52", " logP": "-1.66", " logD": "-4.32", " logSw": "-1.02", " tPSA": "128.7", " RotatableB": "6", " RigidB": "22", " Flexibility": "0.21", " HBD": "3", " HBA": "9", " HBD_HBA": "12", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "152691.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.518", "link_html_complex": "/ACE_complex_html/ACE_LPPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPPP.png", "phi_psi": "/peptide_da/LPPP.pdb", "link_html_peptide": "/Peptide_html/LPPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPPP.pdb", "link_png_peptide": "/Peptide_pics/LPPP.png"}
{"Peptide_Sequence": "LPPPVH", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "796", " Ligand_ID": "LPPPVH_minimized.pdb_796", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O", " MW": "658.79", " logP": "-1.3", " logD": "-4.01", " logSw": "-2.29", " tPSA": "215.58", " RotatableB": "13", " RigidB": "31", " Flexibility": "0.3", " HBD": "6", " HBA": "15", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67005.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 658.789", "link_html_complex": "/ACE_complex_html/ACE_LPPPVH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPPPVH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPPPVH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPPPVH.png", "phi_psi": "/peptide_da/LPPPVH.pdb", "link_html_peptide": "/Peptide_html/LPPPVH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPPPVH.pdb", "link_png_peptide": "/Peptide_pics/LPPPVH.png"}
{"Peptide_Sequence": "LPQNILP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "46", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "797", " Ligand_ID": "LPQNILP_minimized.pdb_797", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "793.95", " logP": "-2.63", " logD": "-6.18", " logSw": "-1.72", " tPSA": "310.97", " RotatableB": "21", " RigidB": "27", " Flexibility": "0.44", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "37", " HeteroAtoms": "19", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "142227.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 793.95", "link_html_complex": "/ACE_complex_html/ACE_LPQNILP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPQNILP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPQNILP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPQNILP.png", "phi_psi": "/peptide_da/LPQNILP.pdb", "link_html_peptide": "/Peptide_html/LPQNILP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPQNILP.pdb", "link_png_peptide": "/Peptide_pics/LPQNILP.png"}
{"Peptide_Sequence": "LPYPY", " Origin": "ovine milk", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "UF, FPLC, RP-HPLC, IT-MS (CE-MS)", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "28.9 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "798", " Ligand_ID": "LPYPY_minimized.pdb_798", " Smiles": "CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "651.75", " logP": "0.39", " logD": "-2.43", " logSw": "-3.37", " tPSA": "207.05", " RotatableB": "13", " RigidB": "31", " Flexibility": "0.3", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "34", " HeteroAtoms": "13", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "22524.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 651.75", "link_html_complex": "/ACE_complex_html/ACE_LPYPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LPYPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LPYPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LPYPY.png", "phi_psi": "/peptide_da/LPYPY.pdb", "link_html_peptide": "/Peptide_html/LPYPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LPYPY.pdb", "link_png_peptide": "/Peptide_pics/LPYPY.png"}
{"Peptide_Sequence": "LQ", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "802", " Ligand_ID": "LQ_minimized.pdb_802", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "259.3", " logP": "-3.95", " logD": "-3.76", " logSw": "1.57", " tPSA": "139.96", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1244912.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 259.302", "link_html_complex": "/ACE_complex_html/ACE_LQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQ.png", "phi_psi": "/peptide_da/LQ.pdb", "link_html_peptide": "/Peptide_html/LQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQ.pdb", "link_png_peptide": "/Peptide_pics/LQ.png"}
{"Peptide_Sequence": "LQC", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "799", " Ligand_ID": "LQC_minimized.pdb_799", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O", " MW": "362.45", " logP": "-3.86", " logD": "-5.34", " logSw": "1.07", " tPSA": "207.86", " RotatableB": "11", " RigidB": "7", " Flexibility": "0.61", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1057342.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 362.444", "link_html_complex": "/ACE_complex_html/ACE_LQC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQC.png", "phi_psi": "/peptide_da/LQC.pdb", "link_html_peptide": "/Peptide_html/LQC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQC.pdb", "link_png_peptide": "/Peptide_pics/LQC.png"}
{"Peptide_Sequence": "LQEDG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "800", " Ligand_ID": "LQEDG_minimized.pdb_800", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O", " MW": "560.55", " logP": "-5.64", " logD": "-15.11", " logSw": "1.49", " tPSA": "307.52", " RotatableB": "19", " RigidB": "13", " Flexibility": "0.59", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "39", " CarbonAtoms": "22", " HeteroAtoms": "17", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2491616.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 560.555", "link_html_complex": "/ACE_complex_html/ACE_LQEDG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQEDG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQEDG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQEDG.png", "phi_psi": "/peptide_da/LQEDG.pdb", "link_html_peptide": "/Peptide_html/LQEDG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQEDG.pdb", "link_png_peptide": "/Peptide_pics/LQEDG.png"}
{"Peptide_Sequence": "LQKW", " Origin": " whey proteins, beta-lactoglobulin  ", " Peptide_Preparation": "simulated gastro-intestinal digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and cheung (1971) modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3.5 \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of synthetic \u03b2-lactoglobulin peptide sequences.\" Journal of Dairy Research 74.3 (2007): 336-339.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "801", " Ligand_ID": "LQKW_minimized.pdb_801", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "573.68", " logP": "-3.45", " logD": "-5.92", " logSw": "-0.11", " tPSA": "241.59", " RotatableB": "18", " RigidB": "19", " Flexibility": "0.49", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "511552.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 573.684", "link_html_complex": "/ACE_complex_html/ACE_LQKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQKW.png", "phi_psi": "/peptide_da/LQKW.pdb", "link_html_peptide": "/Peptide_html/LQKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQKW.pdb", "link_png_peptide": "/Peptide_pics/LQKW.png"}
{"Peptide_Sequence": "LQP", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.9", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "804", " Ligand_ID": "LQP_minimized.pdb_804", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "356.42", " logP": "-4.06", " logD": "-5.12", " logSw": "1.1", " tPSA": "160.27", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1072893.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 356.417", "link_html_complex": "/ACE_complex_html/ACE_LQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQP.png", "phi_psi": "/peptide_da/LQP.pdb", "link_html_peptide": "/Peptide_html/LQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQP.pdb", "link_png_peptide": "/Peptide_pics/LQP.png"}
{"Peptide_Sequence": "LQPGS", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "803", " Ligand_ID": "LQPGS_minimized.pdb_803", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "500.55", " logP": "-6.51", " logD": "-8.24", " logSw": "2.08", " tPSA": "238.7", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4014285.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 500.546", "link_html_complex": "/ACE_complex_html/ACE_LQPGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQPGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQPGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQPGS.png", "phi_psi": "/peptide_da/LQPGS.pdb", "link_html_peptide": "/Peptide_html/LQPGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQPGS.pdb", "link_png_peptide": "/Peptide_pics/LQPGS.png"}
{"Peptide_Sequence": "LQPSS", " Origin": "MIlk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "805", " Ligand_ID": "LQPSS_minimized.pdb_805", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O", " MW": "530.57", " logP": "-7.16", " logD": "-8.72", " logSw": "2.37", " tPSA": "258.93", " RotatableB": "15", " RigidB": "16", " Flexibility": "0.48", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "22", " HeteroAtoms": "15", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5682858.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 530.572", "link_html_complex": "/ACE_complex_html/ACE_LQPSS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQPSS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQPSS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQPSS.png", "phi_psi": "/peptide_da/LQPSS.pdb", "link_html_peptide": "/Peptide_html/LQPSS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQPSS.pdb", "link_png_peptide": "/Peptide_pics/LQPSS.png"}
{"Peptide_Sequence": "LQQ", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "100", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "806", " Ligand_ID": "LQQ_minimized.pdb_806", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "387.43", " logP": "-5.91", " logD": "-6.56", " logSw": "2.27", " tPSA": "212.15", " RotatableB": "12", " RigidB": "9", " Flexibility": "0.57", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "16", " HeteroAtoms": "11", " ratio_H_by_C": "0.69", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3762219.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 387.431", "link_html_complex": "/ACE_complex_html/ACE_LQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQQ.png", "phi_psi": "/peptide_da/LQQ.pdb", "link_html_peptide": "/Peptide_html/LQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQQ.pdb", "link_png_peptide": "/Peptide_pics/LQQ.png"}
{"Peptide_Sequence": "LQSW", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "500", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "807", " Ligand_ID": "LQSW_minimized.pdb_807", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "532.59", " logP": "-4.27", " logD": "-5.55", " logSw": "0.45", " tPSA": "234.18", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "833635.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 532.589", "link_html_complex": "/ACE_complex_html/ACE_LQSW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQSW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQSW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQSW.png", "phi_psi": "/peptide_da/LQSW.pdb", "link_html_peptide": "/Peptide_html/LQSW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQSW.pdb", "link_png_peptide": "/Peptide_pics/LQSW.png"}
{"Peptide_Sequence": "LQW", " Origin": "human \u03b1s1-casein", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Kim et al. (1999)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4 \u03bcM", " Reference": "Kim, Yoo Kyeong, and Bong Hyun Chung. \"A novel angiotensin-I-converting enzyme inhibitory peptide from human \u03b1 s1-casein.\" Biotechnology letters 21.7 (1999): 575-578.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "808", " Ligand_ID": "LQW_minimized.pdb_808", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "445.51", " logP": "-2.3", " logD": "-3.61", " logSw": "-0.47", " tPSA": "184.85", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "279313.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 445.512", "link_html_complex": "/ACE_complex_html/ACE_LQW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQW.png", "phi_psi": "/peptide_da/LQW.pdb", "link_html_peptide": "/Peptide_html/LQW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQW.pdb", "link_png_peptide": "/Peptide_pics/LQW.png"}
{"Peptide_Sequence": "LQY", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "809", " Ligand_ID": "LQY_minimized.pdb_809", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "422.48", " logP": "-3.82", " logD": "-4.05", " logSw": "0.67", " tPSA": "189.29", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "821706.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 422.475", "link_html_complex": "/ACE_complex_html/ACE_LQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LQY.png", "phi_psi": "/peptide_da/LQY.pdb", "link_html_peptide": "/Peptide_html/LQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LQY.pdb", "link_png_peptide": "/Peptide_pics/LQY.png"}
{"Peptide_Sequence": "LR", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "158 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "814", " Ligand_ID": "LR_minimized.pdb_814", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "287.36", " logP": "-3.61", " logD": "-4.64", " logSw": "1.31", " tPSA": "160.51", " RotatableB": "10", " RigidB": "4", " Flexibility": "0.71", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1067855.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.359", "link_html_complex": "/ACE_complex_html/ACE_LR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LR.png", "phi_psi": "/peptide_da/LR.pdb", "link_html_peptide": "/Peptide_html/LR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LR.pdb", "link_png_peptide": "/Peptide_pics/LR.png"}
{"Peptide_Sequence": "LRC", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "811", " Ligand_ID": "LRC_minimized.pdb_811", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(O)=O", " MW": "390.5", " logP": "-3.08", " logD": "-6.67", " logSw": "0.54", " tPSA": "228.41", " RotatableB": "13", " RigidB": "6", " Flexibility": "0.68", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "15", " HeteroAtoms": "11", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "668290.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.501", "link_html_complex": "/ACE_complex_html/ACE_LRC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRC.png", "phi_psi": "/peptide_da/LRC.pdb", "link_html_peptide": "/Peptide_html/LRC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRC.pdb", "link_png_peptide": "/Peptide_pics/LRC.png"}
{"Peptide_Sequence": "LRCGG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "810", " Ligand_ID": "LRCGG_minimized.pdb_810", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(O)=O", " MW": "504.6", " logP": "-4.39", " logD": "-9.56", " logSw": "0.92", " tPSA": "286.61", " RotatableB": "17", " RigidB": "10", " Flexibility": "0.63", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "19", " HeteroAtoms": "15", " ratio_H_by_C": "0.79", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1265127.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 504.603", "link_html_complex": "/ACE_complex_html/ACE_LRCGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRCGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRCGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRCGG.png", "phi_psi": "/peptide_da/LRCGG.pdb", "link_html_peptide": "/Peptide_html/LRCGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRCGG.pdb", "link_png_peptide": "/Peptide_pics/LRCGG.png"}
{"Peptide_Sequence": "LRFF", " Origin": "milk", " Peptide_Preparation": "Kluyveromyces marxianus fermentation", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Wang et al., 2008", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "116.9\u2009\u00b5M", " Reference": "Li, Yun, et al. \"Purification and identification of novel peptides with inhibitory effect against angiotensin I-converting enzyme and optimization of process conditions in milk fermented with the yeast Kluyveromyces marxianus.\" Journal of functional foods 16 (2015): 278-288.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "812", " Ligand_ID": "LRFF_minimized.pdb_812", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "581.71", " logP": "-0.67", " logD": "-5.1", " logSw": "-1.94", " tPSA": "218.71", " RotatableB": "18", " RigidB": "20", " Flexibility": "0.47", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "30", " HeteroAtoms": "12", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "83514.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 581.706", "link_html_complex": "/ACE_complex_html/ACE_LRFF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRFF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRFF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRFF.png", "phi_psi": "/peptide_da/LRFF.pdb", "link_html_peptide": "/Peptide_html/LRFF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRFF.pdb", "link_png_peptide": "/Peptide_pics/LRFF.png"}
{"Peptide_Sequence": "LRIPVA", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.38 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "813", " Ligand_ID": "LRIPVA_minimized.pdb_813", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "667.84", " logP": "-2.88", " logD": "-7.03", " logSw": "-0.85", " tPSA": "268.12", " RotatableB": "20", " RigidB": "17", " Flexibility": "0.54", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "31", " HeteroAtoms": "16", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "286528.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 667.84", "link_html_complex": "/ACE_complex_html/ACE_LRIPVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRIPVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRIPVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRIPVA.png", "phi_psi": "/peptide_da/LRIPVA.pdb", "link_html_peptide": "/Peptide_html/LRIPVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRIPVA.pdb", "link_png_peptide": "/Peptide_pics/LRIPVA.png"}
{"Peptide_Sequence": "LRN", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "815", " Ligand_ID": "LRN_minimized.pdb_815", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "401.46", " logP": "-4.52", " logD": "-8.28", " logSw": "1.44", " tPSA": "232.7", " RotatableB": "14", " RigidB": "8", " Flexibility": "0.64", " HBD": "11", " HBA": "12", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1698755.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 401.461", "link_html_complex": "/ACE_complex_html/ACE_LRN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRN.png", "phi_psi": "/peptide_da/LRN.pdb", "link_html_peptide": "/Peptide_html/LRN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRN.pdb", "link_png_peptide": "/Peptide_pics/LRN.png"}
{"Peptide_Sequence": "LRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.35 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "816", " Ligand_ID": "LRP_minimized.pdb_816", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "384.47", " logP": "-3.72", " logD": "-6.56", " logSw": "0.85", " tPSA": "180.82", " RotatableB": "11", " RigidB": "11", " Flexibility": "0.5", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "895818.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 384.474", "link_html_complex": "/ACE_complex_html/ACE_LRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRP.png", "phi_psi": "/peptide_da/LRP.pdb", "link_html_peptide": "/Peptide_html/LRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRP.pdb", "link_png_peptide": "/Peptide_pics/LRP.png"}
{"Peptide_Sequence": "LRPVAA", " Origin": "Bovine lactoferrin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "4.14 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "817", " Ligand_ID": "LRPVAA_minimized.pdb_817", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O", " MW": "625.76", " logP": "-4.01", " logD": "-8.39", " logSw": "-0.01", " tPSA": "268.12", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "622380.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 625.761", "link_html_complex": "/ACE_complex_html/ACE_LRPVAA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRPVAA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRPVAA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRPVAA.png", "phi_psi": "/peptide_da/LRPVAA.pdb", "link_html_peptide": "/Peptide_html/LRPVAA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRPVAA.pdb", "link_png_peptide": "/Peptide_pics/LRPVAA.png"}
{"Peptide_Sequence": "LRQRQ", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "818", " Ligand_ID": "LRQRQ_minimized.pdb_818", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "699.8", " logP": "-6.66", " logD": "-13.6", " logSw": "1.73", " tPSA": "397.63", " RotatableB": "26", " RigidB": "15", " Flexibility": "0.63", " HBD": "19", " HBA": "21", " HBD_HBA": "40", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "49", " CarbonAtoms": "28", " HeteroAtoms": "21", " ratio_H_by_C": "0.75", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3959296.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 699.803", "link_html_complex": "/ACE_complex_html/ACE_LRQRQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRQRQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRQRQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRQRQ.png", "phi_psi": "/peptide_da/LRQRQ.pdb", "link_html_peptide": "/Peptide_html/LRQRQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRQRQ.pdb", "link_png_peptide": "/Peptide_pics/LRQRQ.png"}
{"Peptide_Sequence": "LRQSQ", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "819", " Ligand_ID": "LRQSQ_minimized.pdb_819", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "630.69", " logP": "-6.89", " logD": "-12.38", " logSw": "2.04", " tPSA": "354.22", " RotatableB": "22", " RigidB": "14", " Flexibility": "0.61", " HBD": "16", " HBA": "19", " HBD_HBA": "35", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "25", " HeteroAtoms": "19", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4862054.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 630.694", "link_html_complex": "/ACE_complex_html/ACE_LRQSQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRQSQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRQSQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRQSQ.png", "phi_psi": "/peptide_da/LRQSQ.pdb", "link_html_peptide": "/Peptide_html/LRQSQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRQSQ.pdb", "link_png_peptide": "/Peptide_pics/LRQSQ.png"}
{"Peptide_Sequence": "LRRGQ", " Origin": "Oat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "820", " Ligand_ID": "LRRGQ_minimized.pdb_820", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "628.72", " logP": "-5.9", " logD": "-14.07", " logSw": "1.56", " tPSA": "354.54", " RotatableB": "24", " RigidB": "13", " Flexibility": "0.65", " HBD": "17", " HBA": "19", " HBD_HBA": "36", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "44", " CarbonAtoms": "25", " HeteroAtoms": "19", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3000696.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 628.725", "link_html_complex": "/ACE_complex_html/ACE_LRRGQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRRGQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRRGQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRRGQ.png", "phi_psi": "/peptide_da/LRRGQ.pdb", "link_html_peptide": "/Peptide_html/LRRGQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRRGQ.pdb", "link_png_peptide": "/Peptide_pics/LRRGQ.png"}
{"Peptide_Sequence": "LRRQQ", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "821", " Ligand_ID": "LRRQQ_minimized.pdb_821", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "699.8", " logP": "-6.66", " logD": "-14.65", " logSw": "1.73", " tPSA": "397.63", " RotatableB": "26", " RigidB": "15", " Flexibility": "0.63", " HBD": "19", " HBA": "21", " HBD_HBA": "40", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "49", " CarbonAtoms": "28", " HeteroAtoms": "21", " ratio_H_by_C": "0.75", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3959296.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 699.803", "link_html_complex": "/ACE_complex_html/ACE_LRRQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRRQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRRQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRRQQ.png", "phi_psi": "/peptide_da/LRRQQ.pdb", "link_html_peptide": "/Peptide_html/LRRQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRRQQ.pdb", "link_png_peptide": "/Peptide_pics/LRRQQ.png"}
{"Peptide_Sequence": "LRW", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.27\u2009\u00b5M", " Reference": "Wu, Jianping, Lujiang Yuan, and Rotimi E. Aluko. \"Restriction of the in vitro formation of angiotensin II by leucinyl-arginyl-tryptophan, a novel peptide with potent angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 70.5 (2006): 1277-1280.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "822", " Ligand_ID": "LRW_minimized.pdb_822", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "473.57", " logP": "-1.89", " logD": "-5.07", " logSw": "-0.76", " tPSA": "205.4", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "221927.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.568", "link_html_complex": "/ACE_complex_html/ACE_LRW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRW.png", "phi_psi": "/peptide_da/LRW.pdb", "link_html_peptide": "/Peptide_html/LRW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRW.pdb", "link_png_peptide": "/Peptide_pics/LRW.png"}
{"Peptide_Sequence": "LRY", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "823", " Ligand_ID": "LRY_minimized.pdb_823", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "450.53", " logP": "-3.48", " logD": "-5.48", " logSw": "0.42", " tPSA": "209.84", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "682838.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 450.532", "link_html_complex": "/ACE_complex_html/ACE_LRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LRY.png", "phi_psi": "/peptide_da/LRY.pdb", "link_html_peptide": "/Peptide_html/LRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LRY.pdb", "link_png_peptide": "/Peptide_pics/LRY.png"}
{"Peptide_Sequence": "LSA", " Origin": "Sesame protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "5.8 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "824", " Ligand_ID": "LSA_minimized.pdb_824", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O", " MW": "289.33", " logP": "-3.67", " logD": "-5.28", " logSw": "1.21", " tPSA": "146.2", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "966640.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 289.328", "link_html_complex": "/ACE_complex_html/ACE_LSA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSA.png", "phi_psi": "/peptide_da/LSA.pdb", "link_html_peptide": "/Peptide_html/LSA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSA.pdb", "link_png_peptide": "/Peptide_pics/LSA.png"}
{"Peptide_Sequence": "LSGNK", " Origin": "common beans (Phaseolus vulgaris L.) ", " Peptide_Preparation": " synthesized ", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "130.6 \u03bcM", " Reference": "Luna-Vital, Diego A., et al. \"Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity.\" Food & function 6.5 (2015): 1470-1479.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "825", " Ligand_ID": "LSGNK_minimized.pdb_825", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "517.58", " logP": "-5.9", " logD": "-8.5", " logSw": "1.86", " tPSA": "275.13", " RotatableB": "18", " RigidB": "11", " Flexibility": "0.62", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "21", " HeteroAtoms": "15", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3311588.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 517.576", "link_html_complex": "/ACE_complex_html/ACE_LSGNK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSGNK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSGNK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSGNK.png", "phi_psi": "/peptide_da/LSGNK.pdb", "link_html_peptide": "/Peptide_html/LSGNK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSGNK.pdb", "link_png_peptide": "/Peptide_pics/LSGNK.png"}
{"Peptide_Sequence": "LSMGSASLSP", " Origin": "Edible Mushroom Hypsizygus marmoreus", " Peptide_Preparation": "pulverized", " Isolation_Method": "UF, SPEC, RP-HPLC", " ACE_inhibition_assay": "modified method of Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.19\u2009mg/mL", " Reference": "Kang, Min-Gu, et al. \"Characterization of an antihypertensive angiotensin I-converting enzyme inhibitory peptide from the edible mushroom Hypsizygus marmoreus.\" BioMed research international 2013 (2013).", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "826", " Ligand_ID": "LSMGSASLSP_minimized.pdb_826", " Smiles": "CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "949.08", " logP": "-7.98", " logD": "-10.95", " logSw": "1.22", " tPSA": "427.1", " RotatableB": "29", " RigidB": "24", " Flexibility": "0.55", " HBD": "15", " HBA": "25", " HBD_HBA": "40", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "65", " CarbonAtoms": "39", " HeteroAtoms": "26", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3205412.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 949.08", "link_html_complex": "/ACE_complex_html/ACE_LSMGSASLSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSMGSASLSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSMGSASLSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSMGSASLSP.png", "phi_psi": "/peptide_da/LSMGSASLSP.pdb", "link_html_peptide": "/Peptide_html/LSMGSASLSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSMGSASLSP.pdb", "link_png_peptide": "/Peptide_pics/LSMGSASLSP.png"}
{"Peptide_Sequence": "LSP", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.7", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "828", " Ligand_ID": "LSP_minimized.pdb_828", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "315.37", " logP": "-3.95", " logD": "-5.01", " logSw": "1.16", " tPSA": "137.41", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1001211.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 315.365", "link_html_complex": "/ACE_complex_html/ACE_LSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSP.png", "phi_psi": "/peptide_da/LSP.pdb", "link_html_peptide": "/Peptide_html/LSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSP.pdb", "link_png_peptide": "/Peptide_pics/LSP.png"}
{"Peptide_Sequence": "LSPA", " Origin": "maize protein \u03b1-Zein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Yamamoto et al.1980", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "315 \u03bcM", " Reference": "Yano, Seiko, Kazumasa Suzuki, and Gunki Funatsu. \"Isolation from \u03b1-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 60.4 (1996): 661-663.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "827", " Ligand_ID": "LSPA_minimized.pdb_827", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "386.44", " logP": "-4.69", " logD": "-5.91", " logSw": "1.31", " tPSA": "166.51", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1436172.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 386.443", "link_html_complex": "/ACE_complex_html/ACE_LSPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSPA.png", "phi_psi": "/peptide_da/LSPA.pdb", "link_html_peptide": "/Peptide_html/LSPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSPA.pdb", "link_png_peptide": "/Peptide_pics/LSPA.png"}
{"Peptide_Sequence": "LSRGQ", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "829", " Ligand_ID": "LSRGQ_minimized.pdb_829", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "559.62", " logP": "-6.13", " logD": "-11.81", " logSw": "1.87", " tPSA": "311.13", " RotatableB": "20", " RigidB": "12", " Flexibility": "0.63", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "22", " HeteroAtoms": "17", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3639238.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 559.616", "link_html_complex": "/ACE_complex_html/ACE_LSRGQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSRGQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSRGQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSRGQ.png", "phi_psi": "/peptide_da/LSRGQ.pdb", "link_html_peptide": "/Peptide_html/LSRGQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSRGQ.pdb", "link_png_peptide": "/Peptide_pics/LSRGQ.png"}
{"Peptide_Sequence": "LSSGDVF", " Origin": " pea seed (Pisum sativum L.)", " Peptide_Preparation": "", " Isolation_Method": "UF, RP-HPLC", " ACE_inhibition_assay": "Udenigwe, Lin, Hou, & Aluko, 2009", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Aluko, Rotimi E., et al. \"Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides.\" Food Research International 77 (2015): 10-16.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "830", " Ligand_ID": "LSSGDVF_minimized.pdb_830", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "723.77", " logP": "-4.04", " logD": "-10.72", " logSw": "-0.37", " tPSA": "322.96", " RotatableB": "22", " RigidB": "20", " Flexibility": "0.52", " HBD": "12", " HBA": "19", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "51", " CarbonAtoms": "32", " HeteroAtoms": "19", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "497648.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 723.771", "link_html_complex": "/ACE_complex_html/ACE_LSSGDVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSSGDVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSSGDVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSSGDVF.png", "phi_psi": "/peptide_da/LSSGDVF.pdb", "link_html_peptide": "/Peptide_html/LSSGDVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSSGDVF.pdb", "link_png_peptide": "/Peptide_pics/LSSGDVF.png"}
{"Peptide_Sequence": "LSW", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "831", " Ligand_ID": "LSW_minimized.pdb_831", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "404.46", " logP": "-2.12", " logD": "-3.5", " logSw": "-0.47", " tPSA": "161.99", " RotatableB": "10", " RigidB": "15", " Flexibility": "0.4", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "253068.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 404.46", "link_html_complex": "/ACE_complex_html/ACE_LSW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSW.png", "phi_psi": "/peptide_da/LSW.pdb", "link_html_peptide": "/Peptide_html/LSW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSW.pdb", "link_png_peptide": "/Peptide_pics/LSW.png"}
{"Peptide_Sequence": "LSYCG", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "832", " Ligand_ID": "LSYCG_minimized.pdb_832", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(O)=O", " MW": "541.62", " logP": "-4.19", " logD": "-5.88", " logSw": "0.37", " tPSA": "263.43", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "23", " HeteroAtoms": "14", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "784121.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 541.617", "link_html_complex": "/ACE_complex_html/ACE_LSYCG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LSYCG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LSYCG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LSYCG.png", "phi_psi": "/peptide_da/LSYCG.pdb", "link_html_peptide": "/Peptide_html/LSYCG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LSYCG.pdb", "link_png_peptide": "/Peptide_pics/LSYCG.png"}
{"Peptide_Sequence": "LT", " Origin": "Oyster protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Yamamoto et al. (1980) with some modificatio", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Shiozaki, Kazuhiro, et al. \"Identification of oyster-derived hypotensive peptide acting as angiotensin-I-converting enzyme inhibitor.\" Fisheries Science 76.5 (2010): 865-872.", " Binding_Energy_kcal_per_mol": "-6", "Serial_ID": "838", " Ligand_ID": "LT_minimized.pdb_838", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "232.28", " logP": "-3.21", " logD": "-3.23", " logSw": "1.14", " tPSA": "117.1", " RotatableB": "6", " RigidB": "3", " Flexibility": "0.67", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "10", " HeteroAtoms": "6", " ratio_H_by_C": "0.6", " Lipinski_Violation": "0", " Solubility_mg_per_l": "724957.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 232.277", "link_html_complex": "/ACE_complex_html/ACE_LT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LT.png", "phi_psi": "/peptide_da/LT.pdb", "link_html_peptide": "/Peptide_html/LT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LT.pdb", "link_png_peptide": "/Peptide_pics/LT.png"}
{"Peptide_Sequence": "LTDLENLHLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "833", " Ligand_ID": "LTDLENLHLP_minimized.pdb_833", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1164.31", " logP": "-3.44", " logD": "-14.38", " logSw": "-2.54", " tPSA": "493.14", " RotatableB": "36", " RigidB": "33", " Flexibility": "0.52", " HBD": "17", " HBA": "30", " HBD_HBA": "47", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "82", " CarbonAtoms": "52", " HeteroAtoms": "30", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "92039.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1164.31", "link_html_complex": "/ACE_complex_html/ACE_LTDLENLHLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTDLENLHLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTDLENLHLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTDLENLHLP.png", "phi_psi": "/peptide_da/LTDLENLHLP.pdb", "link_html_peptide": "/Peptide_html/LTDLENLHLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTDLENLHLP.pdb", "link_png_peptide": "/Peptide_pics/LTDLENLHLP.png"}
{"Peptide_Sequence": "LTF", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.7 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "834", " Ligand_ID": "LTF_minimized.pdb_834", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "379.45", " logP": "-1.24", " logD": "-3.19", " logSw": "-0.83", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "165346.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 379.451", "link_html_complex": "/ACE_complex_html/ACE_LTF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTF.png", "phi_psi": "/peptide_da/LTF.pdb", "link_html_peptide": "/Peptide_html/LTF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTF.pdb", "link_png_peptide": "/Peptide_pics/LTF.png"}
{"Peptide_Sequence": "LTFPG", " Origin": "pea seed", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Udenigwe, Lin, Hou, & Aluko, 2009", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Aluko, Rotimi E., et al. \"Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides.\" Food Research International 77 (2015): 10-16.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "835", " Ligand_ID": "LTFPG_minimized.pdb_835", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "533.62", " logP": "-1.82", " logD": "-4.93", " logSw": "-1.2", " tPSA": "195.61", " RotatableB": "13", " RigidB": "20", " Flexibility": "0.39", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "26", " HeteroAtoms": "12", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "160483.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 533.617", "link_html_complex": "/ACE_complex_html/ACE_LTFPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTFPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTFPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTFPG.png", "phi_psi": "/peptide_da/LTFPG.pdb", "link_html_peptide": "/Peptide_html/LTFPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTFPG.pdb", "link_png_peptide": "/Peptide_pics/LTFPG.png"}
{"Peptide_Sequence": "LTGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "131.1 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "836", " Ligand_ID": "LTGP_minimized.pdb_836", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "386.44", " logP": "-4.17", " logD": "-6.1", " logSw": "0.99", " tPSA": "166.51", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1034979.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 386.443", "link_html_complex": "/ACE_complex_html/ACE_LTGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTGP.png", "phi_psi": "/peptide_da/LTGP.pdb", "link_html_peptide": "/Peptide_html/LTGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTGP.pdb", "link_png_peptide": "/Peptide_pics/LTGP.png"}
{"Peptide_Sequence": "LTLTDVE", " Origin": "Casein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Phelan, Martha, and David Kerins. \"The potential role of milk-derived peptides in cardiovascular disease.\" Food & function 2.3-4 (2011): 153-167.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "837", " Ligand_ID": "LTLTDVE_minimized.pdb_837", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "789.87", " logP": "-3.53", " logD": "-13.37", " logSw": "-0.86", " tPSA": "363.09", " RotatableB": "25", " RigidB": "15", " Flexibility": "0.63", " HBD": "13", " HBA": "21", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "55", " CarbonAtoms": "34", " HeteroAtoms": "21", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "333142.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 789.871", "link_html_complex": "/ACE_complex_html/ACE_LTLTDVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTLTDVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTLTDVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTLTDVE.png", "phi_psi": "/peptide_da/LTLTDVE.pdb", "link_html_peptide": "/Peptide_html/LTLTDVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTLTDVE.pdb", "link_png_peptide": "/Peptide_pics/LTLTDVE.png"}
{"Peptide_Sequence": "LTPTSN", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "839", " Ligand_ID": "LTPTSN_minimized.pdb_839", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "631.68", " logP": "-7.95", " logD": "-9.76", " logSw": "2.37", " tPSA": "308.26", " RotatableB": "17", " RigidB": "18", " Flexibility": "0.49", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "26", " HeteroAtoms": "18", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6785113.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 631.676", "link_html_complex": "/ACE_complex_html/ACE_LTPTSN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTPTSN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTPTSN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTPTSN.png", "phi_psi": "/peptide_da/LTPTSN.pdb", "link_html_peptide": "/Peptide_html/LTPTSN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTPTSN.pdb", "link_png_peptide": "/Peptide_pics/LTPTSN.png"}
{"Peptide_Sequence": "LTQTPVVVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "160 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "841", " Ligand_ID": "LTQTPVVVPP_minimized.pdb_841", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "1050.25", " logP": "-2.55", " logD": "-7.31", " logSw": "-3.03", " tPSA": "386.85", " RotatableB": "26", " RigidB": "36", " Flexibility": "0.42", " HBD": "13", " HBA": "25", " HBD_HBA": "38", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "74", " CarbonAtoms": "49", " HeteroAtoms": "25", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "50792.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1050.25", "link_html_complex": "/ACE_complex_html/ACE_LTQTPVVVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTQTPVVVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTQTPVVVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTQTPVVVPP.png", "phi_psi": "/peptide_da/LTQTPVVVPP.pdb", "link_html_peptide": "/Peptide_html/LTQTPVVVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTQTPVVVPP.pdb", "link_png_peptide": "/Peptide_pics/LTQTPVVVPP.png"}
{"Peptide_Sequence": "LTQTPVVVPPF", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1500 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "840", " Ligand_ID": "LTQTPVVVPPF_minimized.pdb_840", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1197.42", " logP": "-1.21", " logD": "-6.16", " logSw": "-4.55", " tPSA": "415.95", " RotatableB": "30", " RigidB": "44", " Flexibility": "0.41", " HBD": "14", " HBA": "27", " HBD_HBA": "41", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "58", " HeteroAtoms": "27", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12693.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1197.42", "link_html_complex": "/ACE_complex_html/ACE_LTQTPVVVPPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTQTPVVVPPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTQTPVVVPPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTQTPVVVPPF.png", "phi_psi": "/peptide_da/LTQTPVVVPPF.pdb", "link_html_peptide": "/Peptide_html/LTQTPVVVPPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTQTPVVVPPF.pdb", "link_png_peptide": "/Peptide_pics/LTQTPVVVPPF.png"}
{"Peptide_Sequence": "LTWNS", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "842", " Ligand_ID": "LTWNS_minimized.pdb_842", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "619.67", " logP": "-5.1", " logD": "-7.09", " logSw": "0.57", " tPSA": "283.51", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1100913.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 619.667", "link_html_complex": "/ACE_complex_html/ACE_LTWNS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LTWNS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LTWNS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LTWNS.png", "phi_psi": "/peptide_da/LTWNS.pdb", "link_html_peptide": "/Peptide_html/LTWNS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LTWNS.pdb", "link_png_peptide": "/Peptide_pics/LTWNS.png"}
{"Peptide_Sequence": "LVA", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "5.80 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "843", " Ligand_ID": "LVA_minimized.pdb_843", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "301.38", " logP": "-3.06", " logD": "-3.31", " logSw": "0.75", " tPSA": "125.97", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "636262.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.382", "link_html_complex": "/ACE_complex_html/ACE_LVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVA.png", "phi_psi": "/peptide_da/LVA.pdb", "link_html_peptide": "/Peptide_html/LVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVA.pdb", "link_png_peptide": "/Peptide_pics/LVA.png"}
{"Peptide_Sequence": "LVE", " Origin": "pearl oyester", " Peptide_Preparation": "Alcalase, \u03b1-chymotrypsin, Neutrase, papain, pepsin, and trypsin", " Isolation_Method": "IEC, HPLC", " ACE_inhibition_assay": " Cushman and Cheung  with slight modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "14.2 \u03bcM", " Reference": "Qian, Zhong-Ji, et al. \"Antihypertensive effect of an angiotensin I-converting enzyme inhibitory peptide from bullfrog (Rana catesbeiana Shaw) muscle protein in spontaneously hypertensive rats.\" Process Biochemistry 42.10 (2007): 1443-1448.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "844", " Ligand_ID": "LVE_minimized.pdb_844", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "359.42", " logP": "-3.4", " logD": "-6.92", " logSw": "0.8", " tPSA": "166.1", " RotatableB": "11", " RigidB": "6", " Flexibility": "0.65", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "799586.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 359.418", "link_html_complex": "/ACE_complex_html/ACE_LVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVE.png", "phi_psi": "/peptide_da/LVE.pdb", "link_html_peptide": "/Peptide_html/LVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVE.pdb", "link_png_peptide": "/Peptide_pics/LVE.png"}
{"Peptide_Sequence": "LVKF", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "845", " Ligand_ID": "LVKF_minimized.pdb_845", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "505.65", " logP": "-1.81", " logD": "-3.97", " logSw": "-0.83", " tPSA": "182.71", " RotatableB": "16", " RigidB": "13", " Flexibility": "0.55", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "26", " HeteroAtoms": "10", " ratio_H_by_C": "0.38", " Lipinski_Violation": "2", " Solubility_mg_per_l": "219403.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 505.65", "link_html_complex": "/ACE_complex_html/ACE_LVKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVKF.png", "phi_psi": "/peptide_da/LVKF.pdb", "link_html_peptide": "/Peptide_html/LVKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVKF.pdb", "link_png_peptide": "/Peptide_pics/LVKF.png"}
{"Peptide_Sequence": "LVL", " Origin": "Porcine plasma", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Hayakari et al. 1978", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.2 \u03bcg/ml", " Reference": "Hazato, Tadahiko, and Ryoichi Kase. \"Isolation of angiotensin-converting enzyme inhibitor from porcine plasma.\" Biochemical and biophysical research communications 139.1 (1986): 52-55.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "846", " Ligand_ID": "LVL_minimized.pdb_846", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "343.46", " logP": "-1.57", " logD": "-2.03", " logSw": "-0.32", " tPSA": "125.97", " RotatableB": "10", " RigidB": "5", " Flexibility": "0.67", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "249314.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 343.462", "link_html_complex": "/ACE_complex_html/ACE_LVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVL.png", "phi_psi": "/peptide_da/LVL.pdb", "link_html_peptide": "/Peptide_html/LVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVL.pdb", "link_png_peptide": "/Peptide_pics/LVL.png"}
{"Peptide_Sequence": "LVNDLVTPVFDNL", " Origin": "Edible Mushroom Hypsizygus marmoreus", " Peptide_Preparation": "pulverized", " Isolation_Method": "UF, SPEC, RP-HPLC", " ACE_inhibition_assay": "modified method of Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "4\u2009mg/mL", " Reference": "Kang, Min-Gu, et al. \"Characterization of an antihypertensive angiotensin I-converting enzyme inhibitory peptide from the edible mushroom Hypsizygus marmoreus.\" BioMed research international 2013 (2013).", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1458.65", "link_html_complex": "/ACE_complex_html/ACE_LVNDLVTPVFDNL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVNDLVTPVFDNL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVNDLVTPVFDNL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVNDLVTPVFDNL.png", "phi_psi": "/peptide_da/LVNDLVTPVFDNL.pdb", "link_html_peptide": "/Peptide_html/LVNDLVTPVFDNL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVNDLVTPVFDNL.pdb", "link_png_peptide": "/Peptide_pics/LVNDLVTPVFDNL.png"}
{"Peptide_Sequence": "LVP", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "848", " Ligand_ID": "LVP_minimized.pdb_848", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "327.42", " logP": "-1.94", " logD": "-3.04", " logSw": "-0.19", " tPSA": "117.18", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "271902.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 327.419", "link_html_complex": "/ACE_complex_html/ACE_LVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVP.png", "phi_psi": "/peptide_da/LVP.pdb", "link_html_peptide": "/Peptide_html/LVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVP.pdb", "link_png_peptide": "/Peptide_pics/LVP.png"}
{"Peptide_Sequence": "LVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "125 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "849", " Ligand_ID": "LVPP_minimized.pdb_849", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "424.53", " logP": "-1.89", " logD": "-3.71", " logSw": "-0.75", " tPSA": "137.49", " RotatableB": "8", " RigidB": "17", " Flexibility": "0.32", " HBD": "4", " HBA": "9", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "199852.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 424.534", "link_html_complex": "/ACE_complex_html/ACE_LVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVPP.png", "phi_psi": "/peptide_da/LVPP.pdb", "link_html_peptide": "/Peptide_html/LVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVPP.pdb", "link_png_peptide": "/Peptide_pics/LVPP.png"}
{"Peptide_Sequence": "LVQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "851", " Ligand_ID": "LVQ_minimized.pdb_851", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "358.43", " logP": "-4.05", " logD": "-4.49", " logSw": "1.22", " tPSA": "169.06", " RotatableB": "11", " RigidB": "7", " Flexibility": "0.61", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1208284.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.433", "link_html_complex": "/ACE_complex_html/ACE_LVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVQ.png", "phi_psi": "/peptide_da/LVQ.pdb", "link_html_peptide": "/Peptide_html/LVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVQ.pdb", "link_png_peptide": "/Peptide_pics/LVQ.png"}
{"Peptide_Sequence": "LVQGS", " Origin": "Soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "43.7 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "850", " Ligand_ID": "LVQGS_minimized.pdb_850", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "502.56", " logP": "-5.54", " logD": "-7.61", " logSw": "1.59", " tPSA": "247.49", " RotatableB": "16", " RigidB": "11", " Flexibility": "0.59", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2465217.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 502.562", "link_html_complex": "/ACE_complex_html/ACE_LVQGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVQGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVQGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVQGS.png", "phi_psi": "/peptide_da/LVQGS.pdb", "link_html_peptide": "/Peptide_html/LVQGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVQGS.pdb", "link_png_peptide": "/Peptide_pics/LVQGS.png"}
{"Peptide_Sequence": "LVR", " Origin": "Cereals (Maize endosperm)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung with modification", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "14 \u03bcM", " Reference": "Maruyama, Susumu, Shinsuke Miyoshi, and Hideoki Tanaka. \"Angiotensin I-converting enzyme inhibitors derived from Ficus carica.\" Agricultural and biological chemistry 53.10 (1989): 2763-2767.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "852", " Ligand_ID": "LVR_minimized.pdb_852", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "386.49", " logP": "-3.71", " logD": "-4.07", " logSw": "0.96", " tPSA": "189.61", " RotatableB": "13", " RigidB": "6", " Flexibility": "0.68", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1008449.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 386.49", "link_html_complex": "/ACE_complex_html/ACE_LVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVR.png", "phi_psi": "/peptide_da/LVR.pdb", "link_html_peptide": "/Peptide_html/LVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVR.pdb", "link_png_peptide": "/Peptide_pics/LVR.png"}
{"Peptide_Sequence": "LVRT", " Origin": "ovine and caprine \u03b2-lactoglobulin", " Peptide_Preparation": "trypsin, Chymotrypsin, proteinase K and thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971) as modified by Kim, Yoon, Yu, L\u00f6nnerdal, and Chung (1999)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2470 \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"Preparation of ovine and caprine \u03b2-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine \u03b2-lactoglobulin hydrolysed with thermolysin.\" International Dairy Journal 12.10 (2002): 805-812.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "853", " Ligand_ID": "LVRT_minimized.pdb_853", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "487.59", " logP": "-3.57", " logD": "-7.18", " logSw": "0.44", " tPSA": "238.94", " RotatableB": "16", " RigidB": "8", " Flexibility": "0.67", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "21", " HeteroAtoms": "13", " ratio_H_by_C": "0.62", " Lipinski_Violation": "2", " Solubility_mg_per_l": "758620.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 487.594", "link_html_complex": "/ACE_complex_html/ACE_LVRT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVRT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVRT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVRT.png", "phi_psi": "/peptide_da/LVRT.pdb", "link_html_peptide": "/Peptide_html/LVRT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVRT.pdb", "link_png_peptide": "/Peptide_pics/LVRT.png"}
{"Peptide_Sequence": "LVVDGEGY", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "854", " Ligand_ID": "LVVDGEGY_minimized.pdb_854", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "850.91", " logP": "-2.47", " logD": "-12.97", " logSw": "-1.88", " tPSA": "371.96", " RotatableB": "26", " RigidB": "23", " Flexibility": "0.53", " HBD": "13", " HBA": "22", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "60", " CarbonAtoms": "38", " HeteroAtoms": "22", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "129687.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 850.912", "link_html_complex": "/ACE_complex_html/ACE_LVVDGEGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVVDGEGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVVDGEGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVVDGEGY.png", "phi_psi": "/peptide_da/LVVDGEGY.pdb", "link_html_peptide": "/Peptide_html/LVVDGEGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVVDGEGY.pdb", "link_png_peptide": "/Peptide_pics/LVVDGEGY.png"}
{"Peptide_Sequence": "LVVYPWTQ", " Origin": "bovine hemoglobin", " Peptide_Preparation": "porcine pepsin", " Isolation_Method": " RP-HPLC", " ACE_inhibition_assay": "Holmquist 1979", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "11.8 \u03bcM", " Reference": "Zhao, Q., and J. M. Piot. \"Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin.\" Neuropeptides 31.2 (1997): 147-153.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "855", " Ligand_ID": "LVVYPWTQ_minimized.pdb_855", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1005.17", " logP": "-0.39", " logD": "-3.93", " logSw": "-4.19", " tPSA": "362.02", " RotatableB": "26", " RigidB": "38", " Flexibility": "0.41", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "72", " CarbonAtoms": "50", " HeteroAtoms": "22", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "15263.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1005.17", "link_html_complex": "/ACE_complex_html/ACE_LVVYPWTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVVYPWTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVVYPWTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVVYPWTQ.png", "phi_psi": "/peptide_da/LVVYPWTQ.pdb", "link_html_peptide": "/Peptide_html/LVVYPWTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVVYPWTQ.pdb", "link_png_peptide": "/Peptide_pics/LVVYPWTQ.png"}
{"Peptide_Sequence": "LVVYPWTQR", " Origin": "hemoglobin", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Lantz, Ingrid, et al. \"Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity.\" FEBS letters 287.1-2 (1991): 39-41.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "856", " Ligand_ID": "LVVYPWTQR_minimized.pdb_856", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1161.35", " logP": "-1.47", " logD": "-4.82", " logSw": "-4", " tPSA": "454.76", " RotatableB": "33", " RigidB": "41", " Flexibility": "0.45", " HBD": "19", " HBA": "27", " HBD_HBA": "46", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "83", " CarbonAtoms": "56", " HeteroAtoms": "27", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "21212.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1161.35", "link_html_complex": "/ACE_complex_html/ACE_LVVYPWTQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVVYPWTQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVVYPWTQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVVYPWTQR.png", "phi_psi": "/peptide_da/LVVYPWTQR.pdb", "link_html_peptide": "/Peptide_html/LVVYPWTQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVVYPWTQR.pdb", "link_png_peptide": "/Peptide_pics/LVVYPWTQR.png"}
{"Peptide_Sequence": "LVY", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "5.8 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "857", " Ligand_ID": "LVY_minimized.pdb_857", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "393.48", " logP": "-1.7", " logD": "-1.99", " logSw": "-0.62", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "210863.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.477", "link_html_complex": "/ACE_complex_html/ACE_LVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVY.png", "phi_psi": "/peptide_da/LVY.pdb", "link_html_peptide": "/Peptide_html/LVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVY.pdb", "link_png_peptide": "/Peptide_pics/LVY.png"}
{"Peptide_Sequence": "LVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "170", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "864", " Ligand_ID": "LVYP_minimized.pdb_864", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "490.59", " logP": "-1.62", " logD": "-2.65", " logSw": "-1.2", " tPSA": "166.51", " RotatableB": "11", " RigidB": "18", " Flexibility": "0.38", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "25", " HeteroAtoms": "10", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "148371.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 490.592", "link_html_complex": "/ACE_complex_html/ACE_LVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYP.png", "phi_psi": "/peptide_da/LVYP.pdb", "link_html_peptide": "/Peptide_html/LVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYP.pdb", "link_png_peptide": "/Peptide_pics/LVYP.png"}
{"Peptide_Sequence": "LVYPFP", " Origin": "probiotic-fermented milk ", " Peptide_Preparation": "Bifidobacterium bifidum MF 20/5 fermented", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) modified  by Gonzalez-Gonzalez et al. (2011)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "132 \u03bcM", " Reference": "Gonzalez-Gonzalez, Cid, Trevor Gibson, and Paula Jauregi. \"Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5.\" International journal of food microbiology 167.2 (2013): 131-137.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "862", " Ligand_ID": "LVYPFP_minimized.pdb_862", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "734.88", " logP": "1.45", " logD": "-1.76", " logSw": "-4.34", " tPSA": "215.92", " RotatableB": "16", " RigidB": "33", " Flexibility": "0.33", " HBD": "7", " HBA": "14", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "39", " HeteroAtoms": "14", " ratio_H_by_C": "0.36", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9611.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 734.882", "link_html_complex": "/ACE_complex_html/ACE_LVYPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFP.png", "phi_psi": "/peptide_da/LVYPFP.pdb", "link_html_peptide": "/Peptide_html/LVYPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFP.pdb", "link_png_peptide": "/Peptide_pics/LVYPFP.png"}
{"Peptide_Sequence": "LVYPFPGP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "181.97 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "861", " Ligand_ID": "LVYPFPGP_minimized.pdb_861", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "889.05", " logP": "0.85", " logD": "-3.17", " logSw": "-4.7", " tPSA": "265.33", " RotatableB": "19", " RigidB": "42", " Flexibility": "0.31", " HBD": "8", " HBA": "18", " HBD_HBA": "26", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "46", " HeteroAtoms": "18", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8062.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 889.048", "link_html_complex": "/ACE_complex_html/ACE_LVYPFPGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFPGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFPGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFPGP.png", "phi_psi": "/peptide_da/LVYPFPGP.pdb", "link_html_peptide": "/Peptide_html/LVYPFPGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFPGP.pdb", "link_png_peptide": "/Peptide_pics/LVYPFPGP.png"}
{"Peptide_Sequence": "LVYPFPGPIH", " Origin": "Fermented Milk", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al. (1979)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "89 \u03bcM", " Reference": "Pihlanto, Anne, Tarja Virtanen, and Hannu Korhonen. \"Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk.\" International Dairy Journal 20.1 (2010): 3-10.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "858", " Ligand_ID": "LVYPFPGPIH_minimized.pdb_858", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "1139.34", " logP": "1.43", " logD": "-2.5", " logSw": "-6.1", " tPSA": "352.21", " RotatableB": "27", " RigidB": "51", " Flexibility": "0.35", " HBD": "11", " HBA": "24", " HBD_HBA": "35", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "82", " CarbonAtoms": "58", " HeteroAtoms": "24", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2556.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1139.34", "link_html_complex": "/ACE_complex_html/ACE_LVYPFPGPIH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFPGPIH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFPGPIH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFPGPIH.png", "phi_psi": "/peptide_da/LVYPFPGPIH.pdb", "link_html_peptide": "/Peptide_html/LVYPFPGPIH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFPGPIH.pdb", "link_png_peptide": "/Peptide_pics/LVYPFPGPIH.png"}
{"Peptide_Sequence": "LVYPFPGPIHNSLPQN", " Origin": "Fermented Milk", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al. (1979)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "71 \u03bcM", " Reference": "Pihlanto, Anne, Tarja Virtanen, and Hannu Korhonen. \"Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk.\" International Dairy Journal 20.1 (2010): 3-10.", " Binding_Energy_kcal_per_mol": "-2.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1793.03", "link_html_complex": "/ACE_complex_html/ACE_LVYPFPGPIHNSLPQN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFPGPIHNSLPQN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFPGPIHNSLPQN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFPGPIHNSLPQN.png", "phi_psi": "/peptide_da/LVYPFPGPIHNSLPQN.pdb", "link_html_peptide": "/Peptide_html/LVYPFPGPIHNSLPQN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFPGPIHNSLPQN.pdb", "link_png_peptide": "/Peptide_pics/LVYPFPGPIHNSLPQN.png"}
{"Peptide_Sequence": "LVYPFPGPIPNSLPQNIPP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "5.30 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "34.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2060.39", "link_html_complex": "/ACE_complex_html/ACE_LVYPFPGPIPNSLPQNIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFPGPIPNSLPQNIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFPGPIPNSLPQNIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFPGPIPNSLPQNIPP.png", "phi_psi": "/peptide_da/LVYPFPGPIPNSLPQNIPP.pdb", "link_html_peptide": "/Peptide_html/LVYPFPGPIPNSLPQNIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFPGPIPNSLPQNIPP.pdb", "link_png_peptide": "/Peptide_pics/LVYPFPGPIPNSLPQNIPP.png"}
{"Peptide_Sequence": "LVYPFTGPIPN", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "27.9 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "863", " Ligand_ID": "LVYPFTGPIPN_minimized.pdb_863", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "1217.41", " logP": "-0.73", " logD": "-5.53", " logSw": "-5", " tPSA": "415.95", " RotatableB": "30", " RigidB": "50", " Flexibility": "0.38", " HBD": "14", " HBA": "27", " HBD_HBA": "41", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "87", " CarbonAtoms": "60", " HeteroAtoms": "27", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8212.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1217.41", "link_html_complex": "/ACE_complex_html/ACE_LVYPFTGPIPN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LVYPFTGPIPN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LVYPFTGPIPN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LVYPFTGPIPN.png", "phi_psi": "/peptide_da/LVYPFTGPIPN.pdb", "link_html_peptide": "/Peptide_html/LVYPFTGPIPN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LVYPFTGPIPN.pdb", "link_png_peptide": "/Peptide_pics/LVYPFTGPIPN.png"}
{"Peptide_Sequence": "LW", " Origin": "ovalbumin", " Peptide_Preparation": " pepsin,  trypsin, chymotrypsin,  and  thermolysin", " Isolation_Method": "ODS column", " ACE_inhibition_assay": "Cushman and Cheung (1971) with a minor modifi-cation by Yamamoto and others (1980)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "6.8 \u03bcM", " Reference": "Iroyukifujita, H., K. Eiichiyokoyama, and Masaaki Yoshikawa. \"Classification and antihypertensive activity of angiotensin I\u2010converting enzyme inhibitory peptides derived from food proteins.\" Journal of food science 65.4 (2000): 564-569.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "866", " Ligand_ID": "LW_minimized.pdb_866", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "317.38", " logP": "-0.82", " logD": "-0.84", " logSw": "-0.97", " tPSA": "112.66", " RotatableB": "7", " RigidB": "13", " Flexibility": "0.35", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "17", " HeteroAtoms": "6", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "119839.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 317.383", "link_html_complex": "/ACE_complex_html/ACE_LW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LW.png", "phi_psi": "/peptide_da/LW.pdb", "link_html_peptide": "/Peptide_html/LW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LW.pdb", "link_png_peptide": "/Peptide_pics/LW.png"}
{"Peptide_Sequence": "LWA", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "865", " Ligand_ID": "LWA_minimized.pdb_865", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O", " MW": "388.46", " logP": "-1.27", " logD": "-2.46", " logSw": "-0.97", " tPSA": "141.76", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "146775.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 388.461", "link_html_complex": "/ACE_complex_html/ACE_LWA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LWA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LWA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LWA.png", "phi_psi": "/peptide_da/LWA.pdb", "link_html_peptide": "/Peptide_html/LWA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LWA.pdb", "link_png_peptide": "/Peptide_pics/LWA.png"}
{"Peptide_Sequence": "LY", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.4 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "869", " Ligand_ID": "LY_minimized.pdb_869", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "294.35", " logP": "-1.94", " logD": "-1.25", " logSw": "-0.08", " tPSA": "117.1", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "15", " HeteroAtoms": "6", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "270630.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 294.346", "link_html_complex": "/ACE_complex_html/ACE_LY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LY.png", "phi_psi": "/peptide_da/LY.pdb", "link_html_peptide": "/Peptide_html/LY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LY.pdb", "link_png_peptide": "/Peptide_pics/LY.png"}
{"Peptide_Sequence": "LYHVL", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "867", " Ligand_ID": "LYHVL_minimized.pdb_867", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "643.77", " logP": "-1.09", " logD": "-2.58", " logSw": "-2.04", " tPSA": "233.08", " RotatableB": "18", " RigidB": "20", " Flexibility": "0.47", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "32", " HeteroAtoms": "14", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "83509.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 643.774", "link_html_complex": "/ACE_complex_html/ACE_LYHVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYHVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYHVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYHVL.png", "phi_psi": "/peptide_da/LYHVL.pdb", "link_html_peptide": "/Peptide_html/LYHVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYHVL.pdb", "link_png_peptide": "/Peptide_pics/LYHVL.png"}
{"Peptide_Sequence": "LYKNG", " Origin": "Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "868", " Ligand_ID": "LYKNG_minimized.pdb_868", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O", " MW": "593.67", " logP": "-3.61", " logD": "-9.12", " logSw": "-0.04", " tPSA": "275.13", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "567717.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 593.672", "link_html_complex": "/ACE_complex_html/ACE_LYKNG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYKNG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYKNG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYKNG.png", "phi_psi": "/peptide_da/LYKNG.pdb", "link_html_peptide": "/Peptide_html/LYKNG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYKNG.pdb", "link_png_peptide": "/Peptide_pics/LYKNG.png"}
{"Peptide_Sequence": "LYP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.6", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "870", " Ligand_ID": "LYP_minimized.pdb_870", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "391.46", " logP": "-1.67", " logD": "-2.61", " logSw": "-0.76", " tPSA": "137.41", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "182186.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.461", "link_html_complex": "/ACE_complex_html/ACE_LYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYP.png", "phi_psi": "/peptide_da/LYP.pdb", "link_html_peptide": "/Peptide_html/LYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYP.pdb", "link_png_peptide": "/Peptide_pics/LYP.png"}
{"Peptide_Sequence": "LYPVK", " Origin": " latex of Ficus carica", " Peptide_Preparation": "", " Isolation_Method": "ultrafilteration, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified  by Maruyama et. al. (1985).", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.5 \u03bcM", " Reference": "Maruyama, Susumu, Shinsuke Miyoshi, and Hideoki Tanaka. \"Angiotensin I-converting enzyme inhibitors derived from Ficus carica.\" Agricultural and biological chemistry 53.10 (1989): 2763-2767.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "871", " Ligand_ID": "LYPVK_minimized.pdb_871", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "618.76", " logP": "-2.13", " logD": "-2.93", " logSw": "-1.26", " tPSA": "223.25", " RotatableB": "17", " RigidB": "20", " Flexibility": "0.46", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "175572.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.765", "link_html_complex": "/ACE_complex_html/ACE_LYPVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYPVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYPVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYPVK.png", "phi_psi": "/peptide_da/LYPVK.pdb", "link_html_peptide": "/Peptide_html/LYPVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYPVK.pdb", "link_png_peptide": "/Peptide_pics/LYPVK.png"}
{"Peptide_Sequence": "LYQKS", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "872", " Ligand_ID": "LYQKS_minimized.pdb_872", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O", " MW": "637.72", " logP": "-3.91", " logD": "-7.91", " logSw": "0.01", " tPSA": "295.36", " RotatableB": "21", " RigidB": "17", " Flexibility": "0.55", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "642297.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 637.725", "link_html_complex": "/ACE_complex_html/ACE_LYQKS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYQKS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYQKS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYQKS.png", "phi_psi": "/peptide_da/LYQKS.pdb", "link_html_peptide": "/Peptide_html/LYQKS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYQKS.pdb", "link_png_peptide": "/Peptide_pics/LYQKS.png"}
{"Peptide_Sequence": "LYRNG", " Origin": "Legume (Pea proteins), Soybean Protein ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "873", " Ligand_ID": "LYRNG_minimized.pdb_873", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O", " MW": "621.69", " logP": "-4.2", " logD": "-9.71", " logSw": "0.22", " tPSA": "311.13", " RotatableB": "20", " RigidB": "18", " Flexibility": "0.53", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "27", " HeteroAtoms": "17", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "775066.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 621.686", "link_html_complex": "/ACE_complex_html/ACE_LYRNG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYRNG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYRNG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYRNG.png", "phi_psi": "/peptide_da/LYRNG.pdb", "link_html_peptide": "/Peptide_html/LYRNG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYRNG.pdb", "link_png_peptide": "/Peptide_pics/LYRNG.png"}
{"Peptide_Sequence": "LYW", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "874", " Ligand_ID": "LYW_minimized.pdb_874", " Smiles": "CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "480.56", " logP": "-0.06", " logD": "-1.1", " logSw": "-2.22", " tPSA": "161.99", " RotatableB": "11", " RigidB": "21", " Flexibility": "0.34", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "26", " HeteroAtoms": "9", " ratio_H_by_C": "0.35", " Lipinski_Violation": "1", " Solubility_mg_per_l": "52123.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 480.556", "link_html_complex": "/ACE_complex_html/ACE_LYW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_LYW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_LYW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_LYW.png", "phi_psi": "/peptide_da/LYW.pdb", "link_html_peptide": "/Peptide_html/LYW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/LYW.pdb", "link_png_peptide": "/Peptide_pics/LYW.png"}
{"Peptide_Sequence": "MA", " Origin": "", " Peptide_Preparation": "Dipeptidyl peptidases I\u2013IV", " Isolation_Method": "SE, anion-exchange chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "152 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Oligopeptides hydrolysed by muscle dipeptidyl peptidases can generate angiotensin-I converting enzyme inhibitory dipeptides.\" European Food Research and Technology 224.6 (2007): 785-790.", " Binding_Energy_kcal_per_mol": "-5.4", "Serial_ID": "876", " Ligand_ID": "MA_minimized.pdb_876", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](C)C(O)=O", " MW": "220.29", " logP": "-3.49", " logD": "-3.2", " logSw": "1.39", " tPSA": "122.17", " RotatableB": "6", " RigidB": "3", " Flexibility": "0.67", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "8", " HeteroAtoms": "6", " ratio_H_by_C": "0.75", " Lipinski_Violation": "0", " Solubility_mg_per_l": "883461.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 220.289", "link_html_complex": "/ACE_complex_html/ACE_MA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MA.png", "phi_psi": "/peptide_da/MA.pdb", "link_html_peptide": "/Peptide_html/MA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MA.pdb", "link_png_peptide": "/Peptide_pics/MA.png"}
{"Peptide_Sequence": "MAIPPKK", " Origin": "bovine \u03ba-casein ", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "4785 \u03bcM", " Reference": "Miguel, Marta, et al. \"Vascular effects and antihypertensive properties of \u03ba-casein macropeptide.\" International Dairy Journal 17.12 (2007): 1473-1477.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "875", " Ligand_ID": "MAIPPKK_minimized.pdb_875", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCSC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "784.02", " logP": "-2.42", " logD": "-7.95", " logSw": "-1.59", " tPSA": "305.37", " RotatableB": "24", " RigidB": "23", " Flexibility": "0.51", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "54", " CarbonAtoms": "36", " HeteroAtoms": "18", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "159509.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 784.022", "link_html_complex": "/ACE_complex_html/ACE_MAIPPKK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MAIPPKK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MAIPPKK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MAIPPKK.png", "phi_psi": "/peptide_da/MAIPPKK.pdb", "link_html_peptide": "/Peptide_html/MAIPPKK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MAIPPKK.pdb", "link_png_peptide": "/Peptide_pics/MAIPPKK.png"}
{"Peptide_Sequence": "MAP", " Origin": "Cheese", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.8 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "877", " Ligand_ID": "MAP_minimized.pdb_877", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "317.4", " logP": "-3.58", " logD": "-4.55", " logSw": "0.91", " tPSA": "142.48", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "0", " Solubility_mg_per_l": "788134.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 317.404", "link_html_complex": "/ACE_complex_html/ACE_MAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MAP.png", "phi_psi": "/peptide_da/MAP.pdb", "link_html_peptide": "/Peptide_html/MAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MAP.pdb", "link_png_peptide": "/Peptide_pics/MAP.png"}
{"Peptide_Sequence": "MAW", " Origin": " cuttlefish (Sepia officinalis) ", " Peptide_Preparation": "Chymotrypsin, trypsin and pepsin ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "16.32 \u03bcM", " Reference": "Balti, Rafik, et al. \"Three novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) using digestive proteases.\" Food Research International 43.4 (2010): 1136-1143.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "878", " Ligand_ID": "MAW_minimized.pdb_878", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "406.5", " logP": "-1.75", " logD": "-3.04", " logSw": "-0.72", " tPSA": "167.06", " RotatableB": "10", " RigidB": "15", " Flexibility": "0.4", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "197641.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.499", "link_html_complex": "/ACE_complex_html/ACE_MAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MAW.png", "phi_psi": "/peptide_da/MAW.pdb", "link_html_peptide": "/Peptide_html/MAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MAW.pdb", "link_png_peptide": "/Peptide_pics/MAW.png"}
{"Peptide_Sequence": "MCESASSK", " Origin": "sweet potato defensin", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist  et  al.,  1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "75.93 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root defensin and its tryptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Bot Stud 52.3 (2011): 257-264.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "879", " Ligand_ID": "MCESASSK_minimized.pdb_879", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "841.95", " logP": "-10.39", " logD": "-13.37", " logSw": "3.4", " tPSA": "464.03", " RotatableB": "29", " RigidB": "16", " Flexibility": "0.64", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "31", " HeteroAtoms": "25", " ratio_H_by_C": "0.81", " Lipinski_Violation": "3", " Solubility_mg_per_l": "25218399.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 841.949", "link_html_complex": "/ACE_complex_html/ACE_MCESASSK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MCESASSK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MCESASSK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MCESASSK.png", "phi_psi": "/peptide_da/MCESASSK.pdb", "link_html_peptide": "/Peptide_html/MCESASSK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MCESASSK.pdb", "link_png_peptide": "/Peptide_pics/MCESASSK.png"}
{"Peptide_Sequence": "MDFLI", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.01 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "880", " Ligand_ID": "MDFLI_minimized.pdb_880", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCSC)C(O)=O", " MW": "637.79", " logP": "-1.4", " logD": "-4.8", " logSw": "-1.64", " tPSA": "249.6", " RotatableB": "20", " RigidB": "16", " Flexibility": "0.56", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "123585.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 637.788", "link_html_complex": "/ACE_complex_html/ACE_MDFLI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MDFLI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MDFLI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MDFLI.png", "phi_psi": "/peptide_da/MDFLI.pdb", "link_html_peptide": "/Peptide_html/MDFLI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MDFLI.pdb", "link_png_peptide": "/Peptide_pics/MDFLI.png"}
{"Peptide_Sequence": "MDLA", " Origin": "Chickpea legumin ", " Peptide_Preparation": "Alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.011 mg/L", " Reference": "Murray, B. A., and R. J. FitzGerald. \"Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production.\" Current pharmaceutical design 13.8 (2007): 773-791.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "881", " Ligand_ID": "MDLA_minimized.pdb_881", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "448.53", " logP": "-2.66", " logD": "-7.3", " logSw": "-0.02", " tPSA": "220.5", " RotatableB": "14", " RigidB": "8", " Flexibility": "0.64", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "439163.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 448.534", "link_html_complex": "/ACE_complex_html/ACE_MDLA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MDLA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MDLA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MDLA.png", "phi_psi": "/peptide_da/MDLA.pdb", "link_html_peptide": "/Peptide_html/MDLA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MDLA.pdb", "link_png_peptide": "/Peptide_pics/MDLA.png"}
{"Peptide_Sequence": "ME", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "884", " Ligand_ID": "ME_minimized.pdb_884", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "278.33", " logP": "-3.67", " logD": "-6.72", " logSw": "1.34", " tPSA": "162.3", " RotatableB": "9", " RigidB": "4", " Flexibility": "0.69", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "18", " CarbonAtoms": "10", " HeteroAtoms": "8", " ratio_H_by_C": "0.8", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1063450.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 278.325", "link_html_complex": "/ACE_complex_html/ACE_ME.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ME.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ME.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ME.png", "phi_psi": "/peptide_da/ME.pdb", "link_html_peptide": "/Peptide_html/ME.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ME.pdb", "link_png_peptide": "/Peptide_pics/ME.png"}
{"Peptide_Sequence": "MEF", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "882", " Ligand_ID": "MEF_minimized.pdb_882", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "425.5", " logP": "-2.86", " logD": "-6.43", " logSw": "0.1", " tPSA": "191.4", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "471388.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 425.499", "link_html_complex": "/ACE_complex_html/ACE_MEF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MEF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MEF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MEF.png", "phi_psi": "/peptide_da/MEF.pdb", "link_html_peptide": "/Peptide_html/MEF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MEF.pdb", "link_png_peptide": "/Peptide_pics/MEF.png"}
{"Peptide_Sequence": "MEGAQEAQGD", " Origin": "Sea cucumber", " Peptide_Preparation": "", " Isolation_Method": "ESI-MS/MS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "15.9 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "883", " Ligand_ID": "MEGAQEAQGD_minimized.pdb_883", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "1035.04", " logP": "-9.66", " logD": "-22.27", " logSw": "2.14", " tPSA": "561.54", " RotatableB": "35", " RigidB": "26", " Flexibility": "0.57", " HBD": "19", " HBA": "31", " HBD_HBA": "50", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-3", " HeavyAtoms": "71", " CarbonAtoms": "39", " HeteroAtoms": "32", " ratio_H_by_C": "0.82", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8784364.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1035.04", "link_html_complex": "/ACE_complex_html/ACE_MEGAQEAQGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MEGAQEAQGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MEGAQEAQGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MEGAQEAQGD.png", "phi_psi": "/peptide_da/MEGAQEAQGD.pdb", "link_html_peptide": "/Peptide_html/MEGAQEAQGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MEGAQEAQGD.pdb", "link_png_peptide": "/Peptide_pics/MEGAQEAQGD.png"}
{"Peptide_Sequence": "MF", " Origin": "Sardine muscles", " Peptide_Preparation": "alkakine protease", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "2,4,6-trinitroben-zene sulfonate (TNBS) method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "44.7", " Reference": "Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., & Osajima, Y. (1994). Angiotensin I-converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58(12), 2244\u20132245. doi:10.1271/bbb.58.2244 ", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "886", " Ligand_ID": "MF_minimized.pdb_886", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "296.39", " logP": "-1.67", " logD": "-1.55", " logSw": "-0.21", " tPSA": "122.17", " RotatableB": "8", " RigidB": "9", " Flexibility": "0.47", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "240608.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 296.385", "link_html_complex": "/ACE_complex_html/ACE_MF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MF.png", "phi_psi": "/peptide_da/MF.pdb", "link_html_peptide": "/Peptide_html/MF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MF.pdb", "link_png_peptide": "/Peptide_pics/MF.png"}
{"Peptide_Sequence": "MFDL", " Origin": "Chickpea legumin ", " Peptide_Preparation": "Alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.013 mg/L", " Reference": "Murray, B. A., and R. J. FitzGerald. \"Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production.\" Current pharmaceutical design 13.8 (2007): 773-791.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "885", " Ligand_ID": "MFDL_minimized.pdb_885", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "524.63", " logP": "-2.15", " logD": "-6.61", " logSw": "-0.74", " tPSA": "220.5", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "36", " CarbonAtoms": "24", " HeteroAtoms": "12", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "249340.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 524.63", "link_html_complex": "/ACE_complex_html/ACE_MFDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MFDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MFDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MFDL.png", "phi_psi": "/peptide_da/MFDL.pdb", "link_html_peptide": "/Peptide_html/MFDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MFDL.pdb", "link_png_peptide": "/Peptide_pics/MFDL.png"}
{"Peptide_Sequence": "MG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "4800 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5", "Serial_ID": "887", " Ligand_ID": "MG_minimized.pdb_887", " Smiles": "CSCC[C@H](N)C(=O)NCC(O)=O", " MW": "206.26", " logP": "-3.01", " logD": "-3.77", " logSw": "1.17", " tPSA": "122.17", " RotatableB": "6", " RigidB": "3", " Flexibility": "0.67", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "13", " CarbonAtoms": "7", " HeteroAtoms": "6", " ratio_H_by_C": "0.86", " Lipinski_Violation": "0", " Solubility_mg_per_l": "666887.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 206.263", "link_html_complex": "/ACE_complex_html/ACE_MG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MG.png", "phi_psi": "/peptide_da/MG.pdb", "link_html_peptide": "/Peptide_html/MG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MG.pdb", "link_png_peptide": "/Peptide_pics/MG.png"}
{"Peptide_Sequence": "MGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "51.1 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "888", " Ligand_ID": "MGP_minimized.pdb_888", " Smiles": "CSCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "303.38", " logP": "-3.17", " logD": "-5.12", " logSw": "0.74", " tPSA": "142.48", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "0", " Solubility_mg_per_l": "634689.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.378", "link_html_complex": "/ACE_complex_html/ACE_MGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MGP.png", "phi_psi": "/peptide_da/MGP.pdb", "link_html_peptide": "/Peptide_html/MGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MGP.pdb", "link_png_peptide": "/Peptide_pics/MGP.png"}
{"Peptide_Sequence": "MHYGN", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "889", " Ligand_ID": "MHYGN_minimized.pdb_889", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "620.68", " logP": "-4.29", " logD": "-7.44", " logSw": "0.1", " tPSA": "301.47", " RotatableB": "18", " RigidB": "22", " Flexibility": "0.45", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "685584.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 620.678", "link_html_complex": "/ACE_complex_html/ACE_MHYGN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MHYGN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MHYGN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MHYGN.png", "phi_psi": "/peptide_da/MHYGN.pdb", "link_html_peptide": "/Peptide_html/MHYGN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MHYGN.pdb", "link_png_peptide": "/Peptide_pics/MHYGN.png"}
{"Peptide_Sequence": "MIFPGAGGPEL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.03 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "890", " Ligand_ID": "MIFPGAGGPEL_minimized.pdb_890", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "1088.28", " logP": "-1.77", " logD": "-10.06", " logSw": "-3.46", " tPSA": "406.62", " RotatableB": "31", " RigidB": "38", " Flexibility": "0.45", " HBD": "12", " HBA": "25", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "76", " CarbonAtoms": "50", " HeteroAtoms": "26", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "34367.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1088.28", "link_html_complex": "/ACE_complex_html/ACE_MIFPGAGGPEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MIFPGAGGPEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MIFPGAGGPEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MIFPGAGGPEL.png", "phi_psi": "/peptide_da/MIFPGAGGPEL.pdb", "link_html_peptide": "/Peptide_html/MIFPGAGGPEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MIFPGAGGPEL.pdb", "link_png_peptide": "/Peptide_pics/MIFPGAGGPEL.png"}
{"Peptide_Sequence": "MIFPGGPQL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "22.3 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "891", " Ligand_ID": "MIFPGGPQL_minimized.pdb_891", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "959.16", " logP": "-1.51", " logD": "-5.9", " logSw": "-3.09", " tPSA": "351.38", " RotatableB": "27", " RigidB": "35", " Flexibility": "0.44", " HBD": "11", " HBA": "21", " HBD_HBA": "32", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "67", " CarbonAtoms": "45", " HeteroAtoms": "22", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "43822.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 959.163", "link_html_complex": "/ACE_complex_html/ACE_MIFPGGPQL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MIFPGGPQL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MIFPGGPQL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MIFPGGPQL.png", "phi_psi": "/peptide_da/MIFPGGPQL.pdb", "link_html_peptide": "/Peptide_html/MIFPGGPQL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MIFPGGPQL.pdb", "link_png_peptide": "/Peptide_pics/MIFPGGPQL.png"}
{"Peptide_Sequence": "MILLLF", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "892", " Ligand_ID": "MILLLF_minimized.pdb_892", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "749.02", " logP": "1.86", " logD": "0.04", " logSw": "-4.11", " tPSA": "238.57", " RotatableB": "24", " RigidB": "17", " Flexibility": "0.59", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "38", " HeteroAtoms": "14", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12290.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 749.016", "link_html_complex": "/ACE_complex_html/ACE_MILLLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MILLLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MILLLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MILLLF.png", "phi_psi": "/peptide_da/MILLLF.pdb", "link_html_peptide": "/Peptide_html/MILLLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MILLLF.pdb", "link_png_peptide": "/Peptide_pics/MILLLF.png"}
{"Peptide_Sequence": "MILLLFR", " Origin": "tilapia", " Peptide_Preparation": "Virgibacillus halodenitrificans SK1-3-7 proteinases ", " Isolation_Method": "UF, AE, SE, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.12\u2009\u00b5M", " Reference": "Toopcham, Tidarat, Sittiruk Roytrakul, and Jirawat Yongsawatdigul. \"Characterization and identification of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from tilapia using Virgibacillus halodenitrificans SK1-3-7 proteinases.\" journal of functional foods 14 (2015): 435-444.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "893", " Ligand_ID": "MILLLFR_minimized.pdb_893", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "905.2", " logP": "1.66", " logD": "-0.94", " logSw": "-4.48", " tPSA": "331.31", " RotatableB": "31", " RigidB": "20", " Flexibility": "0.61", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "63", " CarbonAtoms": "44", " HeteroAtoms": "19", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10218.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 905.201", "link_html_complex": "/ACE_complex_html/ACE_MILLLFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MILLLFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MILLLFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MILLLFR.png", "phi_psi": "/peptide_da/MILLLFR.pdb", "link_html_peptide": "/Peptide_html/MILLLFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MILLLFR.pdb", "link_png_peptide": "/Peptide_pics/MILLLFR.png"}
{"Peptide_Sequence": "MIPAQK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "300", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "894", " Ligand_ID": "MIPAQK_minimized.pdb_894", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "686.86", " logP": "-3.4", " logD": "-6.12", " logSw": "-0.5", " tPSA": "300.51", " RotatableB": "22", " RigidB": "18", " Flexibility": "0.55", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "30", " HeteroAtoms": "17", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "414710.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 686.864", "link_html_complex": "/ACE_complex_html/ACE_MIPAQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MIPAQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MIPAQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MIPAQK.png", "phi_psi": "/peptide_da/MIPAQK.pdb", "link_html_peptide": "/Peptide_html/MIPAQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MIPAQK.pdb", "link_png_peptide": "/Peptide_pics/MIPAQK.png"}
{"Peptide_Sequence": "MIPAY", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung modified by Hern\u03bcndez-Ledesmaet al", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.7 \u03bcM", " Reference": "Jing, Tao, et al. \"Rational design of angiotensin\u2010I\u2010converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.\" ChemMedChem 8.7 (2013): 1057-1066.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "895", " Ligand_ID": "MIPAY_minimized.pdb_895", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "593.74", " logP": "-0.86", " logD": "-3.34", " logSw": "-2.04", " tPSA": "220.91", " RotatableB": "15", " RigidB": "20", " Flexibility": "0.43", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "77031.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 593.735", "link_html_complex": "/ACE_complex_html/ACE_MIPAY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MIPAY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MIPAY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MIPAY.png", "phi_psi": "/peptide_da/MIPAY.pdb", "link_html_peptide": "/Peptide_html/MIPAY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MIPAY.pdb", "link_png_peptide": "/Peptide_pics/MIPAY.png"}
{"Peptide_Sequence": "MK", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6498.6", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "898", " Ligand_ID": "MK_minimized.pdb_898", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "277.38", " logP": "-3.4", " logD": "-4.66", " logSw": "1.24", " tPSA": "149.81", " RotatableB": "10", " RigidB": "3", " Flexibility": "0.77", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "960662.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 277.384", "link_html_complex": "/ACE_complex_html/ACE_MK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MK.png", "phi_psi": "/peptide_da/MK.pdb", "link_html_peptide": "/Peptide_html/MK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MK.pdb", "link_png_peptide": "/Peptide_pics/MK.png"}
{"Peptide_Sequence": "MKC", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "896", " Ligand_ID": "MKC_minimized.pdb_896", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O", " MW": "380.53", " logP": "-3.18", " logD": "-6.47", " logSw": "0.66", " tPSA": "217.71", " RotatableB": "13", " RigidB": "5", " Flexibility": "0.72", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "737813.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 380.526", "link_html_complex": "/ACE_complex_html/ACE_MKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKC.png", "phi_psi": "/peptide_da/MKC.pdb", "link_html_peptide": "/Peptide_html/MKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKC.pdb", "link_png_peptide": "/Peptide_pics/MKC.png"}
{"Peptide_Sequence": "MKG", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "24 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.4", "Serial_ID": "897", " Ligand_ID": "MKG_minimized.pdb_897", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O", " MW": "334.43", " logP": "-3.5", " logD": "-7.11", " logSw": "1.08", " tPSA": "178.91", " RotatableB": "12", " RigidB": "5", " Flexibility": "0.71", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "1", " Solubility_mg_per_l": "988259.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 334.435", "link_html_complex": "/ACE_complex_html/ACE_MKG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKG.png", "phi_psi": "/peptide_da/MKG.pdb", "link_html_peptide": "/Peptide_html/MKG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKG.pdb", "link_png_peptide": "/Peptide_pics/MKG.png"}
{"Peptide_Sequence": "MKP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "0.3 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "899", " Ligand_ID": "MKP_minimized.pdb_899", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "374.5", " logP": "-3.82", " logD": "-6.27", " logSw": "0.97", " tPSA": "170.12", " RotatableB": "11", " RigidB": "10", " Flexibility": "0.52", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "16", " HeteroAtoms": "9", " ratio_H_by_C": "0.56", " Lipinski_Violation": "1", " Solubility_mg_per_l": "988606.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.499", "link_html_complex": "/ACE_complex_html/ACE_MKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKP.png", "phi_psi": "/peptide_da/MKP.pdb", "link_html_peptide": "/Peptide_html/MKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKP.pdb", "link_png_peptide": "/Peptide_pics/MKP.png"}
{"Peptide_Sequence": "MKPWIQPK", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "300", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "900", " Ligand_ID": "MKPWIQPK_minimized.pdb_900", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1027.28", " logP": "-2.12", " logD": "-7.9", " logSw": "-2.87", " tPSA": "393.35", " RotatableB": "31", " RigidB": "37", " Flexibility": "0.46", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "72", " CarbonAtoms": "49", " HeteroAtoms": "23", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "58132.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1027.28", "link_html_complex": "/ACE_complex_html/ACE_MKPWIQPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKPWIQPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKPWIQPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKPWIQPK.png", "phi_psi": "/peptide_da/MKPWIQPK.pdb", "link_html_peptide": "/Peptide_html/MKPWIQPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKPWIQPK.pdb", "link_png_peptide": "/Peptide_pics/MKPWIQPK.png"}
{"Peptide_Sequence": "MKR", " Origin": "Egg Lysozyme", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "reverse-phase high-performance liquid chromatography", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "25.7", " Reference": "Purification and characterization of angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysate of hen egg white lysozyme", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "901", " Ligand_ID": "MKR_minimized.pdb_901", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "433.57", " logP": "-3.92", " logD": "-8.28", " logSw": "1.06", " tPSA": "242.55", " RotatableB": "17", " RigidB": "6", " Flexibility": "0.74", " HBD": "11", " HBA": "11", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "29", " CarbonAtoms": "17", " HeteroAtoms": "12", " ratio_H_by_C": "0.71", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1255792.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 433.569", "link_html_complex": "/ACE_complex_html/ACE_MKR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKR.png", "phi_psi": "/peptide_da/MKR.pdb", "link_html_peptide": "/Peptide_html/MKR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKR.pdb", "link_png_peptide": "/Peptide_pics/MKR.png"}
{"Peptide_Sequence": "MKY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "902", " Ligand_ID": "MKY_minimized.pdb_902", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "440.56", " logP": "-2.52", " logD": "-5.2", " logSw": "-0.13", " tPSA": "199.14", " RotatableB": "14", " RigidB": "11", " Flexibility": "0.56", " HBD": "8", " HBA": "9", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "386284.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 440.557", "link_html_complex": "/ACE_complex_html/ACE_MKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MKY.png", "phi_psi": "/peptide_da/MKY.pdb", "link_html_peptide": "/Peptide_html/MKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MKY.pdb", "link_png_peptide": "/Peptide_pics/MKY.png"}
{"Peptide_Sequence": "MLLCS", " Origin": "Styela plicata", " Peptide_Preparation": "Protamex, Kojizyme, Neutrase, Flavourzyme, Alcalase, trypsin, \u03b1-chymotrypsin, pepsin, and papain", " Isolation_Method": "UF, GF, RP-HPLC", " ACE_inhibition_assay": "Kim et al. 2001", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "24.7 \u03bcM", " Reference": "Ko, Seok-Chun, et al. \"Effect of angiotensin I-converting enzyme (ACE) inhibitory peptide purified from enzymatic hydrolysates of Styela plicata.\" European Food Research and Technology 233.6 (2011): 915-922.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "903", " Ligand_ID": "MLLCS_minimized.pdb_903", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O", " MW": "565.75", " logP": "-2.29", " logD": "-4.78", " logSw": "-0.72", " tPSA": "268.5", " RotatableB": "18", " RigidB": "9", " Flexibility": "0.67", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "23", " HeteroAtoms": "14", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "276225.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 565.746", "link_html_complex": "/ACE_complex_html/ACE_MLLCS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MLLCS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MLLCS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MLLCS.png", "phi_psi": "/peptide_da/MLLCS.pdb", "link_html_peptide": "/Peptide_html/MLLCS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MLLCS.pdb", "link_png_peptide": "/Peptide_pics/MLLCS.png"}
{"Peptide_Sequence": "MLPAY", " Origin": "Sesame protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "5.8 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "904", " Ligand_ID": "MLPAY_minimized.pdb_904", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "593.74", " logP": "-2.02", " logD": "-3.42", " logSw": "-1.31", " tPSA": "220.91", " RotatableB": "15", " RigidB": "20", " Flexibility": "0.43", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "159974.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 593.735", "link_html_complex": "/ACE_complex_html/ACE_MLPAY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MLPAY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MLPAY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MLPAY.png", "phi_psi": "/peptide_da/MLPAY.pdb", "link_html_peptide": "/Peptide_html/MLPAY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MLPAY.pdb", "link_png_peptide": "/Peptide_pics/MLPAY.png"}
{"Peptide_Sequence": "MLPVY", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "5.4 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "905", " Ligand_ID": "MLPVY_minimized.pdb_905", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "621.79", " logP": "-1.25", " logD": "-2.51", " logSw": "-1.9", " tPSA": "220.91", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "30", " HeteroAtoms": "13", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "92914.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 621.789", "link_html_complex": "/ACE_complex_html/ACE_MLPVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MLPVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MLPVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MLPVY.png", "phi_psi": "/peptide_da/MLPVY.pdb", "link_html_peptide": "/Peptide_html/MLPVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MLPVY.pdb", "link_png_peptide": "/Peptide_pics/MLPVY.png"}
{"Peptide_Sequence": "MM", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "547", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "907", " Ligand_ID": "MM_minimized.pdb_907", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(O)=O", " MW": "280.41", " logP": "-2.52", " logD": "-2.55", " logSw": "0.6", " tPSA": "147.47", " RotatableB": "9", " RigidB": "3", " Flexibility": "0.75", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "512508.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 280.407", "link_html_complex": "/ACE_complex_html/ACE_MM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MM.png", "phi_psi": "/peptide_da/MM.pdb", "link_html_peptide": "/Peptide_html/MM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MM.pdb", "link_png_peptide": "/Peptide_pics/MM.png"}
{"Peptide_Sequence": "MMEPMVK", " Origin": "Sweet potato thioredoxin h2 ", " Peptide_Preparation": "expression of thioredoxin h2 in E. coli", " Isolation_Method": "", " ACE_inhibition_assay": " Lee  et  al.(2003) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.03 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Botanical Studies 52.1 (2011).", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "906", " Ligand_ID": "MMEPMVK_minimized.pdb_906", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "865.14", " logP": "-5.87", " logD": "-7.27", " logSw": "0.41", " tPSA": "377.25", " RotatableB": "29", " RigidB": "19", " Flexibility": "0.6", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "36", " HeteroAtoms": "21", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1301332.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 865.136", "link_html_complex": "/ACE_complex_html/ACE_MMEPMVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MMEPMVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MMEPMVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MMEPMVK.png", "phi_psi": "/peptide_da/MMEPMVK.pdb", "link_html_peptide": "/Peptide_html/MMEPMVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MMEPMVK.pdb", "link_png_peptide": "/Peptide_pics/MMEPMVK.png"}
{"Peptide_Sequence": "MMVPI", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "908", " Ligand_ID": "MMVPI_minimized.pdb_908", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCSC)C(C)C)C(O)=O", " MW": "589.81", " logP": "-1.85", " logD": "-3.08", " logSw": "-1.21", " tPSA": "225.98", " RotatableB": "17", " RigidB": "14", " Flexibility": "0.55", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "175998.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 589.811", "link_html_complex": "/ACE_complex_html/ACE_MMVPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MMVPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MMVPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MMVPI.png", "phi_psi": "/peptide_da/MMVPI.pdb", "link_html_peptide": "/Peptide_html/MMVPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MMVPI.pdb", "link_png_peptide": "/Peptide_pics/MMVPI.png"}
{"Peptide_Sequence": "MNP", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "66.5", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "909", " Ligand_ID": "MNP_minimized.pdb_909", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "360.43", " logP": "-5.1", " logD": "-6.01", " logSw": "1.73", " tPSA": "185.57", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2037817.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 360.429", "link_html_complex": "/ACE_complex_html/ACE_MNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MNP.png", "phi_psi": "/peptide_da/MNP.pdb", "link_html_peptide": "/Peptide_html/MNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MNP.pdb", "link_png_peptide": "/Peptide_pics/MNP.png"}
{"Peptide_Sequence": "MNPPK", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "945.5", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "910", " Ligand_ID": "MNPPK_minimized.pdb_910", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "585.72", " logP": "-4.52", " logD": "-6.93", " logSw": "0.43", " tPSA": "262.62", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "902341.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 585.717", "link_html_complex": "/ACE_complex_html/ACE_MNPPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MNPPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MNPPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MNPPK.png", "phi_psi": "/peptide_da/MNPPK.pdb", "link_html_peptide": "/Peptide_html/MNPPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MNPPK.pdb", "link_png_peptide": "/Peptide_pics/MNPPK.png"}
{"Peptide_Sequence": "MNVKHWPWMK", " Origin": "Chicken Leg Meat", " Peptide_Preparation": "h artificial gastric juice (pepsin)", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "228 \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Novel angiotensin-converting enzyme (ACE) inhibitory peptides derived from boneless chicken leg meat.\" Journal of agricultural and food chemistry 58.12 (2010): 7432-7436.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "911", " Ligand_ID": "MNVKHWPWMK_minimized.pdb_911", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1356.66", " logP": "-1.52", " logD": "-8.06", " logSw": "-4.68", " tPSA": "530.11", " RotatableB": "41", " RigidB": "51", " Flexibility": "0.45", " HBD": "20", " HBA": "29", " HBD_HBA": "49", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "95", " CarbonAtoms": "64", " HeteroAtoms": "31", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "12610.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1356.66", "link_html_complex": "/ACE_complex_html/ACE_MNVKHWPWMK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MNVKHWPWMK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MNVKHWPWMK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MNVKHWPWMK.png", "phi_psi": "/peptide_da/MNVKHWPWMK.pdb", "link_html_peptide": "/Peptide_html/MNVKHWPWMK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MNVKHWPWMK.pdb", "link_png_peptide": "/Peptide_pics/MNVKHWPWMK.png"}
{"Peptide_Sequence": "MPACGSS", " Origin": "common beans (Phaseolus vulgaris L.) ", " Peptide_Preparation": " synthesized ", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "191.5 \u03bcM", " Reference": "Luna-Vital, Diego A., et al. \"Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity.\" Food & function 6.5 (2015): 1470-1479.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "912", " Ligand_ID": "MPACGSS_minimized.pdb_912", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O", " MW": "651.75", " logP": "-6.15", " logD": "-9.71", " logSw": "1.18", " tPSA": "338.14", " RotatableB": "18", " RigidB": "18", " Flexibility": "0.5", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "24", " HeteroAtoms": "19", " ratio_H_by_C": "0.79", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2124508.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 651.752", "link_html_complex": "/ACE_complex_html/ACE_MPACGSS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPACGSS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPACGSS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPACGSS.png", "phi_psi": "/peptide_da/MPACGSS.pdb", "link_html_peptide": "/Peptide_html/MPACGSS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPACGSS.pdb", "link_png_peptide": "/Peptide_pics/MPACGSS.png"}
{"Peptide_Sequence": "MPF", " Origin": "egg", " Peptide_Preparation": "pepsin-pancreatin digest", " Isolation_Method": " ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "17.98", " Reference": "Majumder, K., & Wu, J. (2009). Angiotensin I Converting Enzyme Inhibitory Peptides from Simulatedin VitroGastrointestinal Digestion of Cooked Eggs. Journal of Agricultural and Food Chemistry, 57(2), 471\u2013477. doi:10.1021/jf8028557", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "914", " Ligand_ID": "MPF_minimized.pdb_914", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "393.5", " logP": "-1.97", " logD": "-2.87", " logSw": "-0.53", " tPSA": "142.48", " RotatableB": "9", " RigidB": "16", " Flexibility": "0.36", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "232352.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.5", "link_html_complex": "/ACE_complex_html/ACE_MPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPF.png", "phi_psi": "/peptide_da/MPF.pdb", "link_html_peptide": "/Peptide_html/MPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPF.pdb", "link_png_peptide": "/Peptide_pics/MPF.png"}
{"Peptide_Sequence": "MPFLFK", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "913", " Ligand_ID": "MPFLFK_minimized.pdb_913", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "782", " logP": "-0.49", " logD": "-1.72", " logSw": "-2.94", " tPSA": "257.42", " RotatableB": "23", " RigidB": "28", " Flexibility": "0.45", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "55", " CarbonAtoms": "40", " HeteroAtoms": "15", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "41356.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 782.004", "link_html_complex": "/ACE_complex_html/ACE_MPFLFK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPFLFK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPFLFK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPFLFK.png", "phi_psi": "/peptide_da/MPFLFK.pdb", "link_html_peptide": "/Peptide_html/MPFLFK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPFLFK.pdb", "link_png_peptide": "/Peptide_pics/MPFLFK.png"}
{"Peptide_Sequence": "MPFPKYPVEP", " Origin": "bovine sodium caseinate", " Peptide_Preparation": "fermentatation, Lactobacillus animalis ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Roy et al.(2000)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "59.96 \u03bcM", " Reference": "Hayes, M., et al. \"Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.\" Appl. Environ. Microbiol. 73.14 (2007): 4658-4667.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "915", " Ligand_ID": "MPFPKYPVEP_minimized.pdb_915", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1204.44", " logP": "-2.66", " logD": "-10.35", " logSw": "-3.7", " tPSA": "407.81", " RotatableB": "30", " RigidB": "52", " Flexibility": "0.37", " HBD": "12", " HBA": "25", " HBD_HBA": "37", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "59", " HeteroAtoms": "26", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "29660.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1204.44", "link_html_complex": "/ACE_complex_html/ACE_MPFPKYPVEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPFPKYPVEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPFPKYPVEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPFPKYPVEP.png", "phi_psi": "/peptide_da/MPFPKYPVEP.pdb", "link_html_peptide": "/Peptide_html/MPFPKYPVEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPFPKYPVEP.pdb", "link_png_peptide": "/Peptide_pics/MPFPKYPVEP.png"}
{"Peptide_Sequence": "MPP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "916", " Ligand_ID": "MPP_minimized.pdb_916", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "343.44", " logP": "-2.47", " logD": "-4.27", " logSw": "-0.02", " tPSA": "133.69", " RotatableB": "6", " RigidB": "15", " Flexibility": "0.29", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "337572", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 343.442", "link_html_complex": "/ACE_complex_html/ACE_MPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPP.png", "phi_psi": "/peptide_da/MPP.pdb", "link_html_peptide": "/Peptide_html/MPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPP.pdb", "link_png_peptide": "/Peptide_pics/MPP.png"}
{"Peptide_Sequence": "MPVHTDAD", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "917", " Ligand_ID": "MPVHTDAD_minimized.pdb_917", " Smiles": "CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "884.95", " logP": "-5.45", " logD": "-14.93", " logSw": "-0.27", " tPSA": "417.15", " RotatableB": "25", " RigidB": "27", " Flexibility": "0.48", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "61", " CarbonAtoms": "36", " HeteroAtoms": "25", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "672296.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 884.954", "link_html_complex": "/ACE_complex_html/ACE_MPVHTDAD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MPVHTDAD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MPVHTDAD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MPVHTDAD.png", "phi_psi": "/peptide_da/MPVHTDAD.pdb", "link_html_peptide": "/Peptide_html/MPVHTDAD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MPVHTDAD.pdb", "link_png_peptide": "/Peptide_pics/MPVHTDAD.png"}
{"Peptide_Sequence": "MRKDQ", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "918", " Ligand_ID": "MRKDQ_minimized.pdb_918", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "676.79", " logP": "-8.74", " logD": "-15.89", " logSw": "3.19", " tPSA": "383.97", " RotatableB": "26", " RigidB": "13", " Flexibility": "0.67", " HBD": "16", " HBA": "19", " HBD_HBA": "35", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "26", " HeteroAtoms": "20", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "16374529.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 676.786", "link_html_complex": "/ACE_complex_html/ACE_MRKDQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MRKDQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MRKDQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MRKDQ.png", "phi_psi": "/peptide_da/MRKDQ.pdb", "link_html_peptide": "/Peptide_html/MRKDQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MRKDQ.pdb", "link_png_peptide": "/Peptide_pics/MRKDQ.png"}
{"Peptide_Sequence": "MRW", " Origin": "Spinach Rubisco", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.6 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "919", " Ligand_ID": "MRW_minimized.pdb_919", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "491.61", " logP": "-2.57", " logD": "-5.66", " logSw": "-0.38", " tPSA": "230.7", " RotatableB": "15", " RigidB": "16", " Flexibility": "0.48", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "336774.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 491.607", "link_html_complex": "/ACE_complex_html/ACE_MRW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MRW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MRW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MRW.png", "phi_psi": "/peptide_da/MRW.pdb", "link_html_peptide": "/Peptide_html/MRW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MRW.pdb", "link_png_peptide": "/Peptide_pics/MRW.png"}
{"Peptide_Sequence": "MRWRD", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2.09 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "920", " Ligand_ID": "MRWRD_minimized.pdb_920", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "762.88", " logP": "-4.77", " logD": "-12.91", " logSw": "0.09", " tPSA": "392.67", " RotatableB": "26", " RigidB": "22", " Flexibility": "0.54", " HBD": "17", " HBA": "20", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "32", " HeteroAtoms": "21", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "831876.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 762.88", "link_html_complex": "/ACE_complex_html/ACE_MRWRD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MRWRD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MRWRD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MRWRD.png", "phi_psi": "/peptide_da/MRWRD.pdb", "link_html_peptide": "/Peptide_html/MRWRD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MRWRD.pdb", "link_png_peptide": "/Peptide_pics/MRWRD.png"}
{"Peptide_Sequence": "MTEEY", " Origin": "common beans (Phaseolus vulgaris L.) ", " Peptide_Preparation": " synthesized ", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "90.3 \u03bcM", " Reference": "Luna-Vital, Diego A., et al. \"Peptides present in the non-digestible fraction of common beans (Phaseolus vulgaris L.) inhibit the angiotensin-I converting enzyme by interacting with its catalytic cavity independent of their antioxidant capacity.\" Food & function 6.5 (2015): 1470-1479.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "921", " Ligand_ID": "MTEEY_minimized.pdb_921", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "671.72", " logP": "-4.43", " logD": "-12.86", " logSw": "0.12", " tPSA": "330.19", " RotatableB": "21", " RigidB": "17", " Flexibility": "0.55", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "46", " CarbonAtoms": "28", " HeteroAtoms": "18", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "758285.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 671.717", "link_html_complex": "/ACE_complex_html/ACE_MTEEY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MTEEY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MTEEY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MTEEY.png", "phi_psi": "/peptide_da/MTEEY.pdb", "link_html_peptide": "/Peptide_html/MTEEY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MTEEY.pdb", "link_png_peptide": "/Peptide_pics/MTEEY.png"}
{"Peptide_Sequence": "MVGSAPGVL", " Origin": "Fish (Skin gelatin of skate (Okamejei kenojei))", " Peptide_Preparation": "Alcalase, flavourzyme, protamex, Neutrase, protease, \u03b1-chymotrypsin", " Isolation_Method": "FPLC, DEAE FF anion exchange column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with slight modifications.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.09 \u03bcM", " Reference": "Ngo, Dai-Hung, BoMi Ryu, and Se-Kwon Kim. \"Active peptides from skate (Okamejei kenojei) skin gelatin diminish angiotensin-I converting enzyme activity and intracellular free radical-mediated oxidation.\" Food chemistry 143 (2014): 246-255.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "922", " Ligand_ID": "MVGSAPGVL_minimized.pdb_922", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "830", " logP": "-4.39", " logD": "-7.16", " logSw": "-0.64", " tPSA": "337.31", " RotatableB": "24", " RigidB": "22", " Flexibility": "0.52", " HBD": "11", " HBA": "20", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "36", " HeteroAtoms": "21", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "439265.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 830.004", "link_html_complex": "/ACE_complex_html/ACE_MVGSAPGVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MVGSAPGVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MVGSAPGVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MVGSAPGVL.png", "phi_psi": "/peptide_da/MVGSAPGVL.pdb", "link_html_peptide": "/Peptide_html/MVGSAPGVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MVGSAPGVL.pdb", "link_png_peptide": "/Peptide_pics/MVGSAPGVL.png"}
{"Peptide_Sequence": "MW", " Origin": "Upstream chum salmon muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "277 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "923", " Ligand_ID": "MW_minimized.pdb_923", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "335.42", " logP": "-1.5", " logD": "-1.45", " logSw": "-0.6", " tPSA": "137.96", " RotatableB": "8", " RigidB": "13", " Flexibility": "0.38", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "184456.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 335.421", "link_html_complex": "/ACE_complex_html/ACE_MW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MW.png", "phi_psi": "/peptide_da/MW.pdb", "link_html_peptide": "/Peptide_html/MW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MW.pdb", "link_png_peptide": "/Peptide_pics/MW.png"}
{"Peptide_Sequence": "MY", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "193 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "924", " Ligand_ID": "MY_minimized.pdb_924", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "312.38", " logP": "-2.03", " logD": "-1.86", " logSw": "-0.08", " tPSA": "142.4", " RotatableB": "8", " RigidB": "9", " Flexibility": "0.47", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "288893.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 312.385", "link_html_complex": "/ACE_complex_html/ACE_MY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MY.png", "phi_psi": "/peptide_da/MY.pdb", "link_html_peptide": "/Peptide_html/MY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MY.pdb", "link_png_peptide": "/Peptide_pics/MY.png"}
{"Peptide_Sequence": "MYPGIA", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "MALDI-TOF/TOF", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "925", " Ligand_ID": "MYPGIA_minimized.pdb_925", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](C)C(O)=O", " MW": "650.79", " logP": "-1.52", " logD": "-4.32", " logSw": "-1.84", " tPSA": "250.01", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "30", " HeteroAtoms": "15", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "102936.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 650.787", "link_html_complex": "/ACE_complex_html/ACE_MYPGIA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MYPGIA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MYPGIA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MYPGIA.png", "phi_psi": "/peptide_da/MYPGIA.pdb", "link_html_peptide": "/Peptide_html/MYPGIA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MYPGIA.pdb", "link_png_peptide": "/Peptide_pics/MYPGIA.png"}
{"Peptide_Sequence": "MYY", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.6", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "926", " Ligand_ID": "MYY_minimized.pdb_926", " Smiles": "CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "475.56", " logP": "-1.05", " logD": "-2.14", " logSw": "-1.48", " tPSA": "191.73", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "108451.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 475.558", "link_html_complex": "/ACE_complex_html/ACE_MYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_MYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_MYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_MYY.png", "phi_psi": "/peptide_da/MYY.pdb", "link_html_peptide": "/Peptide_html/MYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/MYY.pdb", "link_png_peptide": "/Peptide_pics/MYY.png"}
{"Peptide_Sequence": "NAGPFTPTVNREQLSTS", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-5.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1818.94", "link_html_complex": "/ACE_complex_html/ACE_NAGPFTPTVNREQLSTS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NAGPFTPTVNREQLSTS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NAGPFTPTVNREQLSTS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NAGPFTPTVNREQLSTS.png", "phi_psi": "/peptide_da/NAGPFTPTVNREQLSTS.pdb", "link_html_peptide": "/Peptide_html/NAGPFTPTVNREQLSTS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NAGPFTPTVNREQLSTS.pdb", "link_png_peptide": "/Peptide_pics/NAGPFTPTVNREQLSTS.png"}
{"Peptide_Sequence": "NAQRP", " Origin": "Arachin", " Peptide_Preparation": "Proteases trypsin, chymotrypsin, pepsin and pancreatin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "32 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion.\" Food chemistry 125.2 (2011): 561-569.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "928", " Ligand_ID": "NAQRP_minimized.pdb_928", " Smiles": "C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "584.63", " logP": "-8.9", " logD": "-10.92", " logSw": "3.26", " tPSA": "323.58", " RotatableB": "17", " RigidB": "19", " Flexibility": "0.47", " HBD": "14", " HBA": "18", " HBD_HBA": "32", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "15295157.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.626", "link_html_complex": "/ACE_complex_html/ACE_NAQRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NAQRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NAQRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NAQRP.png", "phi_psi": "/peptide_da/NAQRP.pdb", "link_html_peptide": "/Peptide_html/NAQRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NAQRP.pdb", "link_png_peptide": "/Peptide_pics/NAQRP.png"}
{"Peptide_Sequence": "NCW", " Origin": "myosin  from Mizuhopecten yessoensis ", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "35.5 \u03bcM", " Reference": "Yu, Zhipeng, et al. \"Identification and the molecular mechanism of a novel myosin-derived ACE inhibitory peptide.\" Food & function 9.1 (2018): 364-370.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "929", " Ligand_ID": "NCW_minimized.pdb_929", " Smiles": "N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "421.47", " logP": "-4.06", " logD": "-4.73", " logSw": "0.64", " tPSA": "222.03", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "1", " Solubility_mg_per_l": "796601.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 421.47", "link_html_complex": "/ACE_complex_html/ACE_NCW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NCW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NCW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NCW.png", "phi_psi": "/peptide_da/NCW.pdb", "link_html_peptide": "/Peptide_html/NCW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NCW.pdb", "link_png_peptide": "/Peptide_pics/NCW.png"}
{"Peptide_Sequence": "NENLLRFFVAPFPEVFG", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "55 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "15.7", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1996.27", "link_html_complex": "/ACE_complex_html/ACE_NENLLRFFVAPFPEVFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NENLLRFFVAPFPEVFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NENLLRFFVAPFPEVFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NENLLRFFVAPFPEVFG.png", "phi_psi": "/peptide_da/NENLLRFFVAPFPEVFG.pdb", "link_html_peptide": "/Peptide_html/NENLLRFFVAPFPEVFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NENLLRFFVAPFPEVFG.pdb", "link_png_peptide": "/Peptide_pics/NENLLRFFVAPFPEVFG.png"}
{"Peptide_Sequence": "NF", " Origin": "Egg White", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": ">1000 \u00b5mol/L", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "931", " Ligand_ID": "NF_minimized.pdb_931", " Smiles": "N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "279.29", " logP": "-3.99", " logD": "-3.84", " logSw": "1.28", " tPSA": "138.34", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1008629.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 279.292", "link_html_complex": "/ACE_complex_html/ACE_NF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NF.png", "phi_psi": "/peptide_da/NF.pdb", "link_html_peptide": "/Peptide_html/NF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NF.pdb", "link_png_peptide": "/Peptide_pics/NF.png"}
{"Peptide_Sequence": "NG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "12000 \u03bcM", " Reference": "Angiotensin converting enzyme inhibitors:Evolution of a new class of antihypertensive drugs (page 19). in:   Horovitz Z. P. (Ed.)(1981), Mechanisms of action and clinical implications, Urban & Schwarzenberg.", " Binding_Energy_kcal_per_mol": "-5.4", "Serial_ID": "932", " Ligand_ID": "NG_minimized.pdb_932", " Smiles": "N[C@@H](CC(N)=O)C(=O)NCC(O)=O", " MW": "189.17", " logP": "-5.17", " logD": "-6.08", " logSw": "2.57", " tPSA": "138.34", " RotatableB": "5", " RigidB": "5", " Flexibility": "0.5", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "13", " CarbonAtoms": "6", " HeteroAtoms": "7", " ratio_H_by_C": "1.17", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2482180.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 189.169", "link_html_complex": "/ACE_complex_html/ACE_NG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NG.png", "phi_psi": "/peptide_da/NG.pdb", "link_html_peptide": "/Peptide_html/NG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NG.pdb", "link_png_peptide": "/Peptide_pics/NG.png"}
{"Peptide_Sequence": "NGTWFEPP", " Origin": "Haruan (Channa striatus) myofibrillar ", " Peptide_Preparation": "thermolysin and proteinase K", " Isolation_Method": "Ultrafiltration, SEC, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.63 \u03bcM", " Reference": "Ghassem, Masomeh, et al. \"Purification and identification of ACE inhibitory peptides from Haruan (Channa striatus) myofibrillar protein hydrolysate using HPLC\u2013ESI-TOF MS/MS.\" Food chemistry 129.4 (2011): 1770-1777.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "933", " Ligand_ID": "NGTWFEPP_minimized.pdb_933", " Smiles": "C[C@@H](O)[C@H](NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "947", " logP": "-3.91", " logD": "-10.25", " logSw": "-1.82", " tPSA": "371.51", " RotatableB": "23", " RigidB": "44", " Flexibility": "0.34", " HBD": "13", " HBA": "23", " HBD_HBA": "36", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "-2", " HeavyAtoms": "68", " CarbonAtoms": "45", " HeteroAtoms": "23", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "153714.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 947.001", "link_html_complex": "/ACE_complex_html/ACE_NGTWFEPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NGTWFEPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NGTWFEPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NGTWFEPP.png", "phi_psi": "/peptide_da/NGTWFEPP.pdb", "link_html_peptide": "/Peptide_html/NGTWFEPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NGTWFEPP.pdb", "link_png_peptide": "/Peptide_pics/NGTWFEPP.png"}
{"Peptide_Sequence": "NHRNRMMDHVH", " Origin": "P-CN", " Peptide_Preparation": "", " Isolation_Method": "UF, HPLC", " ACE_inhibition_assay": "HPLC method by Mao et al., 2007", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "13.42 \u03bcM", " Reference": "Chen, Y., et al. \"Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk.\" Journal of dairy science 93.3 (2010): 884-892.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1446.62", "link_html_complex": "/ACE_complex_html/ACE_NHRNRMMDHVH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NHRNRMMDHVH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NHRNRMMDHVH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NHRNRMMDHVH.png", "phi_psi": "/peptide_da/NHRNRMMDHVH.pdb", "link_html_peptide": "/Peptide_html/NHRNRMMDHVH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NHRNRMMDHVH.pdb", "link_png_peptide": "/Peptide_pics/NHRNRMMDHVH.png"}
{"Peptide_Sequence": "NIFYCP", " Origin": "ovalbumin", " Peptide_Preparation": "pepsin, trypsin, chymotrypsin, and thermolysin", " Isolation_Method": "ODS", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "15", " Reference": "Iroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000). Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins. Journal of Food Science, 65(4), 564\u2013569. doi:10.1111/j.1365-2621.2000.tb16049.x", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "935", " Ligand_ID": "NIFYCP_minimized.pdb_935", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(O)=O", " MW": "755.88", " logP": "-1.41", " logD": "-3.6", " logSw": "-2.47", " tPSA": "304.98", " RotatableB": "19", " RigidB": "30", " Flexibility": "0.39", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "63858.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 755.88", "link_html_complex": "/ACE_complex_html/ACE_NIFYCP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NIFYCP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NIFYCP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NIFYCP.png", "phi_psi": "/peptide_da/NIFYCP.pdb", "link_html_peptide": "/Peptide_html/NIFYCP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NIFYCP.pdb", "link_png_peptide": "/Peptide_pics/NIFYCP.png"}
{"Peptide_Sequence": "NIIPA", " Origin": "Pork (Sus domesticus)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "936", " Ligand_ID": "NIIPA_minimized.pdb_936", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "526.63", " logP": "-4.29", " logD": "-4.81", " logSw": "0.52", " tPSA": "216.85", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "887233.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 526.626", "link_html_complex": "/ACE_complex_html/ACE_NIIPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NIIPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NIIPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NIIPA.png", "phi_psi": "/peptide_da/NIIPA.pdb", "link_html_peptide": "/Peptide_html/NIIPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NIIPA.pdb", "link_png_peptide": "/Peptide_pics/NIIPA.png"}
{"Peptide_Sequence": "NILP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "560", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "937", " Ligand_ID": "NILP_minimized.pdb_937", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "455.55", " logP": "-4.02", " logD": "-4.3", " logSw": "0.66", " tPSA": "187.75", " RotatableB": "12", " RigidB": "14", " Flexibility": "0.46", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "881567.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.548", "link_html_complex": "/ACE_complex_html/ACE_NILP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NILP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NILP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NILP.png", "phi_psi": "/peptide_da/NILP.pdb", "link_html_peptide": "/Peptide_html/NILP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NILP.pdb", "link_png_peptide": "/Peptide_pics/NILP.png"}
{"Peptide_Sequence": "NIPPLTQTPV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "173 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "938", " Ligand_ID": "NIPPLTQTPV_minimized.pdb_938", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "1079.25", " logP": "-4.68", " logD": "-8.54", " logSw": "-1.8", " tPSA": "428.32", " RotatableB": "27", " RigidB": "38", " Flexibility": "0.42", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "76", " CarbonAtoms": "49", " HeteroAtoms": "27", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "178232.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1079.25", "link_html_complex": "/ACE_complex_html/ACE_NIPPLTQTPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NIPPLTQTPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NIPPLTQTPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NIPPLTQTPV.png", "phi_psi": "/peptide_da/NIPPLTQTPV.pdb", "link_html_peptide": "/Peptide_html/NIPPLTQTPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NIPPLTQTPV.pdb", "link_png_peptide": "/Peptide_pics/NIPPLTQTPV.png"}
{"Peptide_Sequence": "NIPPLTQTPVVVPPFIQ", " Origin": "bovine sodium caseinate", " Peptide_Preparation": "fermentatation, Lactobacillus animalis ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Roy et al.(2000)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "45.03 \u03bcM", " Reference": "Hayes, M., et al. \"Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.\" Appl. Environ. Microbiol. 73.14 (2007): 4658-4667.", " Binding_Energy_kcal_per_mol": "5.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1860.2", "link_html_complex": "/ACE_complex_html/ACE_NIPPLTQTPVVVPPFIQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NIPPLTQTPVVVPPFIQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NIPPLTQTPVVVPPFIQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NIPPLTQTPVVVPPFIQ.png", "phi_psi": "/peptide_da/NIPPLTQTPVVVPPFIQ.pdb", "link_html_peptide": "/Peptide_html/NIPPLTQTPVVVPPFIQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NIPPLTQTPVVVPPFIQ.pdb", "link_png_peptide": "/Peptide_pics/NIPPLTQTPVVVPPFIQ.png"}
{"Peptide_Sequence": "NK", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "810", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "941", " Ligand_ID": "NK_minimized.pdb_941", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CC(N)=O)C(O)=O", " MW": "260.29", " logP": "-5.01", " logD": "-6", " logSw": "2.3", " tPSA": "165.98", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "10", " HeteroAtoms": "8", " ratio_H_by_C": "0.8", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2587113.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 260.29", "link_html_complex": "/ACE_complex_html/ACE_NK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NK.png", "phi_psi": "/peptide_da/NK.pdb", "link_html_peptide": "/Peptide_html/NK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NK.pdb", "link_png_peptide": "/Peptide_pics/NK.png"}
{"Peptide_Sequence": "NKL", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "88", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "940", " Ligand_ID": "NKL_minimized.pdb_940", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(O)=O", " MW": "373.45", " logP": "-3.92", " logD": "-6.78", " logSw": "1.17", " tPSA": "195.08", " RotatableB": "13", " RigidB": "7", " Flexibility": "0.65", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1205924.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 373.448", "link_html_complex": "/ACE_complex_html/ACE_NKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NKL.png", "phi_psi": "/peptide_da/NKL.pdb", "link_html_peptide": "/Peptide_html/NKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NKL.pdb", "link_png_peptide": "/Peptide_pics/NKL.png"}
{"Peptide_Sequence": "NKPGDML", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "942", " Ligand_ID": "NKPGDML_minimized.pdb_942", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "773.9", " logP": "-9.07", " logD": "-13.89", " logSw": "2.73", " tPSA": "368.12", " RotatableB": "25", " RigidB": "21", " Flexibility": "0.54", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "32", " HeteroAtoms": "21", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11817933.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 773.898", "link_html_complex": "/ACE_complex_html/ACE_NKPGDML.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NKPGDML.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NKPGDML.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NKPGDML.png", "phi_psi": "/peptide_da/NKPGDML.pdb", "link_html_peptide": "/Peptide_html/NKPGDML.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NKPGDML.pdb", "link_png_peptide": "/Peptide_pics/NKPGDML.png"}
{"Peptide_Sequence": "NLAG", " Origin": "Arachin", " Peptide_Preparation": "Proteases trypsin, chymotrypsin, pepsin and pancreatin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "332 \u03bcM", " Reference": "Jimsheena, V. K., and Lalitha R. Gowda. \"Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion.\" Food chemistry 125.2 (2011): 561-569.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "943", " Ligand_ID": "NLAG_minimized.pdb_943", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(O)=O", " MW": "373.4", " logP": "-4.36", " logD": "-6.51", " logSw": "1.32", " tPSA": "196.54", " RotatableB": "11", " RigidB": "9", " Flexibility": "0.55", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "26", " CarbonAtoms": "15", " HeteroAtoms": "11", " ratio_H_by_C": "0.73", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1394586.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 373.405", "link_html_complex": "/ACE_complex_html/ACE_NLAG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NLAG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NLAG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NLAG.png", "phi_psi": "/peptide_da/NLAG.pdb", "link_html_peptide": "/Peptide_html/NLAG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NLAG.pdb", "link_png_peptide": "/Peptide_pics/NLAG.png"}
{"Peptide_Sequence": "NLHLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "420", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "946", " Ligand_ID": "NLHLP_minimized.pdb_946", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "592.69", " logP": "-4.51", " logD": "-5.38", " logSw": "0.34", " tPSA": "245.53", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "832373.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 592.688", "link_html_complex": "/ACE_complex_html/ACE_NLHLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NLHLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NLHLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NLHLP.png", "phi_psi": "/peptide_da/NLHLP.pdb", "link_html_peptide": "/Peptide_html/NLHLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NLHLP.pdb", "link_png_peptide": "/Peptide_pics/NLHLP.png"}
{"Peptide_Sequence": "NLHLPLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "51", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "945", " Ligand_ID": "NLHLPLP_minimized.pdb_945", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "802.96", " logP": "-1.7", " logD": "-4.95", " logSw": "-2.39", " tPSA": "294.94", " RotatableB": "21", " RigidB": "30", " Flexibility": "0.41", " HBD": "10", " HBA": "19", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "57", " CarbonAtoms": "38", " HeteroAtoms": "19", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "73395.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.96", "link_html_complex": "/ACE_complex_html/ACE_NLHLPLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NLHLPLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NLHLPLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NLHLPLP.png", "phi_psi": "/peptide_da/NLHLPLP.pdb", "link_html_peptide": "/Peptide_html/NLHLPLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NLHLPLP.pdb", "link_png_peptide": "/Peptide_pics/NLHLPLP.png"}
{"Peptide_Sequence": "NLHLPLPLL", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "15 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "944", " Ligand_ID": "NLHLPLPLL_minimized.pdb_944", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)C(O)=O", " MW": "1029.28", " logP": "0.43", " logD": "-3.46", " logSw": "-4.6", " tPSA": "353.14", " RotatableB": "29", " RigidB": "34", " Flexibility": "0.46", " HBD": "12", " HBA": "23", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "73", " CarbonAtoms": "50", " HeteroAtoms": "23", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10325.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1029.28", "link_html_complex": "/ACE_complex_html/ACE_NLHLPLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NLHLPLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NLHLPLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NLHLPLPLL.png", "phi_psi": "/peptide_da/NLHLPLPLL.pdb", "link_html_peptide": "/Peptide_html/NLHLPLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NLHLPLPLL.pdb", "link_png_peptide": "/Peptide_pics/NLHLPLPLL.png"}
{"Peptide_Sequence": "NMAINPSK", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "60", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "947", " Ligand_ID": "NMAINPSK_minimized.pdb_947", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "874.02", " logP": "-6.83", " logD": "-9.35", " logSw": "0.83", " tPSA": "420.41", " RotatableB": "27", " RigidB": "24", " Flexibility": "0.53", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "60", " CarbonAtoms": "36", " HeteroAtoms": "24", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1996388.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 874.017", "link_html_complex": "/ACE_complex_html/ACE_NMAINPSK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NMAINPSK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NMAINPSK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NMAINPSK.png", "phi_psi": "/peptide_da/NMAINPSK.pdb", "link_html_peptide": "/Peptide_html/NMAINPSK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NMAINPSK.pdb", "link_png_peptide": "/Peptide_pics/NMAINPSK.png"}
{"Peptide_Sequence": "NNVMLQW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "40.7 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "948", " Ligand_ID": "NNVMLQW_minimized.pdb_948", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "904.04", " logP": "-5.41", " logD": "-6.82", " logSw": "-0.37", " tPSA": "411.11", " RotatableB": "26", " RigidB": "29", " Flexibility": "0.47", " HBD": "16", " HBA": "22", " HBD_HBA": "38", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "63", " CarbonAtoms": "40", " HeteroAtoms": "23", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "621660", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 904.044", "link_html_complex": "/ACE_complex_html/ACE_NNVMLQW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NNVMLQW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NNVMLQW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NNVMLQW.png", "phi_psi": "/peptide_da/NNVMLQW.pdb", "link_html_peptide": "/Peptide_html/NNVMLQW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NNVMLQW.pdb", "link_png_peptide": "/Peptide_pics/NNVMLQW.png"}
{"Peptide_Sequence": "NP", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2300", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "950", " Ligand_ID": "NP_minimized.pdb_950", " Smiles": "N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "229.23", " logP": "-4.23", " logD": "-5.24", " logSw": "1.67", " tPSA": "129.55", " RotatableB": "4", " RigidB": "10", " Flexibility": "0.29", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "16", " CarbonAtoms": "9", " HeteroAtoms": "7", " ratio_H_by_C": "0.78", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1214872.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 229.233", "link_html_complex": "/ACE_complex_html/ACE_NP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NP.png", "phi_psi": "/peptide_da/NP.pdb", "link_html_peptide": "/Peptide_html/NP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NP.pdb", "link_png_peptide": "/Peptide_pics/NP.png"}
{"Peptide_Sequence": "NPAVVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "19", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "949", " Ligand_ID": "NPAVVRP_minimized.pdb_949", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "751.87", " logP": "-4.32", " logD": "-8.78", " logSw": "-0.46", " tPSA": "329.9", " RotatableB": "20", " RigidB": "26", " Flexibility": "0.43", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "474636.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 751.874", "link_html_complex": "/ACE_complex_html/ACE_NPAVVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NPAVVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NPAVVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NPAVVRP.png", "phi_psi": "/peptide_da/NPAVVRP.pdb", "link_html_peptide": "/Peptide_html/NPAVVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NPAVVRP.pdb", "link_png_peptide": "/Peptide_pics/NPAVVRP.png"}
{"Peptide_Sequence": "NPP", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "290.5", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "952", " Ligand_ID": "NPP_minimized.pdb_952", " Smiles": "N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "326.35", " logP": "-4.42", " logD": "-6.02", " logSw": "1.25", " tPSA": "149.86", " RotatableB": "5", " RigidB": "17", " Flexibility": "0.23", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1140481.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 326.348", "link_html_complex": "/ACE_complex_html/ACE_NPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NPP.png", "phi_psi": "/peptide_da/NPP.pdb", "link_html_peptide": "/Peptide_html/NPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NPP.pdb", "link_png_peptide": "/Peptide_pics/NPP.png"}
{"Peptide_Sequence": "NPPHQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "37", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "951", " Ligand_ID": "NPPHQIYP_minimized.pdb_951", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "965.06", " logP": "-4.22", " logD": "-7.5", " logSw": "-1.77", " tPSA": "378.57", " RotatableB": "22", " RigidB": "45", " Flexibility": "0.33", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "69", " CarbonAtoms": "45", " HeteroAtoms": "24", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "163727.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 965.063", "link_html_complex": "/ACE_complex_html/ACE_NPPHQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NPPHQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NPPHQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NPPHQIYP.png", "phi_psi": "/peptide_da/NPPHQIYP.pdb", "link_html_peptide": "/Peptide_html/NPPHQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NPPHQIYP.pdb", "link_png_peptide": "/Peptide_pics/NPPHQIYP.png"}
{"Peptide_Sequence": "NPPSV", " Origin": "wheat germ", " Peptide_Preparation": "", " Isolation_Method": "ethanol precipitation and chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 40.56 \u03bcM", " Reference": "Yang, Runqiang, et al. \"Accumulation and identification of angiotensin-converting enzyme inhibitory peptides from wheat germ.\" Journal of agricultural and food chemistry 59.8 (2011): 3598-3605.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "953", " Ligand_ID": "NPPSV_minimized.pdb_953", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)C(O)=O", " MW": "512.56", " logP": "-5.01", " logD": "-7.36", " logSw": "0.86", " tPSA": "228.29", " RotatableB": "11", " RigidB": "21", " Flexibility": "0.34", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "36", " CarbonAtoms": "22", " HeteroAtoms": "14", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1216654.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.557", "link_html_complex": "/ACE_complex_html/ACE_NPPSV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NPPSV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NPPSV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NPPSV.png", "phi_psi": "/peptide_da/NPPSV.pdb", "link_html_peptide": "/Peptide_html/NPPSV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NPPSV.pdb", "link_png_peptide": "/Peptide_pics/NPPSV.png"}
{"Peptide_Sequence": "NRVYVHPF", " Origin": "Rabbit lung", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Cushman, D. W., and H. S. Cheung. \"Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.\" Biochemical pharmacology 20.7 (1971): 1637-1648.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "954", " Ligand_ID": "NRVYVHPF_minimized.pdb_954", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1031.17", " logP": "-2.29", " logD": "-8.08", " logSw": "-2.96", " tPSA": "416.7", " RotatableB": "29", " RigidB": "40", " Flexibility": "0.42", " HBD": "17", " HBA": "25", " HBD_HBA": "42", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "74", " CarbonAtoms": "49", " HeteroAtoms": "25", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "53226.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1031.17", "link_html_complex": "/ACE_complex_html/ACE_NRVYVHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NRVYVHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NRVYVHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NRVYVHPF.png", "phi_psi": "/peptide_da/NRVYVHPF.pdb", "link_html_peptide": "/Peptide_html/NRVYVHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NRVYVHPF.pdb", "link_png_peptide": "/Peptide_pics/NRVYVHPF.png"}
{"Peptide_Sequence": "NSWVE", " Origin": "egg white", " Peptide_Preparation": "protease from C. ficifolia fruit", " Isolation_Method": "ultra-flitration", " ACE_inhibition_assay": "spectrophotometric method as described by Hernandez-Ledesma et al. (2005)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "33.9\u03bcg", " Reference": "Pokora, M., Zambrowicz, A., D\u0105browska, A., Eckert, E., Setner, B., Szo\u0142tysik, M., \u2026 Chrzanowska, J. (2014). An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides. Food Chemistry, 151, 500\u2013505. doi:10.1016/j.foodchem.2013.11.111", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "955", " Ligand_ID": "NSWVE_minimized.pdb_955", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "633.65", " logP": "-5.75", " logD": "-9.71", " logSw": "0.96", " tPSA": "301.79", " RotatableB": "18", " RigidB": "22", " Flexibility": "0.45", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "-2", " HeavyAtoms": "45", " CarbonAtoms": "28", " HeteroAtoms": "17", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1659182.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 633.65", "link_html_complex": "/ACE_complex_html/ACE_NSWVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NSWVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NSWVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NSWVE.png", "phi_psi": "/peptide_da/NSWVE.pdb", "link_html_peptide": "/Peptide_html/NSWVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NSWVE.pdb", "link_png_peptide": "/Peptide_pics/NSWVE.png"}
{"Peptide_Sequence": "NVR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "956", " Ligand_ID": "NVR_minimized.pdb_956", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "387.43", " logP": "-4.88", " logD": "-6.13", " logSw": "1.69", " tPSA": "231.08", " RotatableB": "13", " RigidB": "8", " Flexibility": "0.62", " HBD": "11", " HBA": "12", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "15", " HeteroAtoms": "12", " ratio_H_by_C": "0.8", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2100335.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 387.435", "link_html_complex": "/ACE_complex_html/ACE_NVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NVR.png", "phi_psi": "/peptide_da/NVR.pdb", "link_html_peptide": "/Peptide_html/NVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NVR.pdb", "link_png_peptide": "/Peptide_pics/NVR.png"}
{"Peptide_Sequence": "NWGPLV", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "21 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "957", " Ligand_ID": "NWGPLV_minimized.pdb_957", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "684.78", " logP": "-2.22", " logD": "-4.6", " logSw": "-1.63", " tPSA": "261.74", " RotatableB": "17", " RigidB": "28", " Flexibility": "0.38", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "49", " CarbonAtoms": "33", " HeteroAtoms": "16", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "133671.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 684.783", "link_html_complex": "/ACE_complex_html/ACE_NWGPLV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NWGPLV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NWGPLV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NWGPLV.png", "phi_psi": "/peptide_da/NWGPLV.pdb", "link_html_peptide": "/Peptide_html/NWGPLV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NWGPLV.pdb", "link_png_peptide": "/Peptide_pics/NWGPLV.png"}
{"Peptide_Sequence": "NY", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "32.6  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "958", " Ligand_ID": "NY_minimized.pdb_958", " Smiles": "N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "295.29", " logP": "-5", " logD": "-4.17", " logSw": "1.82", " tPSA": "158.57", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "1", " TotalCharge": "-1", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1830445.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 295.291", "link_html_complex": "/ACE_complex_html/ACE_NY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_NY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_NY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_NY.png", "phi_psi": "/peptide_da/NY.pdb", "link_html_peptide": "/Peptide_html/NY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/NY.pdb", "link_png_peptide": "/Peptide_pics/NY.png"}
{"Peptide_Sequence": "#", " Origin": "#", " Peptide_Preparation": "#", " Isolation_Method": "#", " ACE_inhibition_assay": "#", " In-vivo_or_in-vitro": "#", " IC50_micromol_per_L": "#", " Reference": "#", " Binding_Energy_kcal_per_mol": "#", "Serial_ID": "959", " Ligand_ID": "PAAPPK_minimized.pdb_959", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "579.69", " logP": "-3.26", " logD": "-7.48", " logSw": "-0.52", " tPSA": "212.3", " RotatableB": "13", " RigidB": "26", " Flexibility": "0.33", " HBD": "7", " HBA": "14", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "343855.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.689", "link_html_complex": "/ACE_complex_html/ACE_PAAPPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAAPPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAAPPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAAPPK.png", "phi_psi": "/peptide_da/PAAPPK.pdb", "link_html_peptide": "/Peptide_html/PAAPPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAAPPK.pdb", "link_png_peptide": "/Peptide_pics/PAAPPK.png"}
{"Peptide_Sequence": "PADIKWGD", " Origin": "porcine", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "21 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Induction of angiotensin-converting enzyme inhibitory activity by acid-limited proteolysis of glyceraldehyde 3-phosphate dehydrogenase.\" Biochemical and biophysical research communications 161.2 (1989): 456-460.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "960", " Ligand_ID": "PADIKWGD_minimized.pdb_960", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "900.97", " logP": "-6.15", " logD": "-14.88", " logSw": "0.18", " tPSA": "384.13", " RotatableB": "27", " RigidB": "32", " Flexibility": "0.46", " HBD": "14", " HBA": "23", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "64", " CarbonAtoms": "41", " HeteroAtoms": "23", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1075161.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 900.974", "link_html_complex": "/ACE_complex_html/ACE_PADIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PADIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PADIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PADIKWGD.png", "phi_psi": "/peptide_da/PADIKWGD.pdb", "link_html_peptide": "/Peptide_html/PADIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PADIKWGD.pdb", "link_png_peptide": "/Peptide_pics/PADIKWGD.png"}
{"Peptide_Sequence": "PAGPR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "961", " Ligand_ID": "PAGPR_minimized.pdb_961", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "496.56", " logP": "-4.3", " logD": "-8.38", " logSw": "0.65", " tPSA": "227.99", " RotatableB": "13", " RigidB": "20", " Flexibility": "0.39", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "949589.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 496.561", "link_html_complex": "/ACE_complex_html/ACE_PAGPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAGPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAGPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAGPR.png", "phi_psi": "/peptide_da/PAGPR.pdb", "link_html_peptide": "/Peptide_html/PAGPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAGPR.pdb", "link_png_peptide": "/Peptide_pics/PAGPR.png"}
{"Peptide_Sequence": "PAGPVG", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "962", " Ligand_ID": "PAGPVG_minimized.pdb_962", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)NCC(O)=O", " MW": "496.56", " logP": "-3.17", " logD": "-8.23", " logSw": "-0.2", " tPSA": "193.45", " RotatableB": "11", " RigidB": "21", " Flexibility": "0.34", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "22", " HeteroAtoms": "13", " ratio_H_by_C": "0.59", " Lipinski_Violation": "2", " Solubility_mg_per_l": "408357.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 496.557", "link_html_complex": "/ACE_complex_html/ACE_PAGPVG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAGPVG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAGPVG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAGPVG.png", "phi_psi": "/peptide_da/PAGPVG.pdb", "link_html_peptide": "/Peptide_html/PAGPVG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAGPVG.pdb", "link_png_peptide": "/Peptide_pics/PAGPVG.png"}
{"Peptide_Sequence": "PAHIAW", " Origin": "Fish (Tuna (Neothunnus macropterus muscle))", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-11.3", "Serial_ID": "963", " Ligand_ID": "PAHIAW_minimized.pdb_963", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "693.79", " logP": "-0.83", " logD": "-5.61", " logSw": "-2.6", " tPSA": "246.71", " RotatableB": "17", " RigidB": "31", " Flexibility": "0.35", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "34", " HeteroAtoms": "16", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "51354.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 693.793", "link_html_complex": "/ACE_complex_html/ACE_PAHIAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAHIAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAHIAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAHIAW.png", "phi_psi": "/peptide_da/PAHIAW.pdb", "link_html_peptide": "/Peptide_html/PAHIAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAHIAW.pdb", "link_png_peptide": "/Peptide_pics/PAHIAW.png"}
{"Peptide_Sequence": "PANIKWGD", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "31.16 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "964", " Ligand_ID": "PANIKWGD_minimized.pdb_964", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "899.99", " logP": "-6.41", " logD": "-14.33", " logSw": "0.35", " tPSA": "387.09", " RotatableB": "27", " RigidB": "33", " Flexibility": "0.45", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "41", " HeteroAtoms": "23", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1273428.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 899.989", "link_html_complex": "/ACE_complex_html/ACE_PANIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PANIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PANIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PANIKWGD.png", "phi_psi": "/peptide_da/PANIKWGD.pdb", "link_html_peptide": "/Peptide_html/PANIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PANIKWGD.pdb", "link_png_peptide": "/Peptide_pics/PANIKWGD.png"}
{"Peptide_Sequence": "PANLPWGSSNV", " Origin": "Baker's yeast", " Peptide_Preparation": "HCl", " Isolation_Method": "GP, RP-HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "18  \u03bcM", " Reference": "KOHAMA, Yasuhiro, et al. \"Production of angiotensin-converting enzyme inhibitors from baker's yeast glyceraldehyde-3-phosphate dehydrogenase.\" Journal of pharmacobio-dynamics 13.12 (1990): 766-771.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "965", " Ligand_ID": "PANLPWGSSNV_minimized.pdb_965", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "1141.23", " logP": "-6.13", " logD": "-12.34", " logSw": "-1.12", " tPSA": "481.38", " RotatableB": "30", " RigidB": "45", " Flexibility": "0.4", " HBD": "18", " HBA": "30", " HBD_HBA": "48", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "81", " CarbonAtoms": "51", " HeteroAtoms": "30", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "373791.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1141.23", "link_html_complex": "/ACE_complex_html/ACE_PANLPWGSSNV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PANLPWGSSNV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PANLPWGSSNV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PANLPWGSSNV.png", "phi_psi": "/peptide_da/PANLPWGSSNV.pdb", "link_html_peptide": "/Peptide_html/PANLPWGSSNV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PANLPWGSSNV.pdb", "link_png_peptide": "/Peptide_pics/PANLPWGSSNV.png"}
{"Peptide_Sequence": "PAP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "87", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "966", " Ligand_ID": "PAP_minimized.pdb_966", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "283.32", " logP": "-3.03", " logD": "-5.09", " logSw": "0.58", " tPSA": "106.15", " RotatableB": "4", " RigidB": "15", " Flexibility": "0.21", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "504154.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 283.324", "link_html_complex": "/ACE_complex_html/ACE_PAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAP.png", "phi_psi": "/peptide_da/PAP.pdb", "link_html_peptide": "/Peptide_html/PAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAP.pdb", "link_png_peptide": "/Peptide_pics/PAP.png"}
{"Peptide_Sequence": "PAPPK", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "199.58 \u03bcM ", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "967", " Ligand_ID": "PAPPK_minimized.pdb_967", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "508.61", " logP": "-3.01", " logD": "-6.94", " logSw": "-0.37", " tPSA": "183.2", " RotatableB": "11", " RigidB": "24", " Flexibility": "0.31", " HBD": "6", " HBA": "12", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "24", " HeteroAtoms": "12", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "350932.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 508.611", "link_html_complex": "/ACE_complex_html/ACE_PAPPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAPPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAPPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAPPK.png", "phi_psi": "/peptide_da/PAPPK.pdb", "link_html_peptide": "/Peptide_html/PAPPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAPPK.pdb", "link_png_peptide": "/Peptide_pics/PAPPK.png"}
{"Peptide_Sequence": "PAQK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "100", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "968", " Ligand_ID": "PAQK_minimized.pdb_968", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "442.51", " logP": "-6.42", " logD": "-8.11", " logSw": "2.39", " tPSA": "214.77", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "19", " HeteroAtoms": "12", " ratio_H_by_C": "0.63", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4805429.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 442.51", "link_html_complex": "/ACE_complex_html/ACE_PAQK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAQK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAQK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAQK.png", "phi_psi": "/peptide_da/PAQK.pdb", "link_html_peptide": "/Peptide_html/PAQK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAQK.pdb", "link_png_peptide": "/Peptide_pics/PAQK.png"}
{"Peptide_Sequence": "PAVVLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "synthesize by Solid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "45", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "969", " Ligand_ID": "PAVVLP_minimized.pdb_969", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "594.74", " logP": "-1.78", " logD": "-4.92", " logSw": "-1.48", " tPSA": "193.45", " RotatableB": "14", " RigidB": "21", " Flexibility": "0.4", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "135114.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 594.743", "link_html_complex": "/ACE_complex_html/ACE_PAVVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAVVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAVVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAVVLP.png", "phi_psi": "/peptide_da/PAVVLP.pdb", "link_html_peptide": "/Peptide_html/PAVVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAVVLP.pdb", "link_png_peptide": "/Peptide_pics/PAVVLP.png"}
{"Peptide_Sequence": "PAVVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "18", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "970", " Ligand_ID": "PAVVRP_minimized.pdb_970", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "637.77", " logP": "-2.22", " logD": "-8.51", " logSw": "-1.27", " tPSA": "257.09", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "178465.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 637.771", "link_html_complex": "/ACE_complex_html/ACE_PAVVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PAVVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PAVVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PAVVRP.png", "phi_psi": "/peptide_da/PAVVRP.pdb", "link_html_peptide": "/Peptide_html/PAVVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PAVVRP.pdb", "link_png_peptide": "/Peptide_pics/PAVVRP.png"}
{"Peptide_Sequence": "PCHIAW", " Origin": "Fish (Tuna (Neothunnus macropterus muscle))", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "971", " Ligand_ID": "PCHIAW_minimized.pdb_971", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "725.86", " logP": "-0.91", " logD": "-5.46", " logSw": "-2.68", " tPSA": "285.51", " RotatableB": "18", " RigidB": "31", " Flexibility": "0.37", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "49532.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 725.857", "link_html_complex": "/ACE_complex_html/ACE_PCHIAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PCHIAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PCHIAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PCHIAW.png", "phi_psi": "/peptide_da/PCHIAW.pdb", "link_html_peptide": "/Peptide_html/PCHIAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PCHIAW.pdb", "link_png_peptide": "/Peptide_pics/PCHIAW.png"}
{"Peptide_Sequence": "PDHIAW", " Origin": "Fish (Tuna (Neothunnus macropterus muscle))", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-11.1", "Serial_ID": "972", " Ligand_ID": "PDHIAW_minimized.pdb_972", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "737.8", " logP": "-1.7", " logD": "-7.42", " logSw": "-2.19", " tPSA": "286.84", " RotatableB": "19", " RigidB": "32", " Flexibility": "0.37", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "82327.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 737.803", "link_html_complex": "/ACE_complex_html/ACE_PDHIAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PDHIAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PDHIAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PDHIAW.png", "phi_psi": "/peptide_da/PDHIAW.pdb", "link_html_peptide": "/Peptide_html/PDHIAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PDHIAW.pdb", "link_png_peptide": "/Peptide_pics/PDHIAW.png"}
{"Peptide_Sequence": "PDLVF", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "84.9", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "973", " Ligand_ID": "PDLVF_minimized.pdb_973", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "589.68", " logP": "-1.41", " logD": "-5.65", " logSw": "-1.6", " tPSA": "213.27", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "118584.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 589.68", "link_html_complex": "/ACE_complex_html/ACE_PDLVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PDLVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PDLVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PDLVF.png", "phi_psi": "/peptide_da/PDLVF.pdb", "link_html_peptide": "/Peptide_html/PDLVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PDLVF.pdb", "link_png_peptide": "/Peptide_pics/PDLVF.png"}
{"Peptide_Sequence": "PEAAELMMEVDP", " Origin": "Fish muscle proteins", " Peptide_Preparation": "", " Isolation_Method": "IEC, RP-HPLC, ", " ACE_inhibition_assay": "Cushman and Cheung (1971), Yamamoto and others", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Ketnawa, S., and S. Rawdkuen. \"Angiotensin converting enzyme inhibitory peptides from aquatic and their processing by-Products: A review.\" Int. J. Sci. Innov. Discov 2 (2013): 185-199.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "974", " Ligand_ID": "PEAAELMMEVDP_minimized.pdb_974", " Smiles": "CSCC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1331.51", " logP": "-3.69", " logD": "-20.93", " logSw": "-3", " tPSA": "579.17", " RotatableB": "42", " RigidB": "37", " Flexibility": "0.53", " HBD": "16", " HBA": "33", " HBD_HBA": "49", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "-4", " HeavyAtoms": "91", " CarbonAtoms": "56", " HeteroAtoms": "35", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "66380.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1331.51", "link_html_complex": "/ACE_complex_html/ACE_PEAAELMMEVDP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PEAAELMMEVDP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PEAAELMMEVDP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PEAAELMMEVDP.png", "phi_psi": "/peptide_da/PEAAELMMEVDP.pdb", "link_html_peptide": "/Peptide_html/PEAAELMMEVDP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PEAAELMMEVDP.pdb", "link_png_peptide": "/Peptide_pics/PEAAELMMEVDP.png"}
{"Peptide_Sequence": "PER", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "975", " Ligand_ID": "PER_minimized.pdb_975", " Smiles": "NC(=N)NCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "400.43", " logP": "-5.62", " logD": "-8.95", " logSw": "2.08", " tPSA": "218.71", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3192222.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.43", "link_html_complex": "/ACE_complex_html/ACE_PER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PER.png", "phi_psi": "/peptide_da/PER.pdb", "link_html_peptide": "/Peptide_html/PER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PER.pdb", "link_png_peptide": "/Peptide_pics/PER.png"}
{"Peptide_Sequence": "PEW", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "976", " Ligand_ID": "PEW_minimized.pdb_976", " Smiles": "OC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "430.45", " logP": "-2.27", " logD": "-6.7", " logSw": "-0.54", " tPSA": "170.86", " RotatableB": "10", " RigidB": "21", " Flexibility": "0.32", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "31", " CarbonAtoms": "21", " HeteroAtoms": "10", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "251963", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 430.454", "link_html_complex": "/ACE_complex_html/ACE_PEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PEW.png", "phi_psi": "/peptide_da/PEW.pdb", "link_html_peptide": "/Peptide_html/PEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PEW.pdb", "link_png_peptide": "/Peptide_pics/PEW.png"}
{"Peptide_Sequence": "PFFDPQIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "410", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "977", " Ligand_ID": "PFFDPQIP_minimized.pdb_977", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "960.08", " logP": "-1.06", " logD": "-9.18", " logSw": "-3.61", " tPSA": "326.08", " RotatableB": "24", " RigidB": "45", " Flexibility": "0.35", " HBD": "10", " HBA": "21", " HBD_HBA": "31", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "69", " CarbonAtoms": "48", " HeteroAtoms": "21", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "26050.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 960.083", "link_html_complex": "/ACE_complex_html/ACE_PFFDPQIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PFFDPQIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PFFDPQIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PFFDPQIP.png", "phi_psi": "/peptide_da/PFFDPQIP.pdb", "link_html_peptide": "/Peptide_html/PFFDPQIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PFFDPQIP.pdb", "link_png_peptide": "/Peptide_pics/PFFDPQIP.png"}
{"Peptide_Sequence": "PFP", " Origin": "Manchego cheese", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "144 \u03bcM", " Reference": "El-Salam, MH Abd, and S. El-Shibiny. \"Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products.\" Food Reviews International 29.1 (2013): 1-23.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "980", " Ligand_ID": "PFP_minimized.pdb_980", " Smiles": "OC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1", " MW": "359.42", " logP": "-0.85", " logD": "-3.44", " logSw": "-1.22", " tPSA": "106.15", " RotatableB": "6", " RigidB": "21", " Flexibility": "0.22", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "19", " HeteroAtoms": "7", " ratio_H_by_C": "0.37", " Lipinski_Violation": "0", " Solubility_mg_per_l": "105692.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 359.42", "link_html_complex": "/ACE_complex_html/ACE_PFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PFP.png", "phi_psi": "/peptide_da/PFP.pdb", "link_html_peptide": "/Peptide_html/PFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PFP.pdb", "link_png_peptide": "/Peptide_pics/PFP.png"}
{"Peptide_Sequence": "PFPE", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "978", " Ligand_ID": "PFPE_minimized.pdb_978", " Smiles": "OC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "488.53", " logP": "-1.74", " logD": "-8.88", " logSw": "-1.11", " tPSA": "175.38", " RotatableB": "11", " RigidB": "24", " Flexibility": "0.31", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "35", " CarbonAtoms": "24", " HeteroAtoms": "11", " ratio_H_by_C": "0.46", " Lipinski_Violation": "1", " Solubility_mg_per_l": "160522.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 488.534", "link_html_complex": "/ACE_complex_html/ACE_PFPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PFPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PFPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PFPE.png", "phi_psi": "/peptide_da/PFPE.pdb", "link_html_peptide": "/Peptide_html/PFPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PFPE.pdb", "link_png_peptide": "/Peptide_pics/PFPE.png"}
{"Peptide_Sequence": "PFPEVFGK", " Origin": "bovine \u03b1S1-casein", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": " Paul and Van Hekken (2011)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "108 \u03bcM", " Reference": "Paul, Moushumi, John G. Phillips, and John A. Renye Jr. \"Measuring the angiotensin-converting enzyme inhibitory activity of an 8-amino acid (8mer) fragment of the C12 antihypertensive peptide.\" Journal of dairy science 99.5 (2016): 3263-3266.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "979", " Ligand_ID": "PFPEVFGK_minimized.pdb_979", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "920.06", " logP": "-3.12", " logD": "-6.71", " logSw": "-1.93", " tPSA": "319.42", " RotatableB": "26", " RigidB": "38", " Flexibility": "0.41", " HBD": "11", " HBA": "20", " HBD_HBA": "31", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "66", " CarbonAtoms": "46", " HeteroAtoms": "20", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "133469.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 920.062", "link_html_complex": "/ACE_complex_html/ACE_PFPEVFGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PFPEVFGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PFPEVFGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PFPEVFGK.png", "phi_psi": "/peptide_da/PFPEVFGK.pdb", "link_html_peptide": "/Peptide_html/PFPEVFGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PFPEVFGK.pdb", "link_png_peptide": "/Peptide_pics/PFPEVFGK.png"}
{"Peptide_Sequence": "PG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "17000 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.6", "Serial_ID": "982", " Ligand_ID": "PG_minimized.pdb_982", " Smiles": "OC(=O)CNC(=O)[C@@H]1CCCN1", " MW": "172.18", " logP": "-3.81", " logD": "-4.12", " logSw": "1.69", " tPSA": "85.84", " RotatableB": "3", " RigidB": "8", " Flexibility": "0.27", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "7", " HeteroAtoms": "5", " ratio_H_by_C": "0.71", " Lipinski_Violation": "0", " Solubility_mg_per_l": "933857.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 172.182", "link_html_complex": "/ACE_complex_html/ACE_PG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PG.png", "phi_psi": "/peptide_da/PG.pdb", "link_html_peptide": "/Peptide_html/PG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PG.pdb", "link_png_peptide": "/Peptide_pics/PG.png"}
{"Peptide_Sequence": "PGL", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "13.93 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "981", " Ligand_ID": "PGL_minimized.pdb_981", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "285.34", " logP": "-3.06", " logD": "-4.68", " logSw": "0.78", " tPSA": "114.94", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "622893.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_PGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PGL.png", "phi_psi": "/peptide_da/PGL.pdb", "link_html_peptide": "/Peptide_html/PGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PGL.pdb", "link_png_peptide": "/Peptide_pics/PGL.png"}
{"Peptide_Sequence": "PGPIP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Hayes, Maria, et al. \"Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview.\" Biotechnology Journal: Healthcare Nutrition Technology 2.4 (2007): 426-434.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "983", " Ligand_ID": "PGPIP_minimized.pdb_983", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "479.57", " logP": "-1.85", " logD": "-6.38", " logSw": "-1.05", " tPSA": "155.56", " RotatableB": "9", " RigidB": "24", " Flexibility": "0.27", " HBD": "4", " HBA": "11", " HBD_HBA": "15", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "167177.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 479.57", "link_html_complex": "/ACE_complex_html/ACE_PGPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PGPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PGPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PGPIP.png", "phi_psi": "/peptide_da/PGPIP.pdb", "link_html_peptide": "/Peptide_html/PGPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PGPIP.pdb", "link_png_peptide": "/Peptide_pics/PGPIP.png"}
{"Peptide_Sequence": "PGPLGLTGP", " Origin": "Fish (Skate skin)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "95 \u03bcM", " Reference": "He, Hai-Lun, Dan Liu, and Chang-Bei Ma. \"Review on the angiotensin-I-converting enzyme (ACE) inhibitor peptides from marine proteins.\" Applied biochemistry and biotechnology 169.3 (2013): 738-749.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "984", " Ligand_ID": "PGPLGLTGP_minimized.pdb_984", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "807.93", " logP": "-2.96", " logD": "-9.19", " logSw": "-1.66", " tPSA": "292.19", " RotatableB": "20", " RigidB": "32", " Flexibility": "0.38", " HBD": "9", " HBA": "20", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "152946.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 807.934", "link_html_complex": "/ACE_complex_html/ACE_PGPLGLTGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PGPLGLTGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PGPLGLTGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PGPLGLTGP.png", "phi_psi": "/peptide_da/PGPLGLTGP.pdb", "link_html_peptide": "/Peptide_html/PGPLGLTGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PGPLGLTGP.pdb", "link_png_peptide": "/Peptide_pics/PGPLGLTGP.png"}
{"Peptide_Sequence": "PGR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "985", " Ligand_ID": "PGR_minimized.pdb_985", " Smiles": "NC(=N)NCCC[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "328.37", " logP": "-5.21", " logD": "-7.58", " logSw": "2.07", " tPSA": "178.58", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2592959.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 328.367", "link_html_complex": "/ACE_complex_html/ACE_PGR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PGR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PGR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PGR.png", "phi_psi": "/peptide_da/PGR.pdb", "link_html_peptide": "/Peptide_html/PGR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PGR.pdb", "link_png_peptide": "/Peptide_pics/PGR.png"}
{"Peptide_Sequence": "PGTAVFK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "26.5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "986", " Ligand_ID": "PGTAVFK_minimized.pdb_986", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "718.84", " logP": "-2.59", " logD": "-7.22", " logSw": "-1.32", " tPSA": "279.21", " RotatableB": "21", " RigidB": "24", " Flexibility": "0.47", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "191759.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 718.841", "link_html_complex": "/ACE_complex_html/ACE_PGTAVFK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PGTAVFK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PGTAVFK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PGTAVFK.png", "phi_psi": "/peptide_da/PGTAVFK.pdb", "link_html_peptide": "/Peptide_html/PGTAVFK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PGTAVFK.pdb", "link_png_peptide": "/Peptide_pics/PGTAVFK.png"}
{"Peptide_Sequence": "PHA", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "987", " Ligand_ID": "PHA_minimized.pdb_987", " Smiles": "C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "323.35", " logP": "-3.11", " logD": "-5.83", " logSw": "0.49", " tPSA": "143.62", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "529102.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 323.348", "link_html_complex": "/ACE_complex_html/ACE_PHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PHA.png", "phi_psi": "/peptide_da/PHA.pdb", "link_html_peptide": "/Peptide_html/PHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PHA.pdb", "link_png_peptide": "/Peptide_pics/PHA.png"}
{"Peptide_Sequence": "PHQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "30", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "988", " Ligand_ID": "PHQIYP_minimized.pdb_988", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "753.85", " logP": "-2.17", " logD": "-6.97", " logSw": "-1.97", " tPSA": "285.45", " RotatableB": "19", " RigidB": "34", " Flexibility": "0.36", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "36", " HeteroAtoms": "18", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "105101.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 753.845", "link_html_complex": "/ACE_complex_html/ACE_PHQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PHQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PHQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PHQIYP.png", "phi_psi": "/peptide_da/PHQIYP.pdb", "link_html_peptide": "/Peptide_html/PHQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PHQIYP.pdb", "link_png_peptide": "/Peptide_pics/PHQIYP.png"}
{"Peptide_Sequence": "PIW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "590 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "989", " Ligand_ID": "PIW_minimized.pdb_989", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "414.5", " logP": "-0.23", " logD": "-2.27", " logSw": "-1.78", " tPSA": "130.73", " RotatableB": "9", " RigidB": "20", " Flexibility": "0.31", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "22", " HeteroAtoms": "8", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "69761.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 414.498", "link_html_complex": "/ACE_complex_html/ACE_PIW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PIW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PIW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PIW.png", "phi_psi": "/peptide_da/PIW.pdb", "link_html_peptide": "/Peptide_html/PIW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PIW.pdb", "link_png_peptide": "/Peptide_pics/PIW.png"}
{"Peptide_Sequence": "PKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "185", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "990", " Ligand_ID": "PKAIP_minimized.pdb_990", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "524.65", " logP": "-1.99", " logD": "-8.78", " logSw": "-0.92", " tPSA": "191.99", " RotatableB": "14", " RigidB": "19", " Flexibility": "0.42", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "25", " HeteroAtoms": "12", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "210100.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 524.653", "link_html_complex": "/ACE_complex_html/ACE_PKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PKAIP.png", "phi_psi": "/peptide_da/PKAIP.pdb", "link_html_peptide": "/Peptide_html/PKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PKAIP.pdb", "link_png_peptide": "/Peptide_pics/PKAIP.png"}
{"Peptide_Sequence": "PKDLREN", " Origin": "P-CN", " Peptide_Preparation": "", " Isolation_Method": "UF, HPLC", " ACE_inhibition_assay": "HPLC method by Mao et al., 2007", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.8 \u03bcM", " Reference": "Chen, Y., et al. \"Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk.\" Journal of dairy science 93.3 (2010): 884-892.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "991", " Ligand_ID": "PKDLREN_minimized.pdb_991", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "870.95", " logP": "-8.8", " logD": "-19.1", " logSw": "2.35", " tPSA": "445.97", " RotatableB": "31", " RigidB": "23", " Flexibility": "0.57", " HBD": "18", " HBA": "25", " HBD_HBA": "43", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "36", " HeteroAtoms": "25", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9133407.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 870.95", "link_html_complex": "/ACE_complex_html/ACE_PKDLREN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PKDLREN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PKDLREN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PKDLREN.png", "phi_psi": "/peptide_da/PKDLREN.pdb", "link_html_peptide": "/Peptide_html/PKDLREN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PKDLREN.pdb", "link_png_peptide": "/Peptide_pics/PKDLREN.png"}
{"Peptide_Sequence": "PKHKEMPFPPKYPVEPFT", " Origin": "Casein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Phelan, Martha, and David Kerins. \"The potential role of milk-derived peptides in cardiovascular disease.\" Food & function 2.3-4 (2011): 153-167.", " Binding_Energy_kcal_per_mol": "-", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": "#", "link_html_complex": "/ACE_complex_html/ACE_PKHKEMPFPPKYPVEPFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PKHKEMPFPPKYPVEPFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PKHKEMPFPPKYPVEPFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PKHKEMPFPPKYPVEPFT.png", "phi_psi": "#", "link_html_peptide": "/Peptide_html/PKHKEMPFPPKYPVEPFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PKHKEMPFPPKYPVEPFT.pdb", "link_png_peptide": "/Peptide_pics/PKHKEMPFPPKYPVEPFT.png"}
{"Peptide_Sequence": "PKHP", " Origin": " Roncal  cheese", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "709 \u03bcM", " Reference": "El-Salam, MH Abd, and S. El-Shibiny. \"Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products.\" Food Reviews International 29.1 (2013): 1-23.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "993", " Ligand_ID": "PKHP_minimized.pdb_993", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "477.56", " logP": "-3.9", " logD": "-9.9", " logSw": "0.39", " tPSA": "191.57", " RotatableB": "12", " RigidB": "22", " Flexibility": "0.35", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "708539.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 477.557", "link_html_complex": "/ACE_complex_html/ACE_PKHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PKHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PKHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PKHP.png", "phi_psi": "/peptide_da/PKHP.pdb", "link_html_peptide": "/Peptide_html/PKHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PKHP.pdb", "link_png_peptide": "/Peptide_pics/PKHP.png"}
{"Peptide_Sequence": "PKIDAMREKVLA", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "103 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "994", " Ligand_ID": "PKIDAMREKVLA_minimized.pdb_994", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O", " MW": "1370.66", " logP": "-8.14", " logD": "-23.5", " logSw": "0.02", " tPSA": "601.32", " RotatableB": "49", " RigidB": "31", " Flexibility": "0.61", " HBD": "23", " HBA": "34", " HBD_HBA": "57", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "7", " TotalCharge": "1", " HeavyAtoms": "95", " CarbonAtoms": "60", " HeteroAtoms": "35", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1404103.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1370.66", "link_html_complex": "/ACE_complex_html/ACE_PKIDAMREKVLA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PKIDAMREKVLA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PKIDAMREKVLA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PKIDAMREKVLA.png", "phi_psi": "/peptide_da/PKIDAMREKVLA.pdb", "link_html_peptide": "/Peptide_html/PKIDAMREKVLA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PKIDAMREKVLA.pdb", "link_png_peptide": "/Peptide_pics/PKIDAMREKVLA.png"}
{"Peptide_Sequence": "PL", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "337.3 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "998", " Ligand_ID": "PL_minimized.pdb_998", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "228.29", " logP": "-2.41", " logD": "-2.3", " logSw": "0.59", " tPSA": "85.84", " RotatableB": "5", " RigidB": "8", " Flexibility": "0.38", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "11", " HeteroAtoms": "5", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "413030.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 228.288", "link_html_complex": "/ACE_complex_html/ACE_PL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PL.png", "phi_psi": "/peptide_da/PL.pdb", "link_html_peptide": "/Peptide_html/PL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PL.pdb", "link_png_peptide": "/Peptide_pics/PL.png"}
{"Peptide_Sequence": "PLFPK", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "995", " Ligand_ID": "PLFPK_minimized.pdb_995", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "600.75", " logP": "-0.4", " logD": "-4.3", " logSw": "-2.31", " tPSA": "191.99", " RotatableB": "16", " RigidB": "25", " Flexibility": "0.39", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "31", " HeteroAtoms": "12", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "59903.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 600.749", "link_html_complex": "/ACE_complex_html/ACE_PLFPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLFPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLFPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLFPK.png", "phi_psi": "/peptide_da/PLFPK.pdb", "link_html_peptide": "/Peptide_html/PLFPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLFPK.pdb", "link_png_peptide": "/Peptide_pics/PLFPK.png"}
{"Peptide_Sequence": "PLG", " Origin": "FIsh Alaska pollack (Theragra chalcogramma)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "4.74 \u03bcM", " Reference": "Byun, Hee-Guk, and Se-Kwon Kim. \"Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin.\" BMB Reports 35.2 (2002): 239-243.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "996", " Ligand_ID": "PLG_minimized.pdb_996", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(O)=O", " MW": "285.34", " logP": "-3.06", " logD": "-4.68", " logSw": "0.78", " tPSA": "114.94", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "622893.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_PLG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLG.png", "phi_psi": "/peptide_da/PLG.pdb", "link_html_peptide": "/Peptide_html/PLG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLG.pdb", "link_png_peptide": "/Peptide_pics/PLG.png"}
{"Peptide_Sequence": "PLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.4", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "997", " Ligand_ID": "PLIYP_minimized.pdb_997", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "601.73", " logP": "0.8", " logD": "-3.53", " logSw": "-3.2", " tPSA": "184.58", " RotatableB": "14", " RigidB": "25", " Flexibility": "0.36", " HBD": "6", " HBA": "12", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "31", " HeteroAtoms": "12", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "24525.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 601.734", "link_html_complex": "/ACE_complex_html/ACE_PLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLIYP.png", "phi_psi": "/peptide_da/PLIYP.pdb", "link_html_peptide": "/Peptide_html/PLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLIYP.pdb", "link_png_peptide": "/Peptide_pics/PLIYP.png"}
{"Peptide_Sequence": "PLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "430", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1000", " Ligand_ID": "PLP_minimized.pdb_1000", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "325.4", " logP": "-2.27", " logD": "-3.84", " logSw": "-0.03", " tPSA": "106.15", " RotatableB": "6", " RigidB": "15", " Flexibility": "0.29", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "315344.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 325.403", "link_html_complex": "/ACE_complex_html/ACE_PLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLP.png", "phi_psi": "/peptide_da/PLP.pdb", "link_html_peptide": "/Peptide_html/PLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLP.pdb", "link_png_peptide": "/Peptide_pics/PLP.png"}
{"Peptide_Sequence": "PLPLL", " Origin": "Milk (Yak milk casein)", " Peptide_Preparation": "", " Isolation_Method": "UF, GF, HPLC, LC-MS, LC-ESI-MS/MS", " ACE_inhibition_assay": "HPLC with Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.25 mg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "999", " Ligand_ID": "PLPLL_minimized.pdb_999", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "551.72", " logP": "-0.54", " logD": "-3.6", " logSw": "-2", " tPSA": "164.35", " RotatableB": "14", " RigidB": "19", " Flexibility": "0.42", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "28", " HeteroAtoms": "11", " ratio_H_by_C": "0.39", " Lipinski_Violation": "2", " Solubility_mg_per_l": "74932.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 551.718", "link_html_complex": "/ACE_complex_html/ACE_PLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLPLL.png", "phi_psi": "/peptide_da/PLPLL.pdb", "link_html_peptide": "/Peptide_html/PLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLPLL.pdb", "link_png_peptide": "/Peptide_pics/PLPLL.png"}
{"Peptide_Sequence": "PLW", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "36 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1001", " Ligand_ID": "PLW_minimized.pdb_1001", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "414.5", " logP": "-0.35", " logD": "-2.35", " logSw": "-1.71", " tPSA": "130.73", " RotatableB": "9", " RigidB": "20", " Flexibility": "0.31", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "22", " HeteroAtoms": "8", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "75239.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 414.498", "link_html_complex": "/ACE_complex_html/ACE_PLW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PLW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PLW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PLW.png", "phi_psi": "/peptide_da/PLW.pdb", "link_html_peptide": "/Peptide_html/PLW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PLW.pdb", "link_png_peptide": "/Peptide_pics/PLW.png"}
{"Peptide_Sequence": "PNNKPFQ", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "33 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1002", " Ligand_ID": "PNNKPFQ_minimized.pdb_1002", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "843.93", " logP": "-6.43", " logD": "-13.69", " logSw": "0.46", " tPSA": "379.46", " RotatableB": "23", " RigidB": "35", " Flexibility": "0.4", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "60", " CarbonAtoms": "38", " HeteroAtoms": "22", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1334982.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 843.926", "link_html_complex": "/ACE_complex_html/ACE_PNNKPFQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PNNKPFQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PNNKPFQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PNNKPFQ.png", "phi_psi": "/peptide_da/PNNKPFQ.pdb", "link_html_peptide": "/Peptide_html/PNNKPFQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PNNKPFQ.pdb", "link_png_peptide": "/Peptide_pics/PNNKPFQ.png"}
{"Peptide_Sequence": "PNRIKYGD", " Origin": "bonito muscle", " Peptide_Preparation": "artificial gastric juice ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifi-cation", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4 \u03bcM", " Reference": "Hasan, Fida, et al. \"Production kinetics of angiotensin-I converting enzyme inhibitory peptides from bonito meat in artificial gastric juice.\" Process Biochemistry 41.3 (2006): 505-511.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1003", " Ligand_ID": "PNRIKYGD_minimized.pdb_1003", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "962.06", " logP": "-7.71", " logD": "-18.07", " logSw": "1.13", " tPSA": "455.17", " RotatableB": "32", " RigidB": "30", " Flexibility": "0.52", " HBD": "19", " HBA": "26", " HBD_HBA": "45", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "68", " CarbonAtoms": "42", " HeteroAtoms": "26", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2983082.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 962.061", "link_html_complex": "/ACE_complex_html/ACE_PNRIKYGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PNRIKYGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PNRIKYGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PNRIKYGD.png", "phi_psi": "/peptide_da/PNRIKYGD.pdb", "link_html_peptide": "/Peptide_html/PNRIKYGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PNRIKYGD.pdb", "link_png_peptide": "/Peptide_pics/PNRIKYGD.png"}
{"Peptide_Sequence": "PNSHP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1004", " Ligand_ID": "PNSHP_minimized.pdb_1004", " Smiles": "NC(=O)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "550.56", " logP": "-5.88", " logD": "-10.1", " logSw": "1.26", " tPSA": "256.35", " RotatableB": "13", " RigidB": "26", " Flexibility": "0.33", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "23", " HeteroAtoms": "16", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1937507.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 550.565", "link_html_complex": "/ACE_complex_html/ACE_PNSHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PNSHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PNSHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PNSHP.png", "phi_psi": "/peptide_da/PNSHP.pdb", "link_html_peptide": "/Peptide_html/PNSHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PNSHP.pdb", "link_png_peptide": "/Peptide_pics/PNSHP.png"}
{"Peptide_Sequence": "PP", " Origin": "egg, ovotransferrin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1009", " Ligand_ID": "PP_minimized.pdb_1009", " Smiles": "OC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1", " MW": "212.25", " logP": "-2.32", " logD": "-3.28", " logSw": "0.44", " tPSA": "77.05", " RotatableB": "2", " RigidB": "13", " Flexibility": "0.13", " HBD": "2", " HBA": "5", " HBD_HBA": "7", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "10", " HeteroAtoms": "5", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "328790.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 212.246", "link_html_complex": "/ACE_complex_html/ACE_PP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PP.png", "phi_psi": "/peptide_da/PP.pdb", "link_html_peptide": "/Peptide_html/PP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PP.pdb", "link_png_peptide": "/Peptide_pics/PP.png"}
{"Peptide_Sequence": "PPEIN", " Origin": "Milk (Yak milk casein)", " Peptide_Preparation": "", " Isolation_Method": "UF, GF, HPLC, LC-MS, LC-ESI-MS/MS", " ACE_inhibition_assay": "HPLC with Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.29 mg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1005", " Ligand_ID": "PPEIN_minimized.pdb_1005", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "568.62", " logP": "-3.79", " logD": "-11", " logSw": "0.01", " tPSA": "247.57", " RotatableB": "15", " RigidB": "22", " Flexibility": "0.41", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "575632.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 568.62", "link_html_complex": "/ACE_complex_html/ACE_PPEIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPEIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPEIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPEIN.png", "phi_psi": "/peptide_da/PPEIN.pdb", "link_html_peptide": "/Peptide_html/PPEIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPEIN.pdb", "link_png_peptide": "/Peptide_pics/PPEIN.png"}
{"Peptide_Sequence": "PPHQIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "22", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1006", " Ligand_ID": "PPHQIYP_minimized.pdb_1006", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "850.96", " logP": "-2.12", " logD": "-7.24", " logSw": "-2.53", " tPSA": "305.76", " RotatableB": "20", " RigidB": "41", " Flexibility": "0.33", " HBD": "10", " HBA": "20", " HBD_HBA": "30", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "41", " HeteroAtoms": "20", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67870.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 850.96", "link_html_complex": "/ACE_complex_html/ACE_PPHQIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPHQIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPHQIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPHQIYP.png", "phi_psi": "/peptide_da/PPHQIYP.pdb", "link_html_peptide": "/Peptide_html/PPHQIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPHQIYP.pdb", "link_png_peptide": "/Peptide_pics/PPHQIYP.png"}
{"Peptide_Sequence": "PPK", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": ">1000", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1007", " Ligand_ID": "PPK_minimized.pdb_1007", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(O)=O", " MW": "340.42", " logP": "-2.8", " logD": "-6.15", " logSw": "0.34", " tPSA": "133.79", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "478943.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 340.418", "link_html_complex": "/ACE_complex_html/ACE_PPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPK.png", "phi_psi": "/peptide_da/PPK.pdb", "link_html_peptide": "/Peptide_html/PPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPK.pdb", "link_png_peptide": "/Peptide_pics/PPK.png"}
{"Peptide_Sequence": "PPL", " Origin": "Milk ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Vercruysse, Lieselot, et al. \"Ala-Val-Phe and Val-Phe: ACE inhibitory peptides derived from insect protein with antihypertensive activity in spontaneously hypertensive rats.\" Peptides 31.3 (2010): 482-488.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1008", " Ligand_ID": "PPL_minimized.pdb_1008", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(O)=O", " MW": "325.4", " logP": "-2.25", " logD": "-3.84", " logSw": "-0.04", " tPSA": "106.15", " RotatableB": "6", " RigidB": "15", " Flexibility": "0.29", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "311395.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 325.403", "link_html_complex": "/ACE_complex_html/ACE_PPL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPL.png", "phi_psi": "/peptide_da/PPL.pdb", "link_html_peptide": "/Peptide_html/PPL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPL.pdb", "link_png_peptide": "/Peptide_pics/PPL.png"}
{"Peptide_Sequence": "PPP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "1.86", " Reference": "Wang, Xiaoyu, et al. \"QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors.\" Journal of molecular modeling 17.7 (2011): 1599-1606.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1010", " Ligand_ID": "PPP_minimized.pdb_1010", " Smiles": "OC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1", " MW": "309.36", " logP": "-2.26", " logD": "-4.82", " logSw": "-0.14", " tPSA": "97.36", " RotatableB": "3", " RigidB": "20", " Flexibility": "0.13", " HBD": "2", " HBA": "7", " HBD_HBA": "9", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "15", " HeteroAtoms": "7", " ratio_H_by_C": "0.47", " Lipinski_Violation": "0", " Solubility_mg_per_l": "269959.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 309.361", "link_html_complex": "/ACE_complex_html/ACE_PPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPP.png", "phi_psi": "/peptide_da/PPP.pdb", "link_html_peptide": "/Peptide_html/PPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPP.pdb", "link_png_peptide": "/Peptide_pics/PPP.png"}
{"Peptide_Sequence": "PPPVHL", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "110", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1011", " Ligand_ID": "PPPVHL_minimized.pdb_1011", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(C)C)C(O)=O", " MW": "658.79", " logP": "-0.97", " logD": "-5.91", " logSw": "-2.43", " tPSA": "213.34", " RotatableB": "14", " RigidB": "31", " Flexibility": "0.31", " HBD": "6", " HBA": "15", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "58140.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 658.789", "link_html_complex": "/ACE_complex_html/ACE_PPPVHL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPPVHL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPPVHL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPPVHL.png", "phi_psi": "/peptide_da/PPPVHL.pdb", "link_html_peptide": "/Peptide_html/PPPVHL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPPVHL.pdb", "link_png_peptide": "/Peptide_pics/PPPVHL.png"}
{"Peptide_Sequence": "PPQSVLSLSQSKVLPVPQ", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "25 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "3.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1904.21", "link_html_complex": "/ACE_complex_html/ACE_PPQSVLSLSQSKVLPVPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PPQSVLSLSQSKVLPVPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PPQSVLSLSQSKVLPVPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PPQSVLSLSQSKVLPVPQ.png", "phi_psi": "/peptide_da/PPQSVLSLSQSKVLPVPQ.pdb", "link_html_peptide": "/Peptide_html/PPQSVLSLSQSKVLPVPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PPQSVLSLSQSKVLPVPQ.pdb", "link_png_peptide": "/Peptide_pics/PPQSVLSLSQSKVLPVPQ.png"}
{"Peptide_Sequence": "PQ", " Origin": "procine skeletal muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Castellano, Patricia, et al. \"Peptides with angiotensin I converting enzyme (ACE) inhibitory activity generated from porcine skeletal muscle proteins by the action of meat-borne Lactobacillus.\" Journal of proteomics 89 (2013): 183-190.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "1015", " Ligand_ID": "PQ_minimized.pdb_1015", " Smiles": "NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "243.26", " logP": "-4.89", " logD": "-4.71", " logSw": "2.13", " tPSA": "128.93", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "2043909.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.26", "link_html_complex": "/ACE_complex_html/ACE_PQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQ.png", "phi_psi": "/peptide_da/PQ.pdb", "link_html_peptide": "/Peptide_html/PQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQ.pdb", "link_png_peptide": "/Peptide_pics/PQ.png"}
{"Peptide_Sequence": "PQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "300", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1013", " Ligand_ID": "PQAFP_minimized.pdb_1013", " Smiles": "C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "558.63", " logP": "-2.65", " logD": "-6.89", " logSw": "-0.83", " tPSA": "207.44", " RotatableB": "13", " RigidB": "27", " Flexibility": "0.33", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "242881.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 558.627", "link_html_complex": "/ACE_complex_html/ACE_PQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQAFP.png", "phi_psi": "/peptide_da/PQAFP.pdb", "link_html_peptide": "/Peptide_html/PQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQAFP.pdb", "link_png_peptide": "/Peptide_pics/PQAFP.png"}
{"Peptide_Sequence": "PQEVLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "910", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1014", " Ligand_ID": "PQEVLP_minimized.pdb_1014", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "681.78", " logP": "-2.72", " logD": "-10.4", " logSw": "-1.1", " tPSA": "276.67", " RotatableB": "19", " RigidB": "24", " Flexibility": "0.44", " HBD": "9", " HBA": "17", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "48", " CarbonAtoms": "31", " HeteroAtoms": "17", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "227075.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 681.778", "link_html_complex": "/ACE_complex_html/ACE_PQEVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQEVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQEVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQEVLP.png", "phi_psi": "/peptide_da/PQEVLP.pdb", "link_html_peptide": "/Peptide_html/PQEVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQEVLP.pdb", "link_png_peptide": "/Peptide_pics/PQEVLP.png"}
{"Peptide_Sequence": "PQNILP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "440", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1016", " Ligand_ID": "PQNILP_minimized.pdb_1016", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "680.79", " logP": "-3.37", " logD": "-7.97", " logSw": "-0.75", " tPSA": "279.63", " RotatableB": "18", " RigidB": "25", " Flexibility": "0.42", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "31", " HeteroAtoms": "17", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "321643.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 680.793", "link_html_complex": "/ACE_complex_html/ACE_PQNILP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQNILP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQNILP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQNILP.png", "phi_psi": "/peptide_da/PQNILP.pdb", "link_html_peptide": "/Peptide_html/PQNILP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQNILP.pdb", "link_png_peptide": "/Peptide_pics/PQNILP.png"}
{"Peptide_Sequence": "PQPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "340", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1017", " Ligand_ID": "PQPIP_minimized.pdb_1017", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "550.65", " logP": "-2.61", " logD": "-6.97", " logSw": "-0.82", " tPSA": "198.65", " RotatableB": "12", " RigidB": "26", " Flexibility": "0.32", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "243077.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 550.648", "link_html_complex": "/ACE_complex_html/ACE_PQPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQPIP.png", "phi_psi": "/peptide_da/PQPIP.pdb", "link_html_peptide": "/Peptide_html/PQPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQPIP.pdb", "link_png_peptide": "/Peptide_pics/PQPIP.png"}
{"Peptide_Sequence": "PQPLIYP", " Origin": "Synthetic peptides of human beta-casein", " Peptide_Preparation": "The liquid phase method", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3", " Reference": "Li, G.-H., Le, G.-W., Shi, Y.-H., & Shrestha, S. (2004). Angiotensin I\u2013converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research, 24(7), 469\u2013486. doi:10.1016/j.nutres.2003.10.014", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1018", " Ligand_ID": "PQPLIYP_minimized.pdb_1018", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "826.98", " logP": "-0.56", " logD": "-5.49", " logSw": "-3.33", " tPSA": "277.08", " RotatableB": "20", " RigidB": "36", " Flexibility": "0.36", " HBD": "9", " HBA": "18", " HBD_HBA": "27", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "41", " HeteroAtoms": "18", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "29565.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 826.979", "link_html_complex": "/ACE_complex_html/ACE_PQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQPLIYP.png", "phi_psi": "/peptide_da/PQPLIYP.pdb", "link_html_peptide": "/Peptide_html/PQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/PQPLIYP.png"}
{"Peptide_Sequence": "PQR", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">400 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1019", " Ligand_ID": "PQR_minimized.pdb_1019", " Smiles": "NC(=O)CC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "399.45", " logP": "-6.27", " logD": "-8.17", " logSw": "2.49", " tPSA": "221.67", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "16", " HeteroAtoms": "12", " ratio_H_by_C": "0.75", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4825240", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 399.445", "link_html_complex": "/ACE_complex_html/ACE_PQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQR.png", "phi_psi": "/peptide_da/PQR.pdb", "link_html_peptide": "/Peptide_html/PQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQR.pdb", "link_png_peptide": "/Peptide_pics/PQR.png"}
{"Peptide_Sequence": "PQTLALP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "110", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1020", " Ligand_ID": "PQTLALP_minimized.pdb_1020", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "738.87", " logP": "-2.72", " logD": "-7.7", " logSw": "-1.39", " tPSA": "285.87", " RotatableB": "20", " RigidB": "25", " Flexibility": "0.44", " HBD": "10", " HBA": "18", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "34", " HeteroAtoms": "18", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "184512.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 738.872", "link_html_complex": "/ACE_complex_html/ACE_PQTLALP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PQTLALP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PQTLALP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PQTLALP.png", "phi_psi": "/peptide_da/PQTLALP.pdb", "link_html_peptide": "/Peptide_html/PQTLALP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PQTLALP.pdb", "link_png_peptide": "/Peptide_pics/PQTLALP.png"}
{"Peptide_Sequence": "PR", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.1", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "1023", " Ligand_ID": "PR_minimized.pdb_1023", " Smiles": "NC(=N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "271.32", " logP": "-4.55", " logD": "-6.52", " logSw": "1.87", " tPSA": "149.48", " RotatableB": "8", " RigidB": "9", " Flexibility": "0.47", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1764503.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 271.316", "link_html_complex": "/ACE_complex_html/ACE_PR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PR.png", "phi_psi": "/peptide_da/PR.pdb", "link_html_peptide": "/Peptide_html/PR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PR.pdb", "link_png_peptide": "/Peptide_pics/PR.png"}
{"Peptide_Sequence": "PRHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "55", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1021", " Ligand_ID": "PRHQG_minimized.pdb_1021", " Smiles": "NC(=O)CC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1)C(=O)NCC(O)=O", " MW": "593.64", " logP": "-6", " logD": "-13.27", " logSw": "1.47", " tPSA": "308.55", " RotatableB": "19", " RigidB": "22", " Flexibility": "0.46", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "24", " HeteroAtoms": "18", " ratio_H_by_C": "0.75", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2576131.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 593.636", "link_html_complex": "/ACE_complex_html/ACE_PRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PRHQG.png", "phi_psi": "/peptide_da/PRHQG.pdb", "link_html_peptide": "/Peptide_html/PRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PRHQG.pdb", "link_png_peptide": "/Peptide_pics/PRHQG.png"}
{"Peptide_Sequence": "PRKEKLCTTS", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "142 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1022", " Ligand_ID": "PRKEKLCTTS_minimized.pdb_1022", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O", " MW": "1162.36", " logP": "-9.77", " logD": "-23.52", " logSw": "1.81", " tPSA": "577.18", " RotatableB": "41", " RigidB": "26", " Flexibility": "0.61", " HBD": "23", " HBA": "31", " HBD_HBA": "54", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "2", " HeavyAtoms": "80", " CarbonAtoms": "48", " HeteroAtoms": "32", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7134334.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1162.36", "link_html_complex": "/ACE_complex_html/ACE_PRKEKLCTTS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PRKEKLCTTS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PRKEKLCTTS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PRKEKLCTTS.png", "phi_psi": "/peptide_da/PRKEKLCTTS.pdb", "link_html_peptide": "/Peptide_html/PRKEKLCTTS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PRKEKLCTTS.pdb", "link_png_peptide": "/Peptide_pics/PRKEKLCTTS.png"}
{"Peptide_Sequence": "PRVF", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "110 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1024", " Ligand_ID": "PRVF_minimized.pdb_1024", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "517.62", " logP": "-1.9", " logD": "-7.88", " logSw": "-0.92", " tPSA": "207.68", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "25", " HeteroAtoms": "12", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "206143.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 517.621", "link_html_complex": "/ACE_complex_html/ACE_PRVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PRVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PRVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PRVF.png", "phi_psi": "/peptide_da/PRVF.pdb", "link_html_peptide": "/Peptide_html/PRVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PRVF.pdb", "link_png_peptide": "/Peptide_pics/PRVF.png"}
{"Peptide_Sequence": "PRY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.5", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1025", " Ligand_ID": "PRY_minimized.pdb_1025", " Smiles": "NC(=N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "434.49", " logP": "-3.5", " logD": "-7.17", " logSw": "0.39", " tPSA": "198.81", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "641975.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 434.489", "link_html_complex": "/ACE_complex_html/ACE_PRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PRY.png", "phi_psi": "/peptide_da/PRY.pdb", "link_html_peptide": "/Peptide_html/PRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PRY.pdb", "link_png_peptide": "/Peptide_pics/PRY.png"}
{"Peptide_Sequence": "PSFQP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "73", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1026", " Ligand_ID": "PSFQP_minimized.pdb_1026", " Smiles": "NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "574.63", " logP": "-3.7", " logD": "-7.99", " logSw": "-0.2", " tPSA": "227.67", " RotatableB": "14", " RigidB": "27", " Flexibility": "0.34", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "468640.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 574.626", "link_html_complex": "/ACE_complex_html/ACE_PSFQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSFQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSFQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSFQP.png", "phi_psi": "/peptide_da/PSFQP.pdb", "link_html_peptide": "/Peptide_html/PSFQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSFQP.pdb", "link_png_peptide": "/Peptide_pics/PSFQP.png"}
{"Peptide_Sequence": "PSFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.7", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1027", " Ligand_ID": "PSFQPQPLIYP_minimized.pdb_1027", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1286.47", " logP": "-1.9", " logD": "-7.92", " logSw": "-4.56", " tPSA": "448.01", " RotatableB": "32", " RigidB": "57", " Flexibility": "0.36", " HBD": "15", " HBA": "29", " HBD_HBA": "44", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "92", " CarbonAtoms": "63", " HeteroAtoms": "29", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "13517.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1286.47", "link_html_complex": "/ACE_complex_html/ACE_PSFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSFQPQPLIYP.png", "phi_psi": "/peptide_da/PSFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/PSFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/PSFQPQPLIYP.png"}
{"Peptide_Sequence": "PSGQYY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "344.1 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1028", " Ligand_ID": "PSGQYY_minimized.pdb_1028", " Smiles": "NC(=O)CC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "713.73", " logP": "-3.78", " logD": "-8.36", " logSw": "-0.72", " tPSA": "306.02", " RotatableB": "19", " RigidB": "30", " Flexibility": "0.39", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "33", " HeteroAtoms": "18", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "345947.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 713.735", "link_html_complex": "/ACE_complex_html/ACE_PSGQYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSGQYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSGQYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSGQYY.png", "phi_psi": "/peptide_da/PSGQYY.pdb", "link_html_peptide": "/Peptide_html/PSGQYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSGQYY.pdb", "link_png_peptide": "/Peptide_pics/PSGQYY.png"}
{"Peptide_Sequence": "PSNPP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "250.9 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1029", " Ligand_ID": "PSNPP_minimized.pdb_1029", " Smiles": "NC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "510.54", " logP": "-5.34", " logD": "-9.65", " logSw": "1.02", " tPSA": "218.88", " RotatableB": "10", " RigidB": "26", " Flexibility": "0.28", " HBD": "7", " HBA": "14", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "22", " HeteroAtoms": "14", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1414197.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 510.541", "link_html_complex": "/ACE_complex_html/ACE_PSNPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSNPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSNPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSNPP.png", "phi_psi": "/peptide_da/PSNPP.pdb", "link_html_peptide": "/Peptide_html/PSNPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSNPP.pdb", "link_png_peptide": "/Peptide_pics/PSNPP.png"}
{"Peptide_Sequence": "PSSNK", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "129.3", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1030", " Ligand_ID": "PSSNK_minimized.pdb_1030", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "531.56", " logP": "-7.24", " logD": "-11.03", " logSw": "2.55", " tPSA": "284.33", " RotatableB": "17", " RigidB": "16", " Flexibility": "0.52", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "21", " HeteroAtoms": "16", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6790936.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 531.56", "link_html_complex": "/ACE_complex_html/ACE_PSSNK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSSNK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSSNK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSSNK.png", "phi_psi": "/peptide_da/PSSNK.pdb", "link_html_peptide": "/Peptide_html/PSSNK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSSNK.pdb", "link_png_peptide": "/Peptide_pics/PSSNK.png"}
{"Peptide_Sequence": "PSY", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "16  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1031", " Ligand_ID": "PSY_minimized.pdb_1031", " Smiles": "OC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "365.38", " logP": "-3.73", " logD": "-5.07", " logSw": "0.68", " tPSA": "155.4", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "722607.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 365.381", "link_html_complex": "/ACE_complex_html/ACE_PSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PSY.png", "phi_psi": "/peptide_da/PSY.pdb", "link_html_peptide": "/Peptide_html/PSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PSY.pdb", "link_png_peptide": "/Peptide_pics/PSY.png"}
{"Peptide_Sequence": "PT", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "1046", " Ligand_ID": "PT_minimized.pdb_1046", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "216.23", " logP": "-4.35", " logD": "-4.18", " logSw": "1.82", " tPSA": "106.07", " RotatableB": "4", " RigidB": "8", " Flexibility": "0.33", " HBD": "4", " HBA": "6", " HBD_HBA": "10", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "9", " HeteroAtoms": "6", " ratio_H_by_C": "0.67", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1339711.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 216.234", "link_html_complex": "/ACE_complex_html/ACE_PT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PT.png", "phi_psi": "/peptide_da/PT.pdb", "link_html_peptide": "/Peptide_html/PT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PT.pdb", "link_png_peptide": "/Peptide_pics/PT.png"}
{"Peptide_Sequence": "PTFIAW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-11.4", "Serial_ID": "1032", " Ligand_ID": "PTFIAW_minimized.pdb_1032", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "733.85", " logP": "0.38", " logD": "-4.1", " logSw": "-3.55", " tPSA": "238.26", " RotatableB": "18", " RigidB": "32", " Flexibility": "0.36", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "38", " HeteroAtoms": "15", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "21121.39", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 733.854", "link_html_complex": "/ACE_complex_html/ACE_PTFIAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTFIAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTFIAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTFIAW.png", "phi_psi": "/peptide_da/PTFIAW.pdb", "link_html_peptide": "/Peptide_html/PTFIAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTFIAW.pdb", "link_png_peptide": "/Peptide_pics/PTFIAW.png"}
{"Peptide_Sequence": "PTHDAW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1033", " Ligand_ID": "PTHDAW_minimized.pdb_1033", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "725.75", " logP": "-3.64", " logD": "-11.39", " logSw": "-0.97", " tPSA": "307.07", " RotatableB": "18", " RigidB": "32", " Flexibility": "0.36", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "52", " CarbonAtoms": "33", " HeteroAtoms": "19", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "275809.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 725.749", "link_html_complex": "/ACE_complex_html/ACE_PTHDAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHDAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHDAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHDAW.png", "phi_psi": "/peptide_da/PTHDAW.pdb", "link_html_peptide": "/Peptide_html/PTHDAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHDAW.pdb", "link_png_peptide": "/Peptide_pics/PTHDAW.png"}
{"Peptide_Sequence": "PTHGAW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1034", " Ligand_ID": "PTHGAW_minimized.pdb_1034", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "667.71", " logP": "-3.17", " logD": "-8.1", " logSw": "-1.04", " tPSA": "266.94", " RotatableB": "16", " RigidB": "31", " Flexibility": "0.34", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "31", " HeteroAtoms": "17", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "235270.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 667.713", "link_html_complex": "/ACE_complex_html/ACE_PTHGAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHGAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHGAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHGAW.png", "phi_psi": "/peptide_da/PTHGAW.pdb", "link_html_peptide": "/Peptide_html/PTHGAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHGAW.pdb", "link_png_peptide": "/Peptide_pics/PTHGAW.png"}
{"Peptide_Sequence": "PTHIAW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.39 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1035", " Ligand_ID": "PTHIAW_minimized.pdb_1035", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "723.82", " logP": "-1.45", " logD": "-6.24", " logSw": "-2.33", " tPSA": "266.94", " RotatableB": "18", " RigidB": "31", " Flexibility": "0.37", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "70512.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 723.819", "link_html_complex": "/ACE_complex_html/ACE_PTHIAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIAW.png", "phi_psi": "/peptide_da/PTHIAW.pdb", "link_html_peptide": "/Peptide_html/PTHIAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIAW.pdb", "link_png_peptide": "/Peptide_pics/PTHIAW.png"}
{"Peptide_Sequence": "PTHIDW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1.8 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1036", " Ligand_ID": "PTHIDW_minimized.pdb_1036", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "767.83", " logP": "-2.32", " logD": "-10.15", " logSw": "-1.92", " tPSA": "307.07", " RotatableB": "20", " RigidB": "32", " Flexibility": "0.38", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "55", " CarbonAtoms": "36", " HeteroAtoms": "19", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "112732.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 767.829", "link_html_complex": "/ACE_complex_html/ACE_PTHIDW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIDW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIDW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIDW.png", "phi_psi": "/peptide_da/PTHIDW.pdb", "link_html_peptide": "/Peptide_html/PTHIDW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIDW.pdb", "link_png_peptide": "/Peptide_pics/PTHIDW.png"}
{"Peptide_Sequence": "PTHIK", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1037", " Ligand_ID": "PTHIK_minimized.pdb_1037", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "594.7", " logP": "-3.15", " logD": "-7.27", " logSw": "-0.4", " tPSA": "249.69", " RotatableB": "18", " RigidB": "19", " Flexibility": "0.49", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "399956.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 594.704", "link_html_complex": "/ACE_complex_html/ACE_PTHIK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIK.png", "phi_psi": "/peptide_da/PTHIK.pdb", "link_html_peptide": "/Peptide_html/PTHIK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIK.pdb", "link_png_peptide": "/Peptide_pics/PTHIK.png"}
{"Peptide_Sequence": "PTHIKW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "11.8 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1041", " Ligand_ID": "PTHIKW_minimized.pdb_1041", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "780.91", " logP": "-1.68", " logD": "-7.66", " logSw": "-2.26", " tPSA": "294.58", " RotatableB": "22", " RigidB": "31", " Flexibility": "0.42", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "56", " CarbonAtoms": "38", " HeteroAtoms": "18", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "81182.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 780.913", "link_html_complex": "/ACE_complex_html/ACE_PTHIKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIKW.png", "phi_psi": "/peptide_da/PTHIKW.pdb", "link_html_peptide": "/Peptide_html/PTHIKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIKW.pdb", "link_png_peptide": "/Peptide_pics/PTHIKW.png"}
{"Peptide_Sequence": "n artificial gastric juice.\"\" Process Biochemistry 41.3 (2006): 505-511.\"", " Origin": "-11.1", " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "1038", " Ligand_ID": "PTHIKWD_minimized.pdb_1038", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "896", " logP": "-5.09", " logD": "-12.67", " logSw": "-0.56", " tPSA": "363.81", " RotatableB": "26", " RigidB": "34", " Flexibility": "0.43", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "42", " HeteroAtoms": "22", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "514171.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 896.001", "link_html_complex": "/ACE_complex_html/ACE_PTHIKWD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIKWD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIKWD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIKWD.png", "phi_psi": "/peptide_da/PTHIKWD.pdb", "link_html_peptide": "/Peptide_html/PTHIKWD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIKWD.pdb", "link_png_peptide": "/Peptide_pics/PTHIKWD.png"}
{"Peptide_Sequence": "PTHIKWG", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "7.6 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1040", " Ligand_ID": "PTHIKWG_minimized.pdb_1040", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(O)=O", " MW": "837.96", " logP": "-2.34", " logD": "-10.12", " logSw": "-2.06", " tPSA": "323.68", " RotatableB": "24", " RigidB": "33", " Flexibility": "0.42", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "60", " CarbonAtoms": "40", " HeteroAtoms": "20", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "106350.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 837.965", "link_html_complex": "/ACE_complex_html/ACE_PTHIKWG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIKWG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIKWG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIKWG.png", "phi_psi": "/peptide_da/PTHIKWG.pdb", "link_html_peptide": "/Peptide_html/PTHIKWG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIKWG.pdb", "link_png_peptide": "/Peptide_pics/PTHIKWG.png"}
{"Peptide_Sequence": "PTHIKWGD", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "0.9 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1039", " Ligand_ID": "PTHIKWGD_minimized.pdb_1039", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "953.05", " logP": "-5.74", " logD": "-14", " logSw": "-0.36", " tPSA": "392.91", " RotatableB": "28", " RigidB": "36", " Flexibility": "0.44", " HBD": "15", " HBA": "24", " HBD_HBA": "39", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "68", " CarbonAtoms": "44", " HeteroAtoms": "24", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "662792.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 953.052", "link_html_complex": "/ACE_complex_html/ACE_PTHIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIKWGD.png", "phi_psi": "/peptide_da/PTHIKWGD.pdb", "link_html_peptide": "/Peptide_html/PTHIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIKWGD.pdb", "link_png_peptide": "/Peptide_pics/PTHIKWGD.png"}
{"Peptide_Sequence": "PTHIKWN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "38.02 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1042", " Ligand_ID": "PTHIKWN_minimized.pdb_1042", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "895.02", " logP": "-3.46", " logD": "-11.02", " logSw": "-1.58", " tPSA": "366.77", " RotatableB": "26", " RigidB": "35", " Flexibility": "0.43", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "64", " CarbonAtoms": "42", " HeteroAtoms": "22", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "185178.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 895.016", "link_html_complex": "/ACE_complex_html/ACE_PTHIKWN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIKWN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIKWN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIKWN.png", "phi_psi": "/peptide_da/PTHIKWN.pdb", "link_html_peptide": "/Peptide_html/PTHIKWN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIKWN.pdb", "link_png_peptide": "/Peptide_pics/PTHIKWN.png"}
{"Peptide_Sequence": "PTHIW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "1043", " Ligand_ID": "PTHIW_minimized.pdb_1043", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "652.74", " logP": "-1.2", " logD": "-5.65", " logSw": "-2.19", " tPSA": "237.84", " RotatableB": "16", " RigidB": "29", " Flexibility": "0.36", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "73137.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 652.741", "link_html_complex": "/ACE_complex_html/ACE_PTHIW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHIW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHIW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHIW.png", "phi_psi": "/peptide_da/PTHIW.pdb", "link_html_peptide": "/Peptide_html/PTHIW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHIW.pdb", "link_png_peptide": "/Peptide_pics/PTHIW.png"}
{"Peptide_Sequence": "PTHKAW", " Origin": "Tuna muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": ">100 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1044", " Ligand_ID": "PTHKAW_minimized.pdb_1044", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "738.83", " logP": "-3.01", " logD": "-10.31", " logSw": "-1.31", " tPSA": "294.58", " RotatableB": "20", " RigidB": "31", " Flexibility": "0.39", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "200341.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 738.834", "link_html_complex": "/ACE_complex_html/ACE_PTHKAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHKAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHKAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHKAW.png", "phi_psi": "/peptide_da/PTHKAW.pdb", "link_html_peptide": "/Peptide_html/PTHKAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHKAW.pdb", "link_png_peptide": "/Peptide_pics/PTHKAW.png"}
{"Peptide_Sequence": "PTHVAW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "1.51 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1045", " Ligand_ID": "PTHVAW_minimized.pdb_1045", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "709.79", " logP": "-1.81", " logD": "-6.69", " logSw": "-2.08", " tPSA": "266.94", " RotatableB": "17", " RigidB": "31", " Flexibility": "0.35", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "88309.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 709.793", "link_html_complex": "/ACE_complex_html/ACE_PTHVAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTHVAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTHVAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTHVAW.png", "phi_psi": "/peptide_da/PTHVAW.pdb", "link_html_peptide": "/Peptide_html/PTHVAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTHVAW.pdb", "link_png_peptide": "/Peptide_pics/PTHVAW.png"}
{"Peptide_Sequence": "PTPAP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "33", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1047", " Ligand_ID": "PTPAP_minimized.pdb_1047", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "481.54", " logP": "-3.39", " logD": "-7.82", " logSw": "-0.16", " tPSA": "175.79", " RotatableB": "8", " RigidB": "24", " Flexibility": "0.25", " HBD": "5", " HBA": "12", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "1", " Solubility_mg_per_l": "409579.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 481.543", "link_html_complex": "/ACE_complex_html/ACE_PTPAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTPAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTPAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTPAP.png", "phi_psi": "/peptide_da/PTPAP.pdb", "link_html_peptide": "/Peptide_html/PTPAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTPAP.pdb", "link_png_peptide": "/Peptide_pics/PTPAP.png"}
{"Peptide_Sequence": "PTPVP", " Origin": "Dry-cured ham", " Peptide_Preparation": "Artifically synthesized", " Isolation_Method": "solid phase extraction", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Escudero, E., Mora, L., & Toldr\u00e1, F. (2014). Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion. Food Chemistry, 161, 305\u2013311. doi:10.1016/j.foodchem.2014.03.117", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1048", " Ligand_ID": "PTPVP_minimized.pdb_1048", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1)[C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "509.6", " logP": "-2.42", " logD": "-6.9", " logSw": "-0.88", " tPSA": "175.79", " RotatableB": "9", " RigidB": "24", " Flexibility": "0.27", " HBD": "5", " HBA": "12", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "24", " HeteroAtoms": "12", " ratio_H_by_C": "0.5", " Lipinski_Violation": "2", " Solubility_mg_per_l": "211182.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.596", "link_html_complex": "/ACE_complex_html/ACE_PTPVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PTPVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PTPVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PTPVP.png", "phi_psi": "/peptide_da/PTPVP.pdb", "link_html_peptide": "/Peptide_html/PTPVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PTPVP.pdb", "link_png_peptide": "/Peptide_pics/PTPVP.png"}
{"Peptide_Sequence": "PVGLVQPASATLYDY", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "19 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-4.8", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1593.77", "link_html_complex": "/ACE_complex_html/ACE_PVGLVQPASATLYDY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVGLVQPASATLYDY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVGLVQPASATLYDY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVGLVQPASATLYDY.png", "phi_psi": "/peptide_da/PVGLVQPASATLYDY.pdb", "link_html_peptide": "/Peptide_html/PVGLVQPASATLYDY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVGLVQPASATLYDY.pdb", "link_png_peptide": "/Peptide_pics/PVGLVQPASATLYDY.png"}
{"Peptide_Sequence": "PVNNPQIH", " Origin": "red bean (Phaseolus vulgaris)", " Peptide_Preparation": "Alcalase/papain,  pepsin, trypsin and \u03b1-chymotrypsin ", " Isolation_Method": "HPLC, SEC, ultrafiltration, gel filtration", " ACE_inhibition_assay": "Barbana and Boye, 2010, Wu and Ding, 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "206.7 \u03bcM", " Reference": "Rui, Xin, et al. \"Purification and characterization of angiotensin I-converting enzyme inhibitory peptides of small red bean (Phaseolus vulgaris) hydrolysates.\" Journal of Functional Foods 5.3 (2013): 1116-1124.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1050", " Ligand_ID": "PVNNPQIH_minimized.pdb_1050", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "918.01", " logP": "-5.99", " logD": "-10.54", " logSw": "-0.2", " tPSA": "409.6", " RotatableB": "24", " RigidB": "36", " Flexibility": "0.4", " HBD": "15", " HBA": "25", " HBD_HBA": "40", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "65", " CarbonAtoms": "40", " HeteroAtoms": "25", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "749457.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 918.008", "link_html_complex": "/ACE_complex_html/ACE_PVNNPQIH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVNNPQIH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVNNPQIH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVNNPQIH.png", "phi_psi": "/peptide_da/PVNNPQIH.pdb", "link_html_peptide": "/Peptide_html/PVNNPQIH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVNNPQIH.pdb", "link_png_peptide": "/Peptide_pics/PVNNPQIH.png"}
{"Peptide_Sequence": "PVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "181 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1051", " Ligand_ID": "PVPP_minimized.pdb_1051", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "408.49", " logP": "-1.55", " logD": "-5.74", " logSw": "-1", " tPSA": "126.46", " RotatableB": "6", " RigidB": "22", " Flexibility": "0.21", " HBD": "3", " HBA": "9", " HBD_HBA": "12", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "150253.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 408.492", "link_html_complex": "/ACE_complex_html/ACE_PVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVPP.png", "phi_psi": "/peptide_da/PVPP.pdb", "link_html_peptide": "/Peptide_html/PVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVPP.pdb", "link_png_peptide": "/Peptide_pics/PVPP.png"}
{"Peptide_Sequence": "PVPQP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "110", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "1052", " Ligand_ID": "PVPQP_minimized.pdb_1052", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "536.62", " logP": "-2.97", " logD": "-7.47", " logSw": "-0.57", " tPSA": "198.65", " RotatableB": "11", " RigidB": "26", " Flexibility": "0.3", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "303487.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 536.621", "link_html_complex": "/ACE_complex_html/ACE_PVPQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVPQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVPQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVPQP.png", "phi_psi": "/peptide_da/PVPQP.pdb", "link_html_peptide": "/Peptide_html/PVPQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVPQP.pdb", "link_png_peptide": "/Peptide_pics/PVPQP.png"}
{"Peptide_Sequence": "PVQ", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">2500 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1053", " Ligand_ID": "PVQ_minimized.pdb_1053", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "342.39", " logP": "-4.48", " logD": "-5.64", " logSw": "1.45", " tPSA": "158.03", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1464882.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 342.391", "link_html_complex": "/ACE_complex_html/ACE_PVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVQ.png", "phi_psi": "/peptide_da/PVQ.pdb", "link_html_peptide": "/Peptide_html/PVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVQ.pdb", "link_png_peptide": "/Peptide_pics/PVQ.png"}
{"Peptide_Sequence": "PVRAVP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "170", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1054", " Ligand_ID": "PVRAVP_minimized.pdb_1054", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "637.77", " logP": "-2.22", " logD": "-9.48", " logSw": "-1.27", " tPSA": "257.09", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "178465.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 637.771", "link_html_complex": "/ACE_complex_html/ACE_PVRAVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVRAVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVRAVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVRAVP.png", "phi_psi": "/peptide_da/PVRAVP.pdb", "link_html_peptide": "/Peptide_html/PVRAVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVRAVP.pdb", "link_png_peptide": "/Peptide_pics/PVRAVP.png"}
{"Peptide_Sequence": "PVRGPF", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2834 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1055", " Ligand_ID": "PVRGPF_minimized.pdb_1055", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "671.79", " logP": "-2", " logD": "-9.3", " logSw": "-1.6", " tPSA": "257.09", " RotatableB": "18", " RigidB": "28", " Flexibility": "0.39", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "135244.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 671.788", "link_html_complex": "/ACE_complex_html/ACE_PVRGPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVRGPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVRGPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVRGPF.png", "phi_psi": "/peptide_da/PVRGPF.pdb", "link_html_peptide": "/Peptide_html/PVRGPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVRGPF.pdb", "link_png_peptide": "/Peptide_pics/PVRGPF.png"}
{"Peptide_Sequence": "PVVVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "117 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1056", " Ligand_ID": "PVVVPP_minimized.pdb_1056", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "606.75", " logP": "-0.13", " logD": "-5.06", " logSw": "-2.73", " tPSA": "184.66", " RotatableB": "12", " RigidB": "26", " Flexibility": "0.32", " HBD": "5", " HBA": "13", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "30", " HeteroAtoms": "13", " ratio_H_by_C": "0.43", " Lipinski_Violation": "2", " Solubility_mg_per_l": "39652.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 606.754", "link_html_complex": "/ACE_complex_html/ACE_PVVVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PVVVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PVVVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PVVVPP.png", "phi_psi": "/peptide_da/PVVVPP.pdb", "link_html_peptide": "/Peptide_html/PVVVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PVVVPP.pdb", "link_png_peptide": "/Peptide_pics/PVVVPP.png"}
{"Peptide_Sequence": "PYK", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2400  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1058", " Ligand_ID": "PYK_minimized.pdb_1058", " Smiles": "NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O", " MW": "406.48", " logP": "-2.91", " logD": "-5.06", " logSw": "0.12", " tPSA": "162.81", " RotatableB": "11", " RigidB": "16", " Flexibility": "0.41", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "460088.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.476", "link_html_complex": "/ACE_complex_html/ACE_PYK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYK.png", "phi_psi": "/peptide_da/PYK.pdb", "link_html_peptide": "/Peptide_html/PYK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYK.pdb", "link_png_peptide": "/Peptide_pics/PYK.png"}
{"Peptide_Sequence": "PYKLRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "10.2 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1057", " Ligand_ID": "PYKLRP_minimized.pdb_1057", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "772.93", " logP": "-1.83", " logD": "-10.42", " logSw": "-2", " tPSA": "304.96", " RotatableB": "23", " RigidB": "28", " Flexibility": "0.45", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "55", " CarbonAtoms": "37", " HeteroAtoms": "18", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "104615.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 772.935", "link_html_complex": "/ACE_complex_html/ACE_PYKLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYKLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYKLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYKLRP.png", "phi_psi": "/peptide_da/PYKLRP.pdb", "link_html_peptide": "/Peptide_html/PYKLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYKLRP.pdb", "link_png_peptide": "/Peptide_pics/PYKLRP.png"}
{"Peptide_Sequence": "PYKW", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "13.3  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1060", " Ligand_ID": "PYKW_minimized.pdb_1060", " Smiles": "NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "592.69", " logP": "-1.24", " logD": "-5.45", " logSw": "-1.88", " tPSA": "207.7", " RotatableB": "15", " RigidB": "28", " Flexibility": "0.35", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "31", " HeteroAtoms": "12", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "90692.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 592.686", "link_html_complex": "/ACE_complex_html/ACE_PYKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYKW.png", "phi_psi": "/peptide_da/PYKW.pdb", "link_html_peptide": "/Peptide_html/PYKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYKW.pdb", "link_png_peptide": "/Peptide_pics/PYKW.png"}
{"Peptide_Sequence": "PYKWLP", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "5.5  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1059", " Ligand_ID": "PYKWLP_minimized.pdb_1059", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "802.96", " logP": "0.36", " logD": "-6.33", " logSw": "-3.82", " tPSA": "257.11", " RotatableB": "20", " RigidB": "37", " Flexibility": "0.35", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "58", " CarbonAtoms": "42", " HeteroAtoms": "16", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "17592.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 802.959", "link_html_complex": "/ACE_complex_html/ACE_PYKWLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYKWLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYKWLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYKWLP.png", "phi_psi": "/peptide_da/PYKWLP.pdb", "link_html_peptide": "/Peptide_html/PYKWLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYKWLP.pdb", "link_png_peptide": "/Peptide_pics/PYKWLP.png"}
{"Peptide_Sequence": "PYP", " Origin": "Casein", " Peptide_Preparation": "SP-Sephadex C-25 column chromatography", " Isolation_Method": "liquid phase method using DMF", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "220 \u03bcM", " Reference": "1987, Susumu MARUYAMA, Hajime MITACHI, Hideoki TANAKA, Noboru TOMIZUKA and Hideo SUZUKI. Studies on the Active Site and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitors Derived from Casein.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1061", " Ligand_ID": "PYP_minimized.pdb_1061", " Smiles": "OC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1", " MW": "375.42", " logP": "-1.65", " logD": "-3.75", " logSw": "-0.82", " tPSA": "126.38", " RotatableB": "6", " RigidB": "21", " Flexibility": "0.22", " HBD": "4", " HBA": "8", " HBD_HBA": "12", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "165763.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 375.419", "link_html_complex": "/ACE_complex_html/ACE_PYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYP.png", "phi_psi": "/peptide_da/PYP.pdb", "link_html_peptide": "/Peptide_html/PYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYP.pdb", "link_png_peptide": "/Peptide_pics/PYP.png"}
{"Peptide_Sequence": "PYVRYL", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.4 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1062", " Ligand_ID": "PYVRYL_minimized.pdb_1062", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(C)C)C(O)=O", " MW": "809.95", " logP": "0.3", " logD": "-6.73", " logSw": "-3.61", " tPSA": "306.34", " RotatableB": "23", " RigidB": "29", " Flexibility": "0.44", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "58", " CarbonAtoms": "40", " HeteroAtoms": "18", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "21941.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 809.951", "link_html_complex": "/ACE_complex_html/ACE_PYVRYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_PYVRYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_PYVRYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_PYVRYL.png", "phi_psi": "/peptide_da/PYVRYL.pdb", "link_html_peptide": "/Peptide_html/PYVRYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/PYVRYL.pdb", "link_png_peptide": "/Peptide_pics/PYVRYL.png"}
{"Peptide_Sequence": "QAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1063", " Ligand_ID": "QAFP_minimized.pdb_1063", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "461.51", " logP": "-4.72", " logD": "-5.4", " logSw": "0.93", " tPSA": "189.37", " RotatableB": "11", " RigidB": "20", " Flexibility": "0.35", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "22", " HeteroAtoms": "11", " ratio_H_by_C": "0.5", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1168365.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 461.511", "link_html_complex": "/ACE_complex_html/ACE_QAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QAFP.png", "phi_psi": "/peptide_da/QAFP.pdb", "link_html_peptide": "/Peptide_html/QAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QAFP.pdb", "link_png_peptide": "/Peptide_pics/QAFP.png"}
{"Peptide_Sequence": "QAFT", " Origin": " b-CN (56-59), mouse", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1001.00 \u03bcM", " Reference": "ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1064", " Ligand_ID": "QAFT_minimized.pdb_1064", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O)C(O)=O", " MW": "465.5", " logP": "-4.77", " logD": "-6.33", " logSw": "1.07", " tPSA": "218.39", " RotatableB": "13", " RigidB": "15", " Flexibility": "0.46", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1353889.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 465.5", "link_html_complex": "/ACE_complex_html/ACE_QAFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QAFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QAFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QAFT.png", "phi_psi": "/peptide_da/QAFT.pdb", "link_html_peptide": "/Peptide_html/QAFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QAFT.pdb", "link_png_peptide": "/Peptide_pics/QAFT.png"}
{"Peptide_Sequence": "QDNSRYTHFLTQHYDAFPQGR", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "St. Clair (1987)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Rybak, Susanna M., et al. \"C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.\" Biochemical and biophysical research communications 162.1 (1989): 535-543.", " Binding_Energy_kcal_per_mol": "29.3", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2581.71", "link_html_complex": "/ACE_complex_html/ACE_QDNSRYTHFLTQHYDAFPQGR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QDNSRYTHFLTQHYDAFPQGR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QDNSRYTHFLTQHYDAFPQGR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QDNSRYTHFLTQHYDAFPQGR.png", "phi_psi": "/peptide_da/QDNSRYTHFLTQHYDAFPQGR.pdb", "link_html_peptide": "/Peptide_html/QDNSRYTHFLTQHYDAFPQGR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QDNSRYTHFLTQHYDAFPQGR.pdb", "link_png_peptide": "/Peptide_pics/QDNSRYTHFLTQHYDAFPQGR.png"}
{"Peptide_Sequence": "QELPG", " Origin": "porcine hemoglobin", " Peptide_Preparation": "alcalase, trypsin, neutral, papain, protamex, and pepsin", " Isolation_Method": "macroporous resin, GFC", " ACE_inhibition_assay": "Cushman and Cheung with slight modification", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.02 mg/mL", " Reference": "Deng, HuiLing, et al. \"Isolation of angiotensin I-converting enzyme inhibitor from pepsin hydrolysate of porcine hemoglobin.\" European Food Research and Technology 239.6 (2014): 933-940.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1066", " Ligand_ID": "QELPG_minimized.pdb_1066", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "542.58", " logP": "-6.15", " logD": "-10.09", " logSw": "1.73", " tPSA": "258.6", " RotatableB": "16", " RigidB": "17", " Flexibility": "0.48", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3049790.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 542.583", "link_html_complex": "/ACE_complex_html/ACE_QELPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QELPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QELPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QELPG.png", "phi_psi": "/peptide_da/QELPG.pdb", "link_html_peptide": "/Peptide_html/QELPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QELPG.pdb", "link_png_peptide": "/Peptide_pics/QELPG.png"}
{"Peptide_Sequence": "QEPVLGPVRGPFP", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1067", " Ligand_ID": "QEPVLGPVRGPFP_minimized.pdb_1067", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1392.6", " logP": "-3.28", " logD": "-11.23", " logSw": "-3.92", " tPSA": "528.67", " RotatableB": "38", " RigidB": "55", " Flexibility": "0.41", " HBD": "18", " HBA": "34", " HBD_HBA": "52", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "99", " CarbonAtoms": "65", " HeteroAtoms": "34", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "27577.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1392.6", "link_html_complex": "/ACE_complex_html/ACE_QEPVLGPVRGPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QEPVLGPVRGPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QEPVLGPVRGPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QEPVLGPVRGPFP.png", "phi_psi": "/peptide_da/QEPVLGPVRGPFP.pdb", "link_html_peptide": "/Peptide_html/QEPVLGPVRGPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QEPVLGPVRGPFP.pdb", "link_png_peptide": "/Peptide_pics/QEPVLGPVRGPFP.png"}
{"Peptide_Sequence": "QEVLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1068", " Ligand_ID": "QEVLP_minimized.pdb_1068", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "584.66", " logP": "-4.79", " logD": "-8.55", " logSw": "0.67", " tPSA": "258.6", " RotatableB": "17", " RigidB": "17", " Flexibility": "0.5", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1148058.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.662", "link_html_complex": "/ACE_complex_html/ACE_QEVLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QEVLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QEVLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QEVLP.png", "phi_psi": "/peptide_da/QEVLP.pdb", "link_html_peptide": "/Peptide_html/QEVLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QEVLP.pdb", "link_png_peptide": "/Peptide_pics/QEVLP.png"}
{"Peptide_Sequence": "QFYAV", " Origin": "rice wine", " Peptide_Preparation": "", " Isolation_Method": "UF, Chromatography, SPEC, RP-HPCL, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Kang, Min Gu, et al. \"Characterization of new antihypertensive angiotensin I-converting enzyme inhibitory peptides from Korean traditional rice wine.\" Journal of microbiology and biotechnology 22.3 (2012): 339-342.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1069", " Ligand_ID": "QFYAV_minimized.pdb_1069", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(N)=O)C(O)=O", " MW": "626.7", " logP": "-3.32", " logD": "-3.97", " logSw": "-0.61", " tPSA": "247.49", " RotatableB": "17", " RigidB": "23", " Flexibility": "0.42", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "31", " HeteroAtoms": "14", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "339154.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 626.701", "link_html_complex": "/ACE_complex_html/ACE_QFYAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QFYAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QFYAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QFYAV.png", "phi_psi": "/peptide_da/QFYAV.pdb", "link_html_peptide": "/Peptide_html/QFYAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QFYAV.pdb", "link_png_peptide": "/Peptide_pics/QFYAV.png"}
{"Peptide_Sequence": "QG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "7400 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "1071", " Ligand_ID": "QG_minimized.pdb_1071", " Smiles": "N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "203.2", " logP": "-4.52", " logD": "-5.6", " logSw": "2.14", " tPSA": "139.96", " RotatableB": "6", " RigidB": "5", " Flexibility": "0.55", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1733601.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 203.196", "link_html_complex": "/ACE_complex_html/ACE_QG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QG.png", "phi_psi": "/peptide_da/QG.pdb", "link_html_peptide": "/Peptide_html/QG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QG.pdb", "link_png_peptide": "/Peptide_pics/QG.png"}
{"Peptide_Sequence": "QGIH", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1070", " Ligand_ID": "QGIH_minimized.pdb_1070", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "453.49", " logP": "-4.24", " logD": "-6.24", " logSw": "0.88", " tPSA": "226.84", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "19", " HeteroAtoms": "13", " ratio_H_by_C": "0.68", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1098602.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 453.493", "link_html_complex": "/ACE_complex_html/ACE_QGIH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QGIH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QGIH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QGIH.png", "phi_psi": "/peptide_da/QGIH.pdb", "link_html_peptide": "/Peptide_html/QGIH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QGIH.pdb", "link_png_peptide": "/Peptide_pics/QGIH.png"}
{"Peptide_Sequence": "QGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "149.5 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1072", " Ligand_ID": "QGP_minimized.pdb_1072", " Smiles": "N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "300.31", " logP": "-4.76", " logD": "-6.88", " logSw": "1.76", " tPSA": "160.27", " RotatableB": "7", " RigidB": "12", " Flexibility": "0.37", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1743570.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 300.311", "link_html_complex": "/ACE_complex_html/ACE_QGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QGP.png", "phi_psi": "/peptide_da/QGP.pdb", "link_html_peptide": "/Peptide_html/QGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QGP.pdb", "link_png_peptide": "/Peptide_pics/QGP.png"}
{"Peptide_Sequence": "QHEAT", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1073", " Ligand_ID": "QHEAT_minimized.pdb_1073", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCC(N)=O)C(O)=O", " MW": "584.58", " logP": "-6.54", " logD": "-12.68", " logSw": "1.8", " tPSA": "316.3", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3521519.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.58", "link_html_complex": "/ACE_complex_html/ACE_QHEAT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QHEAT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QHEAT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QHEAT.png", "phi_psi": "/peptide_da/QHEAT.pdb", "link_html_peptide": "/Peptide_html/QHEAT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QHEAT.pdb", "link_png_peptide": "/Peptide_pics/QHEAT.png"}
{"Peptide_Sequence": "QIGLF", " Origin": "Egg", " Peptide_Preparation": "Alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "Wu et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "75 \u03bcM", " Reference": "Yu, Zhipeng, et al. \"QIGLF, a novel angiotensin I\u2010converting enzyme\u2010inhibitory peptide from egg white protein.\" Journal of the Science of Food and Agriculture 91.5 (2011): 921-926.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1074", " Ligand_ID": "QIGLF_minimized.pdb_1074", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "576.68", " logP": "-2.74", " logD": "-4.14", " logSw": "-0.55", " tPSA": "227.26", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "331561.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 576.685", "link_html_complex": "/ACE_complex_html/ACE_QIGLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QIGLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QIGLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QIGLF.png", "phi_psi": "/peptide_da/QIGLF.pdb", "link_html_peptide": "/Peptide_html/QIGLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QIGLF.pdb", "link_png_peptide": "/Peptide_pics/QIGLF.png"}
{"Peptide_Sequence": "QIGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "194.8 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1075", " Ligand_ID": "QIGP_minimized.pdb_1075", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "413.47", " logP": "-3.7", " logD": "-6.38", " logSw": "0.65", " tPSA": "189.37", " RotatableB": "11", " RigidB": "14", " Flexibility": "0.44", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "794788.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 413.469", "link_html_complex": "/ACE_complex_html/ACE_QIGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QIGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QIGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QIGP.png", "phi_psi": "/peptide_da/QIGP.pdb", "link_html_peptide": "/Peptide_html/QIGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QIGP.pdb", "link_png_peptide": "/Peptide_pics/QIGP.png"}
{"Peptide_Sequence": "QK", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "885", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "1077", " Ligand_ID": "QK_minimized.pdb_1077", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(O)=O", " MW": "274.32", " logP": "-4.65", " logD": "-6.31", " logSw": "2.05", " tPSA": "167.6", " RotatableB": "10", " RigidB": "5", " Flexibility": "0.67", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2128173.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 274.317", "link_html_complex": "/ACE_complex_html/ACE_QK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QK.png", "phi_psi": "/peptide_da/QK.pdb", "link_html_peptide": "/Peptide_html/QK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QK.pdb", "link_png_peptide": "/Peptide_pics/QK.png"}
{"Peptide_Sequence": "QKF", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1076", " Ligand_ID": "QKF_minimized.pdb_1076", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "421.49", " logP": "-3.18", " logD": "-6.55", " logSw": "0.4", " tPSA": "196.7", " RotatableB": "14", " RigidB": "13", " Flexibility": "0.52", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "629652.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 421.491", "link_html_complex": "/ACE_complex_html/ACE_QKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QKF.png", "phi_psi": "/peptide_da/QKF.pdb", "link_html_peptide": "/Peptide_html/QKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QKF.pdb", "link_png_peptide": "/Peptide_pics/QKF.png"}
{"Peptide_Sequence": "QKPRN", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1078", " Ligand_ID": "QKPRN_minimized.pdb_1078", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "641.72", " logP": "-8.96", " logD": "-14.14", " logSw": "3.21", " tPSA": "352.84", " RotatableB": "21", " RigidB": "19", " Flexibility": "0.53", " HBD": "16", " HBA": "19", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "45", " CarbonAtoms": "26", " HeteroAtoms": "19", " ratio_H_by_C": "0.73", " Lipinski_Violation": "3", " Solubility_mg_per_l": "15935215.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 641.72", "link_html_complex": "/ACE_complex_html/ACE_QKPRN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QKPRN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QKPRN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QKPRN.png", "phi_psi": "/peptide_da/QKPRN.pdb", "link_html_peptide": "/Peptide_html/QKPRN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QKPRN.pdb", "link_png_peptide": "/Peptide_pics/QKPRN.png"}
{"Peptide_Sequence": "QKTAP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "30", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1079", " Ligand_ID": "QKTAP_minimized.pdb_1079", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "543.61", " logP": "-7.41", " logD": "-11.06", " logSw": "2.51", " tPSA": "266.34", " RotatableB": "16", " RigidB": "16", " Flexibility": "0.5", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6715232.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 543.614", "link_html_complex": "/ACE_complex_html/ACE_QKTAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QKTAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QKTAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QKTAP.png", "phi_psi": "/peptide_da/QKTAP.pdb", "link_html_peptide": "/Peptide_html/QKTAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QKTAP.pdb", "link_png_peptide": "/Peptide_pics/QKTAP.png"}
{"Peptide_Sequence": "QLDAYPSGAWYYVP", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "-5.5", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1629.77", "link_html_complex": "/ACE_complex_html/ACE_QLDAYPSGAWYYVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QLDAYPSGAWYYVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QLDAYPSGAWYYVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QLDAYPSGAWYYVP.png", "phi_psi": "/peptide_da/QLDAYPSGAWYYVP.pdb", "link_html_peptide": "/Peptide_html/QLDAYPSGAWYYVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QLDAYPSGAWYYVP.pdb", "link_png_peptide": "/Peptide_pics/QLDAYPSGAWYYVP.png"}
{"Peptide_Sequence": "QLGFLGPR", " Origin": " skate skin", " Peptide_Preparation": "alcalase, \u03b1-chymotrypsin, papain, pepsin, neutrase and trypsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 148 \u03bcM", " Reference": "Lee, Jung Kwon, Joong-Kyun Jeon, and Hee-Guk Byun. \"Effect of angiotensin I converting enzyme inhibitory peptide purified from skate skin hydrolysate.\" Food Chemistry 125.2 (2011): 495-499.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1081", " Ligand_ID": "QLGFLGPR_minimized.pdb_1081", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "887.04", " logP": "-3.02", " logD": "-6.59", " logSw": "-1.62", " tPSA": "369.41", " RotatableB": "28", " RigidB": "29", " Flexibility": "0.49", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "63", " CarbonAtoms": "41", " HeteroAtoms": "22", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "174939.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 887.037", "link_html_complex": "/ACE_complex_html/ACE_QLGFLGPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QLGFLGPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QLGFLGPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QLGFLGPR.png", "phi_psi": "/peptide_da/QLGFLGPR.pdb", "link_html_peptide": "/Peptide_html/QLGFLGPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QLGFLGPR.pdb", "link_png_peptide": "/Peptide_pics/QLGFLGPR.png"}
{"Peptide_Sequence": "QLGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "311.7 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1082", " Ligand_ID": "QLGP_minimized.pdb_1082", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "413.47", " logP": "-4.72", " logD": "-6.43", " logSw": "1.3", " tPSA": "189.37", " RotatableB": "11", " RigidB": "14", " Flexibility": "0.44", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "18", " HeteroAtoms": "11", " ratio_H_by_C": "0.61", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1511225.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 413.469", "link_html_complex": "/ACE_complex_html/ACE_QLGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QLGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QLGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QLGP.png", "phi_psi": "/peptide_da/QLGP.pdb", "link_html_peptide": "/Peptide_html/QLGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QLGP.pdb", "link_png_peptide": "/Peptide_pics/QLGP.png"}
{"Peptide_Sequence": "QLLKLK", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "342.4 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1083", " Ligand_ID": "QLLKLK_minimized.pdb_1083", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "741.96", " logP": "-1.94", " logD": "-7.2", " logSw": "-1.37", " tPSA": "311.64", " RotatableB": "28", " RigidB": "13", " Flexibility": "0.68", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "188544.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 741.962", "link_html_complex": "/ACE_complex_html/ACE_QLLKLK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QLLKLK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QLLKLK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QLLKLK.png", "phi_psi": "/peptide_da/QLLKLK.pdb", "link_html_peptide": "/Peptide_html/QLLKLK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QLLKLK.pdb", "link_png_peptide": "/Peptide_pics/QLLKLK.png"}
{"Peptide_Sequence": "QNALIVRYTR", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "4.6 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1084", " Ligand_ID": "QNALIVRYTR_minimized.pdb_1084", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1233.42", " logP": "-5.38", " logD": "-11.54", " logSw": "-1.42", " tPSA": "583.59", " RotatableB": "41", " RigidB": "31", " Flexibility": "0.57", " HBD": "26", " HBA": "33", " HBD_HBA": "59", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "87", " CarbonAtoms": "54", " HeteroAtoms": "33", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "299147.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1233.42", "link_html_complex": "/ACE_complex_html/ACE_QNALIVRYTR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QNALIVRYTR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QNALIVRYTR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QNALIVRYTR.png", "phi_psi": "/peptide_da/QNALIVRYTR.pdb", "link_html_peptide": "/Peptide_html/QNALIVRYTR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QNALIVRYTR.pdb", "link_png_peptide": "/Peptide_pics/QNALIVRYTR.png"}
{"Peptide_Sequence": "QNILP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1085", " Ligand_ID": "QNILP_minimized.pdb_1085", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "583.68", " logP": "-5.44", " logD": "-6.48", " logSw": "1.02", " tPSA": "261.56", " RotatableB": "16", " RigidB": "18", " Flexibility": "0.47", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1625787.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 583.677", "link_html_complex": "/ACE_complex_html/ACE_QNILP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QNILP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QNILP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QNILP.png", "phi_psi": "/peptide_da/QNILP.pdb", "link_html_peptide": "/Peptide_html/QNILP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QNILP.pdb", "link_png_peptide": "/Peptide_pics/QNILP.png"}
{"Peptide_Sequence": "QP", " Origin": "Manchego, Roncal, Idiaz\u00e1bal,  goat  cheese", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "598 \u03bcM", " Reference": "El-Salam, MH Abd, and S. El-Shibiny. \"Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products.\" Food Reviews International 29.1 (2013): 1-23.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "1088", " Ligand_ID": "QP_minimized.pdb_1088", " Smiles": "N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "243.26", " logP": "-4.24", " logD": "-4.76", " logSw": "1.65", " tPSA": "131.17", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1270441.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 243.26", "link_html_complex": "/ACE_complex_html/ACE_QP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QP.png", "phi_psi": "/peptide_da/QP.pdb", "link_html_peptide": "/Peptide_html/QP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QP.pdb", "link_png_peptide": "/Peptide_pics/QP.png"}
{"Peptide_Sequence": "QPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "860", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1086", " Ligand_ID": "QPIP_minimized.pdb_1086", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "453.53", " logP": "-2.99", " logD": "-5.47", " logSw": "-0.11", " tPSA": "180.58", " RotatableB": "10", " RigidB": "19", " Flexibility": "0.34", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "407021.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 453.532", "link_html_complex": "/ACE_complex_html/ACE_QPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QPIP.png", "phi_psi": "/peptide_da/QPIP.pdb", "link_html_peptide": "/Peptide_html/QPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QPIP.pdb", "link_png_peptide": "/Peptide_pics/QPIP.png"}
{"Peptide_Sequence": "QPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.6", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1087", " Ligand_ID": "QPLIYP_minimized.pdb_1087", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "729.86", " logP": "-0.94", " logD": "-3.99", " logSw": "-2.63", " tPSA": "259.01", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "36", " HeteroAtoms": "16", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "52794.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 729.863", "link_html_complex": "/ACE_complex_html/ACE_QPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QPLIYP.png", "phi_psi": "/peptide_da/QPLIYP.pdb", "link_html_peptide": "/Peptide_html/QPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QPLIYP.pdb", "link_png_peptide": "/Peptide_pics/QPLIYP.png"}
{"Peptide_Sequence": "QPQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "610", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1089", " Ligand_ID": "QPQAFP_minimized.pdb_1089", " Smiles": "C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "686.76", " logP": "-4.39", " logD": "-7.35", " logSw": "-0.32", " tPSA": "281.87", " RotatableB": "16", " RigidB": "31", " Flexibility": "0.34", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "32", " HeteroAtoms": "17", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "497231.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 686.756", "link_html_complex": "/ACE_complex_html/ACE_QPQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QPQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QPQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QPQAFP.png", "phi_psi": "/peptide_da/QPQAFP.pdb", "link_html_peptide": "/Peptide_html/QPQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QPQAFP.pdb", "link_png_peptide": "/Peptide_pics/QPQAFP.png"}
{"Peptide_Sequence": "QPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1090", " Ligand_ID": "QPQPLIYP_minimized.pdb_1090", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "955.11", " logP": "-2.31", " logD": "-5.95", " logSw": "-2.82", " tPSA": "351.51", " RotatableB": "23", " RigidB": "40", " Flexibility": "0.37", " HBD": "12", " HBA": "22", " HBD_HBA": "34", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "68", " CarbonAtoms": "46", " HeteroAtoms": "22", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "56899.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 955.108", "link_html_complex": "/ACE_complex_html/ACE_QPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QPQPLIYP.png", "phi_psi": "/peptide_da/QPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/QPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/QPQPLIYP.png"}
{"Peptide_Sequence": "QSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "750", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1091", " Ligand_ID": "QSEPKAIP_minimized.pdb_1091", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "868.97", " logP": "-8.08", " logD": "-15.02", " logSw": "1.58", " tPSA": "384.98", " RotatableB": "26", " RigidB": "28", " Flexibility": "0.48", " HBD": "14", " HBA": "23", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "38", " HeteroAtoms": "23", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4213608.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 868.974", "link_html_complex": "/ACE_complex_html/ACE_QSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSEPKAIP.png", "phi_psi": "/peptide_da/QSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/QSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/QSEPKAIP.png"}
{"Peptide_Sequence": "QSGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "168.6 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1092", " Ligand_ID": "QSGP_minimized.pdb_1092", " Smiles": "N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "387.39", " logP": "-6.07", " logD": "-8.75", " logSw": "2.24", " tPSA": "209.6", " RotatableB": "10", " RigidB": "14", " Flexibility": "0.42", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "15", " HeteroAtoms": "12", " ratio_H_by_C": "0.8", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3647218.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 387.388", "link_html_complex": "/ACE_complex_html/ACE_QSGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSGP.png", "phi_psi": "/peptide_da/QSGP.pdb", "link_html_peptide": "/Peptide_html/QSGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSGP.pdb", "link_png_peptide": "/Peptide_pics/QSGP.png"}
{"Peptide_Sequence": "QSLTL", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1093", " Ligand_ID": "QSLTL_minimized.pdb_1093", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(O)=O", " MW": "560.64", " logP": "-4.64", " logD": "-7.04", " logSw": "0.8", " tPSA": "267.72", " RotatableB": "18", " RigidB": "11", " Flexibility": "0.62", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1241787", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 560.641", "link_html_complex": "/ACE_complex_html/ACE_QSLTL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSLTL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSLTL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSLTL.png", "phi_psi": "/peptide_da/QSLTL.pdb", "link_html_peptide": "/Peptide_html/QSLTL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSLTL.pdb", "link_png_peptide": "/Peptide_pics/QSLTL.png"}
{"Peptide_Sequence": "QSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "41", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1094", " Ligand_ID": "QSLVYP_minimized.pdb_1094", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "705.8", " logP": "-2.65", " logD": "-5.76", " logSw": "-1.34", " tPSA": "288.03", " RotatableB": "19", " RigidB": "24", " Flexibility": "0.44", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "33", " HeteroAtoms": "17", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "185474.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 705.799", "link_html_complex": "/ACE_complex_html/ACE_QSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSLVYP.png", "phi_psi": "/peptide_da/QSLVYP.pdb", "link_html_peptide": "/Peptide_html/QSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSLVYP.pdb", "link_png_peptide": "/Peptide_pics/QSLVYP.png"}
{"Peptide_Sequence": "QSQPQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "700", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1095", " Ligand_ID": "QSQPQAFP_minimized.pdb_1095", " Smiles": "C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "901.96", " logP": "-7.11", " logD": "-10.64", " logSw": "0.53", " tPSA": "403.39", " RotatableB": "23", " RigidB": "37", " Flexibility": "0.38", " HBD": "15", " HBA": "24", " HBD_HBA": "39", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "40", " HeteroAtoms": "24", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1530896.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 901.962", "link_html_complex": "/ACE_complex_html/ACE_QSQPQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSQPQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSQPQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSQPQAFP.png", "phi_psi": "/peptide_da/QSQPQAFP.pdb", "link_html_peptide": "/Peptide_html/QSQPQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSQPQAFP.pdb", "link_png_peptide": "/Peptide_pics/QSQPQAFP.png"}
{"Peptide_Sequence": "QSWMHQPHQ", " Origin": "milk derived ", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": " Shalaby, Zakora, and Otte (2006)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "19.26 \u03bcM", " Reference": "Phelan, Martha, et al. \"Angiotensin converting enzyme and nitric oxide inhibitory activities of novel milk derived peptides.\" International Dairy Journal 35.1 (2014): 38-42.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1096", " Ligand_ID": "QSWMHQPHQ_minimized.pdb_1096", " Smiles": "CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1178.28", " logP": "-7.37", " logD": "-11.38", " logSw": "-0.42", " tPSA": "539.73", " RotatableB": "33", " RigidB": "48", " Flexibility": "0.41", " HBD": "20", " HBA": "31", " HBD_HBA": "51", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "83", " CarbonAtoms": "51", " HeteroAtoms": "32", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "777650.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1178.28", "link_html_complex": "/ACE_complex_html/ACE_QSWMHQPHQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QSWMHQPHQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QSWMHQPHQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QSWMHQPHQ.png", "phi_psi": "/peptide_da/QSWMHQPHQ.pdb", "link_html_peptide": "/Peptide_html/QSWMHQPHQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QSWMHQPHQ.pdb", "link_png_peptide": "/Peptide_pics/QSWMHQPHQ.png"}
{"Peptide_Sequence": "QTQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "73", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1097", " Ligand_ID": "QTQSLVYP_minimized.pdb_1097", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "935.03", " logP": "-4.94", " logD": "-8.63", " logSw": "-0.84", " tPSA": "409.55", " RotatableB": "26", " RigidB": "30", " Flexibility": "0.46", " HBD": "16", " HBA": "24", " HBD_HBA": "40", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "66", " CarbonAtoms": "42", " HeteroAtoms": "24", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "402600.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 935.032", "link_html_complex": "/ACE_complex_html/ACE_QTQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QTQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QTQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QTQSLVYP.png", "phi_psi": "/peptide_da/QTQSLVYP.pdb", "link_html_peptide": "/Peptide_html/QTQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QTQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/QTQSLVYP.png"}
{"Peptide_Sequence": "QTQYTDAPSFSDIPNPIGSENSEKTTMPLW", " Origin": "alpha-s1 casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "346", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "122.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 3355.59", "link_html_complex": "/ACE_complex_html/ACE_QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.png", "phi_psi": "/peptide_da/QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdb", "link_html_peptide": "/Peptide_html/QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.pdb", "link_png_peptide": "/Peptide_pics/QTQYTDAPSFSDIPNPIGSENSEKTTMPLW.png"}
{"Peptide_Sequence": "QV", " Origin": "wheat germ", " Peptide_Preparation": "", " Isolation_Method": "ethanol precipitation and chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "26.82 \u03bcM", " Reference": "Yang, Runqiang, et al. \"Accumulation and identification of angiotensin-converting enzyme inhibitory peptides from wheat germ.\" Journal of agricultural and food chemistry 59.8 (2011): 3598-3605.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "1100", " Ligand_ID": "QV_minimized.pdb_1100", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(O)=O", " MW": "245.28", " logP": "-4.53", " logD": "-4.14", " logSw": "1.96", " tPSA": "139.96", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1732938.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.276", "link_html_complex": "/ACE_complex_html/ACE_QV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QV.png", "phi_psi": "/peptide_da/QV.pdb", "link_html_peptide": "/Peptide_html/QV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QV.pdb", "link_png_peptide": "/Peptide_pics/QV.png"}
{"Peptide_Sequence": "QVGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "160.8 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1099", " Ligand_ID": "QVGP_minimized.pdb_1099", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "399.44", " logP": "-4.05", " logD": "-6.82", " logSw": "0.89", " tPSA": "189.37", " RotatableB": "10", " RigidB": "14", " Flexibility": "0.42", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "977528.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 399.442", "link_html_complex": "/ACE_complex_html/ACE_QVGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QVGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QVGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QVGP.png", "phi_psi": "/peptide_da/QVGP.pdb", "link_html_peptide": "/Peptide_html/QVGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QVGP.pdb", "link_png_peptide": "/Peptide_pics/QVGP.png"}
{"Peptide_Sequence": "QVPQPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "660", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1101", " Ligand_ID": "QVPQPIP_minimized.pdb_1101", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "777.91", " logP": "-3.64", " logD": "-7.08", " logSw": "-1.18", " tPSA": "302.18", " RotatableB": "18", " RigidB": "32", " Flexibility": "0.36", " HBD": "10", " HBA": "19", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "36", " HeteroAtoms": "19", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "238597.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 777.908", "link_html_complex": "/ACE_complex_html/ACE_QVPQPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QVPQPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QVPQPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QVPQPIP.png", "phi_psi": "/peptide_da/QVPQPIP.pdb", "link_html_peptide": "/Peptide_html/QVPQPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QVPQPIP.pdb", "link_png_peptide": "/Peptide_pics/QVPQPIP.png"}
{"Peptide_Sequence": "QVSLNSGYY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "22.9 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1102", " Ligand_ID": "QVSLNSGYY_minimized.pdb_1102", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1030.09", " logP": "-5.46", " logD": "-9.36", " logSw": "-0.87", " tPSA": "467.67", " RotatableB": "30", " RigidB": "33", " Flexibility": "0.48", " HBD": "19", " HBA": "27", " HBD_HBA": "46", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "73", " CarbonAtoms": "46", " HeteroAtoms": "27", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "431481.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1030.09", "link_html_complex": "/ACE_complex_html/ACE_QVSLNSGYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QVSLNSGYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QVSLNSGYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QVSLNSGYY.png", "phi_psi": "/peptide_da/QVSLNSGYY.pdb", "link_html_peptide": "/Peptide_html/QVSLNSGYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QVSLNSGYY.pdb", "link_png_peptide": "/Peptide_pics/QVSLNSGYY.png"}
{"Peptide_Sequence": "QVTSTAV", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1103", " Ligand_ID": "QVTSTAV_minimized.pdb_1103", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(O)=O", " MW": "704.77", " logP": "-6.04", " logD": "-9.53", " logSw": "0.98", " tPSA": "346.15", " RotatableB": "21", " RigidB": "15", " Flexibility": "0.58", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "29", " HeteroAtoms": "20", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1880888.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 704.77", "link_html_complex": "/ACE_complex_html/ACE_QVTSTAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QVTSTAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QVTSTAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QVTSTAV.png", "phi_psi": "/peptide_da/QVTSTAV.pdb", "link_html_peptide": "/Peptide_html/QVTSTAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QVTSTAV.pdb", "link_png_peptide": "/Peptide_pics/QVTSTAV.png"}
{"Peptide_Sequence": "QVVF", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "140 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1104", " Ligand_ID": "QVVF_minimized.pdb_1104", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "491.58", " logP": "-3.09", " logD": "-3.91", " logSw": "-0.08", " tPSA": "198.16", " RotatableB": "14", " RigidB": "15", " Flexibility": "0.48", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "24", " HeteroAtoms": "11", " ratio_H_by_C": "0.46", " Lipinski_Violation": "2", " Solubility_mg_per_l": "454346.46", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 491.581", "link_html_complex": "/ACE_complex_html/ACE_QVVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QVVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QVVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QVVF.png", "phi_psi": "/peptide_da/QVVF.pdb", "link_html_peptide": "/Peptide_html/QVVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QVVF.pdb", "link_png_peptide": "/Peptide_pics/QVVF.png"}
{"Peptide_Sequence": "QW", " Origin": "Human Alpha-Casein ", " Peptide_Preparation": "pepsine digestion", " Isolation_Method": "", " ACE_inhibition_assay": "reversed-phase HPLC, as described by Kim et al. (1999)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "59\u00b5mol/ l", " Reference": "Kim YK, Chung BH. A novel angiotensin-I\u2013converting enzyme inhibitory peptide from human a'er'fas1-casein. Biotechnol Lett 1999;21:575\u20138.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1105", " Ligand_ID": "QW_minimized.pdb_1105", " Smiles": "N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "332.35", " logP": "-3.3", " logD": "-3.27", " logSw": "0.56", " tPSA": "155.75", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "578964.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 332.354", "link_html_complex": "/ACE_complex_html/ACE_QW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_QW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_QW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_QW.png", "phi_psi": "/peptide_da/QW.pdb", "link_html_peptide": "/Peptide_html/QW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/QW.pdb", "link_png_peptide": "/Peptide_pics/QW.png"}
{"Peptide_Sequence": "RA", " Origin": "Fructose-bisphosphate aldolase (rabbit)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Castellano, Patricia, et al. \"Peptides with angiotensin I converting enzyme (ACE) inhibitory activity generated from porcine skeletal muscle proteins by the action of meat-borne Lactobacillus.\" Journal of proteomics 89 (2013): 183-190.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "1110", " Ligand_ID": "RA_minimized.pdb_1110", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "245.28", " logP": "-4.07", " logD": "-7.06", " logSw": "1.73", " tPSA": "160.51", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "17", " CarbonAtoms": "9", " HeteroAtoms": "8", " ratio_H_by_C": "0.89", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1385431.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.279", "link_html_complex": "/ACE_complex_html/ACE_RA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RA.png", "phi_psi": "/peptide_da/RA.pdb", "link_html_peptide": "/Peptide_html/RA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RA.pdb", "link_png_peptide": "/Peptide_pics/RA.png"}
{"Peptide_Sequence": "RADHP", " Origin": "synthetic", " Peptide_Preparation": "simulated gastrointestinal digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "153 \u03bcg/mL", " Reference": "Miguel, M., et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin.\" Journal of Agricultural and Food Chemistry 54.3 (2006): 726-731.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1108", " Ligand_ID": "RADHP_minimized.pdb_1108", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "594.62", " logP": "-5.63", " logD": "-13.29", " logSw": "1.1", " tPSA": "307.83", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "24", " HeteroAtoms": "18", " ratio_H_by_C": "0.75", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1779211.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 594.621", "link_html_complex": "/ACE_complex_html/ACE_RADHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RADHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RADHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RADHP.png", "phi_psi": "/peptide_da/RADHP.pdb", "link_html_peptide": "/Peptide_html/RADHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RADHP.pdb", "link_png_peptide": "/Peptide_pics/RADHP.png"}
{"Peptide_Sequence": "RADHPF", " Origin": "ovalbumin", " Peptide_Preparation": "Chymotryptic digestion", " Isolation_Method": "HPLC on ODS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": ">1 mM", " Reference": "A novel anti-hypertensive peptide derived from ovalbumin induces nitricoxide-mediated vasorelaxation in an isolated SHR mesenteric arteryNobuyuki Matobaa, Hachiro Usuia, Hiroyuki Fujitaa;b, Masaaki Yoshikawaa", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1107", " Ligand_ID": "RADHPF_minimized.pdb_1107", " Smiles": "C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "741.79", " logP": "-4.3", " logD": "-12.16", " logSw": "-0.43", " tPSA": "336.93", " RotatableB": "21", " RigidB": "29", " Flexibility": "0.42", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "484707.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 741.795", "link_html_complex": "/ACE_complex_html/ACE_RADHPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RADHPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RADHPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RADHPF.png", "phi_psi": "/peptide_da/RADHPF.pdb", "link_html_peptide": "/Peptide_html/RADHPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RADHPF.pdb", "link_png_peptide": "/Peptide_pics/RADHPF.png"}
{"Peptide_Sequence": "RADHPFL", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.2", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1106", " Ligand_ID": "RADHPFL_minimized.pdb_1106", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "854.95", " logP": "-3.23", " logD": "-11.44", " logSw": "-1.52", " tPSA": "366.03", " RotatableB": "25", " RigidB": "31", " Flexibility": "0.45", " HBD": "14", " HBA": "22", " HBD_HBA": "36", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "39", " HeteroAtoms": "22", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "186203.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 854.952", "link_html_complex": "/ACE_complex_html/ACE_RADHPFL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RADHPFL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RADHPFL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RADHPFL.png", "phi_psi": "/peptide_da/RADHPFL.pdb", "link_html_peptide": "/Peptide_html/RADHPFL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RADHPFL.pdb", "link_png_peptide": "/Peptide_pics/RADHPFL.png"}
{"Peptide_Sequence": "RALP", " Origin": "Rapeseed Protein", " Peptide_Preparation": "Alcalase", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al (1979)", " In-vivo_or_in-vitro": "In-vitro, in-vivo", " IC50_micromol_per_L": "0.65 mM", " Reference": "He, Rong, et al. \"Glycinyl-histidinyl-serine (GHS), a novel rapeseed protein-derived peptide has blood pressure-lowering effect in spontaneously hypertensive rats.\" Journal of agricultural and food chemistry 61.35 (2013): 8396-8402.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1109", " Ligand_ID": "RALP_minimized.pdb_1109", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "455.55", " logP": "-4.64", " logD": "-7.83", " logSw": "1.12", " tPSA": "209.92", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "20", " HeteroAtoms": "12", " ratio_H_by_C": "0.6", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1391710.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.552", "link_html_complex": "/ACE_complex_html/ACE_RALP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RALP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RALP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RALP.png", "phi_psi": "/peptide_da/RALP.pdb", "link_html_peptide": "/Peptide_html/RALP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RALP.pdb", "link_png_peptide": "/Peptide_pics/RALP.png"}
{"Peptide_Sequence": "RASDPLLSV", " Origin": "Chemical synthesis", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung with modification described by Miguel et. al. 2004", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.7 \u03bcmol/L", " Reference": "Eckert, Ewelina, et al. \"Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia).\" Journal of proteomics 110 (2014): 107-116.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1111", " Ligand_ID": "RASDPLLSV_minimized.pdb_1111", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "957.08", " logP": "-4.91", " logD": "-14.56", " logSw": "-0.7", " tPSA": "436.01", " RotatableB": "30", " RigidB": "24", " Flexibility": "0.56", " HBD": "17", " HBA": "26", " HBD_HBA": "43", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "67", " CarbonAtoms": "41", " HeteroAtoms": "26", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "474982.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 957.082", "link_html_complex": "/ACE_complex_html/ACE_RASDPLLSV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RASDPLLSV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RASDPLLSV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RASDPLLSV.png", "phi_psi": "/peptide_da/RASDPLLSV.pdb", "link_html_peptide": "/Peptide_html/RASDPLLSV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RASDPLLSV.pdb", "link_png_peptide": "/Peptide_pics/RASDPLLSV.png"}
{"Peptide_Sequence": "RCPET", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1112", " Ligand_ID": "RCPET_minimized.pdb_1112", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "604.68", " logP": "-5.74", " logD": "-13.79", " logSw": "1.22", " tPSA": "338.18", " RotatableB": "18", " RigidB": "16", " Flexibility": "0.53", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2038353.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 604.676", "link_html_complex": "/ACE_complex_html/ACE_RCPET.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RCPET.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RCPET.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RCPET.png", "phi_psi": "/peptide_da/RCPET.pdb", "link_html_peptide": "/Peptide_html/RCPET.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RCPET.pdb", "link_png_peptide": "/Peptide_pics/RCPET.png"}
{"Peptide_Sequence": "RDILNQ", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "435.7", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1113", " Ligand_ID": "RDILNQ_minimized.pdb_1113", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "757.84", " logP": "-5.99", " logD": "-10.44", " logSw": "0.95", " tPSA": "403.22", " RotatableB": "26", " RigidB": "17", " Flexibility": "0.6", " HBD": "17", " HBA": "22", " HBD_HBA": "39", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "31", " HeteroAtoms": "22", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1961738.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 757.835", "link_html_complex": "/ACE_complex_html/ACE_RDILNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RDILNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RDILNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RDILNQ.png", "phi_psi": "/peptide_da/RDILNQ.pdb", "link_html_peptide": "/Peptide_html/RDILNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RDILNQ.pdb", "link_png_peptide": "/Peptide_pics/RDILNQ.png"}
{"Peptide_Sequence": "RDMPIQAF", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "209 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1114", " Ligand_ID": "RDMPIQAF_minimized.pdb_1114", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "977.14", " logP": "-3.77", " logD": "-8.74", " logSw": "-1.51", " tPSA": "434.84", " RotatableB": "31", " RigidB": "30", " Flexibility": "0.51", " HBD": "16", " HBA": "24", " HBD_HBA": "40", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "68", " CarbonAtoms": "43", " HeteroAtoms": "25", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "215901.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 977.138", "link_html_complex": "/ACE_complex_html/ACE_RDMPIQAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RDMPIQAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RDMPIQAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RDMPIQAF.png", "phi_psi": "/peptide_da/RDMPIQAF.pdb", "link_html_peptide": "/Peptide_html/RDMPIQAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RDMPIQAF.pdb", "link_png_peptide": "/Peptide_pics/RDMPIQAF.png"}
{"Peptide_Sequence": "REKVLASS", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "32 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1115", " Ligand_ID": "REKVLASS_minimized.pdb_1115", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O", " MW": "889.01", " logP": "-8.44", " logD": "-14.75", " logSw": "2.08", " tPSA": "443.34", " RotatableB": "32", " RigidB": "17", " Flexibility": "0.65", " HBD": "19", " HBA": "25", " HBD_HBA": "44", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "62", " CarbonAtoms": "37", " HeteroAtoms": "25", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7097192.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 889.008", "link_html_complex": "/ACE_complex_html/ACE_REKVLASS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_REKVLASS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_REKVLASS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_REKVLASS.png", "phi_psi": "/peptide_da/REKVLASS.pdb", "link_html_peptide": "/Peptide_html/REKVLASS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/REKVLASS.pdb", "link_png_peptide": "/Peptide_pics/REKVLASS.png"}
{"Peptide_Sequence": "RELEEL", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1116", " Ligand_ID": "RELEEL_minimized.pdb_1116", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "787.86", " logP": "-3.98", " logD": "-15.77", " logSw": "-0.3", " tPSA": "397.3", " RotatableB": "29", " RigidB": "15", " Flexibility": "0.66", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "6", " TotalCharge": "-2", " HeavyAtoms": "55", " CarbonAtoms": "33", " HeteroAtoms": "22", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "581724.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 787.858", "link_html_complex": "/ACE_complex_html/ACE_RELEEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RELEEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RELEEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RELEEL.png", "phi_psi": "/peptide_da/RELEEL.pdb", "link_html_peptide": "/Peptide_html/RELEEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RELEEL.pdb", "link_png_peptide": "/Peptide_pics/RELEEL.png"}
{"Peptide_Sequence": "RELKDL", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1117", " Ligand_ID": "RELKDL_minimized.pdb_1117", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "772.89", " logP": "-6.34", " logD": "-12.72", " logSw": "1.28", " tPSA": "384.81", " RotatableB": "29", " RigidB": "14", " Flexibility": "0.67", " HBD": "16", " HBA": "21", " HBD_HBA": "37", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "6", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "33", " HeteroAtoms": "21", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2769492.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 772.89", "link_html_complex": "/ACE_complex_html/ACE_RELKDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RELKDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RELKDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RELKDL.png", "phi_psi": "/peptide_da/RELKDL.pdb", "link_html_peptide": "/Peptide_html/RELKDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RELKDL.pdb", "link_png_peptide": "/Peptide_pics/RELKDL.png"}
{"Peptide_Sequence": "RF", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "93", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1119", " Ligand_ID": "RF_minimized.pdb_1119", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "321.37", " logP": "-3.29", " logD": "-5.41", " logSw": "0.8", " tPSA": "160.51", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "717851.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 321.375", "link_html_complex": "/ACE_complex_html/ACE_RF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RF.png", "phi_psi": "/peptide_da/RF.pdb", "link_html_peptide": "/Peptide_html/RF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RF.pdb", "link_png_peptide": "/Peptide_pics/RF.png"}
{"Peptide_Sequence": "RFH", " Origin": "Sardine muscles", " Peptide_Preparation": "alkakine protease", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "2,4,6-trinitroben-zene sulfonate (TNBS) method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "330", " Reference": "Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., & Osajima, Y. (1994). Angiotensin I-converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58(12), 2244\u20132245. doi:10.1271/bbb.58.2244 ", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1118", " Ligand_ID": "RFH_minimized.pdb_1118", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "458.51", " logP": "-2.97", " logD": "-7.53", " logSw": "-0.02", " tPSA": "218.29", " RotatableB": "14", " RigidB": "17", " Flexibility": "0.45", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "450833.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 458.514", "link_html_complex": "/ACE_complex_html/ACE_RFH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RFH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RFH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RFH.png", "phi_psi": "/peptide_da/RFH.pdb", "link_html_peptide": "/Peptide_html/RFH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RFH.pdb", "link_png_peptide": "/Peptide_pics/RFH.png"}
{"Peptide_Sequence": "RG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1200 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1120", " Ligand_ID": "RG_minimized.pdb_1120", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O", " MW": "231.25", " logP": "-5.31", " logD": "-7.63", " logSw": "2.6", " tPSA": "160.51", " RotatableB": "8", " RigidB": "4", " Flexibility": "0.67", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "16", " CarbonAtoms": "8", " HeteroAtoms": "8", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "3112075.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 231.252", "link_html_complex": "/ACE_complex_html/ACE_RG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RG.png", "phi_psi": "/peptide_da/RG.pdb", "link_html_peptide": "/Peptide_html/RG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RG.pdb", "link_png_peptide": "/Peptide_pics/RG.png"}
{"Peptide_Sequence": "RGY", " Origin": "Egg Lysozyme", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "reverse-phase high-performance liquid chromatography", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "61.9", " Reference": "Purification and characterization of angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysate of hen egg white lysozyme", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1121", " Ligand_ID": "RGY_minimized.pdb_1121", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "394.43", " logP": "-4.27", " logD": "-7.94", " logSw": "1.11", " tPSA": "209.84", " RotatableB": "12", " RigidB": "12", " Flexibility": "0.5", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1202153.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 394.426", "link_html_complex": "/ACE_complex_html/ACE_RGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RGY.png", "phi_psi": "/peptide_da/RGY.pdb", "link_html_peptide": "/Peptide_html/RGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RGY.pdb", "link_png_peptide": "/Peptide_pics/RGY.png"}
{"Peptide_Sequence": "RHPHP", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1122", " Ligand_ID": "RHPHP_minimized.pdb_1122", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "642.71", " logP": "-4.7", " logD": "-10.44", " logSw": "0.11", " tPSA": "287.59", " RotatableB": "16", " RigidB": "30", " Flexibility": "0.35", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "28", " HeteroAtoms": "18", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "716086.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 642.71", "link_html_complex": "/ACE_complex_html/ACE_RHPHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RHPHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RHPHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RHPHP.png", "phi_psi": "/peptide_da/RHPHP.pdb", "link_html_peptide": "/Peptide_html/RHPHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RHPHP.pdb", "link_png_peptide": "/Peptide_pics/RHPHP.png"}
{"Peptide_Sequence": "RHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "330", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1123", " Ligand_ID": "RHQG_minimized.pdb_1123", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "496.52", " logP": "-6.38", " logD": "-11.68", " logSw": "2.17", " tPSA": "290.48", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "19", " HeteroAtoms": "16", " ratio_H_by_C": "0.84", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4338884.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 496.521", "link_html_complex": "/ACE_complex_html/ACE_RHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RHQG.png", "phi_psi": "/peptide_da/RHQG.pdb", "link_html_peptide": "/Peptide_html/RHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RHQG.pdb", "link_png_peptide": "/Peptide_pics/RHQG.png"}
{"Peptide_Sequence": "RIGLF", " Origin": "mushroom (Agaricus bisporus) ", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "ACE kit-WST, Dojindo Laboratories, Kumamoto, Japan", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "115.9", " Reference": "Lau, Ching Ching, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (JE Lange) Imbach identified by LC\u2013MS/MS.\" Food chemistry 148 (2014): 396-401.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1124", " Ligand_ID": "RIGLF_minimized.pdb_1124", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "604.74", " logP": "-2.4", " logD": "-6.22", " logSw": "-0.81", " tPSA": "247.81", " RotatableB": "20", " RigidB": "16", " Flexibility": "0.56", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "29", " HeteroAtoms": "14", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "270051.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 604.741", "link_html_complex": "/ACE_complex_html/ACE_RIGLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RIGLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RIGLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RIGLF.png", "phi_psi": "/peptide_da/RIGLF.pdb", "link_html_peptide": "/Peptide_html/RIGLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RIGLF.pdb", "link_png_peptide": "/Peptide_pics/RIGLF.png"}
{"Peptide_Sequence": "RINK", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1126", " Ligand_ID": "RINK_minimized.pdb_1126", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "529.63", " logP": "-5.01", " logD": "-9.32", " logSw": "1.35", " tPSA": "289.44", " RotatableB": "20", " RigidB": "10", " Flexibility": "0.67", " HBD": "14", " HBA": "15", " HBD_HBA": "29", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "37", " CarbonAtoms": "22", " HeteroAtoms": "15", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2048283.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 529.633", "link_html_complex": "/ACE_complex_html/ACE_RINK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RINK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RINK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RINK.png", "phi_psi": "/peptide_da/RINK.pdb", "link_html_peptide": "/Peptide_html/RINK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RINK.pdb", "link_png_peptide": "/Peptide_pics/RINK.png"}
{"Peptide_Sequence": "RINKK", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1125", " Ligand_ID": "RINKK_minimized.pdb_1125", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "657.81", " logP": "-5.5", " logD": "-12.58", " logSw": "1.26", " tPSA": "346.18", " RotatableB": "26", " RigidB": "12", " Flexibility": "0.68", " HBD": "17", " HBA": "18", " HBD_HBA": "35", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "46", " CarbonAtoms": "28", " HeteroAtoms": "18", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2325089.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 657.806", "link_html_complex": "/ACE_complex_html/ACE_RINKK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RINKK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RINKK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RINKK.png", "phi_psi": "/peptide_da/RINKK.pdb", "link_html_peptide": "/Peptide_html/RINKK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RINKK.pdb", "link_png_peptide": "/Peptide_pics/RINKK.png"}
{"Peptide_Sequence": "RIY", " Origin": "rapeseed", " Peptide_Preparation": "proteolytic enzymes", " Isolation_Method": "octadecyl silica (ODS) column, cyanopropyl silica (CN) column, phenetyl silica and nitrophenetyl column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with modification by Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "28", " Reference": "Marczak, Ewa D., et al. \"New antihypertensive peptides isolated from rapeseed.\" Peptides 24.6 (2003): 791-798.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1127", " Ligand_ID": "RIY_minimized.pdb_1127", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "450.53", " logP": "-2.86", " logD": "-6.01", " logSw": "0.03", " tPSA": "209.84", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "462043.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 450.532", "link_html_complex": "/ACE_complex_html/ACE_RIY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RIY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RIY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RIY.png", "phi_psi": "/peptide_da/RIY.pdb", "link_html_peptide": "/Peptide_html/RIY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RIY.pdb", "link_png_peptide": "/Peptide_pics/RIY.png"}
{"Peptide_Sequence": "RL", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "2439 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1128", " Ligand_ID": "RL_minimized.pdb_1128", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "287.36", " logP": "-3.61", " logD": "-5.81", " logSw": "1.31", " tPSA": "160.51", " RotatableB": "10", " RigidB": "4", " Flexibility": "0.71", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1067855.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.359", "link_html_complex": "/ACE_complex_html/ACE_RL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RL.png", "phi_psi": "/peptide_da/RL.pdb", "link_html_peptide": "/Peptide_html/RL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RL.pdb", "link_png_peptide": "/Peptide_pics/RL.png"}
{"Peptide_Sequence": "RLPSEFDLSAFLRA", " Origin": " Pleurotus cornucopiae", " Peptide_Preparation": " stimulated gastric fluids and stimulated intestinal fluids ", " Isolation_Method": "UF, SCX, HP-HPLC", " ACE_inhibition_assay": " modified method of Cushman and Cheong (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 52 \u03bcM", " Reference": "Jang, Jeong-Hoon, et al. \"Characterisation of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae.\" Food chemistry 127.2 (2011): 412-418.", " Binding_Energy_kcal_per_mol": "-5.4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1621.83", "link_html_complex": "/ACE_complex_html/ACE_RLPSEFDLSAFLRA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RLPSEFDLSAFLRA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RLPSEFDLSAFLRA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RLPSEFDLSAFLRA.png", "phi_psi": "/peptide_da/RLPSEFDLSAFLRA.pdb", "link_html_peptide": "/Peptide_html/RLPSEFDLSAFLRA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RLPSEFDLSAFLRA.pdb", "link_png_peptide": "/Peptide_pics/RLPSEFDLSAFLRA.png"}
{"Peptide_Sequence": "RLSGQTIEVTSEYLFRH", " Origin": " Pleurotus cornucopiae", " Peptide_Preparation": " stimulated gastric fluids and stimulated intestinal fluids ", " Isolation_Method": "UF, SCX, HP-HPLC", " ACE_inhibition_assay": " modified method of Cushman and Cheong (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1079 \u03bcM", " Reference": "Jang, Jeong-Hoon, et al. \"Characterisation of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae.\" Food chemistry 127.2 (2011): 412-418.", " Binding_Energy_kcal_per_mol": "12.4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2036.25", "link_html_complex": "/ACE_complex_html/ACE_RLSGQTIEVTSEYLFRH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RLSGQTIEVTSEYLFRH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RLSGQTIEVTSEYLFRH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RLSGQTIEVTSEYLFRH.png", "phi_psi": "/peptide_da/RLSGQTIEVTSEYLFRH.pdb", "link_html_peptide": "/Peptide_html/RLSGQTIEVTSEYLFRH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RLSGQTIEVTSEYLFRH.pdb", "link_png_peptide": "/Peptide_pics/RLSGQTIEVTSEYLFRH.png"}
{"Peptide_Sequence": "RML", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1134", " Ligand_ID": "RML_minimized.pdb_1134", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "418.55", " logP": "-2.91", " logD": "-6.74", " logSw": "0.39", " tPSA": "214.91", " RotatableB": "15", " RigidB": "6", " Flexibility": "0.71", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "1", " Solubility_mg_per_l": "617123.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 418.555", "link_html_complex": "/ACE_complex_html/ACE_RML.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RML.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RML.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RML.png", "phi_psi": "/peptide_da/RML.pdb", "link_html_peptide": "/Peptide_html/RML.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RML.pdb", "link_png_peptide": "/Peptide_pics/RML.png"}
{"Peptide_Sequence": "RMLGQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "354.8 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1131", " Ligand_ID": "RMLGQ_minimized.pdb_1131", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "603.74", " logP": "-4.44", " logD": "-9.83", " logSw": "0.67", " tPSA": "316.2", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "24", " HeteroAtoms": "17", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1175180.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 603.735", "link_html_complex": "/ACE_complex_html/ACE_RMLGQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RMLGQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RMLGQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RMLGQ.png", "phi_psi": "/peptide_da/RMLGQ.pdb", "link_html_peptide": "/Peptide_html/RMLGQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RMLGQ.pdb", "link_png_peptide": "/Peptide_pics/RMLGQ.png"}
{"Peptide_Sequence": "RMLGQTP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "501.2 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1132", " Ligand_ID": "RMLGQTP_minimized.pdb_1132", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "801.95", " logP": "-5.26", " logD": "-11.24", " logSw": "0.22", " tPSA": "385.84", " RotatableB": "26", " RigidB": "21", " Flexibility": "0.55", " HBD": "15", " HBA": "21", " HBD_HBA": "36", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "55", " CarbonAtoms": "33", " HeteroAtoms": "22", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "996984.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 801.954", "link_html_complex": "/ACE_complex_html/ACE_RMLGQTP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RMLGQTP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RMLGQTP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RMLGQTP.png", "phi_psi": "/peptide_da/RMLGQTP.pdb", "link_html_peptide": "/Peptide_html/RMLGQTP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RMLGQTP.pdb", "link_png_peptide": "/Peptide_pics/RMLGQTP.png"}
{"Peptide_Sequence": "RMLGQTPTK", " Origin": "porcine skeletal", " Peptide_Preparation": "Alcalase, \u03b1-chymotrypsin, Neutrase, papain, pepsin, and trypsin", " Isolation_Method": "IEC, HPLC", " ACE_inhibition_assay": " Cushman and Cheung  with slight modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "14.2 \u03bcM", " Reference": "Qian, Zhong-Ji, et al. \"Antihypertensive effect of an angiotensin I-converting enzyme inhibitory peptide from bullfrog (Rana catesbeiana Shaw) muscle protein in spontaneously hypertensive rats.\" Process Biochemistry 42.10 (2007): 1443-1448.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1133", " Ligand_ID": "RMLGQTPTK_minimized.pdb_1133", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1031.23", " logP": "-6.62", " logD": "-12.69", " logSw": "0.25", " tPSA": "491.91", " RotatableB": "35", " RigidB": "25", " Flexibility": "0.58", " HBD": "20", " HBA": "27", " HBD_HBA": "47", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "71", " CarbonAtoms": "43", " HeteroAtoms": "28", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1320121.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1031.23", "link_html_complex": "/ACE_complex_html/ACE_RMLGQTPTK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RMLGQTPTK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RMLGQTPTK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RMLGQTPTK.png", "phi_psi": "/peptide_da/RMLGQTPTK.pdb", "link_html_peptide": "/Peptide_html/RMLGQTPTK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RMLGQTPTK.pdb", "link_png_peptide": "/Peptide_pics/RMLGQTPTK.png"}
{"Peptide_Sequence": "RNDDLNYIQ", " Origin": "Chemical synthesis", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung with modification described by Miguel et. al. 2004", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.72 \u03bcmol/L", " Reference": "Eckert, Ewelina, et al. \"Egg-yolk protein by-product as a source of ACE-inhibitory peptides obtained with using unconventional proteinase from Asian pumpkin (Cucurbita ficifolia).\" Journal of proteomics 110 (2014): 107-116.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1135", " Ligand_ID": "RNDDLNYIQ_minimized.pdb_1135", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1150.2", " logP": "-7.91", " logD": "-19.22", " logSw": "0.43", " tPSA": "593.97", " RotatableB": "37", " RigidB": "32", " Flexibility": "0.54", " HBD": "24", " HBA": "33", " HBD_HBA": "57", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "81", " CarbonAtoms": "48", " HeteroAtoms": "33", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1760399.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1150.2", "link_html_complex": "/ACE_complex_html/ACE_RNDDLNYIQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RNDDLNYIQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RNDDLNYIQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RNDDLNYIQ.png", "phi_psi": "/peptide_da/RNDDLNYIQ.pdb", "link_html_peptide": "/Peptide_html/RNDDLNYIQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RNDDLNYIQ.pdb", "link_png_peptide": "/Peptide_pics/RNDDLNYIQ.png"}
{"Peptide_Sequence": "RP", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "15.2 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1141", " Ligand_ID": "RP_minimized.pdb_1141", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "271.32", " logP": "-3.9", " logD": "-6.79", " logSw": "1.4", " tPSA": "151.72", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1096769.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 271.316", "link_html_complex": "/ACE_complex_html/ACE_RP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RP.png", "phi_psi": "/peptide_da/RP.pdb", "link_html_peptide": "/Peptide_html/RP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RP.pdb", "link_png_peptide": "/Peptide_pics/RP.png"}
{"Peptide_Sequence": "RPK", " Origin": "Ovine and Caprine cheese", " Peptide_Preparation": "Proteases from Cynara cardunculus", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Vermeirssen et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "36.68 \u03bcg/mL", " Reference": "Silva, S. V., Anne Pihlanto, and F. Xavier Malcata. \"Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus.\" Journal of dairy science 89.9 (2006): 3336-3344.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "1140", " Ligand_ID": "RPK_minimized.pdb_1140", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "399.49", " logP": "-5.26", " logD": "-8.39", " logSw": "1.85", " tPSA": "208.46", " RotatableB": "13", " RigidB": "11", " Flexibility": "0.54", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2553337.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 399.488", "link_html_complex": "/ACE_complex_html/ACE_RPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPK.png", "phi_psi": "/peptide_da/RPK.pdb", "link_html_peptide": "/Peptide_html/RPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPK.pdb", "link_png_peptide": "/Peptide_pics/RPK.png"}
{"Peptide_Sequence": "RPKH", " Origin": "milk caseins from bovine, sheep, goat, pig, buffalo, human", " Peptide_Preparation": "L. helveticus PR4", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "Minervini, F., et al. \"Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species.\" Appl. Environ. Microbiol. 69.9 (2003): 5297-5305.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1136", " Ligand_ID": "RPKH_minimized.pdb_1136", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "536.63", " logP": "-6.18", " logD": "-11.02", " logSw": "1.8", " tPSA": "266.24", " RotatableB": "17", " RigidB": "18", " Flexibility": "0.49", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "38", " CarbonAtoms": "23", " HeteroAtoms": "15", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3249241.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 536.628", "link_html_complex": "/ACE_complex_html/ACE_RPKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPKH.png", "phi_psi": "/peptide_da/RPKH.pdb", "link_html_peptide": "/Peptide_html/RPKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPKH.pdb", "link_png_peptide": "/Peptide_pics/RPKH.png"}
{"Peptide_Sequence": "RPKHPI", " Origin": "alpha-s1 casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1139", " Ligand_ID": "RPKHPI_minimized.pdb_1139", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "746.9", " logP": "-3.63", " logD": "-11.83", " logSw": "-0.77", " tPSA": "315.65", " RotatableB": "22", " RigidB": "27", " Flexibility": "0.45", " HBD": "13", " HBA": "19", " HBD_HBA": "32", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "53", " CarbonAtoms": "34", " HeteroAtoms": "19", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "347482.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 746.901", "link_html_complex": "/ACE_complex_html/ACE_RPKHPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPKHPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPKHPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPKHPI.png", "phi_psi": "/peptide_da/RPKHPI.pdb", "link_html_peptide": "/Peptide_html/RPKHPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPKHPI.pdb", "link_png_peptide": "/Peptide_pics/RPKHPI.png"}
{"Peptide_Sequence": "RPKHPIKH", " Origin": "Ovine and Caprine cheese", " Peptide_Preparation": "Proteases from Cynara cardunculus", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Vermeirssen et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "892 \u03bcg/mL", " Reference": "Silva, S. V., Anne Pihlanto, and F. Xavier Malcata. \"Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus.\" Journal of dairy science 89.9 (2006): 3336-3344.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1137", " Ligand_ID": "RPKHPIKH_minimized.pdb_1137", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "1012.21", " logP": "-4.61", " logD": "-14.78", " logSw": "-1.15", " tPSA": "430.17", " RotatableB": "32", " RigidB": "36", " Flexibility": "0.47", " HBD": "18", " HBA": "26", " HBD_HBA": "44", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "72", " CarbonAtoms": "46", " HeteroAtoms": "26", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "320798.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1012.21", "link_html_complex": "/ACE_complex_html/ACE_RPKHPIKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPKHPIKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPKHPIKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPKHPIKH.png", "phi_psi": "/peptide_da/RPKHPIKH.pdb", "link_html_peptide": "/Peptide_html/RPKHPIKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPKHPIKH.pdb", "link_png_peptide": "/Peptide_pics/RPKHPIKH.png"}
{"Peptide_Sequence": "RPKHPIKHQ", " Origin": "alpha-s1 casein", " Peptide_Preparation": "Protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman & Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by anextracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994;77:917\u201322.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1138", " Ligand_ID": "RPKHPIKHQ_minimized.pdb_1138", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1140.34", " logP": "-6.02", " logD": "-17.88", " logSw": "-0.72", " tPSA": "502.36", " RotatableB": "37", " RigidB": "40", " Flexibility": "0.48", " HBD": "21", " HBA": "30", " HBD_HBA": "51", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "81", " CarbonAtoms": "51", " HeteroAtoms": "30", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "555011.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1140.34", "link_html_complex": "/ACE_complex_html/ACE_RPKHPIKHQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPKHPIKHQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPKHPIKHQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPKHPIKHQ.png", "phi_psi": "/peptide_da/RPKHPIKHQ.pdb", "link_html_peptide": "/Peptide_html/RPKHPIKHQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPKHPIKHQ.pdb", "link_png_peptide": "/Peptide_pics/RPKHPIKHQ.png"}
{"Peptide_Sequence": "RPP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1142", " Ligand_ID": "RPP_minimized.pdb_1142", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "368.43", " logP": "-3.72", " logD": "-8.15", " logSw": "0.75", " tPSA": "172.03", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "777886.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 368.431", "link_html_complex": "/ACE_complex_html/ACE_RPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPP.png", "phi_psi": "/peptide_da/RPP.pdb", "link_html_peptide": "/Peptide_html/RPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPP.pdb", "link_png_peptide": "/Peptide_pics/RPP.png"}
{"Peptide_Sequence": "RPQIPP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "166 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1143", " Ligand_ID": "RPQIPP_minimized.pdb_1143", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "706.83", " logP": "-4.01", " logD": "-9.54", " logSw": "-0.51", " tPSA": "293.63", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "50", " CarbonAtoms": "32", " HeteroAtoms": "18", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "425271.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 706.833", "link_html_complex": "/ACE_complex_html/ACE_RPQIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPQIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPQIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPQIPP.png", "phi_psi": "/peptide_da/RPQIPP.pdb", "link_html_peptide": "/Peptide_html/RPQIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPQIPP.pdb", "link_png_peptide": "/Peptide_pics/RPQIPP.png"}
{"Peptide_Sequence": "RPR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "382", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1145", " Ligand_ID": "RPR_minimized.pdb_1145", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "427.5", " logP": "-5.85", " logD": "-8.98", " logSw": "2.12", " tPSA": "244.46", " RotatableB": "14", " RigidB": "12", " Flexibility": "0.54", " HBD": "12", " HBA": "13", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "30", " CarbonAtoms": "17", " HeteroAtoms": "13", " ratio_H_by_C": "0.76", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3557976.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 427.502", "link_html_complex": "/ACE_complex_html/ACE_RPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPR.png", "phi_psi": "/peptide_da/RPR.pdb", "link_html_peptide": "/Peptide_html/RPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPR.pdb", "link_png_peptide": "/Peptide_pics/RPR.png"}
{"Peptide_Sequence": "RPRHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "22", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1144", " Ligand_ID": "RPRHQG_minimized.pdb_1144", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "749.82", " logP": "-7.4", " logD": "-15.8", " logSw": "1.79", " tPSA": "403.53", " RotatableB": "25", " RigidB": "25", " Flexibility": "0.5", " HBD": "18", " HBA": "23", " HBD_HBA": "41", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "53", " CarbonAtoms": "30", " HeteroAtoms": "23", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4479937.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 749.822", "link_html_complex": "/ACE_complex_html/ACE_RPRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPRHQG.png", "phi_psi": "/peptide_da/RPRHQG.pdb", "link_html_peptide": "/Peptide_html/RPRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPRHQG.pdb", "link_png_peptide": "/Peptide_pics/RPRHQG.png"}
{"Peptide_Sequence": "RPVQ", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "300 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1146", " Ligand_ID": "RPVQ_minimized.pdb_1146", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "498.58", " logP": "-6.18", " logD": "-9.45", " logSw": "1.95", " tPSA": "253.01", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3512147.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 498.576", "link_html_complex": "/ACE_complex_html/ACE_RPVQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPVQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPVQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPVQ.png", "phi_psi": "/peptide_da/RPVQ.pdb", "link_html_peptide": "/Peptide_html/RPVQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPVQ.pdb", "link_png_peptide": "/Peptide_pics/RPVQ.png"}
{"Peptide_Sequence": "RPY", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1148", " Ligand_ID": "RPY_minimized.pdb_1148", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "434.49", " logP": "-3.79", " logD": "-7.09", " logSw": "0.51", " tPSA": "201.05", " RotatableB": "11", " RigidB": "17", " Flexibility": "0.39", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "721440.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 434.489", "link_html_complex": "/ACE_complex_html/ACE_RPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPY.png", "phi_psi": "/peptide_da/RPY.pdb", "link_html_peptide": "/Peptide_html/RPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPY.pdb", "link_png_peptide": "/Peptide_pics/RPY.png"}
{"Peptide_Sequence": "RPYL", " Origin": "bovine lactoferrin", " Peptide_Preparation": " porcine pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo, ex-vivo", " IC50_micromol_per_L": "56.5 \u03bcM", " Reference": "Ruiz-Gim\u00e9nez, Pedro, et al. \"Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides.\" Food Chemistry 131.1 (2012): 266-273.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "1147", " Ligand_ID": "RPYL_minimized.pdb_1147", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(O)=O", " MW": "547.65", " logP": "-3.15", " logD": "-6.56", " logSw": "-0.32", " tPSA": "230.15", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "399102.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 547.647", "link_html_complex": "/ACE_complex_html/ACE_RPYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RPYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RPYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RPYL.png", "phi_psi": "/peptide_da/RPYL.pdb", "link_html_peptide": "/Peptide_html/RPYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RPYL.pdb", "link_png_peptide": "/Peptide_pics/RPYL.png"}
{"Peptide_Sequence": "RR", " Origin": "porcine skeletal muscle", " Peptide_Preparation": "Dipeptidyl peptidases ", " Isolation_Method": "selective precipitation followed by anion exchange chromatographies", " ACE_inhibition_assay": "fluorimetric assay using o-aminobenzoylglycyl-p-nitrophenylalanylproline ((Sentandreu & Toldr\u00e1, 2006) ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "267.1 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Evaluation of ACE inhibitory activity of dipeptides generated by the action of porcine muscle dipeptidyl peptidases.\" Food Chemistry 102.2 (2007): 511-515.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1149", " Ligand_ID": "RR_minimized.pdb_1149", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "330.39", " logP": "-5.76", " logD": "-8.91", " logSw": "2.6", " tPSA": "224.15", " RotatableB": "13", " RigidB": "5", " Flexibility": "0.72", " HBD": "12", " HBA": "11", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "23", " CarbonAtoms": "12", " HeteroAtoms": "11", " ratio_H_by_C": "0.92", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4441140.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.387", "link_html_complex": "/ACE_complex_html/ACE_RR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RR.png", "phi_psi": "/peptide_da/RR.pdb", "link_html_peptide": "/Peptide_html/RR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RR.pdb", "link_png_peptide": "/Peptide_pics/RR.png"}
{"Peptide_Sequence": "RRR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "", " Reference": "Wu, Jianping, and Rotimi E. Aluko. \"Quantitative structure\u2010activity relationship study of bitter di\u2010and tri\u2010peptides including relationship with angiotensin I\u2010converting enzyme inhibitory activity.\" Journal of peptide science: an official publication of the European Peptide Society 13.1 (2007): 63-69.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1150", " Ligand_ID": "RRR_minimized.pdb_1150", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "486.57", " logP": "-7.37", " logD": "-12.56", " logSw": "3.11", " tPSA": "316.89", " RotatableB": "20", " RigidB": "8", " Flexibility": "0.71", " HBD": "17", " HBA": "16", " HBD_HBA": "33", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "3", " HeavyAtoms": "34", " CarbonAtoms": "18", " HeteroAtoms": "16", " ratio_H_by_C": "0.89", " Lipinski_Violation": "2", " Solubility_mg_per_l": "10869730.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 486.572", "link_html_complex": "/ACE_complex_html/ACE_RRR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RRR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RRR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RRR.png", "phi_psi": "/peptide_da/RRR.pdb", "link_html_peptide": "/Peptide_html/RRR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RRR.pdb", "link_png_peptide": "/Peptide_pics/RRR.png"}
{"Peptide_Sequence": "RS", " Origin": "", " Peptide_Preparation": "Dipeptidyl peptidases I\u2013IV", " Isolation_Method": "SE, anion-exchange chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "61 \u03bcM", " Reference": "Sentandreu, Miguel Angel, and Fidel Toldr\u00e1. \"Oligopeptides hydrolysed by muscle dipeptidyl peptidases can generate angiotensin-I converting enzyme inhibitory dipeptides.\" European Food Research and Technology 224.6 (2007): 785-790.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1152", " Ligand_ID": "RS_minimized.pdb_1152", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O", " MW": "261.28", " logP": "-5.12", " logD": "-8.11", " logSw": "2.36", " tPSA": "180.74", " RotatableB": "9", " RigidB": "4", " Flexibility": "0.69", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "18", " CarbonAtoms": "9", " HeteroAtoms": "9", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2766285.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 261.278", "link_html_complex": "/ACE_complex_html/ACE_RS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RS.png", "phi_psi": "/peptide_da/RS.pdb", "link_html_peptide": "/Peptide_html/RS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RS.pdb", "link_png_peptide": "/Peptide_pics/RS.png"}
{"Peptide_Sequence": "RSIKGF", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "32.7 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1151", " Ligand_ID": "RSIKGF_minimized.pdb_1151", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "706.83", " logP": "-4.37", " logD": "-11.87", " logSw": "0.14", " tPSA": "324.78", " RotatableB": "25", " RigidB": "18", " Flexibility": "0.58", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "50", " CarbonAtoms": "32", " HeteroAtoms": "18", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "811460.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 706.833", "link_html_complex": "/ACE_complex_html/ACE_RSIKGF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RSIKGF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RSIKGF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RSIKGF.png", "phi_psi": "/peptide_da/RSIKGF.pdb", "link_html_peptide": "/Peptide_html/RSIKGF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RSIKGF.pdb", "link_png_peptide": "/Peptide_pics/RSIKGF.png"}
{"Peptide_Sequence": "RVCLP", " Origin": " lizard fish ", " Peptide_Preparation": "", " Isolation_Method": " ion exchange column, RPC, HPLC, capillary electrophoresis", " ACE_inhibition_assay": "Wu et al., 2012", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "175 \u03bcM", " Reference": "Wu, Shanguang, et al. \"Purification and identification of Angiotensin-I Converting Enzyme (ACE) inhibitory peptide from lizard fish (Saurida elongata) hydrolysate.\" Journal of functional foods 13 (2015): 295-299.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1153", " Ligand_ID": "RVCLP_minimized.pdb_1153", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "586.75", " logP": "-4.01", " logD": "-6.77", " logSw": "0.17", " tPSA": "277.82", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "695797.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 586.747", "link_html_complex": "/ACE_complex_html/ACE_RVCLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RVCLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RVCLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RVCLP.png", "phi_psi": "/peptide_da/RVCLP.pdb", "link_html_peptide": "/Peptide_html/RVCLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RVCLP.pdb", "link_png_peptide": "/Peptide_pics/RVCLP.png"}
{"Peptide_Sequence": "RVPSL", " Origin": "egg white", " Peptide_Preparation": "heating, centrigugation", " Isolation_Method": "ion-exchange column", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "20 \u03bcM", " Reference": "Liu, JingBo, et al. \"Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates.\" Food chemistry 122.4 (2010): 1159-1163.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1154", " Ligand_ID": "RVPSL_minimized.pdb_1154", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(O)=O", " MW": "570.68", " logP": "-5", " logD": "-8.62", " logSw": "0.89", " tPSA": "259.25", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1394935.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 570.682", "link_html_complex": "/ACE_complex_html/ACE_RVPSL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RVPSL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RVPSL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RVPSL.png", "phi_psi": "/peptide_da/RVPSL.pdb", "link_html_peptide": "/Peptide_html/RVPSL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RVPSL.pdb", "link_png_peptide": "/Peptide_pics/RVPSL.png"}
{"Peptide_Sequence": "RVPSLM", " Origin": "egg white", " Peptide_Preparation": "heating, centrigugation", " Isolation_Method": "ion-exchange column", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Liu, JingBo, et al. \"Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates.\" Food chemistry 122.4 (2010): 1159-1163.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1155", " Ligand_ID": "RVPSLM_minimized.pdb_1155", " Smiles": "CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(O)=O", " MW": "701.88", " logP": "-4.61", " logD": "-8.45", " logSw": "0.16", " tPSA": "313.65", " RotatableB": "22", " RigidB": "17", " Flexibility": "0.56", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "30", " HeteroAtoms": "18", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "827504.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 701.878", "link_html_complex": "/ACE_complex_html/ACE_RVPSLM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RVPSLM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RVPSLM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RVPSLM.png", "phi_psi": "/peptide_da/RVPSLM.pdb", "link_html_peptide": "/Peptide_html/RVPSLM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RVPSLM.pdb", "link_png_peptide": "/Peptide_pics/RVPSLM.png"}
{"Peptide_Sequence": "RVR", " Origin": "Hemp Seed (Cannabis sativa L.)", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "526  \u00b5M        ", " Reference": "Orio, Lara P., et al. \"New ACE-inhibitory peptides from hemp seed (Cannabis sativa L.) proteins.\" Journal of agricultural and food chemistry 65.48 (2017): 10482-10488.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1156", " Ligand_ID": "RVR_minimized.pdb_1156", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "429.52", " logP": "-5.86", " logD": "-8.37", " logSw": "2.24", " tPSA": "253.25", " RotatableB": "16", " RigidB": "7", " Flexibility": "0.7", " HBD": "13", " HBA": "13", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "30", " CarbonAtoms": "17", " HeteroAtoms": "13", " ratio_H_by_C": "0.76", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4053975.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.518", "link_html_complex": "/ACE_complex_html/ACE_RVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RVR.png", "phi_psi": "/peptide_da/RVR.pdb", "link_html_peptide": "/Peptide_html/RVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RVR.pdb", "link_png_peptide": "/Peptide_pics/RVR.png"}
{"Peptide_Sequence": "RVY", " Origin": "Sardine muscles", " Peptide_Preparation": "alkakine protease", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "2,4,6-trinitroben-zene sulfonate (TNBS) method ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "205.6", " Reference": "Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., & Osajima, Y. (1994). Angiotensin I-converting Enzyme Inhibitory Peptides in an Alkaline Protease Hydrolyzate Derived from Sardine Muscle. Bioscience, Biotechnology, and Biochemistry, 58(12), 2244\u20132245. doi:10.1271/bbb.58.2244 ", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1157", " Ligand_ID": "RVY_minimized.pdb_1157", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "436.51", " logP": "-3.78", " logD": "-6.46", " logSw": "0.62", " tPSA": "209.84", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "813537.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 436.505", "link_html_complex": "/ACE_complex_html/ACE_RVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RVY.png", "phi_psi": "/peptide_da/RVY.pdb", "link_html_peptide": "/Peptide_html/RVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RVY.pdb", "link_png_peptide": "/Peptide_pics/RVY.png"}
{"Peptide_Sequence": "RW", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "16 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1158", " Ligand_ID": "RW_minimized.pdb_1158", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "360.41", " logP": "-2.96", " logD": "-5.31", " logSw": "0.32", " tPSA": "176.3", " RotatableB": "10", " RigidB": "14", " Flexibility": "0.42", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "494871.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 360.411", "link_html_complex": "/ACE_complex_html/ACE_RW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RW.png", "phi_psi": "/peptide_da/RW.pdb", "link_html_peptide": "/Peptide_html/RW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RW.pdb", "link_png_peptide": "/Peptide_pics/RW.png"}
{"Peptide_Sequence": "RY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10.5", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1161", " Ligand_ID": "RY_minimized.pdb_1161", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "337.37", " logP": "-4.08", " logD": "-5.72", " logSw": "1.2", " tPSA": "180.74", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1124849.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 337.374", "link_html_complex": "/ACE_complex_html/ACE_RY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RY.png", "phi_psi": "/peptide_da/RY.pdb", "link_html_peptide": "/Peptide_html/RY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RY.pdb", "link_png_peptide": "/Peptide_pics/RY.png"}
{"Peptide_Sequence": "RYLG", " Origin": "cheese", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "225 \u03bcM", " Reference": "Stuknyt\u0117, Milda, et al. \"Occurrence and fate of ACE-inhibitor peptides in cheeses and in their digestates following in vitro static gastrointestinal digestion.\" Food chemistry 168 (2015): 27-33.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1159", " Ligand_ID": "RYLG_minimized.pdb_1159", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)NCC(O)=O", " MW": "507.58", " logP": "-3.63", " logD": "-7.35", " logSw": "0.3", " tPSA": "238.94", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "681790.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 507.583", "link_html_complex": "/ACE_complex_html/ACE_RYLG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RYLG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RYLG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RYLG.png", "phi_psi": "/peptide_da/RYLG.pdb", "link_html_peptide": "/Peptide_html/RYLG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RYLG.pdb", "link_png_peptide": "/Peptide_pics/RYLG.png"}
{"Peptide_Sequence": "RYLGY", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.71 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1160", " Ligand_ID": "RYLGY_minimized.pdb_1160", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "670.76", " logP": "-1.89", " logD": "-6.63", " logSw": "-1.58", " tPSA": "288.27", " RotatableB": "20", " RigidB": "22", " Flexibility": "0.48", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "137819.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 670.756", "link_html_complex": "/ACE_complex_html/ACE_RYLGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RYLGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RYLGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RYLGY.png", "phi_psi": "/peptide_da/RYLGY.pdb", "link_html_peptide": "/Peptide_html/RYLGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RYLGY.pdb", "link_png_peptide": "/Peptide_pics/RYLGY.png"}
{"Peptide_Sequence": "RYPS", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1162", " Ligand_ID": "RYPS_minimized.pdb_1162", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O", " MW": "521.57", " logP": "-5.6", " logD": "-8.89", " logSw": "1.32", " tPSA": "250.38", " RotatableB": "14", " RigidB": "19", " Flexibility": "0.42", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "23", " HeteroAtoms": "14", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1945855.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 521.567", "link_html_complex": "/ACE_complex_html/ACE_RYPS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RYPS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RYPS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RYPS.png", "phi_psi": "/peptide_da/RYPS.pdb", "link_html_peptide": "/Peptide_html/RYPS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RYPS.pdb", "link_png_peptide": "/Peptide_pics/RYPS.png"}
{"Peptide_Sequence": "RYQ", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1164", " Ligand_ID": "RYQ_minimized.pdb_1164", " Smiles": "N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "465.5", " logP": "-5.97", " logD": "-8.52", " logSw": "1.96", " tPSA": "252.93", " RotatableB": "15", " RigidB": "14", " Flexibility": "0.52", " HBD": "12", " HBA": "13", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3290264.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 465.503", "link_html_complex": "/ACE_complex_html/ACE_RYQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RYQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RYQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RYQ.png", "phi_psi": "/peptide_da/RYQ.pdb", "link_html_peptide": "/Peptide_html/RYQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RYQ.pdb", "link_png_peptide": "/Peptide_pics/RYQ.png"}
{"Peptide_Sequence": "RYQKF", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1163", " Ligand_ID": "RYQKF_minimized.pdb_1163", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "740.85", " logP": "-3.41", " logD": "-9.5", " logSw": "-0.72", " tPSA": "338.77", " RotatableB": "25", " RigidB": "24", " Flexibility": "0.51", " HBD": "16", " HBA": "18", " HBD_HBA": "34", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "360776.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 740.85", "link_html_complex": "/ACE_complex_html/ACE_RYQKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_RYQKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_RYQKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_RYQKF.png", "phi_psi": "/peptide_da/RYQKF.pdb", "link_html_peptide": "/Peptide_html/RYQKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/RYQKF.pdb", "link_png_peptide": "/Peptide_pics/RYQKF.png"}
{"Peptide_Sequence": "SAGPM", " Origin": "Spanish dry-cured hams", " Peptide_Preparation": "", " Isolation_Method": "Reversed-phase high performance liquid chromatography", " ACE_inhibition_assay": "method developed by Sentandreu and Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "In-vivo/in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Escudero, E., Mora, L., Fraser, P. D., Aristoy, M.-C., Arihara, K., & Toldr\u00e1, F. (2013). Purification and Identification of antihypertensive peptides in Spanish dry-cured ham. Journal of Proteomics, 78, 499\u2013507. doi:10.1016/j.jprot.2012.10.019", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1165", " Ligand_ID": "SAGPM_minimized.pdb_1165", " Smiles": "CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(O)=O", " MW": "461.53", " logP": "-4.52", " logD": "-7.15", " logSw": "0.94", " tPSA": "220.91", " RotatableB": "12", " RigidB": "14", " Flexibility": "0.46", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "18", " HeteroAtoms": "13", " ratio_H_by_C": "0.72", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1179267.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 461.533", "link_html_complex": "/ACE_complex_html/ACE_SAGPM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SAGPM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SAGPM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SAGPM.png", "phi_psi": "/peptide_da/SAGPM.pdb", "link_html_peptide": "/Peptide_html/SAGPM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SAGPM.pdb", "link_png_peptide": "/Peptide_pics/SAGPM.png"}
{"Peptide_Sequence": "SALAM", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "229.1", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1166", " Ligand_ID": "SALAM_minimized.pdb_1166", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(O)=O", " MW": "491.6", " logP": "-3.22", " logD": "-5.61", " logSw": "0.13", " tPSA": "229.7", " RotatableB": "15", " RigidB": "9", " Flexibility": "0.63", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "20", " HeteroAtoms": "13", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "560224.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 491.602", "link_html_complex": "/ACE_complex_html/ACE_SALAM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SALAM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SALAM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SALAM.png", "phi_psi": "/peptide_da/SALAM.pdb", "link_html_peptide": "/Peptide_html/SALAM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SALAM.pdb", "link_png_peptide": "/Peptide_pics/SALAM.png"}
{"Peptide_Sequence": "SAPLRVY", " Origin": "Whey protein (Beta Lactoglobulin)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung, Gomez-Ruiz et al.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8 \u03bcM", " Reference": "\"Alpha-Lactoglobulin\t\tSEC, RP-HPLC, LC-MS/MS\tShalaby et al. (2006)\tin-vitro\t30 \u03bcM\tHernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.\"", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1167", " Ligand_ID": "SAPLRVY_minimized.pdb_1167", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "804.93", " logP": "-2.57", " logD": "-8.2", " logSw": "-1.73", " tPSA": "337.68", " RotatableB": "23", " RigidB": "25", " Flexibility": "0.48", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "142497.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 804.933", "link_html_complex": "/ACE_complex_html/ACE_SAPLRVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SAPLRVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SAPLRVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SAPLRVY.png", "phi_psi": "/peptide_da/SAPLRVY.pdb", "link_html_peptide": "/Peptide_html/SAPLRVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SAPLRVY.pdb", "link_png_peptide": "/Peptide_pics/SAPLRVY.png"}
{"Peptide_Sequence": "SAYPGQITSN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "7.08 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1168", " Ligand_ID": "SAYPGQITSN_minimized.pdb_1168", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "1037.08", " logP": "-8.22", " logD": "-12.2", " logSw": "0.79", " tPSA": "487.98", " RotatableB": "29", " RigidB": "34", " Flexibility": "0.46", " HBD": "19", " HBA": "29", " HBD_HBA": "48", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "73", " CarbonAtoms": "44", " HeteroAtoms": "29", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2287864.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1037.08", "link_html_complex": "/ACE_complex_html/ACE_SAYPGQITSN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SAYPGQITSN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SAYPGQITSN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SAYPGQITSN.png", "phi_psi": "/peptide_da/SAYPGQITSN.pdb", "link_html_peptide": "/Peptide_html/SAYPGQITSN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SAYPGQITSN.pdb", "link_png_peptide": "/Peptide_pics/SAYPGQITSN.png"}
{"Peptide_Sequence": "SCHTG", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1169", " Ligand_ID": "SCHTG_minimized.pdb_1169", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CO)C(=O)NCC(O)=O", " MW": "503.53", " logP": "-6.39", " logD": "-9.21", " logSw": "1.93", " tPSA": "292.11", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "18", " HeteroAtoms": "16", " ratio_H_by_C": "0.89", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3465898.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 503.529", "link_html_complex": "/ACE_complex_html/ACE_SCHTG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SCHTG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SCHTG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SCHTG.png", "phi_psi": "/peptide_da/SCHTG.pdb", "link_html_peptide": "/Peptide_html/SCHTG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SCHTG.pdb", "link_png_peptide": "/Peptide_pics/SCHTG.png"}
{"Peptide_Sequence": "SDNRNQGY", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1170", " Ligand_ID": "SDNRNQGY_minimized.pdb_1170", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "952.92", " logP": "-10.88", " logD": "-15.89", " logSw": "3.05", " tPSA": "544.97", " RotatableB": "30", " RigidB": "29", " Flexibility": "0.51", " HBD": "23", " HBA": "30", " HBD_HBA": "53", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "67", " CarbonAtoms": "37", " HeteroAtoms": "30", " ratio_H_by_C": "0.81", " Lipinski_Violation": "3", " Solubility_mg_per_l": "20124735.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 952.925", "link_html_complex": "/ACE_complex_html/ACE_SDNRNQGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SDNRNQGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SDNRNQGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SDNRNQGY.png", "phi_psi": "/peptide_da/SDNRNQGY.pdb", "link_html_peptide": "/Peptide_html/SDNRNQGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SDNRNQGY.pdb", "link_png_peptide": "/Peptide_pics/SDNRNQGY.png"}
{"Peptide_Sequence": "SEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "430", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1171", " Ligand_ID": "SEPKAIP_minimized.pdb_1171", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "740.84", " logP": "-6.67", " logD": "-10.61", " logSw": "1.15", " tPSA": "312.79", " RotatableB": "21", " RigidB": "24", " Flexibility": "0.47", " HBD": "11", " HBA": "19", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "33", " HeteroAtoms": "19", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2351135.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 740.845", "link_html_complex": "/ACE_complex_html/ACE_SEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SEPKAIP.png", "phi_psi": "/peptide_da/SEPKAIP.pdb", "link_html_peptide": "/Peptide_html/SEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/SEPKAIP.png"}
{"Peptide_Sequence": "SF", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "130.2  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1173", " Ligand_ID": "SF_minimized.pdb_1173", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "252.27", " logP": "-3.52", " logD": "-3.31", " logSw": "1.08", " tPSA": "117.1", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "742071.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 252.266", "link_html_complex": "/ACE_complex_html/ACE_SF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SF.png", "phi_psi": "/peptide_da/SF.pdb", "link_html_peptide": "/Peptide_html/SF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SF.pdb", "link_png_peptide": "/Peptide_pics/SF.png"}
{"Peptide_Sequence": "SFHPYFSY", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "82.71 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-11", "Serial_ID": "1172", " Ligand_ID": "SFHPYFSY_minimized.pdb_1172", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1047.12", " logP": "-1.16", " logD": "-4.44", " logSw": "-4.04", " tPSA": "372.28", " RotatableB": "26", " RigidB": "49", " Flexibility": "0.35", " HBD": "14", " HBA": "23", " HBD_HBA": "37", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "76", " CarbonAtoms": "53", " HeteroAtoms": "23", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "18411.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.34", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1047.12", "link_html_complex": "/ACE_complex_html/ACE_SFHPYFSY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SFHPYFSY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SFHPYFSY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SFHPYFSY.png", "phi_psi": "/peptide_da/SFHPYFSY.pdb", "link_html_peptide": "/Peptide_html/SFHPYFSY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SFHPYFSY.pdb", "link_png_peptide": "/Peptide_pics/SFHPYFSY.png"}
{"Peptide_Sequence": "SFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.4", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1174", " Ligand_ID": "SFQPQPLIYP_minimized.pdb_1174", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1189.36", " logP": "-2.27", " logD": "-6.17", " logSw": "-3.86", " tPSA": "429.94", " RotatableB": "30", " RigidB": "50", " Flexibility": "0.38", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "58", " HeteroAtoms": "27", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "25146.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1189.36", "link_html_complex": "/ACE_complex_html/ACE_SFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SFQPQPLIYP.png", "phi_psi": "/peptide_da/SFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/SFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/SFQPQPLIYP.png"}
{"Peptide_Sequence": "SG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "8500 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.2", "Serial_ID": "1176", " Ligand_ID": "SG_minimized.pdb_1176", " Smiles": "N[C@@H](CO)C(=O)NCC(O)=O", " MW": "162.14", " logP": "-4.7", " logD": "-5.54", " logSw": "2.38", " tPSA": "117.1", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "11", " CarbonAtoms": "5", " HeteroAtoms": "6", " ratio_H_by_C": "1.2", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1751437.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 162.144", "link_html_complex": "/ACE_complex_html/ACE_SG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SG.png", "phi_psi": "/peptide_da/SG.pdb", "link_html_peptide": "/Peptide_html/SG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SG.pdb", "link_png_peptide": "/Peptide_pics/SG.png"}
{"Peptide_Sequence": "SGIQSEPKAIP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "650", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1175", " Ligand_ID": "SGIQSEPKAIP_minimized.pdb_1175", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1126.26", " logP": "-8.97", " logD": "-16.7", " logSw": "1.14", " tPSA": "492.51", " RotatableB": "35", " RigidB": "34", " Flexibility": "0.51", " HBD": "18", " HBA": "30", " HBD_HBA": "48", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "79", " CarbonAtoms": "49", " HeteroAtoms": "30", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3515526.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1126.26", "link_html_complex": "/ACE_complex_html/ACE_SGIQSEPKAIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SGIQSEPKAIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SGIQSEPKAIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SGIQSEPKAIP.png", "phi_psi": "/peptide_da/SGIQSEPKAIP.pdb", "link_html_peptide": "/Peptide_html/SGIQSEPKAIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SGIQSEPKAIP.pdb", "link_png_peptide": "/Peptide_pics/SGIQSEPKAIP.png"}
{"Peptide_Sequence": "SGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "77.7 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1177", " Ligand_ID": "SGP_minimized.pdb_1177", " Smiles": "N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "259.26", " logP": "-4.65", " logD": "-6.65", " logSw": "1.81", " tPSA": "137.41", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "10", " HeteroAtoms": "8", " ratio_H_by_C": "0.8", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1587509.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 259.259", "link_html_complex": "/ACE_complex_html/ACE_SGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SGP.png", "phi_psi": "/peptide_da/SGP.pdb", "link_html_peptide": "/Peptide_html/SGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SGP.pdb", "link_png_peptide": "/Peptide_pics/SGP.png"}
{"Peptide_Sequence": "SHP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "280", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1178", " Ligand_ID": "SHP_minimized.pdb_1178", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "339.35", " logP": "-5.09", " logD": "-6.28", " logSw": "1.64", " tPSA": "166.09", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "14", " HeteroAtoms": "10", " ratio_H_by_C": "0.71", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1753816.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 339.347", "link_html_complex": "/ACE_complex_html/ACE_SHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SHP.png", "phi_psi": "/peptide_da/SHP.pdb", "link_html_peptide": "/Peptide_html/SHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SHP.pdb", "link_png_peptide": "/Peptide_pics/SHP.png"}
{"Peptide_Sequence": "SIQSQPQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "560", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1179", " Ligand_ID": "SIQSQPQAFP_minimized.pdb_1179", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1102.2", " logP": "-7.35", " logD": "-11.17", " logSw": "-0.09", " tPSA": "481.82", " RotatableB": "30", " RigidB": "41", " Flexibility": "0.42", " HBD": "18", " HBA": "29", " HBD_HBA": "47", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "78", " CarbonAtoms": "49", " HeteroAtoms": "29", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1005176.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1102.2", "link_html_complex": "/ACE_complex_html/ACE_SIQSQPQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SIQSQPQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SIQSQPQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SIQSQPQAFP.png", "phi_psi": "/peptide_da/SIQSQPQAFP.pdb", "link_html_peptide": "/Peptide_html/SIQSQPQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SIQSQPQAFP.pdb", "link_png_peptide": "/Peptide_pics/SIQSQPQAFP.png"}
{"Peptide_Sequence": "SKPHT", " Origin": "Legume (Pea proteins)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1180", " Ligand_ID": "SKPHT_minimized.pdb_1180", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(O)=O", " MW": "568.62", " logP": "-5.85", " logD": "-10.91", " logSw": "1.33", " tPSA": "272.16", " RotatableB": "16", " RigidB": "19", " Flexibility": "0.46", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2149529.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 568.623", "link_html_complex": "/ACE_complex_html/ACE_SKPHT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SKPHT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SKPHT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SKPHT.png", "phi_psi": "/peptide_da/SKPHT.pdb", "link_html_peptide": "/Peptide_html/SKPHT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SKPHT.pdb", "link_png_peptide": "/Peptide_pics/SKPHT.png"}
{"Peptide_Sequence": "SKVLPVPE", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "93 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "1181", " Ligand_ID": "SKVLPVPE_minimized.pdb_1181", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "868.03", " logP": "-4.99", " logD": "-12.05", " logSw": "-0.43", " tPSA": "341.89", " RotatableB": "25", " RigidB": "26", " Flexibility": "0.49", " HBD": "12", " HBA": "21", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "40", " HeteroAtoms": "21", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "565746.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 868.029", "link_html_complex": "/ACE_complex_html/ACE_SKVLPVPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SKVLPVPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SKVLPVPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SKVLPVPE.png", "phi_psi": "/peptide_da/SKVLPVPE.pdb", "link_html_peptide": "/Peptide_html/SKVLPVPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SKVLPVPE.pdb", "link_png_peptide": "/Peptide_pics/SKVLPVPE.png"}
{"Peptide_Sequence": "SKVPP", " Origin": "dried salt fish", " Peptide_Preparation": "protease digestion", " Isolation_Method": "GFC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "74.22 \u03bcM", " Reference": "Astawan, Made, et al. \"Effects of angiotensin I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats.\" Bioscience, biotechnology, and biochemistry 59.3 (1995): 425-429.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1182", " Ligand_ID": "SKVPP_minimized.pdb_1182", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "526.63", " logP": "-3.73", " logD": "-8.88", " logSw": "0.1", " tPSA": "214.46", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "583653.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 526.626", "link_html_complex": "/ACE_complex_html/ACE_SKVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SKVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SKVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SKVPP.png", "phi_psi": "/peptide_da/SKVPP.pdb", "link_html_peptide": "/Peptide_html/SKVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SKVPP.pdb", "link_png_peptide": "/Peptide_pics/SKVPP.png"}
{"Peptide_Sequence": "SKVYP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "1.4 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1184", " Ligand_ID": "SKVYP_minimized.pdb_1184", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "592.68", " logP": "-2.8", " logD": "-7.82", " logSw": "-0.75", " tPSA": "243.48", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "42", " CarbonAtoms": "28", " HeteroAtoms": "14", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "281010.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 592.684", "link_html_complex": "/ACE_complex_html/ACE_SKVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SKVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SKVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SKVYP.png", "phi_psi": "/peptide_da/SKVYP.pdb", "link_html_peptide": "/Peptide_html/SKVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SKVYP.pdb", "link_png_peptide": "/Peptide_pics/SKVYP.png"}
{"Peptide_Sequence": "SKVYPFPGPI", " Origin": "milk", " Peptide_Preparation": "fermentation", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1.7 mg/ml", " Reference": "Korhonen, H., and Anne Pihlanto. \"Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum.\" Current Pharmaceutical Design 13.8 (2007): 829-843.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1183", " Ligand_ID": "SKVYPFPGPI_minimized.pdb_1183", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(C)C)C(O)=O", " MW": "1104.3", " logP": "-0.94", " logD": "-7.44", " logSw": "-4.3", " tPSA": "371.4", " RotatableB": "28", " RigidB": "46", " Flexibility": "0.38", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "79", " CarbonAtoms": "55", " HeteroAtoms": "24", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "14954.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1104.3", "link_html_complex": "/ACE_complex_html/ACE_SKVYPFPGPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SKVYPFPGPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SKVYPFPGPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SKVYPFPGPI.png", "phi_psi": "/peptide_da/SKVYPFPGPI.pdb", "link_html_peptide": "/Peptide_html/SKVYPFPGPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SKVYPFPGPI.pdb", "link_png_peptide": "/Peptide_pics/SKVYPFPGPI.png"}
{"Peptide_Sequence": "SLPQ", " Origin": "Milk (Goat milk hydrolysate)", " Peptide_Preparation": "", " Isolation_Method": "RP-LC, HPLC", " ACE_inhibition_assay": "Wu J et al., 2002", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "330 \u03bcM", " Reference": "Geerlings, A., et al. \"Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk.\" Journal of dairy science 89.9 (2006): 3326-3335.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "1185", " Ligand_ID": "SLPQ_minimized.pdb_1185", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "443.49", " logP": "-5.86", " logD": "-6.65", " logSw": "1.89", " tPSA": "209.6", " RotatableB": "12", " RigidB": "14", " Flexibility": "0.46", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "19", " HeteroAtoms": "12", " ratio_H_by_C": "0.63", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2947813.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 443.495", "link_html_complex": "/ACE_complex_html/ACE_SLPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SLPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SLPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SLPQ.png", "phi_psi": "/peptide_da/SLPQ.pdb", "link_html_peptide": "/Peptide_html/SLPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SLPQ.pdb", "link_png_peptide": "/Peptide_pics/SLPQ.png"}
{"Peptide_Sequence": "SLPQN", " Origin": "probiotic yoghurt", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications (Donkor et al., 2005)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "5.26 \u03bcg/mL", " Reference": "Donkor, Osaana N., et al. \"ACE-inhibitory activity of probiotic yoghurt.\" International dairy journal 17.11 (2007): 1321-1331.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1186", " Ligand_ID": "SLPQN_minimized.pdb_1186", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "557.6", " logP": "-7.63", " logD": "-8.68", " logSw": "2.5", " tPSA": "281.79", " RotatableB": "15", " RigidB": "18", " Flexibility": "0.45", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "23", " HeteroAtoms": "16", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6791546.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 557.597", "link_html_complex": "/ACE_complex_html/ACE_SLPQN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SLPQN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SLPQN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SLPQN.png", "phi_psi": "/peptide_da/SLPQN.pdb", "link_html_peptide": "/Peptide_html/SLPQN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SLPQN.pdb", "link_png_peptide": "/Peptide_pics/SLPQN.png"}
{"Peptide_Sequence": "SLVLPVPE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "39 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1187", " Ligand_ID": "SLVLPVPE_minimized.pdb_1187", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "853.01", " logP": "-1.16", " logD": "-8", " logSw": "-2.88", " tPSA": "314.25", " RotatableB": "23", " RigidB": "26", " Flexibility": "0.47", " HBD": "10", " HBA": "20", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "60", " CarbonAtoms": "40", " HeteroAtoms": "20", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "47889.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 853.014", "link_html_complex": "/ACE_complex_html/ACE_SLVLPVPE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SLVLPVPE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SLVLPVPE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SLVLPVPE.png", "phi_psi": "/peptide_da/SLVLPVPE.pdb", "link_html_peptide": "/Peptide_html/SLVLPVPE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SLVLPVPE.pdb", "link_png_peptide": "/Peptide_pics/SLVLPVPE.png"}
{"Peptide_Sequence": "SLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "40", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1188", " Ligand_ID": "SLVYP_minimized.pdb_1188", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "577.67", " logP": "-2.93", " logD": "-3.81", " logSw": "-0.7", " tPSA": "215.84", " RotatableB": "14", " RigidB": "20", " Flexibility": "0.41", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "28", " HeteroAtoms": "13", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "285571.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 577.67", "link_html_complex": "/ACE_complex_html/ACE_SLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SLVYP.png", "phi_psi": "/peptide_da/SLVYP.pdb", "link_html_peptide": "/Peptide_html/SLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SLVYP.pdb", "link_png_peptide": "/Peptide_pics/SLVYP.png"}
{"Peptide_Sequence": "SNIP", " Origin": "Sweet-potato tuber trypsin inhibitor", " Peptide_Preparation": " trypsin_x005F_x0007_Sepharose-4B affinity column", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist et al., 1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "228.3 \u03bcM", " Reference": "Pihlanto, Anne, and Sari Ma\u0308kinen. \"Antihypertensive properties of plant protein derived peptides.\" Bioactive food peptides in health and disease. IntechOpen, 2013.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1189", " Ligand_ID": "SNIP_minimized.pdb_1189", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "429.47", " logP": "-6.39", " logD": "-6.78", " logSw": "2.25", " tPSA": "209.6", " RotatableB": "11", " RigidB": "14", " Flexibility": "0.44", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4070599.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 429.468", "link_html_complex": "/ACE_complex_html/ACE_SNIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SNIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SNIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SNIP.png", "phi_psi": "/peptide_da/SNIP.pdb", "link_html_peptide": "/Peptide_html/SNIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SNIP.pdb", "link_png_peptide": "/Peptide_pics/SNIP.png"}
{"Peptide_Sequence": "SPPPFYL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "63.10 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1190", " Ligand_ID": "SPPPFYL_minimized.pdb_1190", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO)C(O)=O", " MW": "819.94", " logP": "-0.51", " logD": "-3.5", " logSw": "-3.56", " tPSA": "256.46", " RotatableB": "17", " RigidB": "40", " Flexibility": "0.3", " HBD": "8", " HBA": "17", " HBD_HBA": "25", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "42", " HeteroAtoms": "17", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "23390.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 819.943", "link_html_complex": "/ACE_complex_html/ACE_SPPPFYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SPPPFYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SPPPFYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SPPPFYL.png", "phi_psi": "/peptide_da/SPPPFYL.pdb", "link_html_peptide": "/Peptide_html/SPPPFYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SPPPFYL.pdb", "link_png_peptide": "/Peptide_pics/SPPPFYL.png"}
{"Peptide_Sequence": "SPRCR", " Origin": "lizard fish protein", " Peptide_Preparation": "", " Isolation_Method": "magnetic affinity separation, RP-HPLC", " ACE_inhibition_assay": "Wu et al., 2012", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "41 \u03bcM", " Reference": "Lan, Xiongdiao, et al. \"Rapid purification and characterization of angiotensin converting enzyme inhibitory peptides from lizard fish protein hydrolysates with magnetic affinity separation.\" Food chemistry 182 (2015): 136-142.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1191", " Ligand_ID": "SPRCR_minimized.pdb_1191", " Smiles": "N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "617.72", " logP": "-7.91", " logD": "-10.91", " logSw": "2.63", " tPSA": "361.69", " RotatableB": "20", " RigidB": "16", " Flexibility": "0.56", " HBD": "15", " HBA": "18", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "42", " CarbonAtoms": "23", " HeteroAtoms": "19", " ratio_H_by_C": "0.83", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8599523.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.721", "link_html_complex": "/ACE_complex_html/ACE_SPRCR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SPRCR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SPRCR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SPRCR.png", "phi_psi": "/peptide_da/SPRCR.pdb", "link_html_peptide": "/Peptide_html/SPRCR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SPRCR.pdb", "link_png_peptide": "/Peptide_pics/SPRCR.png"}
{"Peptide_Sequence": "SPYP", " Origin": "Soybean ((\u03b2-conglycinin and glycinin)", " Peptide_Preparation": "acid proteinase from Monascus purpureus", " Isolation_Method": "IEC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "850 \u03bcM", " Reference": "Kuba, M., et al. \"Production of angiotensin I-converting enzyme inhibitory peptides from soybean protein with Monascus purpureus acid proteinase.\" Process Biochemistry 40.6 (2005): 2191-2196.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1192", " Ligand_ID": "SPYP_minimized.pdb_1192", " Smiles": "N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "462.5", " logP": "-3.28", " logD": "-5.14", " logSw": "-0.18", " tPSA": "177.95", " RotatableB": "8", " RigidB": "23", " Flexibility": "0.26", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "22", " HeteroAtoms": "11", " ratio_H_by_C": "0.5", " Lipinski_Violation": "2", " Solubility_mg_per_l": "384939.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 462.496", "link_html_complex": "/ACE_complex_html/ACE_SPYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SPYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SPYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SPYP.png", "phi_psi": "/peptide_da/SPYP.pdb", "link_html_peptide": "/Peptide_html/SPYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SPYP.pdb", "link_png_peptide": "/Peptide_pics/SPYP.png"}
{"Peptide_Sequence": "SQPK", " Origin": "Milk (Goat milk hydrolysate)", " Peptide_Preparation": "", " Isolation_Method": "RP-LC, HPLC", " ACE_inhibition_assay": "Wu J et al., 2002", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "354 \u03bcM", " Reference": "Geerlings, A., et al. \"Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk.\" Journal of dairy science 89.9 (2006): 3326-3335.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1193", " Ligand_ID": "SQPK_minimized.pdb_1193", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O", " MW": "458.51", " logP": "-7.41", " logD": "-7.67", " logSw": "2.91", " tPSA": "237.24", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "19", " HeteroAtoms": "13", " ratio_H_by_C": "0.68", " Lipinski_Violation": "2", " Solubility_mg_per_l": "8412913.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 458.509", "link_html_complex": "/ACE_complex_html/ACE_SQPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SQPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SQPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SQPK.png", "phi_psi": "/peptide_da/SQPK.pdb", "link_html_peptide": "/Peptide_html/SQPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SQPK.pdb", "link_png_peptide": "/Peptide_pics/SQPK.png"}
{"Peptide_Sequence": "SQPQAFP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "710", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1194", " Ligand_ID": "SQPQAFP_minimized.pdb_1194", " Smiles": "C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "773.83", " logP": "-5.7", " logD": "-8.69", " logSw": "0.17", " tPSA": "331.2", " RotatableB": "19", " RigidB": "33", " Flexibility": "0.37", " HBD": "12", " HBA": "20", " HBD_HBA": "32", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "35", " HeteroAtoms": "20", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "912970.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 773.833", "link_html_complex": "/ACE_complex_html/ACE_SQPQAFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SQPQAFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SQPQAFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SQPQAFP.png", "phi_psi": "/peptide_da/SQPQAFP.pdb", "link_html_peptide": "/Peptide_html/SQPQAFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SQPQAFP.pdb", "link_png_peptide": "/Peptide_pics/SQPQAFP.png"}
{"Peptide_Sequence": "SQSKVLPVPQ", " Origin": "bovine sodium caseinate", " Peptide_Preparation": "fermentatation, Lactobacillus animalis ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Roy et al.(2000)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "37.17 \u03bcM", " Reference": "Hayes, M., et al. \"Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.\" Appl. Environ. Microbiol. 73.14 (2007): 4658-4667.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1195", " Ligand_ID": "SQSKVLPVPQ_minimized.pdb_1195", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1082.25", " logP": "-6.08", " logD": "-12.8", " logSw": "-0.61", " tPSA": "466.37", " RotatableB": "32", " RigidB": "33", " Flexibility": "0.49", " HBD": "18", " HBA": "28", " HBD_HBA": "46", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "76", " CarbonAtoms": "48", " HeteroAtoms": "28", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "589481.71", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1082.25", "link_html_complex": "/ACE_complex_html/ACE_SQSKVLPVPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SQSKVLPVPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SQSKVLPVPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SQSKVLPVPQ.png", "phi_psi": "/peptide_da/SQSKVLPVPQ.pdb", "link_html_peptide": "/Peptide_html/SQSKVLPVPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SQSKVLPVPQ.pdb", "link_png_peptide": "/Peptide_pics/SQSKVLPVPQ.png"}
{"Peptide_Sequence": "SRGKQ", " Origin": "meat-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1196", " Ligand_ID": "SRGKQ_minimized.pdb_1196", " Smiles": "NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "574.63", " logP": "-7.68", " logD": "-13.96", " logSw": "2.89", " tPSA": "338.77", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "16", " HBA": "18", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "40", " CarbonAtoms": "22", " HeteroAtoms": "18", " ratio_H_by_C": "0.82", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10315630.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 574.631", "link_html_complex": "/ACE_complex_html/ACE_SRGKQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SRGKQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SRGKQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SRGKQ.png", "phi_psi": "/peptide_da/SRGKQ.pdb", "link_html_peptide": "/Peptide_html/SRGKQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SRGKQ.pdb", "link_png_peptide": "/Peptide_pics/SRGKQ.png"}
{"Peptide_Sequence": "SRY", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1197", " Ligand_ID": "SRY_minimized.pdb_1197", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "424.45", " logP": "-5.85", " logD": "-7.4", " logSw": "2", " tPSA": "230.07", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "11", " HBA": "12", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3121742.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 424.452", "link_html_complex": "/ACE_complex_html/ACE_SRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SRY.png", "phi_psi": "/peptide_da/SRY.pdb", "link_html_peptide": "/Peptide_html/SRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SRY.pdb", "link_png_peptide": "/Peptide_pics/SRY.png"}
{"Peptide_Sequence": "SRYPS", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1198", " Ligand_ID": "SRYPS_minimized.pdb_1198", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O", " MW": "608.64", " logP": "-5.4", " logD": "-10.32", " logSw": "0.86", " tPSA": "299.71", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "26", " HeteroAtoms": "17", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1433890.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 608.644", "link_html_complex": "/ACE_complex_html/ACE_SRYPS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SRYPS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SRYPS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SRYPS.png", "phi_psi": "/peptide_da/SRYPS.pdb", "link_html_peptide": "/Peptide_html/SRYPS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SRYPS.pdb", "link_png_peptide": "/Peptide_pics/SRYPS.png"}
{"Peptide_Sequence": "SSIQSQPQAFT", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "1001 \u03bcM", " Reference": "Meisel H., Walsh D. J., Murray B., FitzGerald R. J. ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.2006", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1199", " Ligand_ID": "SSIQSQPQAFT_minimized.pdb_1199", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "1193.26", " logP": "-9.57", " logD": "-13.68", " logSw": "1.07", " tPSA": "560.17", " RotatableB": "35", " RigidB": "38", " Flexibility": "0.48", " HBD": "22", " HBA": "33", " HBD_HBA": "55", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "84", " CarbonAtoms": "51", " HeteroAtoms": "33", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3492040.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1193.26", "link_html_complex": "/ACE_complex_html/ACE_SSIQSQPQAFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SSIQSQPQAFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SSIQSQPQAFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SSIQSQPQAFT.png", "phi_psi": "/peptide_da/SSIQSQPQAFT.pdb", "link_html_peptide": "/Peptide_html/SSIQSQPQAFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SSIQSQPQAFT.pdb", "link_png_peptide": "/Peptide_pics/SSIQSQPQAFT.png"}
{"Peptide_Sequence": "ST", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "fermented by Lactobacillus fermentum SM 605", " Isolation_Method": "UF, GF, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.03 \u03bcM", " Reference": "Wang, Yu-Kai, et al. \"Production of novel angiotensin I-converting enzyme inhibitory peptides by fermentation of marine shrimp Acetes chinensis with Lactobacillus fermentum SM 605.\" Applied microbiology and biotechnology 79.5 (2008): 785-791.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "1201", " Ligand_ID": "ST_minimized.pdb_1201", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)CO)C(O)=O", " MW": "206.2", " logP": "-4.92", " logD": "-5.6", " logSw": "2.31", " tPSA": "137.33", " RotatableB": "5", " RigidB": "3", " Flexibility": "0.63", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "14", " CarbonAtoms": "7", " HeteroAtoms": "7", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2079767.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 206.196", "link_html_complex": "/ACE_complex_html/ACE_ST.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_ST.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_ST.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_ST.png", "phi_psi": "/peptide_da/ST.pdb", "link_html_peptide": "/Peptide_html/ST.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/ST.pdb", "link_png_peptide": "/Peptide_pics/ST.png"}
{"Peptide_Sequence": "STHGVW", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "19.3 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1200", " Ligand_ID": "STHGVW_minimized.pdb_1200", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "685.73", " logP": "-3.79", " logD": "-7.01", " logSw": "-0.63", " tPSA": "298.2", " RotatableB": "18", " RigidB": "26", " Flexibility": "0.41", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "31", " HeteroAtoms": "18", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "365789.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 685.728", "link_html_complex": "/ACE_complex_html/ACE_STHGVW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_STHGVW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_STHGVW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_STHGVW.png", "phi_psi": "/peptide_da/STHGVW.pdb", "link_html_peptide": "/Peptide_html/STHGVW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/STHGVW.pdb", "link_png_peptide": "/Peptide_pics/STHGVW.png"}
{"Peptide_Sequence": "STYQT", " Origin": "Sweet-potato protein isolate", " Peptide_Preparation": "", " Isolation_Method": "Absorption Chromatography, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "300.4 \u03bcM", " Reference": "Ishiguro, Koji, et al. \"Hypotensive effect of a sweetpotato protein digest in spontaneously hypertensive rats and purification of angiotensin I-converting enzyme inhibitory peptides.\" Food chemistry 131.3 (2012): 774-779.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1202", " Ligand_ID": "STYQT_minimized.pdb_1202", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(O)=O", " MW": "598.6", " logP": "-6.23", " logD": "-8.64", " logSw": "1.44", " tPSA": "308.18", " RotatableB": "17", " RigidB": "17", " Flexibility": "0.5", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "25", " HeteroAtoms": "17", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2526678.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 598.603", "link_html_complex": "/ACE_complex_html/ACE_STYQT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_STYQT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_STYQT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_STYQT.png", "phi_psi": "/peptide_da/STYQT.pdb", "link_html_peptide": "/Peptide_html/STYQT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/STYQT.pdb", "link_png_peptide": "/Peptide_pics/STYQT.png"}
{"Peptide_Sequence": "SVAKL", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "900 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1205", " Ligand_ID": "SVAKL_minimized.pdb_1205", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O", " MW": "516.63", " logP": "-3.5", " logD": "-6.78", " logSw": "0.28", " tPSA": "232.04", " RotatableB": "17", " RigidB": "9", " Flexibility": "0.65", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "686231.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 516.631", "link_html_complex": "/ACE_complex_html/ACE_SVAKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SVAKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SVAKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SVAKL.png", "phi_psi": "/peptide_da/SVAKL.pdb", "link_html_peptide": "/Peptide_html/SVAKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SVAKL.pdb", "link_png_peptide": "/Peptide_pics/SVAKL.png"}
{"Peptide_Sequence": "SVAKLE", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2200 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1204", " Ligand_ID": "SVAKLE_minimized.pdb_1204", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "645.75", " logP": "-6.54", " logD": "-12.41", " logSw": "1.73", " tPSA": "301.27", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "28", " HeteroAtoms": "17", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3637251.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 645.745", "link_html_complex": "/ACE_complex_html/ACE_SVAKLE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SVAKLE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SVAKLE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SVAKLE.png", "phi_psi": "/peptide_da/SVAKLE.pdb", "link_html_peptide": "/Peptide_html/SVAKLE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SVAKLE.pdb", "link_png_peptide": "/Peptide_pics/SVAKLE.png"}
{"Peptide_Sequence": "SVAKLEK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "82 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1203", " Ligand_ID": "SVAKLEK_minimized.pdb_1203", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "773.92", " logP": "-7.03", " logD": "-9.77", " logSw": "1.64", " tPSA": "358.01", " RotatableB": "28", " RigidB": "14", " Flexibility": "0.67", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "54", " CarbonAtoms": "34", " HeteroAtoms": "20", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3984135.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 773.918", "link_html_complex": "/ACE_complex_html/ACE_SVAKLEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SVAKLEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SVAKLEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SVAKLEK.png", "phi_psi": "/peptide_da/SVAKLEK.pdb", "link_html_peptide": "/Peptide_html/SVAKLEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SVAKLEK.pdb", "link_png_peptide": "/Peptide_pics/SVAKLEK.png"}
{"Peptide_Sequence": "SVY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "\t<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1206", " Ligand_ID": "SVY_minimized.pdb_1206", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "367.4", " logP": "-4.01", " logD": "-4.11", " logSw": "0.92", " tPSA": "166.43", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "917656.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 367.397", "link_html_complex": "/ACE_complex_html/ACE_SVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SVY.png", "phi_psi": "/peptide_da/SVY.pdb", "link_html_peptide": "/Peptide_html/SVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SVY.pdb", "link_png_peptide": "/Peptide_pics/SVY.png"}
{"Peptide_Sequence": "SW", " Origin": "egg white", " Peptide_Preparation": "protease from C. ficifolia fruit", " Isolation_Method": "ultra-flitration", " ACE_inhibition_assay": "spectrophotometric method as described by Hernandez-Ledesma et al. (2005)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Pokora, M., Zambrowicz, A., D\u0105browska, A., Eckert, E., Setner, B., Szo\u0142tysik, M., \u2026 Chrzanowska, J. (2014). An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides. Food Chemistry, 151, 500\u2013505. doi:10.1016/j.foodchem.2013.11.111", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1207", " Ligand_ID": "SW_minimized.pdb_1207", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "291.3", " logP": "-3.26", " logD": "-3.21", " logSw": "0.63", " tPSA": "132.89", " RotatableB": "6", " RigidB": "13", " Flexibility": "0.32", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "14", " HeteroAtoms": "7", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "546111.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 291.302", "link_html_complex": "/ACE_complex_html/ACE_SW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SW.png", "phi_psi": "/peptide_da/SW.pdb", "link_html_peptide": "/Peptide_html/SW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SW.pdb", "link_png_peptide": "/Peptide_pics/SW.png"}
{"Peptide_Sequence": "SWSF", " Origin": "wine", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "76.3 \u03bcM", " Reference": "Garc\u00eda, M. C., et al. \"Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities.\" Talanta 106 (2013): 328-349.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1208", " Ligand_ID": "SWSF_minimized.pdb_1208", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "525.55", " logP": "-3.08", " logD": "-4.64", " logSw": "-0.46", " tPSA": "211.32", " RotatableB": "13", " RigidB": "23", " Flexibility": "0.36", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "26", " HeteroAtoms": "12", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "331474.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 525.554", "link_html_complex": "/ACE_complex_html/ACE_SWSF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SWSF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SWSF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SWSF.png", "phi_psi": "/peptide_da/SWSF.pdb", "link_html_peptide": "/Peptide_html/SWSF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SWSF.pdb", "link_png_peptide": "/Peptide_pics/SWSF.png"}
{"Peptide_Sequence": "SWV", " Origin": "egg white", " Peptide_Preparation": "protease from C. ficifolia fruit", " Isolation_Method": "ultra-flitration", " ACE_inhibition_assay": "spectrophotometric method as described by Hernandez-Ledesma et al. (2005)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "36.2 \u03bcg/ml", " Reference": "Pokora, M., Zambrowicz, A., D\u0105browska, A., Eckert, E., Setner, B., Szo\u0142tysik, M., \u2026 Chrzanowska, J. (2014). An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides. Food Chemistry, 151, 500\u2013505. doi:10.1016/j.foodchem.2013.11.111", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1210", " Ligand_ID": "SWV_minimized.pdb_1210", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(O)=O", " MW": "390.43", " logP": "-2.46", " logD": "-3.66", " logSw": "-0.24", " tPSA": "161.99", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "307057.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.434", "link_html_complex": "/ACE_complex_html/ACE_SWV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SWV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SWV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SWV.png", "phi_psi": "/peptide_da/SWV.pdb", "link_html_peptide": "/Peptide_html/SWV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SWV.pdb", "link_png_peptide": "/Peptide_pics/SWV.png"}
{"Peptide_Sequence": "SWVE", " Origin": "egg white", " Peptide_Preparation": "protease from C. ficifolia fruit", " Isolation_Method": "ultra-flitration", " ACE_inhibition_assay": "spectrophotometric method as described by Hernandez-Ledesma et al. (2005)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "33.9\u03bcg", " Reference": "Pokora, M., Zambrowicz, A., D\u0105browska, A., Eckert, E., Setner, B., Szo\u0142tysik, M., \u2026 Chrzanowska, J. (2014). An attractive way of egg white protein by-product use for producing of novel anti-hypertensive peptides. Food Chemistry, 151, 500\u2013505. doi:10.1016/j.foodchem.2013.11.111", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1209", " Ligand_ID": "SWVE_minimized.pdb_1209", " Smiles": "CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "519.55", " logP": "-3.98", " logD": "-7.95", " logSw": "0.28", " tPSA": "231.22", " RotatableB": "14", " RigidB": "18", " Flexibility": "0.44", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "37", " CarbonAtoms": "24", " HeteroAtoms": "13", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "684043.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 519.548", "link_html_complex": "/ACE_complex_html/ACE_SWVE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SWVE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SWVE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SWVE.png", "phi_psi": "/peptide_da/SWVE.pdb", "link_html_peptide": "/Peptide_html/SWVE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SWVE.pdb", "link_png_peptide": "/Peptide_pics/SWVE.png"}
{"Peptide_Sequence": "SY", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "66.3  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1211", " Ligand_ID": "SY_minimized.pdb_1211", " Smiles": "N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "268.27", " logP": "-4.53", " logD": "-3.63", " logSw": "1.62", " tPSA": "137.33", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1355293.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 268.266", "link_html_complex": "/ACE_complex_html/ACE_SY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_SY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_SY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_SY.png", "phi_psi": "/peptide_da/SY.pdb", "link_html_peptide": "/Peptide_html/SY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/SY.pdb", "link_png_peptide": "/Peptide_pics/SY.png"}
{"Peptide_Sequence": "TAP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.5", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1212", " Ligand_ID": "TAP_minimized.pdb_1212", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "287.31", " logP": "-4.84", " logD": "-5.7", " logSw": "1.76", " tPSA": "137.41", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "12", " HeteroAtoms": "8", " ratio_H_by_C": "0.67", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1666421.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.312", "link_html_complex": "/ACE_complex_html/ACE_TAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TAP.png", "phi_psi": "/peptide_da/TAP.pdb", "link_html_peptide": "/Peptide_html/TAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TAP.pdb", "link_png_peptide": "/Peptide_pics/TAP.png"}
{"Peptide_Sequence": "TAPY", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "13.6 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1213", " Ligand_ID": "TAPY_minimized.pdb_1213", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "450.49", " logP": "-4.35", " logD": "-5.01", " logSw": "0.63", " tPSA": "186.74", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "21", " HeteroAtoms": "11", " ratio_H_by_C": "0.52", " Lipinski_Violation": "2", " Solubility_mg_per_l": "845732.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 450.486", "link_html_complex": "/ACE_complex_html/ACE_TAPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TAPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TAPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TAPY.png", "phi_psi": "/peptide_da/TAPY.pdb", "link_html_peptide": "/Peptide_html/TAPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TAPY.pdb", "link_png_peptide": "/Peptide_pics/TAPY.png"}
{"Peptide_Sequence": "TCSP", " Origin": "Fish (Pacific cod skin)", " Peptide_Preparation": "alcalase, neutrase, papain, pepsin, \u03b1-chymotrypsin and trypsin", " Isolation_Method": "FPLC, HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "Ngo, Dai-Hung, et al. \"Free radical scavenging and angiotensin-I converting enzyme inhibitory peptides from Pacific cod (Gadus macrocephalus) skin gelatin.\" International journal of biological macromolecules 49.5 (2011): 1110-1116.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1214", " Ligand_ID": "TCSP_minimized.pdb_1214", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "406.45", " logP": "-6.89", " logD": "-7.38", " logSw": "2.57", " tPSA": "225.54", " RotatableB": "9", " RigidB": "12", " Flexibility": "0.43", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "15", " HeteroAtoms": "12", " ratio_H_by_C": "0.8", " Lipinski_Violation": "2", " Solubility_mg_per_l": "5335585.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.454", "link_html_complex": "/ACE_complex_html/ACE_TCSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TCSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TCSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TCSP.png", "phi_psi": "/peptide_da/TCSP.pdb", "link_html_peptide": "/Peptide_html/TCSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TCSP.pdb", "link_png_peptide": "/Peptide_pics/TCSP.png"}
{"Peptide_Sequence": "TD", " Origin": "Oyster protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Yamamoto et al. (1980) with some modificatio", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "", " Reference": "Shiozaki, Kazuhiro, et al. \"Identification of oyster-derived hypotensive peptide acting as angiotensin-I-converting enzyme inhibitor.\" Fisheries Science 76.5 (2010): 865-872.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "1215", " Ligand_ID": "TD_minimized.pdb_1215", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "234.21", " logP": "-4.74", " logD": "-7.43", " logSw": "2.09", " tPSA": "157.23", " RotatableB": "6", " RigidB": "4", " Flexibility": "0.6", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "16", " CarbonAtoms": "8", " HeteroAtoms": "8", " ratio_H_by_C": "1", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1893766.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 234.207", "link_html_complex": "/ACE_complex_html/ACE_TD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TD.png", "phi_psi": "/peptide_da/TD.pdb", "link_html_peptide": "/Peptide_html/TD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TD.pdb", "link_png_peptide": "/Peptide_pics/TD.png"}
{"Peptide_Sequence": "TDQHQDKIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "380", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1216", " Ligand_ID": "TDQHQDKIYP_minimized.pdb_1216", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1244.31", " logP": "-9.85", " logD": "-16.87", " logSw": "1.11", " tPSA": "584.1", " RotatableB": "38", " RigidB": "41", " Flexibility": "0.48", " HBD": "22", " HBA": "34", " HBD_HBA": "56", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "88", " CarbonAtoms": "54", " HeteroAtoms": "34", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3777994.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1244.31", "link_html_complex": "/ACE_complex_html/ACE_TDQHQDKIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TDQHQDKIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TDQHQDKIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TDQHQDKIYP.png", "phi_psi": "/peptide_da/TDQHQDKIYP.pdb", "link_html_peptide": "/Peptide_html/TDQHQDKIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TDQHQDKIYP.pdb", "link_png_peptide": "/Peptide_pics/TDQHQDKIYP.png"}
{"Peptide_Sequence": "TE", " Origin": "Milk hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "van Platerink C. J., Janssen H.-G. M., Haverkamp J. Application of at-line two-dimensional liquid chromatography-mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates. Anal. Bioanal. Chem., 2008, 391, 299-307.", " Binding_Energy_kcal_per_mol": "-6.5", "Serial_ID": "1217", " Ligand_ID": "TE_minimized.pdb_1217", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "248.23", " logP": "-4.51", " logD": "-8.08", " logSw": "1.92", " tPSA": "157.23", " RotatableB": "7", " RigidB": "4", " Flexibility": "0.64", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "9", " HeteroAtoms": "8", " ratio_H_by_C": "0.89", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1700407.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 248.233", "link_html_complex": "/ACE_complex_html/ACE_TE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TE.png", "phi_psi": "/peptide_da/TE.pdb", "link_html_peptide": "/Peptide_html/TE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TE.pdb", "link_png_peptide": "/Peptide_pics/TE.png"}
{"Peptide_Sequence": "TESQSLT", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1218", " Ligand_ID": "TESQSLT_minimized.pdb_1218", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "764.78", " logP": "-8.21", " logD": "-14.17", " logSw": "2.24", " tPSA": "406.51", " RotatableB": "25", " RigidB": "16", " Flexibility": "0.61", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "30", " HeteroAtoms": "23", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7188657.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 764.778", "link_html_complex": "/ACE_complex_html/ACE_TESQSLT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TESQSLT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TESQSLT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TESQSLT.png", "phi_psi": "/peptide_da/TESQSLT.pdb", "link_html_peptide": "/Peptide_html/TESQSLT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TESQSLT.pdb", "link_png_peptide": "/Peptide_pics/TESQSLT.png"}
{"Peptide_Sequence": "TF", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "17.8 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1219", " Ligand_ID": "TF_minimized.pdb_1219", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "266.29", " logP": "-3.09", " logD": "-2.88", " logSw": "0.73", " tPSA": "117.1", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "13", " HeteroAtoms": "6", " ratio_H_by_C": "0.46", " Lipinski_Violation": "0", " Solubility_mg_per_l": "553510.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 266.293", "link_html_complex": "/ACE_complex_html/ACE_TF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TF.png", "phi_psi": "/peptide_da/TF.pdb", "link_html_peptide": "/Peptide_html/TF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TF.pdb", "link_png_peptide": "/Peptide_pics/TF.png"}
{"Peptide_Sequence": "TFPHGP", " Origin": "Fish (Seaweed pipefish)", " Peptide_Preparation": "", " Isolation_Method": "FPLC AND RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "833  \u03bcM", " Reference": "Purification and identification of antihypertensive peptides from seaweed pipefish (Syngnathus schlegeli) muscle protein hydrolysate. Food Res. Int., 44, 703-707, 2011", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1220", " Ligand_ID": "TFPHGP_minimized.pdb_1220", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "654.71", " logP": "-3.32", " logD": "-6.59", " logSw": "-0.98", " tPSA": "244.6", " RotatableB": "14", " RigidB": "32", " Flexibility": "0.3", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "31", " HeteroAtoms": "16", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "246931.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 654.714", "link_html_complex": "/ACE_complex_html/ACE_TFPHGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TFPHGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TFPHGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TFPHGP.png", "phi_psi": "/peptide_da/TFPHGP.pdb", "link_html_peptide": "/Peptide_html/TFPHGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TFPHGP.pdb", "link_png_peptide": "/Peptide_pics/TFPHGP.png"}
{"Peptide_Sequence": "TG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "9900 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.5", "Serial_ID": "1223", " Ligand_ID": "TG_minimized.pdb_1223", " Smiles": "C[C@@H](O)[C@H](N)C(=O)NCC(O)=O", " MW": "176.17", " logP": "-4.27", " logD": "-5.11", " logSw": "2.02", " tPSA": "117.1", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "6", " HeteroAtoms": "6", " ratio_H_by_C": "1", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1330480.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 176.17", "link_html_complex": "/ACE_complex_html/ACE_TG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TG.png", "phi_psi": "/peptide_da/TG.pdb", "link_html_peptide": "/Peptide_html/TG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TG.pdb", "link_png_peptide": "/Peptide_pics/TG.png"}
{"Peptide_Sequence": "TGGGNV", " Origin": "Fish (Pacific cod skin)", " Peptide_Preparation": "alcalase, neutrase, papain, pepsin, \u03b1-chymotrypsin and trypsin", " Isolation_Method": "FPLC, HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "Ngo, Dai-Hung, et al. \"Free radical scavenging and angiotensin-I converting enzyme inhibitory peptides from Pacific cod (Gadus macrocephalus) skin gelatin.\" International journal of biological macromolecules 49.5 (2011): 1110-1116.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1221", " Ligand_ID": "TGGGNV_minimized.pdb_1221", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(O)=O", " MW": "503.51", " logP": "-6.64", " logD": "-9.97", " logSw": "2.21", " tPSA": "276.59", " RotatableB": "15", " RigidB": "13", " Flexibility": "0.54", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "19", " HeteroAtoms": "16", " ratio_H_by_C": "0.84", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4596520.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 503.507", "link_html_complex": "/ACE_complex_html/ACE_TGGGNV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGGGNV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGGGNV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGGGNV.png", "phi_psi": "/peptide_da/TGGGNV.pdb", "link_html_peptide": "/Peptide_html/TGGGNV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGGGNV.pdb", "link_png_peptide": "/Peptide_pics/TGGGNV.png"}
{"Peptide_Sequence": "TGLKP", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "51.57 \u03bcM", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1222", " Ligand_ID": "TGLKP_minimized.pdb_1222", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "514.62", " logP": "-5.33", " logD": "-7.6", " logSw": "1.32", " tPSA": "223.25", " RotatableB": "15", " RigidB": "14", " Flexibility": "0.52", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1921196.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 514.616", "link_html_complex": "/ACE_complex_html/ACE_TGLKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGLKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGLKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGLKP.png", "phi_psi": "/peptide_da/TGLKP.pdb", "link_html_peptide": "/Peptide_html/TGLKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGLKP.pdb", "link_png_peptide": "/Peptide_pics/TGLKP.png"}
{"Peptide_Sequence": "TGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "79.1 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1226", " Ligand_ID": "TGP_minimized.pdb_1226", " Smiles": "C[C@@H](O)[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "273.29", " logP": "-4.22", " logD": "-6.28", " logSw": "1.45", " tPSA": "137.41", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1169985.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 273.286", "link_html_complex": "/ACE_complex_html/ACE_TGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGP.png", "phi_psi": "/peptide_da/TGP.pdb", "link_html_peptide": "/Peptide_html/TGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGP.pdb", "link_png_peptide": "/Peptide_pics/TGP.png"}
{"Peptide_Sequence": "TGPIPN", " Origin": "Milk (Goat milk hydrolysate)", " Peptide_Preparation": "", " Isolation_Method": "RP-LC, HPLC", " ACE_inhibition_assay": "Wu J et al., 2002", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "316 \u03bcM", " Reference": "Geerlings, A., et al. \"Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk.\" Journal of dairy science 89.9 (2006): 3326-3335.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1224", " Ligand_ID": "TGPIPN_minimized.pdb_1224", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "597.66", " logP": "-4.87", " logD": "-7.89", " logSw": "0.45", " tPSA": "259.01", " RotatableB": "14", " RigidB": "23", " Flexibility": "0.38", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "26", " HeteroAtoms": "16", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "934138.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 597.661", "link_html_complex": "/ACE_complex_html/ACE_TGPIPN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGPIPN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGPIPN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGPIPN.png", "phi_psi": "/peptide_da/TGPIPN.pdb", "link_html_peptide": "/Peptide_html/TGPIPN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGPIPN.pdb", "link_png_peptide": "/Peptide_pics/TGPIPN.png"}
{"Peptide_Sequence": "TGPIPNSLPQ", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1225", " Ligand_ID": "TGPIPNSLPQ_minimized.pdb_1225", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1023.14", " logP": "-6.47", " logD": "-10.68", " logSw": "-0.39", " tPSA": "429.94", " RotatableB": "26", " RigidB": "38", " Flexibility": "0.41", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "72", " CarbonAtoms": "45", " HeteroAtoms": "27", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "691775.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1023.14", "link_html_complex": "/ACE_complex_html/ACE_TGPIPNSLPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGPIPNSLPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGPIPNSLPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGPIPNSLPQ.png", "phi_psi": "/peptide_da/TGPIPNSLPQ.pdb", "link_html_peptide": "/Peptide_html/TGPIPNSLPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGPIPNSLPQ.pdb", "link_png_peptide": "/Peptide_pics/TGPIPNSLPQ.png"}
{"Peptide_Sequence": "TGVY", " Origin": "Cereals (Rice protein)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, MALDI-TOF MS/MS", " ACE_inhibition_assay": "Spectrophotometric measurement", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "18.2 \u03bcM", " Reference": "Mart\u00ednez-Maqueda, Daniel, et al. \"Antihypertensive peptides from food proteins: a review.\" Food & Function 3.4 (2012): 350-361.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1227", " Ligand_ID": "TGVY_minimized.pdb_1227", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "438.47", " logP": "-2.6", " logD": "-4.96", " logSw": "-0.27", " tPSA": "195.53", " RotatableB": "11", " RigidB": "13", " Flexibility": "0.46", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "335617.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 438.475", "link_html_complex": "/ACE_complex_html/ACE_TGVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TGVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TGVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TGVY.png", "phi_psi": "/peptide_da/TGVY.pdb", "link_html_peptide": "/Peptide_html/TGVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TGVY.pdb", "link_png_peptide": "/Peptide_pics/TGVY.png"}
{"Peptide_Sequence": "THIKWGD", " Origin": "Fish (Tuna (Neothunnus macropterus muscle))", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "50 \u03bcM", " Reference": "Kohama, Yasuhiro, et al. \"Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle.\" Agricultural and biological chemistry 55.8 (1991): 2169-2170.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1228", " Ligand_ID": "THIKWGD_minimized.pdb_1228", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "855.94", " logP": "-6.12", " logD": "-12.29", " logSw": "0.34", " tPSA": "374.84", " RotatableB": "26", " RigidB": "29", " Flexibility": "0.47", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "39", " HeteroAtoms": "22", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1198937.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 855.937", "link_html_complex": "/ACE_complex_html/ACE_THIKWGD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_THIKWGD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_THIKWGD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_THIKWGD.png", "phi_psi": "/peptide_da/THIKWGD.pdb", "link_html_peptide": "/Peptide_html/THIKWGD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/THIKWGD.pdb", "link_png_peptide": "/Peptide_pics/THIKWGD.png"}
{"Peptide_Sequence": "TIIPLPV", " Origin": "Soybean (OKara protein of soybean Glycine max)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "Jim\u00e9nez-Escrig, Antonio, et al. \"Health-promoting activities of ultra-filtered okara protein hydrolysates released by in vitro gastrointestinal digestion: identification of active peptide from soybean lipoxygenase.\" European Food Research and Technology 230.4 (2010): 655-663.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1229", " Ligand_ID": "TIIPLPV_minimized.pdb_1229", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "751.95", " logP": "-1.31", " logD": "-2.85", " logSw": "-2.42", " tPSA": "245.02", " RotatableB": "19", " RigidB": "23", " Flexibility": "0.45", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "37", " HeteroAtoms": "16", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "66677.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 751.953", "link_html_complex": "/ACE_complex_html/ACE_TIIPLPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TIIPLPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TIIPLPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TIIPLPV.png", "phi_psi": "/peptide_da/TIIPLPV.pdb", "link_html_peptide": "/Peptide_html/TIIPLPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TIIPLPV.pdb", "link_png_peptide": "/Peptide_pics/TIIPLPV.png"}
{"Peptide_Sequence": "TIMPLW", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1230", " Ligand_ID": "TIMPLW_minimized.pdb_1230", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "759.96", " logP": "0.42", " logD": "-2.37", " logSw": "-3.56", " tPSA": "265.8", " RotatableB": "20", " RigidB": "26", " Flexibility": "0.43", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "37", " HeteroAtoms": "16", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "21679.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 759.956", "link_html_complex": "/ACE_complex_html/ACE_TIMPLW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TIMPLW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TIMPLW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TIMPLW.png", "phi_psi": "/peptide_da/TIMPLW.pdb", "link_html_peptide": "/Peptide_html/TIMPLW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TIMPLW.pdb", "link_png_peptide": "/Peptide_pics/TIMPLW.png"}
{"Peptide_Sequence": "TK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "1232", " Ligand_ID": "TK_minimized.pdb_1232", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "247.29", " logP": "-4.24", " logD": "-5.54", " logSw": "1.83", " tPSA": "144.74", " RotatableB": "8", " RigidB": "3", " Flexibility": "0.73", " HBD": "7", " HBA": "7", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1535422.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 247.291", "link_html_complex": "/ACE_complex_html/ACE_TK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TK.png", "phi_psi": "/peptide_da/TK.pdb", "link_html_peptide": "/Peptide_html/TK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TK.pdb", "link_png_peptide": "/Peptide_pics/TK.png"}
{"Peptide_Sequence": "TKIVP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "400 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1231", " Ligand_ID": "TKIVP_minimized.pdb_1231", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "556.7", " logP": "-3.97", " logD": "-7.43", " logSw": "0.27", " tPSA": "223.25", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "726041.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 556.695", "link_html_complex": "/ACE_complex_html/ACE_TKIVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TKIVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TKIVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TKIVP.png", "phi_psi": "/peptide_da/TKIVP.pdb", "link_html_peptide": "/Peptide_html/TKIVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TKIVP.pdb", "link_png_peptide": "/Peptide_pics/TKIVP.png"}
{"Peptide_Sequence": "TKTGRSAHVLSRYRPRA", " Origin": "bonito muscle", " Peptide_Preparation": "artificial gastric juice ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971) with modifi-cation", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.8 \u03bcM", " Reference": "Hasan, Fida, et al. \"Production kinetics of angiotensin-I converting enzyme inhibitory peptides from bonito meat in artificial gastric juice.\" Process Biochemistry 41.3 (2006): 505-511.", " Binding_Energy_kcal_per_mol": "-1.6", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1956.22", "link_html_complex": "/ACE_complex_html/ACE_TKTGRSAHVLSRYRPRA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TKTGRSAHVLSRYRPRA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TKTGRSAHVLSRYRPRA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TKTGRSAHVLSRYRPRA.png", "phi_psi": "/peptide_da/TKTGRSAHVLSRYRPRA.pdb", "link_html_peptide": "/Peptide_html/TKTGRSAHVLSRYRPRA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TKTGRSAHVLSRYRPRA.pdb", "link_png_peptide": "/Peptide_pics/TKTGRSAHVLSRYRPRA.png"}
{"Peptide_Sequence": "TKVIP", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "400", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1234", " Ligand_ID": "TKVIP_minimized.pdb_1234", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "556.7", " logP": "-3.97", " logD": "-7.42", " logSw": "0.27", " tPSA": "223.25", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "726041.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 556.695", "link_html_complex": "/ACE_complex_html/ACE_TKVIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TKVIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TKVIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TKVIP.png", "phi_psi": "/peptide_da/TKVIP.pdb", "link_html_peptide": "/Peptide_html/TKVIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TKVIP.pdb", "link_png_peptide": "/Peptide_pics/TKVIP.png"}
{"Peptide_Sequence": "TKY", " Origin": "royal jelly of honeybee", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "2.3 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR.\" The Journal of nutritional biochemistry 13.2 (2002): 80-86.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1235", " Ligand_ID": "TKY_minimized.pdb_1235", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "410.46", " logP": "-4.84", " logD": "-6.13", " logSw": "1.38", " tPSA": "194.07", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1633294.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 410.465", "link_html_complex": "/ACE_complex_html/ACE_TKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TKY.png", "phi_psi": "/peptide_da/TKY.pdb", "link_html_peptide": "/Peptide_html/TKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TKY.pdb", "link_png_peptide": "/Peptide_pics/TKY.png"}
{"Peptide_Sequence": "TLKYP", " Origin": "hornbackray muscle", " Peptide_Preparation": "Bacillus subtilisA26 proteases", " Isolation_Method": "SEC", " ACE_inhibition_assay": "Escuderoet al.(2014) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "170 \u03bcM", " Reference": "Lassoued, Imen, et al. \"Angiotensin I\u2010converting enzyme inhibitory peptides FQPSF and LKYPI identified in Bacillus subtilis A26 hydrolysate of thornback ray muscle.\" International Journal of Food Science & Technology 51.7 (2016): 1604-1609.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1236", " Ligand_ID": "TLKYP_minimized.pdb_1236", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "620.74", " logP": "-3.7", " logD": "-7.06", " logSw": "-0.28", " tPSA": "243.48", " RotatableB": "17", " RigidB": "20", " Flexibility": "0.46", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "467348.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 620.738", "link_html_complex": "/ACE_complex_html/ACE_TLKYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TLKYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TLKYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TLKYP.png", "phi_psi": "/peptide_da/TLKYP.pdb", "link_html_peptide": "/Peptide_html/TLKYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TLKYP.pdb", "link_png_peptide": "/Peptide_pics/TLKYP.png"}
{"Peptide_Sequence": "TLS", " Origin": " sweet sorghum", " Peptide_Preparation": "alcalase", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "102.1 \u03bcM", " Reference": "Wu G., Du J., Jia J., Kuang C.Production of ACE inhibitory peptides from sweet sorghum grain protein using alcalase: Hydrolysis kinetic, purification and molecular docking study. Food Chem., 199, 140-149, 2016", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "1237", " Ligand_ID": "TLS_minimized.pdb_1237", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O", " MW": "319.35", " logP": "-3.98", " logD": "-5.75", " logSw": "1.28", " tPSA": "166.43", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1150216.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 319.354", "link_html_complex": "/ACE_complex_html/ACE_TLS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TLS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TLS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TLS.png", "phi_psi": "/peptide_da/TLS.pdb", "link_html_peptide": "/Peptide_html/TLS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TLS.pdb", "link_png_peptide": "/Peptide_pics/TLS.png"}
{"Peptide_Sequence": "TNGIIR", " Origin": "Egg (Ovalbumin of egg white protein)", " Peptide_Preparation": "", " Isolation_Method": "LC/MS/MS, TMS", " ACE_inhibition_assay": "Liu et al., 2010", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "70 \u03bcM", " Reference": "Yu, Zhipeng, et al. \"Primary and secondary structure of novel ACE-inhibitory peptides from egg white protein.\" Food chemistry 133.2 (2012): 315-322.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1238", " Ligand_ID": "TNGIIR_minimized.pdb_1238", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "672.77", " logP": "-4.98", " logD": "-7.43", " logSw": "0.64", " tPSA": "340.23", " RotatableB": "23", " RigidB": "14", " Flexibility": "0.62", " HBD": "15", " HBA": "19", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "28", " HeteroAtoms": "19", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1281274.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 672.774", "link_html_complex": "/ACE_complex_html/ACE_TNGIIR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TNGIIR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TNGIIR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TNGIIR.png", "phi_psi": "/peptide_da/TNGIIR.pdb", "link_html_peptide": "/Peptide_html/TNGIIR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TNGIIR.pdb", "link_png_peptide": "/Peptide_pics/TNGIIR.png"}
{"Peptide_Sequence": "TNP", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "945.5", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1239", " Ligand_ID": "TNP_minimized.pdb_1239", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "330.34", " logP": "-6.36", " logD": "-7.16", " logSw": "2.58", " tPSA": "180.5", " RotatableB": "7", " RigidB": "12", " Flexibility": "0.37", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "13", " HeteroAtoms": "10", " ratio_H_by_C": "0.77", " Lipinski_Violation": "1", " Solubility_mg_per_l": "4362602.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 330.337", "link_html_complex": "/ACE_complex_html/ACE_TNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TNP.png", "phi_psi": "/peptide_da/TNP.pdb", "link_html_peptide": "/Peptide_html/TNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TNP.pdb", "link_png_peptide": "/Peptide_pics/TNP.png"}
{"Peptide_Sequence": "TNW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "61 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1240", " Ligand_ID": "TNW_minimized.pdb_1240", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "419.43", " logP": "-4.6", " logD": "-5.64", " logSw": "1", " tPSA": "205.08", " RotatableB": "10", " RigidB": "17", " Flexibility": "0.37", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "19", " HeteroAtoms": "11", " ratio_H_by_C": "0.58", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1136073.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.37", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 419.432", "link_html_complex": "/ACE_complex_html/ACE_TNW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TNW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TNW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TNW.png", "phi_psi": "/peptide_da/TNW.pdb", "link_html_peptide": "/Peptide_html/TNW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TNW.pdb", "link_png_peptide": "/Peptide_pics/TNW.png"}
{"Peptide_Sequence": "TP", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "290", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "1241", " Ligand_ID": "TP_minimized.pdb_1241", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "216.23", " logP": "-3.33", " logD": "-4.27", " logSw": "1.12", " tPSA": "108.31", " RotatableB": "3", " RigidB": "8", " Flexibility": "0.27", " HBD": "4", " HBA": "6", " HBD_HBA": "10", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "9", " HeteroAtoms": "6", " ratio_H_by_C": "0.67", " Lipinski_Violation": "0", " Solubility_mg_per_l": "659584.32", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 216.234", "link_html_complex": "/ACE_complex_html/ACE_TP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TP.png", "phi_psi": "/peptide_da/TP.pdb", "link_html_peptide": "/Peptide_html/TP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TP.pdb", "link_png_peptide": "/Peptide_pics/TP.png"}
{"Peptide_Sequence": "TPRVF", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "200 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1242", " Ligand_ID": "TPRVF_minimized.pdb_1242", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "618.72", " logP": "-4.3", " logD": "-7.64", " logSw": "0.11", " tPSA": "259.25", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "29", " HeteroAtoms": "15", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "687617.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.725", "link_html_complex": "/ACE_complex_html/ACE_TPRVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TPRVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TPRVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TPRVF.png", "phi_psi": "/peptide_da/TPRVF.pdb", "link_html_peptide": "/Peptide_html/TPRVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TPRVF.pdb", "link_png_peptide": "/Peptide_pics/TPRVF.png"}
{"Peptide_Sequence": "TPSPR", " Origin": "egg white", " Peptide_Preparation": "heating, centrigugation", " Isolation_Method": "ion-exchange column", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Liu, JingBo, et al. \"Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates.\" Food chemistry 122.4 (2010): 1159-1163.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1243", " Ligand_ID": "TPSPR_minimized.pdb_1243", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "556.61", " logP": "-5.89", " logD": "-8.03", " logSw": "1.34", " tPSA": "270.69", " RotatableB": "14", " RigidB": "20", " Flexibility": "0.41", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "23", " HeteroAtoms": "16", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2133612.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 556.613", "link_html_complex": "/ACE_complex_html/ACE_TPSPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TPSPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TPSPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TPSPR.png", "phi_psi": "/peptide_da/TPSPR.pdb", "link_html_peptide": "/Peptide_html/TPSPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TPSPR.pdb", "link_png_peptide": "/Peptide_pics/TPSPR.png"}
{"Peptide_Sequence": "TPTQQS", " Origin": "yeast  (Saccharomyces cerevisiae) ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "73.25 \u03bcM", " Reference": "Ni, He, et al. \"Isolation and identification of an Angiotensin-I converting enzyme inhibitory peptide from yeast (Saccharomyces cerevisiae).\" Current Analytical Chemistry 8.1 (2012): 180-185.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1244", " Ligand_ID": "TPTQQS_minimized.pdb_1244", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O", " MW": "660.67", " logP": "-8.57", " logD": "-11.47", " logSw": "2.65", " tPSA": "351.35", " RotatableB": "18", " RigidB": "20", " Flexibility": "0.47", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "26", " HeteroAtoms": "20", " ratio_H_by_C": "0.77", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9359825.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 660.674", "link_html_complex": "/ACE_complex_html/ACE_TPTQQS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TPTQQS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TPTQQS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TPTQQS.png", "phi_psi": "/peptide_da/TPTQQS.pdb", "link_html_peptide": "/Peptide_html/TPTQQS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TPTQQS.pdb", "link_png_peptide": "/Peptide_pics/TPTQQS.png"}
{"Peptide_Sequence": "TPVVVPPFLQP", " Origin": "pepsin,trypsin,chymotrypsin, proteinase K, actinase E, thermolysin,and  papain", " Peptide_Preparation": "Proteinase K", " Isolation_Method": "RP-HPLC, GFC", " ACE_inhibition_assay": "  Yamamoto  et  al. 1994 ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "749 \u03bcM", " Reference": "Abubakar, Amhar, et al. \"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.\" Journal of Dairy Science 81.12 (1998): 3131-3138.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1245", " Ligand_ID": "TPVVVPPFLQP_minimized.pdb_1245", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1193.43", " logP": "-0.29", " logD": "-4.89", " logSw": "-5.23", " tPSA": "386.93", " RotatableB": "28", " RigidB": "49", " Flexibility": "0.36", " HBD": "12", " HBA": "26", " HBD_HBA": "38", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "59", " HeteroAtoms": "26", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6365.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1193.43", "link_html_complex": "/ACE_complex_html/ACE_TPVVVPPFLQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TPVVVPPFLQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TPVVVPPFLQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TPVVVPPFLQP.png", "phi_psi": "/peptide_da/TPVVVPPFLQP.pdb", "link_html_peptide": "/Peptide_html/TPVVVPPFLQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TPVVVPPFLQP.pdb", "link_png_peptide": "/Peptide_pics/TPVVVPPFLQP.png"}
{"Peptide_Sequence": "TPWVPPFLQP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "749 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1246", " Ligand_ID": "TPWVPPFLQP_minimized.pdb_1246", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1181.38", " logP": "-0.25", " logD": "-4.38", " logSw": "-5.36", " tPSA": "373.62", " RotatableB": "26", " RigidB": "57", " Flexibility": "0.31", " HBD": "12", " HBA": "25", " HBD_HBA": "37", " Rings": "6", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "85", " CarbonAtoms": "60", " HeteroAtoms": "25", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5571.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1181.38", "link_html_complex": "/ACE_complex_html/ACE_TPWVPPFLQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TPWVPPFLQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TPWVPPFLQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TPWVPPFLQP.png", "phi_psi": "/peptide_da/TPWVPPFLQP.pdb", "link_html_peptide": "/Peptide_html/TPWVPPFLQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TPWVPPFLQP.pdb", "link_png_peptide": "/Peptide_pics/TPWVPPFLQP.png"}
{"Peptide_Sequence": "TQ", " Origin": "milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1247", " Ligand_ID": "TQ_minimized.pdb_1247", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "247.25", " logP": "-5.16", " logD": "-5.7", " logSw": "2.34", " tPSA": "160.19", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "9", " HeteroAtoms": "8", " ratio_H_by_C": "0.89", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2566384.72", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 247.248", "link_html_complex": "/ACE_complex_html/ACE_TQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TQ.png", "phi_psi": "/peptide_da/TQ.pdb", "link_html_peptide": "/Peptide_html/TQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TQ.pdb", "link_png_peptide": "/Peptide_pics/TQ.png"}
{"Peptide_Sequence": "TQPKTNAIPY", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3745.9 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1248", " Ligand_ID": "TQPKTNAIPY_minimized.pdb_1248", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1132.27", " logP": "-6.27", " logD": "-12.66", " logSw": "-0.89", " tPSA": "486.6", " RotatableB": "31", " RigidB": "39", " Flexibility": "0.44", " HBD": "19", " HBA": "29", " HBD_HBA": "48", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "80", " CarbonAtoms": "51", " HeteroAtoms": "29", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "464261.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1132.27", "link_html_complex": "/ACE_complex_html/ACE_TQPKTNAIPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TQPKTNAIPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TQPKTNAIPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TQPKTNAIPY.png", "phi_psi": "/peptide_da/TQPKTNAIPY.pdb", "link_html_peptide": "/Peptide_html/TQPKTNAIPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TQPKTNAIPY.pdb", "link_png_peptide": "/Peptide_pics/TQPKTNAIPY.png"}
{"Peptide_Sequence": "TQSLVYP", " Origin": "synthetic peptides of \u03b2-caseins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "64", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various \u03b2-caseins.\" Agricultural and biological chemistry 54.4 (1990): 1101-1102.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1249", " Ligand_ID": "TQSLVYP_minimized.pdb_1249", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "806.9", " logP": "-3.53", " logD": "-6.72", " logSw": "-1.21", " tPSA": "337.36", " RotatableB": "22", " RigidB": "26", " Flexibility": "0.46", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "37", " HeteroAtoms": "20", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "241699.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 806.903", "link_html_complex": "/ACE_complex_html/ACE_TQSLVYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TQSLVYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TQSLVYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TQSLVYP.png", "phi_psi": "/peptide_da/TQSLVYP.pdb", "link_html_peptide": "/Peptide_html/TQSLVYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TQSLVYP.pdb", "link_png_peptide": "/Peptide_pics/TQSLVYP.png"}
{"Peptide_Sequence": "TQVY", " Origin": "Cereals (Rye)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Li G-H et al. 2005", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "18.2 \u03bcM", " Reference": "Matsui, Toshiro, et al. \"Depressor Effect of Wheat Germ Hydrolysate and Its Novel Angiotensin I-Converting Enzyme Inhibitory Peptide, Ile-Val-Tyr, and the Metabplism in Rat and Human Plasma.\" Biological and Pharmaceutical Bulletin 23.4 (2000): 427-431.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1250", " Ligand_ID": "TQVY_minimized.pdb_1250", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "509.55", " logP": "-5.03", " logD": "-5.56", " logSw": "1.03", " tPSA": "238.62", " RotatableB": "14", " RigidB": "15", " Flexibility": "0.48", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1428915.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.553", "link_html_complex": "/ACE_complex_html/ACE_TQVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TQVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TQVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TQVY.png", "phi_psi": "/peptide_da/TQVY.pdb", "link_html_peptide": "/Peptide_html/TQVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TQVY.pdb", "link_png_peptide": "/Peptide_pics/TQVY.png"}
{"Peptide_Sequence": "TRDQQ", " Origin": "milk-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1251", " Ligand_ID": "TRDQQ_minimized.pdb_1251", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "646.65", " logP": "-8.64", " logD": "-16.01", " logSw": "3.05", " tPSA": "394.35", " RotatableB": "22", " RigidB": "15", " Flexibility": "0.59", " HBD": "17", " HBA": "21", " HBD_HBA": "38", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "45", " CarbonAtoms": "24", " HeteroAtoms": "21", " ratio_H_by_C": "0.88", " Lipinski_Violation": "3", " Solubility_mg_per_l": "13599278.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 646.651", "link_html_complex": "/ACE_complex_html/ACE_TRDQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TRDQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TRDQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TRDQQ.png", "phi_psi": "/peptide_da/TRDQQ.pdb", "link_html_peptide": "/Peptide_html/TRDQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TRDQQ.pdb", "link_png_peptide": "/Peptide_pics/TRDQQ.png"}
{"Peptide_Sequence": "TRGKQ", " Origin": "fish-derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1252", " Ligand_ID": "TRGKQ_minimized.pdb_1252", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "588.66", " logP": "-7.25", " logD": "-13.59", " logSw": "2.53", " tPSA": "338.77", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "16", " HBA": "18", " HBD_HBA": "34", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "41", " CarbonAtoms": "23", " HeteroAtoms": "18", " ratio_H_by_C": "0.78", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7388406.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 588.658", "link_html_complex": "/ACE_complex_html/ACE_TRGKQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TRGKQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TRGKQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TRGKQ.png", "phi_psi": "/peptide_da/TRGKQ.pdb", "link_html_peptide": "/Peptide_html/TRGKQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TRGKQ.pdb", "link_png_peptide": "/Peptide_pics/TRGKQ.png"}
{"Peptide_Sequence": "TTENVLFG", " Origin": "Edible Mushroom Hypsizygus marmoreus", " Peptide_Preparation": "pulverized", " Isolation_Method": "UF, SPEC, RP-HPLC", " ACE_inhibition_assay": "modified method of Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3.03\u2009mg/mL", " Reference": "Kang, Min-Gu, et al. \"Characterization of an antihypertensive angiotensin I-converting enzyme inhibitory peptide from the edible mushroom Hypsizygus marmoreus.\" BioMed research international 2013 (2013).", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1253", " Ligand_ID": "TTENVLFG_minimized.pdb_1253", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O", " MW": "879.95", " logP": "-4.59", " logD": "-11.31", " logSw": "-0.66", " tPSA": "395.15", " RotatableB": "27", " RigidB": "24", " Flexibility": "0.53", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "62", " CarbonAtoms": "39", " HeteroAtoms": "23", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "455665.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 879.954", "link_html_complex": "/ACE_complex_html/ACE_TTENVLFG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TTENVLFG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TTENVLFG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TTENVLFG.png", "phi_psi": "/peptide_da/TTENVLFG.pdb", "link_html_peptide": "/Peptide_html/TTENVLFG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TTENVLFG.pdb", "link_png_peptide": "/Peptide_pics/TTENVLFG.png"}
{"Peptide_Sequence": "-8.8", " Origin": null, " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "1254", " Ligand_ID": "TTI_minimized.pdb_1254", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(O)=O", " MW": "333.38", " logP": "-4.24", " logD": "-5.24", " logSw": "1.36", " tPSA": "166.43", " RotatableB": "9", " RigidB": "5", " Flexibility": "0.64", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1296631.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 333.381", "link_html_complex": "/ACE_complex_html/ACE_TTI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TTI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TTI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TTI.png", "phi_psi": "/peptide_da/TTI.pdb", "link_html_peptide": "/Peptide_html/TTI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TTI.pdb", "link_png_peptide": "/Peptide_pics/TTI.png"}
{"Peptide_Sequence": "TTMPLW", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "51 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1255", " Ligand_ID": "TTMPLW_minimized.pdb_1255", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "747.9", " logP": "-1.86", " logD": "-4.33", " logSw": "-2.11", " tPSA": "286.03", " RotatableB": "19", " RigidB": "26", " Flexibility": "0.42", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "90256.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.902", "link_html_complex": "/ACE_complex_html/ACE_TTMPLW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TTMPLW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TTMPLW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TTMPLW.png", "phi_psi": "/peptide_da/TTMPLW.pdb", "link_html_peptide": "/Peptide_html/TTMPLW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TTMPLW.pdb", "link_png_peptide": "/Peptide_pics/TTMPLW.png"}
{"Peptide_Sequence": "TTN", " Origin": "porcine skelatal muscle", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vivo", " IC50_micromol_per_L": "672", " Reference": "Nakashima Y, Arihara K, Mio H, Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. J Food Sci 2002;67:434\u20137.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1256", " Ligand_ID": "TTN_minimized.pdb_1256", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "334.33", " logP": "-6.26", " logD": "-8.07", " logSw": "2.62", " tPSA": "209.52", " RotatableB": "9", " RigidB": "7", " Flexibility": "0.56", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "12", " HeteroAtoms": "11", " ratio_H_by_C": "0.92", " Lipinski_Violation": "2", " Solubility_mg_per_l": "4615134.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 334.326", "link_html_complex": "/ACE_complex_html/ACE_TTN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TTN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TTN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TTN.png", "phi_psi": "/peptide_da/TTN.pdb", "link_html_peptide": "/Peptide_html/TTN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TTN.pdb", "link_png_peptide": "/Peptide_pics/TTN.png"}
{"Peptide_Sequence": "TTW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "0.61 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1257", " Ligand_ID": "TTW_minimized.pdb_1257", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "406.43", " logP": "-3.7", " logD": "-4.81", " logSw": "0.44", " tPSA": "182.22", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "633616.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.433", "link_html_complex": "/ACE_complex_html/ACE_TTW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TTW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TTW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TTW.png", "phi_psi": "/peptide_da/TTW.pdb", "link_html_peptide": "/Peptide_html/TTW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TTW.pdb", "link_png_peptide": "/Peptide_pics/TTW.png"}
{"Peptide_Sequence": "TVDQHQ", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "288.4 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1258", " Ligand_ID": "TVDQHQ_minimized.pdb_1258", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "726.74", " logP": "-7.35", " logD": "-13.23", " logSw": "1.7", " tPSA": "388.49", " RotatableB": "22", " RigidB": "21", " Flexibility": "0.51", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "51", " CarbonAtoms": "29", " HeteroAtoms": "22", " ratio_H_by_C": "0.76", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3972531.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 726.735", "link_html_complex": "/ACE_complex_html/ACE_TVDQHQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVDQHQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVDQHQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVDQHQ.png", "phi_psi": "/peptide_da/TVDQHQ.pdb", "link_html_peptide": "/Peptide_html/TVDQHQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVDQHQ.pdb", "link_png_peptide": "/Peptide_pics/TVDQHQ.png"}
{"Peptide_Sequence": "TVPY", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1259", " Ligand_ID": "TVPY_minimized.pdb_1259", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "478.54", " logP": "-2.22", " logD": "-4.16", " logSw": "-0.81", " tPSA": "186.74", " RotatableB": "10", " RigidB": "18", " Flexibility": "0.36", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "212109.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 478.539", "link_html_complex": "/ACE_complex_html/ACE_TVPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVPY.png", "phi_psi": "/peptide_da/TVPY.pdb", "link_html_peptide": "/Peptide_html/TVPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVPY.pdb", "link_png_peptide": "/Peptide_pics/TVPY.png"}
{"Peptide_Sequence": "TVQVTSTAV", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1260", " Ligand_ID": "TVQVTSTAV_minimized.pdb_1260", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(O)=O", " MW": "905", " logP": "-6.2", " logD": "-10.13", " logSw": "0.24", " tPSA": "424.58", " RotatableB": "27", " RigidB": "19", " Flexibility": "0.59", " HBD": "17", " HBA": "25", " HBD_HBA": "42", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "63", " CarbonAtoms": "38", " HeteroAtoms": "25", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1147007.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 905.005", "link_html_complex": "/ACE_complex_html/ACE_TVQVTSTAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVQVTSTAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVQVTSTAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVQVTSTAV.png", "phi_psi": "/peptide_da/TVQVTSTAV.pdb", "link_html_peptide": "/Peptide_html/TVQVTSTAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVQVTSTAV.pdb", "link_png_peptide": "/Peptide_pics/TVQVTSTAV.png"}
{"Peptide_Sequence": "TVVPG", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "17.8 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1261", " Ligand_ID": "TVVPG_minimized.pdb_1261", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "471.55", " logP": "-3.7", " logD": "-5.72", " logSw": "0.29", " tPSA": "195.61", " RotatableB": "11", " RigidB": "14", " Flexibility": "0.44", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "632338.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 471.548", "link_html_complex": "/ACE_complex_html/ACE_TVVPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVVPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVVPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVVPG.png", "phi_psi": "/peptide_da/TVVPG.pdb", "link_html_peptide": "/Peptide_html/TVVPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVVPG.pdb", "link_png_peptide": "/Peptide_pics/TVVPG.png"}
{"Peptide_Sequence": "TVY", " Origin": "bovine \u03b1S2\u2010casein", " Peptide_Preparation": "tryptic hydrolysate", " Isolation_Method": "RP\u2010HPLC", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "15", " Reference": "Angiotensin\u2010I\u2010converting enzyme inhibitory peptides from tryptic hydrolysate of bovine \u03b1S2\u2010caseinJ\u00e9r\u00f4me TauzinLaurent MicloJean-Luc Gaillard", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1262", " Ligand_ID": "TVY_minimized.pdb_1262", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "381.42", " logP": "-3.58", " logD": "-3.73", " logSw": "0.56", " tPSA": "166.43", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "18", " HeteroAtoms": "9", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "669320.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 381.424", "link_html_complex": "/ACE_complex_html/ACE_TVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVY.png", "phi_psi": "/peptide_da/TVY.pdb", "link_html_peptide": "/Peptide_html/TVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVY.pdb", "link_png_peptide": "/Peptide_pics/TVY.png"}
{"Peptide_Sequence": "TVYTKGRVMP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "38", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1263", " Ligand_ID": "TVYTKGRVMP_minimized.pdb_1263", " Smiles": "CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1151.38", " logP": "-3.87", " logD": "-13.09", " logSw": "-2.19", " tPSA": "498.15", " RotatableB": "36", " RigidB": "31", " Flexibility": "0.54", " HBD": "20", " HBA": "28", " HBD_HBA": "48", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "80", " CarbonAtoms": "51", " HeteroAtoms": "29", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "128704.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1151.38", "link_html_complex": "/ACE_complex_html/ACE_TVYTKGRVMP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TVYTKGRVMP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TVYTKGRVMP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TVYTKGRVMP.png", "phi_psi": "/peptide_da/TVYTKGRVMP.pdb", "link_html_peptide": "/Peptide_html/TVYTKGRVMP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TVYTKGRVMP.pdb", "link_png_peptide": "/Peptide_pics/TVYTKGRVMP.png"}
{"Peptide_Sequence": "TYCQ", " Origin": "Sweet-potato tuber trypsin inhibitor", " Peptide_Preparation": " trypsin_x005F_x0007_Sepharose-4B affinity column", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist et al., 1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.3 \u03bcM", " Reference": "Pihlanto, Anne, and Sari Ma\u0308kinen. \"Antihypertensive properties of plant protein derived peptides.\" Bioactive food peptides in health and disease. IntechOpen, 2013.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1264", " Ligand_ID": "TYCQ_minimized.pdb_1264", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "513.56", " logP": "-4.38", " logD": "-6.41", " logSw": "0.59", " tPSA": "277.42", " RotatableB": "14", " RigidB": "15", " Flexibility": "0.48", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "928344.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 513.564", "link_html_complex": "/ACE_complex_html/ACE_TYCQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TYCQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TYCQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TYCQ.png", "phi_psi": "/peptide_da/TYCQ.pdb", "link_html_peptide": "/Peptide_html/TYCQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TYCQ.pdb", "link_png_peptide": "/Peptide_pics/TYCQ.png"}
{"Peptide_Sequence": "TYKEE", " Origin": "probiotic yoghurt", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications (Donkor et al., 2005)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "12.41 \u03bcg/mL", " Reference": "Donkor, Osaana N., et al. \"ACE-inhibitory activity of probiotic yoghurt.\" International dairy journal 17.11 (2007): 1321-1331.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1265", " Ligand_ID": "TYKEE_minimized.pdb_1265", " Smiles": "C[C@@H](O)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "668.69", " logP": "-6.94", " logD": "-15.87", " logSw": "1.79", " tPSA": "332.53", " RotatableB": "22", " RigidB": "17", " Flexibility": "0.56", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4003158.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 668.693", "link_html_complex": "/ACE_complex_html/ACE_TYKEE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TYKEE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TYKEE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TYKEE.png", "phi_psi": "/peptide_da/TYKEE.pdb", "link_html_peptide": "/Peptide_html/TYKEE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TYKEE.pdb", "link_png_peptide": "/Peptide_pics/TYKEE.png"}
{"Peptide_Sequence": "TYLGS", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.86 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1266", " Ligand_ID": "TYLGS_minimized.pdb_1266", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O", " MW": "539.58", " logP": "-3.82", " logD": "-6.24", " logSw": "0.15", " tPSA": "244.86", " RotatableB": "15", " RigidB": "15", " Flexibility": "0.5", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "628163.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 539.579", "link_html_complex": "/ACE_complex_html/ACE_TYLGS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_TYLGS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_TYLGS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_TYLGS.png", "phi_psi": "/peptide_da/TYLGS.pdb", "link_html_peptide": "/Peptide_html/TYLGS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/TYLGS.pdb", "link_png_peptide": "/Peptide_pics/TYLGS.png"}
{"Peptide_Sequence": "VAA", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "13", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1267", " Ligand_ID": "VAA_minimized.pdb_1267", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O", " MW": "259.3", " logP": "-3.25", " logD": "-4.62", " logSw": "1", " tPSA": "125.97", " RotatableB": "6", " RigidB": "5", " Flexibility": "0.55", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "11", " HeteroAtoms": "7", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "701920.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 259.302", "link_html_complex": "/ACE_complex_html/ACE_VAA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAA.png", "phi_psi": "/peptide_da/VAA.pdb", "link_html_peptide": "/Peptide_html/VAA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAA.pdb", "link_png_peptide": "/Peptide_pics/VAA.png"}
{"Peptide_Sequence": "VADVYVGK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "2.82 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1268", " Ligand_ID": "VADVYVGK_minimized.pdb_1268", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "849.97", " logP": "-5.83", " logD": "-7.76", " logSw": "0.24", " tPSA": "359.47", " RotatableB": "26", " RigidB": "22", " Flexibility": "0.54", " HBD": "14", " HBA": "21", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "60", " CarbonAtoms": "39", " HeteroAtoms": "21", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1083754.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 849.971", "link_html_complex": "/ACE_complex_html/ACE_VADVYVGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VADVYVGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VADVYVGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VADVYVGK.png", "phi_psi": "/peptide_da/VADVYVGK.pdb", "link_html_peptide": "/Peptide_html/VADVYVGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VADVYVGK.pdb", "link_png_peptide": "/Peptide_pics/VADVYVGK.png"}
{"Peptide_Sequence": "VAE", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "55900 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1269", " Ligand_ID": "VAE_minimized.pdb_1269", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "317.34", " logP": "-4.22", " logD": "-8.29", " logSw": "1.45", " tPSA": "166.1", " RotatableB": "9", " RigidB": "6", " Flexibility": "0.6", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "22", " CarbonAtoms": "13", " HeteroAtoms": "9", " ratio_H_by_C": "0.69", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1346240.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.69", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 317.338", "link_html_complex": "/ACE_complex_html/ACE_VAE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAE.png", "phi_psi": "/peptide_da/VAE.pdb", "link_html_peptide": "/Peptide_html/VAE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAE.pdb", "link_png_peptide": "/Peptide_pics/VAE.png"}
{"Peptide_Sequence": "VAF", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "35.8 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1270", " Ligand_ID": "VAF_minimized.pdb_1270", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "335.4", " logP": "-1.66", " logD": "-2.95", " logSw": "-0.44", " tPSA": "125.97", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "17", " HeteroAtoms": "7", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "216813.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 335.398", "link_html_complex": "/ACE_complex_html/ACE_VAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAF.png", "phi_psi": "/peptide_da/VAF.pdb", "link_html_peptide": "/Peptide_html/VAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAF.pdb", "link_png_peptide": "/Peptide_pics/VAF.png"}
{"Peptide_Sequence": "VAGTW", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "534ug/ml", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1271", " Ligand_ID": "VAGTW_minimized.pdb_1271", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "532.59", " logP": "-3.68", " logD": "-5.49", " logSw": "-0.06", " tPSA": "220.19", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "503758.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 532.589", "link_html_complex": "/ACE_complex_html/ACE_VAGTW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAGTW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAGTW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAGTW.png", "phi_psi": "/peptide_da/VAGTW.pdb", "link_html_peptide": "/Peptide_html/VAGTW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAGTW.pdb", "link_png_peptide": "/Peptide_pics/VAGTW.png"}
{"Peptide_Sequence": "VAGTWY", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1682 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-10.9", "Serial_ID": "1272", " Ligand_ID": "VAGTWY_minimized.pdb_1272", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "695.76", " logP": "-2.7", " logD": "-4.76", " logSw": "-1.45", " tPSA": "269.52", " RotatableB": "17", " RigidB": "27", " Flexibility": "0.39", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "50", " CarbonAtoms": "34", " HeteroAtoms": "16", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "163602.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 695.763", "link_html_complex": "/ACE_complex_html/ACE_VAGTWY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAGTWY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAGTWY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAGTWY.png", "phi_psi": "/peptide_da/VAGTWY.pdb", "link_html_peptide": "/Peptide_html/VAGTWY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAGTWY.pdb", "link_png_peptide": "/Peptide_pics/VAGTWY.png"}
{"Peptide_Sequence": "VAHINVGK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "6.76 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1273", " Ligand_ID": "VAHINVGK_minimized.pdb_1273", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O", " MW": "836.98", " logP": "-3.91", " logD": "-7.77", " logSw": "-0.81", " tPSA": "370.88", " RotatableB": "27", " RigidB": "22", " Flexibility": "0.55", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "59", " CarbonAtoms": "37", " HeteroAtoms": "22", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "370832.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 836.978", "link_html_complex": "/ACE_complex_html/ACE_VAHINVGK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAHINVGK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAHINVGK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAHINVGK.png", "phi_psi": "/peptide_da/VAHINVGK.pdb", "link_html_peptide": "/Peptide_html/VAHINVGK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAHINVGK.pdb", "link_png_peptide": "/Peptide_pics/VAHINVGK.png"}
{"Peptide_Sequence": "VAHINVWK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "3.47 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1274", " Ligand_ID": "VAHINVWK_minimized.pdb_1274", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "966.14", " logP": "-1.8", " logD": "-5.44", " logSw": "-2.86", " tPSA": "386.67", " RotatableB": "29", " RigidB": "32", " Flexibility": "0.48", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "69", " CarbonAtoms": "46", " HeteroAtoms": "23", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "55548.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 966.137", "link_html_complex": "/ACE_complex_html/ACE_VAHINVWK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAHINVWK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAHINVWK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAHINVWK.png", "phi_psi": "/peptide_da/VAHINVWK.pdb", "link_html_peptide": "/Peptide_html/VAHINVWK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAHINVWK.pdb", "link_png_peptide": "/Peptide_pics/VAHINVWK.png"}
{"Peptide_Sequence": "VAKLEK", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "100 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1275", " Ligand_ID": "VAKLEK_minimized.pdb_1275", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "686.84", " logP": "-5.24", " logD": "-8.67", " logSw": "0.85", " tPSA": "308.68", " RotatableB": "25", " RigidB": "12", " Flexibility": "0.68", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "31", " HeteroAtoms": "17", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1611452.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 686.84", "link_html_complex": "/ACE_complex_html/ACE_VAKLEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAKLEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAKLEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAKLEK.png", "phi_psi": "/peptide_da/VAKLEK.pdb", "link_html_peptide": "/Peptide_html/VAKLEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAKLEK.pdb", "link_png_peptide": "/Peptide_pics/VAKLEK.png"}
{"Peptide_Sequence": "VALDGGL", " Origin": "egg, ovatransferrin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1276", " Ligand_ID": "VALDGGL_minimized.pdb_1276", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "643.73", " logP": "-4.17", " logD": "-9.64", " logSw": "0.12", " tPSA": "282.5", " RotatableB": "20", " RigidB": "14", " Flexibility": "0.59", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "45", " CarbonAtoms": "28", " HeteroAtoms": "17", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "722888.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 643.729", "link_html_complex": "/ACE_complex_html/ACE_VALDGGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VALDGGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VALDGGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VALDGGL.png", "phi_psi": "/peptide_da/VALDGGL.pdb", "link_html_peptide": "/Peptide_html/VALDGGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VALDGGL.pdb", "link_png_peptide": "/Peptide_pics/VALDGGL.png"}
{"Peptide_Sequence": "VAND", " Origin": "Rice koji", " Peptide_Preparation": "Pepsin digestion", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "411 \u03bcM", " Reference": "Garc\u00eda, M. C., et al. \"Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities.\" Talanta 106 (2013): 328-349.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1277", " Ligand_ID": "VAND_minimized.pdb_1277", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "417.41", " logP": "-5.18", " logD": "-10.22", " logSw": "1.63", " tPSA": "238.29", " RotatableB": "12", " RigidB": "10", " Flexibility": "0.55", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "16", " HeteroAtoms": "13", " ratio_H_by_C": "0.81", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2124965.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 417.414", "link_html_complex": "/ACE_complex_html/ACE_VAND.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAND.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAND.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAND.png", "phi_psi": "/peptide_da/VAND.pdb", "link_html_peptide": "/Peptide_html/VAND.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAND.pdb", "link_png_peptide": "/Peptide_pics/VAND.png"}
{"Peptide_Sequence": "VAP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "2 \u03bcM", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1279", " Ligand_ID": "VAP_minimized.pdb_1279", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "285.34", " logP": "-3.26", " logD": "-4.35", " logSw": "0.77", " tPSA": "117.18", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "619166.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_VAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAP.png", "phi_psi": "/peptide_da/VAP.pdb", "link_html_peptide": "/Peptide_html/VAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAP.pdb", "link_png_peptide": "/Peptide_pics/VAP.png"}
{"Peptide_Sequence": "VAPFPEVF", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "362 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1278", " Ligand_ID": "VAPFPEVF_minimized.pdb_1278", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "905.05", " logP": "0.43", " logD": "-6.49", " logSw": "-4.34", " tPSA": "294.02", " RotatableB": "22", " RigidB": "38", " Flexibility": "0.37", " HBD": "9", " HBA": "19", " HBD_HBA": "28", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "65", " CarbonAtoms": "46", " HeteroAtoms": "19", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11810.12", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 905.048", "link_html_complex": "/ACE_complex_html/ACE_VAPFPEVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAPFPEVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAPFPEVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAPFPEVF.png", "phi_psi": "/peptide_da/VAPFPEVF.pdb", "link_html_peptide": "/Peptide_html/VAPFPEVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAPFPEVF.pdb", "link_png_peptide": "/Peptide_pics/VAPFPEVF.png"}
{"Peptide_Sequence": "VAV", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "260 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1280", " Ligand_ID": "VAV_minimized.pdb_1280", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "287.36", " logP": "-3.07", " logD": "-3.72", " logSw": "0.77", " tPSA": "125.97", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "623417.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 287.355", "link_html_complex": "/ACE_complex_html/ACE_VAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAV.png", "phi_psi": "/peptide_da/VAV.pdb", "link_html_peptide": "/Peptide_html/VAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAV.pdb", "link_png_peptide": "/Peptide_pics/VAV.png"}
{"Peptide_Sequence": "VAW", " Origin": "Egg Lysozyme", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "reverse-phase high-performance liquid chromatography", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.86", " Reference": "Purification and characterization of angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysate of hen egg white lysozyme", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1282", " Ligand_ID": "VAW_minimized.pdb_1282", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "374.43", " logP": "-1.5", " logD": "-2.84", " logSw": "-0.81", " tPSA": "141.76", " RotatableB": "8", " RigidB": "15", " Flexibility": "0.35", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "165879.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.434", "link_html_complex": "/ACE_complex_html/ACE_VAW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAW.png", "phi_psi": "/peptide_da/VAW.pdb", "link_html_peptide": "/Peptide_html/VAW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAW.pdb", "link_png_peptide": "/Peptide_pics/VAW.png"}
{"Peptide_Sequence": "VAWKL", " Origin": "dried salt fish", " Peptide_Preparation": "protease digestion", " Isolation_Method": "GFC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "31.97 \u03bcM", " Reference": "Astawan, Made, et al. \"Effects of angiotensin I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats.\" Bioscience, biotechnology, and biochemistry 59.3 (1995): 425-429.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1281", " Ligand_ID": "VAWKL_minimized.pdb_1281", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "615.76", " logP": "-1.18", " logD": "-4.47", " logSw": "-1.8", " tPSA": "227.6", " RotatableB": "18", " RigidB": "19", " Flexibility": "0.49", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "101993.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 615.764", "link_html_complex": "/ACE_complex_html/ACE_VAWKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAWKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAWKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAWKL.png", "phi_psi": "/peptide_da/VAWKL.pdb", "link_html_peptide": "/Peptide_html/VAWKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAWKL.pdb", "link_png_peptide": "/Peptide_pics/VAWKL.png"}
{"Peptide_Sequence": "VAY", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "16", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1283", " Ligand_ID": "VAY_minimized.pdb_1283", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "351.4", " logP": "-2.77", " logD": "-3.28", " logSw": "0.17", " tPSA": "146.2", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "414699.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 351.398", "link_html_complex": "/ACE_complex_html/ACE_VAY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VAY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VAY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VAY.png", "phi_psi": "/peptide_da/VAY.pdb", "link_html_peptide": "/Peptide_html/VAY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VAY.pdb", "link_png_peptide": "/Peptide_pics/VAY.png"}
{"Peptide_Sequence": "VDF", " Origin": "egg", " Peptide_Preparation": "pepsin-pancreatin digest", " Isolation_Method": " ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "6.59", " Reference": "Majumder, K., & Wu, J. (2009). Angiotensin I Converting Enzyme Inhibitory Peptides from Simulatedin VitroGastrointestinal Digestion of Cooked Eggs. Journal of Agricultural and Food Chemistry, 57(2), 471\u2013477. doi:10.1021/jf8028557", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1285", " Ligand_ID": "VDF_minimized.pdb_1285", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "379.41", " logP": "-2.53", " logD": "-6.16", " logSw": "-0.02", " tPSA": "166.1", " RotatableB": "10", " RigidB": "12", " Flexibility": "0.45", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "27", " CarbonAtoms": "18", " HeteroAtoms": "9", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "370479.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 379.408", "link_html_complex": "/ACE_complex_html/ACE_VDF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VDF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VDF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VDF.png", "phi_psi": "/peptide_da/VDF.pdb", "link_html_peptide": "/Peptide_html/VDF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VDF.pdb", "link_png_peptide": "/Peptide_pics/VDF.png"}
{"Peptide_Sequence": "VDFEG", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1284", " Ligand_ID": "VDFEG_minimized.pdb_1284", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O", " MW": "565.57", " logP": "-4.64", " logD": "-11.55", " logSw": "0.64", " tPSA": "264.43", " RotatableB": "17", " RigidB": "17", " Flexibility": "0.5", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1072006.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 565.573", "link_html_complex": "/ACE_complex_html/ACE_VDFEG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VDFEG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VDFEG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VDFEG.png", "phi_psi": "/peptide_da/VDFEG.pdb", "link_html_peptide": "/Peptide_html/VDFEG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VDFEG.pdb", "link_png_peptide": "/Peptide_pics/VDFEG.png"}
{"Peptide_Sequence": "VDP", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1286", " Ligand_ID": "VDP_minimized.pdb_1286", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "329.35", " logP": "-4.13", " logD": "-7.57", " logSw": "1.18", " tPSA": "157.31", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1073902.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 329.349", "link_html_complex": "/ACE_complex_html/ACE_VDP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VDP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VDP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VDP.png", "phi_psi": "/peptide_da/VDP.pdb", "link_html_peptide": "/Peptide_html/VDP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VDP.pdb", "link_png_peptide": "/Peptide_pics/VDP.png"}
{"Peptide_Sequence": "VDSDVVKG", " Origin": "bitter melon seed", " Peptide_Preparation": " trypsin , \u03b1-chymotrypsin, pepsin, alcalase,  thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman et al. with partial modification", " In-vivo_or_in-vitro": "in-vitro, in-vivo, in-silico", " IC50_micromol_per_L": "13.30 \u03bcM", " Reference": "Priyanto, Anugerah Dany, et al. \"Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.\" Journal of proteomics 128 (2015): 424-435.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1287", " Ligand_ID": "VDSDVVKG_minimized.pdb_1287", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O", " MW": "817.88", " logP": "-7.59", " logD": "-14.1", " logSw": "1.65", " tPSA": "399.6", " RotatableB": "27", " RigidB": "17", " Flexibility": "0.61", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "57", " CarbonAtoms": "34", " HeteroAtoms": "23", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4270725.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 817.884", "link_html_complex": "/ACE_complex_html/ACE_VDSDVVKG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VDSDVVKG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VDSDVVKG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VDSDVVKG.png", "phi_psi": "/peptide_da/VDSDVVKG.pdb", "link_html_peptide": "/Peptide_html/VDSDVVKG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VDSDVVKG.pdb", "link_png_peptide": "/Peptide_pics/VDSDVVKG.png"}
{"Peptide_Sequence": "VDW", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1288", " Ligand_ID": "VDW_minimized.pdb_1288", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "418.44", " logP": "-2.37", " logD": "-6.04", " logSw": "-0.4", " tPSA": "181.89", " RotatableB": "10", " RigidB": "16", " Flexibility": "0.38", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "280440.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 418.444", "link_html_complex": "/ACE_complex_html/ACE_VDW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VDW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VDW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VDW.png", "phi_psi": "/peptide_da/VDW.pdb", "link_html_peptide": "/Peptide_html/VDW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VDW.pdb", "link_png_peptide": "/Peptide_pics/VDW.png"}
{"Peptide_Sequence": "VE", " Origin": "milk powder", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC-TOF-MS", " ACE_inhibition_assay": "Nakamura Y et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "1294", " Ligand_ID": "VE_minimized.pdb_1294", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "246.26", " logP": "-3.9", " logD": "-6.37", " logSw": "1.55", " tPSA": "137", " RotatableB": "7", " RigidB": "4", " Flexibility": "0.64", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1162787.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 246.26", "link_html_complex": "/ACE_complex_html/ACE_VE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VE.png", "phi_psi": "/peptide_da/VE.pdb", "link_html_peptide": "/Peptide_html/VE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VE.pdb", "link_png_peptide": "/Peptide_pics/VE.png"}
{"Peptide_Sequence": "VECYGPNRPQF", " Origin": "Algae", " Peptide_Preparation": " enzymatic hydrolysis", " Isolation_Method": "ASF(Ammonium Sulfate fractionation), GFC, IEC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "29.6", " Reference": "Sheih, I-Chuan, Tony J. Fang, and Tung-Kung Wu. \"Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste.\" Food Chemistry 115.1 (2009): 279-284.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1289", " Ligand_ID": "VECYGPNRPQF_minimized.pdb_1289", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1309.45", " logP": "-5.63", " logD": "-12.27", " logSw": "-2.02", " tPSA": "590.17", " RotatableB": "37", " RigidB": "49", " Flexibility": "0.43", " HBD": "21", " HBA": "33", " HBD_HBA": "54", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "92", " CarbonAtoms": "58", " HeteroAtoms": "34", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "173681.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1309.45", "link_html_complex": "/ACE_complex_html/ACE_VECYGPNRPQF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VECYGPNRPQF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VECYGPNRPQF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VECYGPNRPQF.png", "phi_psi": "/peptide_da/VECYGPNRPQF.pdb", "link_html_peptide": "/Peptide_html/VECYGPNRPQF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VECYGPNRPQF.pdb", "link_png_peptide": "/Peptide_pics/VECYGPNRPQF.png"}
{"Peptide_Sequence": "VEF", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1291", " Ligand_ID": "VEF_minimized.pdb_1291", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "393.43", " logP": "-2.17", " logD": "-6.18", " logSw": "-0.27", " tPSA": "166.1", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "301266.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.434", "link_html_complex": "/ACE_complex_html/ACE_VEF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEF.png", "phi_psi": "/peptide_da/VEF.pdb", "link_html_peptide": "/Peptide_html/VEF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEF.pdb", "link_png_peptide": "/Peptide_pics/VEF.png"}
{"Peptide_Sequence": "VEFEG", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1290", " Ligand_ID": "VEFEG_minimized.pdb_1290", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O", " MW": "579.6", " logP": "-4.28", " logD": "-11.62", " logSw": "0.39", " tPSA": "264.43", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "9", " HBA": "15", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "859454.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.6", "link_html_complex": "/ACE_complex_html/ACE_VEFEG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEFEG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEFEG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEFEG.png", "phi_psi": "/peptide_da/VEFEG.pdb", "link_html_peptide": "/Peptide_html/VEFEG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEFEG.pdb", "link_png_peptide": "/Peptide_pics/VEFEG.png"}
{"Peptide_Sequence": "VEGY", " Origin": "marine Chlorella ellipsoidea ", " Peptide_Preparation": "Protamex, Kojizyme, Neutrase, Flavourzyme, Alcalase, trypsin, \u03b1-chymotrypsin, pepsin and papain", " Isolation_Method": "UF, GEC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung with slight modification", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "128.4 \u03bcM", " Reference": "Ko, Seok-Chun, et al. \"A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from a marine Chlorella ellipsoidea and its antihypertensive effect in spontaneously hypertensive rats.\" Process biochemistry 47.12 (2012): 2005-2011.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1292", " Ligand_ID": "VEGY_minimized.pdb_1292", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "466.48", " logP": "-2.97", " logD": "-7.71", " logSw": "-0.07", " tPSA": "215.43", " RotatableB": "13", " RigidB": "14", " Flexibility": "0.48", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "433392.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 466.485", "link_html_complex": "/ACE_complex_html/ACE_VEGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEGY.png", "phi_psi": "/peptide_da/VEGY.pdb", "link_html_peptide": "/Peptide_html/VEGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEGY.pdb", "link_png_peptide": "/Peptide_pics/VEGY.png"}
{"Peptide_Sequence": "VELYP", " Origin": "cuttlefish mucle", " Peptide_Preparation": " Enzymatic hydrolysis ", " Isolation_Method": "", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "5.22 \u03bcM", " Reference": "Balti, Rafik, et al. \"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats.\" Food chemistry 170 (2015): 519-525.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1293", " Ligand_ID": "VELYP_minimized.pdb_1293", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "619.71", " logP": "-2.39", " logD": "-6.14", " logSw": "-1.17", " tPSA": "235.74", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "192265.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 619.706", "link_html_complex": "/ACE_complex_html/ACE_VELYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VELYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VELYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VELYP.png", "phi_psi": "/peptide_da/VELYP.pdb", "link_html_peptide": "/Peptide_html/VELYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VELYP.pdb", "link_png_peptide": "/Peptide_pics/VELYP.png"}
{"Peptide_Sequence": "VENLHLPLPLL", " Origin": "milk proteins", " Peptide_Preparation": "Fermentation,  Lactobacillus helveticus", " Isolation_Method": "GPC, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "175 \u00b5M", " Reference": "Robert, Marie-Claude, et al. \"Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765.\" Journal of Agricultural and Food Chemistry 52.23 (2004): 6923-6931.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1295", " Ligand_ID": "VENLHLPLPLL_minimized.pdb_1295", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "1257.52", " logP": "0.38", " logD": "-7.27", " logSw": "-5.45", " tPSA": "453.09", " RotatableB": "37", " RigidB": "39", " Flexibility": "0.49", " HBD": "15", " HBA": "29", " HBD_HBA": "44", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "89", " CarbonAtoms": "60", " HeteroAtoms": "29", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5383.25", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1257.52", "link_html_complex": "/ACE_complex_html/ACE_VENLHLPLPLL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VENLHLPLPLL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VENLHLPLPLL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VENLHLPLPLL.png", "phi_psi": "/peptide_da/VENLHLPLPLL.pdb", "link_html_peptide": "/Peptide_html/VENLHLPLPLL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VENLHLPLPLL.pdb", "link_png_peptide": "/Peptide_pics/VENLHLPLPLL.png"}
{"Peptide_Sequence": "VEP", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1296", " Ligand_ID": "VEP_minimized.pdb_1296", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "343.38", " logP": "-3.77", " logD": "-7.55", " logSw": "0.93", " tPSA": "157.31", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "0", " Solubility_mg_per_l": "873926.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 343.376", "link_html_complex": "/ACE_complex_html/ACE_VEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEP.png", "phi_psi": "/peptide_da/VEP.pdb", "link_html_peptide": "/Peptide_html/VEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEP.pdb", "link_png_peptide": "/Peptide_pics/VEP.png"}
{"Peptide_Sequence": "VEQKHIQKE", " Origin": "milk-derived", " Peptide_Preparation": "Hebert   et   al.  (2000)", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Vermeirssen   et   al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Villegas, Josefina M., et al. \"Milk-derived angiotensin-I-converting enzymeinhibitory peptides generated by Lactobacillus delbrueckii subsp. lactis CRL 581.\" Peptidomics 1.1 (2014).", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1297", " Ligand_ID": "VEQKHIQKE_minimized.pdb_1297", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "1138.27", " logP": "-11.35", " logD": "-16.88", " logSw": "2.94", " tPSA": "550.97", " RotatableB": "41", " RigidB": "28", " Flexibility": "0.59", " HBD": "22", " HBA": "31", " HBD_HBA": "53", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "6", " TotalCharge": "0", " HeavyAtoms": "80", " CarbonAtoms": "49", " HeteroAtoms": "31", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "21456201.61", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1138.27", "link_html_complex": "/ACE_complex_html/ACE_VEQKHIQKE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEQKHIQKE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEQKHIQKE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEQKHIQKE.png", "phi_psi": "/peptide_da/VEQKHIQKE.pdb", "link_html_peptide": "/Peptide_html/VEQKHIQKE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEQKHIQKE.pdb", "link_png_peptide": "/Peptide_pics/VEQKHIQKE.png"}
{"Peptide_Sequence": "VEV", " Origin": "wheat germ", " Peptide_Preparation": "", " Isolation_Method": "ethanol precipitation and chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "115.20 \u03bcM", " Reference": "Yang, Runqiang, et al. \"Accumulation and identification of angiotensin-converting enzyme inhibitory peptides from wheat germ.\" Journal of agricultural and food chemistry 59.8 (2011): 3598-3605.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1298", " Ligand_ID": "VEV_minimized.pdb_1298", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "345.39", " logP": "-3.93", " logD": "-6.88", " logSw": "1.15", " tPSA": "166.1", " RotatableB": "10", " RigidB": "6", " Flexibility": "0.63", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1095703.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 345.391", "link_html_complex": "/ACE_complex_html/ACE_VEV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEV.png", "phi_psi": "/peptide_da/VEV.pdb", "link_html_peptide": "/Peptide_html/VEV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEV.pdb", "link_png_peptide": "/Peptide_pics/VEV.png"}
{"Peptide_Sequence": "VEY", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1299", " Ligand_ID": "VEY_minimized.pdb_1299", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "409.43", " logP": "-3.29", " logD": "-6.52", " logSw": "0.34", " tPSA": "186.33", " RotatableB": "11", " RigidB": "12", " Flexibility": "0.48", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "575765.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 409.434", "link_html_complex": "/ACE_complex_html/ACE_VEY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VEY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VEY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VEY.png", "phi_psi": "/peptide_da/VEY.pdb", "link_html_peptide": "/Peptide_html/VEY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VEY.pdb", "link_png_peptide": "/Peptide_pics/VEY.png"}
{"Peptide_Sequence": "VF", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "9.2 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1304", " Ligand_ID": "VF_minimized.pdb_1304", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "264.32", " logP": "-2.16", " logD": "-1.3", " logSw": "0.16", " tPSA": "96.87", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "14", " HeteroAtoms": "5", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "311478.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 264.32", "link_html_complex": "/ACE_complex_html/ACE_VF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VF.png", "phi_psi": "/peptide_da/VF.pdb", "link_html_peptide": "/Peptide_html/VF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VF.pdb", "link_png_peptide": "/Peptide_pics/VF.png"}
{"Peptide_Sequence": "VFER", " Origin": "Antarctic krill (Euphausia superba) tail meat", " Peptide_Preparation": "", " Isolation_Method": "SEC, UPLC-ESI-MS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "152.8 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1300", " Ligand_ID": "VFER_minimized.pdb_1300", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "549.62", " logP": "-3.13", " logD": "-7.2", " logSw": "-0.14", " tPSA": "258.84", " RotatableB": "18", " RigidB": "15", " Flexibility": "0.55", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "39", " CarbonAtoms": "25", " HeteroAtoms": "14", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "475592.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 549.62", "link_html_complex": "/ACE_complex_html/ACE_VFER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VFER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VFER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VFER.png", "phi_psi": "/peptide_da/VFER.pdb", "link_html_peptide": "/Peptide_html/VFER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VFER.pdb", "link_png_peptide": "/Peptide_pics/VFER.png"}
{"Peptide_Sequence": "VFEWAFAR", " Origin": "bovine brisket ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Di Bernardini, Roberta, et al. \"Assessment of the angiotensin-I-converting enzyme (ACE-I) inhibitory and antioxidant activities of hydrolysates of bovine brisket sarcoplasmic proteins produced by papain and characterisation of associated bioactive peptidic fractions.\" Meat science 90.1 (2012): 226-235.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1301", " Ligand_ID": "VFEWAFAR_minimized.pdb_1301", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1025.16", " logP": "-1.18", " logD": "-5.93", " logSw": "-3.58", " tPSA": "391.03", " RotatableB": "30", " RigidB": "39", " Flexibility": "0.43", " HBD": "16", " HBA": "23", " HBD_HBA": "39", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "74", " CarbonAtoms": "51", " HeteroAtoms": "23", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "28519.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1025.16", "link_html_complex": "/ACE_complex_html/ACE_VFEWAFAR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VFEWAFAR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VFEWAFAR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VFEWAFAR.png", "phi_psi": "/peptide_da/VFEWAFAR.pdb", "link_html_peptide": "/Peptide_html/VFEWAFAR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VFEWAFAR.pdb", "link_png_peptide": "/Peptide_pics/VFEWAFAR.png"}
{"Peptide_Sequence": "VFK", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "1029 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "1303", " Ligand_ID": "VFK_minimized.pdb_1303", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "392.49", " logP": "-1.03", " logD": "-3.15", " logSw": "-0.91", " tPSA": "153.61", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "158533.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.493", "link_html_complex": "/ACE_complex_html/ACE_VFK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VFK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VFK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VFK.png", "phi_psi": "/peptide_da/VFK.pdb", "link_html_peptide": "/Peptide_html/VFK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VFK.pdb", "link_png_peptide": "/Peptide_pics/VFK.png"}
{"Peptide_Sequence": "VFKAF", " Origin": "Mactra veneriformis", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung with minor modifications", " In-vivo_or_in-vitro": "in-vitro, in-silico", " IC50_micromol_per_L": "100.1 \u00b5M", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1302", " Ligand_ID": "VFKAF_minimized.pdb_1302", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "610.74", " logP": "-0.81", " logD": "-5.52", " logSw": "-2.03", " tPSA": "211.81", " RotatableB": "18", " RigidB": "21", " Flexibility": "0.46", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "32", " HeteroAtoms": "12", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "80454.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 610.744", "link_html_complex": "/ACE_complex_html/ACE_VFKAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VFKAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VFKAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VFKAF.png", "phi_psi": "/peptide_da/VFKAF.pdb", "link_html_peptide": "/Peptide_html/VFKAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VFKAF.pdb", "link_png_peptide": "/Peptide_pics/VFKAF.png"}
{"Peptide_Sequence": "VFPS", " Origin": "Wheat germ", " Peptide_Preparation": "alkaline hydrolysis", " Isolation_Method": "four-step  HPLC  (Shimadzu  LC-9A  instru-ment, Kyoto, Japan)", " ACE_inhibition_assay": "pro-posed 2,4,6-trinitro benzene sulfonate(TNBS)method", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "0.46 \u03bcM", " Reference": "Matsui T, Li CH, Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I\u2013converting enzyme inhibition from wheat germ. J Pept Sci 1999;5:289\u201397.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1305", " Ligand_ID": "VFPS_minimized.pdb_1305", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O", " MW": "448.51", " logP": "-3.46", " logD": "-4.71", " logSw": "0.15", " tPSA": "166.51", " RotatableB": "10", " RigidB": "18", " Flexibility": "0.36", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "520913.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 448.513", "link_html_complex": "/ACE_complex_html/ACE_VFPS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VFPS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VFPS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VFPS.png", "phi_psi": "/peptide_da/VFPS.pdb", "link_html_peptide": "/Peptide_html/VFPS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VFPS.pdb", "link_png_peptide": "/Peptide_pics/VFPS.png"}
{"Peptide_Sequence": "VG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "1100 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-5.8", "Serial_ID": "1310", " Ligand_ID": "VG_minimized.pdb_1310", " Smiles": "CC(C)[C@H](N)C(=O)NCC(O)=O", " MW": "174.2", " logP": "-2.69", " logD": "-3.53", " logSw": "1.04", " tPSA": "96.87", " RotatableB": "4", " RigidB": "3", " Flexibility": "0.57", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "12", " CarbonAtoms": "7", " HeteroAtoms": "5", " ratio_H_by_C": "0.71", " Lipinski_Violation": "0", " Solubility_mg_per_l": "492190.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 174.198", "link_html_complex": "/ACE_complex_html/ACE_VG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VG.png", "phi_psi": "/peptide_da/VG.pdb", "link_html_peptide": "/Peptide_html/VG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VG.pdb", "link_png_peptide": "/Peptide_pics/VG.png"}
{"Peptide_Sequence": "VGGPR", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1306", " Ligand_ID": "VGGPR_minimized.pdb_1306", " Smiles": "CC(C)[C@H](N)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "484.55", " logP": "-4.37", " logD": "-7.33", " logSw": "0.83", " tPSA": "239.02", " RotatableB": "14", " RigidB": "15", " Flexibility": "0.48", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "20", " HeteroAtoms": "14", " ratio_H_by_C": "0.7", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1114444.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 484.55", "link_html_complex": "/ACE_complex_html/ACE_VGGPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGGPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGGPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGGPR.png", "phi_psi": "/peptide_da/VGGPR.pdb", "link_html_peptide": "/Peptide_html/VGGPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGGPR.pdb", "link_png_peptide": "/Peptide_pics/VGGPR.png"}
{"Peptide_Sequence": "VGINYWLAHK", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "327", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1308", " Ligand_ID": "VGINYWLAHK_minimized.pdb_1308", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1200.39", " logP": "-2.44", " logD": "-5.37", " logSw": "-3.46", " tPSA": "465.1", " RotatableB": "36", " RigidB": "42", " Flexibility": "0.46", " HBD": "19", " HBA": "28", " HBD_HBA": "47", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "86", " CarbonAtoms": "58", " HeteroAtoms": "28", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "37888.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1200.39", "link_html_complex": "/ACE_complex_html/ACE_VGINYWLAHK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGINYWLAHK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGINYWLAHK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGINYWLAHK.png", "phi_psi": "/peptide_da/VGINYWLAHK.pdb", "link_html_peptide": "/Peptide_html/VGINYWLAHK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGINYWLAHK.pdb", "link_png_peptide": "/Peptide_pics/VGINYWLAHK.png"}
{"Peptide_Sequence": "VGINYWLAHKHK", " Origin": "Alpha-Lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "SDS-PAGE, RP-HPLC", " ACE_inhibition_assay": "Vermeirssen et al.", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "327 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1465.7", "link_html_complex": "/ACE_complex_html/ACE_VGINYWLAHKHK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGINYWLAHKHK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGINYWLAHKHK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGINYWLAHKHK.png", "phi_psi": "/peptide_da/VGINYWLAHKHK.pdb", "link_html_peptide": "/Peptide_html/VGINYWLAHKHK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGINYWLAHKHK.pdb", "link_png_peptide": "/Peptide_pics/VGINYWLAHKHK.png"}
{"Peptide_Sequence": "VGLPIF", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "30.9 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1309", " Ligand_ID": "VGLPIF_minimized.pdb_1309", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "644.8", " logP": "0.48", " logD": "-2.64", " logSw": "-3.06", " tPSA": "204.48", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "33", " HeteroAtoms": "13", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "30128.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 644.802", "link_html_complex": "/ACE_complex_html/ACE_VGLPIF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGLPIF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGLPIF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGLPIF.png", "phi_psi": "/peptide_da/VGLPIF.pdb", "link_html_peptide": "/Peptide_html/VGLPIF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGLPIF.pdb", "link_png_peptide": "/Peptide_pics/VGLPIF.png"}
{"Peptide_Sequence": "VGP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1311", " Ligand_ID": "VGP_minimized.pdb_1311", " Smiles": "CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "271.31", " logP": "-2.8", " logD": "-4.93", " logSw": "0.57", " tPSA": "117.18", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "0", " Solubility_mg_per_l": "480646.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 271.313", "link_html_complex": "/ACE_complex_html/ACE_VGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGP.png", "phi_psi": "/peptide_da/VGP.pdb", "link_html_peptide": "/Peptide_html/VGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGP.pdb", "link_png_peptide": "/Peptide_pics/VGP.png"}
{"Peptide_Sequence": "VGPR", " Origin": "pork meat", " Peptide_Preparation": "simulated gut", " Isolation_Method": "chromatography", " ACE_inhibition_assay": " Sentandreu and Toldra\n(2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Escudero, Elizabeth, et al. \"Angiotensin I-converting enzyme inhibitory peptides generated from in vitro gastrointestinal digestion of pork meat.\" Journal of Agricultural and Food Chemistry 58.5 (2010): 2895-2901.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1312", " Ligand_ID": "VGPR_minimized.pdb_1312", " Smiles": "CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "427.5", " logP": "-3.71", " logD": "-6.23", " logSw": "0.64", " tPSA": "209.92", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "809777.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 427.499", "link_html_complex": "/ACE_complex_html/ACE_VGPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGPR.png", "phi_psi": "/peptide_da/VGPR.pdb", "link_html_peptide": "/Peptide_html/VGPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGPR.pdb", "link_png_peptide": "/Peptide_pics/VGPR.png"}
{"Peptide_Sequence": "VGRPRHQG", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "81", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1313", " Ligand_ID": "VGRPRHQG_minimized.pdb_1313", " Smiles": "CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "906", " logP": "-7.35", " logD": "-16.91", " logSw": "1.12", " tPSA": "461.73", " RotatableB": "30", " RigidB": "29", " Flexibility": "0.51", " HBD": "20", " HBA": "27", " HBD_HBA": "47", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "64", " CarbonAtoms": "37", " HeteroAtoms": "27", " ratio_H_by_C": "0.73", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2788293.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 906.004", "link_html_complex": "/ACE_complex_html/ACE_VGRPRHQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGRPRHQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGRPRHQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGRPRHQG.png", "phi_psi": "/peptide_da/VGRPRHQG.pdb", "link_html_peptide": "/Peptide_html/VGRPRHQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGRPRHQG.pdb", "link_png_peptide": "/Peptide_pics/VGRPRHQG.png"}
{"Peptide_Sequence": "VGVIKAVDKKAGGAGKVT", " Origin": "fertilized egg", " Peptide_Preparation": "", " Isolation_Method": "centrifugation, membrane filteration, UF", " ACE_inhibition_assay": "Terashima et al (2011)", " In-vivo_or_in-vitro": "in-vitro, in-vivo\n", " IC50_micromol_per_L": "125 \u03bcM", " Reference": "Duan, Xiang, et al. \"Naturally occurring angiotensin I-converting enzyme inhibitory peptide from a fertilized egg and its inhibitory mechanism.\" Journal of agricultural and food chemistry 62.24 (2014): 5500-5506.", " Binding_Energy_kcal_per_mol": "-3.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1698.02", "link_html_complex": "/ACE_complex_html/ACE_VGVIKAVDKKAGGAGKVT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGVIKAVDKKAGGAGKVT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGVIKAVDKKAGGAGKVT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGVIKAVDKKAGGAGKVT.png", "phi_psi": "/peptide_da/VGVIKAVDKKAGGAGKVT.pdb", "link_html_peptide": "/Peptide_html/VGVIKAVDKKAGGAGKVT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGVIKAVDKKAGGAGKVT.pdb", "link_png_peptide": "/Peptide_pics/VGVIKAVDKKAGGAGKVT.png"}
{"Peptide_Sequence": "VGVPGGV", " Origin": "olive seeds", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "(Esteve, del R\u00edo, Marina, & Garc\u00eda, 2010)", " ACE_inhibition_assay": " Geng, He, Yang, and Wang (2010", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Esteve, C., M. L. Marina, and M. C. Garc\u00eda. \"Novel strategy for the revalorization of olive (Olea europaea) residues based on the extraction of bioactive peptides.\" Food chemistry 167 (2015): 272-280.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1315", " Ligand_ID": "VGVPGGV_minimized.pdb_1315", " Smiles": "CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O", " MW": "583.68", " logP": "-3.43", " logD": "-6.8", " logSw": "-0.31", " tPSA": "233.58", " RotatableB": "15", " RigidB": "18", " Flexibility": "0.45", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "428996.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 583.678", "link_html_complex": "/ACE_complex_html/ACE_VGVPGGV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VGVPGGV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VGVPGGV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VGVPGGV.png", "phi_psi": "/peptide_da/VGVPGGV.pdb", "link_html_peptide": "/Peptide_html/VGVPGGV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VGVPGGV.pdb", "link_png_peptide": "/Peptide_pics/VGVPGGV.png"}
{"Peptide_Sequence": "VHIPP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "10", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1316", " Ligand_ID": "VHIPP_minimized.pdb_1316", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "561.67", " logP": "-1.35", " logD": "-4.72", " logSw": "-1.72", " tPSA": "195.27", " RotatableB": "12", " RigidB": "24", " Flexibility": "0.33", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "100129.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 561.674", "link_html_complex": "/ACE_complex_html/ACE_VHIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHIPP.png", "phi_psi": "/peptide_da/VHIPP.pdb", "link_html_peptide": "/Peptide_html/VHIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHIPP.pdb", "link_png_peptide": "/Peptide_pics/VHIPP.png"}
{"Peptide_Sequence": "VHLAP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "4.5", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1317", " Ligand_ID": "VHLAP_minimized.pdb_1317", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "535.64", " logP": "-3.35", " logD": "-5.06", " logSw": "-0.24", " tPSA": "204.06", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "421649.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 535.636", "link_html_complex": "/ACE_complex_html/ACE_VHLAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHLAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHLAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHLAP.png", "phi_psi": "/peptide_da/VHLAP.pdb", "link_html_peptide": "/Peptide_html/VHLAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHLAP.pdb", "link_png_peptide": "/Peptide_pics/VHLAP.png"}
{"Peptide_Sequence": "VHLPP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "18", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1318", " Ligand_ID": "VHLPP_minimized.pdb_1318", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "561.67", " logP": "-1.35", " logD": "-4.78", " logSw": "-1.72", " tPSA": "195.27", " RotatableB": "12", " RigidB": "24", " Flexibility": "0.33", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "100129.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 561.674", "link_html_complex": "/ACE_complex_html/ACE_VHLPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHLPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHLPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHLPP.png", "phi_psi": "/peptide_da/VHLPP.pdb", "link_html_peptide": "/Peptide_html/VHLPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHLPP.pdb", "link_png_peptide": "/Peptide_pics/VHLPP.png"}
{"Peptide_Sequence": "VHLPPP", " Origin": "Maize", " Peptide_Preparation": "liquid phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro assay", " IC50_micromol_per_L": "200", " Reference": "Angiotensin I-Converting Enzyme Inhibitory Activities of Synthetic Peptides Related to the Tandem Repeated Sequence of a Maize Endosperm Protein Susumu Maruyama, Shinsuke Miyoshi, Toshiyuki Kaneko & Hideoki Tanaka", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1319", " Ligand_ID": "VHLPPP_minimized.pdb_1319", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "658.79", " logP": "-1.3", " logD": "-5.07", " logSw": "-2.29", " tPSA": "215.58", " RotatableB": "13", " RigidB": "31", " Flexibility": "0.3", " HBD": "6", " HBA": "15", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67005.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 658.789", "link_html_complex": "/ACE_complex_html/ACE_VHLPPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHLPPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHLPPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHLPPP.png", "phi_psi": "/peptide_da/VHLPPP.pdb", "link_html_peptide": "/Peptide_html/VHLPPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHLPPP.pdb", "link_png_peptide": "/Peptide_pics/VHLPPP.png"}
{"Peptide_Sequence": "VHRKC", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1320", " Ligand_ID": "VHRKC_minimized.pdb_1320", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(O)=O", " MW": "641.79", " logP": "-4.42", " logD": "-11.19", " logSw": "0.38", " tPSA": "342.93", " RotatableB": "22", " RigidB": "15", " Flexibility": "0.59", " HBD": "14", " HBA": "17", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "44", " CarbonAtoms": "26", " HeteroAtoms": "18", " ratio_H_by_C": "0.69", " Lipinski_Violation": "3", " Solubility_mg_per_l": "935536.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 641.786", "link_html_complex": "/ACE_complex_html/ACE_VHRKC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHRKC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHRKC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHRKC.png", "phi_psi": "/peptide_da/VHRKC.pdb", "link_html_peptide": "/Peptide_html/VHRKC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHRKC.pdb", "link_png_peptide": "/Peptide_pics/VHRKC.png"}
{"Peptide_Sequence": "VHSSIQSQPQAFT", " Origin": "b-CN (47-59), mouse", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1001 \u03bcM", " Reference": "ACE inhibitory peptides. in: Nutraceutical proteins and peptides in health and disease. Mine Y., Shahidi F. (Eds.), CRC Taylor & Francis Group, Boca Raton, London, New York, 269-315.", " Binding_Energy_kcal_per_mol": "-6.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1429.53", "link_html_complex": "/ACE_complex_html/ACE_VHSSIQSQPQAFT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHSSIQSQPQAFT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHSSIQSQPQAFT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHSSIQSQPQAFT.png", "phi_psi": "/peptide_da/VHSSIQSQPQAFT.pdb", "link_html_peptide": "/Peptide_html/VHSSIQSQPQAFT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHSSIQSQPQAFT.pdb", "link_png_peptide": "/Peptide_pics/VHSSIQSQPQAFT.png"}
{"Peptide_Sequence": "VHW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "0.9 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1322", " Ligand_ID": "VHW_minimized.pdb_1322", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "440.5", " logP": "-1.73", " logD": "-3.17", " logSw": "-0.99", " tPSA": "170.44", " RotatableB": "10", " RigidB": "20", " Flexibility": "0.33", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "163050.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 440.496", "link_html_complex": "/ACE_complex_html/ACE_VHW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHW.png", "phi_psi": "/peptide_da/VHW.pdb", "link_html_peptide": "/Peptide_html/VHW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHW.pdb", "link_png_peptide": "/Peptide_pics/VHW.png"}
{"Peptide_Sequence": "VHY", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1324", " Ligand_ID": "VHY_minimized.pdb_1324", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "417.46", " logP": "-3.32", " logD": "-3.59", " logSw": "0.18", " tPSA": "174.88", " RotatableB": "10", " RigidB": "16", " Flexibility": "0.38", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "20", " HeteroAtoms": "10", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "500062.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 417.459", "link_html_complex": "/ACE_complex_html/ACE_VHY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHY.png", "phi_psi": "/peptide_da/VHY.pdb", "link_html_peptide": "/Peptide_html/VHY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHY.pdb", "link_png_peptide": "/Peptide_pics/VHY.png"}
{"Peptide_Sequence": "VHYEA", " Origin": "Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1323", " Ligand_ID": "VHYEA_minimized.pdb_1323", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O", " MW": "617.65", " logP": "-2.56", " logD": "-8.92", " logSw": "-1.03", " tPSA": "273.21", " RotatableB": "17", " RigidB": "21", " Flexibility": "0.45", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "44", " CarbonAtoms": "28", " HeteroAtoms": "16", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "219909.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.651", "link_html_complex": "/ACE_complex_html/ACE_VHYEA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VHYEA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VHYEA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VHYEA.png", "phi_psi": "/peptide_da/VHYEA.pdb", "link_html_peptide": "/Peptide_html/VHYEA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VHYEA.pdb", "link_png_peptide": "/Peptide_pics/VHYEA.png"}
{"Peptide_Sequence": "VIEKYP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "173 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1325", " Ligand_ID": "VIEKYP_minimized.pdb_1325", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "747.88", " logP": "-3.47", " logD": "-9.95", " logSw": "-0.88", " tPSA": "292.48", " RotatableB": "22", " RigidB": "23", " Flexibility": "0.49", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "310483.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.879", "link_html_complex": "/ACE_complex_html/ACE_VIEKYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIEKYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIEKYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIEKYP.png", "phi_psi": "/peptide_da/VIEKYP.pdb", "link_html_peptide": "/Peptide_html/VIEKYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIEKYP.pdb", "link_png_peptide": "/Peptide_pics/VIEKYP.png"}
{"Peptide_Sequence": "VIGSPPEIN", " Origin": "fermented milk", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "> 1000 \u03bcM/L", " Reference": "Gobbetti, Marco, et al. \"Production of Angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckiisubsp. bulgaricus SS1 and Lactococcus lactissubsp. cremoris FT4.\" Appl. Environ. Microbiol. 66.9 (2000): 3898-3904.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1326", " Ligand_ID": "VIGSPPEIN_minimized.pdb_1326", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "925.04", " logP": "-4.29", " logD": "-11.71", " logSw": "-1.16", " tPSA": "386.44", " RotatableB": "26", " RigidB": "30", " Flexibility": "0.46", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "65", " CarbonAtoms": "41", " HeteroAtoms": "24", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "290994.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 925.037", "link_html_complex": "/ACE_complex_html/ACE_VIGSPPEIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIGSPPEIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIGSPPEIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIGSPPEIN.png", "phi_psi": "/peptide_da/VIGSPPEIN.pdb", "link_html_peptide": "/Peptide_html/VIGSPPEIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIGSPPEIN.pdb", "link_png_peptide": "/Peptide_pics/VIGSPPEIN.png"}
{"Peptide_Sequence": "VIGSPPQIN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1327", " Ligand_ID": "VIGSPPQIN_minimized.pdb_1327", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "924.05", " logP": "-4.94", " logD": "-9.25", " logSw": "-0.81", " tPSA": "389.4", " RotatableB": "25", " RigidB": "31", " Flexibility": "0.45", " HBD": "14", " HBA": "24", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "65", " CarbonAtoms": "41", " HeteroAtoms": "24", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "412338.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 924.052", "link_html_complex": "/ACE_complex_html/ACE_VIGSPPQIN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIGSPPQIN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIGSPPQIN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIGSPPQIN.png", "phi_psi": "/peptide_da/VIGSPPQIN.pdb", "link_html_peptide": "/Peptide_html/VIGSPPQIN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIGSPPQIN.pdb", "link_png_peptide": "/Peptide_pics/VIGSPPQIN.png"}
{"Peptide_Sequence": "VIIF", " Origin": " cuttlefish (Sepia officinalis) ", " Peptide_Preparation": "Chymotrypsin, trypsin and pepsin ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "8.7 \u03bcM", " Reference": "Balti, Rafik, et al. \"Three novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) using digestive proteases.\" Food Research International 43.4 (2010): 1136-1143.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1328", " Ligand_ID": "VIIF_minimized.pdb_1328", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "490.64", " logP": "-0.73", " logD": "-1.19", " logSw": "-1.56", " tPSA": "155.07", " RotatableB": "14", " RigidB": "13", " Flexibility": "0.52", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "26", " HeteroAtoms": "9", " ratio_H_by_C": "0.35", " Lipinski_Violation": "1", " Solubility_mg_per_l": "103544.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 490.635", "link_html_complex": "/ACE_complex_html/ACE_VIIF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIIF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIIF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIIF.png", "phi_psi": "/peptide_da/VIIF.pdb", "link_html_peptide": "/Peptide_html/VIIF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIIF.pdb", "link_png_peptide": "/Peptide_pics/VIIF.png"}
{"Peptide_Sequence": "VIKP", " Origin": "Amaranthus hypochondriacus 11S globulin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "175", " Reference": "Vecchi, B., and M. C. A\u00f1\u00f3n. \"ACE inhibitory tetrapeptides from Amaranthus hypochondriacus 11S globulin.\" Phytochemistry 70.7 (2009): 864-870.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1329", " Ligand_ID": "VIKP_minimized.pdb_1329", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "455.59", " logP": "-3.09", " logD": "-5.35", " logSw": "0.14", " tPSA": "173.92", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "524072.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.591", "link_html_complex": "/ACE_complex_html/ACE_VIKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIKP.png", "phi_psi": "/peptide_da/VIKP.pdb", "link_html_peptide": "/Peptide_html/VIKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIKP.pdb", "link_png_peptide": "/Peptide_pics/VIKP.png"}
{"Peptide_Sequence": "VIP", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "1331", " Ligand_ID": "VIP_minimized.pdb_1331", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "327.42", " logP": "-1.08", " logD": "-3", " logSw": "-0.73", " tPSA": "117.18", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "158165.57", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 327.419", "link_html_complex": "/ACE_complex_html/ACE_VIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIP.png", "phi_psi": "/peptide_da/VIP.pdb", "link_html_peptide": "/Peptide_html/VIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIP.pdb", "link_png_peptide": "/Peptide_pics/VIP.png"}
{"Peptide_Sequence": "VIPEL", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1330", " Ligand_ID": "VIPEL_minimized.pdb_1330", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "569.69", " logP": "-2.32", " logD": "-6.91", " logSw": "-0.85", " tPSA": "215.51", " RotatableB": "16", " RigidB": "15", " Flexibility": "0.52", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "242405.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 569.691", "link_html_complex": "/ACE_complex_html/ACE_VIPEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIPEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIPEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIPEL.png", "phi_psi": "/peptide_da/VIPEL.pdb", "link_html_peptide": "/Peptide_html/VIPEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIPEL.pdb", "link_png_peptide": "/Peptide_pics/VIPEL.png"}
{"Peptide_Sequence": "VIY", " Origin": "Sesame protein hydrolysate", " Peptide_Preparation": "", " Isolation_Method": "SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "5.8 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1332", " Ligand_ID": "VIY_minimized.pdb_1332", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "393.48", " logP": "-1.77", " logD": "-1.94", " logSw": "-0.58", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "220370.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.477", "link_html_complex": "/ACE_complex_html/ACE_VIY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VIY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VIY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VIY.png", "phi_psi": "/peptide_da/VIY.pdb", "link_html_peptide": "/Peptide_html/VIY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VIY.pdb", "link_png_peptide": "/Peptide_pics/VIY.png"}
{"Peptide_Sequence": "VK", " Origin": "milk", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "", " Reference": "van Platerink, Chris J., Hans-Gerd M. Janssen, and Johan Haverkamp. \"Application of at-line two-dimensional liquid chromatography\u2013mass spectrometry for identification of small hydrophilic angiotensin I-inhibiting peptides in milk hydrolysates.\" Analytical and bioanalytical chemistry 391.1 (2008): 299-307.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "1347", " Ligand_ID": "VK_minimized.pdb_1347", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "245.32", " logP": "-3.63", " logD": "-4.51", " logSw": "1.45", " tPSA": "124.51", " RotatableB": "8", " RigidB": "3", " Flexibility": "0.73", " HBD": "6", " HBA": "6", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "17", " CarbonAtoms": "11", " HeteroAtoms": "6", " ratio_H_by_C": "0.55", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1049933.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.319", "link_html_complex": "/ACE_complex_html/ACE_VK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VK.png", "phi_psi": "/peptide_da/VK.pdb", "link_html_peptide": "/Peptide_html/VK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VK.pdb", "link_png_peptide": "/Peptide_pics/VK.png"}
{"Peptide_Sequence": "VKAGE", " Origin": "Sweet-potato tuber trypsin inhibitor", " Peptide_Preparation": " trypsin_x005F_x0007_Sepharose-4B affinity column", " Isolation_Method": "", " ACE_inhibition_assay": "Holmquist et al., 1979", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">250 \u03bcM", " Reference": "Pihlanto, Anne, and Sari Ma\u0308kinen. \"Antihypertensive properties of plant protein derived peptides.\" Bioactive food peptides in health and disease. IntechOpen, 2013.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1333", " Ligand_ID": "VKAGE_minimized.pdb_1333", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "502.56", " logP": "-6.48", " logD": "-13.17", " logSw": "2.25", " tPSA": "251.94", " RotatableB": "17", " RigidB": "10", " Flexibility": "0.63", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "35", " CarbonAtoms": "21", " HeteroAtoms": "14", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4761106.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 502.562", "link_html_complex": "/ACE_complex_html/ACE_VKAGE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKAGE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKAGE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKAGE.png", "phi_psi": "/peptide_da/VKAGE.pdb", "link_html_peptide": "/Peptide_html/VKAGE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKAGE.pdb", "link_png_peptide": "/Peptide_pics/VKAGE.png"}
{"Peptide_Sequence": "VKAGF", " Origin": "Sardine Meat", " Peptide_Preparation": "peptic hydrolysis", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "83 \u03bcM", " Reference": "Ukeda, Hiroyuki, et al. \"Peptides from peptic hydrolyzate of heated sardine meat that inhibit angiotensin I converting enzyme.\" Nippon Nogeikagaku Kaishi 66.1 (1992): 25-29.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1334", " Ligand_ID": "VKAGF_minimized.pdb_1334", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "520.62", " logP": "-2.54", " logD": "-7.73", " logSw": "-0.47", " tPSA": "211.81", " RotatableB": "16", " RigidB": "15", " Flexibility": "0.52", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "37", " CarbonAtoms": "25", " HeteroAtoms": "12", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "325612.1", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 520.622", "link_html_complex": "/ACE_complex_html/ACE_VKAGF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKAGF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKAGF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKAGF.png", "phi_psi": "/peptide_da/VKAGF.pdb", "link_html_peptide": "/Peptide_html/VKAGF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKAGF.pdb", "link_png_peptide": "/Peptide_pics/VKAGF.png"}
{"Peptide_Sequence": "VKCFR", " Origin": "Rhopilema esculentum (Jellyfish)", " Peptide_Preparation": "", " Isolation_Method": "HPLC, Ultrafiltration, IEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "34.5 \u03bcM", " Reference": "Li, Jun, et al. \"Peptides derived from Rhopilema esculentum hydrolysate exhibit angiotensin converting enzyme (ACE) inhibitory and antioxidant abilities.\" Molecules 19.9 (2014): 13587-13602.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1335", " Ligand_ID": "VKCFR_minimized.pdb_1335", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "651.82", " logP": "-2.59", " logD": "-7.5", " logSw": "-0.84", " tPSA": "314.25", " RotatableB": "22", " RigidB": "16", " Flexibility": "0.58", " HBD": "13", " HBA": "15", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "45", " CarbonAtoms": "29", " HeteroAtoms": "16", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "280043.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 651.82", "link_html_complex": "/ACE_complex_html/ACE_VKCFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKCFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKCFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKCFR.png", "phi_psi": "/peptide_da/VKCFR.pdb", "link_html_peptide": "/Peptide_html/VKCFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKCFR.pdb", "link_png_peptide": "/Peptide_pics/VKCFR.png"}
{"Peptide_Sequence": "VKD", " Origin": "Meat protein, Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "1336", " Ligand_ID": "VKD_minimized.pdb_1336", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O", " MW": "360.41", " logP": "-5.93", " logD": "-9.26", " logSw": "2.45", " tPSA": "193.74", " RotatableB": "12", " RigidB": "6", " Flexibility": "0.67", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "15", " HeteroAtoms": "10", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "4190661.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 360.406", "link_html_complex": "/ACE_complex_html/ACE_VKD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKD.png", "phi_psi": "/peptide_da/VKD.pdb", "link_html_peptide": "/Peptide_html/VKD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKD.pdb", "link_png_peptide": "/Peptide_pics/VKD.png"}
{"Peptide_Sequence": "VKEDQ", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1337", " Ligand_ID": "VKEDQ_minimized.pdb_1337", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "617.65", " logP": "-8.11", " logD": "-17.61", " logSw": "2.89", " tPSA": "335.16", " RotatableB": "22", " RigidB": "13", " Flexibility": "0.63", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "25", " HeteroAtoms": "18", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11134409.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.649", "link_html_complex": "/ACE_complex_html/ACE_VKEDQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKEDQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKEDQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKEDQ.png", "phi_psi": "/peptide_da/VKEDQ.pdb", "link_html_peptide": "/Peptide_html/VKEDQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKEDQ.pdb", "link_png_peptide": "/Peptide_pics/VKEDQ.png"}
{"Peptide_Sequence": "VKELQ", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1338", " Ligand_ID": "VKELQ_minimized.pdb_1338", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "615.72", " logP": "-5.92", " logD": "-12.27", " logSw": "1.52", " tPSA": "295.03", " RotatableB": "22", " RigidB": "12", " Flexibility": "0.65", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "27", " HeteroAtoms": "16", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2826885.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 615.719", "link_html_complex": "/ACE_complex_html/ACE_VKELQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKELQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKELQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKELQ.png", "phi_psi": "/peptide_da/VKELQ.pdb", "link_html_peptide": "/Peptide_html/VKELQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKELQ.pdb", "link_png_peptide": "/Peptide_pics/VKELQ.png"}
{"Peptide_Sequence": "VKETT", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1339", " Ligand_ID": "VKETT_minimized.pdb_1339", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "576.64", " logP": "-7.31", " logD": "-13.66", " logSw": "2.44", " tPSA": "292.4", " RotatableB": "19", " RigidB": "10", " Flexibility": "0.66", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "6643196.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 576.64", "link_html_complex": "/ACE_complex_html/ACE_VKETT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKETT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKETT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKETT.png", "phi_psi": "/peptide_da/VKETT.pdb", "link_html_peptide": "/Peptide_html/VKETT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKETT.pdb", "link_png_peptide": "/Peptide_pics/VKETT.png"}
{"Peptide_Sequence": "VKF", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "< 100 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1340", " Ligand_ID": "VKF_minimized.pdb_1340", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "392.49", " logP": "-1.05", " logD": "-4.73", " logSw": "-0.89", " tPSA": "153.61", " RotatableB": "12", " RigidB": "11", " Flexibility": "0.52", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "160543.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 392.493", "link_html_complex": "/ACE_complex_html/ACE_VKF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKF.png", "phi_psi": "/peptide_da/VKF.pdb", "link_html_peptide": "/Peptide_html/VKF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKF.pdb", "link_png_peptide": "/Peptide_pics/VKF.png"}
{"Peptide_Sequence": "VKH", " Origin": "Meat protein, Fish", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1341", " Ligand_ID": "VKH_minimized.pdb_1341", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "382.46", " logP": "-3.01", " logD": "-6.81", " logSw": "0.41", " tPSA": "182.29", " RotatableB": "12", " RigidB": "10", " Flexibility": "0.55", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "17", " HeteroAtoms": "10", " ratio_H_by_C": "0.59", " Lipinski_Violation": "1", " Solubility_mg_per_l": "577534", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 382.458", "link_html_complex": "/ACE_complex_html/ACE_VKH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKH.png", "phi_psi": "/peptide_da/VKH.pdb", "link_html_peptide": "/Peptide_html/VKH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKH.pdb", "link_png_peptide": "/Peptide_pics/VKH.png"}
{"Peptide_Sequence": "VKHTT", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1342", " Ligand_ID": "VKHTT_minimized.pdb_1342", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "584.67", " logP": "-4.75", " logD": "-10.64", " logSw": "0.67", " tPSA": "280.95", " RotatableB": "18", " RigidB": "14", " Flexibility": "0.56", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "25", " HeteroAtoms": "16", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1144912.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.666", "link_html_complex": "/ACE_complex_html/ACE_VKHTT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKHTT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKHTT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKHTT.png", "phi_psi": "/peptide_da/VKHTT.pdb", "link_html_peptide": "/Peptide_html/VKHTT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKHTT.pdb", "link_png_peptide": "/Peptide_pics/VKHTT.png"}
{"Peptide_Sequence": "VKHWPW", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1343", " Ligand_ID": "VKHWPW_minimized.pdb_1343", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "851.99", " logP": "-0.04", " logD": "-6.04", " logSw": "-3.85", " tPSA": "292.38", " RotatableB": "21", " RigidB": "41", " Flexibility": "0.34", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "62", " CarbonAtoms": "44", " HeteroAtoms": "18", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "18054.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 851.993", "link_html_complex": "/ACE_complex_html/ACE_VKHWPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKHWPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKHWPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKHWPW.png", "phi_psi": "/peptide_da/VKHWPW.pdb", "link_html_peptide": "/Peptide_html/VKHWPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKHWPW.pdb", "link_png_peptide": "/Peptide_pics/VKHWPW.png"}
{"Peptide_Sequence": "VKK", " Origin": "Fresh water clam solid wastes", " Peptide_Preparation": "peptidases and pepsin  or  trypsin", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": " Cushman andCheung  with  some  modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "58.51 \u03bcM", " Reference": "Sun, Yuanxia, et al. \"Evaluation of angiotensin I-converting enzyme (ACE) inhibitory activities of hydrolysates generated from byproducts of freshwater clam.\" Food Science and Biotechnology 20.2 (2011): 303-31", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1344", " Ligand_ID": "VKK_minimized.pdb_1344", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "373.49", " logP": "-4.68", " logD": "-7.53", " logSw": "1.72", " tPSA": "181.25", " RotatableB": "14", " RigidB": "5", " Flexibility": "0.74", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "2079016.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 373.491", "link_html_complex": "/ACE_complex_html/ACE_VKK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKK.png", "phi_psi": "/peptide_da/VKK.pdb", "link_html_peptide": "/Peptide_html/VKK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKK.pdb", "link_png_peptide": "/Peptide_pics/VKK.png"}
{"Peptide_Sequence": "VKKTC", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1345", " Ligand_ID": "VKKTC_minimized.pdb_1345", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(O)=O", " MW": "577.74", " logP": "-4.22", " logD": "-11.79", " logSw": "0.56", " tPSA": "298.48", " RotatableB": "20", " RigidB": "9", " Flexibility": "0.69", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "39", " CarbonAtoms": "24", " HeteroAtoms": "15", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1008023.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 577.737", "link_html_complex": "/ACE_complex_html/ACE_VKKTC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKKTC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKKTC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKKTC.png", "phi_psi": "/peptide_da/VKKTC.pdb", "link_html_peptide": "/Peptide_html/VKKTC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKKTC.pdb", "link_png_peptide": "/Peptide_pics/VKKTC.png"}
{"Peptide_Sequence": "VKKVLGNP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "28.5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1346", " Ligand_ID": "VKKVLGNP_minimized.pdb_1346", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "854.05", " logP": "-3.61", " logD": "-12.83", " logSw": "-1.01", " tPSA": "361.05", " RotatableB": "28", " RigidB": "22", " Flexibility": "0.56", " HBD": "15", " HBA": "21", " HBD_HBA": "36", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "60", " CarbonAtoms": "39", " HeteroAtoms": "21", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "310190.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 854.049", "link_html_complex": "/ACE_complex_html/ACE_VKKVLGNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKKVLGNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKKVLGNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKKVLGNP.png", "phi_psi": "/peptide_da/VKKVLGNP.pdb", "link_html_peptide": "/Peptide_html/VKKVLGNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKKVLGNP.pdb", "link_png_peptide": "/Peptide_pics/VKKVLGNP.png"}
{"Peptide_Sequence": "VKN", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-6.7", "Serial_ID": "1350", " Ligand_ID": "VKN_minimized.pdb_1350", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "359.42", " logP": "-4.3", " logD": "-7.84", " logSw": "1.43", " tPSA": "196.7", " RotatableB": "12", " RigidB": "7", " Flexibility": "0.63", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "15", " HeteroAtoms": "10", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1505805.6", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 359.421", "link_html_complex": "/ACE_complex_html/ACE_VKN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKN.png", "phi_psi": "/peptide_da/VKN.pdb", "link_html_peptide": "/Peptide_html/VKN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKN.pdb", "link_png_peptide": "/Peptide_pics/VKN.png"}
{"Peptide_Sequence": "VKNDT", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1348", " Ligand_ID": "VKNDT_minimized.pdb_1348", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "575.61", " logP": "-8.57", " logD": "-15", " logSw": "3.24", " tPSA": "315.26", " RotatableB": "19", " RigidB": "12", " Flexibility": "0.61", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "23", " HeteroAtoms": "17", " ratio_H_by_C": "0.74", " Lipinski_Violation": "3", " Solubility_mg_per_l": "14760899.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 575.613", "link_html_complex": "/ACE_complex_html/ACE_VKNDT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKNDT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKNDT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKNDT.png", "phi_psi": "/peptide_da/VKNDT.pdb", "link_html_peptide": "/Peptide_html/VKNDT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKNDT.pdb", "link_png_peptide": "/Peptide_pics/VKNDT.png"}
{"Peptide_Sequence": "VKNEE", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.4", "Serial_ID": "1349", " Ligand_ID": "VKNEE_minimized.pdb_1349", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "617.65", " logP": "-8.11", " logD": "-17.74", " logSw": "2.89", " tPSA": "335.16", " RotatableB": "22", " RigidB": "13", " Flexibility": "0.63", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "43", " CarbonAtoms": "25", " HeteroAtoms": "18", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "11134409.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.68", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 617.649", "link_html_complex": "/ACE_complex_html/ACE_VKNEE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKNEE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKNEE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKNEE.png", "phi_psi": "/peptide_da/VKNEE.pdb", "link_html_peptide": "/Peptide_html/VKNEE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKNEE.pdb", "link_png_peptide": "/Peptide_pics/VKNEE.png"}
{"Peptide_Sequence": "VKP", " Origin": "freshwater clam (Corbicula fluminea, Muller)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "Cheung & Chushman and Wu & Ding", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3.7 \u03bcM", " Reference": "Tsai, J. S., et al. \"The inhibitory effects of freshwater clam (Corbicula fluminea, Muller) muscle protein hydrolysates on angiotensin I converting enzyme.\" Process Biochemistry 41.11 (2006): 2276-2281.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1351", " Ligand_ID": "VKP_minimized.pdb_1351", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "342.43", " logP": "-3.49", " logD": "-6.11", " logSw": "0.83", " tPSA": "144.82", " RotatableB": "9", " RigidB": "10", " Flexibility": "0.47", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "16", " HeteroAtoms": "8", " ratio_H_by_C": "0.5", " Lipinski_Violation": "1", " Solubility_mg_per_l": "785003.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 342.434", "link_html_complex": "/ACE_complex_html/ACE_VKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VKP.png", "phi_psi": "/peptide_da/VKP.pdb", "link_html_peptide": "/Peptide_html/VKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VKP.pdb", "link_png_peptide": "/Peptide_pics/VKP.png"}
{"Peptide_Sequence": "VL", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.9 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "1359", " Ligand_ID": "VL_minimized.pdb_1359", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "230.3", " logP": "-2.07", " logD": "-1.7", " logSw": "0.43", " tPSA": "96.87", " RotatableB": "6", " RigidB": "3", " Flexibility": "0.67", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "11", " HeteroAtoms": "5", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "354821.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 230.304", "link_html_complex": "/ACE_complex_html/ACE_VL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VL.png", "phi_psi": "/peptide_da/VL.pdb", "link_html_peptide": "/Peptide_html/VL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VL.pdb", "link_png_peptide": "/Peptide_pics/VL.png"}
{"Peptide_Sequence": "VLAQYK", " Origin": "Beef rump", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "23.2 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1352", " Ligand_ID": "VLAQYK_minimized.pdb_1352", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "720.86", " logP": "-2.14", " logD": "-4.97", " logSw": "-1.48", " tPSA": "304.23", " RotatableB": "23", " RigidB": "19", " Flexibility": "0.55", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "34", " HeteroAtoms": "17", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "163339.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 720.857", "link_html_complex": "/ACE_complex_html/ACE_VLAQYK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLAQYK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLAQYK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLAQYK.png", "phi_psi": "/peptide_da/VLAQYK.pdb", "link_html_peptide": "/Peptide_html/VLAQYK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLAQYK.pdb", "link_png_peptide": "/Peptide_pics/VLAQYK.png"}
{"Peptide_Sequence": "VLDTDYK", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "946", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1353", " Ligand_ID": "VLDTDYK_minimized.pdb_1353", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "852.93", " logP": "-6.69", " logD": "-11.66", " logSw": "0.83", " tPSA": "390.73", " RotatableB": "27", " RigidB": "21", " Flexibility": "0.56", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "60", " CarbonAtoms": "38", " HeteroAtoms": "22", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1959060.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 852.928", "link_html_complex": "/ACE_complex_html/ACE_VLDTDYK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLDTDYK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLDTDYK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLDTDYK.png", "phi_psi": "/peptide_da/VLDTDYK.pdb", "link_html_peptide": "/Peptide_html/VLDTDYK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLDTDYK.pdb", "link_png_peptide": "/Peptide_pics/VLDTDYK.png"}
{"Peptide_Sequence": "VLGPVRGPFP", " Origin": "milk fermented", " Peptide_Preparation": "E. faecalis ", " Isolation_Method": "RP-HPLC, UF", " ACE_inhibition_assay": " Cushman andCheung  with  some  modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "137 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis.\" International Dairy Journal 17.1 (2007): 33-41.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1355", " Ligand_ID": "VLGPVRGPFP_minimized.pdb_1355", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1038.24", " logP": "-1.15", " logD": "-8.65", " logSw": "-3.8", " tPSA": "366.94", " RotatableB": "27", " RigidB": "41", " Flexibility": "0.4", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "74", " CarbonAtoms": "50", " HeteroAtoms": "24", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "23235.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1038.24", "link_html_complex": "/ACE_complex_html/ACE_VLGPVRGPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLGPVRGPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLGPVRGPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLGPVRGPFP.png", "phi_psi": "/peptide_da/VLGPVRGPFP.pdb", "link_html_peptide": "/Peptide_html/VLGPVRGPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLGPVRGPFP.pdb", "link_png_peptide": "/Peptide_pics/VLGPVRGPFP.png"}
{"Peptide_Sequence": "VLGPVRGPFPIIV", " Origin": "milk fermented", " Peptide_Preparation": "E. faecalis ", " Isolation_Method": "RP-HPLC, UF", " ACE_inhibition_assay": " Cushman andCheung  with  some  modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "> 700 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis.\" International Dairy Journal 17.1 (2007): 33-41.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1354", " Ligand_ID": "VLGPVRGPFPIIV_minimized.pdb_1354", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "1363.69", " logP": "1.7", " logD": "-6.66", " logSw": "-6.88", " tPSA": "454.24", " RotatableB": "38", " RigidB": "47", " Flexibility": "0.45", " HBD": "16", " HBA": "30", " HBD_HBA": "46", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "97", " CarbonAtoms": "67", " HeteroAtoms": "30", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1403.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "13", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1363.69", "link_html_complex": "/ACE_complex_html/ACE_VLGPVRGPFPIIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLGPVRGPFPIIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLGPVRGPFPIIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLGPVRGPFPIIV.png", "phi_psi": "/peptide_da/VLGPVRGPFPIIV.pdb", "link_html_peptide": "/Peptide_html/VLGPVRGPFPIIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLGPVRGPFPIIV.pdb", "link_png_peptide": "/Peptide_pics/VLGPVRGPFPIIV.png"}
{"Peptide_Sequence": "VLIVP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "4.20 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1356", " Ligand_ID": "VLIVP_minimized.pdb_1356", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "539.71", " logP": "-0.83", " logD": "-2.35", " logSw": "-1.74", " tPSA": "175.38", " RotatableB": "14", " RigidB": "14", " Flexibility": "0.5", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "27", " HeteroAtoms": "11", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "94797.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 539.708", "link_html_complex": "/ACE_complex_html/ACE_VLIVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLIVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLIVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLIVP.png", "phi_psi": "/peptide_da/VLIVP.pdb", "link_html_peptide": "/Peptide_html/VLIVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLIVP.pdb", "link_png_peptide": "/Peptide_pics/VLIVP.png"}
{"Peptide_Sequence": "VLKP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Majumder & Wu (2009)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "5.27 \u03bcM", " Reference": "Ren, Yanrong, et al. \"Integrating Computational Modeling and Experimental Assay to Discover New Potent ACE\u2010Inhibitory Peptides.\" Molecular informatics 33.1 (2014): 43-52.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1357", " Ligand_ID": "VLKP_minimized.pdb_1357", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "455.59", " logP": "-3.09", " logD": "-5.42", " logSw": "0.14", " tPSA": "173.92", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "524072.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.82", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 455.591", "link_html_complex": "/ACE_complex_html/ACE_VLKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLKP.png", "phi_psi": "/peptide_da/VLKP.pdb", "link_html_peptide": "/Peptide_html/VLKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLKP.pdb", "link_png_peptide": "/Peptide_pics/VLKP.png"}
{"Peptide_Sequence": "VLLPDEVSGL", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1358", " Ligand_ID": "VLLPDEVSGL_minimized.pdb_1358", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(C)C)C(O)=O", " MW": "1041.2", " logP": "-1.92", " logD": "-13.08", " logSw": "-2.97", " tPSA": "421.37", " RotatableB": "32", " RigidB": "26", " Flexibility": "0.55", " HBD": "14", " HBA": "26", " HBD_HBA": "40", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "-2", " HeavyAtoms": "73", " CarbonAtoms": "47", " HeteroAtoms": "26", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "53213.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1041.2", "link_html_complex": "/ACE_complex_html/ACE_VLLPDEVSGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLLPDEVSGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLLPDEVSGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLLPDEVSGL.png", "phi_psi": "/peptide_da/VLLPDEVSGL.pdb", "link_html_peptide": "/Peptide_html/VLLPDEVSGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLLPDEVSGL.pdb", "link_png_peptide": "/Peptide_pics/VLLPDEVSGL.png"}
{"Peptide_Sequence": "VLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "320", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1363", " Ligand_ID": "VLP_minimized.pdb_1363", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "327.42", " logP": "-1.94", " logD": "-3.07", " logSw": "-0.19", " tPSA": "117.18", " RotatableB": "7", " RigidB": "10", " Flexibility": "0.41", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "271902.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 327.419", "link_html_complex": "/ACE_complex_html/ACE_VLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLP.png", "phi_psi": "/peptide_da/VLP.pdb", "link_html_peptide": "/Peptide_html/VLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLP.pdb", "link_png_peptide": "/Peptide_pics/VLP.png"}
{"Peptide_Sequence": "VLPEI", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1360", " Ligand_ID": "VLPEI_minimized.pdb_1360", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "569.69", " logP": "-2.32", " logD": "-6.85", " logSw": "-0.85", " tPSA": "215.51", " RotatableB": "16", " RigidB": "15", " Flexibility": "0.52", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "242405.24", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 569.691", "link_html_complex": "/ACE_complex_html/ACE_VLPEI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLPEI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLPEI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLPEI.png", "phi_psi": "/peptide_da/VLPEI.pdb", "link_html_peptide": "/Peptide_html/VLPEI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLPEI.pdb", "link_png_peptide": "/Peptide_pics/VLPEI.png"}
{"Peptide_Sequence": "VLPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "31", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1361", " Ligand_ID": "VLPIP_minimized.pdb_1361", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "537.69", " logP": "-1.5", " logD": "-2.94", " logSw": "-1.44", " tPSA": "166.59", " RotatableB": "12", " RigidB": "19", " Flexibility": "0.39", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "27", " HeteroAtoms": "11", " ratio_H_by_C": "0.41", " Lipinski_Violation": "2", " Solubility_mg_per_l": "127816.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 537.692", "link_html_complex": "/ACE_complex_html/ACE_VLPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLPIP.png", "phi_psi": "/peptide_da/VLPIP.pdb", "link_html_peptide": "/Peptide_html/VLPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLPIP.pdb", "link_png_peptide": "/Peptide_pics/VLPIP.png"}
{"Peptide_Sequence": "VLPIPQ", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "5300", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1362", " Ligand_ID": "VLPIPQ_minimized.pdb_1362", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "665.82", " logP": "-2.92", " logD": "-4.7", " logSw": "-1.01", " tPSA": "238.78", " RotatableB": "17", " RigidB": "23", " Flexibility": "0.42", " HBD": "8", " HBA": "15", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "243357.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 665.821", "link_html_complex": "/ACE_complex_html/ACE_VLPIPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLPIPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLPIPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLPIPQ.png", "phi_psi": "/peptide_da/VLPIPQ.pdb", "link_html_peptide": "/Peptide_html/VLPIPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLPIPQ.pdb", "link_png_peptide": "/Peptide_pics/VLPIPQ.png"}
{"Peptide_Sequence": "VLPYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "36", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1364", " Ligand_ID": "VLPYP_minimized.pdb_1364", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "587.71", " logP": "0.12", " logD": "-2.98", " logSw": "-2.82", " tPSA": "186.82", " RotatableB": "12", " RigidB": "25", " Flexibility": "0.32", " HBD": "6", " HBA": "12", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "30", " HeteroAtoms": "12", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "35086.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 587.708", "link_html_complex": "/ACE_complex_html/ACE_VLPYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLPYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLPYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLPYP.png", "phi_psi": "/peptide_da/VLPYP.pdb", "link_html_peptide": "/Peptide_html/VLPYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLPYP.pdb", "link_png_peptide": "/Peptide_pics/VLPYP.png"}
{"Peptide_Sequence": "VLPYPV", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "420", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1365", " Ligand_ID": "VLPYPV_minimized.pdb_1365", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "686.84", " logP": "-0.88", " logD": "-2.55", " logSw": "-2.6", " tPSA": "215.92", " RotatableB": "15", " RigidB": "27", " Flexibility": "0.36", " HBD": "7", " HBA": "14", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "35", " HeteroAtoms": "14", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "51161.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.66", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 686.839", "link_html_complex": "/ACE_complex_html/ACE_VLPYPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLPYPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLPYPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLPYPV.png", "phi_psi": "/peptide_da/VLPYPV.pdb", "link_html_peptide": "/Peptide_html/VLPYPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLPYPV.pdb", "link_png_peptide": "/Peptide_pics/VLPYPV.png"}
{"Peptide_Sequence": "VLRP", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.89 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1366", " Ligand_ID": "VLRP_minimized.pdb_1366", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "483.6", " logP": "-3.68", " logD": "-6.35", " logSw": "0.4", " tPSA": "209.92", " RotatableB": "14", " RigidB": "13", " Flexibility": "0.52", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "22", " HeteroAtoms": "12", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "724381.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 483.605", "link_html_complex": "/ACE_complex_html/ACE_VLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLRP.png", "phi_psi": "/peptide_da/VLRP.pdb", "link_html_peptide": "/Peptide_html/VLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLRP.pdb", "link_png_peptide": "/Peptide_pics/VLRP.png"}
{"Peptide_Sequence": "VLSLSQPKVLPVPQKAVPQ", " Origin": "milk", " Peptide_Preparation": "fermentation OR enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Chen, Hsiao-Ling, and Chuan-Mu Chen. \"Antihypertensive peptide and use thereof.\" U.S. Patent No. 7,763,281. 27 Jul. 2010.", " Binding_Energy_kcal_per_mol": "12.6", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2028.44", "link_html_complex": "/ACE_complex_html/ACE_VLSLSQPKVLPVPQKAVPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLSLSQPKVLPVPQKAVPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLSLSQPKVLPVPQKAVPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLSLSQPKVLPVPQKAVPQ.png", "phi_psi": "/peptide_da/VLSLSQPKVLPVPQKAVPQ.pdb", "link_html_peptide": "/Peptide_html/VLSLSQPKVLPVPQKAVPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLSLSQPKVLPVPQKAVPQ.pdb", "link_png_peptide": "/Peptide_pics/VLSLSQPKVLPVPQKAVPQ.png"}
{"Peptide_Sequence": "VLSRYP", " Origin": "milk", " Peptide_Preparation": "Kluyveromyces marxianus fermentation", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Wang et al., 2008", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "36.7\u2009\u00b5M", " Reference": "Li, Yun, et al. \"Purification and identification of novel peptides with inhibitory effect against angiotensin I-converting enzyme and optimization of process conditions in milk fermented with the yeast Kluyveromyces marxianus.\" Journal of functional foods 16 (2015): 278-288.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1368", " Ligand_ID": "VLSRYP_minimized.pdb_1368", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "733.86", " logP": "-2.31", " logD": "-8.16", " logSw": "-1.59", " tPSA": "308.58", " RotatableB": "21", " RigidB": "23", " Flexibility": "0.48", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "52", " CarbonAtoms": "34", " HeteroAtoms": "18", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "149637.13", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 733.855", "link_html_complex": "/ACE_complex_html/ACE_VLSRYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLSRYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLSRYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLSRYP.png", "phi_psi": "/peptide_da/VLSRYP.pdb", "link_html_peptide": "/Peptide_html/VLSRYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLSRYP.pdb", "link_png_peptide": "/Peptide_pics/VLSRYP.png"}
{"Peptide_Sequence": "VLVPK", " Origin": "tomato waste proteins", " Peptide_Preparation": "", " Isolation_Method": "GF, RP-HPLC, SEC, membrane filteration", " ACE_inhibition_assay": "Sentandreu & Toldr\u00e1 (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "365 \u03bcM", " Reference": "Moayedi, Ali, et al. \"Peptidomic analysis of antioxidant and ACE-inhibitory peptides obtained from tomato waste proteins fermented using Bacillus subtilis.\" Food chemistry 250 (2018): 180-187.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "1369", " Ligand_ID": "VLVPK_minimized.pdb_1369", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "554.72", " logP": "-2.4", " logD": "-3.46", " logSw": "-0.71", " tPSA": "203.02", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "27", " HeteroAtoms": "12", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "272377.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 554.723", "link_html_complex": "/ACE_complex_html/ACE_VLVPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLVPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLVPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLVPK.png", "phi_psi": "/peptide_da/VLVPK.pdb", "link_html_peptide": "/Peptide_html/VLVPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLVPK.pdb", "link_png_peptide": "/Peptide_pics/VLVPK.png"}
{"Peptide_Sequence": "VLY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1370", " Ligand_ID": "VLY_minimized.pdb_1370", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "393.48", " logP": "-1.7", " logD": "-2.01", " logSw": "-0.62", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "210863.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.477", "link_html_complex": "/ACE_complex_html/ACE_VLY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VLY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VLY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VLY.png", "phi_psi": "/peptide_da/VLY.pdb", "link_html_peptide": "/Peptide_html/VLY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VLY.pdb", "link_png_peptide": "/Peptide_pics/VLY.png"}
{"Peptide_Sequence": "VM", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "120 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1372", " Ligand_ID": "VM_minimized.pdb_1372", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "248.34", " logP": "-2.75", " logD": "-2.31", " logSw": "0.81", " tPSA": "122.17", " RotatableB": "7", " RigidB": "3", " Flexibility": "0.7", " HBD": "4", " HBA": "5", " HBD_HBA": "9", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "16", " CarbonAtoms": "10", " HeteroAtoms": "6", " ratio_H_by_C": "0.6", " Lipinski_Violation": "0", " Solubility_mg_per_l": "560924.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 248.342", "link_html_complex": "/ACE_complex_html/ACE_VM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VM.png", "phi_psi": "/peptide_da/VM.pdb", "link_html_peptide": "/Peptide_html/VM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VM.pdb", "link_png_peptide": "/Peptide_pics/VM.png"}
{"Peptide_Sequence": "VMDKPQG", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "38.9 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1371", " Ligand_ID": "VMDKPQG_minimized.pdb_1371", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O", " MW": "773.9", " logP": "-7.56", " logD": "-13.67", " logSw": "1.77", " tPSA": "369.74", " RotatableB": "25", " RigidB": "21", " Flexibility": "0.54", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "32", " HeteroAtoms": "21", " ratio_H_by_C": "0.66", " Lipinski_Violation": "3", " Solubility_mg_per_l": "4564542.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 773.898", "link_html_complex": "/ACE_complex_html/ACE_VMDKPQG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VMDKPQG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VMDKPQG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VMDKPQG.png", "phi_psi": "/peptide_da/VMDKPQG.pdb", "link_html_peptide": "/Peptide_html/VMDKPQG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VMDKPQG.pdb", "link_png_peptide": "/Peptide_pics/VMDKPQG.png"}
{"Peptide_Sequence": "VMP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "29", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1373", " Ligand_ID": "VMP_minimized.pdb_1373", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "345.46", " logP": "-2.62", " logD": "-3.69", " logSw": "0.2", " tPSA": "142.48", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "420579.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 345.458", "link_html_complex": "/ACE_complex_html/ACE_VMP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VMP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VMP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VMP.png", "phi_psi": "/peptide_da/VMP.pdb", "link_html_peptide": "/Peptide_html/VMP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VMP.pdb", "link_png_peptide": "/Peptide_pics/VMP.png"}
{"Peptide_Sequence": "VNP", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "32.5 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1374", " Ligand_ID": "VNP_minimized.pdb_1374", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "328.36", " logP": "-4.78", " logD": "-5.81", " logSw": "1.6", " tPSA": "160.27", " RotatableB": "7", " RigidB": "12", " Flexibility": "0.37", " HBD": "6", " HBA": "9", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "14", " HeteroAtoms": "9", " ratio_H_by_C": "0.64", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1622405.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 328.364", "link_html_complex": "/ACE_complex_html/ACE_VNP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VNP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VNP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VNP.png", "phi_psi": "/peptide_da/VNP.pdb", "link_html_peptide": "/Peptide_html/VNP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VNP.pdb", "link_png_peptide": "/Peptide_pics/VNP.png"}
{"Peptide_Sequence": "VP", " Origin": "fermented fish sauce", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "570", " Reference": "Ichimura, Toshiaki, et al. \"Angiotensin I-converting enzyme inhibitory activity and insulin secretion stimulative activity of fermented fish sauce.\" Journal of bioscience and bioengineering 96.5 (2003): 496-499.", " Binding_Energy_kcal_per_mol": "-6.3", "Serial_ID": "1379", " Ligand_ID": "VP_minimized.pdb_1379", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "214.26", " logP": "-2.15", " logD": "-2.69", " logSw": "0.38", " tPSA": "88.08", " RotatableB": "3", " RigidB": "8", " Flexibility": "0.27", " HBD": "3", " HBA": "5", " HBD_HBA": "8", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "15", " CarbonAtoms": "10", " HeteroAtoms": "5", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "314591.79", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 214.262", "link_html_complex": "/ACE_complex_html/ACE_VP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VP.png", "phi_psi": "/peptide_da/VP.pdb", "link_html_peptide": "/Peptide_html/VP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VP.pdb", "link_png_peptide": "/Peptide_pics/VP.png"}
{"Peptide_Sequence": "VPA", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.4\u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "1377", " Ligand_ID": "VPA_minimized.pdb_1377", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "285.34", " logP": "-3.14", " logD": "-4.35", " logSw": "0.7", " tPSA": "117.18", " RotatableB": "5", " RigidB": "10", " Flexibility": "0.33", " HBD": "4", " HBA": "7", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "13", " HeteroAtoms": "7", " ratio_H_by_C": "0.54", " Lipinski_Violation": "0", " Solubility_mg_per_l": "574083.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 285.339", "link_html_complex": "/ACE_complex_html/ACE_VPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPA.png", "phi_psi": "/peptide_da/VPA.pdb", "link_html_peptide": "/Peptide_html/VPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPA.pdb", "link_png_peptide": "/Peptide_pics/VPA.png"}
{"Peptide_Sequence": "VPAAPPK", " Origin": "Haruan (Channa striatus) myofibrillar ", " Peptide_Preparation": "thermolysin and proteinase K", " Isolation_Method": "Ultrafiltration, SEC, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.45 \u03bcM", " Reference": "Ghassem, Masomeh, et al. \"Purification and identification of ACE inhibitory peptides from Haruan (Channa striatus) myofibrillar protein hydrolysate using HPLC\u2013ESI-TOF MS/MS.\" Food chemistry 129.4 (2011): 1770-1777.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1375", " Ligand_ID": "VPAAPPK_minimized.pdb_1375", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "678.82", " logP": "-2.88", " logD": "-6.12", " logSw": "-1.24", " tPSA": "243.64", " RotatableB": "15", " RigidB": "28", " Flexibility": "0.35", " HBD": "8", " HBA": "16", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "195600.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 678.82", "link_html_complex": "/ACE_complex_html/ACE_VPAAPPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPAAPPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPAAPPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPAAPPK.png", "phi_psi": "/peptide_da/VPAAPPK.pdb", "link_html_peptide": "/Peptide_html/VPAAPPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPAAPPK.pdb", "link_png_peptide": "/Peptide_pics/VPAAPPK.png"}
{"Peptide_Sequence": "VPAF", " Origin": "marine shrimp Acetes chinensis", " Peptide_Preparation": "synthetic", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "575 \u03bcM", " Reference": "Hai\u2010Lun, H. E., et al. \"Analysis of novel angiotensin\u2010I\u2010converting enzyme inhibitory peptides from protease\u2010hydrolyzed marine shrimp Acetes chinensis.\" Journal of peptide science: an official publication of the European Peptide Society 12.11 (2006): 726-733.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1376", " Ligand_ID": "VPAF_minimized.pdb_1376", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "432.51", " logP": "-2.61", " logD": "-3.62", " logSw": "-0.35", " tPSA": "146.28", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "22", " HeteroAtoms": "9", " ratio_H_by_C": "0.41", " Lipinski_Violation": "0", " Solubility_mg_per_l": "303643.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 432.513", "link_html_complex": "/ACE_complex_html/ACE_VPAF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPAF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPAF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPAF.png", "phi_psi": "/peptide_da/VPAF.pdb", "link_html_peptide": "/Peptide_html/VPAF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPAF.pdb", "link_png_peptide": "/Peptide_pics/VPAF.png"}
{"Peptide_Sequence": "VPKVK", " Origin": "Ovine and Caprine cheese", " Peptide_Preparation": "Proteases from Cynara cardunculus", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Vermeirssen et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "93.7 \u03bcg/mL", " Reference": "Silva, S. V., Anne Pihlanto, and F. Xavier Malcata. \"Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus.\" Journal of dairy science 89.9 (2006): 3336-3344.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1378", " Ligand_ID": "VPKVK_minimized.pdb_1378", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "569.74", " logP": "-3.96", " logD": "-7.45", " logSw": "0.31", " tPSA": "230.66", " RotatableB": "18", " RigidB": "14", " Flexibility": "0.56", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "777127.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 569.737", "link_html_complex": "/ACE_complex_html/ACE_VPKVK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPKVK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPKVK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPKVK.png", "phi_psi": "/peptide_da/VPKVK.pdb", "link_html_peptide": "/Peptide_html/VPKVK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPKVK.pdb", "link_png_peptide": "/Peptide_pics/VPKVK.png"}
{"Peptide_Sequence": "VPP", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "9 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1382", " Ligand_ID": "VPP_minimized.pdb_1382", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "311.38", " logP": "-2.1", " logD": "-4.07", " logSw": "-0.18", " tPSA": "108.39", " RotatableB": "4", " RigidB": "15", " Flexibility": "0.21", " HBD": "3", " HBA": "7", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "15", " HeteroAtoms": "7", " ratio_H_by_C": "0.47", " Lipinski_Violation": "0", " Solubility_mg_per_l": "259165.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 311.377", "link_html_complex": "/ACE_complex_html/ACE_VPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPP.png", "phi_psi": "/peptide_da/VPP.pdb", "link_html_peptide": "/Peptide_html/VPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPP.pdb", "link_png_peptide": "/Peptide_pics/VPP.png"}
{"Peptide_Sequence": "VPPAK", " Origin": " Spanish dry-cured ham", " Peptide_Preparation": "gastrointestinal proteases", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Escudero, Elizabeth, Leticia Mora, and Fidel Toldr\u00e1. \"Stability of ACE inhibitory ham peptides against heat treatment and in vitro digestion.\" Food chemistry 161 (2014): 305-311.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1380", " Ligand_ID": "VPPAK_minimized.pdb_1380", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "510.63", " logP": "-4.38", " logD": "-5.32", " logSw": "0.55", " tPSA": "194.23", " RotatableB": "12", " RigidB": "19", " Flexibility": "0.39", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "24", " HeteroAtoms": "12", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "881083.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.79", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 510.627", "link_html_complex": "/ACE_complex_html/ACE_VPPAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPPAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPPAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPPAK.png", "phi_psi": "/peptide_da/VPPAK.pdb", "link_html_peptide": "/Peptide_html/VPPAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPPAK.pdb", "link_png_peptide": "/Peptide_pics/VPPAK.png"}
{"Peptide_Sequence": "VPPIPP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Wu & Ding (2002)", " In-vivo_or_in-vitro": " in vitro, in-vivo", " IC50_micromol_per_L": "", " Reference": "Ding, Fengyun, et al. \"VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity.\" PloS one 8.4 (2013): e62384.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1381", " Ligand_ID": "VPPIPP_minimized.pdb_1381", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "618.76", " logP": "-0.76", " logD": "-4.23", " logSw": "-2.54", " tPSA": "178.11", " RotatableB": "10", " RigidB": "31", " Flexibility": "0.24", " HBD": "4", " HBA": "13", " HBD_HBA": "17", " Rings": "4", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "2", " Solubility_mg_per_l": "48919.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.81", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.765", "link_html_complex": "/ACE_complex_html/ACE_VPPIPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPPIPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPPIPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPPIPP.png", "phi_psi": "/peptide_da/VPPIPP.pdb", "link_html_peptide": "/Peptide_html/VPPIPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPPIPP.pdb", "link_png_peptide": "/Peptide_pics/VPPIPP.png"}
{"Peptide_Sequence": "VPQP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1384", " Ligand_ID": "VPQP_minimized.pdb_1384", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "439.51", " logP": "-3.35", " logD": "-6.2", " logSw": "0.14", " tPSA": "180.58", " RotatableB": "9", " RigidB": "19", " Flexibility": "0.32", " HBD": "6", " HBA": "11", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "505331.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 439.506", "link_html_complex": "/ACE_complex_html/ACE_VPQP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPQP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPQP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPQP.png", "phi_psi": "/peptide_da/VPQP.pdb", "link_html_peptide": "/Peptide_html/VPQP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPQP.pdb", "link_png_peptide": "/Peptide_pics/VPQP.png"}
{"Peptide_Sequence": "VPQPIP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "290", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1383", " Ligand_ID": "VPQPIP_minimized.pdb_1383", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "649.78", " logP": "-2.23", " logD": "-5.62", " logSw": "-1.54", " tPSA": "229.99", " RotatableB": "14", " RigidB": "28", " Flexibility": "0.33", " HBD": "7", " HBA": "15", " HBD_HBA": "22", " Rings": "3", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "139338.15", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 649.779", "link_html_complex": "/ACE_complex_html/ACE_VPQPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPQPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPQPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPQPIP.png", "phi_psi": "/peptide_da/VPQPIP.pdb", "link_html_peptide": "/Peptide_html/VPQPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPQPIP.pdb", "link_png_peptide": "/Peptide_pics/VPQPIP.png"}
{"Peptide_Sequence": "VPSERY", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "706.1 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-10.2", "Serial_ID": "1386", " Ligand_ID": "VPSERY_minimized.pdb_1386", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "749.81", " logP": "-4.15", " logD": "-12.06", " logSw": "-0.47", " tPSA": "348.71", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "14", " HBA": "20", " HBD_HBA": "34", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "33", " HeteroAtoms": "20", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "470971.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 749.812", "link_html_complex": "/ACE_complex_html/ACE_VPSERY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPSERY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPSERY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPSERY.png", "phi_psi": "/peptide_da/VPSERY.pdb", "link_html_peptide": "/Peptide_html/VPSERY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPSERY.pdb", "link_png_peptide": "/Peptide_pics/VPSERY.png"}
{"Peptide_Sequence": "VPSERYL", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "249.5 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1385", " Ligand_ID": "VPSERYL_minimized.pdb_1385", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "862.97", " logP": "-3.08", " logD": "-12.37", " logSw": "-1.57", " tPSA": "377.81", " RotatableB": "26", " RigidB": "26", " Flexibility": "0.5", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "61", " CarbonAtoms": "39", " HeteroAtoms": "22", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "179517.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 862.969", "link_html_complex": "/ACE_complex_html/ACE_VPSERYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPSERYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPSERYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPSERYL.png", "phi_psi": "/peptide_da/VPSERYL.pdb", "link_html_peptide": "/Peptide_html/VPSERYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPSERYL.pdb", "link_png_peptide": "/Peptide_pics/VPSERYL.png"}
{"Peptide_Sequence": "VPW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "383 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1387", " Ligand_ID": "VPW_minimized.pdb_1387", " Smiles": "CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "400.47", " logP": "-0.87", " logD": "-2.57", " logSw": "-1.43", " tPSA": "132.97", " RotatableB": "7", " RigidB": "20", " Flexibility": "0.26", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "0", " Solubility_mg_per_l": "95868.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.471", "link_html_complex": "/ACE_complex_html/ACE_VPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VPW.png", "phi_psi": "/peptide_da/VPW.pdb", "link_html_peptide": "/Peptide_html/VPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VPW.pdb", "link_png_peptide": "/Peptide_pics/VPW.png"}
{"Peptide_Sequence": "VQ", " Origin": "bonito intestine", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "Nobuyasu et. al. 1993", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1300 \u03bcM", " Reference": "Matsumura, Nobuyasu, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels.\" Bioscience, biotechnology, and biochemistry 57.10 (1993): 1743-1744.", " Binding_Energy_kcal_per_mol": "-6.6", "Serial_ID": "1388", " Ligand_ID": "VQ_minimized.pdb_1388", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "245.28", " logP": "-4.55", " logD": "-4.12", " logSw": "1.97", " tPSA": "139.96", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "10", " HeteroAtoms": "7", " ratio_H_by_C": "0.7", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1754911.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.7", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 245.276", "link_html_complex": "/ACE_complex_html/ACE_VQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VQ.png", "phi_psi": "/peptide_da/VQ.pdb", "link_html_peptide": "/Peptide_html/VQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VQ.pdb", "link_png_peptide": "/Peptide_pics/VQ.png"}
{"Peptide_Sequence": "VQV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-6.9", "Serial_ID": "1389", " Ligand_ID": "VQV_minimized.pdb_1389", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "344.41", " logP": "-4.58", " logD": "-4.89", " logSw": "1.57", " tPSA": "169.06", " RotatableB": "10", " RigidB": "7", " Flexibility": "0.59", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1655572.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 344.407", "link_html_complex": "/ACE_complex_html/ACE_VQV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VQV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VQV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VQV.png", "phi_psi": "/peptide_da/VQV.pdb", "link_html_peptide": "/Peptide_html/VQV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VQV.pdb", "link_png_peptide": "/Peptide_pics/VQV.png"}
{"Peptide_Sequence": "VQVTSTAV", " Origin": "Whey protein", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Tavares, T\u00e2nia, et al. \"Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes.\" Peptides 32.5 (2011): 1013-1019.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1390", " Ligand_ID": "VQVTSTAV_minimized.pdb_1390", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "803.9", " logP": "-5.33", " logD": "-9.41", " logSw": "0.12", " tPSA": "375.25", " RotatableB": "24", " RigidB": "17", " Flexibility": "0.59", " HBD": "15", " HBA": "22", " HBD_HBA": "37", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "56", " CarbonAtoms": "34", " HeteroAtoms": "22", " ratio_H_by_C": "0.65", " Lipinski_Violation": "3", " Solubility_mg_per_l": "904327.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 803.901", "link_html_complex": "/ACE_complex_html/ACE_VQVTSTAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VQVTSTAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VQVTSTAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VQVTSTAV.png", "phi_psi": "/peptide_da/VQVTSTAV.pdb", "link_html_peptide": "/Peptide_html/VQVTSTAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VQVTSTAV.pdb", "link_png_peptide": "/Peptide_pics/VQVTSTAV.png"}
{"Peptide_Sequence": "VR", " Origin": "ovine milk", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "UF, FPLC, RP-HPLC, IT-MS (CE-MS)", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "52.8 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-6.8", "Serial_ID": "1397", " Ligand_ID": "VR_minimized.pdb_1397", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "273.33", " logP": "-4.21", " logD": "-5.07", " logSw": "1.71", " tPSA": "160.51", " RotatableB": "9", " RigidB": "4", " Flexibility": "0.69", " HBD": "8", " HBA": "8", " HBD_HBA": "16", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "19", " CarbonAtoms": "11", " HeteroAtoms": "8", " ratio_H_by_C": "0.73", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1513724.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 273.332", "link_html_complex": "/ACE_complex_html/ACE_VR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VR.png", "phi_psi": "/peptide_da/VR.pdb", "link_html_peptide": "/Peptide_html/VR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VR.pdb", "link_png_peptide": "/Peptide_pics/VR.png"}
{"Peptide_Sequence": "VRC", " Origin": "Meat protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1391", " Ligand_ID": "VRC_minimized.pdb_1391", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(O)=O", " MW": "376.47", " logP": "-3.44", " logD": "-7.12", " logSw": "0.79", " tPSA": "228.41", " RotatableB": "12", " RigidB": "6", " Flexibility": "0.67", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "25", " CarbonAtoms": "14", " HeteroAtoms": "11", " ratio_H_by_C": "0.79", " Lipinski_Violation": "1", " Solubility_mg_per_l": "825432.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.71", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 376.474", "link_html_complex": "/ACE_complex_html/ACE_VRC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRC.png", "phi_psi": "/peptide_da/VRC.pdb", "link_html_peptide": "/Peptide_html/VRC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRC.pdb", "link_png_peptide": "/Peptide_pics/VRC.png"}
{"Peptide_Sequence": "VRGP", " Origin": " goat  cheese", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "120 \u03bcM", " Reference": "El-Salam, MH Abd, and S. El-Shibiny. \"Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products.\" Food Reviews International 29.1 (2013): 1-23.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1394", " Ligand_ID": "VRGP_minimized.pdb_1394", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "427.5", " logP": "-3.71", " logD": "-9.19", " logSw": "0.64", " tPSA": "209.92", " RotatableB": "12", " RigidB": "13", " Flexibility": "0.48", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "18", " HeteroAtoms": "12", " ratio_H_by_C": "0.67", " Lipinski_Violation": "2", " Solubility_mg_per_l": "809777.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.72", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 427.499", "link_html_complex": "/ACE_complex_html/ACE_VRGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRGP.png", "phi_psi": "/peptide_da/VRGP.pdb", "link_html_peptide": "/Peptide_html/VRGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRGP.pdb", "link_png_peptide": "/Peptide_pics/VRGP.png"}
{"Peptide_Sequence": "VRGPFP", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "592 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-11", "Serial_ID": "1393", " Ligand_ID": "VRGPFP_minimized.pdb_1393", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "671.79", " logP": "-2.33", " logD": "-8.33", " logSw": "-1.46", " tPSA": "259.33", " RotatableB": "17", " RigidB": "28", " Flexibility": "0.38", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "155864.35", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 671.788", "link_html_complex": "/ACE_complex_html/ACE_VRGPFP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRGPFP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRGPFP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRGPFP.png", "phi_psi": "/peptide_da/VRGPFP.pdb", "link_html_peptide": "/Peptide_html/VRGPFP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRGPFP.pdb", "link_png_peptide": "/Peptide_pics/VRGPFP.png"}
{"Peptide_Sequence": "VRGPFPIIV", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "395 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1392", " Ligand_ID": "VRGPFPIIV_minimized.pdb_1392", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "997.23", " logP": "0.52", " logD": "-6.33", " logSw": "-4.53", " tPSA": "346.63", " RotatableB": "28", " RigidB": "34", " Flexibility": "0.45", " HBD": "13", " HBA": "22", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "71", " CarbonAtoms": "49", " HeteroAtoms": "22", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10730.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 997.234", "link_html_complex": "/ACE_complex_html/ACE_VRGPFPIIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRGPFPIIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRGPFPIIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRGPFPIIV.png", "phi_psi": "/peptide_da/VRGPFPIIV.pdb", "link_html_peptide": "/Peptide_html/VRGPFPIIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRGPFPIIV.pdb", "link_png_peptide": "/Peptide_pics/VRGPFPIIV.png"}
{"Peptide_Sequence": "VRK", " Origin": "hard Clam (Meretrix lusoria) ", " Peptide_Preparation": " In vitro gastrointestinal digestion", " Isolation_Method": "SEC, RP-HPLC)", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "700 \u03bcM", " Reference": "Tsai, Jenn-Shou, Jia-Ling Chen, and Bonnie Sun Pan. \"ACE-inhibitory peptides identified from the muscle protein hydrolysate of hard clam (Meretrix lusoria).\" Process Biochemistry 43.7 (2008): 743-747.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1395", " Ligand_ID": "VRK_minimized.pdb_1395", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "401.5", " logP": "-3.6", " logD": "-8.1", " logSw": "0.93", " tPSA": "217.25", " RotatableB": "15", " RigidB": "6", " Flexibility": "0.71", " HBD": "11", " HBA": "11", " HBD_HBA": "22", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "28", " CarbonAtoms": "17", " HeteroAtoms": "11", " ratio_H_by_C": "0.65", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1016267.2", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 401.504", "link_html_complex": "/ACE_complex_html/ACE_VRK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRK.png", "phi_psi": "/peptide_da/VRK.pdb", "link_html_peptide": "/Peptide_html/VRK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRK.pdb", "link_png_peptide": "/Peptide_pics/VRK.png"}
{"Peptide_Sequence": "VRLPT", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1396", " Ligand_ID": "VRLPT_minimized.pdb_1396", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "584.71", " logP": "-4.37", " logD": "-8.54", " logSw": "0.41", " tPSA": "259.25", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "880966.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 584.709", "link_html_complex": "/ACE_complex_html/ACE_VRLPT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRLPT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRLPT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRLPT.png", "phi_psi": "/peptide_da/VRLPT.pdb", "link_html_peptide": "/Peptide_html/VRLPT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRLPT.pdb", "link_png_peptide": "/Peptide_pics/VRLPT.png"}
{"Peptide_Sequence": "VRN", " Origin": "Milk derived, Soybean Protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1398", " Ligand_ID": "VRN_minimized.pdb_1398", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "387.43", " logP": "-4.88", " logD": "-8.71", " logSw": "1.69", " tPSA": "232.7", " RotatableB": "13", " RigidB": "8", " Flexibility": "0.62", " HBD": "11", " HBA": "12", " HBD_HBA": "23", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "27", " CarbonAtoms": "15", " HeteroAtoms": "12", " ratio_H_by_C": "0.8", " Lipinski_Violation": "2", " Solubility_mg_per_l": "2100335.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.67", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 387.435", "link_html_complex": "/ACE_complex_html/ACE_VRN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRN.png", "phi_psi": "/peptide_da/VRN.pdb", "link_html_peptide": "/Peptide_html/VRN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRN.pdb", "link_png_peptide": "/Peptide_pics/VRN.png"}
{"Peptide_Sequence": "VRP", " Origin": "Bonito", " Peptide_Preparation": "protease", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "2.2", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1400", " Ligand_ID": "VRP_minimized.pdb_1400", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "370.45", " logP": "-4.08", " logD": "-6.99", " logSw": "1.09", " tPSA": "180.82", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "16", " HeteroAtoms": "10", " ratio_H_by_C": "0.63", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1105815.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 370.447", "link_html_complex": "/ACE_complex_html/ACE_VRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRP.png", "phi_psi": "/peptide_da/VRP.pdb", "link_html_peptide": "/Peptide_html/VRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRP.pdb", "link_png_peptide": "/Peptide_pics/VRP.png"}
{"Peptide_Sequence": "VRPEK", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1399", " Ligand_ID": "VRPEK_minimized.pdb_1399", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "627.73", " logP": "-8.1", " logD": "-9.26", " logSw": "2.76", " tPSA": "306.79", " RotatableB": "21", " RigidB": "16", " Flexibility": "0.57", " HBD": "13", " HBA": "17", " HBD_HBA": "30", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "27", " HeteroAtoms": "17", " ratio_H_by_C": "0.63", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9888900.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 627.734", "link_html_complex": "/ACE_complex_html/ACE_VRPEK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRPEK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRPEK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRPEK.png", "phi_psi": "/peptide_da/VRPEK.pdb", "link_html_peptide": "/Peptide_html/VRPEK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRPEK.pdb", "link_png_peptide": "/Peptide_pics/VRPEK.png"}
{"Peptide_Sequence": "VRSP", " Origin": "Milk casein", " Peptide_Preparation": "synthesized", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "2018.27 \u03bcM", " Reference": "Wang, Zhan-Li, et al. \"A novel angiotensin I converting enzyme inhibitory peptide from the milk casein: virtual screening and docking studies.\" Agricultural sciences in China 10.3 (2011): 463-467.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1401", " Ligand_ID": "VRSP_minimized.pdb_1401", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "457.52", " logP": "-6.05", " logD": "-9.68", " logSw": "1.99", " tPSA": "230.15", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "32", " CarbonAtoms": "19", " HeteroAtoms": "13", " ratio_H_by_C": "0.68", " Lipinski_Violation": "2", " Solubility_mg_per_l": "3356582.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.74", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 457.525", "link_html_complex": "/ACE_complex_html/ACE_VRSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRSP.png", "phi_psi": "/peptide_da/VRSP.pdb", "link_html_peptide": "/Peptide_html/VRSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRSP.pdb", "link_png_peptide": "/Peptide_pics/VRSP.png"}
{"Peptide_Sequence": "VRW", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1403", " Ligand_ID": "VRW_minimized.pdb_1403", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "459.54", " logP": "-2.25", " logD": "-5.5", " logSw": "-0.51", " tPSA": "205.4", " RotatableB": "13", " RigidB": "16", " Flexibility": "0.45", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "22", " HeteroAtoms": "11", " ratio_H_by_C": "0.5", " Lipinski_Violation": "2", " Solubility_mg_per_l": "274694.94", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 459.542", "link_html_complex": "/ACE_complex_html/ACE_VRW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRW.png", "phi_psi": "/peptide_da/VRW.pdb", "link_html_peptide": "/Peptide_html/VRW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRW.pdb", "link_png_peptide": "/Peptide_pics/VRW.png"}
{"Peptide_Sequence": "VRWCT", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1402", " Ligand_ID": "VRWCT_minimized.pdb_1402", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "663.79", " logP": "-4.18", " logD": "-7.75", " logSw": "-0.14", " tPSA": "322.63", " RotatableB": "19", " RigidB": "20", " Flexibility": "0.49", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "29", " HeteroAtoms": "17", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "576333.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 663.788", "link_html_complex": "/ACE_complex_html/ACE_VRWCT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRWCT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRWCT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRWCT.png", "phi_psi": "/peptide_da/VRWCT.pdb", "link_html_peptide": "/Peptide_html/VRWCT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRWCT.pdb", "link_png_peptide": "/Peptide_pics/VRWCT.png"}
{"Peptide_Sequence": "VRY", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1405", " Ligand_ID": "VRY_minimized.pdb_1405", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "436.51", " logP": "-3.59", " logD": "-5.91", " logSw": "0.5", " tPSA": "209.84", " RotatableB": "13", " RigidB": "12", " Flexibility": "0.52", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "721759.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 436.505", "link_html_complex": "/ACE_complex_html/ACE_VRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRY.png", "phi_psi": "/peptide_da/VRY.pdb", "link_html_peptide": "/Peptide_html/VRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRY.pdb", "link_png_peptide": "/Peptide_pics/VRY.png"}
{"Peptide_Sequence": "VRYL", " Origin": "Manchego cheese", " Peptide_Preparation": "synthesised", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "24.1 \u03bcM", " Reference": "Ruiz, Jos\u00e9 \u00c1ngel G\u00f3mez, Mercedes Ramos, and Isidra Recio. \"Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion.\" International dairy journal 14.12 (2004): 1075-1080.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1404", " Ligand_ID": "VRYL_minimized.pdb_1404", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "549.66", " logP": "-1.65", " logD": "-6.26", " logSw": "-1.14", " tPSA": "238.94", " RotatableB": "17", " RigidB": "14", " Flexibility": "0.55", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "175694.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 549.663", "link_html_complex": "/ACE_complex_html/ACE_VRYL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VRYL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VRYL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VRYL.png", "phi_psi": "/peptide_da/VRYL.pdb", "link_html_peptide": "/Peptide_html/VRYL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VRYL.pdb", "link_png_peptide": "/Peptide_pics/VRYL.png"}
{"Peptide_Sequence": "VSGAGRY", " Origin": "bitter melon seed", " Peptide_Preparation": " trypsin , \u03b1-chymotrypsin, pepsin, alcalase,  thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman et al. with partial modification", " In-vivo_or_in-vitro": "in-vitro, in-vivo, in-silico", " IC50_micromol_per_L": "8.6 \u03bcM", " Reference": "Priyanto, Anugerah Dany, et al. \"Screening, discovery, and characterization of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.\" Journal of proteomics 128 (2015): 424-435.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1406", " Ligand_ID": "VSGAGRY_minimized.pdb_1406", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "708.76", " logP": "-4.99", " logD": "-10.32", " logSw": "0.32", " tPSA": "346.47", " RotatableB": "22", " RigidB": "20", " Flexibility": "0.52", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "50", " CarbonAtoms": "30", " HeteroAtoms": "20", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "972221.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 708.763", "link_html_complex": "/ACE_complex_html/ACE_VSGAGRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSGAGRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSGAGRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSGAGRY.png", "phi_psi": "/peptide_da/VSGAGRY.pdb", "link_html_peptide": "/Peptide_html/VSGAGRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSGAGRY.pdb", "link_png_peptide": "/Peptide_pics/VSGAGRY.png"}
{"Peptide_Sequence": "VSGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "195.4 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1407", " Ligand_ID": "VSGP_minimized.pdb_1407", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "358.39", " logP": "-3.94", " logD": "-6.94", " logSw": "0.95", " tPSA": "166.51", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "15", " HeteroAtoms": "10", " ratio_H_by_C": "0.67", " Lipinski_Violation": "1", " Solubility_mg_per_l": "925008.85", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 358.39", "link_html_complex": "/ACE_complex_html/ACE_VSGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSGP.png", "phi_psi": "/peptide_da/VSGP.pdb", "link_html_peptide": "/Peptide_html/VSGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSGP.pdb", "link_png_peptide": "/Peptide_pics/VSGP.png"}
{"Peptide_Sequence": "VSLPEW", " Origin": "Alpha-Lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "SEC, RP-HPLC, LC-MS/MS", " ACE_inhibition_assay": "Shalaby et al. (2006)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "57 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1408", " Ligand_ID": "VSLPEW_minimized.pdb_1408", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "729.82", " logP": "-1.87", " logD": "-8", " logSw": "-2", " tPSA": "280.63", " RotatableB": "19", " RigidB": "27", " Flexibility": "0.41", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "52", " CarbonAtoms": "35", " HeteroAtoms": "17", " ratio_H_by_C": "0.49", " Lipinski_Violation": "3", " Solubility_mg_per_l": "99022.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 729.82", "link_html_complex": "/ACE_complex_html/ACE_VSLPEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSLPEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSLPEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSLPEW.png", "phi_psi": "/peptide_da/VSLPEW.pdb", "link_html_peptide": "/Peptide_html/VSLPEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSLPEW.pdb", "link_png_peptide": "/Peptide_pics/VSLPEW.png"}
{"Peptide_Sequence": "VSP", " Origin": "Maize endosperm protein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10", " Reference": "Structures and Activity of Angiotensin-convertingEnzyme Inhibitors in an\u03b1-Zein HydrolysateShinsuke Miyoshi, Hiromi Ishikawa, Toshiyuki Kaneko, Fumio Fukui, HideokiTanaka & Susumu Maruyama ", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1409", " Ligand_ID": "VSP_minimized.pdb_1409", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(O)=O", " MW": "301.34", " logP": "-4.31", " logD": "-5.41", " logSw": "1.4", " tPSA": "137.41", " RotatableB": "6", " RigidB": "10", " Flexibility": "0.38", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "0", " Solubility_mg_per_l": "1225659.81", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 301.339", "link_html_complex": "/ACE_complex_html/ACE_VSP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSP.png", "phi_psi": "/peptide_da/VSP.pdb", "link_html_peptide": "/Peptide_html/VSP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSP.pdb", "link_png_peptide": "/Peptide_pics/VSP.png"}
{"Peptide_Sequence": "VSRHFASYAN", " Origin": "sea cucumber (Stichopus horrens)", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Jimsheena and Gowda (2009) with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": " 0.21 mM", " Reference": "Forghani, Bita, et al. \"Purification and characterization of angiotensin converting enzyme-inhibitory peptides derived from Stichopus horrens: Stability study against the ACE and inhibition kinetics.\" Journal of functional foods 20 (2016): 276-290.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1410", " Ligand_ID": "VSRHFASYAN_minimized.pdb_1410", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "1151.23", " logP": "-6.17", " logD": "-13.17", " logSw": "-0.86", " tPSA": "526.69", " RotatableB": "35", " RigidB": "39", " Flexibility": "0.47", " HBD": "22", " HBA": "31", " HBD_HBA": "53", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "82", " CarbonAtoms": "51", " HeteroAtoms": "31", " ratio_H_by_C": "0.61", " Lipinski_Violation": "3", " Solubility_mg_per_l": "486584.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1151.23", "link_html_complex": "/ACE_complex_html/ACE_VSRHFASYAN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSRHFASYAN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSRHFASYAN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSRHFASYAN.png", "phi_psi": "/peptide_da/VSRHFASYAN.pdb", "link_html_peptide": "/Peptide_html/VSRHFASYAN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSRHFASYAN.pdb", "link_png_peptide": "/Peptide_pics/VSRHFASYAN.png"}
{"Peptide_Sequence": "VSV", " Origin": "defatted canola meal", " Peptide_Preparation": "Alcalase", " Isolation_Method": "GPC", " ACE_inhibition_assay": "Wu, Aluko, & Muir, 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "0.15 \u03bcM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Alister D. Muir. \"Purification of angiotensin I-converting enzyme-inhibitory peptides from the enzymatic hydrolysate of defatted canola meal.\" Food chemistry 111.4 (2008): 942-950.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1411", " Ligand_ID": "VSV_minimized.pdb_1411", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "303.35", " logP": "-3.35", " logD": "-4.78", " logSw": "0.92", " tPSA": "146.2", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "759456.93", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.77", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.355", "link_html_complex": "/ACE_complex_html/ACE_VSV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSV.png", "phi_psi": "/peptide_da/VSV.pdb", "link_html_peptide": "/Peptide_html/VSV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSV.pdb", "link_png_peptide": "/Peptide_pics/VSV.png"}
{"Peptide_Sequence": "VSW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1412", " Ligand_ID": "VSW_minimized.pdb_1412", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "390.43", " logP": "-2.55", " logD": "-3.9", " logSw": "-0.18", " tPSA": "161.99", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "19", " HeteroAtoms": "9", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "324971.17", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.434", "link_html_complex": "/ACE_complex_html/ACE_VSW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VSW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VSW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VSW.png", "phi_psi": "/peptide_da/VSW.pdb", "link_html_peptide": "/Peptide_html/VSW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VSW.pdb", "link_png_peptide": "/Peptide_pics/VSW.png"}
{"Peptide_Sequence": "VTC", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-6.4", "Serial_ID": "1413", " Ligand_ID": "VTC_minimized.pdb_1413", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(O)=O", " MW": "321.39", " logP": "-3.99", " logD": "-5.21", " logSw": "1.21", " tPSA": "185", " RotatableB": "8", " RigidB": "5", " Flexibility": "0.62", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "12", " HeteroAtoms": "9", " ratio_H_by_C": "0.75", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1076777.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 321.392", "link_html_complex": "/ACE_complex_html/ACE_VTC.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTC.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTC.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTC.png", "phi_psi": "/peptide_da/VTC.pdb", "link_html_peptide": "/Peptide_html/VTC.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTC.pdb", "link_png_peptide": "/Peptide_pics/VTC.png"}
{"Peptide_Sequence": "VTGRFAGHPAAQ", " Origin": "egg yolk", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Miguel et al. (2004)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "27.3 \u03bcg/ml", " Reference": "Zambrowicz, Aleksandra, et al. \"Multifunctional peptides derived from an egg yolk protein hydrolysate: isolation and characterization.\" Amino acids 47.2 (2015): 369-380.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1414", " Ligand_ID": "VTGRFAGHPAAQ_minimized.pdb_1414", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "1211.33", " logP": "-6.57", " logD": "-14.67", " logSw": "-0.88", " tPSA": "534.72", " RotatableB": "36", " RigidB": "42", " Flexibility": "0.46", " HBD": "21", " HBA": "33", " HBD_HBA": "54", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "86", " CarbonAtoms": "53", " HeteroAtoms": "33", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "500634.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1211.33", "link_html_complex": "/ACE_complex_html/ACE_VTGRFAGHPAAQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTGRFAGHPAAQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTGRFAGHPAAQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTGRFAGHPAAQ.png", "phi_psi": "/peptide_da/VTGRFAGHPAAQ.pdb", "link_html_peptide": "/Peptide_html/VTGRFAGHPAAQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTGRFAGHPAAQ.pdb", "link_png_peptide": "/Peptide_pics/VTGRFAGHPAAQ.png"}
{"Peptide_Sequence": "VTPALR", " Origin": "Mung bean protein", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "13.4 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1415", " Ligand_ID": "VTPALR_minimized.pdb_1415", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "655.79", " logP": "-4.62", " logD": "-6.11", " logSw": "0.26", " tPSA": "288.35", " RotatableB": "19", " RigidB": "17", " Flexibility": "0.53", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "29", " HeteroAtoms": "17", " ratio_H_by_C": "0.59", " Lipinski_Violation": "3", " Solubility_mg_per_l": "849423.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 655.787", "link_html_complex": "/ACE_complex_html/ACE_VTPALR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTPALR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTPALR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTPALR.png", "phi_psi": "/peptide_da/VTPALR.pdb", "link_html_peptide": "/Peptide_html/VTPALR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTPALR.pdb", "link_png_peptide": "/Peptide_pics/VTPALR.png"}
{"Peptide_Sequence": "VTR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1416", " Ligand_ID": "VTR_minimized.pdb_1416", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "374.44", " logP": "-4.11", " logD": "-6.03", " logSw": "1.22", " tPSA": "209.84", " RotatableB": "12", " RigidB": "6", " Flexibility": "0.67", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "26", " CarbonAtoms": "15", " HeteroAtoms": "11", " ratio_H_by_C": "0.73", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1268027.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.73", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 374.436", "link_html_complex": "/ACE_complex_html/ACE_VTR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTR.png", "phi_psi": "/peptide_da/VTR.pdb", "link_html_peptide": "/Peptide_html/VTR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTR.pdb", "link_png_peptide": "/Peptide_pics/VTR.png"}
{"Peptide_Sequence": "VTSTAV", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "52  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1417", " Ligand_ID": "VTSTAV_minimized.pdb_1417", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O", " MW": "576.64", " logP": "-4.62", " logD": "-8.07", " logSw": "0.55", " tPSA": "273.96", " RotatableB": "16", " RigidB": "11", " Flexibility": "0.59", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "24", " HeteroAtoms": "16", " ratio_H_by_C": "0.67", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1000893.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 576.64", "link_html_complex": "/ACE_complex_html/ACE_VTSTAV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTSTAV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTSTAV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTSTAV.png", "phi_psi": "/peptide_da/VTSTAV.pdb", "link_html_peptide": "/Peptide_html/VTSTAV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTSTAV.pdb", "link_png_peptide": "/Peptide_pics/VTSTAV.png"}
{"Peptide_Sequence": "VTVNPYKWLP", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "5.5  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1418", " Ligand_ID": "VTVNPYKWLP_minimized.pdb_1418", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1216.43", " logP": "-0.84", " logD": "-7.78", " logSw": "-4.8", " tPSA": "439.07", " RotatableB": "32", " RigidB": "47", " Flexibility": "0.41", " HBD": "17", " HBA": "27", " HBD_HBA": "44", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "87", " CarbonAtoms": "60", " HeteroAtoms": "27", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "9973.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1216.43", "link_html_complex": "/ACE_complex_html/ACE_VTVNPYKWLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VTVNPYKWLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VTVNPYKWLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VTVNPYKWLP.png", "phi_psi": "/peptide_da/VTVNPYKWLP.pdb", "link_html_peptide": "/Peptide_html/VTVNPYKWLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VTVNPYKWLP.pdb", "link_png_peptide": "/Peptide_pics/VTVNPYKWLP.png"}
{"Peptide_Sequence": "VVCVPW", " Origin": "Mactra veneriformis ", " Peptide_Preparation": "trypsin", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.1 \u03bcM", " Reference": "Liu, Rui, et al. \"Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.\" Marine drugs 12.7 (2014): 3917-3928.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1419", " Ligand_ID": "VVCVPW_minimized.pdb_1419", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "701.88", " logP": "0.22", " logD": "-2.74", " logSw": "-3.34", " tPSA": "259.07", " RotatableB": "16", " RigidB": "26", " Flexibility": "0.38", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "34", " HeteroAtoms": "15", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "24851.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 701.876", "link_html_complex": "/ACE_complex_html/ACE_VVCVPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVCVPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVCVPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVCVPW.png", "phi_psi": "/peptide_da/VVCVPW.pdb", "link_html_peptide": "/Peptide_html/VVCVPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVCVPW.pdb", "link_png_peptide": "/Peptide_pics/VVCVPW.png"}
{"Peptide_Sequence": "VVF", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1420", " Ligand_ID": "VVF_minimized.pdb_1420", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "363.45", " logP": "-1.39", " logD": "-2.05", " logSw": "-0.7", " tPSA": "125.97", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "19", " HeteroAtoms": "7", " ratio_H_by_C": "0.37", " Lipinski_Violation": "0", " Solubility_mg_per_l": "179687.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 363.451", "link_html_complex": "/ACE_complex_html/ACE_VVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVF.png", "phi_psi": "/peptide_da/VVF.pdb", "link_html_peptide": "/Peptide_html/VVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVF.pdb", "link_png_peptide": "/Peptide_pics/VVF.png"}
{"Peptide_Sequence": "VVG", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "39600 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1422", " Ligand_ID": "VVG_minimized.pdb_1422", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O", " MW": "273.33", " logP": "-2.96", " logD": "-4.29", " logSw": "0.79", " tPSA": "125.97", " RotatableB": "7", " RigidB": "5", " Flexibility": "0.58", " HBD": "5", " HBA": "7", " HBD_HBA": "12", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "0", " Solubility_mg_per_l": "603554.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.75", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 273.329", "link_html_complex": "/ACE_complex_html/ACE_VVG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVG.png", "phi_psi": "/peptide_da/VVG.pdb", "link_html_peptide": "/Peptide_html/VVG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVG.pdb", "link_png_peptide": "/Peptide_pics/VVG.png"}
{"Peptide_Sequence": "VVGAK", " Origin": "Sweet potato thioredoxin h2 ", " Peptide_Preparation": "expression of thioredoxin h2 in E. coli", " Isolation_Method": "", " ACE_inhibition_assay": " Lee  et  al.(2003) ", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "1.14 \u03bcM", " Reference": "Huang, Guan-Jhong, et al. \"Sweet potato storage root thioredoxin h2 and their peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activity in vitro.\" Botanical Studies 52.1 (2011).", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1421", " Ligand_ID": "VVGAK_minimized.pdb_1421", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "472.58", " logP": "-3.92", " logD": "-5.56", " logSw": "0.69", " tPSA": "211.81", " RotatableB": "15", " RigidB": "9", " Flexibility": "0.63", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "0", " MaxSizeRing": "0", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "941821.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.579", "link_html_complex": "/ACE_complex_html/ACE_VVGAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVGAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVGAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVGAK.png", "phi_psi": "/peptide_da/VVGAK.pdb", "link_html_peptide": "/Peptide_html/VVGAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVGAK.pdb", "link_png_peptide": "/Peptide_pics/VVGAK.png"}
{"Peptide_Sequence": "VVGP", " Origin": "Porcine skin gelatin, synthetic", " Peptide_Preparation": "Enzymatic hydrolysis", " Isolation_Method": "RP-HPLC, GP-HPLC, UPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) with modifications by Norris et al. (2012)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "97.2 \u03bcM", " Reference": "O'Keeffe, Martina B., et al. \"Peptide identification in a porcine gelatin prolyl endoproteinase hydrolysate with angiotensin converting enzyme (ACE) inhibitory and hypotensive activity.\" Journal of functional foods 34 (2017): 77-88.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1423", " Ligand_ID": "VVGP_minimized.pdb_1423", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "370.44", " logP": "-2.83", " logD": "-5.01", " logSw": "0.17", " tPSA": "146.28", " RotatableB": "8", " RigidB": "12", " Flexibility": "0.4", " HBD": "5", " HBA": "9", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "26", " CarbonAtoms": "17", " HeteroAtoms": "9", " ratio_H_by_C": "0.53", " Lipinski_Violation": "0", " Solubility_mg_per_l": "440914", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 370.444", "link_html_complex": "/ACE_complex_html/ACE_VVGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVGP.png", "phi_psi": "/peptide_da/VVGP.pdb", "link_html_peptide": "/Peptide_html/VVGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVGP.pdb", "link_png_peptide": "/Peptide_pics/VVGP.png"}
{"Peptide_Sequence": "VVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "285 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1425", " Ligand_ID": "VVPP_minimized.pdb_1425", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "410.51", " logP": "-1.22", " logD": "-4.15", " logSw": "-1.15", " tPSA": "137.49", " RotatableB": "7", " RigidB": "17", " Flexibility": "0.29", " HBD": "4", " HBA": "9", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "0", " Solubility_mg_per_l": "129392.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 410.508", "link_html_complex": "/ACE_complex_html/ACE_VVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVPP.png", "phi_psi": "/peptide_da/VVPP.pdb", "link_html_peptide": "/Peptide_html/VVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVPP.pdb", "link_png_peptide": "/Peptide_pics/VVPP.png"}
{"Peptide_Sequence": "VVPPA", " Origin": "Chlorella vulgaris and Spirulina platensis", " Peptide_Preparation": "Synthetic Peptides", " Isolation_Method": "reverse-phase HPLC on a Develosil ODS-5 column (4.6 \u00d7 250 mm)", " ACE_inhibition_assay": " modification  of  themethod of Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "In-vitro, In-vivo", " IC50_micromol_per_L": "79.5 \u03bcM", " Reference": "Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Marine Biotechnol (NY) 2001;3:305\u20139.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1424", " Ligand_ID": "VVPPA_minimized.pdb_1424", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O", " MW": "481.59", " logP": "-3.18", " logD": "-4.69", " logSw": "-0.23", " tPSA": "166.59", " RotatableB": "9", " RigidB": "19", " Flexibility": "0.32", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "1", " Solubility_mg_per_l": "383236.78", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.78", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 481.586", "link_html_complex": "/ACE_complex_html/ACE_VVPPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVPPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVPPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVPPA.png", "phi_psi": "/peptide_da/VVPPA.pdb", "link_html_peptide": "/Peptide_html/VVPPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVPPA.pdb", "link_png_peptide": "/Peptide_pics/VVPPA.png"}
{"Peptide_Sequence": "VVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "81", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1426", " Ligand_ID": "VVRP_minimized.pdb_1426", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "469.58", " logP": "-4.04", " logD": "-6.72", " logSw": "0.65", " tPSA": "209.92", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "5", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "33", " CarbonAtoms": "21", " HeteroAtoms": "12", " ratio_H_by_C": "0.57", " Lipinski_Violation": "2", " Solubility_mg_per_l": "901130.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.76", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 469.578", "link_html_complex": "/ACE_complex_html/ACE_VVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVRP.png", "phi_psi": "/peptide_da/VVRP.pdb", "link_html_peptide": "/Peptide_html/VVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVRP.pdb", "link_png_peptide": "/Peptide_pics/VVRP.png"}
{"Peptide_Sequence": "VVVPP", " Origin": "Fermented milk", " Peptide_Preparation": " Lactobacillus helveticus JCM-1004", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "873 \u03bcM", " Reference": "Nakamura, Yasunori, and Toshiaki Takano. \"Angiotensin converting enzyme inhibitor and method for preparing same.\" U.S. Patent No. 5,449,661. 12 Sep. 1995.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1428", " Ligand_ID": "VVVPP_minimized.pdb_1428", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(O)=O", " MW": "509.64", " logP": "-0.51", " logD": "-3.8", " logSw": "-2.02", " tPSA": "166.59", " RotatableB": "10", " RigidB": "19", " Flexibility": "0.34", " HBD": "5", " HBA": "11", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "5", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "25", " HeteroAtoms": "11", " ratio_H_by_C": "0.44", " Lipinski_Violation": "2", " Solubility_mg_per_l": "67710.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.8", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.639", "link_html_complex": "/ACE_complex_html/ACE_VVVPP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVVPP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVVPP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVVPP.png", "phi_psi": "/peptide_da/VVVPP.pdb", "link_html_peptide": "/Peptide_html/VVVPP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVVPP.pdb", "link_png_peptide": "/Peptide_pics/VVVPP.png"}
{"Peptide_Sequence": "VVVPPF", " Origin": "\u03b2-casein", " Peptide_Preparation": "synthesized\n", " Isolation_Method": "RP-HPLC\u2013MS", " ACE_inhibition_assay": "Sentrandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "> 1500 \u03bcM", " Reference": "Quir\u00f3s, Ana, et al. \"Stability to gastrointestinal enzymes and structure\u2013activity relationship of \u03b2-casein-peptides with antihypertensive properties.\" Peptides 30.10 (2009): 1848-1853.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1427", " Ligand_ID": "VVVPPF_minimized.pdb_1427", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "656.81", " logP": "0.83", " logD": "-2.65", " logSw": "-3.56", " tPSA": "195.69", " RotatableB": "14", " RigidB": "27", " Flexibility": "0.34", " HBD": "6", " HBA": "13", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "34", " HeteroAtoms": "13", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "18754.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.65", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 656.813", "link_html_complex": "/ACE_complex_html/ACE_VVVPPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVVPPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVVPPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVVPPF.png", "phi_psi": "/peptide_da/VVVPPF.pdb", "link_html_peptide": "/Peptide_html/VVVPPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVVPPF.pdb", "link_png_peptide": "/Peptide_pics/VVVPPF.png"}
{"Peptide_Sequence": "VVW", " Origin": "Chlorella vulgaris", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-silico, in-vitro, in-vivo", " IC50_micromol_per_L": "76 \u03bcM", " Reference": "Xie, Jingli, et al. \"Antihypertensive effects, molecular docking study, and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris.\" Journal of agricultural and food chemistry 66.6 (2018): 1359-1368.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1429", " Ligand_ID": "VVW_minimized.pdb_1429", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "402.49", " logP": "-0.54", " logD": "-1.94", " logSw": "-1.51", " tPSA": "141.76", " RotatableB": "9", " RigidB": "15", " Flexibility": "0.38", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "88549.43", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 402.487", "link_html_complex": "/ACE_complex_html/ACE_VVW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVW.png", "phi_psi": "/peptide_da/VVW.pdb", "link_html_peptide": "/Peptide_html/VVW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVW.pdb", "link_png_peptide": "/Peptide_pics/VVW.png"}
{"Peptide_Sequence": "VVY", " Origin": "Rice", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "22.0 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1430", " Ligand_ID": "VVY_minimized.pdb_1430", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "379.45", " logP": "-2.13", " logD": "-2.39", " logSw": "-0.34", " tPSA": "146.2", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "271169.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 379.451", "link_html_complex": "/ACE_complex_html/ACE_VVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVY.png", "phi_psi": "/peptide_da/VVY.pdb", "link_html_peptide": "/Peptide_html/VVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVY.pdb", "link_png_peptide": "/Peptide_pics/VVY.png"}
{"Peptide_Sequence": "VVYPW", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "0.36 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1431", " Ligand_ID": "VVYPW_minimized.pdb_1431", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "662.78", " logP": "0.83", " logD": "-1.76", " logSw": "-3.67", " tPSA": "211.4", " RotatableB": "14", " RigidB": "30", " Flexibility": "0.32", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "35", " HeteroAtoms": "13", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "16949.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 662.776", "link_html_complex": "/ACE_complex_html/ACE_VVYPW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVYPW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVYPW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVYPW.png", "phi_psi": "/peptide_da/VVYPW.pdb", "link_html_peptide": "/Peptide_html/VVYPW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVYPW.pdb", "link_png_peptide": "/Peptide_pics/VVYPW.png"}
{"Peptide_Sequence": "VVYPWT", " Origin": "porcine hemoglobin", " Peptide_Preparation": "pepsin (porcine stomach mucosa), trypsin (bovine pancreas), papain (pawpaw sap) ", " Isolation_Method": "GEC", " ACE_inhibition_assay": "modification of the method of Cushman and Cheung ", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.02 \u03bcM", " Reference": "Yu, Yike, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin.\" Peptides 27.11 (2006): 2950-2956.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1432", " Ligand_ID": "VVYPWT_minimized.pdb_1432", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "763.88", " logP": "-0.05", " logD": "-3.02", " logSw": "-3.53", " tPSA": "260.73", " RotatableB": "17", " RigidB": "32", " Flexibility": "0.35", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "39", " HeteroAtoms": "16", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "22490.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 763.88", "link_html_complex": "/ACE_complex_html/ACE_VVYPWT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVYPWT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVYPWT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVYPWT.png", "phi_psi": "/peptide_da/VVYPWT.pdb", "link_html_peptide": "/Peptide_html/VVYPWT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVYPWT.pdb", "link_png_peptide": "/Peptide_pics/VVYPWT.png"}
{"Peptide_Sequence": "VVYPWTQ", " Origin": "bovine hemoglobin", " Peptide_Preparation": "porcine pepsin", " Isolation_Method": " RP-HPLC", " ACE_inhibition_assay": "Holmquist 1979", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.6 \u03bcM", " Reference": "Zhao, Q., and J. M. Piot. \"Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin.\" Neuropeptides 31.2 (1997): 147-153.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1433", " Ligand_ID": "VVYPWTQ_minimized.pdb_1433", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "892.01", " logP": "-1.46", " logD": "-4.72", " logSw": "-3.09", " tPSA": "332.92", " RotatableB": "22", " RigidB": "36", " Flexibility": "0.38", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "44", " HeteroAtoms": "20", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "40691.58", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 892.009", "link_html_complex": "/ACE_complex_html/ACE_VVYPWTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVYPWTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVYPWTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVYPWTQ.png", "phi_psi": "/peptide_da/VVYPWTQ.pdb", "link_html_peptide": "/Peptide_html/VVYPWTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVYPWTQ.pdb", "link_png_peptide": "/Peptide_pics/VVYPWTQ.png"}
{"Peptide_Sequence": "VVYPWTQRF", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "5.5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1434", " Ligand_ID": "VVYPWTQRF_minimized.pdb_1434", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1195.37", " logP": "-1.2", " logD": "-6.42", " logSw": "-4.41", " tPSA": "454.76", " RotatableB": "33", " RigidB": "47", " Flexibility": "0.41", " HBD": "19", " HBA": "27", " HBD_HBA": "46", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "86", " CarbonAtoms": "59", " HeteroAtoms": "27", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "14533.06", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1195.37", "link_html_complex": "/ACE_complex_html/ACE_VVYPWTQRF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VVYPWTQRF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VVYPWTQRF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VVYPWTQRF.png", "phi_psi": "/peptide_da/VVYPWTQRF.pdb", "link_html_peptide": "/Peptide_html/VVYPWTQRF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VVYPWTQRF.pdb", "link_png_peptide": "/Peptide_pics/VVYPWTQRF.png"}
{"Peptide_Sequence": "VW", " Origin": "Upstream Chum Salmon ", " Peptide_Preparation": "synthesized", " Isolation_Method": "GFC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971),", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2.5 \u03bcM", " Reference": "Ono, S., et al. \"Food Chemistry and Toxicology-Isolation of Peptides with Angiotensin I-converting Enzyme Inhibitory Effect Derived from Hydrolysate of Upstream Chum Salmon Muscle.\" Journal of Food Science 68.5 (2003): 1611-1690.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1438", " Ligand_ID": "VW_minimized.pdb_1438", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "303.36", " logP": "-1.25", " logD": "-1.2", " logSw": "-0.69", " tPSA": "112.66", " RotatableB": "6", " RigidB": "13", " Flexibility": "0.32", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "16", " HeteroAtoms": "6", " ratio_H_by_C": "0.38", " Lipinski_Violation": "0", " Solubility_mg_per_l": "151823.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.356", "link_html_complex": "/ACE_complex_html/ACE_VW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VW.png", "phi_psi": "/peptide_da/VW.pdb", "link_html_peptide": "/Peptide_html/VW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VW.pdb", "link_png_peptide": "/Peptide_pics/VW.png"}
{"Peptide_Sequence": "VWDPPKFD", " Origin": "salmon ", " Peptide_Preparation": "Alcalase, flavourzyme, neutrase, pepsin, protamex and trypsin", " Isolation_Method": "GC, RP-HPLC", " ACE_inhibition_assay": " modification  of  Cheung and Cushman (1973)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.1 \u03bcM", " Reference": "Ahn, Chang-Bum, et al. \"Angiotensin I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis.\" Process Biochemistry 47.12 (2012): 2240-2245.", " Binding_Energy_kcal_per_mol": "-", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": "#", "link_html_complex": "/ACE_complex_html/ACE_VWDPPKFD.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VWDPPKFD.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VWDPPKFD.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VWDPPKFD.png", "phi_psi": "#", "link_html_peptide": "/Peptide_html/VWDPPKFD.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VWDPPKFD.pdb", "link_png_peptide": "/Peptide_pics/VWDPPKFD.png"}
{"Peptide_Sequence": "VWIG", " Origin": "tuna", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "110 \u03bcM", " Reference": "Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr. Pharm. Des., 2007, 13, 773-791.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1436", " Ligand_ID": "VWIG_minimized.pdb_1436", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(O)=O", " MW": "473.57", " logP": "-0.55", " logD": "-2.99", " logSw": "-1.73", " tPSA": "170.86", " RotatableB": "12", " RigidB": "17", " Flexibility": "0.41", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "24", " HeteroAtoms": "10", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "83610.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.565", "link_html_complex": "/ACE_complex_html/ACE_VWIG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VWIG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VWIG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VWIG.png", "phi_psi": "/peptide_da/VWIG.pdb", "link_html_peptide": "/Peptide_html/VWIG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VWIG.pdb", "link_png_peptide": "/Peptide_pics/VWIG.png"}
{"Peptide_Sequence": "VWIS", " Origin": "rapeseed", " Peptide_Preparation": "proteolytic enzymes", " Isolation_Method": "octadecyl silica (ODS) column, cyanopropyl silica (CN) column, phenetyl silica and nitrophenetyl column", " ACE_inhibition_assay": " Cushman and Cheung (1971) with modification by Yamamoto et al. (1980)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "30", " Reference": "Marczak, Ewa D., et al. \"New antihypertensive peptides isolated from rapeseed.\" Peptides 24.6 (2003): 791-798.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1437", " Ligand_ID": "VWIS_minimized.pdb_1437", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CO)C(O)=O", " MW": "503.59", " logP": "-1.2", " logD": "-3.51", " logSw": "-1.44", " tPSA": "191.09", " RotatableB": "13", " RigidB": "17", " Flexibility": "0.43", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "25", " HeteroAtoms": "11", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "119374.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 503.591", "link_html_complex": "/ACE_complex_html/ACE_VWIS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VWIS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VWIS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VWIS.png", "phi_psi": "/peptide_da/VWIS.pdb", "link_html_peptide": "/Peptide_html/VWIS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VWIS.pdb", "link_png_peptide": "/Peptide_pics/VWIS.png"}
{"Peptide_Sequence": "VWP", " Origin": "rice protein", " Peptide_Preparation": "Alcalase", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Chen et al., 2012", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "4.5 \u03bcM", " Reference": "Chen, Jiwang, et al. \"Angiotensin-I converting enzyme (ACE) inhibitory tripeptides from rice protein hydrolysate: Purification and characterization.\" Journal of Functional Foods 5.4 (2013): 1684-1692.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1439", " Ligand_ID": "VWP_minimized.pdb_1439", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(O)=O", " MW": "400.47", " logP": "-0.27", " logD": "-2.58", " logSw": "-1.81", " tPSA": "132.97", " RotatableB": "7", " RigidB": "20", " Flexibility": "0.26", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "21", " HeteroAtoms": "8", " ratio_H_by_C": "0.38", " Lipinski_Violation": "0", " Solubility_mg_per_l": "65692.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 400.471", "link_html_complex": "/ACE_complex_html/ACE_VWP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VWP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VWP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VWP.png", "phi_psi": "/peptide_da/VWP.pdb", "link_html_peptide": "/Peptide_html/VWP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VWP.pdb", "link_png_peptide": "/Peptide_pics/VWP.png"}
{"Peptide_Sequence": "VWY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "9.4", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1440", " Ligand_ID": "VWY_minimized.pdb_1440", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "466.53", " logP": "-0.42", " logD": "-1.52", " logSw": "-1.98", " tPSA": "161.99", " RotatableB": "10", " RigidB": "21", " Flexibility": "0.32", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "25", " HeteroAtoms": "9", " ratio_H_by_C": "0.36", " Lipinski_Violation": "1", " Solubility_mg_per_l": "64328.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.32", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 466.53", "link_html_complex": "/ACE_complex_html/ACE_VWY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VWY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VWY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VWY.png", "phi_psi": "/peptide_da/VWY.pdb", "link_html_peptide": "/Peptide_html/VWY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VWY.pdb", "link_png_peptide": "/Peptide_pics/VWY.png"}
{"Peptide_Sequence": "VY", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "22 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1445", " Ligand_ID": "VY_minimized.pdb_1445", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "280.32", " logP": "-2.52", " logD": "-1.61", " logSw": "0.29", " tPSA": "117.1", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "376361.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 280.32", "link_html_complex": "/ACE_complex_html/ACE_VY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VY.png", "phi_psi": "/peptide_da/VY.pdb", "link_html_peptide": "/Peptide_html/VY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VY.pdb", "link_png_peptide": "/Peptide_pics/VY.png"}
{"Peptide_Sequence": "VYAP", " Origin": " cuttlefish (Sepia officinalis) ", " Peptide_Preparation": "Chymotrypsin, trypsin and pepsin ", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Nakamura et al. (1995)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "6.1 \u03bcM", " Reference": "Balti, Rafik, et al. \"Three novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) using digestive proteases.\" Food Research International 43.4 (2010): 1136-1143.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1442", " Ligand_ID": "VYAP_minimized.pdb_1442", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "448.51", " logP": "-1.57", " logD": "-3.93", " logSw": "-1.11", " tPSA": "166.51", " RotatableB": "9", " RigidB": "18", " Flexibility": "0.33", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "148247.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 448.513", "link_html_complex": "/ACE_complex_html/ACE_VYAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYAP.png", "phi_psi": "/peptide_da/VYAP.pdb", "link_html_peptide": "/Peptide_html/VYAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYAP.pdb", "link_png_peptide": "/Peptide_pics/VYAP.png"}
{"Peptide_Sequence": "VYAPFE", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.055 mg/ml", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1441", " Ligand_ID": "VYAPFE_minimized.pdb_1441", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "724.8", " logP": "-2.39", " logD": "-7.07", " logSw": "-1.73", " tPSA": "264.84", " RotatableB": "18", " RigidB": "29", " Flexibility": "0.38", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "52", " CarbonAtoms": "36", " HeteroAtoms": "16", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "128641.99", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 724.801", "link_html_complex": "/ACE_complex_html/ACE_VYAPFE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYAPFE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYAPFE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYAPFE.png", "phi_psi": "/peptide_da/VYAPFE.pdb", "link_html_peptide": "/Peptide_html/VYAPFE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYAPFE.pdb", "link_png_peptide": "/Peptide_pics/VYAPFE.png"}
{"Peptide_Sequence": "VYHEL", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1443", " Ligand_ID": "VYHEL_minimized.pdb_1443", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "659.73", " logP": "-1.24", " logD": "-7.63", " logSw": "-1.98", " tPSA": "273.21", " RotatableB": "19", " RigidB": "21", " Flexibility": "0.47", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "47", " CarbonAtoms": "31", " HeteroAtoms": "16", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "90760.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 659.731", "link_html_complex": "/ACE_complex_html/ACE_VYHEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYHEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYHEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYHEL.png", "phi_psi": "/peptide_da/VYHEL.pdb", "link_html_peptide": "/Peptide_html/VYHEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYHEL.pdb", "link_png_peptide": "/Peptide_pics/VYHEL.png"}
{"Peptide_Sequence": "VYLPQ", " Origin": "Milk", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1444", " Ligand_ID": "VYLPQ_minimized.pdb_1444", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "618.72", " logP": "-3.06", " logD": "-4.39", " logSw": "-0.74", " tPSA": "238.7", " RotatableB": "16", " RigidB": "22", " Flexibility": "0.42", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "294726.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 618.722", "link_html_complex": "/ACE_complex_html/ACE_VYLPQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYLPQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYLPQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYLPQ.png", "phi_psi": "/peptide_da/VYLPQ.pdb", "link_html_peptide": "/Peptide_html/VYLPQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYLPQ.pdb", "link_png_peptide": "/Peptide_pics/VYLPQ.png"}
{"Peptide_Sequence": "VYNEGLPAP", " Origin": "red deer plasma", " Peptide_Preparation": "trypsin", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman  and  Cheung with  slight  modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "3.1 mM", " Reference": "Liu, Xiaoyan, et al. \"Identification of angiotensin I\u2010converting enzyme inhibitors in peptides mixture of hydrolyzed red deer plasma with proteomic approach.\" Chinese Journal of Chemistry 28.9 (2010): 1665-1672.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1446", " Ligand_ID": "VYNEGLPAP_minimized.pdb_1446", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O", " MW": "959.05", " logP": "-3.33", " logD": "-10.86", " logSw": "-2.07", " tPSA": "386.44", " RotatableB": "25", " RigidB": "36", " Flexibility": "0.41", " HBD": "13", " HBA": "24", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "68", " CarbonAtoms": "44", " HeteroAtoms": "24", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "120853.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 959.053", "link_html_complex": "/ACE_complex_html/ACE_VYNEGLPAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYNEGLPAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYNEGLPAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYNEGLPAP.png", "phi_psi": "/peptide_da/VYNEGLPAP.pdb", "link_html_peptide": "/Peptide_html/VYNEGLPAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYNEGLPAP.pdb", "link_png_peptide": "/Peptide_pics/VYNEGLPAP.png"}
{"Peptide_Sequence": "VYP", " Origin": "pepsin,trypsin,chymotrypsin, proteinase K, actinase E, thermolysin,and  papain", " Peptide_Preparation": "Proteinase K", " Isolation_Method": "RP-HPLC, GFC", " ACE_inhibition_assay": "  Yamamoto  et  al. 1994 ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "288 \u03bcM", " Reference": "Abubakar, Amhar, et al. \"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.\" Journal of Dairy Science 81.12 (1998): 3131-3138.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1450", " Ligand_ID": "VYP_minimized.pdb_1450", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "377.43", " logP": "-1.32", " logD": "-3", " logSw": "-0.97", " tPSA": "137.41", " RotatableB": "7", " RigidB": "16", " Flexibility": "0.3", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "143262.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 377.435", "link_html_complex": "/ACE_complex_html/ACE_VYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYP.png", "phi_psi": "/peptide_da/VYP.pdb", "link_html_peptide": "/Peptide_html/VYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYP.pdb", "link_png_peptide": "/Peptide_pics/VYP.png"}
{"Peptide_Sequence": "VYPFPG", " Origin": "pepsin,trypsin,chymotrypsin, proteinase K, actinase E, thermolysin,and  papain", " Peptide_Preparation": "Proteinase K", " Isolation_Method": "RP-HPLC, GFC", " ACE_inhibition_assay": "  Yamamoto  et  al. 1994 ", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "221 \u03bcM", " Reference": "Abubakar, Amhar, et al. \"Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.\" Journal of Dairy Science 81.12 (1998): 3131-3138.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1447", " Ligand_ID": "VYPFPG_minimized.pdb_1447", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O", " MW": "678.78", " logP": "-0.27", " logD": "-3.65", " logSw": "-3.05", " tPSA": "215.92", " RotatableB": "14", " RigidB": "33", " Flexibility": "0.3", " HBD": "7", " HBA": "14", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "49", " CarbonAtoms": "35", " HeteroAtoms": "14", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "32217.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 678.775", "link_html_complex": "/ACE_complex_html/ACE_VYPFPG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYPFPG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYPFPG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYPFPG.png", "phi_psi": "/peptide_da/VYPFPG.pdb", "link_html_peptide": "/Peptide_html/VYPFPG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYPFPG.pdb", "link_png_peptide": "/Peptide_pics/VYPFPG.png"}
{"Peptide_Sequence": "VYPFPGPI", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "299.25 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1448", " Ligand_ID": "VYPFPGPI_minimized.pdb_1448", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(O)=O", " MW": "889.05", " logP": "0.5", " logD": "-3.05", " logSw": "-4.48", " tPSA": "265.33", " RotatableB": "19", " RigidB": "42", " Flexibility": "0.31", " HBD": "8", " HBA": "18", " HBD_HBA": "26", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "46", " HeteroAtoms": "18", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10051.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 889.048", "link_html_complex": "/ACE_complex_html/ACE_VYPFPGPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYPFPGPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYPFPGPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYPFPGPI.png", "phi_psi": "/peptide_da/VYPFPGPI.pdb", "link_html_peptide": "/Peptide_html/VYPFPGPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYPFPGPI.pdb", "link_png_peptide": "/Peptide_pics/VYPFPGPI.png"}
{"Peptide_Sequence": "VYPHK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "4.59 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1449", " Ligand_ID": "VYPHK_minimized.pdb_1449", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "642.75", " logP": "-1.98", " logD": "-4.74", " logSw": "-1.54", " tPSA": "251.93", " RotatableB": "17", " RigidB": "25", " Flexibility": "0.4", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "137228.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 642.746", "link_html_complex": "/ACE_complex_html/ACE_VYPHK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYPHK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYPHK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYPHK.png", "phi_psi": "/peptide_da/VYPHK.pdb", "link_html_peptide": "/Peptide_html/VYPHK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYPHK.pdb", "link_png_peptide": "/Peptide_pics/VYPHK.png"}
{"Peptide_Sequence": "VYRT", " Origin": " dulse Palmaria palmata", " Peptide_Preparation": "pepsin, trypsin, chymptrypsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": " Cushman and Cheung\u2019s method with slight modification", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "0.14 \u03bcM", " Reference": "Furuta, Tomoe, et al. \"Angiotensin I converting enzyme inhibitory peptides derived from phycobiliproteins of dulse Palmaria palmata.\" Marine drugs 14.2 (2016): 32.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1451", " Ligand_ID": "VYRT_minimized.pdb_1451", " Smiles": "CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O", " MW": "537.61", " logP": "-3.82", " logD": "-7.16", " logSw": "0.23", " tPSA": "259.17", " RotatableB": "16", " RigidB": "14", " Flexibility": "0.53", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "677827.41", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 537.609", "link_html_complex": "/ACE_complex_html/ACE_VYRT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_VYRT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_VYRT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_VYRT.png", "phi_psi": "/peptide_da/VYRT.pdb", "link_html_peptide": "/Peptide_html/VYRT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/VYRT.pdb", "link_png_peptide": "/Peptide_pics/VYRT.png"}
{"Peptide_Sequence": "W", " Origin": "wheat germ", " Peptide_Preparation": "", " Isolation_Method": "ethanol precipitation and chromatography", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "115.20 \u03bcM", " Reference": "Yang, Runqiang, et al. \"Accumulation and identification of angiotensin-converting enzyme inhibitory peptides from wheat germ.\" Journal of agricultural and food chemistry 59.8 (2011): 3598-3605.", " Binding_Energy_kcal_per_mol": "-", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": "#", "link_html_complex": "#", "interaction_atoms": "#", "link_pdb_complex": "#", "link_png_complex": "#", "phi_psi": "#", "link_html_peptide": "#", "link_pdb_peptide": "#", "link_png_peptide": "#"}
{"Peptide_Sequence": "WA", " Origin": "Upstream chum salmon muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "277.3 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1452", " Ligand_ID": "WA_minimized.pdb_1452", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "275.3", " logP": "-1.98", " logD": "-2.15", " logSw": "-0.15", " tPSA": "112.66", " RotatableB": "5", " RigidB": "13", " Flexibility": "0.28", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "237079.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 275.303", "link_html_complex": "/ACE_complex_html/ACE_WA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WA.png", "phi_psi": "/peptide_da/WA.pdb", "link_html_peptide": "/Peptide_html/WA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WA.pdb", "link_png_peptide": "/Peptide_pics/WA.png"}
{"Peptide_Sequence": "WESLSRLLG", " Origin": " Ostrich egg white ", " Peptide_Preparation": "pepsin and pancreatin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Holmquist et al (1979)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "46.7 \u03bcg/mL.", " Reference": "Asoodeh, Ahmad, et al. \"Biochemical characterization of a novel antioxidant and angiotensin I-converting enzyme inhibitory peptide from Struthio camelus egg white protein hydrolysis.\" journal of food and drug analysis 24.2 (2016): 332-342.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1453", " Ligand_ID": "WESLSRLLG_minimized.pdb_1453", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)NCC(O)=O", " MW": "1060.2", " logP": "-3.32", " logD": "-9.78", " logSw": "-2.06", " tPSA": "460.59", " RotatableB": "35", " RigidB": "29", " Flexibility": "0.55", " HBD": "19", " HBA": "27", " HBD_HBA": "46", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "75", " CarbonAtoms": "48", " HeteroAtoms": "27", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "135739.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1060.2", "link_html_complex": "/ACE_complex_html/ACE_WESLSRLLG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WESLSRLLG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WESLSRLLG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WESLSRLLG.png", "phi_psi": "/peptide_da/WESLSRLLG.pdb", "link_html_peptide": "/Peptide_html/WESLSRLLG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WESLSRLLG.pdb", "link_png_peptide": "/Peptide_pics/WESLSRLLG.png"}
{"Peptide_Sequence": "WG", " Origin": "Poultry Protein", " Peptide_Preparation": "Gastrointestinal Digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Carmona et al (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "729", " Reference": "Anna, Torkova, et al. \"Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate.\" Current Research in Nutrition and Food Science Journal 4.Special Issue Nutrition in Conference October 2016 (2016): 77-86.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1454", " Ligand_ID": "WG_minimized.pdb_1454", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(O)=O", " MW": "261.28", " logP": "-2.07", " logD": "-2.71", " logSw": "-0.02", " tPSA": "112.66", " RotatableB": "5", " RigidB": "13", " Flexibility": "0.28", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "13", " HeteroAtoms": "6", " ratio_H_by_C": "0.46", " Lipinski_Violation": "0", " Solubility_mg_per_l": "255668.73", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.23", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 261.276", "link_html_complex": "/ACE_complex_html/ACE_WG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WG.png", "phi_psi": "/peptide_da/WG.pdb", "link_html_peptide": "/Peptide_html/WG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WG.pdb", "link_png_peptide": "/Peptide_pics/WG.png"}
{"Peptide_Sequence": "WH", " Origin": "", " Peptide_Preparation": "synrhesized", " Isolation_Method": "", " ACE_inhibition_assay": "Lieberman's method", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "93 \u03bcM", " Reference": "Suetsuna, Kunio, Keisei Maekawa, and Jiun-Rong Chen. \"Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats.\" The Journal of nutritional biochemistry 15.5 (2004): 267-272.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1457", " Ligand_ID": "WH_minimized.pdb_1457", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "341.36", " logP": "-2.29", " logD": "-2.51", " logSw": "-0.29", " tPSA": "141.34", " RotatableB": "7", " RigidB": "18", " Flexibility": "0.28", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "256143.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.24", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 341.364", "link_html_complex": "/ACE_complex_html/ACE_WH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WH.png", "phi_psi": "/peptide_da/WH.pdb", "link_html_peptide": "/Peptide_html/WH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WH.pdb", "link_png_peptide": "/Peptide_pics/WH.png"}
{"Peptide_Sequence": "WHHT", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "110", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1456", " Ligand_ID": "WHHT_minimized.pdb_1456", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "579.61", " logP": "-3.93", " logD": "-5.54", " logSw": "-0.22", " tPSA": "248.45", " RotatableB": "14", " RigidB": "27", " Flexibility": "0.34", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "27", " HeteroAtoms": "15", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "464618.88", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 579.608", "link_html_complex": "/ACE_complex_html/ACE_WHHT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WHHT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WHHT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WHHT.png", "phi_psi": "/peptide_da/WHHT.pdb", "link_html_peptide": "/Peptide_html/WHHT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WHHT.pdb", "link_png_peptide": "/Peptide_pics/WHHT.png"}
{"Peptide_Sequence": "WHHTF", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "46", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-11.1", "Serial_ID": "1455", " Ligand_ID": "WHHTF_minimized.pdb_1455", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "726.78", " logP": "-2.32", " logD": "-4.74", " logSw": "-1.89", " tPSA": "277.55", " RotatableB": "18", " RigidB": "35", " Flexibility": "0.34", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "4", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "109666.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 726.782", "link_html_complex": "/ACE_complex_html/ACE_WHHTF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WHHTF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WHHTF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WHHTF.png", "phi_psi": "/peptide_da/WHHTF.pdb", "link_html_peptide": "/Peptide_html/WHHTF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WHHTF.pdb", "link_png_peptide": "/Peptide_pics/WHHTF.png"}
{"Peptide_Sequence": "WHP", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.8 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1458", " Ligand_ID": "WHP_minimized.pdb_1458", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "438.48", " logP": "-1.47", " logD": "-3.52", " logSw": "-1.28", " tPSA": "161.65", " RotatableB": "8", " RigidB": "25", " Flexibility": "0.24", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "32", " CarbonAtoms": "22", " HeteroAtoms": "10", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "121537.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 438.48", "link_html_complex": "/ACE_complex_html/ACE_WHP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WHP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WHP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WHP.png", "phi_psi": "/peptide_da/WHP.pdb", "link_html_peptide": "/Peptide_html/WHP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WHP.pdb", "link_png_peptide": "/Peptide_pics/WHP.png"}
{"Peptide_Sequence": "WIHNENQGF", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "no activity", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1459", " Ligand_ID": "WIHNENQGF_minimized.pdb_1459", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1144.2", " logP": "-5.64", " logD": "-12.8", " logSw": "-1.3", " tPSA": "514.44", " RotatableB": "33", " RigidB": "45", " Flexibility": "0.42", " HBD": "20", " HBA": "30", " HBD_HBA": "50", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "82", " CarbonAtoms": "52", " HeteroAtoms": "30", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "311571.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1144.2", "link_html_complex": "/ACE_complex_html/ACE_WIHNENQGF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WIHNENQGF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WIHNENQGF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WIHNENQGF.png", "phi_psi": "/peptide_da/WIHNENQGF.pdb", "link_html_peptide": "/Peptide_html/WIHNENQGF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WIHNENQGF.pdb", "link_png_peptide": "/Peptide_pics/WIHNENQGF.png"}
{"Peptide_Sequence": "WIR", " Origin": "hen egg white lysozyme", " Peptide_Preparation": " simulated human gastrointestinal digestion", " Isolation_Method": "Ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "88.5", " Reference": "Rao, Shengqi, et al. \"ACE inhibitory peptides and antioxidant peptides derived from in vitro digestion hydrolysate of hen egg white lysozyme.\" Food chemistry 135.3 (2012): 1245-1252.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1460", " Ligand_ID": "WIR_minimized.pdb_1460", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "473.57", " logP": "-2.62", " logD": "-2.77", " logSw": "-0.3", " tPSA": "205.4", " RotatableB": "14", " RigidB": "16", " Flexibility": "0.47", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "351514.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.48", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.568", "link_html_complex": "/ACE_complex_html/ACE_WIR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WIR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WIR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WIR.png", "phi_psi": "/peptide_da/WIR.pdb", "link_html_peptide": "/Peptide_html/WIR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WIR.pdb", "link_png_peptide": "/Peptide_pics/WIR.png"}
{"Peptide_Sequence": "WL", " Origin": "lyzozyme", " Peptide_Preparation": "chymotrypsin and thermolysin", " Isolation_Method": "", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "10 \u03bcmol/L", " Reference": "D. Lunow, S. Kaiser, S. Br\u00fcckner, A. Gotsch and T. Henle,\n Eur. Food Res. Technol., 2013, 237, 27\u201337.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1462", " Ligand_ID": "WL_minimized.pdb_1462", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "317.38", " logP": "-0.73", " logD": "-0.89", " logSw": "-1.03", " tPSA": "112.66", " RotatableB": "7", " RigidB": "13", " Flexibility": "0.35", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "17", " HeteroAtoms": "6", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "113233.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 317.383", "link_html_complex": "/ACE_complex_html/ACE_WL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WL.png", "phi_psi": "/peptide_da/WL.pdb", "link_html_peptide": "/Peptide_html/WL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WL.pdb", "link_png_peptide": "/Peptide_pics/WL.png"}
{"Peptide_Sequence": "WLAHK", " Origin": "whey protein", " Peptide_Preparation": "pepsin, trypsine, chymotrypsin", " Isolation_Method": "reversed-phase HPLC", " ACE_inhibition_assay": "Cushman & Cheung (1971) as modi\u00c6ed by Nakamuraet al. (1995a)", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "77", " Reference": "PIHLANTO-LEPP\u00c4L\u00c4, A., KOSKINEN, P., PIILOLA, K., TUPASELA, T., & KORHONEN, H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research, 67(1), 53\u201364. doi:10.1017/s0022029999003982", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1461", " Ligand_ID": "WLAHK_minimized.pdb_1461", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "653.77", " logP": "-2.38", " logD": "-3.81", " logSw": "-1.25", " tPSA": "256.28", " RotatableB": "19", " RigidB": "24", " Flexibility": "0.44", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "32", " HeteroAtoms": "15", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "187271.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 653.772", "link_html_complex": "/ACE_complex_html/ACE_WLAHK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WLAHK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WLAHK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WLAHK.png", "phi_psi": "/peptide_da/WLAHK.pdb", "link_html_peptide": "/Peptide_html/WLAHK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WLAHK.pdb", "link_png_peptide": "/Peptide_pics/WLAHK.png"}
{"Peptide_Sequence": "WLP", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "400  \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1463", " Ligand_ID": "WLP_minimized.pdb_1463", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(O)=O", " MW": "414.5", " logP": "0.09", " logD": "-1.99", " logSw": "-2.05", " tPSA": "132.97", " RotatableB": "8", " RigidB": "20", " Flexibility": "0.29", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "22", " HeteroAtoms": "8", " ratio_H_by_C": "0.36", " Lipinski_Violation": "0", " Solubility_mg_per_l": "53382.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 414.498", "link_html_complex": "/ACE_complex_html/ACE_WLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WLP.png", "phi_psi": "/peptide_da/WLP.pdb", "link_html_peptide": "/Peptide_html/WLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WLP.pdb", "link_png_peptide": "/Peptide_pics/WLP.png"}
{"Peptide_Sequence": "WM", " Origin": "Upstream Chum Salmon ", " Peptide_Preparation": "synthesized", " Isolation_Method": "GFC, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971),", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "96.6 \u03bcM", " Reference": "Ono, S., et al. \"Food Chemistry and Toxicology-Isolation of Peptides with Angiotensin I-converting Enzyme Inhibitory Effect Derived from Hydrolysate of Upstream Chum Salmon Muscle.\" Journal of Food Science 68.5 (2003): 1611-1690.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1464", " Ligand_ID": "WM_minimized.pdb_1464", " Smiles": "CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "335.42", " logP": "-1.41", " logD": "-1.49", " logSw": "-0.65", " tPSA": "137.96", " RotatableB": "8", " RigidB": "13", " Flexibility": "0.38", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "16", " HeteroAtoms": "7", " ratio_H_by_C": "0.44", " Lipinski_Violation": "0", " Solubility_mg_per_l": "174288.48", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 335.421", "link_html_complex": "/ACE_complex_html/ACE_WM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WM.png", "phi_psi": "/peptide_da/WM.pdb", "link_html_peptide": "/Peptide_html/WM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WM.pdb", "link_png_peptide": "/Peptide_pics/WM.png"}
{"Peptide_Sequence": "WNPR", " Origin": "soya milk", " Peptide_Preparation": "bacterial protease ", " Isolation_Method": "SPE, RP-HPLC", " ACE_inhibition_assay": "Takahashi et al., 2011 with minor modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "880 \u03bcM", " Reference": "Tomatsu, Makoto, et al. \"Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk.\" Food chemistry 136.2 (2013): 612-616.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1465", " Ligand_ID": "WNPR_minimized.pdb_1465", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "571.63", " logP": "-3.83", " logD": "-5.82", " logSw": "-0.07", " tPSA": "268.8", " RotatableB": "15", " RigidB": "25", " Flexibility": "0.38", " HBD": "12", " HBA": "15", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "26", " HeteroAtoms": "15", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "534807.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 571.629", "link_html_complex": "/ACE_complex_html/ACE_WNPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WNPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WNPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WNPR.png", "phi_psi": "/peptide_da/WNPR.pdb", "link_html_peptide": "/Peptide_html/WNPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WNPR.pdb", "link_png_peptide": "/Peptide_pics/WNPR.png"}
{"Peptide_Sequence": "WPEAAELMMEVDP", " Origin": "Tuna dark muscle", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "21.6 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-5.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1517.72", "link_html_complex": "/ACE_complex_html/ACE_WPEAAELMMEVDP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WPEAAELMMEVDP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WPEAAELMMEVDP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WPEAAELMMEVDP.png", "phi_psi": "/peptide_da/WPEAAELMMEVDP.pdb", "link_html_peptide": "/Peptide_html/WPEAAELMMEVDP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WPEAAELMMEVDP.pdb", "link_png_peptide": "/Peptide_pics/WPEAAELMMEVDP.png"}
{"Peptide_Sequence": "WPERPPQIP", " Origin": "Walnut", " Peptide_Preparation": "neutral proteinase", " Isolation_Method": "UF, Consecutive chromatography, HPLC", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "25.67 \u03bcg/mL", " Reference": "Liu, Meng, et al. \"Purification and identification of an ACE inhibitory peptide from walnut protein.\" Journal of agricultural and food chemistry 61.17 (2013): 4097-4100.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1467", " Ligand_ID": "WPERPPQIP_minimized.pdb_1467", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(O)=O", " MW": "1119.27", " logP": "-3.27", " logD": "-12.62", " logSw": "-2.91", " tPSA": "428.06", " RotatableB": "28", " RigidB": "51", " Flexibility": "0.35", " HBD": "15", " HBA": "27", " HBD_HBA": "42", " Rings": "5", " MaxSizeRing": "9", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "80", " CarbonAtoms": "53", " HeteroAtoms": "27", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "60757.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1119.27", "link_html_complex": "/ACE_complex_html/ACE_WPERPPQIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WPERPPQIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WPERPPQIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WPERPPQIP.png", "phi_psi": "/peptide_da/WPERPPQIP.pdb", "link_html_peptide": "/Peptide_html/WPERPPQIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WPERPPQIP.pdb", "link_png_peptide": "/Peptide_pics/WPERPPQIP.png"}
{"Peptide_Sequence": "WQVLPNAVPAK", " Origin": "ovine milk proteins", " Peptide_Preparation": "epsin,  trypsin,  and  chymotrypsin.", " Isolation_Method": "Ultrafiltration, RP-HPLC", " ACE_inhibition_assay": "Cushman  and  Cheung  with  some  modifications.", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "10 \u03bcM", " Reference": "G\u00f3mez\u2010Ruiz, Jos\u00e9 \u00c1ngel, Mercedes Ramos, and Isidra Recio. \"Identification of novel angiotensin\u2010converting enzyme\u2010inhibitory peptides from ovine milk proteins by CE\u2010MS and chromatographic techniques.\" Electrophoresis 28.22 (2007): 4202-4211.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1468", " Ligand_ID": "WQVLPNAVPAK_minimized.pdb_1468", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "1222.44", " logP": "-2.87", " logD": "-6.84", " logSw": "-3.47", " tPSA": "470.8", " RotatableB": "33", " RigidB": "45", " Flexibility": "0.42", " HBD": "18", " HBA": "29", " HBD_HBA": "47", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "87", " CarbonAtoms": "58", " HeteroAtoms": "29", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "38022.8", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "11", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1222.44", "link_html_complex": "/ACE_complex_html/ACE_WQVLPNAVPAK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WQVLPNAVPAK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WQVLPNAVPAK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WQVLPNAVPAK.png", "phi_psi": "/peptide_da/WQVLPNAVPAK.pdb", "link_html_peptide": "/Peptide_html/WQVLPNAVPAK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WQVLPNAVPAK.pdb", "link_png_peptide": "/Peptide_pics/WQVLPNAVPAK.png"}
{"Peptide_Sequence": "WQW", " Origin": "Milk derived", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR models", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1469", " Ligand_ID": "WQW_minimized.pdb_1469", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "518.56", " logP": "-2.12", " logD": "-2.94", " logSw": "-1.12", " tPSA": "200.64", " RotatableB": "12", " RigidB": "27", " Flexibility": "0.31", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "27", " HeteroAtoms": "11", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "168625.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.26", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 518.564", "link_html_complex": "/ACE_complex_html/ACE_WQW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WQW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WQW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WQW.png", "phi_psi": "/peptide_da/WQW.pdb", "link_html_peptide": "/Peptide_html/WQW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WQW.pdb", "link_png_peptide": "/Peptide_pics/WQW.png"}
{"Peptide_Sequence": "WSKVVL", " Origin": "dried salt fish", " Peptide_Preparation": "protease digestion", " Isolation_Method": "GFC, RP-HPLC, UF", " ACE_inhibition_assay": "Cushman and Cheung (1971)", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "156.28 \u03bcM", " Reference": "Astawan, Made, et al. \"Effects of angiotensin I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats.\" Bioscience, biotechnology, and biochemistry 59.3 (1995): 425-429.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1470", " Ligand_ID": "WSKVVL_minimized.pdb_1470", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(O)=O", " MW": "730.89", " logP": "-1.92", " logD": "-6.07", " logSw": "-1.77", " tPSA": "276.93", " RotatableB": "22", " RigidB": "21", " Flexibility": "0.51", " HBD": "12", " HBA": "16", " HBD_HBA": "28", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "52", " CarbonAtoms": "36", " HeteroAtoms": "16", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "124434.28", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 730.895", "link_html_complex": "/ACE_complex_html/ACE_WSKVVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WSKVVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WSKVVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WSKVVL.png", "phi_psi": "/peptide_da/WSKVVL.pdb", "link_html_peptide": "/Peptide_html/WSKVVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WSKVVL.pdb", "link_png_peptide": "/Peptide_pics/WSKVVL.png"}
{"Peptide_Sequence": "WSVPQPK", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "21 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1471", " Ligand_ID": "WSVPQPK_minimized.pdb_1471", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "840.97", " logP": "-3.68", " logD": "-6.43", " logSw": "-1.34", " tPSA": "331.54", " RotatableB": "22", " RigidB": "35", " Flexibility": "0.39", " HBD": "13", " HBA": "20", " HBD_HBA": "33", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "60", " CarbonAtoms": "40", " HeteroAtoms": "20", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "220404.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 840.965", "link_html_complex": "/ACE_complex_html/ACE_WSVPQPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WSVPQPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WSVPQPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WSVPQPK.png", "phi_psi": "/peptide_da/WSVPQPK.pdb", "link_html_peptide": "/Peptide_html/WSVPQPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WSVPQPK.pdb", "link_png_peptide": "/Peptide_pics/WSVPQPK.png"}
{"Peptide_Sequence": "WT", " Origin": "", " Peptide_Preparation": "Chemically Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": " Sentandreu and Toldr\u00e1 (2006) with some modifications", " In-vivo_or_in-vitro": "in-silico, in-sitro", " IC50_micromol_per_L": "217 \u03bcM", " Reference": "Norris, Roseanne, et al. \"Predictive modelling of angiotensin converting enzyme inhibitory dipeptides.\" Food Chemistry 133.4 (2012): 1349-1354.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1473", " Ligand_ID": "WT_minimized.pdb_1473", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "305.33", " logP": "-2.6", " logD": "-2.78", " logSw": "0.14", " tPSA": "132.89", " RotatableB": "6", " RigidB": "13", " Flexibility": "0.32", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "15", " HeteroAtoms": "7", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "350692.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 305.329", "link_html_complex": "/ACE_complex_html/ACE_WT.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WT.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WT.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WT.png", "phi_psi": "/peptide_da/WT.pdb", "link_html_peptide": "/Peptide_html/WT.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WT.pdb", "link_png_peptide": "/Peptide_pics/WT.png"}
{"Peptide_Sequence": "WTFR", " Origin": "Neo-fermented buckwheat sprouts", " Peptide_Preparation": "", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": " in vitro, in vivo", " IC50_micromol_per_L": "6700 \u03bcM", " Reference": "Koyama, Masahiro, et al. \"Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: A new approach to estimating ACE-inhibitory activity.\" PloS one 9.9 (2014): e105802.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "1472", " Ligand_ID": "WTFR_minimized.pdb_1472", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "608.69", " logP": "-2.69", " logD": "-3.61", " logSw": "-0.93", " tPSA": "254.73", " RotatableB": "17", " RigidB": "24", " Flexibility": "0.41", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "240325.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.37", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 608.689", "link_html_complex": "/ACE_complex_html/ACE_WTFR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WTFR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WTFR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WTFR.png", "phi_psi": "/peptide_da/WTFR.pdb", "link_html_peptide": "/Peptide_html/WTFR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WTFR.pdb", "link_png_peptide": "/Peptide_pics/WTFR.png"}
{"Peptide_Sequence": "WV", " Origin": "lyzozyme", " Peptide_Preparation": "chymotrypsin and thermolysin", " Isolation_Method": "", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "500 \u03bcmol/L", " Reference": "D. Lunow, S. Kaiser, S. Br\u00fcckner, A. Gotsch and T. Henle,\n Eur. Food Res. Technol., 2013, 237, 27\u201337.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1474", " Ligand_ID": "WV_minimized.pdb_1474", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "303.36", " logP": "-1.02", " logD": "-1.26", " logSw": "-0.84", " tPSA": "112.66", " RotatableB": "6", " RigidB": "13", " Flexibility": "0.32", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "16", " HeteroAtoms": "6", " ratio_H_by_C": "0.38", " Lipinski_Violation": "0", " Solubility_mg_per_l": "131343.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 303.356", "link_html_complex": "/ACE_complex_html/ACE_WV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WV.png", "phi_psi": "/peptide_da/WV.pdb", "link_html_peptide": "/Peptide_html/WV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WV.pdb", "link_png_peptide": "/Peptide_pics/WV.png"}
{"Peptide_Sequence": "WVPSV", " Origin": "porcine hemoglobin", " Peptide_Preparation": " enzymatic  hydrolysis  and  absorption  method (Ren et al., 2010)", " Isolation_Method": "UF, GFC, RP-HPLC", " ACE_inhibition_assay": "Matsui  et  al.  1992", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "0.368 mg/ml", " Reference": "Ren, Yan, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitor peptides derived from porcine hemoglobin.\" Scientific Research and Essays 6.30 (2011): 6262-6269.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1475", " Ligand_ID": "WVPSV_minimized.pdb_1475", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(O)=O", " MW": "586.68", " logP": "-0.86", " logD": "-3.83", " logSw": "-2.16", " tPSA": "211.4", " RotatableB": "13", " RigidB": "24", " Flexibility": "0.35", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "29", " HeteroAtoms": "13", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67868.96", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 586.68", "link_html_complex": "/ACE_complex_html/ACE_WVPSV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WVPSV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WVPSV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WVPSV.png", "phi_psi": "/peptide_da/WVPSV.pdb", "link_html_peptide": "/Peptide_html/WVPSV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WVPSV.pdb", "link_png_peptide": "/Peptide_pics/WVPSV.png"}
{"Peptide_Sequence": "WVPSVY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "25.7 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.1", "Serial_ID": "1476", " Ligand_ID": "WVPSVY_minimized.pdb_1476", " Smiles": "CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "749.85", " logP": "-0.48", " logD": "-3.01", " logSw": "-3.17", " tPSA": "260.73", " RotatableB": "17", " RigidB": "32", " Flexibility": "0.35", " HBD": "10", " HBA": "16", " HBD_HBA": "26", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "38", " HeteroAtoms": "16", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "31483.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 749.853", "link_html_complex": "/ACE_complex_html/ACE_WVPSVY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WVPSVY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WVPSVY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WVPSVY.png", "phi_psi": "/peptide_da/WVPSVY.pdb", "link_html_peptide": "/Peptide_html/WVPSVY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WVPSVY.pdb", "link_png_peptide": "/Peptide_pics/WVPSVY.png"}
{"Peptide_Sequence": "WW", " Origin": "lyzozyme", " Peptide_Preparation": "chymotrypsin and thermolysin", " Isolation_Method": "", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "68 \u03bcmol/L", " Reference": "D. Lunow, S. Kaiser, S. Br\u00fcckner, A. Gotsch and T. Henle,\n Eur. Food Res. Technol., 2013, 237, 27\u201337.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1477", " Ligand_ID": "WW_minimized.pdb_1477", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "390.44", " logP": "-0.27", " logD": "-0.39", " logSw": "-1.89", " tPSA": "128.45", " RotatableB": "7", " RigidB": "23", " Flexibility": "0.23", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "22", " HeteroAtoms": "7", " ratio_H_by_C": "0.32", " Lipinski_Violation": "1", " Solubility_mg_per_l": "58997.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.18", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 390.435", "link_html_complex": "/ACE_complex_html/ACE_WW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WW.png", "phi_psi": "/peptide_da/WW.pdb", "link_html_peptide": "/Peptide_html/WW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WW.pdb", "link_png_peptide": "/Peptide_pics/WW.png"}
{"Peptide_Sequence": "WY", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "38.3  \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1478", " Ligand_ID": "WY_minimized.pdb_1478", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "367.4", " logP": "-1.13", " logD": "-0.8", " logSw": "-1.18", " tPSA": "132.89", " RotatableB": "7", " RigidB": "19", " Flexibility": "0.27", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "20", " HeteroAtoms": "7", " ratio_H_by_C": "0.35", " Lipinski_Violation": "1", " Solubility_mg_per_l": "113434.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.2", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 367.398", "link_html_complex": "/ACE_complex_html/ACE_WY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WY.png", "phi_psi": "/peptide_da/WY.pdb", "link_html_peptide": "/Peptide_html/WY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WY.pdb", "link_png_peptide": "/Peptide_pics/WY.png"}
{"Peptide_Sequence": "WYS", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": ">500   \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1483", " Ligand_ID": "WYS_minimized.pdb_1483", " Smiles": "N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(O)=O", " MW": "454.48", " logP": "-2.43", " logD": "-3.3", " logSw": "-0.65", " tPSA": "182.22", " RotatableB": "10", " RigidB": "21", " Flexibility": "0.32", " HBD": "8", " HBA": "10", " HBD_HBA": "18", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "23", " HeteroAtoms": "10", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "236077.31", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.26", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 454.476", "link_html_complex": "/ACE_complex_html/ACE_WYS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WYS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WYS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WYS.png", "phi_psi": "/peptide_da/WYS.pdb", "link_html_peptide": "/Peptide_html/WYS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WYS.pdb", "link_png_peptide": "/Peptide_pics/WYS.png"}
{"Peptide_Sequence": "WYSL", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "90.4   \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1482", " Ligand_ID": "WYSL_minimized.pdb_1482", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "567.63", " logP": "-1.47", " logD": "-2.68", " logSw": "-1.65", " tPSA": "211.32", " RotatableB": "14", " RigidB": "23", " Flexibility": "0.38", " HBD": "9", " HBA": "12", " HBD_HBA": "21", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "41", " CarbonAtoms": "29", " HeteroAtoms": "12", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "108846.77", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 567.633", "link_html_complex": "/ACE_complex_html/ACE_WYSL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WYSL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WYSL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WYSL.png", "phi_psi": "/peptide_da/WYSL.pdb", "link_html_peptide": "/Peptide_html/WYSL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WYSL.pdb", "link_png_peptide": "/Peptide_pics/WYSL.png"}
{"Peptide_Sequence": "WYSLA", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "86.9   \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "1480", " Ligand_ID": "WYSLA_minimized.pdb_1480", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O", " MW": "638.71", " logP": "-1.73", " logD": "-3.21", " logSw": "-1.78", " tPSA": "240.42", " RotatableB": "16", " RigidB": "25", " Flexibility": "0.39", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "46", " CarbonAtoms": "32", " HeteroAtoms": "14", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "107684.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 638.711", "link_html_complex": "/ACE_complex_html/ACE_WYSLA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WYSLA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WYSLA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WYSLA.png", "phi_psi": "/peptide_da/WYSLA.pdb", "link_html_peptide": "/Peptide_html/WYSLA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WYSLA.pdb", "link_png_peptide": "/Peptide_pics/WYSLA.png"}
{"Peptide_Sequence": "WYSLAM", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "56.3   \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1481", " Ligand_ID": "WYSLAM_minimized.pdb_1481", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(O)=O", " MW": "769.91", " logP": "-1.34", " logD": "-3.11", " logSw": "-2.49", " tPSA": "294.82", " RotatableB": "21", " RigidB": "27", " Flexibility": "0.44", " HBD": "11", " HBA": "16", " HBD_HBA": "27", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "54", " CarbonAtoms": "37", " HeteroAtoms": "17", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "63900.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 769.907", "link_html_complex": "/ACE_complex_html/ACE_WYSLAM.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WYSLAM.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WYSLAM.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WYSLAM.png", "phi_psi": "/peptide_da/WYSLAM.pdb", "link_html_peptide": "/Peptide_html/WYSLAM.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WYSLAM.pdb", "link_png_peptide": "/Peptide_pics/WYSLAM.png"}
{"Peptide_Sequence": "WYSLAMA", " Origin": "\u03b2-Lactoglobulin", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC-MS/MS", " ACE_inhibition_assay": "Cushman and Cheung, with some modifications", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "59.9  \u03bcM", " Reference": "Hern\u00e1ndez-Ledesma, Blanca, et al. \"ACE-inhibitory and radical-scavenging activity of peptides derived from \u03b2-lactoglobulin f (19\u2212 25). Interactions with ascorbic acid.\" Journal of agricultural and food chemistry 55.9 (2007): 3392-3397.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1479", " Ligand_ID": "WYSLAMA_minimized.pdb_1479", " Smiles": "CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(O)=O", " MW": "840.99", " logP": "-1.59", " logD": "-3.61", " logSw": "-2.63", " tPSA": "323.92", " RotatableB": "23", " RigidB": "29", " Flexibility": "0.44", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "59", " CarbonAtoms": "40", " HeteroAtoms": "19", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "60560.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 840.985", "link_html_complex": "/ACE_complex_html/ACE_WYSLAMA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_WYSLAMA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_WYSLAMA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_WYSLAMA.png", "phi_psi": "/peptide_da/WYSLAMA.pdb", "link_html_peptide": "/Peptide_html/WYSLAMA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/WYSLAMA.pdb", "link_png_peptide": "/Peptide_pics/WYSLAMA.png"}
{"Peptide_Sequence": "YA", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "460 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1490", " Ligand_ID": "YA_minimized.pdb_1490", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "252.27", " logP": "-3.07", " logD": "-2.54", " logSw": "0.73", " tPSA": "117.1", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "18", " CarbonAtoms": "12", " HeteroAtoms": "6", " ratio_H_by_C": "0.5", " Lipinski_Violation": "0", " Solubility_mg_per_l": "523190.51", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 252.266", "link_html_complex": "/ACE_complex_html/ACE_YA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YA.png", "phi_psi": "/peptide_da/YA.pdb", "link_html_peptide": "/Peptide_html/YA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YA.pdb", "link_png_peptide": "/Peptide_pics/YA.png"}
{"Peptide_Sequence": "YAEER", " Origin": "synthetic", " Peptide_Preparation": "simulated gastrointestinal digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000 \u03bcg/mL", " Reference": "Miguel, M., et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin.\" Journal of Agricultural and Food Chemistry 54.3 (2006): 726-731.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1484", " Ligand_ID": "YAEER_minimized.pdb_1484", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "666.68", " logP": "-4.62", " logD": "-12.48", " logSw": "0.34", " tPSA": "348.3", " RotatableB": "22", " RigidB": "18", " Flexibility": "0.55", " HBD": "14", " HBA": "19", " HBD_HBA": "33", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "47", " CarbonAtoms": "28", " HeteroAtoms": "19", " ratio_H_by_C": "0.68", " Lipinski_Violation": "3", " Solubility_mg_per_l": "935991.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 666.68", "link_html_complex": "/ACE_complex_html/ACE_YAEER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YAEER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YAEER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YAEER.png", "phi_psi": "/peptide_da/YAEER.pdb", "link_html_peptide": "/Peptide_html/YAEER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YAEER.pdb", "link_png_peptide": "/Peptide_pics/YAEER.png"}
{"Peptide_Sequence": "YAEERYPIL", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.7", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1485", " Ligand_ID": "YAEERYPIL_minimized.pdb_1485", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "1153.28", " logP": "-1.46", " logD": "-13.76", " logSw": "-3.82", " tPSA": "476.14", " RotatableB": "35", " RigidB": "37", " Flexibility": "0.49", " HBD": "18", " HBA": "28", " HBD_HBA": "46", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "-1", " HeavyAtoms": "82", " CarbonAtoms": "54", " HeteroAtoms": "28", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "25406.23", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1153.28", "link_html_complex": "/ACE_complex_html/ACE_YAEERYPIL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YAEERYPIL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YAEERYPIL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YAEERYPIL.png", "phi_psi": "/peptide_da/YAEERYPIL.pdb", "link_html_peptide": "/Peptide_html/YAEERYPIL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YAEERYPIL.pdb", "link_png_peptide": "/Peptide_pics/YAEERYPIL.png"}
{"Peptide_Sequence": "YAKP", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1487", " Ligand_ID": "YAKP_minimized.pdb_1487", " Smiles": "C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(O)=O", " MW": "477.55", " logP": "-4.15", " logD": "-5.84", " logSw": "0.54", " tPSA": "194.15", " RotatableB": "12", " RigidB": "18", " Flexibility": "0.4", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "820566.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 477.554", "link_html_complex": "/ACE_complex_html/ACE_YAKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YAKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YAKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YAKP.png", "phi_psi": "/peptide_da/YAKP.pdb", "link_html_peptide": "/Peptide_html/YAKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YAKP.pdb", "link_png_peptide": "/Peptide_pics/YAKP.png"}
{"Peptide_Sequence": "YAKPA", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1486", " Ligand_ID": "YAKPA_minimized.pdb_1486", " Smiles": "C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "548.63", " logP": "-4.22", " logD": "-7.75", " logSw": "0.28", " tPSA": "223.25", " RotatableB": "14", " RigidB": "20", " Flexibility": "0.41", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "39", " CarbonAtoms": "26", " HeteroAtoms": "13", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "729462.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.58", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 548.632", "link_html_complex": "/ACE_complex_html/ACE_YAKPA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YAKPA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YAKPA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YAKPA.png", "phi_psi": "/peptide_da/YAKPA.pdb", "link_html_peptide": "/Peptide_html/YAKPA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YAKPA.pdb", "link_png_peptide": "/Peptide_pics/YAKPA.png"}
{"Peptide_Sequence": "YAKPVA", " Origin": "milk-casein-derived", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "647  \u03bcM", " Reference": "Miguel, Marta, et al. \"Changes in arterial blood pressure after single oral administration of milk\u2010casein\u2010derived peptides in spontaneously hypertensive rats.\" Molecular nutrition & food research 54.10 (2010): 1422-1427.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1488", " Ligand_ID": "YAKPVA_minimized.pdb_1488", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(O)=O", " MW": "647.76", " logP": "-3.7", " logD": "-7.39", " logSw": "-0.45", " tPSA": "252.35", " RotatableB": "17", " RigidB": "22", " Flexibility": "0.44", " HBD": "10", " HBA": "15", " HBD_HBA": "25", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "31", " HeteroAtoms": "15", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "413086.95", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 647.763", "link_html_complex": "/ACE_complex_html/ACE_YAKPVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YAKPVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YAKPVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YAKPVA.png", "phi_psi": "/peptide_da/YAKPVA.pdb", "link_html_peptide": "/Peptide_html/YAKPVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YAKPVA.pdb", "link_png_peptide": "/Peptide_pics/YAKPVA.png"}
{"Peptide_Sequence": "YALPHA", " Origin": "Mantle Muscle", " Peptide_Preparation": "autolysate", " Isolation_Method": "RT-HPLC", " ACE_inhibition_assay": "Ukeda et al.", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "9.8", " Reference": "Wako Y, Ishikawa S, Muramoto K. Angiotensin I\u2013converting enzyme inhibitors in autolysates of liver and mantle muscle. Biosci Biotech Biochem 1996;60:1353\u20135.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1489", " Ligand_ID": "YALPHA_minimized.pdb_1489", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(O)=O", " MW": "670.76", " logP": "-1.64", " logD": "-4.43", " logSw": "-2", " tPSA": "253.39", " RotatableB": "16", " RigidB": "27", " Flexibility": "0.37", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "91133.04", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 670.756", "link_html_complex": "/ACE_complex_html/ACE_YALPHA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YALPHA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YALPHA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YALPHA.png", "phi_psi": "/peptide_da/YALPHA.pdb", "link_html_peptide": "/Peptide_html/YALPHA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YALPHA.pdb", "link_png_peptide": "/Peptide_pics/YALPHA.png"}
{"Peptide_Sequence": "YANPAVVRP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "7.8", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-10.6", "Serial_ID": "1491", " Ligand_ID": "YANPAVVRP_minimized.pdb_1491", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "986.13", " logP": "-3.59", " logD": "-8.85", " logSw": "-2.01", " tPSA": "409.95", " RotatableB": "26", " RigidB": "36", " Flexibility": "0.42", " HBD": "16", " HBA": "25", " HBD_HBA": "41", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "70", " CarbonAtoms": "45", " HeteroAtoms": "25", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "132425.21", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 986.125", "link_html_complex": "/ACE_complex_html/ACE_YANPAVVRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YANPAVVRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YANPAVVRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YANPAVVRP.png", "phi_psi": "/peptide_da/YANPAVVRP.pdb", "link_html_peptide": "/Peptide_html/YANPAVVRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YANPAVVRP.pdb", "link_png_peptide": "/Peptide_pics/YANPAVVRP.png"}
{"Peptide_Sequence": "YE", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-7.1", "Serial_ID": "1492", " Ligand_ID": "YE_minimized.pdb_1492", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "310.3", " logP": "-3.58", " logD": "-6.13", " logSw": "0.91", " tPSA": "157.23", " RotatableB": "8", " RigidB": "10", " Flexibility": "0.44", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "1", " Solubility_mg_per_l": "769754.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 310.303", "link_html_complex": "/ACE_complex_html/ACE_YE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YE.png", "phi_psi": "/peptide_da/YE.pdb", "link_html_peptide": "/Peptide_html/YE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YE.pdb", "link_png_peptide": "/Peptide_pics/YE.png"}
{"Peptide_Sequence": "YEY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1493", " Ligand_ID": "YEY_minimized.pdb_1493", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "473.48", " logP": "-3.21", " logD": "-6.07", " logSw": "-0.11", " tPSA": "206.56", " RotatableB": "12", " RigidB": "18", " Flexibility": "0.4", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "425505.19", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.3", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 473.476", "link_html_complex": "/ACE_complex_html/ACE_YEY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YEY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YEY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YEY.png", "phi_psi": "/peptide_da/YEY.pdb", "link_html_peptide": "/Peptide_html/YEY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YEY.pdb", "link_png_peptide": "/Peptide_pics/YEY.png"}
{"Peptide_Sequence": "YFYPEL", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1494", " Ligand_ID": "YFYPEL_minimized.pdb_1494", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "830.92", " logP": "-0.6", " logD": "-4.93", " logSw": "-3.34", " tPSA": "285.07", " RotatableB": "21", " RigidB": "35", " Flexibility": "0.38", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "60", " CarbonAtoms": "43", " HeteroAtoms": "17", " ratio_H_by_C": "0.4", " Lipinski_Violation": "3", " Solubility_mg_per_l": "29311.36", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.42", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 830.923", "link_html_complex": "/ACE_complex_html/ACE_YFYPEL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YFYPEL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YFYPEL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YFYPEL.png", "phi_psi": "/peptide_da/YFYPEL.pdb", "link_html_peptide": "/Peptide_html/YFYPEL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YFYPEL.pdb", "link_png_peptide": "/Peptide_pics/YFYPEL.png"}
{"Peptide_Sequence": "YG", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2000 \u03bcM", " Reference": "Cheung, Hong-Son, et al. \"Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.\" Journal of Biological Chemistry 255.2 (1980): 401-407.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1503", " Ligand_ID": "YG_minimized.pdb_1503", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O", " MW": "238.24", " logP": "-2.86", " logD": "-3.11", " logSw": "0.67", " tPSA": "117.1", " RotatableB": "5", " RigidB": "9", " Flexibility": "0.36", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "17", " CarbonAtoms": "11", " HeteroAtoms": "6", " ratio_H_by_C": "0.55", " Lipinski_Violation": "0", " Solubility_mg_per_l": "466270.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 238.24", "link_html_complex": "/ACE_complex_html/ACE_YG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YG.png", "phi_psi": "/peptide_da/YG.pdb", "link_html_peptide": "/Peptide_html/YG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YG.pdb", "link_png_peptide": "/Peptide_pics/YG.png"}
{"Peptide_Sequence": "YGAP", " Origin": "", " Peptide_Preparation": "synthesized", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung modified by Hern\u03bcndez-Ledesmaet al", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "17.4 \u03bcM", " Reference": "Jing, Tao, et al. \"Rational design of angiotensin\u2010I\u2010converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.\" ChemMedChem 8.7 (2013): 1057-1066.", " Binding_Energy_kcal_per_mol": "-9.8", "Serial_ID": "1495", " Ligand_ID": "YGAP_minimized.pdb_1495", " Smiles": "C[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "406.43", " logP": "-2.94", " logD": "-5.01", " logSw": "-0.06", " tPSA": "166.51", " RotatableB": "8", " RigidB": "18", " Flexibility": "0.31", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "29", " CarbonAtoms": "19", " HeteroAtoms": "10", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "382606.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.433", "link_html_complex": "/ACE_complex_html/ACE_YGAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGAP.png", "phi_psi": "/peptide_da/YGAP.pdb", "link_html_peptide": "/Peptide_html/YGAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGAP.pdb", "link_png_peptide": "/Peptide_pics/YGAP.png"}
{"Peptide_Sequence": "YGFLP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "260", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-11", "Serial_ID": "1496", " Ligand_ID": "YGFLP_minimized.pdb_1496", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "595.69", " logP": "-1.65", " logD": "-2.58", " logSw": "-1.68", " tPSA": "195.61", " RotatableB": "14", " RigidB": "26", " Flexibility": "0.35", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "43", " CarbonAtoms": "31", " HeteroAtoms": "12", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "111524.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 595.687", "link_html_complex": "/ACE_complex_html/ACE_YGFLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGFLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGFLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGFLP.png", "phi_psi": "/peptide_da/YGFLP.pdb", "link_html_peptide": "/Peptide_html/YGFLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGFLP.pdb", "link_png_peptide": "/Peptide_pics/YGFLP.png"}
{"Peptide_Sequence": "YGG", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "3.4", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-7.7", "Serial_ID": "1497", " Ligand_ID": "YGG_minimized.pdb_1497", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(O)=O", " MW": "295.29", " logP": "-3.51", " logD": "-5.15", " logSw": "0.89", " tPSA": "146.2", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "715952.98", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "1", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 295.291", "link_html_complex": "/ACE_complex_html/ACE_YGG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGG.png", "phi_psi": "/peptide_da/YGG.pdb", "link_html_peptide": "/Peptide_html/YGG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGG.pdb", "link_png_peptide": "/Peptide_pics/YGG.png"}
{"Peptide_Sequence": "YGGVSLPEW", " Origin": "Alpha-Lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "SEC, RP-HPLC, LC-MS/MS", " ACE_inhibition_assay": "Shalaby et al. (2006)", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "16 \u03bcM", " Reference": "Hernandez-Ledesma, Blanca, and Chia-Chien Hsieh. Bioactive food peptides in health and disease. 2013.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1498", " Ligand_ID": "YGGVSLPEW_minimized.pdb_1498", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "1007.1", " logP": "-2.2", " logD": "-9.02", " logSw": "-3", " tPSA": "388.16", " RotatableB": "27", " RigidB": "39", " Flexibility": "0.41", " HBD": "14", " HBA": "24", " HBD_HBA": "38", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "72", " CarbonAtoms": "48", " HeteroAtoms": "24", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "50319.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1007.1", "link_html_complex": "/ACE_complex_html/ACE_YGGVSLPEW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGGVSLPEW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGGVSLPEW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGGVSLPEW.png", "phi_psi": "/peptide_da/YGGVSLPEW.pdb", "link_html_peptide": "/Peptide_html/YGGVSLPEW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGGVSLPEW.pdb", "link_png_peptide": "/Peptide_pics/YGGVSLPEW.png"}
{"Peptide_Sequence": "YGGY", " Origin": "Sake", " Peptide_Preparation": "Solid Phase Peptide Synthesis with peptide synthesizer", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and cheung method", " In-vivo_or_in-vitro": "In-vivo, In-vitro", " IC50_micromol_per_L": "16.2", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371. ", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1499", " Ligand_ID": "YGGY_minimized.pdb_1499", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "458.46", " logP": "-2.22", " logD": "-4.55", " logSw": "-0.71", " tPSA": "195.53", " RotatableB": "11", " RigidB": "19", " Flexibility": "0.37", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "33", " CarbonAtoms": "22", " HeteroAtoms": "11", " ratio_H_by_C": "0.5", " Lipinski_Violation": "2", " Solubility_mg_per_l": "225765.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 458.464", "link_html_complex": "/ACE_complex_html/ACE_YGGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGGY.png", "phi_psi": "/peptide_da/YGGY.pdb", "link_html_peptide": "/Peptide_html/YGGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGGY.pdb", "link_png_peptide": "/Peptide_pics/YGGY.png"}
{"Peptide_Sequence": "YGL", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "409 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1501", " Ligand_ID": "YGL_minimized.pdb_1501", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "351.4", " logP": "-2.4", " logD": "-3.27", " logSw": "0", " tPSA": "146.2", " RotatableB": "9", " RigidB": "11", " Flexibility": "0.45", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "350883.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 351.397", "link_html_complex": "/ACE_complex_html/ACE_YGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGL.png", "phi_psi": "/peptide_da/YGL.pdb", "link_html_peptide": "/Peptide_html/YGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGL.pdb", "link_png_peptide": "/Peptide_pics/YGL.png"}
{"Peptide_Sequence": "YGLF", " Origin": "Alpha-lactalbumin and alpha-lactoglobulin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "(Chiba and Yoshikawa,  1991", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "171.8 \u03bcM", " Reference": "Mullally, Margaret M., Hans Meisel, and Richard J. FitzGerald. \"Synthetic peptides corresponding to a-lactalbumin and b-lactoglobulin sequences with angiotensin-1-converting enzyme inhibitory activity.\" Biological Chemistry-Hoppe Seyler 377.4 (1996): 259-260.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1500", " Ligand_ID": "YGLF_minimized.pdb_1500", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "498.57", " logP": "-0.15", " logD": "-2.28", " logSw": "-2.11", " tPSA": "175.3", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "26", " HeteroAtoms": "10", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "60718.42", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 498.571", "link_html_complex": "/ACE_complex_html/ACE_YGLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGLF.png", "phi_psi": "/peptide_da/YGLF.pdb", "link_html_peptide": "/Peptide_html/YGLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGLF.pdb", "link_png_peptide": "/Peptide_pics/YGLF.png"}
{"Peptide_Sequence": "YGLYP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "260", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1502", " Ligand_ID": "YGLYP_minimized.pdb_1502", " Smiles": "CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "611.69", " logP": "-2.01", " logD": "-2.97", " logSw": "-1.55", " tPSA": "215.84", " RotatableB": "14", " RigidB": "26", " Flexibility": "0.35", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "31", " HeteroAtoms": "13", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "130268.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 611.686", "link_html_complex": "/ACE_complex_html/ACE_YGLYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YGLYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YGLYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YGLYP.png", "phi_psi": "/peptide_da/YGLYP.pdb", "link_html_peptide": "/Peptide_html/YGLYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YGLYP.pdb", "link_png_peptide": "/Peptide_pics/YGLYP.png"}
{"Peptide_Sequence": "YH", " Origin": "Wakame (Undaria pinnatifida)", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "43.7 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1504", " Ligand_ID": "YH_minimized.pdb_1504", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O", " MW": "318.33", " logP": "-3.5", " logD": "-2.92", " logSw": "0.65", " tPSA": "145.78", " RotatableB": "7", " RigidB": "14", " Flexibility": "0.33", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "23", " CarbonAtoms": "15", " HeteroAtoms": "8", " ratio_H_by_C": "0.53", " Lipinski_Violation": "1", " Solubility_mg_per_l": "612722.82", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.27", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 318.328", "link_html_complex": "/ACE_complex_html/ACE_YH.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YH.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YH.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YH.png", "phi_psi": "/peptide_da/YH.pdb", "link_html_peptide": "/Peptide_html/YH.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YH.pdb", "link_png_peptide": "/Peptide_pics/YH.png"}
{"Peptide_Sequence": "YIEAVNKVSPRAGQF", " Origin": "egg yolk", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Miguel et al. (2004)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "9.4 \u03bcg/ml", " Reference": "Zambrowicz, Aleksandra, et al. \"Multifunctional peptides derived from an egg yolk protein hydrolysate: isolation and characterization.\" Amino acids 47.2 (2015): 369-380.", " Binding_Energy_kcal_per_mol": "-4.4", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1678.89", "link_html_complex": "/ACE_complex_html/ACE_YIEAVNKVSPRAGQF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YIEAVNKVSPRAGQF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YIEAVNKVSPRAGQF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YIEAVNKVSPRAGQF.png", "phi_psi": "/peptide_da/YIEAVNKVSPRAGQF.pdb", "link_html_peptide": "/Peptide_html/YIEAVNKVSPRAGQF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YIEAVNKVSPRAGQF.pdb", "link_png_peptide": "/Peptide_pics/YIEAVNKVSPRAGQF.png"}
{"Peptide_Sequence": "YINQMPQKSRE", " Origin": "egg yolk", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Miguel et al. (2004)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "10.1 \u03bcg/ml", " Reference": "Zambrowicz, Aleksandra, et al. \"Multifunctional peptides derived from an egg yolk protein hydrolysate: isolation and characterization.\" Amino acids 47.2 (2015): 369-380.", " Binding_Energy_kcal_per_mol": "-7.3", "Serial_ID": "1507", " Ligand_ID": "YINQMPQKSRE_minimized.pdb_1507", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "1393.57", " logP": "-10.78", " logD": "-19.18", " logSw": "1.32", " tPSA": "676.42", " RotatableB": "46", " RigidB": "40", " Flexibility": "0.53", " HBD": "27", " HBA": "37", " HBD_HBA": "64", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "97", " CarbonAtoms": "59", " HeteroAtoms": "38", " ratio_H_by_C": "0.64", " Lipinski_Violation": "3", " Solubility_mg_per_l": "5239059.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1393.57", "link_html_complex": "/ACE_complex_html/ACE_YINQMPQKSRE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YINQMPQKSRE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YINQMPQKSRE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YINQMPQKSRE.png", "phi_psi": "/peptide_da/YINQMPQKSRE.pdb", "link_html_peptide": "/Peptide_html/YINQMPQKSRE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YINQMPQKSRE.pdb", "link_png_peptide": "/Peptide_pics/YINQMPQKSRE.png"}
{"Peptide_Sequence": "YINQMPQKSREA", " Origin": "egg yolk", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Miguel et al. (2004)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "12.6 \u03bcg/ml", " Reference": "Zambrowicz, Aleksandra, et al. \"Multifunctional peptides derived from an egg yolk protein hydrolysate: isolation and characterization.\" Amino acids 47.2 (2015): 369-380.", " Binding_Energy_kcal_per_mol": "-7", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1464.65", "link_html_complex": "/ACE_complex_html/ACE_YINQMPQKSREA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YINQMPQKSREA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YINQMPQKSREA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YINQMPQKSREA.png", "phi_psi": "/peptide_da/YINQMPQKSREA.pdb", "link_html_peptide": "/Peptide_html/YINQMPQKSREA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YINQMPQKSREA.pdb", "link_png_peptide": "/Peptide_pics/YINQMPQKSREA.png"}
{"Peptide_Sequence": "YIPIQY", " Origin": "Bovine \u03ba-casein", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) and modified as described by Meisel and Pentzien (2008).", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "132.5  \u03bcM", " Reference": "Short communication: Bovine \u03ba-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides C. Weimann,*1 H. Meisel,\u2020 and G. Erhardt* *Institute of Animal Breeding and Genetics, Ludwigstr. 21B, D-35390 Giessen, Germany \u2020Max Rubner-Institute (MRI), Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, PO Box 6069, D-24121 Kiel, Germany", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1508", " Ligand_ID": "YIPIQY_minimized.pdb_1508", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "795.92", " logP": "-1.72", " logD": "-2.72", " logSw": "-2.38", " tPSA": "288.03", " RotatableB": "21", " RigidB": "30", " Flexibility": "0.41", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "73441.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 795.921", "link_html_complex": "/ACE_complex_html/ACE_YIPIQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YIPIQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YIPIQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YIPIQY.png", "phi_psi": "/peptide_da/YIPIQY.pdb", "link_html_peptide": "/Peptide_html/YIPIQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YIPIQY.pdb", "link_png_peptide": "/Peptide_pics/YIPIQY.png"}
{"Peptide_Sequence": "YIPIQYVLSR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "174.5 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1509", " Ligand_ID": "YIPIQYVLSR_minimized.pdb_1509", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1251.47", " logP": "-0.61", " logD": "-4.09", " logSw": "-4.76", " tPSA": "488.3", " RotatableB": "38", " RigidB": "39", " Flexibility": "0.49", " HBD": "20", " HBA": "29", " HBD_HBA": "49", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "89", " CarbonAtoms": "60", " HeteroAtoms": "29", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "10769.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "12", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1251.47", "link_html_complex": "/ACE_complex_html/ACE_YIPIQYVLSR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YIPIQYVLSR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YIPIQYVLSR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YIPIQYVLSR.png", "phi_psi": "/peptide_da/YIPIQYVLSR.pdb", "link_html_peptide": "/Peptide_html/YIPIQYVLSR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YIPIQYVLSR.pdb", "link_png_peptide": "/Peptide_pics/YIPIQYVLSR.png"}
{"Peptide_Sequence": "YK", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "610", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1511", " Ligand_ID": "YK_minimized.pdb_1511", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "309.36", " logP": "-3.31", " logD": "-3.65", " logSw": "0.82", " tPSA": "144.74", " RotatableB": "9", " RigidB": "9", " Flexibility": "0.5", " HBD": "7", " HBA": "7", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "22", " CarbonAtoms": "15", " HeteroAtoms": "7", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "704229.68", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 309.361", "link_html_complex": "/ACE_complex_html/ACE_YK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YK.png", "phi_psi": "/peptide_da/YK.pdb", "link_html_peptide": "/Peptide_html/YK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YK.pdb", "link_png_peptide": "/Peptide_pics/YK.png"}
{"Peptide_Sequence": "YKLRP", " Origin": "bovine lactoferrin", " Peptide_Preparation": "Simulated Gastrointestinal Digestion", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Sentandreu and Toldra (2006)", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "16.5 \u03bcM", " Reference": "Garc\u00eda-Tejedor, Aurora, et al. \"Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition.\" Journal of agricultural and food chemistry 62.7 (2014): 1609-1616.", " Binding_Energy_kcal_per_mol": "-9", "Serial_ID": "1510", " Ligand_ID": "YKLRP_minimized.pdb_1510", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(O)=O", " MW": "675.82", " logP": "-3.9", " logD": "-8.78", " logSw": "-0.23", " tPSA": "286.89", " RotatableB": "21", " RigidB": "21", " Flexibility": "0.5", " HBD": "13", " HBA": "16", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "48", " CarbonAtoms": "32", " HeteroAtoms": "16", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "536402.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.63", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 675.819", "link_html_complex": "/ACE_complex_html/ACE_YKLRP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKLRP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKLRP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKLRP.png", "phi_psi": "/peptide_da/YKLRP.pdb", "link_html_peptide": "/Peptide_html/YKLRP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKLRP.pdb", "link_png_peptide": "/Peptide_pics/YKLRP.png"}
{"Peptide_Sequence": "YKVPQL", " Origin": "Casein  hydrolysate from Lactobacillus helveticus", " Peptide_Preparation": "proteinase", " Isolation_Method": "filteration, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "22", " Reference": "Maeno, Masafumi, Naoyuki Yamamoto, and Toshiaki Takano. \"Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790.\" Journal of Dairy Science 79.8 (1996): 1316-1321.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1512", " Ligand_ID": "YKVPQL_minimized.pdb_1512", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O", " MW": "746.89", " logP": "-3.54", " logD": "-7.3", " logSw": "-0.83", " tPSA": "295.44", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "12", " HBA": "17", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "53", " CarbonAtoms": "36", " HeteroAtoms": "17", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "326157.65", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 746.894", "link_html_complex": "/ACE_complex_html/ACE_YKVPQL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKVPQL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKVPQL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKVPQL.png", "phi_psi": "/peptide_da/YKVPQL.pdb", "link_html_peptide": "/Peptide_html/YKVPQL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKVPQL.pdb", "link_png_peptide": "/Peptide_pics/YKVPQL.png"}
{"Peptide_Sequence": "YKW", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "13.3 \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1515", " Ligand_ID": "YKW_minimized.pdb_1515", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "495.57", " logP": "-1.62", " logD": "-3.81", " logSw": "-1.19", " tPSA": "189.63", " RotatableB": "13", " RigidB": "21", " Flexibility": "0.38", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "36", " CarbonAtoms": "26", " HeteroAtoms": "10", " ratio_H_by_C": "0.38", " Lipinski_Violation": "1", " Solubility_mg_per_l": "150040.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 495.571", "link_html_complex": "/ACE_complex_html/ACE_YKW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKW.png", "phi_psi": "/peptide_da/YKW.pdb", "link_html_peptide": "/Peptide_html/YKW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKW.pdb", "link_png_peptide": "/Peptide_pics/YKW.png"}
{"Peptide_Sequence": "YKWL", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "48.7 \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1513", " Ligand_ID": "YKWL_minimized.pdb_1513", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "608.73", " logP": "-0.66", " logD": "-4.42", " logSw": "-2.2", " tPSA": "218.73", " RotatableB": "17", " RigidB": "23", " Flexibility": "0.42", " HBD": "10", " HBA": "12", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "44", " CarbonAtoms": "32", " HeteroAtoms": "12", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "67283.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 608.728", "link_html_complex": "/ACE_complex_html/ACE_YKWL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKWL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKWL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKWL.png", "phi_psi": "/peptide_da/YKWL.pdb", "link_html_peptide": "/Peptide_html/YKWL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKWL.pdb", "link_png_peptide": "/Peptide_pics/YKWL.png"}
{"Peptide_Sequence": "YKWLP", " Origin": "chicken leg meat.", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "17.2 \u03bcM", " Reference": "Terashima, Masaaki, et al. \"Inhibition strength of short peptides derived from an ACE inhibitory peptide.\" Journal of agricultural and food chemistry 59.20 (2011): 11234-11237.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1514", " Ligand_ID": "YKWLP_minimized.pdb_1514", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "705.84", " logP": "-0.02", " logD": "-4.69", " logSw": "-3.12", " tPSA": "239.04", " RotatableB": "18", " RigidB": "30", " Flexibility": "0.38", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "51", " CarbonAtoms": "37", " HeteroAtoms": "14", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "31029.55", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 705.844", "link_html_complex": "/ACE_complex_html/ACE_YKWLP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKWLP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKWLP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKWLP.png", "phi_psi": "/peptide_da/YKWLP.pdb", "link_html_peptide": "/Peptide_html/YKWLP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKWLP.pdb", "link_png_peptide": "/Peptide_pics/YKWLP.png"}
{"Peptide_Sequence": "YKY", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "43.5", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1516", " Ligand_ID": "YKY_minimized.pdb_1516", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "472.53", " logP": "-2.94", " logD": "-4.22", " logSw": "-0.19", " tPSA": "194.07", " RotatableB": "13", " RigidB": "17", " Flexibility": "0.43", " HBD": "9", " HBA": "10", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "34", " CarbonAtoms": "24", " HeteroAtoms": "10", " ratio_H_by_C": "0.42", " Lipinski_Violation": "1", " Solubility_mg_per_l": "389184.34", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.534", "link_html_complex": "/ACE_complex_html/ACE_YKY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKY.png", "phi_psi": "/peptide_da/YKY.pdb", "link_html_peptide": "/Peptide_html/YKY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKY.pdb", "link_png_peptide": "/Peptide_pics/YKY.png"}
{"Peptide_Sequence": "YKYY", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "64.2", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1517", " Ligand_ID": "YKYY_minimized.pdb_1517", " Smiles": "NCCCC[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "635.71", " logP": "-2.23", " logD": "-4.81", " logSw": "-1.41", " tPSA": "243.4", " RotatableB": "17", " RigidB": "25", " Flexibility": "0.4", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "33", " HeteroAtoms": "13", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "155578.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 635.707", "link_html_complex": "/ACE_complex_html/ACE_YKYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YKYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YKYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YKYY.png", "phi_psi": "/peptide_da/YKYY.pdb", "link_html_peptide": "/Peptide_html/YKYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YKYY.pdb", "link_png_peptide": "/Peptide_pics/YKYY.png"}
{"Peptide_Sequence": "YL", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "50 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1521", " Ligand_ID": "YL_minimized.pdb_1521", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "294.35", " logP": "-1.75", " logD": "-1.29", " logSw": "-0.2", " tPSA": "117.1", " RotatableB": "7", " RigidB": "9", " Flexibility": "0.44", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "15", " HeteroAtoms": "6", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "240099.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 294.346", "link_html_complex": "/ACE_complex_html/ACE_YL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YL.png", "phi_psi": "/peptide_da/YL.pdb", "link_html_peptide": "/Peptide_html/YL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YL.pdb", "link_png_peptide": "/Peptide_pics/YL.png"}
{"Peptide_Sequence": "YLAGNQ", " Origin": "soyabean", " Peptide_Preparation": "enzyme hydrolysis", " Isolation_Method": "IEC, GF, RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": " 14 mM", " Reference": "Wang, Wenyi, and Elvira Gonzalez De Mejia. \"A new frontier in soy bioactive peptides that may prevent age\u2010related chronic diseases.\" Comprehensive reviews in food science and food safety 4.4 (2005): 63-78.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1518", " Ligand_ID": "YLAGNQ_minimized.pdb_1518", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "664.71", " logP": "-4.43", " logD": "-7.76", " logSw": "0.03", " tPSA": "319.68", " RotatableB": "19", " RigidB": "21", " Flexibility": "0.47", " HBD": "13", " HBA": "18", " HBD_HBA": "31", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "47", " CarbonAtoms": "29", " HeteroAtoms": "18", " ratio_H_by_C": "0.62", " Lipinski_Violation": "3", " Solubility_mg_per_l": "688331.47", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 664.707", "link_html_complex": "/ACE_complex_html/ACE_YLAGNQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLAGNQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLAGNQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLAGNQ.png", "phi_psi": "/peptide_da/YLAGNQ.pdb", "link_html_peptide": "/Peptide_html/YLAGNQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLAGNQ.pdb", "link_png_peptide": "/Peptide_pics/YLAGNQ.png"}
{"Peptide_Sequence": "YLGY", " Origin": "casein-derived", " Peptide_Preparation": " G\u00f3mez Ruiz, Ramos, and Recio (2004) modified by Quir\u00f3s et al. (2009)", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung (1971) with some modifications by Quir\u00f3s et al. (2007)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "41.86 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Resistance of casein-derived bioactive peptides to simulated gastrointestinal digestion.\" International Dairy Journal 32.2 (2013): 71-78.", " Binding_Energy_kcal_per_mol": "-10.8", "Serial_ID": "1519", " Ligand_ID": "YLGY_minimized.pdb_1519", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "514.57", " logP": "-0.5", " logD": "-2.73", " logSw": "-1.98", " tPSA": "195.53", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "26", " HeteroAtoms": "11", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "70875.44", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 514.571", "link_html_complex": "/ACE_complex_html/ACE_YLGY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLGY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLGY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLGY.png", "phi_psi": "/peptide_da/YLGY.pdb", "link_html_peptide": "/Peptide_html/YLGY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLGY.pdb", "link_png_peptide": "/Peptide_pics/YLGY.png"}
{"Peptide_Sequence": "YLLF", " Origin": "Lactalbumin", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Mullally, M.M., Meisel, H. and FitzGerald, R.J. (1996) \"Synthetic Peptides Correspongding to \u03b1-lactalbumin and \u03b2-lactoglobulin Squences with Angiotensin-I-converting Enzyme Inhibitory Activity\" in Biological Chemistry Hoppe-Seyler 377, 259-260.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1520", " Ligand_ID": "YLLF_minimized.pdb_1520", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "554.68", " logP": "0.15", " logD": "-0.48", " logSw": "-2.49", " tPSA": "175.3", " RotatableB": "15", " RigidB": "19", " Flexibility": "0.44", " HBD": "7", " HBA": "10", " HBD_HBA": "17", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "30", " HeteroAtoms": "10", " ratio_H_by_C": "0.33", " Lipinski_Violation": "2", " Solubility_mg_per_l": "45905.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 554.678", "link_html_complex": "/ACE_complex_html/ACE_YLLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLLF.png", "phi_psi": "/peptide_da/YLLF.pdb", "link_html_peptide": "/Peptide_html/YLLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLLF.pdb", "link_png_peptide": "/Peptide_pics/YLLF.png"}
{"Peptide_Sequence": "YLYEIA", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "500 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1522", " Ligand_ID": "YLYEIA_minimized.pdb_1522", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(O)=O", " MW": "770.87", " logP": "-0.87", " logD": "-5.46", " logSw": "-2.7", " tPSA": "293.86", " RotatableB": "22", " RigidB": "24", " Flexibility": "0.48", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "55", " CarbonAtoms": "38", " HeteroAtoms": "17", " ratio_H_by_C": "0.45", " Lipinski_Violation": "3", " Solubility_mg_per_l": "51767.52", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 770.869", "link_html_complex": "/ACE_complex_html/ACE_YLYEIA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLYEIA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLYEIA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLYEIA.png", "phi_psi": "/peptide_da/YLYEIA.pdb", "link_html_peptide": "/Peptide_html/YLYEIA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLYEIA.pdb", "link_png_peptide": "/Peptide_pics/YLYEIA.png"}
{"Peptide_Sequence": "YLYEIAR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "16 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.3", "Serial_ID": "1523", " Ligand_ID": "YLYEIAR_minimized.pdb_1523", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "927.05", " logP": "-0.74", " logD": "-6.04", " logSw": "-3.27", " tPSA": "386.6", " RotatableB": "29", " RigidB": "27", " Flexibility": "0.52", " HBD": "16", " HBA": "22", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "66", " CarbonAtoms": "44", " HeteroAtoms": "22", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "35064.91", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 927.055", "link_html_complex": "/ACE_complex_html/ACE_YLYEIAR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLYEIAR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLYEIAR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLYEIAR.png", "phi_psi": "/peptide_da/YLYEIAR.pdb", "link_html_peptide": "/Peptide_html/YLYEIAR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLYEIAR.pdb", "link_png_peptide": "/Peptide_pics/YLYEIAR.png"}
{"Peptide_Sequence": "YLYEIARR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "86 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1524", " Ligand_ID": "YLYEIARR_minimized.pdb_1524", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1083.24", " logP": "-1.82", " logD": "-7.42", " logSw": "-3.09", " tPSA": "479.34", " RotatableB": "36", " RigidB": "30", " Flexibility": "0.55", " HBD": "21", " HBA": "27", " HBD_HBA": "48", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "5", " TotalCharge": "1", " HeavyAtoms": "77", " CarbonAtoms": "50", " HeteroAtoms": "27", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "49251.11", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1083.24", "link_html_complex": "/ACE_complex_html/ACE_YLYEIARR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YLYEIARR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YLYEIARR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YLYEIARR.png", "phi_psi": "/peptide_da/YLYEIARR.pdb", "link_html_peptide": "/Peptide_html/YLYEIARR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YLYEIARR.pdb", "link_png_peptide": "/Peptide_pics/YLYEIARR.png"}
{"Peptide_Sequence": "YN", " Origin": "hard clam (Meretrix lusoria)", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cheung & Chushman and Wu & Ding", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "51 \u03bcM", " Reference": "Tsai, Jenn-Shou, Jia-Ling Chen, and Bonnie Sun Pan. \"ACE-inhibitory peptides identified from the muscle protein hydrolysate of hard clam (Meretrix lusoria).\" Process Biochemistry 43.7 (2008): 743-747.", " Binding_Energy_kcal_per_mol": "-7.8", "Serial_ID": "1527", " Ligand_ID": "YN_minimized.pdb_1527", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "295.29", " logP": "-4.59", " logD": "-4", " logSw": "1.57", " tPSA": "160.19", " RotatableB": "7", " RigidB": "11", " Flexibility": "0.39", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "21", " CarbonAtoms": "13", " HeteroAtoms": "8", " ratio_H_by_C": "0.62", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1413769.05", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 295.291", "link_html_complex": "/ACE_complex_html/ACE_YN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YN.png", "phi_psi": "/peptide_da/YN.pdb", "link_html_peptide": "/Peptide_html/YN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YN.pdb", "link_png_peptide": "/Peptide_pics/YN.png"}
{"Peptide_Sequence": "YNK", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "125", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1526", " Ligand_ID": "YNK_minimized.pdb_1526", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "423.46", " logP": "-5.08", " logD": "-5.41", " logSw": "1.52", " tPSA": "216.93", " RotatableB": "13", " RigidB": "13", " Flexibility": "0.5", " HBD": "10", " HBA": "11", " HBD_HBA": "21", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "30", " CarbonAtoms": "19", " HeteroAtoms": "11", " ratio_H_by_C": "0.58", " Lipinski_Violation": "2", " Solubility_mg_per_l": "1931668.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 423.463", "link_html_complex": "/ACE_complex_html/ACE_YNK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YNK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YNK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YNK.png", "phi_psi": "/peptide_da/YNK.pdb", "link_html_peptide": "/Peptide_html/YNK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YNK.pdb", "link_png_peptide": "/Peptide_pics/YNK.png"}
{"Peptide_Sequence": "YNKL", " Origin": "Wakame", " Peptide_Preparation": "proteases", " Isolation_Method": "Sephvadex C-25", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "21", " Reference": "Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida) Kunio Suetsuna* and Takahisa Nakano\u2020", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1525", " Ligand_ID": "YNKL_minimized.pdb_1525", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "536.62", " logP": "-4.01", " logD": "-6.31", " logSw": "0.42", " tPSA": "246.03", " RotatableB": "17", " RigidB": "15", " Flexibility": "0.53", " HBD": "11", " HBA": "13", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "38", " CarbonAtoms": "25", " HeteroAtoms": "13", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "820257.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 536.621", "link_html_complex": "/ACE_complex_html/ACE_YNKL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YNKL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YNKL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YNKL.png", "phi_psi": "/peptide_da/YNKL.pdb", "link_html_peptide": "/Peptide_html/YNKL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YNKL.pdb", "link_png_peptide": "/Peptide_pics/YNKL.png"}
{"Peptide_Sequence": "YP", " Origin": "Dried Bonito", " Peptide_Preparation": "Protease digestion (thermolysin, pepsin,trypsin,chymotrypsin)", " Isolation_Method": "ODS Column", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "890", " Reference": "Keiichi Yokoyama, Hideo Chiba, Masaaki Yoshikawa. Peptide Inhibitors for Angiotensin I-Converting Enzyme from Thermolysin Digest of Dried Bonito. Bioscience, Biotechnology, and Biochemistry, Volume 56, 1992, Page 1541-1545.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1539", " Ligand_ID": "YP_minimized.pdb_1539", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "278.3", " logP": "-2.03", " logD": "-2.27", " logSw": "-0.14", " tPSA": "108.31", " RotatableB": "4", " RigidB": "14", " Flexibility": "0.22", " HBD": "4", " HBA": "6", " HBD_HBA": "10", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "242084.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 278.304", "link_html_complex": "/ACE_complex_html/ACE_YP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YP.png", "phi_psi": "/peptide_da/YP.pdb", "link_html_peptide": "/Peptide_html/YP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YP.pdb", "link_png_peptide": "/Peptide_pics/YP.png"}
{"Peptide_Sequence": "0.6", " Origin": null, " Peptide_Preparation": null, " Isolation_Method": null, " ACE_inhibition_assay": null, " In-vivo_or_in-vitro": null, " IC50_micromol_per_L": null, " Reference": null, " Binding_Energy_kcal_per_mol": null, "Serial_ID": "1528", " Ligand_ID": "YPER_minimized.pdb_1528", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "563.6", " logP": "-4.98", " logD": "-8.09", " logSw": "0.8", " tPSA": "270.28", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "11", " HBA": "15", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "25", " HeteroAtoms": "15", " ratio_H_by_C": "0.6", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1256075.53", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 563.603", "link_html_complex": "/ACE_complex_html/ACE_YPER.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPER.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPER.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPER.png", "phi_psi": "/peptide_da/YPER.pdb", "link_html_peptide": "/Peptide_html/YPER.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPER.pdb", "link_png_peptide": "/Peptide_pics/YPER.png"}
{"Peptide_Sequence": "YPF", " Origin": "Caprine Kefir", " Peptide_Preparation": " gastrointestinal digestion", " Isolation_Method": "ultrafiltration, RP-HPLC", " ACE_inhibition_assay": " Cushman and Cheung (1971), with some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "Quir\u00f3s, A., et al. \"Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir.\" Journal of dairy science 88.10 (2005): 3480-3487.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1529", " Ligand_ID": "YPF_minimized.pdb_1529", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "425.48", " logP": "-0.69", " logD": "-2.03", " logSw": "-1.67", " tPSA": "137.41", " RotatableB": "8", " RigidB": "22", " Flexibility": "0.27", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "31", " CarbonAtoms": "23", " HeteroAtoms": "8", " ratio_H_by_C": "0.35", " Lipinski_Violation": "0", " Solubility_mg_per_l": "80226.01", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.35", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 425.478", "link_html_complex": "/ACE_complex_html/ACE_YPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPF.png", "phi_psi": "/peptide_da/YPF.pdb", "link_html_peptide": "/Peptide_html/YPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPF.pdb", "link_png_peptide": "/Peptide_pics/YPF.png"}
{"Peptide_Sequence": "YPFPGPI", " Origin": "bovine casein proteins ", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "", " Reference": "Nagpal, Ravinder, et al. \"Bioactive peptides derived from milk proteins and their health beneficial potentials: an update.\" Food & function 2.1 (2011): 18-27.", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1530", " Ligand_ID": "YPFPGPI_minimized.pdb_1530", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "789.92", " logP": "-0.21", " logD": "-3.02", " logSw": "-3.63", " tPSA": "236.23", " RotatableB": "16", " RigidB": "40", " Flexibility": "0.29", " HBD": "7", " HBA": "16", " HBD_HBA": "23", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "41", " HeteroAtoms": "16", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "20977.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 789.917", "link_html_complex": "/ACE_complex_html/ACE_YPFPGPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPFPGPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPFPGPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPFPGPI.png", "phi_psi": "/peptide_da/YPFPGPI.pdb", "link_html_peptide": "/Peptide_html/YPFPGPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPFPGPI.pdb", "link_png_peptide": "/Peptide_pics/YPFPGPI.png"}
{"Peptide_Sequence": "YPFPGPIP", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "500 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1531", " Ligand_ID": "YPFPGPIP_minimized.pdb_1531", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "887.03", " logP": "-0.16", " logD": "-3.33", " logSw": "-4.19", " tPSA": "256.54", " RotatableB": "17", " RigidB": "47", " Flexibility": "0.27", " HBD": "7", " HBA": "18", " HBD_HBA": "25", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "46", " HeteroAtoms": "18", " ratio_H_by_C": "0.39", " Lipinski_Violation": "3", " Solubility_mg_per_l": "13471.9", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "8", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 887.032", "link_html_complex": "/ACE_complex_html/ACE_YPFPGPIP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPFPGPIP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPFPGPIP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPFPGPIP.png", "phi_psi": "/peptide_da/YPFPGPIP.pdb", "link_html_peptide": "/Peptide_html/YPFPGPIP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPFPGPIP.pdb", "link_png_peptide": "/Peptide_pics/YPFPGPIP.png"}
{"Peptide_Sequence": "YPFPGPIPN", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "15 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.4", "Serial_ID": "1532", " Ligand_ID": "YPFPGPIPN_minimized.pdb_1532", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O", " MW": "1001.13", " logP": "-1.58", " logD": "-5.39", " logSw": "-3.73", " tPSA": "328.73", " RotatableB": "21", " RigidB": "51", " Flexibility": "0.29", " HBD": "10", " HBA": "22", " HBD_HBA": "32", " Rings": "6", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "72", " CarbonAtoms": "50", " HeteroAtoms": "22", " ratio_H_by_C": "0.44", " Lipinski_Violation": "3", " Solubility_mg_per_l": "24042.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1001.13", "link_html_complex": "/ACE_complex_html/ACE_YPFPGPIPN.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPFPGPIPN.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPFPGPIPN.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPFPGPIPN.png", "phi_psi": "/peptide_da/YPFPGPIPN.pdb", "link_html_peptide": "/Peptide_html/YPFPGPIPN.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPFPGPIPN.pdb", "link_png_peptide": "/Peptide_pics/YPFPGPIPN.png"}
{"Peptide_Sequence": "YPGIA", " Origin": "Pork meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "1000 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1533", " Ligand_ID": "YPGIA_minimized.pdb_1533", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(O)=O", " MW": "519.59", " logP": "-1.9", " logD": "-4.14", " logSw": "-1.13", " tPSA": "195.61", " RotatableB": "12", " RigidB": "20", " Flexibility": "0.38", " HBD": "7", " HBA": "12", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "25", " HeteroAtoms": "12", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "167432.38", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.56", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 519.591", "link_html_complex": "/ACE_complex_html/ACE_YPGIA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPGIA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPGIA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPGIA.png", "phi_psi": "/peptide_da/YPGIA.pdb", "link_html_peptide": "/Peptide_html/YPGIA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPGIA.pdb", "link_png_peptide": "/Peptide_pics/YPGIA.png"}
{"Peptide_Sequence": "YPI", " Origin": "synthetic", " Peptide_Preparation": "simulated gastrointestinal digestion", " Isolation_Method": "", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000 \u03bcg/mL", " Reference": "Miguel, M., et al. \"Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin.\" Journal of Agricultural and Food Chemistry 54.3 (2006): 726-731.", " Binding_Energy_kcal_per_mol": "-8.2", "Serial_ID": "1535", " Ligand_ID": "YPI_minimized.pdb_1535", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "391.46", " logP": "-1", " logD": "-2.33", " logSw": "-1.19", " tPSA": "137.41", " RotatableB": "8", " RigidB": "16", " Flexibility": "0.33", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "0", " Solubility_mg_per_l": "119454.03", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "2", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 391.461", "link_html_complex": "/ACE_complex_html/ACE_YPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPI.png", "phi_psi": "/peptide_da/YPI.pdb", "link_html_peptide": "/Peptide_html/YPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPI.pdb", "link_png_peptide": "/Peptide_pics/YPI.png"}
{"Peptide_Sequence": "YPIL", " Origin": "egg white proteins", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": ">1000 \u03bcM", " Reference": "D\u00e1valos, A., et al. \"Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis.\" Journal of food protection 67.9 (2004): 1939-1944.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1534", " Ligand_ID": "YPIL_minimized.pdb_1534", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "504.62", " logP": "-1.28", " logD": "-1.79", " logSw": "-1.43", " tPSA": "166.51", " RotatableB": "12", " RigidB": "18", " Flexibility": "0.4", " HBD": "6", " HBA": "10", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "26", " HeteroAtoms": "10", " ratio_H_by_C": "0.38", " Lipinski_Violation": "2", " Solubility_mg_per_l": "120921.89", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 504.619", "link_html_complex": "/ACE_complex_html/ACE_YPIL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPIL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPIL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPIL.png", "phi_psi": "/peptide_da/YPIL.pdb", "link_html_peptide": "/Peptide_html/YPIL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPIL.pdb", "link_png_peptide": "/Peptide_pics/YPIL.png"}
{"Peptide_Sequence": "YPK", " Origin": "broccoli (Brassica oleracea Italica)", " Peptide_Preparation": "", " Isolation_Method": "column chromatography", " ACE_inhibition_assay": " Cushman and Cheung (1971) with some modification", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "23.7 \u03bcM", " Reference": "Lee, Ju-Eun, et al. \"Tyr-Pro-Lys, an angiotensin I-converting enzyme inhibitory peptide derived from broccoli (Brassica oleracea Italica).\" Food chemistry 99.1 (2006): 143-148.", " Binding_Energy_kcal_per_mol": "-8.1", "Serial_ID": "1536", " Ligand_ID": "YPK_minimized.pdb_1536", " Smiles": "NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "406.48", " logP": "-3.2", " logD": "-3.69", " logSw": "0.24", " tPSA": "165.05", " RotatableB": "10", " RigidB": "16", " Flexibility": "0.38", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "29", " CarbonAtoms": "20", " HeteroAtoms": "9", " ratio_H_by_C": "0.45", " Lipinski_Violation": "1", " Solubility_mg_per_l": "517039.59", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 406.476", "link_html_complex": "/ACE_complex_html/ACE_YPK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPK.png", "phi_psi": "/peptide_da/YPK.pdb", "link_html_peptide": "/Peptide_html/YPK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPK.pdb", "link_png_peptide": "/Peptide_pics/YPK.png"}
{"Peptide_Sequence": "YPLDL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "51 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1538", " Ligand_ID": "YPLDL_minimized.pdb_1538", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "619.71", " logP": "-2.13", " logD": "-6.3", " logSw": "-1.33", " tPSA": "235.74", " RotatableB": "16", " RigidB": "21", " Flexibility": "0.43", " HBD": "8", " HBA": "14", " HBD_HBA": "22", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "44", " CarbonAtoms": "30", " HeteroAtoms": "14", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "163216.66", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 619.706", "link_html_complex": "/ACE_complex_html/ACE_YPLDL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPLDL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPLDL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPLDL.png", "phi_psi": "/peptide_da/YPLDL.pdb", "link_html_peptide": "/Peptide_html/YPLDL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPLDL.pdb", "link_png_peptide": "/Peptide_pics/YPLDL.png"}
{"Peptide_Sequence": "YPLDLF", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "24.4 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10.9", "Serial_ID": "1537", " Ligand_ID": "YPLDLF_minimized.pdb_1537", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "766.88", " logP": "-0.79", " logD": "-5.1", " logSw": "-2.86", " tPSA": "264.84", " RotatableB": "20", " RigidB": "29", " Flexibility": "0.41", " HBD": "9", " HBA": "16", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "55", " CarbonAtoms": "39", " HeteroAtoms": "16", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "43987.49", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.51", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 766.88", "link_html_complex": "/ACE_complex_html/ACE_YPLDLF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPLDLF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPLDLF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPLDLF.png", "phi_psi": "/peptide_da/YPLDLF.pdb", "link_html_peptide": "/Peptide_html/YPLDLF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPLDLF.pdb", "link_png_peptide": "/Peptide_pics/YPLDLF.png"}
{"Peptide_Sequence": "YPR", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "16.5", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1540", " Ligand_ID": "YPR_minimized.pdb_1540", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "434.49", " logP": "-3.79", " logD": "-4.28", " logSw": "0.51", " tPSA": "201.05", " RotatableB": "11", " RigidB": "17", " Flexibility": "0.39", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "31", " CarbonAtoms": "20", " HeteroAtoms": "11", " ratio_H_by_C": "0.55", " Lipinski_Violation": "2", " Solubility_mg_per_l": "721440.84", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 434.489", "link_html_complex": "/ACE_complex_html/ACE_YPR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPR.png", "phi_psi": "/peptide_da/YPR.pdb", "link_html_peptide": "/Peptide_html/YPR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPR.pdb", "link_png_peptide": "/Peptide_pics/YPR.png"}
{"Peptide_Sequence": "YPRY", " Origin": "Sake Lees", " Peptide_Preparation": "solid phase peptide synthesis", " Isolation_Method": "Reverse Phase Chromatography", " ACE_inhibition_assay": "cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "17.4", " Reference": "Saito Y, Wanezaki K, Kawato A, Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 1994;58:1767\u201371.", " Binding_Energy_kcal_per_mol": "-11.1", "Serial_ID": "1541", " Ligand_ID": "YPRY_minimized.pdb_1541", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "597.66", " logP": "-3.24", " logD": "-5.41", " logSw": "-0.62", " tPSA": "250.38", " RotatableB": "15", " RigidB": "25", " Flexibility": "0.38", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "29", " HeteroAtoms": "14", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "320674.09", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 597.663", "link_html_complex": "/ACE_complex_html/ACE_YPRY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPRY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPRY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPRY.png", "phi_psi": "/peptide_da/YPRY.pdb", "link_html_peptide": "/Peptide_html/YPRY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPRY.pdb", "link_png_peptide": "/Peptide_pics/YPRY.png"}
{"Peptide_Sequence": "YPSFQPQPLIYP", " Origin": "Human beta-Casein", " Peptide_Preparation": "liquid-phase method", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "Kasahara and Ashihara", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "4.8", " Reference": "Kohmura M, Nio N, Kubo K, Minoshma Y, Munekata E, Ariyosh E. Inhibition of angiotensin-converting enzyme by synthetic peptides of human_x005F_x0003_-casein. Agric Biol Chem 1989;53:2107\u201314.", " Binding_Energy_kcal_per_mol": "-6.2", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1449.65", "link_html_complex": "/ACE_complex_html/ACE_YPSFQPQPLIYP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPSFQPQPLIYP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPSFQPQPLIYP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPSFQPQPLIYP.png", "phi_psi": "/peptide_da/YPSFQPQPLIYP.pdb", "link_html_peptide": "/Peptide_html/YPSFQPQPLIYP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPSFQPQPLIYP.pdb", "link_png_peptide": "/Peptide_pics/YPSFQPQPLIYP.png"}
{"Peptide_Sequence": "YPSPV", " Origin": "egg yolk", " Peptide_Preparation": " pepsin and pancreatin", " Isolation_Method": "UF, MWCO", " ACE_inhibition_assay": "Wu et al. 2002", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Yousr, Marwa, and Nazlin Howell. \"Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins.\" International journal of molecular sciences 16.12 (2015): 29161-29178.", " Binding_Energy_kcal_per_mol": "-8.4", "Serial_ID": "1543", " Ligand_ID": "YPSPV_minimized.pdb_1543", " Smiles": "CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "561.63", " logP": "-2.61", " logD": "-4.85", " logSw": "-1.01", " tPSA": "207.05", " RotatableB": "11", " RigidB": "25", " Flexibility": "0.31", " HBD": "7", " HBA": "13", " HBD_HBA": "20", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "40", " CarbonAtoms": "27", " HeteroAtoms": "13", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "204966.56", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.59", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 561.627", "link_html_complex": "/ACE_complex_html/ACE_YPSPV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPSPV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPSPV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPSPV.png", "phi_psi": "/peptide_da/YPSPV.pdb", "link_html_peptide": "/Peptide_html/YPSPV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPSPV.pdb", "link_png_peptide": "/Peptide_pics/YPSPV.png"}
{"Peptide_Sequence": "YPWTQR", " Origin": "hemoglobin", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "Lantz, Ingrid, et al. \"Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity.\" FEBS letters 287.1-2 (1991): 39-41.", " Binding_Energy_kcal_per_mol": "-9.7", "Serial_ID": "1544", " Ligand_ID": "YPWTQR_minimized.pdb_1544", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "849.93", " logP": "-3.96", " logD": "-5.93", " logSw": "-1.19", " tPSA": "367.46", " RotatableB": "23", " RigidB": "35", " Flexibility": "0.4", " HBD": "16", " HBA": "21", " HBD_HBA": "37", " Rings": "3", " MaxSizeRing": "9", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "61", " CarbonAtoms": "40", " HeteroAtoms": "21", " ratio_H_by_C": "0.53", " Lipinski_Violation": "3", " Solubility_mg_per_l": "257929.5", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.45", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 849.932", "link_html_complex": "/ACE_complex_html/ACE_YPWTQR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPWTQR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPWTQR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPWTQR.png", "phi_psi": "/peptide_da/YPWTQR.pdb", "link_html_peptide": "/Peptide_html/YPWTQR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPWTQR.pdb", "link_png_peptide": "/Peptide_pics/YPWTQR.png"}
{"Peptide_Sequence": "YPYY", " Origin": "milk", " Peptide_Preparation": "fermentation by Streptococcus thermophilus, Lactobacillus bulgaricus", " Isolation_Method": "SEC, GF, RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung, 1971, Wu and Ding, 2002", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "90.9 \u03bcM", " Reference": "Tsai, Jenn-Shou, et al. \"Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk.\" Food chemistry 106.2 (2008): 552-558.", " Binding_Energy_kcal_per_mol": "-11.4", "Serial_ID": "1545", " Ligand_ID": "YPYY_minimized.pdb_1545", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "604.65", " logP": "-1.18", " logD": "-1.79", " logSw": "-2.22", " tPSA": "206.97", " RotatableB": "12", " RigidB": "30", " Flexibility": "0.29", " HBD": "8", " HBA": "12", " HBD_HBA": "20", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "44", " CarbonAtoms": "32", " HeteroAtoms": "12", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "65675.02", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.31", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 604.65", "link_html_complex": "/ACE_complex_html/ACE_YPYY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YPYY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YPYY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YPYY.png", "phi_psi": "/peptide_da/YPYY.pdb", "link_html_peptide": "/Peptide_html/YPYY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YPYY.pdb", "link_png_peptide": "/Peptide_pics/YPYY.png"}
{"Peptide_Sequence": "YQ", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "629 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.6", "Serial_ID": "1554", " Ligand_ID": "YQ_minimized.pdb_1554", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "309.32", " logP": "-4.23", " logD": "-3.71", " logSw": "1.33", " tPSA": "160.19", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "7", " HBA": "8", " HBD_HBA": "15", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "22", " CarbonAtoms": "14", " HeteroAtoms": "8", " ratio_H_by_C": "0.57", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1165850.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.36", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 309.318", "link_html_complex": "/ACE_complex_html/ACE_YQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQ.png", "phi_psi": "/peptide_da/YQ.pdb", "link_html_peptide": "/Peptide_html/YQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQ.pdb", "link_png_peptide": "/Peptide_pics/YQ.png"}
{"Peptide_Sequence": "YQEP", " Origin": "Ovine and Caprine cheese", " Peptide_Preparation": "Proteases from Cynara cardunculus", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Vermeirssen et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "169 \u03bcg/mL", " Reference": "Silva, S. V., Anne Pihlanto, and F. Xavier Malcata. \"Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus.\" Journal of dairy science 89.9 (2006): 3336-3344.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1546", " Ligand_ID": "YQEP_minimized.pdb_1546", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(O)=O", " MW": "535.55", " logP": "-5.58", " logD": "-9.25", " logSw": "1.22", " tPSA": "249.73", " RotatableB": "14", " RigidB": "21", " Flexibility": "0.4", " HBD": "9", " HBA": "14", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "38", " CarbonAtoms": "24", " HeteroAtoms": "14", " ratio_H_by_C": "0.58", " Lipinski_Violation": "3", " Solubility_mg_per_l": "1807612.86", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 535.547", "link_html_complex": "/ACE_complex_html/ACE_YQEP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQEP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQEP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQEP.png", "phi_psi": "/peptide_da/YQEP.pdb", "link_html_peptide": "/Peptide_html/YQEP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQEP.pdb", "link_png_peptide": "/Peptide_pics/YQEP.png"}
{"Peptide_Sequence": "YQEPVL", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "280 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1549", " Ligand_ID": "YQEPVL_minimized.pdb_1549", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O", " MW": "747.84", " logP": "-3.62", " logD": "-8.11", " logSw": "-0.85", " tPSA": "307.93", " RotatableB": "21", " RigidB": "25", " Flexibility": "0.46", " HBD": "11", " HBA": "18", " HBD_HBA": "29", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "319039.7", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 747.836", "link_html_complex": "/ACE_complex_html/ACE_YQEPVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQEPVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQEPVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQEPVL.png", "phi_psi": "/peptide_da/YQEPVL.pdb", "link_html_peptide": "/Peptide_html/YQEPVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQEPVL.pdb", "link_png_peptide": "/Peptide_pics/YQEPVL.png"}
{"Peptide_Sequence": "YQEPVLGP", " Origin": "Ovine and Caprine cheese", " Peptide_Preparation": "Proteases from Cynara cardunculus", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": " Vermeirssen et al. (2002)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "653 \u03bcg/mL", " Reference": "Silva, S. V., Anne Pihlanto, and F. Xavier Malcata. \"Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus.\" Journal of dairy science 89.9 (2006): 3336-3344.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1547", " Ligand_ID": "YQEPVLGP_minimized.pdb_1547", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O", " MW": "902", " logP": "-2.72", " logD": "-9.56", " logSw": "-2.17", " tPSA": "357.34", " RotatableB": "24", " RigidB": "34", " Flexibility": "0.41", " HBD": "12", " HBA": "22", " HBD_HBA": "34", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "64", " CarbonAtoms": "42", " HeteroAtoms": "22", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "103011.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.62", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 902.002", "link_html_complex": "/ACE_complex_html/ACE_YQEPVLGP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQEPVLGP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQEPVLGP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQEPVLGP.png", "phi_psi": "/peptide_da/YQEPVLGP.pdb", "link_html_peptide": "/Peptide_html/YQEPVLGP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQEPVLGP.pdb", "link_png_peptide": "/Peptide_pics/YQEPVLGP.png"}
{"Peptide_Sequence": "YQEPVLGPVRG", " Origin": "ripened cheese", " Peptide_Preparation": "", " Isolation_Method": "HPLC, strong cation exchange chromatography, RP-HPLC", " ACE_inhibition_assay": " Wu, Aluko, and Muir (2002)", " In-vivo_or_in-vitro": "in-silico, in-vitro", " IC50_micromol_per_L": "412 \u03bcM", " Reference": "Sagardia, Iban, et al. \"Quantitative structure\u2013activity relationship based screening of bioactive peptides identified in ripened cheese.\" International Dairy Journal 33.2 (2013): 184-190.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1548", " Ligand_ID": "YQEPVLGPVRG_minimized.pdb_1548", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O", " MW": "1214.37", " logP": "-3.74", " logD": "-13.18", " logSw": "-2.66", " tPSA": "508.28", " RotatableB": "36", " RigidB": "41", " Flexibility": "0.47", " HBD": "19", " HBA": "31", " HBD_HBA": "50", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "86", " CarbonAtoms": "55", " HeteroAtoms": "31", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "84725.87", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1214.37", "link_html_complex": "/ACE_complex_html/ACE_YQEPVLGPVRG.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQEPVLGPVRG.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQEPVLGPVRG.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQEPVLGPVRG.png", "phi_psi": "/peptide_da/YQEPVLGPVRG.pdb", "link_html_peptide": "/Peptide_html/YQEPVLGPVRG.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQEPVLGPVRG.pdb", "link_png_peptide": "/Peptide_pics/YQEPVLGPVRG.png"}
{"Peptide_Sequence": "YQEPVLQPVR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "300 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.3", "Serial_ID": "1550", " Ligand_ID": "YQEPVLQPVR_minimized.pdb_1550", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1228.4", " logP": "-3.84", " logD": "-10.33", " logSw": "-2.69", " tPSA": "522.27", " RotatableB": "36", " RigidB": "41", " Flexibility": "0.47", " HBD": "20", " HBA": "31", " HBD_HBA": "51", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "87", " CarbonAtoms": "56", " HeteroAtoms": "31", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "83711.63", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1228.4", "link_html_complex": "/ACE_complex_html/ACE_YQEPVLQPVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQEPVLQPVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQEPVLQPVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQEPVLQPVR.png", "phi_psi": "/peptide_da/YQEPVLQPVR.pdb", "link_html_peptide": "/Peptide_html/YQEPVLQPVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQEPVLQPVR.pdb", "link_png_peptide": "/Peptide_pics/YQEPVLQPVR.png"}
{"Peptide_Sequence": "YQIGL", " Origin": "egg", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC/MS/MS", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "173.8 mM", " Reference": "Garcia\u2010Redondo, Ana B., et al. \"Vascular effects of egg white\u2010derived peptides in resistance arteries from rats. Structure\u2013activity relationships.\" Journal of the Science of Food and Agriculture 90.12 (2010): 1988-1993.", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1551", " Ligand_ID": "YQIGL_minimized.pdb_1551", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "592.68", " logP": "-2.91", " logD": "-4.4", " logSw": "-0.54", " tPSA": "247.49", " RotatableB": "18", " RigidB": "17", " Flexibility": "0.51", " HBD": "10", " HBA": "14", " HBD_HBA": "24", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "42", " CarbonAtoms": "28", " HeteroAtoms": "14", " ratio_H_by_C": "0.5", " Lipinski_Violation": "3", " Solubility_mg_per_l": "343673.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.57", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 592.684", "link_html_complex": "/ACE_complex_html/ACE_YQIGL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQIGL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQIGL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQIGL.png", "phi_psi": "/peptide_da/YQIGL.pdb", "link_html_peptide": "/Peptide_html/YQIGL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQIGL.pdb", "link_png_peptide": "/Peptide_pics/YQIGL.png"}
{"Peptide_Sequence": "YQKFPQY", " Origin": "caseins", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC, SEC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "20 \u03bcM", " Reference": "del Mar Contreras, Mar\u00eda, et al. \"Novel casein-derived peptides with antihypertensive activity.\" International Dairy Journal 19.10 (2009): 566-573.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1553", " Ligand_ID": "YQKFPQY_minimized.pdb_1553", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "973.08", " logP": "-2.72", " logD": "-8.18", " logSw": "-2.48", " tPSA": "387.86", " RotatableB": "27", " RigidB": "40", " Flexibility": "0.4", " HBD": "16", " HBA": "22", " HBD_HBA": "38", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "70", " CarbonAtoms": "48", " HeteroAtoms": "22", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "81741.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.44", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 973.082", "link_html_complex": "/ACE_complex_html/ACE_YQKFPQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQKFPQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQKFPQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQKFPQY.png", "phi_psi": "/peptide_da/YQKFPQY.pdb", "link_html_peptide": "/Peptide_html/YQKFPQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQKFPQY.pdb", "link_png_peptide": "/Peptide_pics/YQKFPQY.png"}
{"Peptide_Sequence": "YQKFPQYLQY", " Origin": "bovine casein", " Peptide_Preparation": "pepsin trypsine", " Isolation_Method": "ultraflitration membrane", " ACE_inhibition_assay": "method developed by Zhao", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "11.1", " Reference": "\"Lu Xue, Xiaodan Wang, Zhihe Hu, Zijian Wu, Lijuan Wang, Hui Wang, Ming Yang \"\"Identification and characterization of an angiotensin-converting enzyme inhibitory peptide derived from bovine casein\"\" Peptides, 2017\"", " Binding_Energy_kcal_per_mol": "-7.5", "Serial_ID": "1552", " Ligand_ID": "YQKFPQYLQY_minimized.pdb_1552", " Smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1377.54", " logP": "-2.08", " logD": "-8.33", " logSw": "-4.59", " tPSA": "538.48", " RotatableB": "39", " RigidB": "54", " Flexibility": "0.42", " HBD": "22", " HBA": "31", " HBD_HBA": "53", " Rings": "5", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "99", " CarbonAtoms": "68", " HeteroAtoms": "31", " ratio_H_by_C": "0.46", " Lipinski_Violation": "3", " Solubility_mg_per_l": "13995.18", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.46", " StereoCenters": "10", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1377.54", "link_html_complex": "/ACE_complex_html/ACE_YQKFPQYLQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQKFPQYLQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQKFPQYLQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQKFPQYLQY.png", "phi_psi": "/peptide_da/YQKFPQYLQY.pdb", "link_html_peptide": "/Peptide_html/YQKFPQYLQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQKFPQYLQY.pdb", "link_png_peptide": "/Peptide_pics/YQKFPQYLQY.png"}
{"Peptide_Sequence": "YQNPRLGPTGELDPATQPIVAVHNPVIV", " Origin": "P-CN", " Peptide_Preparation": "", " Isolation_Method": "UF, HPLC", " ACE_inhibition_assay": "HPLC method by Mao et al., 2007", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "14.53 \u03bcM", " Reference": "Chen, Y., et al. \"Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk.\" Journal of dairy science 93.3 (2010): 884-892.", " Binding_Energy_kcal_per_mol": "121.9", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 2996.38", "link_html_complex": "/ACE_complex_html/ACE_YQNPRLGPTGELDPATQPIVAVHNPVIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQNPRLGPTGELDPATQPIVAVHNPVIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQNPRLGPTGELDPATQPIVAVHNPVIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQNPRLGPTGELDPATQPIVAVHNPVIV.png", "phi_psi": "/peptide_da/YQNPRLGPTGELDPATQPIVAVHNPVIV.pdb", "link_html_peptide": "/Peptide_html/YQNPRLGPTGELDPATQPIVAVHNPVIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQNPRLGPTGELDPATQPIVAVHNPVIV.pdb", "link_png_peptide": "/Peptide_pics/YQNPRLGPTGELDPATQPIVAVHNPVIV.png"}
{"Peptide_Sequence": "YQQPVL", " Origin": "Bovine milk protein", " Peptide_Preparation": "hydrolysis", " Isolation_Method": "Chromatography", " ACE_inhibition_assay": "Cushman and Cheung (1971), modified by Nakamuraetal. (1995a", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "280 \u03bcM", " Reference": "Pihlanto-Leppa\u00a8la\u00a8 A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J 1998;8:325\u201331.", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1558", " Ligand_ID": "YQQPVL_minimized.pdb_1558", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O", " MW": "746.85", " logP": "-4.28", " logD": "-5.65", " logSw": "-0.5", " tPSA": "310.89", " RotatableB": "20", " RigidB": "26", " Flexibility": "0.43", " HBD": "12", " HBA": "18", " HBD_HBA": "30", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "53", " CarbonAtoms": "35", " HeteroAtoms": "18", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "454998.83", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.6", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 746.851", "link_html_complex": "/ACE_complex_html/ACE_YQQPVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQQPVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQQPVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQQPVL.png", "phi_psi": "/peptide_da/YQQPVL.pdb", "link_html_peptide": "/Peptide_html/YQQPVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQQPVL.pdb", "link_png_peptide": "/Peptide_pics/YQQPVL.png"}
{"Peptide_Sequence": "YQQPVLGPVR", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "300 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-8.7", "Serial_ID": "1557", " Ligand_ID": "YQQPVLGPVR_minimized.pdb_1557", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1156.33", " logP": "-3.73", " logD": "-7.63", " logSw": "-2.51", " tPSA": "482.14", " RotatableB": "33", " RigidB": "40", " Flexibility": "0.45", " HBD": "19", " HBA": "29", " HBD_HBA": "48", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "82", " CarbonAtoms": "53", " HeteroAtoms": "29", " ratio_H_by_C": "0.55", " Lipinski_Violation": "3", " Solubility_mg_per_l": "94165.3", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.64", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1156.33", "link_html_complex": "/ACE_complex_html/ACE_YQQPVLGPVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQQPVLGPVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQQPVLGPVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQQPVLGPVR.png", "phi_psi": "/peptide_da/YQQPVLGPVR.pdb", "link_html_peptide": "/Peptide_html/YQQPVLGPVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQQPVLGPVR.pdb", "link_png_peptide": "/Peptide_pics/YQQPVLGPVR.png"}
{"Peptide_Sequence": "YQQPVLGPVRGPFPIIV", " Origin": "casein", " Peptide_Preparation": "Lactobacillus helveticus CP790 trypsin", " Isolation_Method": "", " ACE_inhibition_assay": "Cheung and Chushman (1971) with modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "101 \u03bcM", " Reference": "Yamamoto, Naoyuki, Atsuko Akino, and Toshiaki Takano. \"Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.\" Journal of dairy science 77.4 (1994): 917-922.", " Binding_Energy_kcal_per_mol": "0.2", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1880.24", "link_html_complex": "/ACE_complex_html/ACE_YQQPVLGPVRGPFPIIV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQQPVLGPVRGPFPIIV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQQPVLGPVRGPFPIIV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQQPVLGPVRGPFPIIV.png", "phi_psi": "/peptide_da/YQQPVLGPVRGPFPIIV.pdb", "link_html_peptide": "/Peptide_html/YQQPVLGPVRGPFPIIV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQQPVLGPVRGPFPIIV.pdb", "link_png_peptide": "/Peptide_pics/YQQPVLGPVRGPFPIIV.png"}
{"Peptide_Sequence": "YQY", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "SEC, RPC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "4 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1559", " Ligand_ID": "YQY_minimized.pdb_1559", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "472.49", " logP": "-3.86", " logD": "-3.83", " logSw": "0.31", " tPSA": "209.52", " RotatableB": "12", " RigidB": "19", " Flexibility": "0.39", " HBD": "9", " HBA": "11", " HBD_HBA": "20", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "34", " CarbonAtoms": "23", " HeteroAtoms": "11", " ratio_H_by_C": "0.48", " Lipinski_Violation": "2", " Solubility_mg_per_l": "644934.4", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.3", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 472.491", "link_html_complex": "/ACE_complex_html/ACE_YQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YQY.png", "phi_psi": "/peptide_da/YQY.pdb", "link_html_peptide": "/Peptide_html/YQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YQY.pdb", "link_png_peptide": "/Peptide_pics/YQY.png"}
{"Peptide_Sequence": "YR", " Origin": "Egg whites", " Peptide_Preparation": "synthesized", " Isolation_Method": "", " ACE_inhibition_assay": " Cushman and Cheung (1971) modified", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "191 \u03bcM", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-7.9", "Serial_ID": "1562", " Ligand_ID": "YR_minimized.pdb_1562", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "337.37", " logP": "-3.89", " logD": "-4.21", " logSw": "1.08", " tPSA": "180.74", " RotatableB": "10", " RigidB": "10", " Flexibility": "0.5", " HBD": "9", " HBA": "9", " HBD_HBA": "18", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "24", " CarbonAtoms": "15", " HeteroAtoms": "9", " ratio_H_by_C": "0.6", " Lipinski_Violation": "1", " Solubility_mg_per_l": "997951.33", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.4", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 337.374", "link_html_complex": "/ACE_complex_html/ACE_YR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YR.png", "phi_psi": "/peptide_da/YR.pdb", "link_html_peptide": "/Peptide_html/YR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YR.pdb", "link_png_peptide": "/Peptide_pics/YR.png"}
{"Peptide_Sequence": "YRGGLEPI", " Origin": "Egg White", " Peptide_Preparation": "synthetic", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": ">1000 \u00b5mol/L", " Reference": "Miguel, Marta, et al. \"Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.\" Journal of agricultural and food chemistry 55.26 (2007): 10615-10621.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1560", " Ligand_ID": "YRGGLEPI_minimized.pdb_1560", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "904.02", " logP": "-3.08", " logD": "-12.13", " logSw": "-1.69", " tPSA": "386.68", " RotatableB": "28", " RigidB": "28", " Flexibility": "0.5", " HBD": "15", " HBA": "23", " HBD_HBA": "38", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "64", " CarbonAtoms": "41", " HeteroAtoms": "23", " ratio_H_by_C": "0.56", " Lipinski_Violation": "3", " Solubility_mg_per_l": "166651.08", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.61", " StereoCenters": "7", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 904.021", "link_html_complex": "/ACE_complex_html/ACE_YRGGLEPI.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YRGGLEPI.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YRGGLEPI.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YRGGLEPI.png", "phi_psi": "/peptide_da/YRGGLEPI.pdb", "link_html_peptide": "/Peptide_html/YRGGLEPI.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YRGGLEPI.pdb", "link_png_peptide": "/Peptide_pics/YRGGLEPI.png"}
{"Peptide_Sequence": "YRGGLEPINF", " Origin": "egg, ovalbumin", " Peptide_Preparation": "pepsin", " Isolation_Method": "RP-HPLC at a semipreparative scale ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": ">1000", " Reference": "Angiotensin I\u2013Converting Enzyme Inhibitory Activity of Peptides Derived from Egg White Proteins by Enzymatic Hydrolysis  ,                                                       Egg-derived bioactive peptides with ACE-inhibitory\nproperties: a literature update", " Binding_Energy_kcal_per_mol": "-8.6", "Serial_ID": "1561", " Ligand_ID": "YRGGLEPINF_minimized.pdb_1561", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "1165.3", " logP": "-3.16", " logD": "-13.06", " logSw": "-2.75", " tPSA": "487.97", " RotatableB": "36", " RigidB": "40", " Flexibility": "0.47", " HBD": "19", " HBA": "29", " HBD_HBA": "48", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "0", " HeavyAtoms": "83", " CarbonAtoms": "54", " HeteroAtoms": "29", " ratio_H_by_C": "0.54", " Lipinski_Violation": "3", " Solubility_mg_per_l": "74307.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.54", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1165.3", "link_html_complex": "/ACE_complex_html/ACE_YRGGLEPINF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YRGGLEPINF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YRGGLEPINF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YRGGLEPINF.png", "phi_psi": "/peptide_da/YRGGLEPINF.pdb", "link_html_peptide": "/Peptide_html/YRGGLEPINF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YRGGLEPINF.pdb", "link_png_peptide": "/Peptide_pics/YRGGLEPINF.png"}
{"Peptide_Sequence": "YRNTQ", " Origin": "Meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1563", " Ligand_ID": "YRNTQ_minimized.pdb_1563", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "680.71", " logP": "-6.9", " logD": "-11.84", " logSw": "1.62", " tPSA": "374.45", " RotatableB": "21", " RigidB": "20", " Flexibility": "0.51", " HBD": "17", " HBA": "20", " HBD_HBA": "37", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "48", " CarbonAtoms": "28", " HeteroAtoms": "20", " ratio_H_by_C": "0.71", " Lipinski_Violation": "3", " Solubility_mg_per_l": "3454640.54", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 680.71", "link_html_complex": "/ACE_complex_html/ACE_YRNTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YRNTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YRNTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YRNTQ.png", "phi_psi": "/peptide_da/YRNTQ.pdb", "link_html_peptide": "/Peptide_html/YRNTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YRNTQ.pdb", "link_png_peptide": "/Peptide_pics/YRNTQ.png"}
{"Peptide_Sequence": "YRPY", " Origin": "Bonito", " Peptide_Preparation": "synthetic peptide", " Isolation_Method": "reverse phase HPLC", " ACE_inhibition_assay": "Cushman and cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "320", " Reference": "Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. Angiotensin I\u2013converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 1993;57:695\u20137.", " Binding_Energy_kcal_per_mol": "-8.5", "Serial_ID": "1564", " Ligand_ID": "YRPY_minimized.pdb_1564", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "597.66", " logP": "-3.32", " logD": "-6.45", " logSw": "-0.57", " tPSA": "250.38", " RotatableB": "15", " RigidB": "25", " Flexibility": "0.38", " HBD": "11", " HBA": "14", " HBD_HBA": "25", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "43", " CarbonAtoms": "29", " HeteroAtoms": "14", " ratio_H_by_C": "0.48", " Lipinski_Violation": "3", " Solubility_mg_per_l": "337250.27", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 597.663", "link_html_complex": "/ACE_complex_html/ACE_YRPY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YRPY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YRPY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YRPY.png", "phi_psi": "/peptide_da/YRPY.pdb", "link_html_peptide": "/Peptide_html/YRPY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YRPY.pdb", "link_png_peptide": "/Peptide_pics/YRPY.png"}
{"Peptide_Sequence": "YRSTQ", " Origin": "Meat", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "< 10 \u03bcM", " Reference": "Gu, Yuchen, Kaustav Majumder, and Jianping Wu. \"QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides.\" Food Research International 44.8 (2011): 2465-2474.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1565", " Ligand_ID": "YRSTQ_minimized.pdb_1565", " Smiles": "C[C@@H](O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "653.68", " logP": "-6.43", " logD": "-11.46", " logSw": "1.49", " tPSA": "351.59", " RotatableB": "21", " RigidB": "18", " Flexibility": "0.54", " HBD": "16", " HBA": "19", " HBD_HBA": "35", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "46", " CarbonAtoms": "27", " HeteroAtoms": "19", " ratio_H_by_C": "0.7", " Lipinski_Violation": "3", " Solubility_mg_per_l": "2912574.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 653.685", "link_html_complex": "/ACE_complex_html/ACE_YRSTQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YRSTQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YRSTQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YRSTQ.png", "phi_psi": "/peptide_da/YRSTQ.pdb", "link_html_peptide": "/Peptide_html/YRSTQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YRSTQ.pdb", "link_png_peptide": "/Peptide_pics/YRSTQ.png"}
{"Peptide_Sequence": "YS", " Origin": "Synthesized", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "412 \u00b5M", " Reference": "Norris, Roseanne, et al. \"Predictive modelling of angiotensin converting enzyme inhibitory dipeptides.\" Food Chemistry 133.4 (2012): 1349-1354.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1566", " Ligand_ID": "YS_minimized.pdb_1566", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(O)=O", " MW": "268.27", " logP": "-4.12", " logD": "-3.59", " logSw": "1.36", " tPSA": "137.33", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "19", " CarbonAtoms": "12", " HeteroAtoms": "7", " ratio_H_by_C": "0.58", " Lipinski_Violation": "1", " Solubility_mg_per_l": "1046778.97", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.33", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 268.266", "link_html_complex": "/ACE_complex_html/ACE_YS.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YS.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YS.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YS.png", "phi_psi": "/peptide_da/YS.pdb", "link_html_peptide": "/Peptide_html/YS.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YS.pdb", "link_png_peptide": "/Peptide_pics/YS.png"}
{"Peptide_Sequence": "YSQQQQ", " Origin": "maize protein \u03b1-Zein", " Peptide_Preparation": "Thermolysin", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "Yamamoto et al.1980", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "860 \u03bcM", " Reference": "Yano, Seiko, Kazumasa Suzuki, and Gunki Funatsu. \"Isolation from \u03b1-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity.\" Bioscience, biotechnology, and biochemistry 60.4 (1996): 661-663.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1567", " Ligand_ID": "YSQQQQ_minimized.pdb_1567", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "780.78", " logP": "-8.73", " logD": "-11.51", " logSw": "2.29", " tPSA": "426.09", " RotatableB": "23", " RigidB": "25", " Flexibility": "0.48", " HBD": "18", " HBA": "23", " HBD_HBA": "41", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "55", " CarbonAtoms": "32", " HeteroAtoms": "23", " ratio_H_by_C": "0.72", " Lipinski_Violation": "3", " Solubility_mg_per_l": "7740621.37", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 780.783", "link_html_complex": "/ACE_complex_html/ACE_YSQQQQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YSQQQQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YSQQQQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YSQQQQ.png", "phi_psi": "/peptide_da/YSQQQQ.pdb", "link_html_peptide": "/Peptide_html/YSQQQQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YSQQQQ.pdb", "link_png_peptide": "/Peptide_pics/YSQQQQ.png"}
{"Peptide_Sequence": "YTAGV", " Origin": "egg", " Peptide_Preparation": "pepsin-pancreatin digest", " Isolation_Method": " ultrafiltration", " ACE_inhibition_assay": "Cushman and Cheung", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "27.38", " Reference": "Majumder, K., & Wu, J. (2009). Angiotensin I Converting Enzyme Inhibitory Peptides from Simulatedin VitroGastrointestinal Digestion of Cooked Eggs. Journal of Agricultural and Food Chemistry, 57(2), 471\u2013477. doi:10.1021/jf8028557", " Binding_Energy_kcal_per_mol": "-9.1", "Serial_ID": "1568", " Ligand_ID": "YTAGV_minimized.pdb_1568", " Smiles": "CC(C)[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(O)=O", " MW": "509.55", " logP": "-2.86", " logD": "-5.52", " logSw": "-0.4", " tPSA": "224.63", " RotatableB": "13", " RigidB": "15", " Flexibility": "0.46", " HBD": "9", " HBA": "13", " HBD_HBA": "22", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "36", " CarbonAtoms": "23", " HeteroAtoms": "13", " ratio_H_by_C": "0.57", " Lipinski_Violation": "3", " Solubility_mg_per_l": "340893.92", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.52", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 509.553", "link_html_complex": "/ACE_complex_html/ACE_YTAGV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YTAGV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YTAGV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YTAGV.png", "phi_psi": "/peptide_da/YTAGV.pdb", "link_html_peptide": "/Peptide_html/YTAGV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YTAGV.pdb", "link_png_peptide": "/Peptide_pics/YTAGV.png"}
{"Peptide_Sequence": "YTHFLTQHYDAFPQGR", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": "St. Clair (1987)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "No activity", " Reference": "Rybak, Susanna M., et al. \"C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.\" Biochemical and biophysical research communications 162.1 (1989): 535-543.", " Binding_Energy_kcal_per_mol": "-0.1", "Serial_ID": "#", " Ligand_ID": "#", " Smiles": "#", " MW": "#", " logP": "#", " logD": "#", " logSw": "#", " tPSA": "#", " RotatableB": "#", " RigidB": "#", " Flexibility": "#", " HBD": "#", " HBA": "#", " HBD_HBA": "#", " Rings": "#", " MaxSizeRing": "#", " NumCharges": "#", " TotalCharge": "#", " HeavyAtoms": "#", " CarbonAtoms": "#", " HeteroAtoms": "#", " ratio_H_by_C": "#", " Lipinski_Violation": "#", " Solubility_mg_per_l": "#", " SolubilityForecastIndex": "#", " Oral_Bioavailability_VEBER": "#", " Oral_Bioavailability_EGAN": "#", " TrafficLights": "#", " 4_400": "#", " 3_75": "#", " Phospholipidosis": "#", " Fsp3": "#", " StereoCenters": "#", " PPI_Friendly": "#", " Result": "#", " Alert": "#", "mol_wt": " 1981.13", "link_html_complex": "/ACE_complex_html/ACE_YTHFLTQHYDAFPQGR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YTHFLTQHYDAFPQGR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YTHFLTQHYDAFPQGR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YTHFLTQHYDAFPQGR.png", "phi_psi": "/peptide_da/YTHFLTQHYDAFPQGR.pdb", "link_html_peptide": "/Peptide_html/YTHFLTQHYDAFPQGR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YTHFLTQHYDAFPQGR.pdb", "link_png_peptide": "/Peptide_pics/YTHFLTQHYDAFPQGR.png"}
{"Peptide_Sequence": "YTVF", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "crude hydrolysate, RP-HPLC", " ACE_inhibition_assay": "Matsui et al., 1992", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "0.226 mg/ml", " Reference": "Ren, Yan, et al. \"Isolation and characterization of angiotensin I-converting enzyme inhibitor peptides derived from porcine hemoglobin.\" Scientific Research and Essays 6.30 (2011): 6262-6269.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1570", " Ligand_ID": "YTVF_minimized.pdb_1570", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "528.6", " logP": "-2.24", " logD": "-2.79", " logSw": "-0.97", " tPSA": "195.53", " RotatableB": "13", " RigidB": "19", " Flexibility": "0.41", " HBD": "8", " HBA": "11", " HBD_HBA": "19", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "38", " CarbonAtoms": "27", " HeteroAtoms": "11", " ratio_H_by_C": "0.41", " Lipinski_Violation": "3", " Solubility_mg_per_l": "200762.67", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.41", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 528.597", "link_html_complex": "/ACE_complex_html/ACE_YTVF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YTVF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YTVF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YTVF.png", "phi_psi": "/peptide_da/YTVF.pdb", "link_html_peptide": "/Peptide_html/YTVF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YTVF.pdb", "link_png_peptide": "/Peptide_pics/YTVF.png"}
{"Peptide_Sequence": "YV", " Origin": "Cereals (Buckwheat)", " Peptide_Preparation": "", " Isolation_Method": "GPC, HPLC", " ACE_inhibition_assay": "Modified Lieberman\u2019s method", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "628 \u03bcM", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-7.2", "Serial_ID": "1573", " Ligand_ID": "YV_minimized.pdb_1573", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "280.32", " logP": "-2.04", " logD": "-1.65", " logSw": "-0.01", " tPSA": "117.1", " RotatableB": "6", " RigidB": "9", " Flexibility": "0.4", " HBD": "5", " HBA": "6", " HBD_HBA": "11", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "20", " CarbonAtoms": "14", " HeteroAtoms": "6", " ratio_H_by_C": "0.43", " Lipinski_Violation": "0", " Solubility_mg_per_l": "278146.75", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "0", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.43", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 280.32", "link_html_complex": "/ACE_complex_html/ACE_YV.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YV.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YV.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YV.png", "phi_psi": "/peptide_da/YV.pdb", "link_html_peptide": "/Peptide_html/YV.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YV.pdb", "link_png_peptide": "/Peptide_pics/YV.png"}
{"Peptide_Sequence": "YVA", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "<20 mM", " Reference": "Wu, Jianping, Rotimi E. Aluko, and Shuryo Nakai. \"Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure\u2212 activity relationship study of di-and tripeptides.\" Journal of agricultural and food chemistry 54.3 (2006): 732-738.", " Binding_Energy_kcal_per_mol": "-8", "Serial_ID": "1571", " Ligand_ID": "YVA_minimized.pdb_1571", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(O)=O", " MW": "351.4", " logP": "-2.55", " logD": "-3.06", " logSw": "0.03", " tPSA": "146.2", " RotatableB": "8", " RigidB": "11", " Flexibility": "0.42", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "17", " HeteroAtoms": "8", " ratio_H_by_C": "0.47", " Lipinski_Violation": "1", " Solubility_mg_per_l": "361027.29", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 351.398", "link_html_complex": "/ACE_complex_html/ACE_YVA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YVA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YVA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YVA.png", "phi_psi": "/peptide_da/YVA.pdb", "link_html_peptide": "/Peptide_html/YVA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YVA.pdb", "link_png_peptide": "/Peptide_pics/YVA.png"}
{"Peptide_Sequence": "YVL", " Origin": "Casein", " Peptide_Preparation": "porcine pepsin A", " Isolation_Method": "RP-HPLC ", " ACE_inhibition_assay": "Cushman and Cheung (4) with the some modifications", " In-vivo_or_in-vitro": "In-vitro", " IC50_micromol_per_L": "> 1000 \u03bcM", " Reference": "L\u00f3pez-Exp\u00f3sito, Iv\u00e1n, et al. \"Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides.\" Le Lait 87.4-5 (2007): 241-249.", " Binding_Energy_kcal_per_mol": "-8.9", "Serial_ID": "1572", " Ligand_ID": "YVL_minimized.pdb_1572", " Smiles": "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O", " MW": "393.48", " logP": "-1.45", " logD": "-1.76", " logSw": "-0.78", " tPSA": "146.2", " RotatableB": "10", " RigidB": "11", " Flexibility": "0.48", " HBD": "6", " HBA": "8", " HBD_HBA": "14", " Rings": "1", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "28", " CarbonAtoms": "20", " HeteroAtoms": "8", " ratio_H_by_C": "0.4", " Lipinski_Violation": "1", " Solubility_mg_per_l": "180135.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "3", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 393.477", "link_html_complex": "/ACE_complex_html/ACE_YVL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YVL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YVL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YVL.png", "phi_psi": "/peptide_da/YVL.pdb", "link_html_peptide": "/Peptide_html/YVL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YVL.pdb", "link_png_peptide": "/Peptide_pics/YVL.png"}
{"Peptide_Sequence": "YVP", " Origin": "Milk (human casein)", " Peptide_Preparation": "Synthesized", " Isolation_Method": "", " ACE_inhibition_assay": "Kasahara and Ashihara (1981)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "200", " Reference": "Kohmura, Masanori, Noriki Nio, and Yasuo Ariyoshi. \"Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human \u03ba-casein.\" Agricultural and biological chemistry 54.3 (1990): 835-836.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1574", " Ligand_ID": "YVP_minimized.pdb_1574", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "377.43", " logP": "-1.32", " logD": "-2.8", " logSw": "-0.97", " tPSA": "137.41", " RotatableB": "7", " RigidB": "16", " Flexibility": "0.3", " HBD": "5", " HBA": "8", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "19", " HeteroAtoms": "8", " ratio_H_by_C": "0.42", " Lipinski_Violation": "0", " Solubility_mg_per_l": "143262.69", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.53", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 377.435", "link_html_complex": "/ACE_complex_html/ACE_YVP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YVP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YVP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YVP.png", "phi_psi": "/peptide_da/YVP.pdb", "link_html_peptide": "/Peptide_html/YVP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YVP.pdb", "link_png_peptide": "/Peptide_pics/YVP.png"}
{"Peptide_Sequence": "YVVFK", " Origin": "soyabean", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": " Kohmura and others (1989) modified.", " In-vivo_or_in-vitro": "in-vivo", " IC50_micromol_per_L": "44 \u03bcM", " Reference": "Kodera, Tomohiro, and Noriki Nio. \"Identification of an angiotensin I\u2010converting enzyme inhibitory peptides from protein hydrolysates by a soybean protease and the antihypertensive effects of hydrolysates in 4 spontaneously hypertensive model rats.\" Journal of food science 71.3 (2006): C164-C173.", " Binding_Energy_kcal_per_mol": "-9.4", "Serial_ID": "1575", " Ligand_ID": "YVVFK_minimized.pdb_1575", " Smiles": "CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O", " MW": "654.8", " logP": "-1.15", " logD": "-1.61", " logSw": "-2.01", " tPSA": "232.04", " RotatableB": "19", " RigidB": "21", " Flexibility": "0.47", " HBD": "10", " HBA": "13", " HBD_HBA": "23", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "47", " CarbonAtoms": "34", " HeteroAtoms": "13", " ratio_H_by_C": "0.38", " Lipinski_Violation": "3", " Solubility_mg_per_l": "87491.22", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.5", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 654.797", "link_html_complex": "/ACE_complex_html/ACE_YVVFK.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YVVFK.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YVVFK.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YVVFK.png", "phi_psi": "/peptide_da/YVVFK.pdb", "link_html_peptide": "/Peptide_html/YVVFK.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YVVFK.pdb", "link_png_peptide": "/Peptide_pics/YVVFK.png"}
{"Peptide_Sequence": "YW", " Origin": "Milk", " Peptide_Preparation": "Chemsketch", " Isolation_Method": "", " ACE_inhibition_assay": " 3D-QSAR models", " In-vivo_or_in-vitro": "In-silico", " IC50_micromol_per_L": "4.15 \u03bcmol/L", " Reference": "2017, Vladimir R.Vukic, Dajana V. Vukic, Spasenija D.Milanovic, Mirela D.Ilicic, Katarina G.Kanuric, Mark S.Johnson \"In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I\u2013converting enzyme inhibitory activity\" Nutrition Research, Volume 46, October 2017, Pages 22-30", " Binding_Energy_kcal_per_mol": "-9.3", "Serial_ID": "1576", " Ligand_ID": "YW_minimized.pdb_1576", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O", " MW": "367.4", " logP": "-1.13", " logD": "-0.79", " logSw": "-1.18", " tPSA": "132.89", " RotatableB": "7", " RigidB": "19", " Flexibility": "0.27", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "9", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "27", " CarbonAtoms": "20", " HeteroAtoms": "7", " ratio_H_by_C": "0.35", " Lipinski_Violation": "1", " Solubility_mg_per_l": "113434.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.2", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 367.398", "link_html_complex": "/ACE_complex_html/ACE_YW.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YW.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YW.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YW.png", "phi_psi": "/peptide_da/YW.pdb", "link_html_peptide": "/Peptide_html/YW.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YW.pdb", "link_png_peptide": "/Peptide_pics/YW.png"}
{"Peptide_Sequence": "YY", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "680 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-8.8", "Serial_ID": "1584", " Ligand_ID": "YY_minimized.pdb_1584", " Smiles": "N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "344.36", " logP": "-1.87", " logD": "-1.2", " logSw": "-0.53", " tPSA": "137.33", " RotatableB": "7", " RigidB": "15", " Flexibility": "0.32", " HBD": "6", " HBA": "7", " HBD_HBA": "13", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "25", " CarbonAtoms": "18", " HeteroAtoms": "7", " ratio_H_by_C": "0.39", " Lipinski_Violation": "1", " Solubility_mg_per_l": "202232.16", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "1", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.22", " StereoCenters": "2", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 344.362", "link_html_complex": "/ACE_complex_html/ACE_YY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YY.png", "phi_psi": "/peptide_da/YY.pdb", "link_html_peptide": "/Peptide_html/YY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YY.pdb", "link_png_peptide": "/Peptide_pics/YY.png"}
{"Peptide_Sequence": "YYA", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2800 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-9.2", "Serial_ID": "1578", " Ligand_ID": "YYA_minimized.pdb_1578", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "415.44", " logP": "-2.7", " logD": "-2.65", " logSw": "-0.28", " tPSA": "166.43", " RotatableB": "9", " RigidB": "17", " Flexibility": "0.35", " HBD": "7", " HBA": "9", " HBD_HBA": "16", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "30", " CarbonAtoms": "21", " HeteroAtoms": "9", " ratio_H_by_C": "0.43", " Lipinski_Violation": "1", " Solubility_mg_per_l": "313298.62", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Good", " Oral_Bioavailability_EGAN": "Good", " TrafficLights": "4", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.29", " StereoCenters": "3", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 415.44", "link_html_complex": "/ACE_complex_html/ACE_YYA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYA.png", "phi_psi": "/peptide_da/YYA.pdb", "link_html_peptide": "/Peptide_html/YYA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYA.pdb", "link_png_peptide": "/Peptide_pics/YYA.png"}
{"Peptide_Sequence": "YYAKPAAVR", " Origin": "", " Peptide_Preparation": "synthetic", " Isolation_Method": "", " ACE_inhibition_assay": " Shalaby, Zakora, and Otte (2006)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "48.88 \u03bcM", " Reference": "Phelan, Martha, et al. \"Angiotensin converting enzyme and nitric oxide inhibitory activities of novel milk derived peptides.\" International Dairy Journal 35.1 (2014): 38-42.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1577", " Ligand_ID": "YYAKPAAVR_minimized.pdb_1577", " Smiles": "CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O", " MW": "1038.2", " logP": "-2.35", " logD": "-8", " logSw": "-2.88", " tPSA": "423.52", " RotatableB": "30", " RigidB": "35", " Flexibility": "0.46", " HBD": "18", " HBA": "25", " HBD_HBA": "43", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "4", " TotalCharge": "2", " HeavyAtoms": "74", " CarbonAtoms": "49", " HeteroAtoms": "25", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "58516.45", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.55", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1038.2", "link_html_complex": "/ACE_complex_html/ACE_YYAKPAAVR.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAKPAAVR.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAKPAAVR.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAKPAAVR.png", "phi_psi": "/peptide_da/YYAKPAAVR.pdb", "link_html_peptide": "/Peptide_html/YYAKPAAVR.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAKPAAVR.pdb", "link_png_peptide": "/Peptide_pics/YYAKPAAVR.png"}
{"Peptide_Sequence": "YYAP", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "2330 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-10.7", "Serial_ID": "1583", " Ligand_ID": "YYAP_minimized.pdb_1583", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "512.55", " logP": "-1.3", " logD": "-3.09", " logSw": "-1.67", " tPSA": "186.74", " RotatableB": "10", " RigidB": "24", " Flexibility": "0.29", " HBD": "7", " HBA": "11", " HBD_HBA": "18", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "37", " CarbonAtoms": "26", " HeteroAtoms": "11", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "96725", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "5", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 512.555", "link_html_complex": "/ACE_complex_html/ACE_YYAP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAP.png", "phi_psi": "/peptide_da/YYAP.pdb", "link_html_peptide": "/Peptide_html/YYAP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAP.pdb", "link_png_peptide": "/Peptide_pics/YYAP.png"}
{"Peptide_Sequence": "YYAPF", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "4350 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-11", "Serial_ID": "1581", " Ligand_ID": "YYAPF_minimized.pdb_1581", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O", " MW": "659.73", " logP": "-0.11", " logD": "-1.92", " logSw": "-3.09", " tPSA": "215.84", " RotatableB": "14", " RigidB": "32", " Flexibility": "0.3", " HBD": "8", " HBA": "13", " HBD_HBA": "21", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "48", " CarbonAtoms": "35", " HeteroAtoms": "13", " ratio_H_by_C": "0.37", " Lipinski_Violation": "3", " Solubility_mg_per_l": "30118.74", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.34", " StereoCenters": "5", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 659.729", "link_html_complex": "/ACE_complex_html/ACE_YYAPF.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAPF.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAPF.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAPF.png", "phi_psi": "/peptide_da/YYAPF.pdb", "link_html_peptide": "/Peptide_html/YYAPF.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAPF.pdb", "link_png_peptide": "/Peptide_pics/YYAPF.png"}
{"Peptide_Sequence": "YYAPFDGIL", " Origin": "wine", " Peptide_Preparation": "", " Isolation_Method": "RP-HPLC", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "83 \u03bcM", " Reference": "Garc\u00eda, M. C., et al. \"Vegetable foods: A cheap source of proteins and peptides with antihypertensive, antioxidant, and other less occurrence bioactivities.\" Talanta 106 (2013): 328-349.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1579", " Ligand_ID": "YYAPFDGIL_minimized.pdb_1579", " Smiles": "CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O", " MW": "1058.18", " logP": "0.36", " logD": "-5.94", " logSw": "-4.87", " tPSA": "372.37", " RotatableB": "28", " RigidB": "41", " Flexibility": "0.41", " HBD": "13", " HBA": "23", " HBD_HBA": "36", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "76", " CarbonAtoms": "53", " HeteroAtoms": "23", " ratio_H_by_C": "0.43", " Lipinski_Violation": "3", " Solubility_mg_per_l": "8118.64", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1058.18", "link_html_complex": "/ACE_complex_html/ACE_YYAPFDGIL.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAPFDGIL.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAPFDGIL.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAPFDGIL.png", "phi_psi": "/peptide_da/YYAPFDGIL.pdb", "link_html_peptide": "/Peptide_html/YYAPFDGIL.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAPFDGIL.pdb", "link_png_peptide": "/Peptide_pics/YYAPFDGIL.png"}
{"Peptide_Sequence": "YYAPFE", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "3770 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-10.5", "Serial_ID": "1580", " Ligand_ID": "YYAPFE_minimized.pdb_1580", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", " MW": "788.84", " logP": "-0.41", " logD": "-6.23", " logSw": "-3.35", " tPSA": "285.07", " RotatableB": "19", " RigidB": "35", " Flexibility": "0.35", " HBD": "10", " HBA": "17", " HBD_HBA": "27", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "-1", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "27804.14", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 788.843", "link_html_complex": "/ACE_complex_html/ACE_YYAPFE.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAPFE.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAPFE.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAPFE.png", "phi_psi": "/peptide_da/YYAPFE.pdb", "link_html_peptide": "/Peptide_html/YYAPFE.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAPFE.pdb", "link_png_peptide": "/Peptide_pics/YYAPFE.png"}
{"Peptide_Sequence": "YYAPFQ", " Origin": "jellyfish (Stomolophus nomurai)", " Peptide_Preparation": "pepsin", " Isolation_Method": "HPLC", " ACE_inhibition_assay": "cushman and cheung modified", " In-vivo_or_in-vitro": "in-vitro, in-vivo", " IC50_micromol_per_L": "460 \u03bcM", " Reference": "Morinaga, Yae, et al. \"Chemical nature of a new antihypertensive peptide derived from jellyfish.\" Food science and technology research 16.4 (2010): 333-340.", " Binding_Energy_kcal_per_mol": "-9.5", "Serial_ID": "1582", " Ligand_ID": "YYAPFQ_minimized.pdb_1582", " Smiles": "C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O", " MW": "787.86", " logP": "-1.06", " logD": "-3.7", " logSw": "-2.93", " tPSA": "288.03", " RotatableB": "19", " RigidB": "36", " Flexibility": "0.35", " HBD": "11", " HBA": "17", " HBD_HBA": "28", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "57", " CarbonAtoms": "40", " HeteroAtoms": "17", " ratio_H_by_C": "0.42", " Lipinski_Violation": "3", " Solubility_mg_per_l": "42129.07", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.38", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 787.858", "link_html_complex": "/ACE_complex_html/ACE_YYAPFQ.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYAPFQ.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYAPFQ.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYAPFQ.png", "phi_psi": "/peptide_da/YYAPFQ.pdb", "link_html_peptide": "/Peptide_html/YYAPFQ.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYAPFQ.pdb", "link_png_peptide": "/Peptide_pics/YYAPFQ.png"}
{"Peptide_Sequence": "YYPQIMQY", " Origin": "", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "QSAR", " In-vivo_or_in-vitro": "in-silico", " IC50_micromol_per_L": "24.55 \u03bcM", " Reference": "Sagardia, Iban, Rub\u00e9n H. Roa-Ureta, and Carlos Bald. \"A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.\" Food chemistry 136.3-4 (2013): 1370-1376.", " Binding_Energy_kcal_per_mol": "-10", "Serial_ID": "1585", " Ligand_ID": "YYPQIMQY_minimized.pdb_1585", " Smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O", " MW": "1105.26", " logP": "-1.13", " logD": "-4.27", " logSw": "-4.09", " tPSA": "434.85", " RotatableB": "30", " RigidB": "42", " Flexibility": "0.42", " HBD": "16", " HBA": "24", " HBD_HBA": "40", " Rings": "4", " MaxSizeRing": "6", " NumCharges": "2", " TotalCharge": "0", " HeavyAtoms": "78", " CarbonAtoms": "53", " HeteroAtoms": "25", " ratio_H_by_C": "0.47", " Lipinski_Violation": "3", " Solubility_mg_per_l": "18510", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.47", " StereoCenters": "9", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 1105.26", "link_html_complex": "/ACE_complex_html/ACE_YYPQIMQY.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYPQIMQY.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYPQIMQY.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYPQIMQY.png", "phi_psi": "/peptide_da/YYPQIMQY.pdb", "link_html_peptide": "/Peptide_html/YYPQIMQY.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYPQIMQY.pdb", "link_png_peptide": "/Peptide_pics/YYPQIMQY.png"}
{"Peptide_Sequence": "YYQQKP", " Origin": "caseins", " Peptide_Preparation": "Proteolytic enzymes", " Isolation_Method": "", " ACE_inhibition_assay": "Sentandreu and Toldra (2006) as modified by Espejo-Carpio et al. (2013)", " In-vivo_or_in-vitro": "in-vitro", " IC50_micromol_per_L": "", " Reference": "De Gobba, Cristian, Gorazd Tompa, and Jeanette Otte. \"Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense.\" Food chemistry 165 (2014): 205-215.", " Binding_Energy_kcal_per_mol": "-9.9", "Serial_ID": "1586", " Ligand_ID": "YYQQKP_minimized.pdb_1586", " Smiles": "NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(O)=O", " MW": "825.91", " logP": "-5.74", " logD": "-7.88", " logSw": "0.1", " tPSA": "358.76", " RotatableB": "23", " RigidB": "32", " Flexibility": "0.42", " HBD": "15", " HBA": "20", " HBD_HBA": "35", " Rings": "3", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "59", " CarbonAtoms": "39", " HeteroAtoms": "20", " ratio_H_by_C": "0.51", " Lipinski_Violation": "3", " Solubility_mg_per_l": "908832.26", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.49", " StereoCenters": "6", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 825.908", "link_html_complex": "/ACE_complex_html/ACE_YYQQKP.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYQQKP.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYQQKP.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYQQKP.png", "phi_psi": "/peptide_da/YYQQKP.pdb", "link_html_peptide": "/Peptide_html/YYQQKP.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYQQKP.pdb", "link_png_peptide": "/Peptide_pics/YYQQKP.png"}
{"Peptide_Sequence": "YYRA", " Origin": "chicken bone", " Peptide_Preparation": "", " Isolation_Method": "", " ACE_inhibition_assay": "", " In-vivo_or_in-vitro": "", " IC50_micromol_per_L": "33.9 \u03bcg/ml", " Reference": "Puchalska, Patrycja, M. Luisa Marina Alegre, and M. Concepcion Garcia Lopez. \"Isolation and characterization of peptides with antihypertensive activity in foodstuffs.\" Critical reviews in food science and nutrition 55.4 (2015): 521-551.", " Binding_Energy_kcal_per_mol": "-9.6", "Serial_ID": "1587", " Ligand_ID": "YYRA_minimized.pdb_1587", " Smiles": "C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O", " MW": "571.63", " logP": "-3.78", " logD": "-5.69", " logSw": "-0.06", " tPSA": "259.17", " RotatableB": "16", " RigidB": "20", " Flexibility": "0.44", " HBD": "12", " HBA": "14", " HBD_HBA": "26", " Rings": "2", " MaxSizeRing": "6", " NumCharges": "3", " TotalCharge": "1", " HeavyAtoms": "41", " CarbonAtoms": "27", " HeteroAtoms": "14", " ratio_H_by_C": "0.52", " Lipinski_Violation": "3", " Solubility_mg_per_l": "538054.76", " SolubilityForecastIndex": "Good Solubility", " Oral_Bioavailability_VEBER": "Low", " Oral_Bioavailability_EGAN": "Low", " TrafficLights": "6", " 4_400": "good", " 3_75": "good", " Phospholipidosis": "NonInducer", " Fsp3": "0.37", " StereoCenters": "4", " PPI_Friendly": "Not Computed", " Result": "Accepted", " Alert": "", "mol_wt": " 571.625", "link_html_complex": "/ACE_complex_html/ACE_YYRA.pdb.html", "interaction_atoms": "/ACE_complex_html/ACE_YYRA.pdbatoms.txt", "link_pdb_complex": "/ACE_peptide_complex/ACE_YYRA.pdb", "link_png_complex": "/ACE_peptide_complex-pics/ACE_YYRA.png", "phi_psi": "/peptide_da/YYRA.pdb", "link_html_peptide": "/Peptide_html/YYRA.pdb.html", "link_pdb_peptide": "/peptide_minimized_structures/YYRA.pdb", "link_png_peptide": "/Peptide_pics/YYRA.png"}
